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Preface
This book covers material that could be included in a one-quarter or one-
semester course in bioinorganic chemistry for graduate students and advanced
undergraduate students in chemistry or biochemistry. We believe that such a
course should provide students with the background required to follow the
research literature in the field. The topics were chosen to represent those areas of
bioinorganic chemistry that are mature enough for textbook presentation.
Although each chapter presents material at a more advanced level than that of
bioinorganic textbooks published previously, the chapters are not specialized
review articles. What we have attempted to do in each chapter is to teach the
underlying principles of bioinorganic chemistry as well as outlining the state of
knowledge in selected areas.
We have chosen not to include abbreviated summaries of the inorganic
chemistry, biochemistry, and spectroscopy that students may need as background
in order to master the material presented. We instead assume that the instructor
using this book will assign reading from relevant sources that is appropriate to
the background of the students taking the course.
For the convenience of the instructors, students, and other readers of this
book, we have included an appendix that lists references to reviews of the
research literature that we have found to be particularly useful in our courses on
bioinorganic chemistry.
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1
Transition-Metal Storage, Transport,
and Biomineralization
ELIZABETH C. THEIL
Department of Biochemistry
North Carolina State University
KENNETH N. RAYMOND
Department of Chemistry
University of California at Berkeley
I. GENERAL PRINCIPLES
A. Biological Significance of Iron, Zinc, Copper, Molybdenum, Cobalt,
Chromium, Vanadium, and Nickel
Living organisms store and transport transition metals both to provide appro-
priate concentrations of them for use in metalloproteins or cofactors and to pro-
tect themselves against the toxic effects of metal excesses; metalloproteins and
metal cofactors are found in plants, animals, and microorganisms. The normal
concentration range for each metal in biological systems is narrow, with both
deficiencies and excesses causing pathological changes. In multicellular organ-
isms, composed of a variety of specialized cell types, the storage of transition
metals and the synthesis of the transporter molecules are not carried out by all
types of cells, but rather by specific cells that specialize in these tasks. The
form of the metals is always ionic, but the oxidation state can vary, depending
on biological needs. Transition metals for which biological storage and transport
are significant are, in order of decreasing abundance in living organisms: iron,
zinc, copper, molybdenum, cobalt, chromium, vanadium, and nickel. Although
zinc is not strictly a transition metal, it shares many bioinorganic properties with
transition metals and is considered with them in this chapter. Knowledge of iron
storage and transport is more complete than for any other metal in the group.
The transition metals and zinc are among the least abundant metal ions in
the sea water from which contemporary organisms are thought to have evolved
(Table 1.1).1-5 For many of the metals, the concentration in human blood plasma
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Table 1.1
Concentrations of transition metals
and zinc in sea water and human
plasma.a
Sea water Human plasma
Element (M) X 108 (M) X 108
Fe 0.005-2 2230
Zn 8.0 1720
Cu 1.0 1650
Mo 10.0 1000
Co 0.7 0.0025
Cr 0.4 5.5
V 4.0 17.7
Mn 0.7 10.9
Ni 0.5 4.4
a Data from References 1-5 and 12.
greatly exceeds that in sea water. Such data indicate the importance of mecha-
nisms for accumulation, storage, and transport of transition metals and zinc in
living organisms.
The metals are generally found either bound directly to proteins or in cofac-
tors such as porphyrins or cobalamins, or in clusters that are in tum bound by
the protein; the ligands are usually 0, N, S, or C. Proteins with which transition
metals and zinc are most commonly associated catalyze the intramolecular or
intermolecular rearrangement of electrons. Although the redox properties of the
metals are important in many of the reactions, in others the metal appears to
contribute to the structure of the active state, e.g., zinc in the Cu-Zn dismutases
and some of the iron in the photosynthetic reaction center. Sometimes equiva-
lent reactions are catalyzed by proteins with different metal centers; the metal
binding sites and proteins have evolved separately for each type of metal center.
Iron is the most common transition metal in biology. 6,7 Its use has created
a dependence that has survived the appearance of dioxygen in the atmosphere
ca. 2.5 billion years ago, and the concomitant conversion of ferrous ion to ferric
ion and insoluble rust (Figure 1.1 See color plate section, page C-1.). All plants,
animals, and bacteria use iron, except for a lactobacillus that appears to main-
tain high concentrations of manganese instead of iron. The processes and reac-
tions in which iron participates are crucial to the survival of terrestrial organ-
isms, and include ribonucleotide reduction (DNA synthesis), energy production
(respiration), energy conversion (photosynthesis), nitrogen reduction, oxygen
transport (respiration, muscle contraction), and oxygenation (e.g., steroid syn-
thesis, solubilization and detoxification of aromatic compounds). Among the
transition metals used in living organisms, iron is the most abundant in the
environment. Whether this fact alone explains the biological predominance of
iron or whether specific features of iron chemistry contribute is not clear.
I. GENERAL PRINCIPLES
Many of the other transition metals participate in reactions equivalent to
those involving iron, and can sometimes substitute for iron, albeit less effec-
tively, in natural Fe-proteins. Additional biological reactions are unique to non-
ferrous transition metals.
Zinc is relatively abundant in biological materials. 8,9 The major location of
zinc in the body is metallothionein, which also binds copper, chromium, mer-
cury, and other metals. Among the other well-characterized zinc proteins are
the Cu-Zn superoxide dismutases (other forms have Fe or Mn), carbonic anhy-
drase (an abundant protein in red blood cells responsible for maintaining the pH
of the blood), alcohol dehydrogenase, and a variety of hydrolases involved in
the metabolism of sugars, proteins, and nucleic acids. Zinc is a common ele-
ment in nucleic-acid polymerases and transcription factors, where its role is
considered to be structural rather than catalytic. Interestingly, zinc enhances the
stereoselectivity of the polymerization of nucleotides under reaction conditions
designed to simulate the environment for prebiotic reactions. Recently a group
of nucleic-acid binding proteins, with a repeated sequence containing the amino
acids cysteine and histidine, were shown to bind as many as eleven zinc atoms
necessary for protein function (transcribing DNA to RNA). 10 Zinc plays a struc-
tural role, forming the peptide into multiple domains or "zinc fingers" by means
of coordination to cysteine and histidine (Figure 1.2A See color plate section,
page C-l.). A survey of the sequences of many nucleic-acid binding proteins
shows that many of them have the common motif required to form zinc fingers.
Other zinc-finger proteins called steroid receptors bind both steroids such as
progesterone and the progesterone gene DNA (Chapter 8). Much of the zinc in
animals and plants has no known function, but it may be maintaining the struc-
tures of proteins that activate and deactivate genes. 11
Copper and iron proteins participate in many of the same biological reac-
tions:
(1) reversible binding of dioxygen, e.g., hemocyanin (Cu), hemerythrin (Fe),
and hemoglobin (Fe);
(2) activation of dioxygen, e.g., dopamine hydroxylase (Cu) (important in
the synthesis of the hormone epinephrine), tyrosinases (Cu), and ca-
techol dioxygenases (Fe);
(3) electron transfer, e.g., plastocyanins (Cu), ferredoxins, and c-type cy-
tochromes (Fe);
(4) dismutation of superoxide by Cu or Fe as the redox-active metal (super-
oxide dismutases).
The two metal ions also function in concert in proteins such as cytochrome
oxidase, which catalyzes the transfer of four electrons to dioxygen to form water
during respiration. Whether any types of biological reactions are unique to cop-
per proteins is not clear. However, use of stored iron is reduced by copper
deficiency, which suggests that iron metabolism may depend on copper proteins,
3
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such as the serum protein ceruloplasmin, which can function as a ferroxidase,
and the cellular protein ascorbic acid oxidase, which also is a ferrireductase.
Cobalt is found in vitamin B12 , its only apparent biological site. 12 The vi-
tamin is a cyano complex, but a methyl or methylene group replaces CN in
native enzymes. Vitamin-B 12 deficiency causes the severe disease of perniCious
anemia in humans, which indicates the critical role of cobalt. The most common
type of reaction in which cobalamin enzymes participate results in the reciprocal
exchange of hydrogen atoms if they are on adjacent carbon atoms, yet not with
hydrogen in solvent water:
b c b c
I I I I
a-C-C-d~a-C-C-d
I I I I
x H H X
(An important exception is the ribonucleotide reductase from some bacteria and
lower plants, which converts ribonucleotides to the DNA precursors, deoxyri-
bonucleotides, a reaction in which a sugar -OH is replaced by -H. Note that
ribonucleotide reductases catalyzing the same reaction in higher organisms and
viruses are proteins with an oxo-bridged dimeric iron center.) The cobalt in
vitamin B12 is coordinated to five N atoms, four contributed by a tetrapyrrole
(corrin); the sixth ligand is C, provided either by C5 of deoxyadenosine in en-
zymes such as methylmalonyl-CoA mutase (fatty acid metabolism) or by a methyl
group in the enzyme that synthesizes the amino acid methionine in bacteria.
Nickel is a component of a hydrolase (urease), of hydrogenase, of CO de-
hydrogenase, and of S-methyl CoM reductase, which catalyzes the terminal step
in methane production by methanogenic bacteria. All the Ni-proteins known to
date are from plants or bacteria. 13,14 However, about 50 years elapsed between
the crystallization of jack-bean urease in 1925 and the identification of the nickel
component in the plant protein. Thus it is premature to exclude the possibility
of Ni-proteins in animals. Despite the small number of characterized Ni-pro-
teins, it is clear that many different environments exist, from apparently direct
coordination to protein ligands (urease) to the tetrapyrrole F430 in methylre-
ductase and the multiple metal sites of Ni and Fe-S in a hydrogenase from the
bacterium Desulfovibrio gigas. Specific environments for nickel are also indi-
cated for nucleic acids (or nucleic acid-binding proteins), since nickel activates
the gene for hydrogenase. 15
Manganese plays a critical role in oxygen evolution catalyzed by the pro-
teins of the photosynthetic reaction center. The superoxide dismutase of bacteria
and mitochondria, as well as pyruvate carboxylase in mammals, are also man-
ganese proteins. 16,17 How the multiple manganese atoms of the photosynthetic
reaction center participate in the removal of four electrons and protons from
water is the subject of intense investigation by spectroscopists, synthetic inor-
ganic chemists, and molecular biologists. 17
I. GENERAL PRINCIPLES
Vanadium and chromium have several features in common, from a bioinor-
ganic viewpoint. 18a First, both metals are present in only small amounts in most
organisms. Second, the biological roles of each remain largely unknown. 18 Fi-
nally, each has served as a probe to characterize the sites of other metals, such
as iron and zinc. Vanadium is required for normal health, and could act in vivo
either as a metal cation or as a phosphate analogue, depending on the oxidation
state, V(lV) or V(V), respectively. Vanadium in a sea squirt (tunicate), a prim-
itive vertebrate (Figure 1.2B), is concentrated in blood cells, apparently as the
major cellular transition metal, but whether it participates in the transport of
dioxygen (as iron and copper do) is not known. In proteins, vanadium is a
cofactor in an algal bromoperoxidase and in certain prokaryotic nitrogenases.
Chromium imbalance affects sugar metabolism and has been associated with the
glucose tolerance factor in animals. But little is known about the structure of
the factor or of any other specific chromium complexes from plants, animals,
or bacteria.
Molybdenum proteins catalyze the reduction of nitrogen and nitrate, as well
as the oxidation of aldehydes, purines, and sulfite. 19 Few Mo-proteins are known
compared to those involving other transition metals. Nitrogenases, which also
contain iron, have been the focus of intense investigations by bioinorganic chemists
and biologists; the iron is found in a cluster with molybdenum (the iron-molyb-
denum cofactor, or FeMoCo) and in an iron-sulfur center (Chapter 7). Interest-
ingly, certain bacteria (Azotobacter) have alternative nitrogenases, which are
produced when molybdenum is deficient and which contain vanadium and iron
or only iron. All other known Mo-proteins are also Fe-proteins with iron cen-
ters, such as tetrapyrroles (heme and chlorins), Fe-sulfur clusters, and, appar-
ently, non-heme/non-sulfur iron. Some Mo-proteins contain additional cofactors
such as the Havins, e.g., in xanthine oxidase and aldehyde oxidase. The number
of redox centers in some Mo-proteins exceeds the number of electrons trans-
ferred; reasons for this are unknown currently.
B. Chemical Properties Relative to Storage and Transport
1. Iron
Iron is the most abundant transition element in the Earth's crust and, in
general, in all life forms. An outline of the distribution of iron in the Earth's
crust 20,21 is shown in Table 1.2. As can be seen, approximately one-third of the
Earth's mass is estimated to be iron. Of course, only the Earth's crust is relevant
for life forms, but even there it is the most abundant transition element. Its
concentration is relatively high in most crustal rocks (lowest in limestone, which
is more or less pure calcium carbonate). In the oceans, which constitute 70
percent of the Earth's surface, the concentration of iron is low but increases
with depth, since this iron exists as suspended particulate matter rather than as
a soluble species. Iron is a limiting factor in plankton growth, and the rich
5
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Table 1,2
Iron: Its terrestrial distribution.a
One third of Earth's mass, most abundant element by weight
Distribution in crustal rocks (weight %):
igneous 5.6
shale 4.7
sandstone 1.0
limestone 0.4
Ocean (70% of Earth's surface):
0.003--0.1 ppb, increasing with depth; limiting factor in plankton
growth
Rivers:
0.07-7 ppm
Ksp for Fe(OH)3 is approximately 10 -39, hence at pH 7 [Fe3+] 10 -IS M
a Data from References la and 20.
fisheries associated with strong up-welling of ocean depths result at least in part
from the biological growth allowed by these iron supplies. Properties that dom-
inate the transport behavior of most transition metal ions are: (l) redox chem-
istry, (2) hydrolysis, and (3) the solubility of the metal ions in various com-
plexes, particularly the hydroxides.
As an example of the effects of solubility, consider the enormous variation
in the concentration of iron in rivers, depending on whether the water is from a
clear mountain stream running over rock or a muddy river carrying large amounts
of sediment. However, the amount of dissolved iron in the form of free ferric
ion or its hydrolysis products, whatever the source of water, is extremely low.
As can be seen from the solubility of hydrated Fe(III) (Ks ~ 10 -18 M) (Table
1.2), the concentration of free ferric ion is extraordinarily low at neutral pH; so
significant concentrations of soluble iron species can be attained only by strong
complex formation.
One example of the versatility of iron as a function of its environment is
how the ligand field can strongly alter the structural and ligand exchange prop-
erties of the metal ion (Figure 1.3). The ligand field can also alter the redox
properties. For high-spin ferric ion, as found in the aquo complex or in many
other complexes (including the class of microbial iron-transport agents called
siderophores, to be discussed later), the coordination geometry is octahedral or
pseudo-octahedral. In the relatively weak ligand field (high-spin ground state),
the complex is highly labile. In a strong ligand field, such as an axially ligated
porphyrin complex of ferric ion, or the simple example of the ferrocyanide an-
ion, the low-spin complex is exchange-inert. Similarly, the high-spin octahedral
ferrous complexes are exchange-labile, but the corresponding axially ligated
porphyrin complexes, or the ferrocyanide complexes, are spin-paired (diamag-
netic) and ligand exchange-inert. Large, bulky ligands or constrained ligands,
such as those provided by metalloprotein and enzyme sites, can cause a tetra-
hedral environment, in which both ferrous ion and ferric ion form high-spin
complexes.
7
octahedral
~ ~
Fe3+ ~ ~ ~ lL lL ~
high-spin, labile low-spin, inert
~ ~
Fe2+ lL ~ ~ lL lL lL
high-spin, labile low-spin, inert
tetrahedral
~ ~ ~ ~ ~ ~
Fe3+ ~ ~ Fe
2+ lL ~
Figure 1.3
Versatility of Fe coordination complexes.
The distribution of specific iron complexes in living organisms depends
strongly on function. For example, although there are many different iron com-
plexes in the average human, the relative amounts of each type differ more than
650-fold (Table 1.3). The total amount of iron in humans is quite large, aver-
aging more than three and up to five grams for a healthy adult. Most of the iron
is present as hemoglobin, the plasma oxygen-transport protein, where the func-
Table 1.3
Average human Fe distribution.
Protein
Hemoglobin
Myoglobin
Transferrin
Ferritin
Hemosiderin
Catalase
Cytochrome c
Other
Function
Plasma O2 transport
Muscle O2 storage
Plasma Fe transport
Cell Fe storage
Cell Fe storage
H20 z metabolism
Electron transport
Oxidases, other enzymes, etc.
Oxidation state
of Fe
2
2
3
3
3
2
2
3"
Amount of Fe
(g)
2.6
0.13
0.007
0.52
0.48
0.004
0.004
0.14
Percent of total
65
6
0.2
13
12
0.1
0.1
3.6
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tion of the iron is to deliver oxygen for respiration. A much smaller amount of
iron is present in myoglobin, a muscle oxygen-storage protein. For transport,
the most important of these iron-containing proteins is transferrin, the plasma
iron-transport protein that transfers iron from storage sites in the body to loca-
tions where cells synthesizing iron proteins reside; the major consumers of iron
in vertebrates are the red blood cells. However, at any given time relatively
little of the iron in the body is present in transferrin, in much the same way that
at any given time in a large city only a small fraction of the population will be
found in buses or taxis. Other examples of iron-containing proteins and their
functions are included in Table 1.3 for comparison.
An example of different iron-coordination environments, which alter the
chemical properties of iron, is the difference in the redox potentials of hydrated
Fe3+ and the electron-transport protein cytochrome c (Table 1.4). The co()rdina-
Table 1.4
Fe redox potentials.
Complex
Fe(OHz)63+
Cytochrome G3
HIPIP
Cytochrome c
Rubredoxin
Ferredoxins
Coord. no., type
6, aquo complex
6, heme
4, Fe4S4(SR)4 -
6, heme
4, Fe(SR)4
4, Fe4S4(SR)4Z-
770
390
350
250
-60
-400
tion environment of iron in cytochrome c is illustrated in Figure 1.4. For ex-
ample, the standard reduction potential for ferric ion in acid solution is 0.77
volts; so here ferric ion is quite a good oxidant. In contrast, cytochrome c has
a redox potential of 0.25 volts. A wide range of redox potentials for iron is
achieved in biology by subtle differences in protein structure, as listed in Table
1.4. Notice the large difference in the potential of cytochrome c and rubredoxin
(Figure 1.5), 0.25 volts vs. -0.06 volts, respectively. In polynuclear ferredox-
ins, in which each iron is tetrahedrally coordinated by sulfur, reduction poten-
tials are near - 0.4 volts. Thus, the entire range of redox potentials, as illus-
trated in Table 1.4, is more than one volt.
2. Chemical properties of zinc, copper, vanadium, chromium,
molybdenum, and cobalt
The chemical properties of the other essential transition elements simplify
their transport properties. For zinc there is only the +2 oxidation state, and the
hydrolysis of this ion is not a limiting feature of its solubility or transport. Zinc
is an essential element for both animals and plants. 8,9,20,21 In general, metal ion
uptake into the roots of plants is an extremely complex phenomenon. A cross-
sectional diagram of a root is shown in Figure 1.6. It is said that both diffusion
H
H C I C=C-CH -
3 " / 2
/S-F1e-N" I
Met 80 CH C=N
/ 2 H
/CH2 t His 18
heme
group
Figure 1.4 I
Heme group and iron coordination in cytochrome c.
9
cysteine
2 amino acid
cysteine --r-e""'si--:d'--ue-"s-'--'--
Figure 1.5
Fe3+/2+ coordination in rubredoxin.
- stele-
phloem tubes pericycle
cortex ------
air space
xylem
vessels
endodermis with
Casparian band
epidermis with
root hair
Figure 1.6
Transverse section of a typical root. 20 The complex features of the root hair surface that regulate
reductase and other activities in metal uptake are only beginning to be understood.
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and mass flow of the soil solution are of significance in the movement of metal
ions to roots. Chelation and surface adsorption, which -are pH dependent, also
affect the availability of nutrient metal ions. Acid soil conditions in general
retard uptake of essential divalent metal ions but increase the availability (some-
times with toxic results) of manganese, iron, and aluminum, all of which are
normally of very limited availability because of hydrolysis of the trivalent ions.
Vanadium is often taken up as vanadate, in a pathway parallel to phos-
phate. 18 However, its oxidation state within organisms seems to be highly vari-
able. Unusually high concentrations of vanadium occur in certain ascidians (the
specific transport behavior of which will be dealt with later). The workers who
first characterized the vanadium-containing compound of the tunicate, Ascidia
nigra, coined the name tunichrome. 22 The characterization of the compound as
a dicatecholate has been reported. 23
Quite a different chemical environment is found in the vanadium-containing
material isolated from the mushroom Amanita muscaria. Bayer and Kneifel,
who named and first described amavadine,24 also suggested the structure shown
in Figure 1. 7. 25 Recently the preparation, proof of ligand structure, and (by
implication) proof of the complex structure shown in Figure 1.7 have been es-
tablished. 26 Although the exact role of the vanadium complex in the mushroom
Figure 1.7
A structure proposed for amavadineY
remains unclear, the fact that it is a vanadyl complex is now certain, although
it may take a different oxidation state in vivo.
The role of chromium in biology remains even more mysterious. In human
beings the isolation of "glucose tolerance factor" and the discovery that it con-
tains chromium goes back some time. This has been well reviewed by Mertz,
who has played a major role in discovering what is known about this elusive
and apparently quite labile compound. 27 It is well established that chromium is
taken up as chromic ion, predominantly via foodstuffs, such as unrefined sugar,
which presumably contain complexes of chromium, perhaps involving sugar hy-
droxyl groups. Although generally little chromium is taken up when it is admin-
istered as inorganic salts, such as chromic chloride, glucose tolerance in many
adults and elderly people has been reported to be improved after supplementa-
tion with 150-250 mg of chromium per day in the form of chromic chloride.
Similar results have been found in malnourished children in some studies in
Third World countries. Studies using radioactively labeled chromium have shown
that, although inorganic salts of chromium are relatively unavailable to mam-
cytoplasmic
reductants
Figure 1.8
The uptake-reduction model for chromate carcinogenicity. Possible sites for reduction of chro-
mate include the cytoplasm, endoplasmic reticulum, mitochondria, and the nucleusY
mals, brewer's yeast can convert the chromium into a usable form; so l:irewer's
yeast is today the principal source in the isolation of glucose tolerance factor
and has been used as a diet supplement.
Although chromium is essential in milligram amounts for human beings as
the trivalent ion, as chromate it is quite toxic and a recognized carcinogen. 30
The uptake-reduction model for chromate carcinogenicity as suggested by Con-
nett and Wetterhahn is shown in Figure 1.8. Chromate is mutagenic in bacterial
and mammalian cell systems, and it has been hypothesized that the difference
between chromium in the +6 and + 3 oxidation states is explained by the' 'up-
take-reduction" model. Chromium(III), like the ferric ion discussed above, is
readily hydrolyzed at neutral pH and extremely insoluble. Unlike Fe 3+ , it
undergoes extremely slow ligand exchange. For both reasons, transport of chro-
mium(III) into cells can be expected to be extremely slow unless it is present as
specific complexes; for example, chromium(III) transport into bacterial cells has
been reported to be rapid when iron is replaced by chromium in the siderophore
iron-uptake mediators. However, chromate readily crosses cell membranes and
enters cells, much as sulfate does. Because of its high oxidizing power, chro-
mate can undergo reduction inside organelles to give chromium(m), which binds
to small molecules, protein, and DNA, damaging these cellular components.
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In marked contrast to its congener, molybdenum is very different from chro-
mium in both its role in biology and its transport behavior, again because of
fundamental differences in oxidation and coordination chemistry properties. In
contrast to chromium, the higher oxidation states of molybdenum dominate its
chemistry, and molybdate is a relatively poor oxidant. Molybdenum is an essen-
tial element in many enzymes, including xanthine oxidase, aldehyde reductase,
and nitrate reductase. 19 The range of oxidation states and coordination geome-
tries of molybdenum makes its bioinorganic chemistry particularly interesting
and challenging.
The chemistry of iron storage and transport is dominated by high concentra-
tions, redox chemistry (and production of toxic-acting oxygen species), hydrol-
ysis (pKa is about 3, far below physiological pH), and insolubility. High-affinity
chelators or proteins are required for transport of iron and high-capacity seques-
tering protein for storage. By comparison to iron, storage and transport of the
other metals are simple. Zinc, copper, vanadium, chromium, manganese, and
molybdenum appear to be transported as simple salts or loosely bound protein
complexes. In vanadium or molybdenum, the stable anion, vanadate or molyb-
date, appears to dominate transport. Little is known about biological storage of
any metal except iron, which is stored in ferritin. However, zinc and copper are
bound to metallothionein in a fonn that may participate in storage.
II. BIOLOGICAL SYSTEMS OF METAL STORAGE, TRANSPORT,
AND MINERALIZATION
A. Storage
1. The storage of iron
Three properties of iron can account for its extensive use in terrestrial bio-
logical reactions:
(a) facile redox reactions of iron ions;
(b) an extensive repertoire of redox potentials available by ligand substitu-
tion or modification (Table 1.4);
(c) abundance and availability (Table 1.1) under conditions apparently ex-
tant when terrestrial life began (see Section LB.).
Ferrous ion appears to have been the environmentally stable form during
prebiotic times. The combination of the reactivity of ferrous ion and the rela-
tively large amounts of iron used by cells may have necessitated the storage of
ferrous ion; recent results suggest that ferrous ion may be stabilized inside fer-
ritin long enough to be used in some types of cells. As primitive organisms
began to proliferate, the successful photosynthetic cells, which trapped solar
energy by reducing CO2 to make carbohydrates (CH20)n and produce O2 , ex-
hausted from the environment the reductants from H2 or H2S or NH3 . The abil-
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ity of primitive organisms to switch to the use of H20 as a reductant, with the
concomitant production of dioxygen, probably produced the worst case of en-
vironmental pollution in terrestrial history. As a result, the composition of the
atmosphere, the course of biological evolution, and the oxidation state of envi-
ronmental iron all changed profoundly. Paleogeologists and meteorologists es-
timate that there was a lag of about 200-300 million years between the first
dioxygen production and the appearance of significant dioxygen concentrations
in the atmosphere, because the dioxygen produced at first was consumed by the
oxidation of ferrous ions in the oceans. The transition in the atmosphere, which
occurred about 2.5 billion years ago, caused the bioavailability of iron to plum-
met and the need for iron storage to increase. Comparison of the solubility of
Fe 3+ at physiological conditions (about 10 - 18 M) to the iron content of cells
(equivalent to 10 -5 to 10 -8 M) emphasizes the difficulty of acquiring sufficient
Iron.
Iron is stored mainly in the ferritins, a family * of proteins composed of a
protein coat and an iron core of hydrous ferric oxide [Fe203(H20)n] with various
amounts of phosphate.6,7 As many as 4,500 iron atoms can be reversibly stored
inside the protein coat in a complex that is soluble; iron concentrations equiva-
lent to 0.25 M [about 10 16-fold more concentrated than Fe(III) ions] can be
easily achieved in vitro (Figure 1.1). Ferritin is found in animals, plants, and
even in bacteria; the role of the stored iron varies, and includes intracellular use
for Fe-proteins or mineralization, long-term iron storage for other cells, and
detoxification of excess iron. Iron regulates the synthesis of ferritin, with large
amounts of ferritin associated with iron excess, small or undetectable amounts
associated with iron deficiency. [Interestingly, the template (mRNA) for ferritin
synthesis is itself stored in cells and is recruited by intracellular iron or a deriv-
ative for efficient translation into protein. 31 Iron does not appear to interact
directly with ferritin mRNA nor with a ferritin mRNA-specific regulatory (bind-
ing) protein; however, the specific, mRNA regulatory (binding) protein has se-
quence homology to aconitase, and formation of an iron-sulfate cluster prevents
RNA binding.] Because iron itself determines in part the amount of ferritin in
an organism, the environmental concentration of iron needs to be considered
before one can conclude that an organism or cell does not have ferritin.
Ferritin is thought to be the precursor of several forms of iron in living
organisms, including hemosiderin, a form of storage iron found mainly in ani-
mals. The iron in hemosiderin is in a form very similar to that in ferritin, but
the complex with protein is insoluble, and is usually located within an intracel-
lular membrane (lysosomes). Magnetite (Fe304) is another form of biological
iron derived, apparently, from the iron in ferritin. Magnetite plays a role in the
behavior of magnetic bacteria, bees, and homing pigeons (see Section II.C).
The structure of ferritin is the most complete paradigm for bioinorganic
chemistry because of three features: the protein coat, the iron-protein interface,
and the iron core. 6,7
* A family of proteins is a group of related but distinct proteins produced in a single organism and usually
encoded by multiple, related genes.
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Figure 1.9
(A) The protein coat of horse spleen apoferritin deduced from x-ray diffraction of crystals of the
protein. 32 The outer surface of the protein coat shows the arrangement of the 24 ellipsoidal poly-
peptide subunits. N refers to the N-terminus of each polypeptide and E to the E-helix (see B).
Note the channels that form at the four-fold axes where the E-helices interact, and at the three-
fold axes near the N-termini of the subunits. (B) A ribbon model of a subunit showing the
packing of the four main alpha-helices (A, B, C, and D), the connecting L-loop and the E-helix.
Protein Coat Twenty-four peptide chains (with about 175 amino acids each),
folded into ellipsoids, pack to form the protein coat,* which is a hollow sphere
about 100 A in diameter; the organic surface is about 10 A thick (Figure 1.9).
Channels which occur in the protein coat at the trimer interfaces may be in-
volved in the movement of iron in and out of the protein. 62,63,65 Since the pro-
tein coat is stable with or without iron, the center of the hollow sphere may be
filled with solvent, with Fe203' H20, or, more commonly, with both small ag-
gregates of iron and solvent. Very similar amino-acid sequences are found in
ferritin from animals and plants. Sorting out which amino acids are needed to
form the shape of the protein coat and the ligands for iron core formation re-
quires the continued dedication of bioinorganic chemists; identification of tyro-
sine as an Fe(III)-ligand adds a new perspective. 64
Iron-Protein Interface Formation of the iron core appears to be initiated at
an Fe-protein interface where Fe(II)-O-Fe(Ill) dimers and small clusters of Fe(Ill)
atoms have been detected attached to the protein and bridged to each other by
oxo/hydroxo bridges. Evidence for multiple nucleation sites has been obtained
* Some ferritin subunits, notably in ferritin from bacteria, bind heme in a ratio of less than one heme per
two subunits. A possible role of such heme in the oxidation and reduction of iron in the core is being
investigated.
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from electron microscopy of individual ferritin molecules (multiple core crystal-
lites were observed) and by measuring the stoichiometry of binding of metal
ions, which compete with binding of monoatomic iron, e.g., VO(IV) and Th(m)
(about eight sites per molecule). EXAFS (Extended X-ray Absorption Fine
Structure) and Mossbauer spectroscopies suggest coordination of Fe to the pro-
tein by carboxyl groups from glutamic (Glu) and aspartic (Asp) acids. Although
groups of Glu or Asp are conserved in all animal and plant ferritins, the
ones that bind iron are not known. Tyrosine is an Fe(III)-ligand conserved in
rapid mineralizing ferritins identified by Uv-vis and resonance Raman spectro-
scopy.64
Iron Core Only a small fraction of the iron atoms in ferritin bind directly
to the protein. The core contains the bulk of the iron in a polynuclear aggregate
with properties similar to ferrihydrite, a mineral found in nature and formed
experimentally by heating neutral aqueous solutions of Fe(III)(N03h. X-ray dif-
fraction data from ferritin cores are best fit by a model with hexagonal close-
packed layers of oxygen that are interrupted by irregularly incomplete layers of
octahedrally coordinated Fe(III) atoms. The octahedral coordination is con-
firmed by Mossbauer spectroscopy and by EXAFS, which also shows that the
average Fe(In) atom is surrounded by six oxygen atoms at a distance of 1.95 A
and six iron atoms at distances of 3.0 to 3.3 A.
Until recently, all ferritin cores were thought to be microcrystalline and to
be the same. However, x-ray absorption spectroscopy, Mossbauer spectroscopy,
and high-resolution electron microscopy of ferritin from different sources have
revealed variations in the degree of structural and magnetic ordering and/or the
level of hydration. Structural differences in the iron core have been associated
with variations in the anions present, e.g., phosphate 29 or sulfate, and with the
electrochemical properties of iron. Anion concentrations in tum could reflect
both the solvent composition and the properties of the protein coat. To under-
stand iron storage, we need to define in more detail the relationship of the
ferritin protein coat and the environment to the redox properties of iron in the
ferritin core.
Experimental studies of ferritin formation show that Fe(n) and dioxygen are
needed, at least in the early stages of core formation. Oxidation to Fe(nI) and
hydrolysis produce one electron and an average of 2.5 protons for iron atoms
incorporated into the ferritin iron core. Thus, formation of a full iron core of
4,500 iron atoms would produce a total of 4,500 electrons and 11,250 protons.
After core formation by such a mechanism inside the protein coat, the pH would
drop to 0.4 if all the protons were retained. It is known that protons are released
and electrons are transferred to dioxygen. However, the relative rates of proton
release, oxo-bridge formation, and electron transfer have not been studied in
detail. Moreover, recent data indicate migration of iron atoms during the early
stages of core formation and the possible persistence of Fe 2 + for periods of
time up to 24 hours. When large numbers of Fe(n) atoms are added, the protein
coat appears to stabilize the encapsulated Fe(n).34a,b Formation of the iron core
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of ferritin has analogies to surface corrosion, in which electrochemical gradients
are known to occur. Whether such gradients occur during ferritin formation and
how different protein coats might influence proton release or alter the structure
of the core are subjects only beginning to be examined.
2. The storage of zinc, copper, vanadium, chromium, molybdenum,
cobalt, nickel, and manganese
Ions of nonferrous transition metals require a much less complex biological
storage system, because the solubilities are much higher (210 - 8 M) than those
for Fe 3+ . As a result, the storage of nonferrous transition metals is less obvious,
and information is more limited. In addition, investigations are more difficult
than for iron, because the amounts in biological systems are so small. Essen-
tially nothing is known yet about the storage of vanadium, chromium, molyb-
denum, cobalt, nickel, and manganese, with the possible exception of accumu-
lations of vanadium in the blood cells of tunicates.
Zinc and copper, which are used in the highest concentrations of any of
the non-ferrous transition metals, are specifically bound by the protein
metallothionein 35,36 (see Figure 1.10). Like the ferritins, the metallothioneins
are a family of proteins, widespread in nature and regulated by the metals they
bind. In contrast to ferritin, the amounts of metal stored in metallothioneins are
smaller (up to twelve atoms per molecule), the amount of protein in cells is
less, and the template (mRNA) is not stored. Because the cellular concentrations
of the metallothioneins are relatively low and the amount of metal needed is
relatively small, it has been difficult to study the biological fate of copper and
zinc in living organisms, and to discover the natural role of metallothioneins.
However, the regulation of metallothionein synthesis by metals, hormones, and
growth factors attests to the biological importance of the proteins. The unusual
metal environments of metallothioneins have attracted the attention of bioinor-
ganic chemists.
Metallothioneins, especially in higher animals, are small proteins 35,36 rich
in cysteine (20 per molecule) and devoid of the aromatic amino acids phenylal-
anine and tyrosine. The cysteine residues are distributed throughout the peptide
chain. However, in the native form of the protein (Figure 1.10), the peptide
chains fold to produce two clusters of -SH, which bind either three or four
atoms of zinc, cadmium, cobalt, mercury, lead, or nickel. Copper binding is
distinct from zinc, with 12 sites per molecule.
In summary, iron is stored in iron cores of a complicated protein. Ferritin,
composed of a hollow protein coat, iron-protein interface, and an inorganic core,
overcomes the problems of redox and hydrolysis by directing the formation of
the quasi-stable mineral hydrous ferric oxide inside the protein coat. The outer
surface of the protein is generally hydrophilic, making the complex highly sol-
uble; equivalent concentrations of iron are :::::0.25 M. By contrast to iron, stor-
age of zinc, copper, chromium, manganese, vanadium, and molybdenum is rel-
atively simple, because solubility is high and abundance is lower. Little is known
Figure 1.10
The three-dimensional structure of the a domain from rat cd7 metallothionein-2, determined by
NMR in solution (Reference 36a), based on data in Reference 36b. The four metal atoms,
bonded to the sulfur of cysteine side chains, are indicated as spherical collections of small dots.
A recent description of the structure of the cdsZn2 protein, determined from x-ray diffraction of
crystals, agrees with the structure determined by NMR (Reference 36c).
about the molecules that store these metals, with the possible exception of me-
tallothionein, which binds small clusters of zinc or copper.
B. Transport
1. Iron
The storage of iron in humans and other mammals has been dealt with in
the previous section. Only a small fraction of the body's inventory of iron is in
transit at any moment. The transport of iron from storage sites in cellular ferritin
or hemosiderin occurs via the serum-transport protein transferrin. The transfer-
rins are a class of proteins that are bilobal, with each lobe reversibly (and es-
sentially independently) binding ferric ion. 37-39 This complexation of the metal
cation occurs via prior complexation of a synergistic anion that in vivo is bicar-
bonate (or carbonate). Serum transferrin is a monomeric glycoprotein of molec-
ular weight 80 kDa. The crystal structure of the related protein, lactoferrin,39
has been reported, and recently the structure of a mammalian transferrin 40 has
been deduced.
Ferritin is apparently a very ancient protein and is found in higher animals,
plants, and even microbes; in plants and animals a common ferritin progenitor
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is indicated by sequence conservation. 41 In contrast, transferrin has been in ex"
istence only relatively recently, since it is only found ia the phylum Chordata.
Although the two iron-binding sites of transferrin are sufficiently different to be
distinguishable by kinetic and a few other studies, their coordination environ-
ments have been known for some time to be quite similar. This was first dis-
covered by various spectroscopies, and most recently was confirmed by crystal-
structure analysis, which shows that the environment involves two phenolate
oxygens from tyrosine, two oxygens from the synergistic, bidentate bicarbonate
anion, nitrogen from histidine, and (a surprise at the time of crystal-structure
analysis) an oxygen from a carboxylate group of an aspartate. 39
The transferrins are all glycoproteins, and human serum transferrin contains
about 6 percent carbohydrate. These carbohydrate groups are linked to the pro-
tein, and apparently strongly affect the recognition and conformation of the na-
tive protein.
Although transferrins have a high molecular weight and bind only two iron
atoms, transferrin is relatively efficient, because it is used in many cycles of
iron transport in its interaction with the tissues to which it delivers iron. Trans-
ferrin releases iron in vivo by binding to the cell surface and forming a vesicle
inside the cell (endosome) containing a piece of the membrane with transferrin
and iron still complexed. The release of the iron from transferrin occurs in the
relatively low pH of the endosome, and apoprotein is returned to the outside of
the cell for delivery of another pair of iron atoms. This process in active reti-
culocytes (immature red blood cells active in iron uptake) can tum over roughly
a million atoms of iron per cell per minute. 38 A schematic structure of the
protein, deduced from crystal-structure analysis, is shown in Figure 1.11. Trans-
ferrin is an ellipsoidal protein with two subdomains or lobes, each of which
binds iron. The two halves of each subunit are more or less identical, and are
connected by a relatively small hinge. In human lactoferrin, the coordination
site of the iron is the same as the closely related serotransferrin site. A major
question that remains about the mechanism of iron binding and release is how
the protein structure changes in the intracellular compartment of low pH to re-
lease the iron when it forms a specific complex with cell receptors (transferrin
binding proteins) and whether the receptor protein is active or passive in the
process. Recent studies suggest that the cell binding site for transferrin (a mem-
brane, glycoprotein called the transferrin receptor) itself influences the stability
of the iron-transferrin complex. The path of iron from the endosome to Fe-
proteins has not been established; and the form of transported intracellular iron
is not known.
Another major type of biological iron transport occurs at the biological op-
posite of the higher organisms. Although almost all microorganisms have iron
as an essential element, bacteria, fungi, and other microorganisms (unlike hu-
mans and other higher organisms) cannot afford to make high-molecular-weight
protein-complexing agents for this essential element when those complexing agents
would be operating extracellularly and hence most of the time would be lost to
the organism. As described earlier, the first life forms on the surface of the
II
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Figure 1.11
Three-dimensional structure of lactotransferrin. Top: schematic representation of the folding pat-
tern of each lactoferrin lobe; Domain 1 is based on a beta-sheet of four parallel and two antipar-
allel domains; Domain II is formed from four parallel and one antiparallel strand. Bottom: stereo
Ca diagram of the N lobe of lactoferrin; (e) iron atom between domain 1 (residues 6-90 +)
and domain II (residues 91-251); (_) disulfide bridges; (*) carbohydrate attachment site. See
Reference 39.
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Earth grew in a reducing atmosphere, in which the iron was substantially more
available because it was present as ferrous-containing compounds. In contrast
to the profoundly insoluble ferric hydroxide, ferrous hydroxide is relatively sol-
uble at near neutral pH. It has been proposed that this availability of iron in the
ferrous state was one of the factors that led to its early incorporation in so many
metabolic processes of the earliest chemistry of life. 6,38 In an oxidizing environ-
ment, microorganisms were forced to deal with the insolubility of ferric hydrox-
ide and hence when facing iron deficiency secrete high-affinity iron-binding
compounds called siderophores (from the Greek for iron carrier). More than 200
naturally occurring siderophores have been isolated and characterized to date. 42
Most siderophore-mediated iron-uptake studies in microorganisms have been
performed by using cells obtained under iron-deficient aerobic growth condi-
tions. However, uptake studies in E. coli grown under anaerobic conditions
have also established the presence of siderophore-specific mechanisms. In both
cases, uptake of the siderophore-iron complex is both a receptor- and an energy-
dependent process. In some studies the dependence of siderophore uptake rates
on the concentration of the iron-siderophore complex has been found to conform
to kinetics characteristic of protein catalysts, i.e., Michaelis-Menten kinetics.
For example, saturable processes with very low apparent dissociation constants
of under one micromolar (l fLM) have been observed for ferric-enterobactin
transport in E. coli (a bacterium), as shown in Figure 1.12. Similarly, in a very
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different microorganism, the yeast Rhodoturala pilimanae, Michaelis-Menten
kinetics were seen again with a dissociation constant of approximately 6 JLM
for the ferric complex of rhodotoroulic acid; diagrams of some representative
siderophores are shown in Figure 1. 13. The siderophore used by the fungus
Neurospora crassa was found to have a dissociation constant of about 5 JLM
and, again, saturable uptake kinetics.
o;:l OH~ N
~ CH3S /NS~COOH
pyochelin
mycobactin P
pseudobactin
UOH
yOH
enterobactin
Figure 1.13
Examples of bacterial siderophores. See Reference 42.
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Figure 1.14
Model for enterobactin-mediated Fe uptake in E. coli.
Although the behavior just described seems relatively simple, transport
mechanisms in living cells probably have several more kinetically distinct steps
than those assumed for the simple enzyme-substrate reactions underlying the
Michaelis-Menten mechanism. For example, as ferric enterobactin is accumu-
lated in E. coli, it has to pass through the outer membrane, the periplasm, and
the cytoplasm membrane, and is probably subjected to reduction of the metal in
a low-pH compartment or to ligand destruction.
A sketch of a cell of E. coli and some aspects of its transport behavior are
shown in Figure 1.14. Enterobactin-mediated iron uptake in E. coli is one of
the best-characterized of the siderophore-mediated iron-uptake processes in mi-
croorganisms, and can be studied as a model. After this very potent iron-se-
questering agent complexes iron, the ferric-enterobactin complex interacts with
a specific receptor in the outer cell membrane (Figure 1.14), and the complex
is taken into the cell by active transport. The ferric complexes of some synthetic
analogs of enterobactin can act as growth agents in supplying iron to E. coli.
Such a feature could be used to discover which parts of the molecule are in-
volved in the sites of structural recognition of the ferric-enterobactin complex.
Earlier results suggested that the metal-binding part of the molecule is recog-
nized by the receptor, whereas the ligand platform (the triserine lactone ring;
see Figure 1.13) is not specifically recognized.
To find out which domains of enterobactin are required for iron uptake and
recognition, rhodium complexes were prepared with various domains of enter-
obactin (Figure 1.15) as ligands to use as competitors for ferric enterobactin. 44
The goal was to find out if the amide groups (labeled Domain II in Figure 1.15),
Domain:
(III) metal binding unit
(II) amide linkage
(I) backbone
Figure 1.15
Definition of recognition domains in enterobactin.
which linked the metal-binding catechol groups (Domain III, Figure 1.15) to the
central ligand backbone (Domain I, Figure 1.15), are necessary for recognition
by the receptor protein. In addition, synthetic ligands were prepared that dif-
fered from enterobactin by small changes at or near the catecholate ring. Fi-
nally, various labile trivalent metal cations, analogous to iron, were studied to
see how varying the central metal ion would affect the ability of metal entero-
bactin complexes to inhibit competitively the uptake of ferric enterobactin by
the organism. For example, if rhodium MECAM (Figure 1.16) is recognized by
the receptor for ferric enterobactin on living microbial cells, a large excess of
rhodium MECAM will block the uptake of radioactive iron added as ferric en-
terobactin. In fact, the rhodium complex completely inhibited ferric-enterobactin
uptake, proving that Domain I is not required for recognition of ferric entero-
bactin.
However, if only Domain III is important in recognition, it would be ex-
pected that the simple tris(catecholato)-rhodium(III) complex would be an equally
good inhibitor. In fact, even at concentrations in which the rhodium-catechol
complex was in very large excess, no inhibition of iron uptake was observed,
suggesting that Domain II is important in the recognition process.
The role of Domain II in the recognition process was probed by using a
rhodium dimethyl amide of 2,3-dihydroxybenzene (DMB) as a catechol ligand,
with one more carbonyl ligand than in the tris(catecholato)-rhodium(III) com-
plex. Remarkably, this molecule shows substantially the same inhibition of en-
terobactin-mediated iron uptake in E. coli as does rhodium MECAM itself. Thus,
in addition to the iron-catechol portion of the molecule, the carbonyl groups
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Figure 1.16
MECAM and related enterobactin analogues.
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(Domain II) adjacent to the catechol-binding subunits of enterobactin and syn-
thetic analogs are required for recognition by the ferric-enterobactin receptor. In
contrast, when a methyl group was attached to the "top" of the rhodium ME-
CAM complex, essentially no recognition occurred.
In summary, although the structure of the outer-membrane protein receptor
of E. coli is not yet known, the composite of the results just described gives a
sketch of what the ferric-enterobactin binding site must look like: a relatively
rigid pocket for receiving the ferric-catecholate portion of the complex, and
proton donor groups around this pocket positioned to hydrogen bond to the
carbonyl oxygens of the ferric amide groups. The mechanisms of iron release
from enterobactin, though followed phenomenologically, are still not known in
detail.
2. Zinc, copper, vanadium, chromium, molybdenum, and cobalt
As described in an earlier section, transport problems posed by the six ele-
ments listed in the heading are somewhat simpler (with the exception of chro-
mium) than those for iron. One very interesting recent development has been
the characterization of sequestering agents produced by plants which complex a
number of metal ions, not just ferric ions. A key compound, now well-charac-
terized, is mugeneic acid (Figure 1.17).45 The structural and chemical similari-
C3 C3
Figure 1.17
Structure and a stereo view of mugeneic acid. See Reference 42.
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ties of mugeneic acid to ethylenediaminetetraacetic acid (EDTA) have been noted.
Like EDTA, mugeneic acid forms an extremely strong .~omplex with ferric ion,
but also forms quite strong complexes with copper, zinc, and other transition-
metal ions. The structure of the cobalt complex (almost certainly essentially
identical with that of the iron complex) is shown in Figure 1.18. Like the sid-
erophores produced by microorganisms, the coordination environment accom-
modated by mugeneic acid is essentially octahedral. Although the coordination
properties of this ligand are well laid out, and it has been shown that divalent
metal cations, such as copper, competitively inhibit iron uptake by this ligand,
the detailed process of metal-ion delivery by mugeneic acid and related com-
pounds has not been elucidated.
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Figure 1.18
Molecular structures of the complexes (molecules A and B) and coordination about the cobalt
ion in molecules A and B of the mugeneic acid-Co(III) complex. Bond lengths in A; angles in
degrees. See Reference 42.
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As noted in an earlier section, the biochemistry of vanadium potentially
involves four oxidation states that are relatively stable in aqueous solution. These
are V2+, V3+, va 2+ , and V02 + (the oxidation states 2, 3, 4, and 5, respec-
tively). Since even without added sequestering agents, V2+ slowly reduces water
to hydrogen gas, it presumably has no biological significance. Examples of the
remaining three oxidation states of vanadium have all been reported in various
living systems. One of the most extensively investigated examples of transition-
metal-ion accumulation in living organisms is the concentration of vanadium in
sea squirts (tunicates), which is reported to be variable; many species have van-
adium levels that are not exceptionally high. Others such as Ascidia nigra show
exceptionally high vanadium concentrations. 46
In addition to showing a remarkable concentration of a relatively exotic
transition-metal ion, tunicates are a good laboratory model for uptake experi-
ments, since they are relatively simple organisms. They possess a circulation
system with a one-chambered heart, and a digestive system that is essentially a
pump and an inlet and outlet valve connected by a digestive tract. The organism
can absorb dissolved vanadium directly from sea water as it passes through the
animal. The influx of vanadate into the blood cells of A. nigra has been studied
by means of radioisotopes. The corresponding influx of phosphate, sulfate, and
chromate (and the inhibition of vanadate uptake by these structurally similar
oxoanions) has been measured. In the absence of inhibitors, the influx of vana-
date is relatively rapid (a half-life on the order of a minute near ODe) and the
uptake process shows saturation behavior as the vanadate concentration is in-
creased. The uptake process (in contrast to iron delivery in microorganisms, for
example, and to many other uptake processes in microorganisms or higher ani-
mals) is not energy-dependent. Neither inhibitors of glycolysis nor decouplers
of respiration-dependent energy processes show any significant effect on the rate
of vanadate influx.
Phosphate, which is also readily taken up by the cells, is an inhibitor of
vanadate influx. Neither sulfate nor chromate is taken up significantly, nor do
they act as significant inhibitors for the vanadate uptake. Agents that inhibit
transport of anions, in contrast, were found to inhibit uptake of vanadate into
the organism. These results have led to the model proposed in Figure 1.19:
(1) vanadate enters the cell through anionic channels; this process elimi-
nates positively charged metal ion or metal-ion complexes present in
sea water;
(2) vanadate is reduced to vanadium(III); since the product is a cation, and
so cannot be transported through the anionic channels by which vana-
date entered the cell, the vanadium(III) is trapped inside the cell-the
net result is an accumulation of vanadium. [It has been proposed that
the tunichrome could act either as a reducing agent (as the complex) or
(as the ligand) to stabilize the general vanadium(ill); however, this seems
inconsistent with its electrochemical properties (see below).]
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Figure 1.19
Diagram of a vanadium accumulation mechanism. Vanadium enters the vacuole within the vana-
docyte as mononegative H2Y04-, although it may be possible for the dinegative anion, HYO~-,
to enter this channel as well (X - stands for any negative ion such as Cl- , H2PO,;- , etc., that
may exchange across the membrane through the anionic channel). Reduction to y3+ takes place
in two steps, via a Y(IY) intermediate. The resulting cations may be trapped as tightly bound
complexes, or as free ions that the anionic channel will not accept for transport. The nature of
the reducing species is unknown.
Synthetic models of tunichrome b-] (Figure] .20) have been prepared. Tun-
ichrome is a derivative of pyrogallol whose structure precludes the formation of
an octahedral complex of vanadium as a simple] : ] metal: ligand complex. The
close analogue, described as 3,4,5-TRENPAMH9 , also cannot form a simple
octahedral ]:] complex. In contrast, the synthetic ligands TRENCAM and 2,3,4-
TRENPAM can form pseudo-octahedral complexes. The structure of the vana-
dium TRENCAM complex shows that it is indeed a simple pseudo-octahedral
tris-catechol complex. 47 The electrochemical behavior of these complexes is
similar, with vanadium(IVfIll) potentials of about - 0.5 to - 0.6 volts versus
NHE. These results indicate that tunichrome b-l complexes of vanadium(IVfIll)
would show similar differences in their redox couples at high pH. At neutral
pH, in the presence of excess pyrogallol groups, vanadium(IV) can be expected
to form the intensely colored tris-catechol species. However, comparison of the
EPR properties reported for vanadium-tunichrome preparations with model van-
adium(lV)-complexes would indicate predominantly bis(catechol) vanadyl co-
ordination. In any case, the vanadium(III) complexes must remain very highly
reducing. It has been pointed out that the standard potential of pyrogallol is
0.79 V and decreases 60 mV per pH unit (up to about pH 9), so that at pH 7
the potential is about 0.4 V. The potentials of the vanadium couples for the
tunichrome analogs are about - 0.4 V. It has been concluded, therefore, that
tunichrome or similar ligands cannot reduce the vanadium(IV) complex; so the
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Structures of tunichrome b-l and synthetic analogues. 43
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highly reducing vanadium(III) complex of tunichrome must be generated in some
other way. 47
Although a detailed presentation of examples of the known transport prop-
erties of essential transition-metal ions into various biological systems could be
the subject of a large book, the examples that we have given show how the
underlying inorganic chemistry of the elements is used in the biological trans-
port systems that are specific for them. The regulation of metal-ion concentra-
tions, including their specific concentration when necessary from relatively low
concentrations of surrounding solution, is probably one of the first biochemical
problems that was solved in the course of the evolution of life.
Iron is transported in forms in which it is tightly complexed to small che-
lators called siderophores (microorganisms) or to proteins called transferrins (an-
imals) or to citrate or mugeneic acid (plants). The problem of how the iron is
released in a controlled fashion is largely unresolved. The process of mineral
formation, called biomineralization, is a subject of active investigation. Vana-
dium and molybdenum are transported as stable anions. Zinc and copper appear
to be transported loosely associated with peptides or proteins (plants) and pos-
sibly mugeneic acid in plants. Much remains to be learned about the biological
transport of nonferrous metal ions.
C. Iron Biomineralization
Many structures formed by living organisms are minerals. Examples include
apatite [Ca2(OH)P04] in bone and teeth, calcite or aragonite (CaC03) in the
shells of marine organisms and in the otoconia (gravity device) of the mamma-
lian ear, silica (Si02) in grasses and in the shells of small invertebrates such as
radiolara, and iron oxides, such as magnetite (Fe304) in birds and bacteria (nav-
igational devices) and ferrihydrite FeO(OH) in ferritin of mammals, plants, and
bacteria. Biomineralization is the formation of such minerals by the influence of
organic macromolecules, e.g., proteins, carbohydrates, and lipids, on the pre-
cipitation of amorphous phases, on the initiation of nucleation, on the growth
of crystalline phases, and on the volume of the inorganic material.
Iron oxides, as one of the best-studied classes of biominerals containing
transition metals, provide good examples for discussion. One of the most re-
markable recent characterizations of such processes is the continual deposition
of single-crystal ferric oxide in the teeth of chiton. 48 Teeth of chiton form on
what is essentially a continually moving belt, in which new teeth are being
grown and moved forward to replace mature teeth that have been abraded. How-
ever, the study of the mechanisms of biomineralization in general is relatively
recent; a great deal of the information currently available, whether about iron in
ferritin or about calcium in bone, is somewhat descriptive.
Three different forms of biological iron oxides appear to have distinct rela-
tionships to the proteins, lipids, or carbohydrates associated with their formation
and with the degree of crystallinity. 49 Magnetite, on the one hand, often forms
almost perfect crystals inside lipid vesicles of magneto-bacteria. 50 Ferrihydrite,
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on the other hand, exists as large single crystals, or collections of small crystals,
inside the protein coat of ferritin; however, iron oxides in some ferritins that
have large amounts of phosphate are very disordered. Finally, goethite [a-
FeO(OH)] and lepidocrocite [y-FeO(OH)] form as small single crystals in a
complex matrix of carbohydrate and protein in the teeth of some shellfish (lim-
pets and chitons); magnetite is also found in the lepidocrocite-containing teeth.
The differences in the iron-oxide structures reflect differences in some or all of
the following conditions during formation of the mineral: nature of co-precipi-
tating ions, organic substrates or organic boundaries, surface defects, inhibitors,
pH, and temperature. Magnetite can form in both lipid and protein/carbohydrate
environments, and can sometimes be derived from amorphous or semicrystalline
ferrihydrite-like material (ferritin). However, the precise relationship between
the structure of the organic phase and that of the inorganic phase has yet to be
discovered. When the goal of understanding how the shape and structure of
biominerals is achieved, both intellectual satisfaction and practical commercial
and medical information will be provided.
Synthetic iron complexes have provided models for two stages of ferritin
iron storage and biomineralization: 51-59 (1) the early stages, when small num-
bers of clustered iron atoms are bound to the ferritin protein coat, and (2) the
final stages, where the bulk iron is a mineral with relatively few contacts to the
protein coat. In addition, models have begun to be examined for the microen-
vironment inside the protein coat. 54
Among the models for the early or nucleation stage of iron-core formation
are the binuclear Fe(III) complexes with [Fe20(02CR2)]2+ cores;55,56 the three
other Fe(III) ligands are N. The JL-oxo complexes, which are particularly accu-
rate models for the binuclear iron centers in hemerythrin, purple acid phospha-
tases, and, possibly, ribonucleotide reductases, may also serve as models for
ferritin, since an apparently transient Fe(II)-O-Fe(III) complex was detected dur-
ing the reconstitution of ferritin from protein coats and Fe(II). The facile ex-
change of (02CR) for (02PR) in the binuclear complex is particularly significant
as a model for ferritin, because the structure of ferritin cores varies with the
phosphate content. An asymmetric trinuclear (Fe30) 7+ complex 57 and an (FeO)l1
complex (Figure 1.21) have been prepared; these appear to serve as models for
later stages of core nucleation (or growth). 59
Models for the full iron core of ferritin include ferrihydrite, which matches
the ordered regions of ferritin cores that have little phosphate; however, the site
vacancies in the lattice structure of ferrihydrite [FeO(OH)] appear to be more
regular than in crystalline regions of ferritin cores. A polynuclear complex of
iron and microbial dextran (a-l,4-D-glucose)n has spectroscopic (M6ssbauer,
EXAFS) properties very similar to those of mammalian ferritin, presumably
because the organic ligands are similar to those of the protein (-OH, -COOH).
In contrast, a polynuclear complex of iron and mammalian chondroitin sulfate
(a-l ,4-[a-1 ,3-D-glucuronic acid-N-acetyl-D-galactosamine-4-sulfate]n) contains
two types of domains: one like mammalian ferritin [FeO(OH)] and one like
hematite (a-Fe203), which was apparently nucleated by the sulfate, emphasizing
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Figure 1.21
The structure of a model for a possible intermediate in the formation of the ferritin iron core.
The complex consists of 11 Fe(III) atoms with internal oxo-bridges and a coat of benzoate li-
gands; the Fe atoms define a twisted, pentacapped trigonal prism. See Reference 53.
the importance of anions in the structure of iron cores. 60 Finally, a model for
iron cores high in phosphate, such as those from bacteria, is Fe-ATP (4: 1), in
which the phosphate is distributed throughout the polynuclear iron complex,
providing an average of 1 or 2 of the 6 oxygen ligands for iron. 61
The microenvironment inside the protein coat of ferritin has recently been
modeled by encapsulating ferrous ion inside phosphatidylcholine vesicles and
studying the oxidation of iron as the pH is raised. The efficacy of such a model
is indicated by the observation of relatively stable mixtures of Fe(II)/Fe(III)
inside the vesicles, as have also been observed in ferritin reconstituted experi-
mentally from protein coats and ferrous ion. 43 ,54
Models for iron in ferritin must address both the features of traditional metal-
protein interactions and the bulk properties of materials. Although such model-
ing may be more difficult than other types of bioinorganic modeling, the diffi-
culties are balanced by the availability of vast amounts of information on Fe-
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protein interactions, corrosion, and mineralization. Furthermore, powerful tools
such as x-ray absorption, Mossbauer and solid state NMR spectroscopy, scan-
ning electron and proton microscopy, and transmission electron microscopy re-
duce the number of problems encountered in modeling the ferritin ion core.
Construction of models for biomineralization is clearly an extension of mod-
eling for the bulk phase of iron in ferritin, since the major differences between
the iron core of ferritin and that of other iron-biominerals are the size of the
final structure, the generally higher degree of crystallinity, and, at this time, the
more poorly defined organic phases. A model for magnetite formation has been
provided by studying the coulometric reduction of half the Fe 3+ atoms in the
iron core of ferritin itself. Although the conditions for producing magnetite have
.yet to be discovered, the unexpected observation of retention of the Fe 2+ by
the protein coat has provided lessons for understanding the iron core of ferritin.
Phosphatidyl choline vesicles encapsulating Fe 2+ appear to serve as models for
both ferritin and magnetite; only further investigation will allow us to under-
stand the unique features that convert Fe 2+ to [FeO(OH)], on the one hand, and
Fe304, on the other.
III. SUMMARY
Transition metals (Fe, Cu, Mo, Cr, Co, Mn, V) play key roles in such biolog-
ical processes as cell division (Fe, Co), respiration (Fe, Cu), nitrogen fixation
(Fe, Mo, V), and photosynthesis (Mn, Fe). Zn participates in many hydrolytic
reactions and in the control of gene activity by proteins with "zinc fingers."
Among transition metals, Fe predominates in terrestial abundance; since Fe is
involved in a vast number of biologically important reactions, its storage and
transport have been studied extensively. Two types of Fe carriers are known:
specific proteins and low-molecular-weight complexes. In higher animals, the
transport protein transferrin binds two Fe atoms with high affinity; in microor-
ganisms, iron is transported into cells complexed with catecholates or hydroxa-
mates called siderophores; and in plants, small molecules such as citrate, and
possibly plant siderophores, carry Fe. Iron complexes enter cells through com-
plicated paths involving specific membrane sites (receptor proteins). A problem
yet to be solved is the form of iron transported in the cell after release from
transferrin or siderophores but before incorporation into Fe-proteins.
Iron is stored in the protein ferritin. The protein coat of ferritin is a hollow
sphere of 24 polypeptide chains through which Fe2+ passes, is oxidized, and
mineralizes inside in various forms of hydrated Fe203. Control of the formation
and dissolution of the mineral core by the protein and control of protein synthe-
sis by Fe are subjects of current study.
Biomineralization occurs in the ocean (e.g., Ca in shells, Si in coral reefs)
and on land in both plants (e.g., Si in grasses) and animals (e.g., Ca in bone,
Fe in ferritin, Fe in magnetic particles). Specific organic surfaces or matrices of
protein and/or lipid allow living organisms to produce minerals of defined shape
and composition, often in thermodynamically unstable states.
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I. INTRODUCTION
This chapter deals with metalloenzymes wherein the metal acts mainly as a
Lewis acid; i.e., the metal does not change its oxidation state nor, generally, its
protein ligands. Changes in the coordination sphere may occur on the side ex-
posed to solvent.
The substrate interacts with protein residues inside the active cavity and/or
with the metal ion in order to be activated, so that the reaction can occur. Under
these circumstances the catalyzed reactions involve, as central steps with often
complex reaction pathways, the following bond-breaking and/or formation pro-
cesses:
peptide hydrolysis
H H
I I
R-C-N-R' + H 0 ~ R-C-O- + H-W-R'
II 2 II I
o 0 H
carboxylic ester hydrolysis
R-C-O-R' + H 0 ~ R-C-O- + H-O-R' + W
II 2 II
o 0
(2.1)
(2.2)
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phosphoric ester hydrolysis
0- 0-
I I
H-O-P-O-R'+HO ~ H-O-P-O-+H-O-R'+W (2.3)
II 2 II
o 0
nucleophilic addition of OH- and H-
0 H O- R RII
"'- / I IH-O- ---t C ----'" O-C ;O=C <--- H- ~ -O-C-H (2.4)
-----II ~ I I
0 0 R' R'
Scheme (2.3) also pertains to the reactions which need ATP hydrolysis to pro-
mote endoenergetic reactions.
We will also briefly deal with coenzyme BIZ; this is a cobalt(III) complex
that, by interacting with a number of proteins, produces an R-CHz radical by
homolytic breaking of the Co-C bond as follows:
H H
I I
Ca(lil) - C - R ---t Ca(ll) + 'C - R
I I
H H
(2.5)
After an R-CHz radical is formed, it initiates a radical reaction. This is the
only system we treat in which the oxidation state changes.
II. THE NATURAL CATALYSTS
Table 2.1 lists metalloenzymes that catalyze hydrolytic and related reactions.
According to the above guidelines the hydrolysis of peptide bonds is catalyzed
by enzymes called peptidases that belong to the class of hydrolases (according
to the official enzyme classification). Two peptidases (carboxypeptidase and
thermolysin) are known in great detail, because their structures have been elu-
cidated by high-resolution x-ray crystallography. They share many features; e.g.,
their metal ions coordinate to the same kind of protein residues. A discussion
of the possible mechanism of carboxypeptidase A will be given in Section V.A.
Metallopeptidases are zinc enzymes: generally they are single polypeptide chains
with molecular weights in the range 30 to 40 kDa. Metallohydrolases of carbox-
ylic and phosphoric esters are also often zinc enzymes. Alkaline phosphatase
will be described in Section V.B as a representative of this class. Magnesium
is sometimes involved in hydrolytic reactions. This is common when phosphate
groups are involved, probably because the affinity of Mg2+ for phosphate groups
is high. I However, hydrolytic reactions can be performed by other systems (not
treated here) like urease, which contains nickel(II),z or acid phosphatase, which
contains two iron ions,3 or aconitase, which contains an Fe4S4 cluster.4
II. THE NATURAL CATALYSTS
Table 2.1
Representative metalloenzymes catalyzing hydrolytic and related reactions.
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Enzyme
Carboxypeptidase
Leucine aminopeptidases
Dipeptidase
Neutral protease
Collagenase
Phospholipase C
f3-Lactamase II
Thermolysin
Alkaline phosphatase
Carbonic anhydrase
a-Amylase
Phospholipase A2
Inorganic pyrophosphatase
ATPase
Na + -K + -ATPase
Mg 2+ -Ca 2+ -ATPase
Phosphatases
Creatine kinase
Pyruvate kinase
Phosphoglucomutase
DNA polymerase
Alcohol dehydrogenase
Metal(s)
Zn 2+
Zn2+
Zn 2+
Zn 2+, Ca 2+
Zn 2+
Zn 2 +
Zn 2+
Zn 2+, Ca 2+
Zn 2+, Mg2+
Zn 2 +
Ca 2+, Zn 2+
Ca2+
Mg 2 +
Mg 2 +
Na +, K +
Mg 2 +, Ca 2+
Mg 2+, Zn 2+
M 2 +
M +, M 2 +
Mg 2 +
Mg 2 + (Mn 2+)
Zn 2 +
Function
Hydrolysis of C-terminal peptide residues
Hydrolysis of leucine N-terminal peptide residues
Hydrolysis of dipeptides
Hydrolysis of peptides
Hydrolysis of collagen
Hydrolysis of phospholipids
Hydrolysis of f3-lactam ring
Hydrolysis of peptides
Hydrolysis of phosphate esters
Hydration of CO2
Hydrolysis of glucosides
Hydrolysis of phospholipids
Hydrolysis of pyrophosphate
Hydrolysis of ATP
Hydrolysis of ATP with transport of cations
Hydrolysis of phosphate esters
Phosphorylation of creatine
Dephosphorylation of phosphoenolpyruvate
Phosphate transfer converting glucose-I-phosphate to
glucose-6-phosphate
Polymerization of DNA with formation of phosphate esters
Hydride transfer from alcohols to NAD +
Examples of enzymes catalyzing nucleophilic addition of OH - (other than
hydrolysis) and H - are carbonic anhydrase and alcohol dehydrogenase. Both
are zinc enzymes. In the official biochemical classification of enzymes, carbonic
anhydrase belongs to the class of lyases. Lyases are enzymes that cleave C-C,
C-O, C-N, or other bonds by elimination, leaving double bonds, or con-
versely add groups to double bonds. Carbonic anhydrase has a molecular weight
around 30 kDa, and is among the most-studied metalloenzymes. It catalyzes the
deceivingly simple CO2 hydration reaction. The subtleties of its biological func-
tion, unraveled by a combination of techniques, make it an ideal example for
bioinorganic chemistry. Section IV is fully dedicated to this enzyme. Alcohol
dehydrogenase is a 90-kDa enzyme that catalyzes the reversible transfer of a
hydride ion from alcohols to NAD +. Although it is a redox enzyme (in fact,
classified as an oxidoreductase) and not a hydrolytic one, it will illustrate a
different use that Nature makes of zinc to catalyze nucleophilic attack at carbon
(Section V.C).
Finally, the enzymatic transfer of organic radicals by enzymes involving
coenzyme B12 will be briefly considered.
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III. STRATEGIES FOR THE INVESTIGATION OF ZINC ENZYMES
A. Why Zinc?
Zinc has a specific role in bioinorganic processes because of the peculiar prop-
erties of the coordination compounds of the zinc(II) ion.
(1) Zinc(II) can easily be four-, five-, or six-coordinate, without a marked
preference for six coordination. The electronic configuration of zinc(II) is 3d 10
with two electrons per orbital. In coordination compounds, there is no ligand-
field stabilization energy, and the coordination number is determined by a bal-
ance between bonding energies and repulsions among the ligands. Tetrahedral
four-coordinate complexes have shorter metal-donor distances than five-coordi-
nate complexes, and the latter have shorter ones than six-coordinate complexes
(Table 2.2), whereas the ligand repulsion increases in the same order. The re-
Table 2.2
Average zinc(II)-donor atom
distances (A) for some common
zinc(II) ligands in four-, five-, and
six-coordinate complexes.5
Coordination number
Ligand 4 5 6
H2O 2.00 2.08 2.10
R-COO - 1.95 2.02 2.07
Imidazole 2.02 2.08
Pyridine 2.06 2.12 2.11
R-NHz 2.06 2.15
R,R'NH 2.19 2.27
pulsion can be both steric and electronic. In enzymes, zinc(II) usually has co-
ordination numbers smaller than six, so that they have available binding sites in
their coordination spheres. Substrate can in principle bind to zinc by substituting
for a coordinated water or by increasing the coordination number. This behavior
would be typical of Lewis acids, and, indeed, zinc is the most common Lewis
acid in bioinorganic chemistry. Zinc could thus substitute for protons in the task
of polarizing a substrate bond, e.g., the carbonyl C-O bond of peptides and
esters, by accepting a substrate atom (oxygen) as a ligand. This has been shown
to be possible in model systems. Relative to the proton, a metal ion with an
available coordination position has the advantage of being a "superacid," 6 in
the sense that it can exist at pH values where the H30 + concentration is ex-
tremely low. Also, relative to the proton, the double positive charge partly com-
pensates for the smaller electrophilicity due to the smaller charge density.
(2) As a catalyst, zinc in zinc enzymes is exposed to solvent, which for
enzymes is almost always water. A coordinated water molecule exchanges rap-
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idly, because ligands in zinc complexes are kinetically labile. This, again, can
be accounted for by zinc's lack of preference for a given coordination number.
A six-coordinate complex can experience ligand dissociation, giving rise to a
five-coordinate complex with little energy loss and then little energetic barrier.
On the other side, four-coordinate complexes can add a fifth ligand with little
energetic barrier and then another ligand dissociates. 7 The coordinated water has
a pKa sizably lower than free water. Suitable models have been synthesized and
characterized in which a solvent water molecule coordinated to various diposi-
tive metal ions has pKa values as low as 7 (Table 2.3). This is the result of the
formation of the coordination bond. The oxygen atom donates two electrons to
Table 2.3
The pKa values of coordinated water in some metal complexes.
Complex Note Donor set pKa Reference
Ca(N03h(OH2)4 Z+ 0 6 10.3 8
Cr(OH2)63+ 0 6 4.2 8
Cr(NH3)sOHz3 + NsO 5.1 8
Mn(OHz)62+ 0 6 10.5 8
Fe(OH2)6 3 + 0 6 1.4 8
CO(OHZ)6 2 + 0 6 9.8 8
Co(dacoda)OH2 2 + (a) N20 3 9.4 9
Co(TPyMA)OH2 2 + (b) N40 9.0 10
Co(TMC)OH2 2 + (c) N40 8.4 11
Co(CR)OH/+ (d) N40 8.0 12
Co(NH3)sOH2 3 + NsO 6.2 8
Ni(OHz)6 2 + 0 6 10.0 8
Cu(OH2)6 2 + 0 6 7.3 8
Cu(DMAM-PMHD)Om+ (e) N30 2 7.1 13
Cu(C-PMHD)OH2+ (f) N20 3 6.6 14
Zn(OH2)6z+ 0 6 9.0 8
Zn(DMAM-PMHD)Om+ (e) N30 9.2 13
Zn(C-PMHD)OHt (f) N30 2 7.1 14
Zn(CR)OH2 2 + (d) N40 8.7 12
Zn([ 12]aneN3)Om+ (g) N30 7.3 15,16
Zn(HP[ 12]aneN3)OHt (h) N30 2 10.7 16
Zn(TImMP)OHi+ (i) N30 <7 17
Co(TImMP)OHi + (i) N30 7.8 17
(a) dacoda = 1,4-diaza-cyciooctane-l ,4-diacetate. (b) TPyMA = tris(3,5-di-
methyl-l-pyrazolyJmethyl)amine. (c) TMC = 1,4,8,1l-tetramethyl-l,4,8,1l-te-
traaza-cyciotetradecane. (d) CR = Schiff base between 2,6-diacetylpyridine and
bis(3-aminopropyl)amine. (e) DMAM-PMHD = 1-[(6(dimethylamino)methyl)-2-
pyridyl)methyl]hexahydro-l,4-diazepin-5-one. (f) C-PMHD = 1[(6-carboxy)-2-
pyridyl)methyl]hexa-hydro-l,4-diazepin-5-one. (g) [l2]aneN3 = 1,5,9-triaza-cy-
clododecane. (h) HP[12]aneN j = 2-(2-hydroxyphenylate)-1,5,9-triaza-cyciodo-
decane. (i)TImMP = tris(4,5-dimethyl-2-imidazolylmethyl)phosphinoxide.
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the metal ion and formally becomes positively charged:
H • N M+
"01 + M2 + -----"" "0+/
H/ ~ N/-
Under these conditions a proton is easily released. The nucleophilicity of coor-
dinated water is, of course, decreased with respect to free water, owing to the
decreased electronic charge on the oxygen atom, but a significant concentration
of M-OH species may exist in neutral solution. In tum, the coordinated hy-
droxide is a slightly poorer nucleophile than the free OH - ion, but better than
water. On the basis of recent MO calculations,18 the order of nucleophilicity for
solvent-derived species can be summarized as follows:
Therefore, at neutral or slightly alkaline pH, the small decrease in efficiency of
coordinated vs. free hydroxide ions is more than compensated for by the higher
concentration of reactive species available (i.e., HO-M + vs. HO -). Another
common role for zinc enzymes is thus to provide a binding site at which the
substrate can be attacked by the metal-coordinated hydroxide:
Zn -
01 ----+ Substrate
\
H
The pKa of coordinated water in zinc complexes is controlled by the coor-
dination number and by the total charge of the complex, in the sense that it
decreases with decreasing coordination number and with increasing positive charge,
because a zinc ion, bearing in effect a more positive charge, will have greater
attraction for the oxygen lone pair, thus lowering the pKa. Charged ligands af-
fect water pKa's more than does the number of ligands. 18 The pKa in metallo-
proteins is further controlled by the presence of charged groups from protein
side chains inside the cavity or by the binding of charged cofactors. The coor-
dinated water may have a pKa as low as 6, as in carbonic anhydrase (see later).
On the other hand, the pKa of the coordinated water is 7.6 in liver alcohol
dehydrogenase (LADH) when NAD + is bound, 9.2 in the coenzyme-free en-
zyme, and 11.2 in the presence of NADH (see Section V.C).
(3) As mentioned before, Zn complexes show facile four- to five-coordinate
interconversion. The low barrier between these coordination geometries is quite
important, because the substrate may add to the coordination sphere in order to
replace the solvent or to be coordinated together with the solvent. If the inter-
conversion between four- and five-coordination is fast, catalysis is also fast.
Thus, to summarize, zinc is a good Lewis acid, especially in complexes
with lower coordination numbers; it lowers the pKa of coordinated water and is
kinetically labile, and the interconversion among its four-, five-, and six-coor-
dinate states is fast. All of these properties make zinc quite suitable for biolog-
ical catalysis. 19
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1. The groups to which zinc(lI) is bound
Zinc(II) is an ion of borderline hardhess and displays high affinity for nitro-
gen and oxygen donor atoms as well as for sulfur. It is therefore found to be
bound to histidines, glutamates or aspartates, and cysteines. When zinc has a
catalytic role, it is exposed to solvent, and generally one water molecule com-
pletes the coordination, in which case the dominating ligands are histidines. It
has been noted 20 recently that coordinated histidines are often hydrogen-bonded
to carboxylates:
~
zn-N,,=\N-H ····0" ,ft0
- c
I
It is possible that the increase in free energy for the situation in which the
hydrogen is covalently bound to the carboxylate oxygen and H-bonded to the
histidine nitrogen is not large compared to kBT. Under these circumstances the
protein could determine the degree of imidazolate character of the ligand and
therefore affect the charge on the metal.
The binding of zinc(II) (like that of other metal ions) is often determined by
entropic factors. Water molecules are released when zinc(II) enters its binding
position, thus providing a large entropy increase. Most commonly zinc is bound
to three or four protein ligands. Large entropy increases are not observed, how-
ever, when zinc(II) binds to small polypeptides like the recently discovered zinc
fingers, for here the binding site is not preformed (see Section III.B), and zinc(II)
must be present for the protein to fold properly into the biologically active con-
formation.
2. The reactivity of zinc(lI) in cavities
In the preceding section we discussed the properties of zinc(II) as an ion.
These properties are, of course, important in understanding its role in biological
catalysis, but it would be too simplistic to believe that reactivity can be under-
stood solely on this basis. Catalysis occurs in cavities whose surfaces are con-
stituted by protein residues. Catalytic zinc is bound to a water molecule, which
often is H-bonded to other residues in the cavity and/or to other water mole-
cules. The structure of the water molecules in the cavity cannot be the same as
the structure of bulk water. Furthermore, the substrate interacts with the cavity
residues through either hydrophilic (H-bonds or electric charges) or hydrophobic
(London dispersive forces) interactions. As a result, the overall thermodynamics
of the reaction pathway is quite different from that expected in bulk solutions.
Examples of the importance of the above interactions will be given in this chap-
ter.
3. The investigation of zinc enzymes
Direct spectroscopic investigation of zinc enzymes is difficult, because zinc(II)
is colorless and diamagnetic; so it cannot be studied by means of electronic or
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EPR spectroscopy. Its NMR-active isotope, 67Zn, the natural abundance of which
is 4.11 percent, has a small magnetic moment, and cannot (with present tech-
niques) be examined by means of NMR spectroscopy at concentrations as low
as 10- 3 M. The enzymes could be reconstituted with 67Zn. However, 67Zn has
a nuclear quadrupolar moment, which provides efficient relaxation times, espe-
cially in slow-rotating proteins and low-symmetry chromophores, making the
line very broad. 210 Of course, IH NMR can be useful for the investigation of
the native enzymes. However, often the molecular weight is such that the pro-
teins are too large for full signal assignment given the current state of the art.
At the moment the major source of information comes from x-ray data. Once
the structure is resolved, it is possible to obtain reliable structural information
on various derivatives by the so-called Fourier difference map. The new struc-
ture is obtained by comparing the Fourier maps of the native and of the deriva-
tive under investigation. Many x-ray data are now available on carboxypeptidase
(Section V.A) and alcohol dehydrogenase (Section V.C).
The zinc ion can be replaced by other ions, and sometimes the enzymatic
activity is retained fully or partially (Table 2.4). These new systems have at-
tracted the interest of researchers who want to learn about the role of the metal
and of the residues in the cavity, and to characterize the new systems per se.
Table 2.4
Representative metal-substituted zinc enzymes. Percent activities with respect to the na-
tive zinc enzyme in parentheses.a
Enzyme
Alcohol dehydrogenase
Superoxide dismutase
Aspartate transcarbamylase
Transcarboxylase
RNA polymerase
Carboxypeptidase A
Thermolysin
Alkaline phosphatase
f3-Lactamase II
Carbonic anhydrase C
Aldolase
Pyruvate carboxylase
Glyoxalase
Substituted metals
Co(II)(70), Cu(II)(I), Cu(I)(8), Cd(II)(30), Ni(II)(l2)
Co(II)(90), Hg(II)(90), Cd(II)(70), Cu(II)( 100)
Cd(II)( I00), Mn(II)( 100), Ni(II)( 100)
Co(II)(lOO), Cu(II)(O)
Co(II)(100)
Mn(II)(30), Fe(II)(30), Co(II)(200), Ni(II)(50), Cu(II)(O), b
Cd(II)(5), Hg(II)(O), Co(III)(O), Rh(II)(O), Pb(II)(O)
Co(Il)(200), Mn(II)(l 0), Fe(II)(60), Mg(II)(2), Cr(II)(2) ,
Ni(II)(2), Cu(II)(2), Mo(II)(2), Pb(II)(2), Cd(II)(2), Nd(III)(2),
Pr(III)(2)
Co(II)(30), Cd(II)( I), Mn(II)(1), Ni(II)(O), Cu(II)(O), Hg(II)(O)
Mn(II)(3), Co(II)(11), Ni(II)(O), Cu(II)(O), Cd(II)(ll), Hg(II)(4)
Cd(II)(2), Hg(II)(O), Cu(II)(O), Ni(II)(2), Co(II)(50), Co(III)(O),
Mn(II)(18), V(IV)02+(0)
Mn(II)(15), Fe(II)(67), Co(II)(85), Ni(II)(lI), Cu(II)(O),
Cd(II)(O), Hg(II)(O)
Co(lI)(100)
Mg(II)(50), Mn(II)(50), Co(II)(50)
a Taken from Reference 21.
b Recent data indicate nonnegligible catalytic activity. 22
C BCA II, except the value for Cd(II) obtained with HCA II.
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Spectroscopic techniques can be appropriate for the new metal ions; so it is
possible to quickly monitor properties of the new derivative that may be relevant
for the investigation of the zinc enzyme.
B. Metal Substitution
With zinc enzymes, metallosubstitution is a convenient tool for monitoring the
protein and its function by means of spectroscopic techniques. Furthermore, it
is interesting to learn how reactivity depends on the nature of the metal ion and
its coordination properties, because much of it depends on the protein structure,
which seemingly remains constant. As discussed, zinc enzymes can be studied
by replacing zinc with other spectroscopically useful metal ions, whose activi-
ties have been checked, and by transferring the information obtained to the
native enzyme. The strategy of metal substitution is not limited to zinc enzymes,
since it has been used for magnesium-activated enzymes and, occasionally, other
metalloenzymes as well.
By dialyzing a protein solution against chelating agents, such as EDTA,
1,IO-phenanthroline, or 2,6-dipicolinic acid at moderately acidic pH, or by re-
versibly unfolding the protein with denaturing agents (as has been done with
alkaline phosphatase), one can cause zinc proteins to release their metal ions,
giving rise to the corresponding but inactive apoprotein. Sometimes (e.g., by
using alcohol dehydrogenase) dialysis against chelating agents can be applied to
a suspension of protein microcrystals. In this way the chelating agent is still
able to reach and remove the active site metal by slowly diffusing in the crystals
through the hydration water, while the apoprotein is maintained in the native
conformation by the crystal packing forces and denaturation is avoided. After
the chelating agent is dialyzed out, often against a high-salt (e.g., CIOi) buffer
to reduce nonspecific binding, a new metalloprotein can obtained by addition of
the appropriate metal salt. 23
Cobalt(II)-substituted zinc proteins often show about as much activity as the
native zinc enzymes (Table 2.4). This is a general characteristic of the cobalt-
substituted zinc enzymes,24 since the coordination chemistry of cobalt(II) is very
similar to that of zinc(II). The two ions also show virtually identical ionic radii.
Cobalt(II) derivatives generally display useful electronic spectra. High-spin co-
balt(II) ions are paramagnetic, containing three unpaired electrons (5 = ~); thus
they can also give rise to EPR spectra. The electronic relaxation times, i.e., the
average lifetimes of the unpaired electrons in a given spin state of the 5 mani-
fold ( -!, - i, i, ~), are very short (lO - 11 to 10 - J2 s) at room temperature. In
order to detect EPR spectra, the sample temperature is usually decreased, often
down to liquid helium temperature, to increase the electronic relaxation times
and sharpen the EPR linewidths. On the other hand, as the paramagnetic broad-
ening of the NMR lines in such systems is inversely proportional to the elec-
tronic relaxation times (see Section IV.C.3), room-temperature IH NMR spectra
of cobalt(II) complexes can be easily detected, even in the absence of chemical
exchange. Therefore cobalt(II) is an exceptional probe to monitor the structure
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and reactivity of zinc enzymes. Of course, the transfer of information from the
artificial to the native enzyme must be done with cauti{)n. However, if we can
understand the functioning of the cobalt enzyme, we then have a reference frame
by which to understand the kinetic properties of the native enzyme. The spec-
troscopic properties of cobalt(Il) in cobalt-substituted proteins have been re-
viewed. 25
Copper(Il)-substituted zinc proteins are generally inactive with respect to the
natural and most artificial substrates (Table 2.4). In model compounds cop-
per(Il) is often principally four-coordinate, with at most two more ligands pre-
sent at metal-ligand distances that are longer than normal coordination bonds.
As a consequence, the ability of zinc to switch between four- and five-coordi-
nate species without any appreciable barrier and with usual metal-donor dis-
tances is not mimicked by copper. Furthermore, binding at the four principal
coordination positions is generally stronger for copper than for zinc. It follows
that substrates may have slow detachment kinetics. These properties are unfa-
vorable for catalysis.
Copper(II) can be easily and meaningfully studied by means of electronic
spectroscopy. Moreover, the EPR spectra can be recorded even at room temper-
ature because of the long electronic relaxation times, which are of the order of
10 -9 s. Because a protein is a macromolecule, it rotates slowly, and the EPR
spectra in solution at room temperature look like those of crystalline powders or
frozen solutions (powder-like spectra). ENDOR spectra are also easily obtained
for copper proteins at low temperatures, because at low temperature the elec-
tronic relaxation times are even longer, and saturation of the EPR lines (which
is a requirement to obtain ENDOR spectra) is easy to accomplish. The long
electronic relaxation times make the broadening effects on the NMR lines of
nuclei sensing the metal ion too severe; so these lines, unlike those of cobalt(Il)
complexes, generally escape detection. However, if the nucleus under investi-
gation is in fast exchange between a free species in large excess and a bound
species, the line may be observed, because the broadening effects are scaled
down by a factor equal to the molar fraction of bound species. The nuclear
relaxation parameters contain precious structural and/or dynamic information (see
Section IV.C.3). The spectroscopic properties of copper(II) in proteins have
been extensively reviewed. 26,27
Cadmium-substituted zinc proteins may also be active (Table 2.4), although
usually at higher pH. This observation is readily explained in terms of the pKa
of a coordinated water, which is expected to be higher than that of analogous
zinc complexes because the cadmium ion is larger and polarizes the Cd-OH2
bond less.
113Cd and 111Cd are nuclei with relatively high sensitivity for NMR spectro-
scopic study. The 113Cd chemical shift spans from - 200 to 800 ppm relative
to CdS04 in H20, depending on the number and nature of donor atoms. 24,28
Sulfur donor atoms cause larger downfield shifts than oxygens or nitrogens, and
the downfield shift increases with decreasing number of donor atoms. Therefore,
113Cd NMR probes have been used extensively to study zinc enzymes, metal-
storage proteins like thioneins, and other proteins with cysteine ligands, and
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chemical shifts in various cadmium proteins, together with the proposed ligand
donor set, have been obtained (Figure 2.1).
Manganese(II)-containing proteins give rise to detectable EPR signals; how-
ever, their interpretation in terms of structure and dynamics is not always infor-
mative. The electronic relaxation times of Mn 2 + are the longest among metal
ions, of the order of 10 -8 S at room temperature and at the magnetic fields of
interest. This property and the large S = i value account for a large NMR
linewidth, even larger than in copper(II) systems. Manganese(II)- and nickel(II)-
substituted zinc proteins have often been reported to have fractional activity
(Table 2.4).24 Several efforts have been devoted to Mn(II) derivatives, espe-
cially by studying the NMR signals of nuclei in molecules that exchange rapidly
with the metalloprotein.
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Figure 2.1
113Cd chemical shifts in cadmium(II)-substituted
metalloproteins. 24,28 Donor sets and overall
charges (in parentheses) of the complexes are
indicated.
48 2/ THE REACTION PATHWAYS OF ZINC ENZYMES AND RELATED BIOLOGICAL CATALYSTS
Finally, several other metal-substituted zinc metalloprotein derivatives have
been prepared, including those of VO H , Fe(II) , Co(III) , Pt(II) , and HgCh.
Although these systems add little directly to our understanding of the relation-
ship between structure and function of the enzymes, nonetheless they represent
new bioinorganic compounds and are of interest in themselves, or can add in-
formation on the coordinating capabilities, and reactivity in general, of the res-
idues present in the active cavity.
Under the heading zinc enzymes there are several enzymes in which zinc is
essential for the biological function, but is not present in the catalytic site. Among
the most-studied enzymes, zinc has a structural role in superoxide dismutase,
where the ligands are three histidines and one aspartate. In alcohol dehydrogen-
ase there is a zinc ion that has a structural role, besides the catalytically active
one. The former zinc has four cysteine ligands. Cysteine ligands are also present
in zinc thioneins, which are zinc-storage proteins. The recently discovered class
of genetic factors containing "zinc fingers" are zinc proteins in which the metal
has an essentially structural role. 29 Such a role may consist of lowering the
folding enthalpy of a protein to induce an active conformation or to stabilize a
particular quaternary structure.
Zinc may also have a regulatory role; i.e., it does not participate in the
various catalytic steps, but its presence increases the catalytic rate. This is a
rather loose but common definition. Typically, zinc in the B site of alkaline
phosphatase (Section V.B) has such a role, and the ligands are histidines, as-
partates, and water molecules.
The enzymes in which zinc plays a structural or regulatory role will not be
further discussed here, because they do not participate in the catalytic mecha-
nisms; see the broader review articles. 23 ,29,30 Rather, we will describe in some
detail the enzyme carbonic anhydrase, in order to show how researchers have
investigated such complicated systems as enzymes. We will discover as we look
at the details of the structures and mechanisms of enzymes that there are large
differences between reactivities in solution and in enzymatic cavities. The fun-
damental properties underlying these differences are still not fully understood.
IV. ELUCIDATION OF STRUCTURE-FUNCTION RELATIONSHIPS:
CARBONIC ANHYDRASE AS AN EXAMPLE
A. About the Enzyme
Carbon-dioxide hydration and its mechanism in living systems are of fundamen-
tal importance for bioinorganic chemistry. In 1932 the existence of an enzyme
catalyzing CO2 hydration in red blood cells was established,31 The enzyme was
named carbonic anhydrase (abbreviated CA). In 1939 the enzyme was recog-
nized to contain zinc. 32 Because CO2 is either the starting point for photosyn-
thesis or the endpoint of substrate oxidation, carbonic anhydrases are now known
to be ubiquitous, occurring in animals, plants, and several bacteria. Different
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enzymes from different sources, catalyzing the same reaction and usually having
homologous structures, are termed isoenzymes. Sometimes the same organism
has more than one isoenzyme for a particular function, as is true for human
carbonic anhydrase.
CO2 gas is relatively soluble in water (3 x 10 -2 M at room temperature
under Pe02 = 1 atm) , equilibrating with hydrogen carbonate at pKa 6.1:
(2.6)
The uncatalyzed reaction is kinetically slow around physiological pH
(k = 10 -I S -I), whereas, in the presence of the most efficient isoenzyme of
CA, the maximal CO2 turnover number (i.e., the number of substrate molecules
transformed per unit time by each molecule of enzyme) 33 is = 106 S - 1. The
uncatalyzed attack by water on CO2 may be facilitated by two hydrogen-bonded
water molecules, one of which activates the carbon by means of a hydrogen
bond to a terminal CO2 oxygen, the other of which binds the carbon atom via
oxygen: 34,35
H H-------- 0
"- / / "-o H H
t /
o=c=o
(2.7)
Only above pH 9 does the uncatalyzed reaction become fast, owing to direct
attack of OH -, which is a much better nucleophile than H20 (k = 104 M -IS -1,
where M -1 refers to the OH - concentration):
(2.8)
On the other hand, the rate constant in the presence of the enzyme, called kcat,
is pH-independent above pH 8 in every CA isoenzyme (Figure 2.2).33,36
In vitro, carbonic anhydrase is quite versatile, catalyzing several reactions
that involve both OH - and H + , such as the hydrolysis of esters and the hydra-
tion of aldehydes. The various isoenzymes have been characterized to different
degrees of sophistication. High-activity forms are labeled II (kcat = 106 s -I at
25°C); low-activity forms I (k cat = 105 s - I), and the very-low-activity forms
III (kcat = 103 s -1).37 X-ray structural information at nominal 2 Aresolution is
available for HCA 138 and HCA II,39 where H indicates human. The structure
of HCA II has been refined recently. 40 High-resolution structures of mutants and
of their substrate and inhibitor derivatives are being reported. 211 All isoenzymes
are single-chain polypeptides, with M.W. about 30 kDa and one zinc ion per
molecule. They have the shape of a rugby ball with a crevice 16 Adeep running
through the south pole (Figure 2.3 See color plate section, page C-2.). At the
bottom of the crevice, the zinc ion is anchored to the protein by three histidine
nitrogen atoms and is exposed to solvent. Two histidines (His-94 and His-96,
HCA I numbering) are bound to zinc via their NE2 atoms, whereas one (His-
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Figure 2.2
pH dependence of kcat and K m values for CO2 hydration catalyzed
by carbonic anhydrase I, II, and III isoenzymes. 33 ,36
119) is bound via its Nol atom (Figure 2.4). It is quite general that histidines
bind zinc equally well by either of the two histidine nitrogens, the preference
being probably dictated by the steric constraints imposed by the protein folding.
The three histidine NH protons are all engaged in H-bonding (Figure 2.4). His-
tidine-119 is involved in H-bonding with a glutamate residue. As mentioned,
this could be a way of controlling the basicity of the metal ligands. A solvent
molecule bound to zinc is involved in an H-bond with Thr-199, which in tum
is H-bonded to Glu-106. This H-bonding network is important for understanding
the subtle structural changes that occur with pH changes; these could, in prin-
ciple, account for the pH-dependent properties. Although the structure of crys-
tals grown at pH 8 in sulfate-containing buffer gives some indication of a single
solvent molecule bound to zinc (Figures 2.3 and 2.5 See color plate section,
pages C2, C3.), theoretical studies indicate that two water molecules can be at
bonding distances. 42 Such a finding is consistent with spectroscopic studies on
other derivatives and with the concept that attachment and detachment of sub-
strates occur through five coordination.
Just as is true for every zinc enzyme in which zinc is at the catalytic site,
activity is lost if the metal is removed, and is restored by zinc uptake. The
tertiary structure of carbonic anhydrase is maintained in the absence of zinc;
even the denatured apoprotein can refold spontaneously from a random coil to
a native-like conformation. Although such a process is accelerated by zinc,43,44
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Figure 2.4
Schematic representation of the active site of human carbonic anhydrase II.
Hydrogen bonds (---) and ordered water molecules (0) are indicated. 41
the presence of the metal does not seem to be an absolute requirement for the
correct folding of CA, whereas it is an absolute requirement for several other
metalloproteins. 23 ,29,30
Anions are attracted in the metal cavity by the positive Zn(N30H2)2+ moiety,
and are believed to bind to zinc in carbonic anhydrase very effectively; so their
use should be avoided as much as possible if the goal is to study the enzyme as
it is. When the protein is dialyzed against freshly doubly distilled or carefully
deionized water under an inert atmosphere, the pH of the sample approaches the
isoelectric point, which is below 6 for HCA I and bovine (BCA II) enzymes.
The pH can then be adjusted by appropriate additions of NaOH. All the mea-
surements reported in the literature performed in acetate, phosphate, imidazole,
or tris sulfate buffers are affected by the interference of the anion with the metal
ion. However, buffer species containing large anions like Hepes (4[(2-hydrox-
yethyl)-l-piperazinyl]ethanesulfonic acid) can be used,45 since these anions do
not enter the cavity.
There are many indications that zinc in the high-pH form of CA is four-
coordinate with an OH group in the fourth coordination site. At low pH the
enzyme exists in a form that contains coordinated water; the coordination num-
ber can be four (one water molecule) or five (two water molecules). Of course,
the occurrence of the low-pH species depends on the pKa's of the complex acid-
base equilibria.
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B. Steady-State and Equilibrium Kinetics
of Carbonic Anhydrase-Catalyzed C02/HCOa- Interconversion
The CO2 ~ HC03- interconversion catalyzed by CA is extremely fast. The
usual kinetic parameters describing an enzymatic reaction are the turnover num-
ber or kinetic constant for the reaction, kcat , and the Michaelis constant Km . In
the simple catalytic scheme
~ k2
E + S ~ ES --i> E + P,
L ,
where E stands for enzyme, S for substrate, and P for product, K;;; 1 is given by
kl/(L 1 + k2). If k2 is small, kcat = k2 and K;;; 1 = k]/L I, the latter corre-
sponding to the thermodynamic affinity constant of the substrate for the enzyme.
The pH dependences 46 of kcat and Km for CO2 hydration for the high- and low-
activity isoenzymes have been determined (Figure 2.2).33,36 It appears that Km
is pH-independent, whereas kcat increases with pH, reaching a plateau above pH
8. For bicarbonate dehydration (the reverse of Equation 2.6), H + is a cosub-
strate of the enzyme. The pH dependence of kcat/Km for HC03- dehydration is
also mainly due to kcat , which shows the same pH profile as that for CO2 if the
experimental kinetic data are divided by the available concentration of the H +
cosubstrate. 47 ,4s Further measurements have shown that the pH dependence of
kcat reflects at least two ionizations if the measurements are performed in the
absence of anions. 49 The value of kcat reaches its maximum at alkaline pH only
when buffer concentrations exceed 10 -2 M. 50 In other words, the exchange of
the proton with the solvent is the rate-limiting step along the catalytic pathway
if relatively high concentrations of proton acceptors and proton donors are not
provided by a buffer system. This limit results from the high turnover of the
enzyme, which functions at the limit imposed by the diffusion rate of the H +
cosubstrate. At high buffer concentration, kcat shows an isotope effect consistent
with the occurrence of an internal proton transfer as the new rate-limiting step. 51
Measurements of the catalyzed reaction performed at chemical equilibrium
starting from mixtures of 12C-lsO-labeled HC03- and 13C-160-labeled CO2 have
shown the transient formation of l3C-lSO-labeled species (both CO2 and
HC03-) before ISO-labeled water appears in solution. 52 These experiments pro-
vided evidence that, at chemical equilibrium, an oxygen atom can pass from
HC03- to CO2 and vice versa several times before being released to water.
Furthermore, maximal exchange rates are observed even in the absence of buffers.
Under chemical equilibrium conditions, l3C NMR spectroscopy is particu-
larly useful in investigating substrate interconversion rates, since the rates pass
from a slow-exchange regime in the absence of enzyme to fast exchange at
sufficient enzyme concentration. In the absence of enzyme two l3C signals are
observed, one for CO2 and the other for HC03-. In the presence of enzyme only
one averaged signal is observed (Figure 2.6). Starting from the slow exchange
situation, in the absence of enzyme, the increase in linewidth (dv) of the sub-
strate (A) and product (B) signals (caused by exchange broadening that is caused
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Figure 2.6
Calculated lineshape for the NMR signals of nuclei
equally distributed between two sites ([A] = [B]),
as a function of the exchange rate T - I. ~w is the
peak separation in rad s - 1.
in tum by the presence of a small amount of catalyst) depends on the exchange
rate and on the concentration of each species, according to the following rela-
tion:
-1
Texch· (2.9)
Therefore, the exchange rate Te~ch can be calculated. 53 The appearance of the
NMR spectrum for different Texch values is illustrated in Figure 2.6 under the
condition [A] = [B]. For the high-activity enzyme it was found that the maxi-
mal exchange rates are larger than the maximal turnover rates under steady-state
conditions; the ratio between kexch of the high-activity (type II) and low-activity
(type I) forms is 50, i.e., larger than the ratio in kcat49,54 This result is consistent
with the idea that the rate-limiting step in the steady-state process is an intra-
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molecular proton transfer in the presence of buffer for type II enzymes, whereas
it may not be so for the type I enzymes. The exchange is pH-independent in the
pH range 5.7-8, and does not show a proton-deuteron isotope effect. The ap-
parent substrate binding (HC03 -) is weaker than steady-state K m values, indi-
cating that these values are not true dissociation constants. Chloride isa com-
petitive inhibitor of the exchange. 49
A similar investigation was conducted for type I CoHCA at pH 6.3, where
the concentrations of CO2 and HC03- are equal. 55 The two lines for the two
substrates were found to have different linewidths but equal T 1 values. Mea-
surements at two magnetic fields indicate that the line broadening of the HC03 -
resonance is caused by substrate exchange and by a paramagnetic contribution
due to bonding. The temperature dependence of the linewidth shows that the
latter is determined by the dissociation rate. Such a value is only about 2.5
times larger than the overall CO2 :;;:::: HC03 - exchange-rate constant. Therefore
the exchange rate between bound and free HC03 - is close to the threshold for
the rate-limiting step. Such an exchange rate is related to the higher affinity of
the substrate and anions in general for type I isoenzymes than for type II iso-
enzymes. This behavior can be accounted for in terms of the pKa of coordinated
water (see below).
C. What Do We Learn from Cobalt Substitution?
1. Acid-base equilibria
It is convenient to discuss the cobalt-substituted carbonic anhydrase en-
zyme, since its electronic spectra are markedly pH-dependent and easy to mea-
sure (Figures 2.7 and 2.8).56,57 The spectra are well-shaped, and a sharp absorp-
tion at 640 nm is present at high pH and absent at low pH. Whereas CoHCA I
is almost entirely in the low-pH form at pH 5.7, this is not true for the CoBCA
II isoenzyme. The acid-base equilibrium for Co-substituted carbonic anhydrase
(deprotonation of the metal-coordinated water) involves three species:
N" 2 +N-Co-OH
/ 2
N
(2.10)
The first equilibrium has never been directly monitored, and the conditions that
determine it are quite vague. However, the five-coordinate species has been
proposed in HCA I at low pH values. 48 Figure 2.7 at first seems to show isosbestic
points * between 16,000 and 18,000 em - 1, so that a single acidic group could
* An isosbestic point is a value of frequency where the two species in an A :::='" B equilibrium have the
same absorption. As a consequence, all mixtures of A and B also show the same absorption at that frequency,
and all the spectra along, e.g., a pH titration from A to B, plotted one on top of the other, cross at the
isosbestic point. The presence of isosbestic points thus indicates the presence of only two species in equilib-
rium.
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Figure 2.7
pH-variation of the electronic spectra of cobalt(II)-substituted BCA II (A), HCA II (B), HCA I
(C), and BCA III (D). The pH values, in order of increasing 1'15-6, are (A) 5.8, 6.0, 6.3, 6.7,
7.3,7.7,7.9,8.2,8.8; (B) 6.1, 6.6, 7.1, 7.8, 8.3, 8.6,9.5; (C) 5.3, 6.1, 6.6, 7.0, 7.3, 7.5,
7.9,8.4,8.6,9.1,9.6. 56
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Figure 2.8
pH dependence of 1'15.6 for cobalt(II)-substituted BCA III (e), HCA II (0), BCA II (£), and
HCA I (_) isoenzymes. The high pH limit value of 1'15-6 is normalized to I for each isoen-
zyme. 57
56 2/ THE REACTION PATHWAYS OF ZINC ENZYMES AND RELATED BIOLOGICAL CATALYSTS
account for the experimental data. Therefore, CoHCA I would have a pKa of
about 8, CoBCA II and CoHCA II a pKa of about 6..5, and CoBCA III a pKa
around 5.5. The analysis of the dependence of the absorbance on pH, however,
clearly shows that two apparent pKa's can be extracted from the electronic spec-
tra of at least CoCA I and II (Figure 2.8). These kinds of isoenzymes contain
at least another histidine in the cavity, which represents another acidic group,
with a pKa of about 6.5 in its free state. The interaction between such an acidic
group and metal-coordinated water, for example, via a network of hydrogen
bonds, provides a physical picture that can account for the observed experimen-
tal data. 49 Two apparent acid dissociation constants Ka can be obtained from the
fitting of the curves of Figure 2.8. They are called apparent, because they do
not represent actual acid dissociations at the microscopic level. When there are
two acidic groups interacting with each other, the system must be described in
terms of four constants, also called microconstants, because the dissociation of
each of the two groups is described by two different pKa ' s, depending on the
ionization state of the other group (Figure 2.9); so the two apparent constants
2
/OH
Y E ~"NH
/OH2 /OH
E E 4
" NH "N
~ /OH 2~E
"N
3
Figure 2.9
General scheme for two coupled acid-base equilibria applied to carbonic
anhydrase. The two acid-base groups are the metal-coordinated water
molecule and a histidine residue present in the active-site cavity. 58
can be expressed in terms of four microconstants describing two interacting
acidic groups. It is again a general feature of these systems that the four micro-
constants can be obtained only by making some assumptions. In one analysis
the molar absorbances of species (1) and (3), and of species (2) and (4), were
assumed to be equal. 58 In other words, it is assumed that the changes in the
electronic spectra of cobalt(II) (Figure 2.7) are due entirely to the ionization of
the coordinated water, not at all to the ionization state of the other group. This
assumption accounts for the observation of approximate isosbestic points, even
though there is an equilibrium between more than two species. With this as-
sumption the four microconstants could be obtained (Table 2.5). Recall that the
activity and spectroscopic profiles follow one another (see Figure 2.2 and Sec-
tion IV.B). Furthermore, similar microconstant values had been obtained on
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Table 2.5
Values of microconstants associated with
acid-base equilibriaa in cobalt(II)-substituted
carbonic anhydrases.58
pKal pKa2 pKa3 pKa4
CoHCA I 7.14 7.21 8.45 8.38
CoHCA II 5.95 5.62 6.62 6.95
CoBCA II 6.12 6.28 7.75 7.59
a As defined in Figure 2.9.
ZnHCA II by analyzing the pH dependence of the maximum velocity of the
hydration reaction, V max, assuming that the two hydroxo-containing species had
the same activity.49 The present analysis implies that species (2) and (3) of
Figure 2.9 are distinguishable, although their interconversion may be fast.
Metal coordination lowers the pKa of coordinated water. Factors affecting
the acidity of the coordinated water are many, and their effects are probably
overlapping, making the analysis quite complex (see also Section IILA). None-
theless, the following factors probably contribute to the lowering of the pKa :
(1) the charge of the chromophore, which in this case is 2 +, although it
may be somewhat lowered by the H-bonding between a coordinated
histidine and a negative glutamate residue;
(2) the coordination number (which is four), since a higher value leads to a
larger electron density on the metal ion ligands;
(3) the presence of other acidic groups with which the coordinated water
interacts;
(4) the presence of positively charged residues inside the metal binding cav-
ity that favors the removal of a proton from the cavity.
This last factor is presumably operating for CA III, which contains several
arginine residues in the cavity; the same factor may also induce changes in the
microscopic properties of the solvent inside the active cavity. These considera-
tions account for the observation that most model complexes have a significantly
higher pKa value than the protein itself.
2. Coordination Geometries
The binding of inhibitors is also pH-dependent. It is possible, however, to
obtain fully inhibited systems by adjusting the inhibitor concentration and pH.
In this manner the so-called limit spectra of CoCA derivatives are obtained.
Many systems have been characterized, providing a variety of spectral
characteristics 59 (Figure 2.10). The differences in molar absorbance are larger
than expected for changing only one coordinated atom. A rationalization of the
58
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Figure 2.10
Electronic spectra of cyanide (---), cyanate (_0_0_), acetazolamide (---), azide (0 0000),
and thiocyanate (_00_) adducts of cobalt(II)-substituted bovine carbonic anhydrase II. 59
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experimental data came by applying a criterion, first suggested by Gray,60 ac-
cording to which four-coordinate species have larger maximal absorption than
five-coordinate species. This property theoretically arises from greater mixing
of p and d metal orbitals in the four-coordinate case, which makes the d-d
transitions partially allowed, neglecting other factors such as the covalency of
the coordination bond, nephelauxetic effects,* or vicinity of charge transfer bands.
Subsequent extension of the measurements to the near-infrared region was in-
structive: 59 the low-intensity spectra exhibited a weak absorption between 13 ,000
and 15,000 cm - ]. The latter band was assigned to the highest in energy of the
F ~ F transitions, which increases in energy with the coordination number. t
Therefore both the low intensity of the bands (Emax < 200 M -] cm - ]) and the
presence of the F ~ F transition at high energy were taken as evidence for five
coordination. Spectra showing high maximal absorption (Emax > 300 M -] cm - ])
were assigned as arising from four-coordinate species. The corresponding
chromophores are CoN3In(OH2) and CoN3In, where In denotes inhibitor. Inter-
mediate maximal absorptions may indicate an equilibrium between four- and
five-coordinate species. In Table 2.6 some inhibitors are classified according to
their behavior. Bicarbonate, which is a substrate of the enzyme, gives rise to an
equilibrium between four- and five-coordinate species. 48 ,59
The differences in the electronic spectra outlined above also have been de-
tected in both CD and MCD spectra. In the latter, pseudotetrahedral species
Table 2.6
Classification of inhibitors of bovine carbonic anhydrase II according to
the electronic spectral properties of the adducts with cobalt(lI)
derivatives. a 48,59
59
Four-coordinate
Sulphonamides (N4)
Cyanide (N3C)
Cyanate (N4 )
Aniline (N4)
Phenol (N30)
Chlorate (N30)
Equilibria between four-
and five-coordinate species
Bicarbonate (N30-N30 Z)
Chloride (N3C1-N30CI)
Bromide (N3Br-N30Br)
Azide (N4-N40)
Five-coordinate
Carboxylates (N30 Z)
Thiocyanate (N40)
Nitrate (N30 Z)
Iodide (N30I)
a Donor sets in parentheses.
* Nephelauxetic (literally, cloud-expanding) effects are due to partial donation of electrons by the ligand
to the metal, and are stronger for less electronegative and more reducing ligands.
t By F ~ F transition we mean here a transition between two electronic states originating from the same
F term (the ground term) in the free ion and split by the ligand field; the stronger the ligand field, the larger
the splitting. For high-spin cobalt(Il), the free-ion ground state 4F (quartet F) is split in octahedral symmetry
into 4Tzg , 4T ,g , and 4A2g states, the 4Tzg lying lowest; in lower symmetries the T states are further split. The
highest F ~ F transition is, therefore, that from the ground state 4Tzg , or the lowest of its substates in low
symmetry, to the 4Azg state. For the same type of ligands, e.g., nitrogens or oxygens, the ligand field strength,
and therefore the energy of the F ~ F transition, increases with the number of ligands.
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give a sizably positive band in the high-energy region, whereas five-coordinate
species show a much weaker positive band and six-coordinate complexes have
only weak negative bands (Figure 2.11).21,61 This additional empirical criterion
may be helpful in assigning the coordination number. A further criterion is based
on how much of the splitting of the S = i ground state is caused by spin-orbit
coupling (zero-field splitting). This splitting can be indirectly measured from the
temperature dependence of the electronic relaxation times of the cobalt com-
plexes, in tum estimated from their ability to saturate the EPR lines of the
complexes at low temperatures. 62 There are theoretical reasons to predict that
the above splitting increases in the order four coordination < five coordina-
tion < six coordination. 63
Three binding sites have been identified in the cavity of CA 40,64-66 (Figure
2.12). The OH - binding site, which provides a tetrahedral structure around the
metal ion, is called the A site. The hydrogen interacts via hydrogen bonding
with the oxygen of Thr-199. Thr-199 and Thr-200, together with their protein
backbone, identify a hydrophilic region that probably plays a fundamental role
in the energetic balance of ligand binding. On the back of the cavity there is a
hydrophobic region formed by Val-143, Leu-198, and Trp-209. Although this
cavity is hydrophobic, the x-ray structure shows evidence of a water molecule,
H-bonded to the coordinated water. Ligands with a hydrophobic end could eas-
ily be located in this binding position, which is called B. The coordinated water
(A) (B)
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(A) MCD spectra of model six-coordinate (Co(Gly-Gly)z, --), five-coordinate ((Co-
Me6tren)Br2' ..... , and four-coordinate (Co(Py)zBr2' ---) cobalt(II) complexes and (B)
MCD spectra of the cobalt(II) derivatives of pyruvate kinase (--), alkaline phosphatase
(.....), and carbonic anhydrase in the presence of acetazolamide ( ).21,61
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Figure 2.12
Schematic drawing of the active cavity of HCA II showing the three
possible ligand binding sites. 64- 66 Site A is the site of the OH - ligand
in the active form; site B is the binding site of NCS - , which gives
rise to a five-coordinate adduct with a w"ter molecule in the C site. 64-66
molecule would change its position in order to make reasonable angles between
coordinated groups. The new position is labeled C. The x-ray structure of the
thiocyanate derivative of HCA n40,64 illustrates the latter case (see Figure 2.5).
The NCS - ion is in van der Waals contact with Val-143, Leu-198, and Trp-
209. The water interacts with the hydroxyl group of Thr-199. The geometry of
the five-coordinate derivative can be roughly described as a distorted square
pyramid with His-94 in the apical position (Figure 2. 13A). This could be a
typical structure for those derivatives that have spectra typical of five-coordinate
adducts, like the carboxylate derivatives.
In aromatic sulfonamide (Ar-S02-NH2) derivatives, which probably bind
as anions (see Section IV.C.4), the NH - group binds zinc in the A posi-
tion,64--66 giving rise to an H-bond with Thr-199. The oxygens do not interact
with the metal; one of them sits in the hydrophobic pocket. The chromophore
around zinc is pseudotetrahedral (Figure 2.13B). The energy involved in the
coordination includes the coordination bond, the hydrophobic interactions of the
aromatic sulfonamide ring, and the maintainance of the Zn-X-H-Thr-199 hydro-
gen bonding (X=N,O). It is interesting to note that cyanate, according to spec-
troscopic studies,48,59 gives rise to tetrahedral derivatives, probably because the
terminal oxygen can enter into H-bonds with the hydrophilic region of the cav-
ity. 13C NMR data on N l3CO - interacting with CoBCA indicate that the anion
interacts directly with the metal ion. 67 We do not have direct information on
where it binds. 212
The fine balance between hydrophobic and hydrophilic interactions, as well
as major steric requirements, play important roles in the binding of inhibitors.
Cyanide is the only ligand that may bind in a 2: I ratio. 68 It is likely that the
bis-cyanide adduct has the same arrangement as the NCS - -H20 derivative.
The spin state of the bis-cyanide adduct is S = i. 68
61
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Figure 2.13
Stereo views of the NCS (A) and acetazolamide (B) adducts of HCA II. 40
3. Coordinated water and NMR
It is quite relevant to know whether a water molecule is coordinated to the
metal ion in a metalloenzyme, and whether it is still coordinated in the presence
of substrates and inhibitors. The presence or absence of H20 coordinated to a
paramagnetic center can in principle be monitored by solvent water IH NMR,69
by exploiting the occurrence of a magnetic interaction between the magnetic
moments of the unpaired electrons and the nuclear magnetic moments of the
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water protons. When this interaction fluctuates with time, it causes a shortening
of the water-proton relaxation times. *
The longitudinal relaxation rate values, Tj I , of all the solvent water protons
increase when even a single water molecule interacts with a paramagnetic cen-
ter, provided that this bound water exchanges rapidly with free water molecules.
To obtain the necessary experimental data, a methodology has been developed
based on the measurement of water IH Tjl values at various magnetic fields
(Nuclear Magnetic Relaxation Dispersion, NMRD).69-71 The experimental data
contain information on the correlation time, i.e., the time constant for the dy-
namic process that causes the proton-unpaired electron interaction to fluctuate
with time; furthermore, under certain conditions, they may provide quantitative
information on the number of interacting protons and their distance to the metal.
The enhancement of Tj I, called TIPI, is caused by the paramagnetic effect on
bound water molecules and by the exchange time Tm, according to the relation-
ship
(2.11)
where 1M is the molar fraction of bound water and TIM is the relaxation time of
a bound water proton. Therefore we measure the water IH Tjl, subtract the
diamagnetic effect (i.e., the water-proton relaxation rate measured in a solution
of a diamagnetic analogue), obtain TIPI, then check that Tm is negligible with
respect to TIM' For high-spin cobalt(II), TIM is of the order of 10 -3 s, whereas
'Tm is about 10 -5 s. Then the experimental Tip can be safely related to TIM. It
is now important, in order to proceed with the analysis, to define the correlation
time for the interaction between proton nuclei and unpaired electrons, Te . Its
definition is important in order to obtain a physical picture of the system, and
to quantitatively analyze the obtained TIM values. 69 Tc is defined by
(2.12)
where Tr is the rotational correlation time, Ts is the electronic relaxation time,
and Tm has been previously defined. 'Tr depends on the size of the molecule,
which can be calculated rigorously if the molecule is spherical, or approximately
if it is not. The appropriate expression is
(2.13)
* The nuclear longitudinal relaxation time, T" can be defined as the rate constant by which the populations
of the M/ t and M/ = - t (for protons) levels reach their equilibrium value after an external perturbation
(e.g., a radiofrequency pulse in an NMR experiment). The transverse relaxation time, T2 , can be defined as
the average lifetime of a hydrogen nucleus in a given spin state. The NMR linewidth is inversely proportional
to T2 . The relation T2 .,; T, always holds.
64 2 I THE REACTION PATHWAYS OF ZINC ENZYMES AND RELATED BIOLOGICAL CATALYSTS
where 1] is the microviscosity of the solution, a is the radius (or approximate
radius) of the molecule, kB is the Boltzmann constant, and T is the absolute
temperature. For CA, Tr can be safely calculated to be =10 -8 S at room tem-
perature. Since the correlation time Tc in high-spin cobalt proteins varies be-
tween 10 -II and 10 12 s, it must therefore be determined by the electronic
relaxation time.
Water IH NMRO profiles are often analyzed by using the classical dipolar
interaction approach, as first described by Solomon: 72
(2.14)
where /La is the permeability of vacuum, 'YI is the nuclear magnetogyric ratio,
ge is the electron g-factor, S is the electron spin quantum number, r is the
electron-nucleus distance, and Ws and w[ are the electron and nuclear Larmor
frequencies, respectively. This equation describes the dipolar interaction be-
tween the magnetic moment ofnucleus I (Ii 'YI y'I(I + 1)) and the magnetic moment
of the electrons S (ge/LB y'S(S + I)) as a function of the correlation time (Tc)
and of the magnetic field (expressed as w[ and ws). Neglect of the zero-field
splitting of the S = i manifold may introduce an error in the quantitative esti-
mates within a factor of two. 73
Fitting of the data for pseudotetrahedral complexes shows that they have Ts
of 10 II s, whereas five-coordinate complexes have a shorter Ts , on the order
of 10 -12 s. The latter derivatives also have exchangeable protons that could
correspond to a water molecule in the coordination sphere, whereas the former
do not. 25 The Ts values are thus proposed as indicators of the coordination num-
ber in low-symmetry, four- and five-coordinate cobalt complexes. The shorter
electronic relaxation times are related to low-lying excited states, which, inde-
pendently of the particular mechanism, favor electron relaxation. 74
Short electronic relaxation times in paramagnetic compounds cause only mi-
nor broadening of IH NMR lines, whereas the isotropic shifts (i.e., the shifts
due to the presence of unpaired electron(s), usually very large) are independent
of the value of the electronic relaxation times. For cobalt-substituted carbonic
anhydrase, the IH NMR spectra have been recorded for several derivatives, and
the proton signals of histidines coordinated to the metal were found to be shifted
well outside the diamagnetic region (Figure 2.14).75 Five-coordinate species give
sharper signals than four-coordinate ones. The spectra in 0 20 for both kinds of
derivatives show three fewer isotropically shifted signals than in H20. These
signals are assigned to histidine NH protons, which are replaced by deuterons
in 0 20. Five-coordinate species provide IH NMR spectra with many signals
slightly shifted from the diamagnetic position. It is believed that such complexes
have relatively large magnetic anisotropy, which, summed up to the external
magnetic field, provides further differentiation in shifts of the protons. Such
shift contributions are called pseudocontact shifts. These shifts depend on the
third power of the distance from the metal and on the position of the proton
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Figure 2.14
IH NMR spectra of cobalt(II)-substituted bovine carbonic anhydrase II and some inhibitor deriv-
atives. The three sharp downfield signals in each spectrum disappear in D20 and are assigned to
the exchangeable ring NH protons of the three coordinated histidines. The sharp signal labeled
with an arrow is assigned to the H8Z proton of His-119, which is the only non-exchangeable
ring proton in a meta-like rather than in an ortho-like position with respect to the coordinating
nitrogen. The T 1 values (ms) of the signals for the I - and CZ0 4 2 - derivatives are also
shown. 25 ,75
with respect to the molecular axes. These signals belong to protons of noncoor-
dinated residues from 5 to 10 A from the metal. Their assignment in principle
provides further information on the structure in the vicinity of the metal ion.
The 1H NMR spectra of cobalt(II) enzymes thus afford a powerful method for
monitoring structure and reactivity of the metal-bound residues. This is one task
for future investigations of the enzyme.
4. pH dependence of inhibitor binding
The ease with which electronic spectra can be obtained provides a simple
way of determining the affinity constants of inhibitors for the cobalt-substituted
enzymes. An aliquot of enzyme is diluted in a spectrophotometric cell up to a
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Figure 2.15
Types of pH dependences observed for the affinity constants of inhibitors
for cobalt(II)-substituted carbonic anhydrases. pKalE] represents the main
pKa value of the enzyme, pKalI] that of the inhibitor, if present. 48
fixed volume, and the spectrum is measured. Then the spectra are remeasured
on samples containing the same amount of enzyme plus increasing amounts of
inhibitor in the same cell volume. The pH is rigorously controlled. If solutions
of enzyme and inhibitor have the same pH, the pH should be verified after the
spectral measurements, in order to avoid contamination from the electrode salt
medium. Both absolute values and pH dependences of affinity constants ob-
tained from electronic spectra are the same as those obtained from inhibition
measurements, where known, and are comparable to those obtained on the na-
tive enzyme.
Although affinity constant values reported in the literature were measured
under different experimental conditions of, e.g., pH, buffer type, and buffer
concentration, several pH-dependent trends are apparent. According to such de-
pendences, three classes of inhibitors can be identified 48 (Figure 2.15). In the
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Figure 2.16
pH dependence of the apparent affinity constants of nitrate for human I (_),
bovine II (.6.), and human II (e) carbonic anhydrases. The curves are best-fit
curves obtained assuming non-zero affinity of the anion for species I and 3
of Figure 2.9. The best-fit parameters are reported in Table 2.6. Points in
parentheses for HCA I reflect possible binding of a second nitrate ion and
have been excluded from the fit. 57
first class, the affinity constant, expressed as log K, decreases linearly with
increasing pH. Anions that are weak Lewis bases (Cl ~ ,N3 ,CH3COO - , N03 - ,
etc.) behave in this manner, as do neutral ligands like CH30H and aniline. An
example is shown in Figure 2.16. A qualitative fit to such curves can be ob-
tained using a single pKa . This behavior could be accounted for by assuming
that the ligand binds only the low-pH form of the enzyme, in a simplified scheme
in which only one pKa value determines the species distribution in CA. We
know, however, that the picture is more complex. If the species distribution
calculated according to the scheme of Figure 2.9 is assumed to hold, and if it
is assumed that only the two water-containing species (1) and (3) can be bound
by the ligand, then actual affinity constants can be evaluated for both species
(1) and (3)57 (see Table 2.7). Such constants are similar for the three isoen-
zymes, whereas the apparent affinity constants at pH 7, for example, mainly
depend on the pKa ' s of the coordinated water according to the values of Table
2.5. Therefore, the low-activity species CA I has larger affinity for anions like
nitrate (and bicarbonate) than do the high-activity forms at pH 7.
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Table 2.7
Affinity constants of nitrate for species 1 and.3 a of
cobalt(II)-substituted carbonic anhydrases.57
HCA I
3.74 ± 0.04
2.62 ± 0.06
" As defined in Figure 2.9.
BCA II
4.01 ± 0.02
2.56 ± 0.04
HCA II
4.34 ± 0.04
2.61 ± 0.05
A second type of behavior occurs for weak acids like HCN, H2S, and aro-
matic sulfonamides (ArS02NH2).76,77 Assuming that the anions (conjugated bases)
bind the low-pH species of the enzyme, the bell-shaped plot of log K versus pH
(Figure 2.15) can be accounted for. In fact, at low pH, the inhibitors are in the
protonated form, which is not suitable for metal binding. At high pH the con-
centration of the low-pH species of the enzyme decreases. The maximal appar-
ent affinity is experimentally halfway between the pKa of the inhibitor and the
"pKa " of the enzyme, treated as if it were only one. The same type of curve is
also expected if the high-pH species of the enzyme binds the weak acid. Indeed,
kinetic measurements seem to favor this hypothesis for sulfonamides. 78
A third type of behavior obtains for inhibitors like imidazole and triazoles,
HC=CH HC=CH N=CH
I I I I I I
N~ NH N~ NH HC~ NH~c/ ~N/ ~N/
H
imidazole 1,2,3-triazole 1,2,4-triazole
which bind the enzyme with similar affinities over a large range of pH (Figure
2.15),79,80 because both the imidazolate anion and the neutral imidazole can bind
to the aquo forms of the enzyme with essentially the same affinity,48,80,81 and
the reaction of imidazole with the Zn-OH species cannot be distinguished
thermodynamically from the reaction of imidazolate with the aquo forms:
2 + -H+ +
Zn-OH2 ~ Zn-OH
~I~~JI ~201l~~:~'
2+ +
Zn-lmH ~ Zn-Im
-H'
It is possible that the noncoordinated nitrogen can interact with a group in the
protein via a hydrogen bond. A candidate could be the NH group of His-200 in
HCA I or the hydroxyl group of Thr-200 in HCA II. Indeed, only imidazole
and triazoles, which have two nitrogens in 1,3-positions, seem to have this
ability. 213
In summary, from cobalt substitution we have learned:
(1) the coordination geometry of the high- and low-pH forms by means of
electronic spectroscopy;
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(2) the values of the pKa's from the pH dependence of the electronic spec-
tra;
(3) the four and five coordination of the various derivatives with exogenous
ligands;
(4) the affinity constants of exogenous ligands and their pH dependence;
(5) a fingerprint in the IH NMR spectra that can be used to monitor struc-
tural variations.
Most of these conclusions can be safely transferred to the native zinc en-
zyme, although minor differences can occur, for example, in the position of the
equilibrium between four- and five-coordinate species.
D. What Do We Learn from Copper Substitution?
The coordination chemistry of CuCA is not yet fully understood, since the elec-
tronic spectra are not very pH-sensitive. Nevertheless, the affinity of anions is
pH-dependent, as it is for CoCA. 82 As could be anticipated from Section III.B,
the affinity of anions, including HC03- , is higher than that of CoCA. Water is
usually present in the coordination sphere, along with the anion, as checked by
water IH NMRD. 83 ,84 The steric requirements of the three histidines and of the
cavity allow the anion and the water molecule to arrange in an essentially square
pyramidal geometry (Figure 2.17). This is consistent with the electronic and
His-94
HiS;;i?;iS-96
(8 site) X- OH2 (C site)(or X- for X- = CW )
Figure 2.17
Schematic representation of the suggested
coordination geometry for the anion adducts
ofCuCA.
EPR spectra. In particular, the EPR spectra are all axial, with g-values decreas-
ing from 2.31 in the nonligated enzyme to 2.24 in the various anion adducts. 84
The water molecule would be in the C site or hydrophilic binding site, and the
anion would be in the B site or hydrophobic pocket. His-94 would be in the
apical position of the square pyramid. It has been shown by EPR spectroscopy
that at low temperature two cyanide anions bind to copper. The donor atoms
are two cyanide carbon and two histidine nitrogen atoms in the basal plane, and
the third histidine nitrogen in the axial position. 85 The hyperfine splitting is
observed only with nuclei in the basal plane. It is observed both with I3C nuclei
of I3C-enriched CN - and with the two 14N of two histidines. The second cya-
nide may thus displace the coordinated water (Figure 2.17). Oxalate and sulfon-
amides displace water from the coordination sphere. 85 ,86 For the oxalate ion this
may occur through bidentate behavior. Coordination to an oxygen of the sulfon-
70 2 I THE REACTION PATHWAYS OF ZINC ENZYMES AND RELATED BIOLOGICAL CATALYSTS
amide cannot be ruled out, although the electronic and EPR spectra of the sul-
fonamide complex are more consistent with a pseudotetrahedral chromophore.
The S02 moiety would in any case point toward the B binding site. It is likely
that sulfonamides bind as in ZnCA. Bicarbonate also shows less water relaxivity
than other monodentate anions. 83,84.86
13C NMR spectroscopy has been used to investigate the location of the two
substrates, CO2 and HC03 ,with respect to the metal ion in CuCA.86-88 As
was pointed out in Section IV. B, the interconversion between the two species
is slow on the NMR timescale in the absence of catalysts. Therefore, two sig-
nals are observed (Figures 2.6 and 2.18). In the presence of the catalytically
active CoCA, only one signal is observed at suitable enzyme concentrations,
and individual information on CO2 binding cannot be obtained. 89,90 In the pres-
ence of inactive CuCA, two signals are again observed, which are broadened to
different extents.
For the HC03- signal the Ti I values as estimated from the linewidth are
much larger than TIl. Since the equation for Til, analogous to Equation (2.14),
would predict similar Tl and T2 values,69,72 a sizeable broadening due to chem-
ical exchange must be present. Indeed, unlike TiP I (Equation 2.1l), Tip I may
be a complicated function of the exchange time TM and of the isotropic shift,
~WM,
T- l _ fM TiJ + TiJTM: l + (~WM)2
2p - TM (TiJ + TM 1)2 + (~~)2 . (2.15)
In the slow-exchange region, i.e., when two separate signals are observed and
the broadening is due to exchange, Tip I = fMTM: 1. This region is characterized
no enzyme A
CoBCA II
Figure 2.18
Schematic representation of the l3C NMR spectra
of the C02/HC0 3- system (A) in pure water,
(B) in the presence of CoCA, and (C) in the
presence of CuCA. 56
162
1\
CuBCA II
is (ppm)
B
C
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by a marked increase in linewidth with increasing temperature, as confirmed by
measurements at 4 and 25°C. Therefore, T2p gives a direct measure of 'TM. 56 The
13C TIl values of HC03 - are consistent with bicarbonate bound to the metal.
The Cu-C distance would be 2.5 A if the unpaired electron were completely
on the copper ion, as estimated by using Equation (2.1) and a value of
'Tc 2.1 x 10 -9 S independently obtained from water IH NMRD. 83 This dis-
tance is much too short for a coordinated bicarbonate; however, electron delo-
calization on the bicarbonate ligand may account for such a short calculated
distance; the possibility of a bidentate type of ligation cannot be discarded. The
dissociation rate, which is very low, by itself accounts for the lack of activity
of the derivative.
For CO2 , a carbon-copper distance could be calculated if the affinity con-
stants of the substrate for the protein were known. When the binding site, if
any, starts being saturated, fast exchange with excess ligand (in this case, CO2)
decreases the observed paramagnetic effect. From this behavior, the affinity
constant may be estimated. For CO2 the paramagnetic effect remained constant
up to I M CO2; i.e., the affinity constant is smaller than I M -I. This means
that practically there is no affinity for copper; yet the paramagnetic effect is
paradoxically high. 88
Another picture comes by analyzing the NMR data in terms of a pure dif-
fusive model. 88 Here Hubbard's equation 91 has been used:
(2.16)
where
ISf (w, 'TD) = "2 1(u);
u = [W'TD] l/2;
I(u) = U -5{U 2 - 2 + e U[(u 2 - 2) sin u + (u 2 + 4u + 2) cos un;
d is the distance of closest approach, DN and DM are the diffusion coefficients
of the molecules containing the nucleus under investigation, and 'TD = 2d 2j
(DN + DM ). The experimental paramagnetic effect can be reproduced with a
CO2 concentration inside the cavity much larger than the one in the bulk solu-
tion. This result indicates that substrate does not bind to a specific site, but
probably binds in the hydrophobic region. Note that CO2 is more soluble in
organic solvents than in water.
The effect of the cavity is to attract CO2 by interaction either with the metal
ion or with a hydrophobic part of the cavity itself. But the affinity constant is
in any case lower than expected from the Michaelis constant (see Section IV.B)
measured under steady-state conditions, indicating that the latter does not rep-
resent the dissociation constant of the enzyme-C02 system.
In summary, the main information concerning the catalytic cycle obtained
from the copper derivative is the structural and kinetic characterization of both
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CO2 and HC03- species when they are not interconverting but present within
the cavity. In this way we have further proof that HC03 - is bound to the metal
and that CO2 is attracted inside the cavity either by hydrophobic interactions or
by the metal ion or both. The data obtained on the geometry around copper are
consistent with those obtained on cobalt.
E. What Do We Learn from Manganese and Cadmium Substitution?
Several studies have been performed on MnCA. Although CA is not the protein
for which Mn(II) has been most extensively used as a paramagnetic probe to
map substrates and inhibitors within the metal cavity, by measuring the Tn,}
values of protons of the inhibitor N-acetyl-sulfanilamide, and by assuming that
dipolar contributions are dominant, researchers have mapped the orientation of
the inhibitor inside the active cavity (Figure 2.19).92 This orientation is consis-
tent with x-ray data on stronger binding sulfonamides. 64- 66 MnCA is not com-
pletely inactive. 13C NMR studies of the CO2 ;;:::: HC03- interconversion at pH
8.5 showed that the interconversion rate is about 4 percent that of the native
enzyme. 93 The TIl and Ti 1 values of H 13C03 - suggest that bicarbonate might
be bidentate in the central step of the catalytic cycle. 93
Data from 1l3Cd studies that have been performed on CdBCA II and CdHCA
I are consistent with the general picture presented here. 94 The 113Cd chemical
shifts are indeed consistent with a donor set of three nitrogens and two oxygens.
The cadmium(II) derivative could thus be five-coordinate with two water mole-
Figure 2.19
Schematic drawing of the geometric arrangement of the inhibitor N-acetyl-
sulfanilamide in the active cavity of manganese(II)-substituted CA, as revealed
by IH NMR spectroscopy.92
IV. ELUCIDATION OF STRUCTURE-FUNCTION RELATIONSHIPS: CARBONIC ANHYDRASE 73
A
J 190 Hz
B Figure 2.20
113Cd NMR spectra of Cd-substituted
bovine carbonic anhydrase II in the
presence of 15N-enriched (A) or
14N-enriched (B) benzenesulfonamide
inhibitor. 95
400
0, ppm
300
cules, in agreement with the expectation based on its ionic radius being larger
than that of zinc(II). The 113Cd signal of CdBCA II in the presence of benzene-
sulfonamide enriched in 15N is split into a doublet because of the nitrogen-
cadmium coupling (Figure 2.20).95 This result provides direct evidence for metal-
nitrogen bonding in sulfonamides, which has been confirmed by x-ray data. 65
F. Catalytic Mechanism
All the above structural and kinetic information obtained under a variety of
conditions with different metal ions can be used to propose a catalytic cycle for
carbonic anhydrase (Figure 2.21), As shown by studies on the pH-dependent
properties of native and metal-substituted CAs, both type-I and type-II proteins
have two acidic groups, the zinc-coordinated water and a free histidine. At
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Proposed catalytic cycle of CA.
physiological pH the enzyme is essentially in the Zn-OH form (step A in
Figure 2.21). A Zn-OH moiety is a relatively good nucleophile, poised for
nucleophilic attack on carbon dioxide. It is possible that the hydrogen bond with
Thr-199, which seems to be consistent with an Sp3 oxygen, orients the OH for
attack at the substrate CO2 . Studies of the copper derivative indicated that the
concentration of CO2 in the cavity is higher than in bulk solution (step B).
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Molecular dynamics calculations have shown that there are either three 96 or
two 97 potential wells for CO2 in the hydrophobic pocket. It was shown 98 that
when Val-143 is replaced by the much larger Phe, the activity decreases by a
factor of 10 3. Apparently the large Phe residue does not leave space within the
cavity to accomodate CO2,
It would also be nice if the enzyme were able to activate CO2 . There is no
evidence that it does, even though the positive charge around zinc and the NH
of Thr-199 would represent two electrostatic attraction points that could activate
CO2 . It is well-known that CO2's interactions with positive charges activate the
carbon for nucleophilic attack. 99, 100 The positioning of CO2 between zinc and
the peptide NH of Thr-199 would be ideal for the OH attack. Merz 97 locates it
as shown in Figure 2.22.
It was believed that, once bicarbonate is formed (C), the proton has to
transfer to a terminal oxygen atom, either via an intermediate in which bicar-
bonate is bidentate (D) or via a hydrogen-bond network (E). Indeed, in model
compounds one would expect HC03 - to bind through a nonprotonated oxygen.
However, the possibility of restoring the hydrogen bond with Thr-199 as in
sulfonamide adducts could justify the presence of the hydrogen on the coordi-
nating oxygen. 214 The bicarbonate derivative is presumably in equilibrium be-
tween four- and five-coordinate species (F), as shown by the electronic spectra
of the cobalt derivative. 59 The five-coordinate species provides a low barrier for
the substrate detachment step via an associative mechanism involving coordina-
tion of a water molecule (G). A possible five-coordinate species would contain
bicarbonate in the B site and water in the C site (Figure 2.12). It is reasonable
that the measured K m for the reaction of bicarbonate dehydration is the thermo-
dynamic dissociation constant of the M-HC03 - species. Anionic or neutral
~CAD ~CAD)
CA(198 LEU)
HA)
Figure 2.22
Stereo view of the site of activation of CO2 in the cavity of CA as proposed by Merz. 97
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inhibitors are competitive with bicarbonate because they tend to bind at the same
site. At this stage the second substrate, which is H +, has to be released (H). It
is reasonable that the water proton transfers to a group inside the cavity, e.g. ,
the free histidine mentioned above, and subsequently to the solvent. In the ab-
sence of buffers the latter step is rate-limiting for the high-activity isoenzymes,
since the diffusion rate cannot exceed the product of the concentration times the
diffusion coefficient, i.e., 10 -7 M X 10 11 M - 1 S - 1. Such a limit is then 104 s 1,
whereas the turnover rate is 10 6 S 1. The presence of buffer can assist in proton
transfer at this stage, in such a way that the rate-limiting step becomes the
internal proton transfer. The release of H + from the Zn-OH2 moiety is also
the rate-limiting step for the low-activity CA III, as nicely shown by the elec-
tronic spectra of CoCA III. These spectra change from the basic form at the
beginning of the reaction to the acidic form upon CO2 addition (Figure 2.23).101
After the interconversion of CO2 into bicarbonate, there is an accumulation of
the CoOH2 species, the deprotonation of which is slower than the release of
HC03 -.
G. Model Chemistry
Some efforts have been reported in the literature to simulate the activity of CA
and therefore to obtain further information on the mechanism. The pKa of
Zn-OH2 moieties in various complexes has been studied as discussed in Sec-
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Time dependence of E15.6 and E18'1 of cobalt(II)-substituted CA III after addition of CO2 to a
buffered enzyme solution at pH 8. The initial drop of absorbance reflects the accumulation of a
CoOH2 intermediate. 101
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Figure 2.24
Electronic spectra of Co(TPyMA)OH/+ (Table 2.3) at various pH values. to Note the similarity
to the electronic spectra of cobalt-substituted carbonic anhydrase at various pH values as re-
ported in Figure 2.7. 56
tion IILA. The electronic spectra of some cobalt analogues have been found to
be similar. One such example is shown in Figure 2.24; the complex
Co(TPyMA)OH22+ (Table 2.3) 10 provides a five-coordinate adduct with a weakly
bound axial nitrogen (Figure 2.25A).
The interconversion between Co(TPyMA)OH}+ and Co(TPyMA)OH + was
studied by electronic spectroscopy (Figure 2.24). Despite the difference in the
number of coordinated nitrogens, the difference between the high- and low-pH
forms resembles that of the cobalt enzyme (cf. Figure 2.7).10
Table 2.3 shows that only one compound, with zinc(II) as the metal ion,
seems to have three nitrogens and a water, whereas all the other models have a
higher coordination numberY-17 The simple [Co IlI(NH3hOH]2+ complex has
been shown to accelerate the formation of bicarbonate (k = 2 x 102MIS 1),
but, of course, bicarbonate remains coordinated to the metal because of the
kinetic inertness of cobalt(III).102,103 Some relatively ill-defined systems have
been reported to have some kind of activity. The ligand shown in Figure 2.25B,
with zinc(II) as the metal ion in H20, accelerates the attainment of the
equilibrium 104
(2.17)
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(A)
cyclodextrin
(B) (C)
Figure 2.25
Some multidentate ligands as models of CA: (A) tris-(3,5-dimethyl-l-
pyrazolylmethyl) amine4 (cobalt[II] complex); (8) tris (4,5-
diisopropylimidozal-2yl)phosphine104 (zinc[II] complex); (C)
bis(histamino) f3-cyclodextrin.
with kobs = kl + L I = 103 M -I S -I. The system in Figure 2.25C, with Zn 2 +
and excess imidazole, promotes CO2 hydration, though not the back reaction. 105
The cobalt(II) analogue shows no activity. 106
It can be concluded that the M-OH group can indeed be involved in one
step of the enzymatic pathway. The sophistication of the whole enzymatic func-
tion has not yet been fully achieved with the present generation of models, even
though the functionalization of both hydrophilic and hydrophobic molecules like
cyclodextrins (Figure 2.25C) has also been used. 105
V. OTHER ENZYMATIC MECHANISMS AND MODEL CHEMISTRY
A. Peptide Hydrolysis
At neutral pH the uncatalyzed hydrolysis of amides or peptides
79
(2.18)
is a slow process, with rate constants as low as 10 II S -I. Peptide hydrolysis
catalyzed by carboxypeptidase or thermolysin can attain kcat values of 10 4 s -I.
Organic chemistry teaches us that amide hydrolysis is relatively efficiently cat-
alyzed by acids and bases. The general mechanisms involve protonation of the
carbonyl oxygen (or amide nitrogen), and addition of OH - (or of a general
nucleophile) to the carbonyl carbon atom. Several organic and inorganic bases
have been found to be reasonably efficient catalysts. On the other hand, transi-
tion metal aqua-ions or small metal-ion complexes also display catalytic effi-
ciency (Table 2.8).107-114 A metal ion is a Lewis acid, capable of effectively
polarizing the carbonyl bond by metal-oxygen coordination. Furthermore, the
metal ion can coordinate a hydroxide group in such a way that there is a high
OH - concentration at neutral or slightly alkaline pH. It is thus conceivable that
a metalloenzyme may combine some or all of these features and provide a very
efficient catalyst.
Much experimental work has been done on mimicking ester and especially
peptide hydrolysis with model coordination compounds. Most of the work car-
Table 2.8
Rate constants for amide and ester hydrolysis catalyzed by acids, bases, or metal ions.
Compound
Glycine amide
[Co(enh(glycine amide»)H
D,L-phenylalanine ethylester
(tn)z03PO-C6H4NOz
CoIU-(tn)z03PO-C6H4N02
Ethyl-{3-phenylpropionate
Adenosine triphosphate
Glycine methylester
Glycine propylester
a autohydrolysis.
Catalyst
and conditions
pH 9.35
Cu 2 +, pH 9.35
pH 9.0 a
pH 7.3
Cu 2 +, pH 7.3
OH-
H+
OH-
pH 5.3
Cu 2 +, pH 5.3
Co 2 +(I: I), pH 7.9
Cu2+(l: I), pH 7.3
CoH(I: I), pH 0
CoH(l:I), pH 8.5
Rate constant
1.9 x 10- 5 S-1
2.6 X 10- 3 M-
'
s I
2.6 x 10 -4 S - I
5.8 X 1O-9 s -1
3.4 x 10 -2 MiS -1
5.1 M-
'
S-I
7x 1O- 5 s 1
5 x 10 - 3M - 1 s - I
1.3 x 1O- 6 M IS-I
5.6 x 10 -6 S - I
1.1 x 10 -2 M -I S - I
1.6 x 1O- 2 s- 1
4.2 x 10- 2 S-I
1.1 X 1O- 3 s-
'
>1 X 1O- 2 s- 1
Reference
107
107
108
109
109
110
110
III
III
112
112
113
113
114
114
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ried out has involved 108,110,115,116 cobalt(III), Although such an ion may not be
the best conceivable model for zinc-promoted hydrolytic reactions (see Section
IV,G), it has the great advantage of being substitutionally inert, thus removing
mechanistic ambiguities due to equilibration among isomeric structures in the
course of the reaction, Interesting amide hydrolysis reactions also have been
described using complexes with other metal ions, such as copper(Il) 117 and
zinc(Il) 118 itself. In recent years efforts have focused on the construction of
bifunctional catalysts to better mimic or test the enzymatic function. For in-
stance, phenolic and carboxylic groups can be placed within reach of Co(III)-
chelated amides in peptidase models. 116 The presence of the phenolic group
clearly accelerates amide hydrolysis, but carboxyl groups are ineffective. This
model chemistry is too simple to provide insights into the actual enzymatic
mechanism, which must start with recognizing the substrate through several steps,
orienting it, activating it, performing the reaction, and finally releasing the
products. See the more specialized reviews dealing with nonenzymatic reactiv-
ity.119~121
From basic knowledge of the chemistry of hydrolytic reactions, the x-ray
structures of carboxypeptidase A and a variety of its derivatives with inhibitors
as substrate analogues, product analogues, and transition-state analogues have
revealed several features of the active site that are potentially relevant for the
catalytic mechanism (Figures 2.26-2.28 See color plate section, pages C4,
C5.). 122 The metal ion is coordinated to two histidine residues (His-69 and His-
196), to a glutamate residue that acts as a bidentate ligand (Glu-72), and to a
water molecule. The metal is thus solvent-accessible and, as such, can activate
the deprotonation of a water molecule to form a hydroxide ion, or polarize the
carbonyl oxygen of the substrate by coordinating it in the place of the solvent
HO-Tyr-248
hydrophobic
pocket
o
II
C
Glu-270/ "0\ H
'HO
\
Zn 2 +
/ I \ Arg-127
His- Glu- His-
196 72 69
Asn-144
Arg-145
Figure 2.26
Schematic drawing of the active-site cavity of carboxypeptidase A. 122
Only the residues believed to playa role in the catalytic mechanism
are shown.
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molecule, or both, if some flexibility of the coordination sphere is allowed.
Another glutamic-acid residue (Glu-270) is in close proximity to the metal cen-
ter. If the role of the metal were mainly to polarize the carbonyl carbon, Glu-
270 in its deprotonated form could be positioned to perform a nucleophilic at-
tack on the carbonyl carbon, yielding an anhydride intermediate. Alternatively,
the metal could mainly serve to provide a coordinated hydroxide ion that, in
tum, could attack the carbonyl carbon; here Glu-270 would help form ZnOH by
transferring the proton to the carboxylate group:
o~ Zn
-c" I
O····H-O
"H
o~ Zn
~ -c" I
O-H····O
"H
On the opposite side of the cavity is a tyrosine residue that has been shown to
be quite mobile and therefore able to approach the site where the catalytic events
occur. The cavity has a hydrophobic pocket that can accommodate the residue,
R, of nonpolar C-terminal amino acids of the peptide undergoing hydrolysis
(Figures 2.26 and 2.28), thereby accounting for the higher efficiency with which
hydrophobic C-terminal peptides are cleaved. Finally, an Asn and three Arg
residues are distributed in the peptide-binding domain; Asn-144 and Arg-145
can interact via hydrogen bonds with the terminal carboxyl group. Arg-127 can
hydrogen-bond the carbonyl oxygen of the substrate.
All these features have enabled detailed interpretation of many chemical and
physico-chemical data at the molecular level. The essential data are as follows:
(1) Metal substitution. Table 2.9 lists the divalent metals that have been
substituted for zinc(II) in CPA, together with their relative peptidase
(and esterase) activities. 22 For some of them, the available x-ray data
Table 2.9
Catalytic activities of metal-sub-
stituted carboxypeptidases.a 22
Apo
Cobalt
Nickel
Manganese
Cadmium
Mercury
Rhodium
Lead
Copper
Peptidase
o
200
50
30
5
o
o
o
Esterase
o
110
40
160
140
90
70
60
a Activities are relative to the native
enzyme, taken as 100%.
b Some activity toward both peptides
and esters has recently been observed. 22
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(2.19)
B
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"H
show 123 that the active-site structure is essentially maintained. Even the
copper derivative is slightly active. The apoenzyme is completely inac-
tive, however.
(2) Active-site modifications. Chemical modification and site-directed mu-
tagenesis experiments suggest that Glu-270 is essential for cataly-
SiS. 124,125 Tyr_248,126 Tyr-198,127 and one or more of the arginines 124
are involved but not essential.
(3) Kinetics. kcat/Km pH profiles are bell-shaped, characterized by an acid
pK, limb around 6 and an alkaline pKa limb around 9: kcat increases
with the pKa of 6 and then levels off, and K m increases with a pKa of
9. Several lines of evidence suggest that the pKa = 6 corresponds to the
ionization of the Glu-270-coordinated H20 moiety:
H
I
o
-c/ M~ I
0 ... /0
H "H
A
Site-directed mutagenesis has ruled out Tyr-248 as the group with the
pKa of 9 in the rat enzyme. 125,126 Unfortunately, in this enzyme the pKa
of 9 is observed in kcat rather than K m ; so the situation for the most-
studied bovine enzyme is still unclear. Tyr-248 favors substrate binding
three to five times more than the mutagenized Phe-248 derivative. 126
The three possible candidates for this pK, are the coordinated water,
Tyr-248, and the metal-coordinated His-196, whose ring NH is not hy-
drogen-bonded to any protein residue. 128 The x-ray data at different pH
values show a shortening of the Zn-O bond upon increasing pH. 129
This favors the ZnOH hypothesis.
(4) Anion binding. The metal binds anionic ligands only below pH 6, i.e.,
when Glu-270 is protonated, when Glu-270 is chemically 130 or
genetically 125 modified, or when aromatic amino acids or related mole-
cules are bound in the C-terminal binding domain (Arg-145 + hydro-
phobic pocket). 131-134
(5) Intermediates. An anhydride intermediate involving Glu-270 for a slowly
hydrolyzed substrate may have been identified. 135 Some other interme-
diates have been observed spectroscopically at subzero temperatures with
the cobalt(II) derivative. 22,136 Peptides bind in a fast step without alter-
ing the spectroscopic properties of cobalt(II), following which a metal
adduct forms and accumulates. 22 Thus, if an anhydride intermediate is
formed, it is further along the catalytic path.
On the basis of these data, and many related experiments, a detailed mech-
anism can be formulated (Figure 2.29). The incoming peptide interacts with
(A) (8)
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Figure 2.29
Possible catalytic cycle of CPA.
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arginine residues through its terminal carboxylate group. The interaction could
initially involve Arg-71 (not shown); then the peptide would smoothly slide to
its final docking position at Arg-145, while the R residue, if hydrophobic, moves
to the hydrophobic pocket (Figure 2.29B). The carbonyl oxygen forms a strong
hydrogen bond with Arg-127. Additional stabilization could come from hydro-
gen bonding of Tyr-248 to the penultimate peptide NH. This adduct might be
the first intermediate suggested by cryospectroscopy 22, 136 (Figure 2.24).
At this point the metal-bound hydroxide, whose formation is assisted by
Glu-270, could perform a nucleophilic attack on the carbonyl carbon activated
by Arg-127 and possibly, but not necessarily, by a further electrostatic interac-
tion of the carbonyl oxygen with the metal ion. The structure of the substrate
analogue a-R-,B-phenylpropionate shows that the carbonyl binds in a bidentate
fashion:
CH3 PhCH2 CH2PhI I I
CH -C-O-C-NH-CH-C-CH -CH-COO-
3 I II II 2
CH3 0 0
(Figure 2.30).137 Five coordination is maintained by switching the Glu-72 metal
H
OH RC 2 R'I,,
Glu-270 ....... c'::::::-o ----- HO:- C 0------ Arg-127
" ,,"
Figure 2.30
Binding mode of a-R-I3-phenylpropionate to the zinc(II) ion in CPA. 137
ligand from bidentate to monodentate, because the metal moves toward Arg-
127. It is likely that this situation mimics an intermediate of the catalytic cycle.
The resulting adduct might be the second spectroscopic intermediate (Figure
2.29C).
The system then evolves toward breaking of the C-N bond, caused by
addition of a proton to the amino nitrogen. This proton could come from Glu-
270, which thereby returns to the ionized state. The breaking of the peptide
bond could be the rate-limiting step.22 The second proton required to transform
the amino nitrogen into an NH3 + group could come from the coordinated car-
boxylic group of the substrate, which now bears one excess proton, again through
Glu-270 (Figure 2.29D). The system shown in Figure 2.290 can, in fact, be
seen as a ternary complex with a carboxylate ligand and an amino-acid zwitter-
ion, bound synergistically. 131-134 Finally, the metal moves back to regain a bi-
dentate Glu-72 ligand, and the cleaved peptide leaves, while a further water
molecule adds to the metal ion and shares its proton with the free carboxylate
group of Glu-270.
Figure 1.1
The stabilization of Fe in aqueous solution by the
protein coat of ferritin. In the absence of protein,
at neutral pH, in air, flocculent precipitates of
ferric hydrous oxide form. The equivalent concen-
tration of Fe(III) in the solution of ferritin is about
10 14 times greater than in the inorganic solution.
Left: a solution of Fe(II)S04, pH 7, in air after
IS min. Right: the same solution in the presence
of apoferritin, the protein coat of ferritin
(reprinted from Reference 6).
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Figure 1.2
(A) Zinc-binding domains of a DNA-binding protein from frog eggs. Two of the nine repeating
units of polypeptide with Zn-binding ligands are displayed, with two of the 7-11 zinc atoms per
molecule in the configuration originally proposed by Klug and coworkers for "zinc fingers."
The protein studied regulates the transcription of DNA to RNA and also binds to RNA, forming
a storage particle.9 Recently, the putative zinc-binding sequence has been shown to occur in
many nucleic acid-binding proteins. 10 Each finger binds to a site on the double helix. However,
other zinc-finger proteins function with fewer fingers, related apparently to the structure of the
nucleic acid site. (B) Examples of the sea squirt (tunicate) Ascidia nigra (reproduced with per-
mission from Reference 18a).
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Figure 2.3
Human carbonic anhydrase II viewed as a CPK model. The zinc ion is the green sphere at the
bottom of the active site. The color codes for the other atoms are: C = white, H = cyan, N
= blue, 0 = red, S = yellow. Among the zinc ligands, the His-94 ring and the water mole-
cule are clearly visible at the right- and left-hand side of the zinc ion, respectively. The presence
of a hydrophobic region above the zinc ion can also be discerned. The crevice that runs longitu-
dinally below the active site is obstructed by the histidine ring of His-64, one of the invariant
active-site residues.
AB
Figure 2.5
Active site of human carbonic anhydrase II (A) and its NCS - adduct (B) viewed as CPK
models. It is apparent from the comparison that the NCS - ion occupies a binding site (B site)
that is more buried than the binding site of the OH - ion in the active form (A site). The water
molecule in the NCS - adduct occupies the C site, which is pointing more toward the entrance
of the cavity. 64
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Figure 2.27
Carboxypeptidase A viewed as a CPK model. The color codes are as in carbonic anhydrase.
Note the shallower active-site cavity with respect to carbonic anhydrase.
AB
Figure 2.28
Active site of carboxypeptidase A viewed as CPK (A) and stick (B) models. The two views are
taken from about the same perspective, i.e., from the entrance of the cavity. View B is self-
explanatory. In view A, the zinc ion is the green sphere; its ligands are His-69 (on the right),
His-l96 (in the back), and Glu-72 (one of the two coordinated oxygens is clearly visible below
the zinc ion). The coordinated water molecule (pointing outward) is hydrogen-bonded to Glu-
270. On the opposite side of Glu-270 the three arginines (Arg-145, Arg-127, and Arg-7l) can
be seen, more or less on a vertical line, running from top to bottom of the figure. In the upper
part of the figure, pointing outward, is the aromatic ring of Tyr-248. Behind it is the hydropho-
bic pocket.
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Figure 2.34
Liver alcohol dehydrogenase subunit viewed as a CPK model. The left-hand side of the mole-
cule is the coenzyme binding domain and the right-hand side is the catalytic domain. The cata-
lytic zinc ion is accessible from two channels located above (not visible) and below the coen-
zyme binding domain. The upper channel permits approach of the nicotinamide ring of the
coenzyme. The lower channel permits approach of the substrate. The substrate channel closes
up, trapping the substrate inside the molecule, when both coenzyme and substrate are present.
C-7
Figure 3.4
A Fura-2 study of the transient Ca2 + fluxes in an egg of the sea urchin (Lutechinus pictus). The
diameter of this egg is about 120 p.M. The fluorescent dye was injected into the egg, and the
fluorescence intensity with excitation at 350 and 385 nm was measured with a lower-light-Ievel
television camera feeding a digital image processor (512 x 486 pixels). The image finally dis-
played in pseudocolor is the ratio of intensities at the two excitation wavelengths. The series of
images shows a wave of high Ca2 + concentration that traverses the egg after it is fertilized by a
sperm. Resting Ca2+ concentration is typically 100 nM and uniform through the cell. The fertil-
izing sperm sets off a transient wave of high Ca2 + that begins as a local elevation and thereafter
spreads rapidly. After 20-30 seconds, the Ca2 + concentration of the entire egg is uniformly
high (-2 p.M). The figure is from an experiment by M. Poenie, J. Alderton, R. Steinhardt, and
R. Tsien; see also Reference 26.
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Figure 3.7 •
The elemental distribution of Ca, Si, and Mn in the hair of the common stinging nettle (Urtica
dioica) obtained using the Oxford University PIXE microprobe. The color code for Ca is: yel-
low, >3.4 M; orange, 2.0-3.4 M; red, 1.5-2.0 M; dark blue, 1-1.5 M; blue, 0.5-1.0 M; light
blue, 0.1-0.5 M; white, <0.1 M. The color codes of Si and Mn are similar. The PIXE data
show that the tip mainly is made up of Si (presumably amorphous silica), but the region behind
is largely made up of Ca (calcium oxalate crystals). The base of the hair contains substantial
amounts of Mn. The pictures were kindly provided by R. J. P. Williams.
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Figure 3.17
Space-filling stereo model of bovine brain calmodulin. Residues 5 to 147 are included, N-termi-
nal half at the top. Positively charged side chains (Arg, Lys, His) are dark blue, negatively
charged (Asp, Glu) red, hydrophobic (Ala, Val, Leu, lie, Phe) green, Met yellow, Asn and Gin
purple, Ser, Thr, and Tyr orange, and Pro, Gly, and main-chain atoms light blue. The figure
was kindly provided by Y. S. Babu et al.Bs
C-10
Figure 3.25
The backbone trace of the solution structure of porcine calbindin D9k calculated from NMR
data 124 shown in two different views. The position of the calcium ions (blue spheres) is modeled
after the crystal structure 123 of bovine calbindin D9k • Figure kindly provided by M. Pique, M.
Akke, and W. J. Chazin.
C-11
Figure 3.26
Drawing of the crystal structure of the sarcoplasmic calcium-binding protein from Nereis diversi-
color. 130 The drawing is based on the a-carbon positions; helices are represented by thin ribbons,
l3-strands by thick ribbons, and Ca2 + ions by white spheres. Domain I (residues 1-40) is col-
ored blue, domain II (41-86) yellow, domain III (87-126) red, and domain IV (127-174) green.
Figore kindly provided by W. J. Cook.
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Figure 6.29
Computer-graphics models of the cytochrome bs/cytochrome c complex: (left) static model
produced by docking the x-ray structures of the individual proteins; (right) after extension
by molecular dynamics simulations. III Reproduced with permission from Reference 112.
C-13
Figure 6.36
Rps. sphaeroides RC cofactors. Electron transfer proceeds preferentially along the A branch. 177
Reproduced with permission from Reference 177.
Figure 6.37
Position of the Rps. sphaeroides RC in the membrane bilayer. Cofactors are displayed in red,
lipids in yellow, the H subunit in green, and Land M subunits in blue. 178 Reproduced with
permission from Reference 178.
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Figure 8.2
(A) Space-filling models depicting A- (left), B- (center), and Z- (right) DNA based on crystallo-
graphic data. 2- 4 The sugar-phosphate backbone is shown in aqua and the base pairs in purple.
This representation as well as subsequent graphics representations Were obtained using the pro-
gram Macromodel. (B) Schematic illustration of unusual conformations of DNA. (C) Space-fill-
ing models of tRNA Pho based on crystallographic data.4 The sugar-phosphate backbone is shown
in aqua and the bases in purple.
Bc
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Once the hydrolysis has been performed, the cleaved amino acid still inter-
acts with Arg-145 and with the hydrophobic pocket, whereas the amino group
interacts with Glu-270. The carboxylate group of the new terminal amino acid
interacts with zinc. This picture, which is a reasonable subsequent step in the
catalytic mechanism, finds support from the interaction of L- and D-phenylala-
nine with carboxypeptidase. 131-134.138
This mechanism, essentially based on the recent proposal by Christianson
and Lipscomb,137 underlines the role of the Zn-OH moiety in performing the
nucleophilic attack much as carbonic anhydrase does. This mechanism can ap-
ply with slight changes to thermolysin 139 and other proteases. Thermolysin cleaves
peptidic bonds somewhere in the peptidic chain. The mechanism could be very
similar, involving zinc bound to two histidines and Glu-166 (Figure 2.31).139
Glu-166 is monodentate. The role of Glu-270 in CPA is played by Glu-143 and
the role of Arg-127 is played by His-231.
""" 213
Figure 2.31
Stereo view of the active site of thennolysin. 139
B. Ester Hydrolysis and Phosphoryl Transfer
Hydrolysis of carboxylic and phosphoric esters is also a slow process at neutral
pH, and is catalyzed by acids and bases by mechanisms similar to those in-
volved in amide and peptide hydrolysis. Metal ions are also good catalysts of
both carboxylic and phosphoric ester hydrolysis, typically with rate increases
much higher than those observed for hydrolysis of amides or peptides (Table
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2.8). The ability of metal ions to coordinate to the carbonyl oxygen-which is
higher in amides than in esters-is inversely correlated with their catalytic prop-
erties, perhaps because the main role of the metal ion is not in polarizing the
carbonyl group, but in providing a metal-coordinated hydroxide as the attacking
nucleophile. 108 For the hydrolysis of phosphate esters, it is difficult to draw
conclusions based on experience with carboxylic esters, because, although the
coordinating ability of the phosphoric oxygen may be higher, thus favoring the
polarizing role ofthe metal, the nucleophilic attack is also likely to be easier,
because the energy of the trigonal bipyramidal intermediate is probably rather
low. Base-catalyzed hydrolysis of phosphate esters occurs with inversion of con-
figuration, and this supports the existence of a trigonal bipyramidal intermedi-
ate. 140 The metal acts both as activator of substrate through binding and as
Lewis acid to provide the OH moiety for the nucleophilic attack:
o OH OH
\ I /
H-OI - O...-P-OR ~ O-P-OR ~ o-P--.. o + RO- (2.20)/ / / /\ / \
M----O M-O 0 M 0
As with peptide hydrolysis, several enzyme systems exist that catalyze car-
boxylic and phosphoric ester hydrolysis without the need for a metal ion. They
generally involve a serine residue as the nuc1eophile; in turn, serine may be
activated by hydrogen-bond formation-or even proton abstraction-by other
acid-base groups in the active site. The reaction proceeds to form an acyl- or
phosphoryl-enzyme intermediate, which is then hydrolyzed with readdition of a
proton to the serine oxygen. Mechanisms of this type have been proposed for
chymotrypsin. 141 In glucose-6-phosphatase the nuc1eophile has been proposed to
be a histidine residue. 142
Again by analogy with peptide hydrolysis, metalloenzymes catalyzing ester
hydrolysis may take advantage of additional chemical features provided by amino-
acid residues present in the active-site cavity. This situation occurs with car-
boxypeptidase,143 which shows esterase activity in vitro. Although the rate-lim-
iting steps for carboxylic esters and peptides may differ, several features, such
as the pH dependences of kcat and K m and the presence of two spectroscopically
observable intermediates, point to substantially similar mechanisms. On the other
hand, carboxylic ester hydrolysis catalyzed by carbonic anhydrase seems to rely
on fewer additional features of the active-site cavity, perhaps only on the pres-
ence of a metal-coordinated hydroxide that can perform the nucleophilic attack
on the carbonyl carbon atom. 47
Metalloenzyme-catalyzed phosphoric ester hydrolysis can be illustrated by
alkaline phosphatase, by far the most-investigated enzyme of this class. The
protein is a dimer of 94 kDa containing two zinc(II) and one magnesium(II)
ions per monomer, and catalyzes, rather unspecifically, the hydrolysis of a va-
riety of phosphate monoesters as well as transphosphorylation reactions. The x-
ray structure at 2.8 A resolution obtained on a derivative in which all the native
metal ions were replaced by cadmium(II) reveals three metals in each subunit,
Figure 2.32
Schematic drawing of the active-site cavity of a subunit of alkaline phosphatase. 28 ,144,145
The catalytic metal is labeled MI' The MI-M2 distance is =4 A, the Mr M3 distance
is =5 A, and the MI-M3 distance is =7 A.I44,145
all located in a single binding region (Figure 2.32). In the native enzyme M1
and M2 sites are occupied by zinc and M3 by magnesium. 144 M1 was first re-
ported to be coordinated to three histidine residues (His-331, 372, and 412 in
Figure 2.32). Further refinement indicated that Asp-327 could be a ligand to
M1, in the place of His-372. 145 IH NMR spectroscopy of the enzyme with cobalt
substituted in the M j site shows that there are three exchangeable protons sens-
ing the paramagnetic metal ion. 146 They could come from three histidine NHs,
or from two histidine NHs and another group containing the exchangeable pro-
ton very close to the metal ion, like an arginine. Protein ligands to M2 are Asp-
369, His-370, and Asp-51, the latter probably bridging M2 to M3 with the other
carboxyl oxygen. M3 is coordinated, in addition, to Asp-51, to Asp-153, to Thr-
155, and to Glu-322. Several spectroscopic pieces of evidence on the native and
metal-substituted derivatives indicate that M j is five-coordinate, but M2 and M3
are six-coordinate, probably with water molecules completing the coordination
spheres. 28
M1 is essential for activity, but full catalytic efficiency is reached only when
all metal ions are present. These data suggest that maximum activity is the result
of fine-tuning several chemical properties of the active site as a whole, including
the nature of the M j metal, which can be only zinc or cobalt (Table 2.4).
A further key feature of the active site is the presence of a serine residue
(Ser-102), the oxygen atom of which is close to the M1 - M2 pair (especially
to M2), although not at direct binding distance according to the crystal structure.
There is ample and direct evidence that Ser-102 is reversibly phosphorylated
87
88
N""
N-Zn-OH
./ 2
N
""I./N
Zn
o ""./ I""II 0
N O-P-OH
""./ ""N-Zn OH ~
N./ ""OH +Hp
2
"" I ./NZn
o ""./ I""II 0
N O-P-OH
""./ ""N-Zn OH ~
N./
Figure 2.33
Possible catalytic cycle of AP.
during the course of the catalytic reaction, and that M1 is able to coordinate a
phosphate ion. 28
Another crucial piece of information obtained by physico-chemical tech-
niques is that the lability of the phosphoseryl intermediate and the catalytic
activity increase with pH, depending on the state of ionization of an active-site
group, which is most likely a water molecule coordinated to M1. 147 Thus the
active form of the enzyme is again a metal-hydroxide species. Furthermore, an
inactive derivative with copper ions in the M] and M2 sites shows evidence of
magnetic coupling between the metal ions, of the magnitude expected if the two
metals shared a common donor atom. ]48 Likely candidates are a bridging hy-
droxide ion or Ser-102, which thus might be somewhat mobile relative to the
position occupied in the x-ray structure, and demonstrate its potential ability to
be activated for the nucleophilic attack by coordination to a metal ion. Such a
mechanism would be an "inorganic" version of the type of activation postulated
for chymotrypsin and other hydroIases.
A possible mechanism for alkaline phosphatase-catalyzed phosphoric ester
hydrolysis could involve the following steps (Figure 2.33):
(1) Binding of the phosphate group to M]-in the place of a water mole-
cule-by one of the nonprotonated oxygens, and subsequent activation
of the phosphorus atom for nucleophilic attack. The binding of the sub-
strate may be strengthened by interaction with the positively charged
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Arg-166 residue 149 (not shown). The steric alteration in the active site
could cause movement of Ser-102 toward M2 , with deprotonation upon
binding.
(2) Nucleophilic attack on phosphorus by the coordinated serine alkoxide,
cleaving the ester bond and liberating the alcohol product.
(3) Formation of the phosphoseryl intermediate with cleavage of the M l -
phosphate bond, decreasing the pKa of the second coordinated water
molecule, the proton of which could be taken up by the leaving alco-
hol.
(4) Attack by the metal-coordinated hydroxide on the phosphoryl deriva-
tive, possibly with M2 again polarizing the seryl oxygen, yielding a free
phosphate ion coordinated to MI' A further water molecule could aid in
the liberation of phosphate via an associative mechanism.
In the presence of alcohols, alkaline phosphatase displays transphosphory-
lation activity, i.e., hydrolysis of the starting ester and esterification of the phos-
phate group with a different alcohol. This ability is easily understood if one
keeps in mind that the reaction depicted above is reversible, and that a different
alcohol may be involved in the formation of the ester bond. Most group-transfer
reactions catalyzed by metalloenzymes are likely to proceed through the same
elementary steps proposed for hydrolytic reactions.
C. Nucleophilic Addition of OH ~ and H -
Nucleophilic addition of OH - ions as a step in enzymatic pathways is not re-
stricted to hydrolytic processes; it often occurs in lyases, the class of enzymes
catalyzing removal (or incorporation in the reverse reaction) of neutral mole-
cules such as H20-but also NH3 , CO2 , etc.-from a substrate. It is outside
the scope of this section to review all other mechanisms involved in lyase re-
actions, especially because they are not reducible to common steps and because
several of them do not require the presence of a metal ion. We restrict ourselves
to H20 removal (or incorporation), a widespread feature of which seems to be
the splitting of water into the constituents H + and OH - ions at some step of
the mechanism. As an example, the dehydration of 2-phospho-D-glycerate to
phosphoenolpyruvate catalyzed by enolase, a Mg-activated enzyme,
o H OH
II I I
HO-P-O-G-G-H
I I I
OH HOOG H
-H 0~
o
II
HO-P-O-G=G-H
I I I
OH HOOG H
(2.21)
has been shown by kinetic isotope-effect studies 150 to proceed via fast H + re-
moval from substrate followed by slow release of the product, and finally by
release of OH ~. The role of a metal ion like magnesium might be to activate
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the substrate by coordinating the phosphate group, rather than by providing a
coordinated hydroxide for nucleophilic attack.
Other lyases, however, contain transition metal ions [often iron(II)], and
their main role might well be that of lowering the pKa of water. None of them,
however, is yet known well enough to allow a detailed discussion of the molec-
ular mechanism. A striking exception is carbonic anhydrase, which has been so
extensively and successfully studied that it is ideal as a case study (Section IV).
Hydride transfer is another elementary process encountered in many enzy-
matic reactions. Although hydride transfer implies a redox reaction, it also in-
volves nucleophilic attack on substrate as in the foregoing examples. Unlike
OH - , hydride ions do not exist in aqueous solutions as free ions. In biological
systems hydride is always directly transferred from one organic moiety to an-
other by simultaneous breakage and formation of covalent bonds. The activation
energy for this process is much higher than, for example, that of H + transfer
via the formation of hydrogen bonds. Moreover, unlike hydrogen-bonded spe-
cies, there is no intermediate in the process that can be stabilized by the catalyst.
Instead, reacting species can be destabilized in order to lower the activation
energy barrier. The role of the enzyme, and of the metal ion when present, is
to provide binding sites for both substrates. The enzyme achieves this both geo-
metrically, by allowing for proper orientation of the groups, and electronically,
by providing energy to overcome the activation barrier.
These general concepts can be exemplified by liver alcohol dehydrogenases
(LADH), dimeric zinc enzymes of 80 kDa that catalyze the following class of
reactions using the NADH/NAD + system as coenzyme (or, really, as cosub-
strate):
C--+7nc=o/=\ H I/ \ '/ R'
-N C9 "H
CONH 2
(2.22)
In particular, LADHs catalyze the reversible dehydrogenation of primary and
secondary alcohols to aldehydes and ketones, respectively. Other enzymatic ac-
tivities of LADHs are aldehyde dismutation and aldehyde oxidation. ]5] The
physiological role, although surely related to the metabolism of the above spe-
cies, is not definitely settled. Much effort is being devoted to understanding the
mechanism of action of this class of enzymes, which have obvious implications
for the social problem of alcoholism.
Each monomer unit of LADH contains two zinc ions: one coordinated to
four cysteine sulfurs, the other coordinated to two cysteine sulfurs, one histidine
nitrogen, and a water molecule. The former has no apparent role in catalysis;
the latter is essential for catalytic activity. The x-ray structure of the metal-
depleted enzyme from horse liver has been solved at 2.4 Aresolution, and that
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Figure 2.35
Schematic drawing of (A) the LADH dimer and (B) the domains constituting
the active site of a subunit. 154
of the holoenzyme at 2.9 A resolution (Figure 2.34 See color plate section,
page C-6.). Many crystal structures are also available for binary complexes with
substrates, pseudosubstrates, or coenzymes, as well as for ternary complexes
with coenzyme and substrates. 152 The very detailed picture emerging from such
structural information has helped us understand how LADH functions. As will
be evident from the following discussion, elucidation of this mechanism also
reveals some important fundamental chemistry.
A key property of the enzyme, established by x-ray data, is the existence of
two protein domains in each monomer that are relatively free to rotate relative
to each other. The apo- and holo-enzymes exist in the so-called open form,
whereas binding of NADH coenzyme induces rotation of one domain, resulting
in the so-called closed form 153,154 (Figures 2.34 and 2.35). Closure brings the
catalytic zinc ion into an ideal position to bind the aldehyde substrate in such a
way that the reactive CH2 group of the nicotinamide ring of NADH points toward
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the carbonyl carbon (Figure 2.35). The main functions of the metal are thus to
orient the substrate geometrically and to polarize the carbon-oxygen bond. Al-
though the latter makes obvious chemical sense for the aldehyde reduction re-
action, since polarization of the C=O bond facilitates nucleophilic attack of
hydride at the carbonyl carbon, coordination of an alcohol to a metal is expected
to decrease the alcohol's tendency to transfer hydride to NAD +, unless the
hydroxyl proton is released upon coordination. 155
R
1
C
/1"HO R' H
S" _ /R
S-Zn- O-C-H
N / "R'
(2.23)
Formation of an alkoxide ion as an intermediate has often been questioned,
because the pKa of the alcohol would have to be reduced by about 10 units upon
coordination. 156 The possibility that hydride transfer from alcohol to NAD + and
hydroxyl proton release could occur simultaneously is attractive, but careful
experiments have shown that the two steps must be kinetically separate. 157 We
summarize here the key information that leads to a full, although circumstantial,
rationalization of the chemical behavior of the enzyme.
(1) The activity versus pH profiles 156,158 are bell-shaped, with kcat increasing
with a pKa below 7, reaching a plateau, and decreasing with a pKa above 11,
and Km increasing with a pKa of about 9.
(2) X-ray data show that the zinc ion is accessible to solvent in the open
conformation, much less so in the closed conformation when the reduced coen-
zyme is bound, and inaccessible when the substrate is coordinated to the metal
in the ternary complex, extruding all the water molecules from the active site. 152
None of the complexes has a coordinated water molecule as a fifth ligand when
substrates or inhibitors are bound to the metal. The metal ion is always four
coordinate and pseudotetrahedral. Computer graphics reveal beyond any doubt
that there is no room for a fifth ligand in the active site, at least in the closed
form.
(3) Many (although not all) spectroscopic data on metal-substituted deriva-
tives and their binary and ternary complexes have also been interpreted as indic-
ative of a four-coordinate metal. 159 Even nickel(II) and copper(II), which have
little tendency to adapt to a pseudotetrahedral ligand environment, do so in
LADH, the electronic structure of the latter resembling that of blue proteins
(Figure 2.36).160
(4) The substrate binding site is actually "created" by the closure of the
protein (Figure 2.34). The reactive species are thus trapped in an absolutely
anhydrous environment.
The chromophoric aldehyde DACA
(2.24)
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Figure 2.36
Electronic spectra of liver alcohol dehydrogenase substituted with copper at the catalytie site
( •••••),160 together with the spectra of blue (stellacyanin, ---) 161 and non-blue (superoxide dis-
mutase, ---) 162 copper proteins.
has been extensively used as an "indicator" of the polarity of the binding site.
Large red shifts of the ligand 7T- 7T* transition upon binding indicate the polarity
of the site to be much higher than in water; there is a further sizeable increase
in polarity when NAD + instead of NADH is bound in the ternary complex. 163
(5) The electronic spectra of the cobalt-substituted derivative are character-
istically different when different anions are bound to the metal (Figure 2.37).164
A catalytically competent ternary complex intermediate displays the electronic
absorption pattern typical of anion adducts. 166
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Figure 2.37
Electronic spectra of liver alcohol dehydrogenase substituted with cobalt at the catalytic site.
Binary complex with NAD + (---); 165 ternary complex with NAD + and CI ( ); 165 bi-
nary complex with acetate (.....); 164 intermediate in the oxidation of benzyl alcohol with
NAD + ( ).166
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Protonation scheme for LADH and its adducts with coenzymes and substrates. 157,167
(6) From extended kinetics measurements a protonation scheme (Figure 2.38)
has been proposed that accounts for the many pKa values observed under differ-
ent conditions. 167 This scheme again requires formation of a coordinated alkox-
ide intermediate, but has the advantage of rationalizing in a simple way a com-
plex pattern. In essence, the only relevant acid-base group supplied by the enzyme
is the metal-coordinated water, which has a pKa of 9.2 in the free enzyme (open
form). Upon binding of NADH the pKa increases to 11.2. Since NADH disso-
ciation is the last and rate-limiting step of the alcohol oxidation reaction, the
decrease in kCa1 with this pKa is accounted for by a decrease in dissociation rate
of NADH from the hydroxo form. On the other hand, the pKa of water is
decreased to 7.6 upon binding of NAD +. These rather large changes in both
directions are best explained by a marked sensitivity of the coordinated water
molecule to the polarity of the environment, which, with the possible exception
of the unligated form that has a more or less "regular" pKa value of 9.2, can
be almost completely anhydrous and much different from that of bulk water.
The nonpolar nicotinamide ring of NADH decreases the overall electrostatic
interactions of the water molecule, whereas the positive charge of NAD + drasti-
cally increases them. In this scheme, the association rates of both coenzymes
are predicted to (and, in fact, do) decrease with a pKa of 9.2, the dissociation
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rate of NAD + is predicted to (and does) decrease with a pKa of 7.6, and the
dissociation rate of NADH is predicted to decrease with a pKa of 11.2 (and,
indeed, it is pH-independent up to and above pH 10).
The decrease of kCal at low pH depends on an ionization that in turn depends
on the substrate. This pKa must be that of the coordinated alcohol; at too Iowa
pH, deprotonation of the coordinated alcohol becomes the rate-limiting step.
The pKa values observed for this process range from 6.4 for ethanol to 4.3 for
triftuoroethanol. What is surprising for aqueous-solution chemistry-that the pKa
of a coordinated alcohol is lower than the pKa of a coordinated water mole-
cule-can now be explained in terms of the different polarity of the two adducts
in LADH. In the binary complex with NAD + (pKa = 7.6), the water molecule
is still free to interact through H-bonding with the solvent and partially dissipate
the electrostatic charge. In the ternary complex with any alcohol, the R group
may prevent access of the solvent to the cavity, decreasing the dielectric con-
stant of the medium. As a consequence, the polarity of the environment is in-
creased. It is interesting to speculate that Nature could have chosen a stronger
Lewis acid than a zinc ion coordinated to two negatively charged residues to
decrease the pKa of a coordinated alkoxide, but then the pKa of the coordinated
water would have simultaneously undergone a parallel and possibly even stronger
decrease. Instead, LADH provides a self-regulating environment that is tailored
to decrease the pKa of a coordinated alcohol, once properly positioned, more
than that of a coordinated water. The full catalytic cycle for the dehydrogenation
reaction at pH around 7 can be summarized as follows (Figure 2.39):
(1) NAD + binds to the open, water-containing form of the enzyme with a
maximal on-rate. The pKa of water is decreased to 7.6, but water is still
mostly unionized.
(2) A neutral alcohol molecule enters the crevice between the two domains,
and coordinates the zinc ion by displacing the water molecule. The pro-
tein is still in the open form.
(3) Domain rotation brings the protein into the closed form, excluding all
the residual water molecules from the active site; the combined effect
of the metal positive charge and of the unshielded positive charge of the
nicotinamide ring lowers the pKa of the coordinated alcohol below 7. A
proton is expelled from the cavity, possibly via a hydrogen-bond net-
work of protein residues.
(4) Direct hydride transfer takes place from the alcohol CH to the 4-position
of the properly oriented nicotinamide ring. The resulting ternary com-
plex is an NADH-aldehyde adduct. The polarity of the active site dra-
matically drops.
(5) The aldehyde product leaves and is replaced by a neutral water molecule
(its pKa now being 11.2). Additional water molecules can now enter the
crevice, favoring the partial opening of the structure.
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Figure 2.39
Possible catalytic cycle of LADH.
(6) The loss of contacts between the two halves of the channel favors a
complete opening and then the release of NADH, whose dissociation
rate is maximal and pH-independent.
D. Group Transfer and Vitamin 8 12
1. Group transfer enzymes
The phosphodiester bond in ATP and in related molecules is a high-energy
bond whose hydrolysis liberates a large quantity of energy:
ATP + H20 ~ ADP + Pi + 30-50 kJ mol- 1 (2.25)
In many systems, typically the ATPases, the terminal phosphoryl group is trans-
ferred to another acidic group of the enzyme, e.g., a carboxylate group, to form
another high-energy bond whose energy of hydrolysis is needed later for some
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endoenergetic transformation. Therefore the first step of the reaction is the phos-
phoryl transfer to a group of the enzyme.
Kinases, a subset of the class of transferases, constitute a large group of
enzymes that phosphorylate organic substrates:
ATp 4 - + HX;;:::ADp3- + PX 2 - + H + (2.26)
In some kinases, such as nucleoside diphosphate kinase,168,169 an intermediate
step is the phosphoryl transfer to a group belonging to the enzyme, as happens
in ATPase and as was discussed in detail for alkaline phosphatase (Section V.B).
In other kinases the phosphoryl transfer occurs directly from the donor to the
acceptor in a ternary complex of the enzyme with the two substrates. 170 Often
metal ions like magnesium or manganese are needed. These ions interact with
the terminal oxygen of the ATP molecule, thus facilitating the nucleophilic at-
tack by the acceptor. The metal ion is often associated with the enzyme. For
mechanistic schemes, see the proposed mechanism of action of alkaline phos-
phatase, especially when a phosphoryl enzyme intermediate is involved.
2. The B12-dependent enzymes
There are many enzymes that need a cobalt complex as cofactor in order to
carry out vicinal 1,2 interchange:
or
X H H X
I I I I
-c-c-~ -C-C-
I I I I
X H H X H
I I I I l,ij 0
-C-C-OH ~ -C-C-OH ~ -C-C~ + XH
I I I I I
(2.27)
(2.28)
For the former type of reactions, X can be a group containing either C or N.
Typical reactions 17l include insertion of a secondary methyl group into a main
chain
o
Il -,COOH
CoA-S/ X
H CH 3
o
COA-S~~COOH (2.29)
isomerization of an amino group from a primary to a secondary carbon
(2.30)
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and deamination reactions
o
~~H
A list of coenzyme-B!2-dependent enzymes is given in Table 2.10.
Table 2.10
Some coenzyme-B12-dependent
enzymes.
MethylmalonylCoA mutase
Glutamate mutase
a-Methylene-glutarate mutase
Dioldehydrase
Glyceroldehydrase
Ethanoldeaminase
L-,B-lysine mutase
D-a-Iysine mutase
Ribonucleotide reductase
Methionine synthetase
Methane synthetase
Methyl transferase
Acetate synthetase
(2.31)
In coenzyme-B I2 , cobalt is bound to a tetraazamacrocyclic ligand 172 (Figure
2.40). The cobalt atom lies approximately in the plane of the corrin ligand
(shown in bold). Note that rings A and D are directly linked. The conjugation
therefore extends over only 13 atoms, excluding the cobalt, and involves 14 7T
electrons. Complexes that possess the a-D-ribofuranose-3-phosphate and the ter-
minal 5,6-dimethylbenzimidazole as an axial ligand are called cobalamins. The
name cobamides applies to complexes that lack or have different heterocyclic
groups. Finally, the upper or f3 position is occupied by another ligand, which
may be water, OH -, CN -, an alkyl group, etc. The cyano derivative (ii) is
vitamin B!2. 5' -deoxyadenosylcobalamin (i) is called coenzyme B!2' The cobalt
atom in these complexes is a diamagnetic cobalt(III) system (d 6).
The aquo complex has a pKa of 7.8, which compares with that of 5.7 for
the aquopentaamminecobalt(III) complex at 298 K. 173 The difference has been
mainly ascribed to the difference in solvation of the two complexes, although
the corrin ligand bears a negative charge, which reduces the positive charge and
therefore the Lewis acidity of the metal ion. The standard reduction potential
between pH 2.9 and 7.8 is -0.04 V vs. SCE, featuring the conversion from
aquocobalamin with bound benzimidazole (base on) to base-on cob(II)alamin. 174
The potential decreases with pH above pH 7.8 down to -0.3 V. The reduced
form is five-coordinate, without the water molecule above pH 2.9, and low-
spin. 175 ,176 The system can be further reduced at a potential of -0.85 V to
(i)
(ii)
R
R
H OH OH
H
99
Figure 2.40
Structure of (i) coenzyme B12, 5' -deoxyadenosylcobalamin, and
(ii) vitamin B12 , cyanocobalamin. 172
obtain cob(I)alamin, in which the metal ion is four-coordinate and low-spin
(d 8). The standard reduction potential for the hexaaquocobalt(III) complex is
1.95 V, which is lowered to 0.10 for the hexaammine complex, to -0.13 for
the tris-ethylenediamine complex, and to - 0.80 for the hexacyanocobaltate(III)
ion. 173 After reduction to cobalt(II), the model complexes are reduced to the
metal.
The electronic spectrum of the metal-free corrin resembles that of metal
derivatives; it seems therefore that the bands are essentially 7T-7T* transitions
modified by the central atom and by the axial ligands. 177,178 The cob(III)alamins
are red, whereas the cob(II)alamins, which are brown, show an additional band
at 600 nm. 179 The latter have an EPR spectrum typical of an unpaired electron
in the d~ orbital with some 4s mixing: the cob(II)alamin at pH 7 has gil = 2.004,
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g~ = 2.32, AII(Co) = 0.0100, A~ (Co) = 0.0027 cm -I, and All (N) =
0.00173 cm -I.
Both cobalt(I) and cobalt(II)-containing cobalamins readily react with alkyl
derivatives to give alkylcob(III)alamins:
Cob(lI)alamin + CH3 1---'> CH3-Cob(llI)alamin + 1/212
Cob(l)alamin + CH31---'> CH3-Cob(llI)alamin + 1-
(2.32)
(2.33)
These can formally be regarded as complexes of cobalt(III) with a carbanion.
These are rare examples of naturally occurring organometallic compounds. The
Co-C bond in alkylcobalamins is relatively weak (bond dissociation energy
= 100 kJ mol - I, though higher values are reported in the literature 182,183) and
can be broken thermally (by heating the complex above 100°C) 182-184 or pho-
tochemically, even in daylight exposure. 180,181 The energy of the Co-C bond
is about 17 kJ mol - 1 greater when the transaxial base is absent. 184
The cobalamin coenzyme is bound by the apoenzyme with no significant
change in the absorption spectrum. 185 This suggests that no major change occurs
in the coordination of cobalt(III). The first step of the reaction involves homo-
lytic fission of the Co-C bond: 182-184, 186-188
B-Co"1-R---,> B-Co 11 . + R' (2.34)
where Band R are the ligands at the a and f3 apical positions. The 5' -deoxy-
adenosyl radical probably reacts with the substrate, generically indicated as SubH,
to give the Sub' radical and RH. Then the rearrangement reaction proceeds
along a not-well-established pathway. It is the protein-substrate binding that
controls the subsequent chemistry. In the absence of protein the Co-C bond is
kinetically stable; in the presence of protein and substrate the rate of labilization
of the Co-C bond increases by a factor of 1011_1012. 182-185 By generating the
radical in the coenzyme without the protein by means of photolysis or thermo-
lysis, we enable the coenzyme to catalyze some rearrangement reactions without
the protein. It may therefore be that the protein plays a major role in inducing
the homolytic fission, but a relatively minor role in the subsequent steps, per-
haps confined to preventing the various species from diffusing away from each
other.
Studies on protein-free corrinoids and model complexes have shown that
increasing the steric bulkiness around the coordinated Co: atom can cause a
dramatic labilization of the Co-C bond. 189 The protein-coenzyme adduct might
contain the coenzyme in a resting state and the protein in a strained state; the
substrate would then switch the system into a strained coenzyme and a relaxed
enzyme with little thermodynamic barrier. The strained form of the coenzyme
is then in labile equilibrium with base-on cobalt(II) and the free radical. 190 This
hypothesis, that conformational changes in cobalamin can switch chemical re-
actions on and off, is closely analogous with the known aspects of hemoglobin
function.
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It has been suggested that the radical formation in the coenzyme is triggered
by a steric perturbation involving an enzyme-induced conformational distortion
of the corrin ring toward the deoxyadenosyl group, thereby weakening the co-
balt-carbon bond. 187,190-194 Structural studies of different corrinoid complexes
reveal highly puckered and variable conformations of the corrin ring, attesting
to its flexibility. 195 For the dimethy19lyoxime models, it has been shown that
increasing the size of the axial ligand B does induce Co-C bond lengthening
and weakening because of conformational distortion of the equatorial ligand
away from B and toward the R group. 196 It has been proposed that the flexibility
of the corrin ligand is the reason why Nature does not use the porphyrin ligand
in vitamin B12 . 197 In an alternative explanation, the weakening of the Co-C
bond would be an electronic effect associated with the labilization of the Co-N
bond. 198
VI. PERSPECTIVES
Although a great deal is known about the biophysical characteristics of the var-
ious enzyme derivatives mentioned in this chapter, we are still far from a clear
understanding of their mechanisms of action, especially if we take into consid-
eration the role of each amino-acid residue inside the active-site cavity. Al-
though we can successfully discuss why certain metal ions are used in certain
biological reactions, we still do not know why nickel(II), for example, is in-
volved in the enzymatic hydrolysis of urea. 199,200 If we are content with the
explanations given in Sections IILA or V.D, we would need model compounds
that are good catalysts and perform the job in several steps. This latter require-
ment would make the various models much more interesting, and would repre-
sent a new objective in the investigation of the structure-function relationship of
catalytically active molecules. Indeed, the synthesis of large polypeptides may
in principle provide such models. In this respect we need to know more about
protein folding, for which emerging techniques like protein computer graphics
and molecular dynamics are very promising.
Chemical modifications of proteins like the alkylation of carboxylate 124,201
or histidine 202 residues have been performed for a long time. A newer approach
toward modeling the function of a protein, and understanding the role of the
active site, involves cleaving part of a naturally occurring protein through en-
zymatic or chemical procedures, and then replacing it with a synthetic polypep-
tide. The use of modem techniques of molecular genetics has allowed site-di-
rected mutagenesis to become in principle a very powerful technique for changing
a single residue in a cavity. Site-directed mutagenesis is a very popular ap-
proach, and its principal limitation with respect to the synthetic polypeptide
route is that only natural amino acids can be used (aside from the technical
difficulties in both approaches). Small quantities of site-directed mutants have
been obtained for CPA 125-127 and AP,203 whereas the expression of CA 204,205
is now satisfactory.
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Predictions of the changes in structure needed to affect the reaction pathway
can nowadays be made with the aid of computers. The occurrence of the pre-
dicted change can be checked through x-ray analysis and NMR. The latter spec-
troscopy is today well-recognized as being able to provide structural information
on small (:::;20 kDa) proteins through 2- or 3-dimensional teclmiques.206-208 These
techniques are increasingly being applied to paramagnetic metalloproteins such
as many of those discussed here. 208 ,209 The advantage of handling a paramag-
netic metalloprotein is that we can analyze signals shifted far away from their
diamagnetic positions, which correspond to protons close to the metal ion,69
even for larger proteins. It is possible to monitor the distances between two or
more protons under various conditions, such as after the addition of inhibitors
or pseudosubstrates, chemical modification, or substitution of a specific amino
acid.
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I. INTRODUCTION
Calcium, like many other "inorganic elements" in biological systems, has dur-
ing the last decade become the subject of much attention both by scientists and
by the general public. 1 The presence and central role of calcium in mammalian
bones and other mineralized tissues were recognized soon after its discovery as
an element by Davy in 1808. Much later, the insight arrived that Ca 2 + ions
could play an important role in other tissues as well. Experiments of great his-
torical influence were performed by the British physiologist Sidney Ringer a
little over a century ago. 2 He was interested in the effects of various cations on
frog-heart muscle and somewhat serendipitously discovered that Ca 2+ ions, ev-
erpresent in the tap water distributed in central London, in millimolar concen-
trations were necessary for muscle contraction and tissue survival.
Today it is widely recognized that Ca 2 + ions are central to a complex intra-
cellular messenger system that is mediating a wide range of biological pro-
cesses: muscle contraction, secretion, glycolysis and gluconeogenesis, ion
transport, cell division and growth (for definitions of terms in boldface, see
Appendix A in Section IX). The detailed organization of this messenger system
is presently the subject of considerable scientific activity, and some details are
already known. One of the links in the system is a class of highly homologous
Ca 2+ -binding proteins, to be discussed later on in this chapter, that undergo
Ca 2+ -dependent conformational changes and respond to transitory increases in
intracellular Ca 2+ -ion concentrations. A prerequisite for the proper function of
the calcium messenger system in higher organisms is that the cytosolic Ca 2+
concentration in a "resting" cell be kept very low, on the order of 100 to
200 nM. Transitory increases in the Ca 2 + concentration that may result from
hormonal action on a membrane receptor must rapidly be reduced. Several
transport proteins, driven either by ATP hydrolysis or by gradients of some
other ion like Na +, are involved in this activity. 107
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Ca 2+ ions are also known to play various roles outside cells. In the plant
kingdom Ca2+ ions often form links between individual cells and are required
for maintaining the rigidity of whole plants; some seaweeds are typical ex-
amples. In the blood plasma of mammals, in which the Ca 2+ concentration
exceeds the intracellular by a factor of about 104, Ca2+ ions are instrumental
in joining certain proteins in the blood-clotting system with membrane surfaces
of circulating cells. Many extracellular enzymes also contain Ca 2+ ions, some-
times at the active site but most often at other locations. It is generally believed
that Ca 2+ ions confer on proteins an increased thermal stability, and indeed
proteins in heat-tolerant microorganisms often hold many such ions.
Vertebrates require much calcium in their food; in the USA the recom-
mended daily allowance (RDA) for adult humans is 800 mg, and most other
countries have comparable recommendations. During gestation in mammals,
calcium must be transported across the placenta into the fetus, in particular
during those phases of pregnancy when bone formation is most rapid. Interest-
ingly, there appear to be some parallels between intestinal and placental trans-
port that will be discussed further below. The role of calcium in biominerals is
a vast subject that we can treat only superficially in this chapter.
To provide a background to the more biologically oriented sections that
follow, we begin with a brief recapitulation of some basic facts about calcium.
Then we continue with an outline of calcium distribution in biological tissues
and organelles, and of the methods that can be used to obtain this information.
After this follows a brief section on Ca2+ transport, and an account of the
mechanism of intracellular Ca 2+ release as it is presently understood. A discus-
sion of some selected Ca2+-binding proteins of general interest, both intracel-
lular and extracellular, then follows. Before we conclude the chapter, we will
summarize some recent observations on Ca2+-binding proteins in prokaryotes.
II. BASIC FACTS ABOUT CALCIUM: ITS COMPOUNDS
AND REACTIONS
A. Basic Facts
Calcium was first recognized as an element in 1808 by Humphry Davy, and the
name was given after the Latin for lime: calx. Several isotopes of calcium are
known. The stable isotopes are, in order of decreasing natural abundance, 40Ca
(96.94%), 44Ca (2.1%), 42Ca (0.64%), and 43Ca (0.145%). 43Ca is the only
isotope with a nuclear spin (I = ~) different from zero, which makes it amen-
able to NMR studies. 45Ca is a radioactive isotope of some importance ({3
decay; 8.8 min half life).3 It has been used in studies of calcium localization
and transport in biological systems.
Calcium constitutes about 3 percent by weight of the Earth's crust, mostly
in the form of sedimentary rocks of biological origin dating back some three
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Table 3.1
Ca 2 + concentrations in fluids and tissues.6-9
Specimen
Sea water
Fresh water
Rain water
"Hard" tap water
"Good" beer
Adult human serum
Serum of other vertebrates
Nematote body fluids
Molluscan serum-marine
-fresh water
-land
Milk
Bone
Mitochondria from rat liver
Endoplasmatic reticulum
Cytoplasm of a resting mammalian cell
Cytoplasm of E. coli
Units are mM if not otherwise stated
10
0.02-2
0.002-0.02
1.5
4
2.45 ± 0.05
1.5-5
6
9-15
1.5-7.8
3.3-12.3
70
0.8-1.0
0.8 ± 0.1 mmol/kg
8-10 mmollkg
0.0001
0.0001
billion years. In sea water the total concentration of calcium ranges from 5 to
50 times higher than in fresh water, which, in tum, has a calcium concentration
ten times that of rain water (see Table 3.1). This explains the pleasant feeling
when ordinary soaps are used in rain water. The calcium concentration in ordi-
nary tap water varies with location; calcium is usually added to water in distrib-
uting networks in order to prevent corrosion of iron pipes. Tap water with a
calcium concentration above 1.5 mM is usually classified as "hard." Interest-
ingly, the taste of beer seems related to the calcium concentration, and it is
claimed that "good" beer should have a concentration higher than that of "hard"
tap water.
In the body fluids of higher organisms the total calcium concentration is
usually on the order of a few millimolar (see Table 3.1). In adult human serum,
the concentration is observed to be, within narrow limits, 2.45 mM.
B. Essentials of Ca 2 + Chemistry
Since the Ca 2 + ion accomplishes its biological tasks in an environment with 1
to 3 mM Mg 2 +, it is of particular interest to compare the properties of these
two ions in order to understand how a discrimination is made in biological
systems. In addition, the coordination chemistry of Ca 2+ is closely related to
that of Mg 2 + (as well as Cd 2 +), though there are several obvious differences.
First of all, the ionic radius of a Ca 2 + ion with a given coordination number
(CN) is always higher than that of an Mg 2 + or Cd 2 + ion with the same CN.
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At CN = 6, the ionic radii of Ca2+, Cd2+, and Mg 2+ are 1.00, 0.95, and
0.72 A, respectively, whereas at eN = 8 they are 1.12, 1.10, and 0.89 A,
respectively. 4
Ligand preferences of Ca 2+ depend on the fact that it is a hard metal ion.
Thus Ca 2+ strongly prefers oxygen ligands over nitrogen or sulfur ligands;
Ca 2+ .... N bonds are about 0.25-0.3 A longer than Ca 2+ ····0 bonds. 5,6,10
Large differences in coordination number and geometry have been observed for
Ca2+ complexes. In a study of 170 x-ray structures of Ca 2+ complexes involv-
ing carboxylate groups, 11 binding was found to be either (i) unidentate, in which
the Ca2+ ion interacts with only one of the two carboxylate oxygens, (ii) biden-
tate, in which the Ca 2+ ion is chelated by both carboxylate oxygens, or (iii)
mixed ("a-mode") in which the Ca 2+ ion is chelated by one of the carboxylate
oxygens and another ligand attached to the a-carbon (see Figure 3.1). The Ca2+-
oxygen distances span a range from 2.30 to 2.50 A, with the average distance
being 2.38 A in the unidentate and 2.53 A in the bidentate mode, respec-
tively.II Observed coordination numbers follow the order 8 > 7 > 6 > 9. By
contrast, Mg 2+ nearly always occupies the center of an octahedron of oxygen
atoms (CN = 6) at a fixed Mg 2+ -oxygen distance of 2.05 ± 0.05 A.
In Table 3.2, stability constants for the binding of Ca 2+and Mg 2+ to var-
ious ligands are collected. We may note that selectivity of Ca 2+ over Mg2+ is
not very great for simple carboxylate ligands, but that it tends to increase for
large multidentate ligands, such as EDTA and in particular EGTA. The Ca2+
sites in many intracellular proteins with "EF-hand" binding sites (see Section
V. C) bind Ca2+ about 104 times more strongly than Mg 2+.
Another difference in ligand-binding properties of Mg 2+ and Ca 2+ can be
seen by comparing the rates of substitution of water molecules in the inner
/ ,
/ ,
/ ,
/ ,
/
.-'
/
(A) (B) (C)
Figure 3.1
The three commonly observed modes of calcium carboxylate ligation. (A) The unidentate mode,
in which the calcium ion interacts with only one of the two carboxylate oxygens. (B) The biden-
tate mode, in which the calcium ion is chelated by both oxygen atoms. (C) The a-mode, in
which the calcium ion is chelated by one carboxylate oxygen, and another ligand is attached to
the a-carbon. Adapted from Reference II.
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Table 3.2
Ca2+ and Mg 2+ (where available) stability
constants (log K) for different organic and
biochemical ligands. Most values are at ionic
strength 0.1 and 25°C.5,6,12-15
Ligand
Acetate
Lactate
Malonate
Aspartate
Citrate
Nitrilotriacetate
EGTAa
EDTA b
Glycine (Gly)
y-Carboxyglutamic acid (Gla)
Gly-Gly dipeptide
Gla-Gla dipeptide
Macrobicyclic amino cryptate [2.2.2]
Fluo-3
Fura-2
BAPTA
Quin-2
Phospholipase A2
Thrombin fragment I
Trypsinogen
Chymotrypsinogen
Chymotrypsin
Calmodulin, N-terminal
Trypsin
Calmodulin, C-terminal
Protein kinase C
a-Lactalbumin
Rabbit skeletal muscle
Troponin C, Ca 2 + /Mg 2 + sites
Carp parvalbumin
Bovine calbindin D9k
0.5
l.l
1.5
1.6
3.5
6.4
10.9
10.6
1.4
1.3
1.2
3.2
4.5
6.2
6.9
7.0
7.1
3.6
3.7
3.8
3.9
4.1
4.5
4.6
5.3
~7
~7
7.3
~8.5
8.8
0.5
0.9
2.1
2.4
3.4
5.5
5.3
8.8
3.4
2.0
2.0
1.8
2.7
3.0
3.3
3.6
4.2
~4.3
" EGTA: ethylenebis(oxyethylenenitrilo)tetraacetate
b EDTA: ethylenedinitrilotetraacetate
hydration sphere by simple ligands, according to
This rate (log k, with k in s- 1) has been determined to be 8.4 for Ca 2 + and 5.2
for Mg 2 + ,16
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The formation of biominerals is a complex phenomenon. In order to obtain
a feeling for the conditions under which inorganic solid phases in biological
systems are stable, it is of some interest to look at solubility products. Solubility
products, K~p, have a meaning only if the composition of the solid phase is
specified. For a solid compound with the general composition (A) k(B) ,(C) m the
solubility product is defined as
(3.1)
where [A], [B], etc., denote activities of the respective species, usually ionic,
in equilibrium with the solid. Activities are concentrations multiplied by an ac-
tivity coefficient, 'Y, nearly always less than unity. Activity coefficients for ions
in real solutions can be estimated from Debye-Hiickel theory 17 if the ionic strength
of the solution is known. In human blood plasma, the ionic strength, I, is about
0.16, and the activity coefficient for Ca 2 + at 37°C is 0.34. In many discussions
it may be sufficient to equate concentrations with activities.
The solid phase involved is essentially assumed to be an infinitely large,
defect- and impurity-free crystal with a well-defined structure. Microscopic crystals
have higher solubilities than large crystals, a well-known phenomenon that leads
to "aging" of precipitates, in which larger crystals grow at the expense of
smaller ones.
Many anionic species appearing in the solubility products may also be in-
volved in protonation equilibria in solution, such as those of phosphoric acid:
H2P04 - ~ H+ + HP04 2 -; HP04 2 - ~ P04 3 + H+; etc. When the pros-
pects for the formation of a solid phase under certain solution conditions are
investigated, the activity, or concentration, of the particular anionic species
specified in the solubility product must be known, not only "total phosphate"
or "total calcium," etc. The data in Table 3.3 show that, at pH > 5, the most
stable (i.e., insoluble) solid calcium phosphate is hydroxyapatite.
Table 3.3
Solubility products, at pH 5 and 25°C, for solid calcium phosphates.
Solid phase
CaS04 ' 2H20 (sulfate, "gypsum")
Ca(OH)2 (hydroxide)
CaHP04 ' 2H20 (hydrogen phosphate)
CaC03 (carbonate, "calcite," "aragonite")
CaC20 4 ' H20 (oxalate, "whewellite")
{3-Ca3(P04h ({3-phosphate)
Cas(P04hOH (hydroxyapatite)
log /C,p
5.1
5.3
6.6
8.5
10.5
29
58
-log /C,p of
corresponding
Mg 2 + compound
where applicable
< 1.0
10.7
7.5
5.0
III. CALCIUM IN LIVING CELLS: METHODS FOR DETERMINING
CONCENTRATIONS AND SPATIAL DISTRIBUTIONS
Much of our present knowledge of the biological role of Ca 2+ ions in the reg-
ulation and modulation of cellular activities rests on the development of analyt-
ical techniques in three different areas: our ability to measure the low concen-
tration levels in the cytoplasm of resting cells, follow the concentration changes,
both temporally and spatially, that may occur as a result of an external stimulus,
and measure the distribution of Ca 2+ in various compartments of a cell. The
last decade has seen the emergence of many such new techniques, and the im-
provement of old ones, which has had a major impact on our understanding of
the detailed molecular mechanisms and dynamics of the Ca 2+ messenger sys-
tem. In this section, we will survey some of the most important techniques and
results obtained using these. Broadly speaking there are two main groups of
experimental techniques: those that aim at measuring the concentration of "free"
(or uncomplexed) Ca 2 + -ion concentrations (or activities), and those that mea-
sure total calcium.
A. Measurements of "Free" Calcium Concentrations
1. Ca 2 + -selective microelectrodes
Ion-selective electrodes can be made from a micropipette (external diameter
O.l-l/Lm) with an ion-selective membrane at the tip.18.19 For Ca2+ the mem-
brane can be made of a polyvinyl chloride gel containing a suitable Ca2+ -selec-
tive complexing agent soluble in the polymer gel. A commonly used complex-
ing agent is "ETH 1001" (see Figure 3.2A). An additional "indifferent" reference
electrode is needed. For measurements inside cells, the reference electrode can
also be made from a micropipette filled with an electrolyte gel. Often the ion-
selective and reference electrodes are connected in a double-barrelled combina-
tion microelectrode. 21 The whole assembly can then be inserted, using a micro-
manipulator, into a single cell typically 30-50 /Lm across. The arrangement is
depicted in Figure 3.2B. With proper care, Ca 2+ microelectrodes can be used
to measure Ca2+-ion concentrations down to 10 ~ 8 M. 19, 21 One limitation of
the technique is that the response time is usually in seconds or even minutes,
making rapid concentration transients difficult to follow.
2. Bioluminescence
Several living oganisms are able to emit light. The light-emitting system in
the jellyfish (Aequorea) is a protein called aequorin (Mr :::=: 20 kDa). The light
is emitted when a high-energy state involving a prosthetic group (coelenterazine)
returns to the ground state in a chemical reaction that is promoted by Ca2+
113
114 (A)
(B)
"N~O"
~O 0
oXoly0 0
/N~/o
"ETH 1001"
reference
electrode
(KCI- gel)
plasma membrane
of cell
II
II
II
II
II
II
II
II
II
-10 mM CaCI2
porous plug containing
Ca2+- specific ligand
Figure 3.2
(A) Structure of a commonly used neutral Ca 2 + chelator in Ca 2 + -selective electrodes, "ETH
1001" (N,N'-di[ll-(ethoxycarbonyl) undecul]-N,N'-4,S-tetramethyl-3,6-dioxaoctan-l ,8-diam-
ide).20 (B) Schematic arrangement for the measurement of the activity (or concentration) of
Ca2+ ions in cells using a Ca 2 + -selective double-barreled microelectrode. Frequently the mi-
croelectrode is supplemented by a third, indifferent, electrode inserted into the bathing medium
surrounding the cell. 21
ions. At Ca2 + concentrations below ~O.3 ILM the emission is weak, but in the
range 0.5-10 ILM the emission is a very steep function of the concentration
(roughly as [Ca 2 +V5).18,19,22 The response to a Ca 2 +-concentration transient is
rapid (TI/2 = 10 ms at room temperature), and the light emitted can be accu-
rately measured even at very low light levels by means of image intensifiers
and/or photon counting. For measurements of Ca2 + concentrations inside cells,
aequorin has usually been introduced either through microinjection or through
some other means. A novel idea, however, is to utilize recombinant aequorin
reconstituted within the cells of interest, thus circumventing the often difficult
injection step.174
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3. Complexing agents with Ca 2 + -dependent light absorption or
fluorescence
An important advance in the field of Ca 2 + -ion detennination was made by
R. Y. Tsien, who in 1980 described 23 the synthesis and spectroscopic properties
of several new tetracarboxylate indicator dyes that had high affinity and reason-
able selectivity for Ca2+. All these dye molecules have a high UV absorbance
that is dependent on whether Ca 2 + is bound or not; a few also show a Ca 2 + -
dependent fluorescence. Tsien has also demonstrated that these anionic chelators
can be taken up by cells as tetraesters, which, once inside the cells, are rapidly
enzymatically hydrolyzed to give back the Ca 2+ -binding anionic forms. Flu-
orescent tetracarboxylate chelators with somewhat improved Ca 2+ selectivity
such as "BAPTA," "Quin-2," and "Fura-2" (Figure 3.3) were later de-
scribed. 24 These chelators are very suitable for measurement of Ca 2+ -ion con-
centrations in the range 1 J.LM to 10 nM in the presence of 1 mM Mg 2 + and
100 mM Na + and/or K +-i.e., conditions typically prevailing in animal cells.
Recently a new set of chelators that are more suitable for measurements of
calcium concentrations above 1 J.LM was presented. 25 The most interesting of
these is "Fluo-3," with a calcium-binding constant of 1.7 x 10 6 .
Whereas the emission spectrum for Fura-2 (Figure 3.3B), which peaks at
505-510 nm, hardly shifts wavelength when Ca 2 + is bound, the absorption
spectrum shifts toward shorter wavelengths. In studies of free Ca 2+ concentra-
tions where internal referencing is necessary, for example, in studies of single
cells, it is therefore advantageous to excite alternately at ~ 350 and 385 nm,
and to measure the ratio of fluorescence intensity at ~ 51 0 nm.
The use of fluorescent chelators has recently permitted studies in single cells
of rapid fluctuations or oscillations of free Ca 2 + and the formation of Ca 2 +
concentration gradients. Using a fluorescence microscope coupled to a low-light-
level television camera feeding a digital image processor, Tsien et al. 26 have
been able to reach a time resolution of about 1 s in single-cell studies. The
results of some highly informative studies made using this instrument are shown
in Figure 3.4. (See color plate section, page C-7.) The concentration of free
Ca 2 + is presented in pseudocolor, and the Fura-2 concentration inside cells is
50-200 J.LM, as indicated in the figures. We see a Ca 2 + gradient diffusing through
an entire sea-urchin egg (~120 J.L across) in 30 s. The free Ca 2+ concentration
of the resting egg (~100 nM) is increased to about 2 J.LM as Ca 2 + diffuses
through the egg. The mechanism of propagation is believed to be a positive
feedback loop with inositol trisphosphate releasing Ca 2+ and vice versa (see
Section V).
A pertinent question concerning the uses of intracellular Ca 2 + chelators is
whether or not the chelator significantly perturbs the cell. The chelator will
obviously act as a Ca 2 + buffer in addition to all other Ca 2 + -binding biomole-
cules in the cell. The buffer effect is probably not of any major consequence,
since the cell may adjust to the new situation by an increase in total Ca 2 + ,
especially if the chelator concentration is in the J.LM range. The chelators could,
however, interact with and inhibit intracellular enzymes or other molecules, an
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Molecular structure of three chelators frequently used in measurements of "free" Ca 2+ -ion con-
centrations. They may all be regarded as aromatic analogues of the classical chelator "EDTA";
their optical spectroscopic properties change upon binding Ca 2 + ions. (A) For "BAPTA" the
spectral changes are confined to the absorption spectrum, whereas "Quin-2" and the "Fura-2"
in (B) show Ca 2+ -dependent changes in their fluorescence spectra. 23, 24 (B) The relative fluores-
cence intensity of "Fura-2" at 505 nm as a function of the wavelength of the excitation light at
different Ca2+ concentrations, The data 26 refer to a solution containing 115 mM KCI, 20 mM
NaCl, and I mM Mg 2 + at 37°C and pH 7,05, At increasing Ca2+ concentration, the excitation
efficiency at ~ 350 nm is increased, but that at ~ 385 nm is decreased, In order to eliminate (as
much as possible) variations in fluorescence intensity in biological samples due to slight varia-
tions in dye concentrations and/or cell thickness, it is often advantageous to measure the inten-
sity ratio at 345 and 385 nm excitation wavelengths.
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effect that could result in aberrant cellular behavior. It is not unlikely that BAPTA
will bind to certain proteins. 27
4. Complexing agents with Ca 2 +-dependent NMR spectra
A series of symmetrically substituted fluorine derivatives of BAPTA (see
Figure 3.3A) has been synthesized. 28 ,29 One of these chelators is 5F-BAPTA
(Figure 3.5A), which has a binding constant for Ca 2 +, K~a, of 1.4 X 10 6 M- 1
and a 19F NMR chemical shift, 0, that in the free ligand is different from that
in the complex with Ca 2 + (L~oCa2+ = 6 ppm). The rate of Ca 2 + dissociation,
koff ' is 5.7 x 10 2 S - I, which gives the rate of association, kon ' as 8 x 10 8
M 1 S - 1 according to
(3.2)
This exchange rate means that we are approaching the slow exchange limit in
19F NMR, and in subsaturating concentrations of Ca 2 + two 19F signals are seen
(see Figure 3.5B).
Since the areas of the NMR signals from the bound (B) and free (F) forms
of the ligand are proportional to their concentration, the free Ca 2+ concentration
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Figure 3.5
(A) Molecular structure of the calcium chelator 5F-BAPTA whose 19F
chemical shift changes upon calcium binding. (B) 19F NMR spectrum
of a solution containing 5F-BAPTA and Ca 2+ in a molar ratio of 3: I.
Signal B originates from the Ca2+ -5F-BAPTA complex, and F from
free 5F-BAPTA. Adapted from Reference 29.
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is obtained simply as
2+ _ ~. 1[Ca ]free - F K
B
'
(3.3)
An additional beneficial property of SF-BAPTA and other fluorinated analogues
of BAPTA is that they will also bind other metal ions with a 19F chemical shift
of the complex that is characteristic of the metal ion. 29 Under favorable circum-
stances, it is thus possible to measure simultaneously the concentrations of sev-
eral cations.
For SF-BAPTA the selectivity for Ca2+ over Mg 2+ is very good
(KB M g2 + = 1 M~l). In applications of SF-BAPTA to intracellular studies, the
same protocol is used as with the parent compound and its fluorescent deriva-
tives: some esterified derivative, e.g., the acetoxymethyl ester, is taken up by
the cells and allowed to hydrolyze in the cytoplasm. The intracellular concentra-
tions of SF-BAPTA needed to get good 19F NMR signals depend on the density
of cells in the sample tube and the number of spectra accumulated. With accu-
mulation times on the order of ten minutes (thus precluding the observation of
concentration transients shorter than this time), Ca2+ concentrations of the order
of llLM have been studied in perfused rat hearts using SF-BAPTA concentra-
tions of about 201LM.34
B. Measurements of Total Calcium Concentrations
The measurement of total calcium in a biological sample can be made by any
method sensitive only to the element and not to its particular chemical form.
Atomic absorption spectroscopy is excellent as such a method. Obviously, the
spatial resolution that can be obtained with this method is limited, and it is hard
to imagine its application to elemental mapping of single cells. The techniques
discussed in this subsection have been limited to those that permit a spatial
resolution of at least 1 ILm on samples usually prepared by sectioning the frozen
biological specimens.
1. Electron probe and electron energy-loss techniques
When the electron beam in an electron microscope hits a thin sample, some
atoms in the sample will be excited or ionized, and returning to their ground
state will emit characteristic x-rays. The x-ray emission at different wavelengths
may then be measured by a photon-energy-sensitive detector. This is the basis
of electron probe x-ray microanalysis (EPMA). The electrons that pass through
the sample, and that give the transmission image in electron microscopy, will
suffer energy losses that depend on the nature (to some extent also, the chemical
state) and distribution of different elements. The outcome of these phenomena
forms the basis of electron energy-loss spectroscopy (EELS; see Figure 3.6).
scanned electron beam energy dispersive
______ detector (gives "EPMA"
....--- spectra)
Ill,
f i\ \ -+-- transmitted electron beam;
tttt gives energy loss spectra ("EELS")
Figure 3.6
Principles of electron probe microanalysis ("EPMA") and electron energy loss spectroscopy
("EELS" ).
A thin slice of a freeze-dried sample is exposed to a collimated beam of electrons that may be
scanned across the sample. Atoms ionized by electron collisions will emit x-radiation at wave-
lengths characteristic of their nuclear charge (i.e., characteristic of each element). With the use
of an energy dispersive x-ray detector, signals from different elements can be differentiated.
Apart from the characteristic x-rays, a broad-spectrum background x-ray emission is also present
because of inelastic scattering of the incident electrons. Some of the electrons that pass through
the sample will have lost energy because of ionization of atoms in the sample. The energy loss
is again characteristic for each element, and if the energy distribution of the transmitted elec-
trons is analyzed, this will have "peaks" at certain characteristic energies. If the energy resolu-
tion is pushed far enough «I eV), the loss peaks even become sensitive to the chemical state
of the element.
The EPMA technique as applied to calcium has been improved by Somlyo
in particular. 30 Typically samples are rapidly frozen and sectioned at low tem-
peratures (- 130°C) to preserve the in vivo localization of diffusible ions and
molecules. Spatial resolutions of 10 nm or better have been attained on 2:100 nm
thick freeze-dried cryosections. The minimal detectable concentration, which
requires some signal averaging, is approximately 0.3 mmol Ca per kg dry spec-
imen (i.e., 10 ppm). The calcium content of mitochondria and endoplasmic
reticulum in rat liver cells has been studied by EPMA (see Table 3.1).8
The high calcium content of endoplasmic reticulum (ER) is consistent with
the view that this organelle is the major source of intracellular Ca 2 + released
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through the messenger inositol trisphosphate (see Section IV.C). Other EPMA
studies have shown mitochondria to have a large capacity for massive calcium
accumulation in cells where cytoplasmic Ca 2 + concentrations have been abnor-
mally high, for example, as a result of damage of the cell membrane. 30
EELS is presently less well-developed than EPMA. Two of the major dif-
ficulties in the use of EELS for quantitative analysis of calcium and other ele-
ments are (i) large background, since it is a difference technique, and (ii) sen-
sitivity to specimen thickness. The major advantage of EELS is that the spatial
resolution is potentially much better than in EPMA, and can be I to 2.5 nm in
favorable specimens.
2. Proton-induced x-ray emission (PIXE)
A specimen exposed to a beam of high-energy (1 to 4 MeV) protons will
also emit characteristic x-rays just as in EPMA. The advantage of using protons
instead of electrons is that protons are more likely to collide with an atom, thus
producing excited atoms emitting x-rays. The sensitivity in detecting a particular
element is therefore much higher in PIXE than in EPMA or EELS. The PIXE
technique, which was developed at the University of Lund, Sweden, in the late
1960s, was originally used mainly for studies of fairly large objects. 9
In 1980 a group at Oxford University succeeded in focusing the proton
beam to a diameter of 1 f.Lm with sufficient energy (4 MeV) and beam intensity
(lOa pAJf.Lm 2) to allow elemental mapping at ppm concentrations. 31 Similar beam
performances (~0.5f.Lm diameter) are now also available at the University of
Lund and other laboratories. Beam diameters of 0.1 f.Lm are likely to be achieved
in the near future. Like EPMA, the PIXE method allows the simultaneous ob-
servation of several elements in the same sample. The biological applications of
the microbeam PIXE technique are limited, but it is clear that its potential is
great. Some representative results obtained with the Oxford microbeam are shown
in Figure 3.7. (See color plate section, page C-8.)
3. Ion microscopy
Ion microscopy is another technique capable of detecting all elements at the
ppm level. The basic idea is to expose a freeze-fixed, cryofractured, and freeze-
dried sample, which has been put onto a conducting substrate in a vacuum
chamber, to a beam of ions (e.g., D2 + or Ar + ). These ions will remove the top
two or three atomic layers of the sample surface by sputtering. A certain fraction
of the removed atoms will leave as ions. This secondary ion beam is accelerated
into a double-focusing mass spectrometer, where the ions are separated accord-
ing to their mass-to-charge ratio. The ion optics are designed to preserve the
spatial distribution of the emitted secondary ions, and an element image of the
sample can thus be produced with a spatial resolution of ~0.5 f.Lm. 32 The ion-
microscope technique can form images of a particular isotope of an element. In
principle, then, one could perform isotope labeling or "isotope chase" studies
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and follow, say, the fate of isotope-enriched 43Ca externally applied to a cell.
The ion-microscope technique has not yet come into widespread use, but the
quality of element (or ion) images obtained on single cells is impressive. 33
C. Summary
Much of our present knowledge about the biological role of Ca 2+ rests on de-
tailed measurements of the concentration, distribution, and chemical nature of
Ca 2 + and its complexes. Concentrations of uncomplexed, or "free," Ca 2 + can
be measured by Ca 2 + -selective microelectrodes, bioluminescence and com-
plexing agents with Ca 2 + -dependent light absorption, fluorescence, or NMR
spectra. An outcome of such studies is that the "free" Ca 2+ concentration in
resting eukaryotic cells generally is very low, on the order of 100 to 200 nM.
Total Ca 2+ concentrations, uncomplexed and complexed, can be measured by
a variety of physical techniques. Some techniques, like atomic absorption, are
sensitive but give poor spatial resolution. Others involve the bombardment of
the sample with electrons or charged atoms, and can yield spatial resolutions of
the order of a few nm; however, there is a trade-off between detectability and
resolution.
IV. THE TRANSPORT AND REGULATION OF Ca 2 + IONS
IN HIGHER ORGANISMS
All living organisms need calcium, which must be taken up from the environ-
ment. Thus, Ca 2 + ions have to be distributed throughout the organism and
made available where needed. In higher organisms, such as humans, the blood-
plasma level of total calcium is kept constant (=2.45 mM) within narrow limits,
and there must be a mechanism for regulating this concentration. On a cellular
level we have already seen in the preceding section that the basal cytoplasmic
Ca 2+ concentration, at least in eucaryotic cells, is very low, on the order of
100 nM. At the same time the concentrations of Ca 2+ in certain organelles,
such as endoplasmic (or sarcoplasmic) reticulum or mitochondria, may be con-
siderably higher. If Ca 2+ ions are to be useful as intracellular "messengers,"
as all present evidence has it, Ca 2+ levels in the cytoplasm would have to be
raised transitorily as a result of some stimulus. Ca 2+ ions may enter the cyto-
plasm either from the extracellular pool or from the Ca 2+ -rich organelles inside
the cell (or both). We could imagine Ca 2 + channels being regulated by chemi-
cal signaling, perhaps by a hormone acting directly on the channel, or by a
small molecule released intracellularly when a hormone is attached to a mem-
brane-bound receptor. Some channels may be switched on by voltage gradients,
and both these mechanisms may operate concurrently.
Increased intracellular Ca 2 + levels must eventually be brought back to the
basal levels, in some cells very quickly. The ions could be transported out of
the cell or back into the Ca 2+ -rich organelles. This transport will be against an
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electrochemical potential gradient, and thus requires energy. There are many
possibilities for different forms of Ca 2+ transport and. regulation in living sys-
tems, and we still know fairly little about the whole picture. Detailed studies
are also complicated by the fact that, in higher organisms, cells are differen-
tiated. Nature is multifarious, and what is valid for one type of cell may not be
relevant for another. With these words of caution we will start out on a macro-
scopic level and continue on toward molecular levels.
A. Ca 2 + Uptake and Secretion
The uptake of Ca 2+ from food has mostly been studied in typical laboratory
animals, such as rats, hamsters, chickens, and humans. In humans, uptake oc-
curs in the small intestine, and transport is regulated by a metabolite of vitamin
D, calcitriol (l,25-dihydroxy vitamin D3).34 The uptake process is not without
loss; roughly 50 percent of the calcium content in an average diet is not ab-
sorbed. To maintain homeostasis and keep the calcium level in blood plasma
constant, excess Ca 2+ is excreted through the kidney. The main factor control-
ling this phenomenon in vertebrates is the level of the parathyroid hormone that
acts on kidney (increases Ca 2 + resorption), on bone, and, indirectly, via stim-
ulated production of calcitriol, on the intestinal tract (increases Ca 2 + uptake).
Calcium enters the cells from the outside world, i.e., the intestinal lumen, by
traveling through the brush-border membrane of the intestinal epithelial cells,
through the cytosolic interior of these cells, and into the body fluids through the
basal lateral membranes of the same cells. The molecular events involved
need to be studied further. Figure 3.8 outlines the Ca 2 + transport processes
known or thought to occur.
Transfer through the brush-border membrane is assumed to be "passive"
although indirectly facilitated by calcitriol. The calcitriol effect may be due to
synthesis of a carrier protein,35 but could also be an effect of altered membrane
lipid composition. 36 The fate of Ca 2 + ions, once inside the epithelial cell, is a
much-debated subject. What appears clear is that the Ca 2 + ions entering through
the brush-border membrane do not cause an increase of the low cytosolic Ca 2 +
concentration. It is thus quite likely that the Ca 2 + ions are carried through the
cell but the means of transportation is unknown. One plausible carrier is the
intracellular low-molecular-weight Ca 2+ -binding protein calbindin D9K (Mr = 9
kDa) formerly known as ICaBP (see Section V.C).35 Its synthesis is induced by
vitamin D, and it is mainly found in mammalian intestines. The porcine and
bovine calbindin D9K has a Ca 2 + binding constant of KB = 3 X 108 M - 1 in
low ionic strength media 37 and K B = 2 X 106 M -1 in the presence of 1 mM
Mg 2 + and 150 mM K + .38 The concentration of calbindin D9K in epithelial cells
can reach millimolar levels, 35 which could allow it to facilitate Ca 2 + diffusion
across the cytosol. This was first suggested by Williams, subsequently elabo-
rated by Kretsinger et aI. in 1982,39 and later demonstrated in a model cell by
Feher. 40 The basic idea is that, although the diffusion rate of Ca 2 + ions
(~1O ~5 cm 2 s -1) is higher than for the (Ca 2+)2 calbindin complex
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Figure 3.8
A scheme representing some of the known and hypothetical molecular participants in the trans-
port of Ca 2 + across intestinal epithelial cells. Transport across the brush-border membrane is
generally assumed to be passive or to be facilitated by a carrier (1M Cal), and is also influenced
by vitamin D. Transport through the cell may be in vesicles and/or in association with Ca 2+_
binding proteins (CaBP), notably calbindins D9k (mammals) or D28k (avians). Temporary storage
or buffering of Ca 2 + may be through cytosolic CaBPs, mitochondria, endoplasmic reticula
(ER), or other organelles. Transport of Ca 2 + out of the cell through the basal-lateral membranes
is energetically uphill, and appears primarily accomplished by a Ca 2 + -ATPase and possibly to
some extent by a Na 2 + _Ca 2 + antiport. Adapted from Reference 35.
(~ 0.2 X 10 - 5 cm 2 s - I), the fact that the concentration of the latter complex
may be about 10 3 times higher than that of free Ca 2+ will result in an increased
net calcium transport rate. Calbindin would, in fact, act very much like myo-
globin in facilitating oxygen transport through muscle tissue.
Plausible as the above mechanism may seem, it may, however, not be the
whole truth. An alternative mechanism is vesicular transport. In chicken intes-
tine it has been shown that the only epithelial organelles that increased in Ca 2+
content as a result of calcitriol treatment were the lysosomes. 41 The result lends
support to a transport mechanism involving Ca 2+ uptake across the brush-bor-
der membrane by endocytic vesicles, fusion of these vesicles with lysosomes,
and possibly also delivery of Ca 2+ to the basal lateral membrane of the epithe-
lial cell by exocytosis. This process would also explain the vitamin-D-induced
alterations in brush-border-membrane lipid compositions as a consequences of
preferential incorporation of certain types of lipids into the vesicles. Interest-
ingly, the lysosomes in the chicken studies also contained high levels of calbin-
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din D28k-a type of vitamin-D-induced Ca 2+ -binding protein found in avian
intestines-making it conceivable that this protein acts as a "receptor" for Ca 2 +
at the brush-border membrane and upon Ca 2 + binding could become internal-
ized in endocytic vesicles. 41
The basal lateral plasma membrane contains at least two types of Ca 2+
pumps that also may playa role in Ca2 + uptake, one ATP-driven, one driven
by a concurrent flow of Na + ions into the cytoplasm (i.e., a Na + -Ca 2+ anti-
port; see Figure 3.8). We discuss these types of transporting proteins in the
next subsection.
There are some apparent analogies between intestinal Ca 2 + transport and
that occurring in the placenta. Transplacental movements of Ca 2+ increase dra-
matically during the last trimester of gestation. 42 In mammalian placental troph-
oblasts, high concentrations of calbindin D9K are found. 43 ,44 The protein synthe-
sis also in this tissue appears to be under calcitriol regulation. Ca 2 + ions have
to be supplied by mammalian females, not only to the fetus during pregnancy,
but also to the newborn child through the mother's milk. The molecular details
of Ca 2 + transport in the mammalian glands have not been extensively studied.
In milk, Ca 2 + is bound mainly to micelles of casein, and the average Ca2 +
content is reported to be 2.5 glliter (see Table 3.1).
B. Intracellular Ca 2+ Transport
In order to provide a better understanding of the role of Ca 2 + as an almost
universal regulator of cellular function, we need to take a brief look at the many
ways by which Ca 2 + ions can be transported in or out of eukaryotic cells.
Although various transport pathways have been elucidated, the present picture
is probably not complete, since the molecular structures and properties of the
transport proteins are only partially known. The major pathways for Ca 2 + trans-
port across cellular membranes involve three membrane systems: the plasma
membrane, the inner mitochondrial membrane, and the membrane of the endo-
plasmic reticulum (ER) (or, in striated muscle cells, a specialized form of ER
called the sarcoplasmic reticulum (SR): (Figure 3.9). Two of the membrane-
bound transport systems are Ca 2 + -ATPases, since they derive their main energy
from the hydrolysis of ATP (l and 2 in Figure 3.9). Their properties do, how-
ever, differ in many other respects, as we will see.
1. The Ca 2 + -ATPases
The plasma membrane Ca 2 + -ATPase (PM Ca2 + -ATPase) of erythro-
cytes-first recognized by Schatzmann in 1966 45-was isolated in pure form
by Niggli et at. in 1979, using an affinity column with an ATP-ase binding
protein, calmodulin (see Section V.A), coupled to the ge1. 46 Ca 2 + -ATPases
purified from other types of plasma membranes appear to be very similar. The
schematic structure of the erythrocyte membrane Ca 2 + -ATPase is presented in
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Figure 3.9
Schematic representation of the major pathways for the transport of Ca 2 + across cellular mem-
branes. PM, plasma membrane; ER(SR), endoplasmic reticulum (sarcoplasmic reticulum); M,
mitochondria; ~ 'IT, difference in membrane potential. The transport proteins shown are: I and 2,
PM and ER(SR) Ca 2 + -ATPases; 3 and 4, PM and ER(SR) receptor-mediated Ca 2 + channels; 5
and 6, PM and M (inner-membrane) Na + ICa 2+ exchangers; 7 and 8, PM and M voltage-sensi-
tive Ca 2+ channels. In addition, some not-wellCdefined "passive" transport pathways are indi-
cated by dashed arrows.
Figure 3.10.47 The sarcroplasmic reticulum in muscle cells is abundant in Ca 2 + -
ATPase. It is estimated that this protein constitutes more than 80 percent of the
integral membrane proteins, and covers a third of the surface area.
The sarcoplasmic reticulum Ca 2 + -ATPase (SR Ca 2 + -ATPase) was first pu-
rified by MacLennan in 1970.48 Presently it is the best characterized Ca 2 + -
ATPase. A schematic model and a summary of some properties are given in
Figure 3.11. 49 Ten hydrophobic segments of about 20 amino-acid residues each
are revealed by hydropathy plots, and these segments are assumed to span the
membrane as a-helices. (For the one-letter codes for amino acids, see Appendix
B in Section IX.) The phosphorylation site has been identified as Asp-35I, and
the nucleotide binding domain is following the phosphorylation domain. The
Ca 2 + -binding sites are located within the predicted trans-membrane domains
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Figure 3.10
Schematic structure of the calmodulin (CaM)-activated plasma membrane Ca 2 +-ATPase of
erythrocytes. Some molecular characteristics are: My = 138,000: transport rate (30°C), 20-70
Ca 2 + ions per protein molecule per second; KM(Ca 2 +) = 0.5 J.LM (cytoplasmic side in high-
affinity form); Ca 2 +/ATP ratio, I(?); activated not only by CaM but also by acidic phospho-
lipids and unsaturated fatty acids. Figure kindly provided by R. Moser and E. Carafoli.
(see Figure 3.11). This was shown through a series of site-directed mutations in
which likely Ca 2+ -liganding residues like Asp, GIu, and Thr were mutated into
residues lacking possible side-chain ligands (e.g., Asn, GIn, and Ala).50
The presently accepted reaction cycle involves two main alternative confor-
mations, E] and E2, the former with two high-affinity sites (Km ;5 1 J.LM)4 on
the cytoplasmic side, which in E2 are open to the luminal side with
Km ~ 1 mM. 49 ,5] The mechanism suggested for Ca2+ transport (Figure 3.12)
has many features similar to that suggested by Williams for H + translocation in
the mitochondrial ATPase. 52
It is instructive to consider briefly the thermodynamic limits of the transport.
(The discussions about the thermodynamics behind Ca2+INa + transport pertain
to Na +IK + gradients in excitable tissues as well). Let us define an "inside"
and an "outside" separated by a membrane, as shown in Figure 3.13, where
[Ca 2+] and l/J denote activities and membrane potentials, respectively. The dif-
ference in electrochemical potential, /).p" , across the membrane for a Ca 2+ ion
is given by
(3.4)
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Figure 3.11
Schematic structure of the Ca 2 + -ATPase of sarcoplasmic reticulum. Some molecular characteris-
tics are: My = 110,000; Km < li-LM (two Ca 2+ sites on cytoplasmic side in high-affinity form);
Ca 2 +/ATP ratio, 2; Mg 2 + required for activity. The amino-acid residues labeled were mutated
to a residue lacking side chains capable of binding Ca 2 + . Mutations at the circled positions
resulted in complete loss of Ca 2+ transport activity, suggesting that the circled residues partici-
pate in Ca 2 + binding. Adapted from Reference 50.
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Figure 3.12
Simplified schematic reaction cycle of the Ca 2 + -ATPase of sarcoplasmic reticulum (SR).49,51
The transport protein is assumed to be in either of two states, E] on the cytoplasmic side, or E2
on the side of the SR lumen. Starting from E] in the upper left comer, the reactions steps shown
are: (a) binding of Ca 2 + and ATP (approximate dissociation constants within parentheses); (b)
rapid phosphorylation of Asp-351 of the protein (E] -P) and release of ADP; (c) transformation
from an energy-rich, high-Ca 2+ -affinity conformation (E] -P) (Ca 2+)z to a low-energy, low-af-
finity conformation (E2 -P)(Ca 2+)z; (d) hydrolysis of the phosphorylated protein and release of
the phosphate into the lumen; (e) return to the original state.
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Figure 3.13
Schematic representation of Ca2 + transport through a membrane
by a Ca2 + -ATPase molecule. '¥ denotes membrane potentials.
where F is Faraday's constant, T the temperature, and R the gas constant. If we
assume ~'\)I = 0, which appears reasonable for the SR membrane according to
experimental evidence, we may calculate the free-energy change, ~G, at 25°C
for transferring ~n moles of Ca 2 + across the membrane. This becomes ~G =
-~n X ~/-LCa2+ = ~n X 4.1 kcallmol if [Ca 2 +]j[Ca 2 +]j = 10- 3 and ~G =
~n X 5.4 kcallmol if [Ca 2 +lo/[Ca 2 +]j = 10 -4. Under the pertinent cellular
conditions, the free-energy change associated with ATP hydrolysis to ADP and
Pi has been calculated by Tanford to be ~G = - 13 to - 14 kcallmop3 In the
absence of a membrane potential, it is thus possible to transport two Ca 2 + ions
for every ATP molecule hydrolyzed against a concentration (or activity) gradient
of 104 or more. This treatment says nothing, of course, about the molecular
details of this transport. A more detailed model for the transport cycle has been
proposed by Tanford. 53
In the specialized cells of muscle tissue, the sarcoplasmic reticulum may
contain much calcium, and if all were "free" Ca 2 +, the concentration could be
as high as 30 mM. 54 This value would cause an osmotic pressure difference
across the membrane, as well as put a high demand on the SR Ca 2 +-ATPase.
A lowering of the free Ca 2 + concentration inside the SR would clearly be ben-
eficial. In the presence of oxalate or phosphate ions in the external medium,
calcium oxalate or phosphate may precipitate inside the sarcoplasmic reticulum,
but under normal circumstances it appears that Ca 2 + ions inside the SR are
bound to a very acidic protein, calsequestrin. 54 Each molecule (Mr = 40 kDa)
is able to bind 40 to 50 Ca 2 + ions with an effective dissociation constant of
about 1 mM (at I = O. 1). The protein has a low cation specificity and behaves
in many respects like a negatively charged polyelectrolyte. It has been crystallized 55
and we may soon have access to its x-ray structure.
outside (0) inside (i)
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Figure 3.14
Schematic representation of the Ca2 + INa + exchanger of the
plasma membrane. 'I' denotes membrane potentials.
2. The Na +ICa 2 + exchanger of the plasma membrane
Presently available information on the Na +ICa 2+ exchanger has mainly been
obtained from studies of the large cells of the giant squid axon and of plasma-
membrane vesicles from various other tissues. 56,57 In heart plasma-membrane
vesicles, the exchanger has the following characteristics: Km = 1.5-5,uM for
Ca 2+ and ~20 nM for Na+; Vmax = 20 nmol Ca 2 +/mg protein. 58 The stoichi-
ometry is at least 3: 1 Na +ICa 2+. Very few molecular details of the exchanger
are available at present. We may again briefly consider the thermodynamic
framework for an Na +ICa 2+ exchanger (Figure 3. 14). The difference in elec-
trochemical potential for Na + and Ca 2+ across the membrane is:
(3.5)
(3.6)
The free-energy change, LlGfa2 +, associated with a transfer of LlnCa2+ moles of
Ca 2+ from the inside to the outside is LlG f a2 + = Llnca2+ x Ll,uca2+, and the
corresponding change associated with the movement of LlnNa+ moles of Na +
from the outside in is LlG~a+ = - LlnNa+ X Ll,uNa+' If these free-energy changes
are coupled via the exchanger, there will be a net flux of Ca2+ as long as the
free-energy difference,
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is less than zero. We can write ~~G for the transport of 1 mol Ca 2+ as
[
[Ca2+]0 [Na+]o]~~G = 2.303 RT log 2+] - ~nNa+ X log [ +][Ca i Na i (3.8)
+ (2 - ~nNa+) X F~'\(f.
Equating ion activities with concentrations, we note that in a typical mammalian
cell [Na +]0 = 110-145 mM, and [Na +]i = 7-15 mM, or [Na +]J[Na +]i = 10.
In the absence of a membrane potential difference (~'\(f = 0), Equation (3.8)
can thus be simplified to
(3.9)
To pump one Ca2+ ion out of a cell against a concentration gradient of about
10 3 (l fLM ~ 1 mM) requires that at least 3 Na + ions pass in the opposite
direction, thus maintaining ~~G < O. What then will be the effect of a mem-
brane potential difference? Most animal cells, particularly excitable cells such
as nerve and muscle cells, have resting potential differences, ~'\(f, over the plasma
membrane of 30 to 90 mV (cytoplasm negative). For this value we find the
change in free energy, ~~G, for the transport of one mol Ca 2+ to be
[
[Ca2+]0 ]~~G = 2.3 RT log 2+ - ~nNa+ + (2 - ~nNa+) 0.1 F.[Ca ]i (3.10)
Thus for ~nNa+ > 2, we have ~~G < 0, and the transport of Ca 2+ against a
concentration gradient of about 10 3 will be promoted. This is another good
reason for having a Na +ICa 2+ exchange stoichiometry of 3: 1.
3. Mitochondrial Ca 2 + transport: influx
Mitochondria isolated from various types of animal cells-but, interest-
ingly, not those from plant cells--can rapidly accumulate exogenous Ca2+ .59
The transporter is located in the inner membrane and the driving force behind
the Ca2+ transport appears to be merely the high potential difference across this
membrane (~'\(f = 150 to 180 mY, negative in the inner matrix). This potential
difference is fairly closely maintained by the pumping out of H + from the
matrix by cell respiration. For the transport of 1 mol Ca 2+ from the "outside"
(= cytoplasm) to the "inside" (= inner mitchondrial matrix), we may deduce
from Equation (3.4) that the free-energy change ~G may be written
(~nCa2+ = - 1)
[Ca 2 +]0~G = - RT· In C 2+ - 2F ~'\(f.[a ]i (3.1l)
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From this analysis it may be inferred that the limiting Ca 2+ concentration (or
activity) ratio that can be achieved by this electrogenic pump (i.e., /)"G = 0)
IS
e -2F!!.P/RT (3.12)
With /)"'l' = 150 mV, this ratio is calculated to be 8.4 X 10 - 6 at 25°C. It is
evident that, as long as the Ca2+ influx would not lower the membrane potential
difference, the Ca 2+ uniporter has a very high pumping potential. Measured
values of the pumping rate, Vmax, are indeed high (> 10 nmol/mg protein 59) and
probably limited only by the rate of electron transport and H + extrusion in the
mitochondria.
Mitochondria may accumulate large quantities of Ca2+, probably to main-
tain electroneutrality. To prevent the buildup of high concentrations of free Ca 2+
(and of osmotic pressure), phosphate ions are also transported into the inner
matrix, where an amorphous calcium phosphate--or possibly a phosphocitrate 60-
is formed. The equilibrium concentration of free Ca 2+ in the mitochondrial
matrix may as a result be comparatively low, on the order of 1 p,M.
The molecular nature of the mitochondrial Ca2+ uniporter continues to be
elusive, and needs to be studied further.
4. Mitochondrial Ca 2+ transport: efflux
Mitochondria, as well as SR, release Ca2+ ions by mechanisms other than
"back leakage" through the pumps. In mitochondria from excitable cells, the
efflux occurs mainly through an antiport, where 2 Na + ions are transported
inward for every Ca2+ ion departing for the cytosolic compartment.6l In other
cells there is evidence for the dominance of a 2H + - Ca2+ antiport .59 In all
likelihood the Ca 2+ efflux is regulated, possibly by the redox state of pyridine
nucleotides in the mitochondria. As with the Ca2+ uniporter, few details on the
molecular nature of the antiporters are presently available.
5. Ca 2+ efflux from non-mitochondrial stores
Release of Ca2+ from ER and SR presently appears to be the prime effect
of the new intracellular messenger 1,4,5-triphosphoinositol (l,4,5-IP3) released
into the cytoplasm as a result of an external hormonal stimulus (see Section
IV.C). It seems that receptors for 1,4,5-IP3 have been established on ER, and
that the binding of 1,4,5-IP3 causes a release of Ca 2+ stored in this orga-
nelle. 62 ,63,170,J71 In addition to the receptor-controlled Ca2+ efflux, there may be
other pathways for Ca2+ release, and Ca2+ mobilization may be regulated by
other intracellular entities, the Ca2+ ions themselves included.
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6. Other voltage-gated or receptor-activated Ca 2 + channels
In addition to the transport pathways already discussed, some cells seem to
have Ca 2 + channels in the plasma membrane that can be opened by the action
of an agonist on a receptor or that are gated in response to changes in membrane
potential. 64 For example, Ca2 + channels can be opened by nicotinic cholinergic
agonists 65 or by the excitatory amino acid N-methyl-D-aspartate (NMDA).66
Endochrine cells and also some muscle and neuronal cells have voltage-sensitive
Ca 2 + channels. 67,68 We will not discuss these further, but merely point to their
existence. We finally note that during the last few years knowledge about the
mechanisms of Ca2 + entry and release to and from extracellular and intracellular
pools has increased dramatically, and we refer the reader to recent reviews of
the field. 175,176
C. Inositol Trisphosphate and the Ca 2 + Messenger System
A "second" messenger is an entity that inside a cell mediates the action of
some hormone at the plasma membrane, the hormone being considered the "first"
messenger. The first such second messenger to be discovered-in fact, the very
molecule that led to the formulation of the whole concept-was cyclic AMP. 69
During the decade following the discovery of cAMP, it was gradually realized
that intracellular release of Ca 2 + ions also accompanied hormonal stimuli, and
the Ca 2+ ion slowly became regarded as a second messenger. This idea was
first clearly enunciated by Rasmussen 70 as early as 1970, and gained general
acceptance when the ubiquitous intracellular Ca 2+ -binding protein calmodulin
(see Section V.A) was discovered. In the mid-1970s this protein was shown to
be a Ca 2 + -dependent regulator of a large number of Ca 2 + -dependent enzymes,
transport proteins, etc., establishing a molecular basis for Ca 2+ action in cells.
There were some puzzling facts, however. Although a transitory increase in
intracellular Ca 2 + concentration in response to the binding of a hormone or
transmitter substance to a surface receptor could result from extracellular Ca 2+
being released into the cytoplasm, there was compelling evidence for muscle
cells that the main Ca 2 + source was the sarcoplasmic reticulum (SR). This
result led to the hypothesis of ''Ca2+ -induced Ca 2+ release," i.e., that upon
stimulation of the cell, a small amount of Ca 2 + entered into the cytoplasm and
triggered the release of greater amounts of Ca 2 + from the SR. For some cell
types it could, however, be shown that transient increases in intracellular Ca 2 +
could occur even when extracellular Ca 2 + was removed, although prolonged
responses required the presence of extracellular Ca2 +. Although some special-
ized cells have gated plasma-membrane Ca 2 + channels, release of Ca 2 + into
the cytoplasm from intracellular stores appears to be of at least equal impor-
tance. Furthermore, there is now overwhelming evidence 63 ,70-72 that intracellu-
lar Ca 2 + is released in response to the formation of a new type of intracellular
messenger: 1,4,5-IP3. Receptors for this messenger have recently been found in
the membranes of intracellular organelles, and binding of 1,4,5-IP3 to these
receptors results in the release of Ca 2 + ions. 73
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Figure 3.15
Outline of the presumed role of inositol phosphates in the intracellular mobilization of Caz+.
Upon binding of an agonist to a plasma-membrane receptor, phosphatidylinositol 4,5-bisphos-
phate (PIPz) membrane lipids are hydrolyzed to give diacylglycerol (DG) and inositol 1,4,5-
trisphosphate (1,4,5-IP3). The latter interacts with specific receptors on the endoplasmic reticu-
lum (ER) membrane that trigger the release of Caz+ into the cytosol. Ca2+ may be returned to
the ER through the Ca2+ -ATPase of the ER membrane (see Figure 3.9) and also by a direct
influx of Ca 2 + from the extracellular medium. 70 ,8l
1,4,5-IP3 is formed as a product in the hydrolysis of a special phospholipid
present in the cell membrane: phosphatidyl-inositol-4,5-bisphosphate. This re-
action, then, is the initial receptor-stimulated event. The newly formed 1,4,5-
IP3 is assumed to diffuse into the cytoplasm, and eventually reach intracellular
1,4,5-IP3 receptors on the ER, thereby triggering the release of Ca2+. A sim-
plified reaction scheme is shown in Figure 3.15. A diacylglycerol (DG) is also
formed in the hydrolysis step. DG can also act as an intracellular messenger,
and stimulates the activity of a membrane-bound protein kinase, known as pro-
tein kinase C (PKC). As a result, PKC may phosphorylate certain key proteins
and influence their activity. Protein kinase C is also activated by Ca 2 + ions, a
fact that illustrates Nature's knack in designing regulatory networks! 1,4,5-IP3
is either directly degraded in a series of enzymatic steps back to inositol, which
is then used to resynthesize the phospholipid, or it may be further phosphor-
ylated to inositol-l,3,4,5,-tetraphosphate (1,3,4,5-IP4)' which may undergo de-
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phosphorylation to form inositol-I,3,4-trisphosphate (l,3,4-IP3). The biological
functions of the latter compounds are now being investigated.
The intracellular levels of Ca 2 + are restored back to the normal low resting
values (loa to 200 nM) via transport back into the SR, and/or into mitochon-
dria, or out through the plasma membrane by the pumping mechanisms dis-
cussed in Section IV.B. As was briefly mentioned above, depriving a cell of
extracellular Ca 2+ will eventually make the cell incapable of prolonged re-
sponses to external stimuli. It appears that the intracellular Ca 2+ stores may
become depleted if not replenished. It has been suggested that the intracellular
ER Ca 2+ pool has a direct route of access to the extracellular pool, a route that
is closed when the ER pool is full. 74
In a sense, then, Ca 2+ seems to have been downgraded by the inositolphos-
phates from a "second" to a "third" messenger; however, the pivotal role of
Ca 2 + as a regulator of cellular activities remains undisputed.
D. Summary
The fluxes of Ca 2 + ions and their regulation in higher organisms, as well as in
microorganisms, depend on several transport proteins in addition to vesicular
and gated processes. An important class of transport proteins are the Ca 2 +-
ATPases, which are particularly abundant in muscle cells. These proteins trans-
locate Ca 2 + ions against large activity (or concentration) gradients through the
expenditure of ATP. Transport of Ca 2 + ions against activity gradients across
membranes may also be accomplished by coupled transport of other ions, like
Na +, with a gradient in the opposite direction.
As a result of some external stimulus-the action of a hormone, for ex-
ample-the "free" Ca 2 + -ion concentrations in the cytoplasm of many cell types
may transiently increase several orders of magnitude. This increase largely re-
sults from the release of Ca 2+ from intracellular stores (ER, SR) in response to
the initial formation of a new type of messenger, 1,4,5-IP3 . The activity of
Ca 2 +-transport proteins eventually restores the Ca 2 + concentration levels to resting
levels. This sequence of events forms the basis for Ca 2 + , s role in the regulation
of a wide variety of cellular activities (see Section V).
V. MOLECULAR ASPECTS OF Ca 2 +-REGULATED
INTRACELLULAR PROCESSES
So far we have mainly discussed the routes and means by which the concentra-
tion of Ca 2+ ions in the cytoplasm can be transiently increased and brought
back to resting levels. But changing the cytoplasmic Ca 2 + concentration is not
enough. In order to influence the cellular machinery, the Ca 2 + ions must inter-
act with different proteins, intracellular Ca 2 + receptors if you like. These in-
tracellular Ca 2 + -receptor proteins must have certain properties in order to func-
tion.
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(i) Their Ca 2 + -affinity must be such that their Ca 2 + -binding sites are essen-
tially unoccupied at resting levels of free Ca 2 + (~1O -7 M) and occupied at
levels reached upon stimulus (generally assumed to be 10 -5 to 10 -6 M). This
means that the binding constants Kf?2+ should be ~10 6 M -1.
(ii) We should also remember that Ca 2 + must exert its function in the pres-
ence of a number of other ions; in mammalian cells the intracellular concentra-
tion of "free" Mg 2 + ions is around 1 mM, and that of K + ions around 100 to
150 mM. The receptors must therefore have an adequate selectivity for Ca 2+ .
(iii) In response to Ca 2 + binding, a Ca 2 + receptor must undergo some kind
of conformation change that either alters its interaction with other molecules or
changes its activity if it is an enzyme.
(iv) Finally, there are kinetic considerations. In many cells a rapid response
is essential, and therefore the receptors must be able to interact swiftly-within
milliseconds-with incoming Ca 2 + ions, and the ions must also be able to de-
part almost as rapidly.
A few proteins have been discovered that qualify as intracellular Ca 2+ re-
ceptors. The best known of these is calmodulin (CaM), which appears to be
present in all eukaryotic cells. Most of the cellular responses elicited by Ca 2 +
appear to result from interactions between the Ca 2+ -calmodulin complex and
various other target enzymes and proteins. 75 Another important Ca 2 + -receptor
protein is troponin C (TnC), which occurs in muscle cells and is instrumental
in mediating muscle contraction. 76 These two types of proteins are highly ho-
mologous, as we shall see, and may be considered members of a superfamily
of closely related intracellular Ca 2 + -binding proteins. This superfamily has been
given the name' 'the calmodulin superfamily," and close to 200 distinct family
members are presently known. 77 Not all members of the superfamily may qual-
ify as Ca 2 + receptors; some like parvalbumins and calbindins (see Section IV.A)
appear to have a role in intracellular transport and/or Ca 2+ -buffering. For oth-
ers, such as the 5-100 proteins 78 found predominantly in brain tissue, and cal-
cimedins,79 isolated from smooth muscle, the biological function is still unclear.
One Ca 2 + receptor with enzymatic activity is protein kinase C. Its activity
is markedly increased in the presence of Ca 2+ , and it has a high calcium-bind-
ing constant (see Table 3.2) in the presence of diacylglycerol or phorbol es-
ters. 80
During recent years, groups interested in the role of Ca 2 + in secretion and
in the control of membrane cytoskeleton have identified some intracellular Ca 2+ /
phospholipid-binding proteins that appear to be distinct from the calmodulin
superfamily; these include lipocortin, endonexin, calelectrin, p36, and calpac-
tin. 81-83 These membrane-binding proteins are collectively called annexins,84 and
contain repeated domains distinct from EF-hands. The Ca2 + sites are very sim-
ilar to that observed in phospholipase A2 , as shown by the recently determined
x-ray structure of annexin V. 172 A condensed overview of the interaction of
Ca 2 + with intracellular proteins is shown in Figure 3.16. We will now go on to
discuss the molecular properties of some of the proteins mentioned above, start-
ing with calmodulin.
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Figure 3.16
Condensed overview of the interaction of Ca 2+ with intracellular proteins.
A. Calmodulin
Calmodulin is a small acidic protein (My = 16,700), the amino-acid sequence
of which has been remarkably preserved during evolution. Early on, an analysis
of its amino-acid sequence indicated that it should have four Ca 2+ -binding sites,
a deduction that proved to be correct. The three-dimensional x-ray structure of
bovine brain calmodulin 85 has been solved to a resolution of 2.2 A. A space-
filling model is shown in Figure 3. 17. (See color plate section, page C-9.) The
molecule has a dumbbell-like shape, with two globular domains connected by
an eight-tum a-helix-an unusual structural feature. In the crystal structure,
there are no direct contacts between the two globular domains, each of which
contains two Ca 2+ -binding sites. The Ca 2+ sites are all constructed in the same
way: two a-helices separated by a calcium-binding loop, 12 amino acids long,
and wrapped around the Ca 2 + ion. This structural arrangement is nearly iden-
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tical with that first observed in the x-ray structure of carp parvalbumin, and is
colloquially termed "the EF-hand." 86 This structural unit is also observed in
all available x-ray structures of proteins of the calmodulin superfamily (see Sec-
tions V.B and V.C). The Ca 2 + ligands are all oxygen atoms, located approxi-
mately at the vertices of a pentagonal bipyramid.
The binding of Ca2 + and other cations to CaM has been extensively inves-
tigated. 87 The first two Ca 2 + ions are bound in a cooperative manner, with an
average binding constant of about 2 X 10 5 M -I in 150 mM KCI and
1 mM Mg 2 +. The third and fourth Ca 2 + ions are bound with binding constants
of about 3 X 10 4 M -I under the same conditions. Spectroscopic evidence has
shown that the first two Ca 2 + -ions are bound in the C-terminal domain. Mg 2 +
has been shown to bind primarily to the N-terminal domain (see Table 3.2).88
The rates of dissociation of Ca 2 + from the (Ca 2 +)4 CaM complex have
been studied by both stopped-flow and NMR techniques. 89,90 Fast and slow pro-
cesses are observed, both corresponding to the release of two Ca 2 + ions. At an
ionic strength I = 0.1 and 25°C, the rates for the two processes differ by a
factor of 30 (see Table 3.4).
A body of biophysical measurements, mostly made before the advent of x-
ray structures, indicated that CaM is constructed from two largely independent
domains. 87 This conclusion emanated from studies of the two tryptic fragments,
TR1C and TR2C. The major site of cleavage is between Lys-77 and Asp-78 of
the central helix, and results in N-terminal and C-terminal fragments of nearly
equal size. To a good approximation, the biophysical properties of the intact
CaM molecule-NMR, UV and CD spectra, kinetic properties, thermochemical
data, etc.-are the sum of the same properties of the fragments TR1C and TR2C.
This means that we may assign the slow dissociation process, k~ff, to the C-
terminal domain, and the fast, k;ff' to the N-terminal domain of CaM. Combin-
ing binding constants and off-rates, we may calculate that the rates of Ca 2+
binding to CaM are on the order of 10 7 M -I S - 1 at high ionic strength, and
Table 3.4
Rates of Ca 2+ -dissociation and -association of some enzymes and
proenzymes.
Macrobicyclic amino cryptate [2.2.2]
Phospholipase A2
sTroponin C: Ca 2 + sites
Ca 2 + _Mg 2 + sites
Trypsin
Trypsinogen
Chymotrypsin
Chymotrypsinogen
Calmodulin: N-terminal
Calmodulin: C-terminal
0.3
1.1 x 10 3
300
5
3
,,; 10
70
350
300-500
10-20
1.1 X 10 5
6 X 104
~ 10 6
2.8 X 10 5
107
138 3 I CALCIUM IN BIOLOGICAL SYSTEMS
10 8 M -I S -lor higher at low ionic strength. Recently the x-ray structure of the
C-terminal fragment TR2C was solved, and indeed showed a structure nearly
identical with C-terminal domain of intact CaM. 91
The structural changes occurring in CaM as Ca 2 + ions are bound are asso-
ciated with pronounced changes in IH NMR, UV, fluorescence, and CD spec-
tra. 87 The observed changes in CD and fluorescence spectra in the presence of
Mg 2 + are only about 20 to 25 percent of those induced by Ca 2+ . A comparison
of the CD spectra of CaM and its tryptic fragments indicates that the structural
changes induced by Ca 2+ are substantially greater in the C-terminal than in the
N-terminal half. 92 By and large, few structural details of the conformation changes
have as yet been obtained. However, one aspect of the Ca 2 + -induced confor-
mation change is that hydrophobic sites, probably one on each domain of the
molecule, become exposed. In the presence of excess Ca 2 +, CaM will bind to
other hydrophobic molecules, e.g., phenyl-Sepharose, a variety of drugs, many
small peptides, and-last but not least-its target proteins. This brings us to the
question of how CaM recognizes and interacts with the latter. We may suspect
that the hydrophobic sites on each domain are somehow involved, but the role
played by the central helix is still not clear. To explain small-angle x-ray scat-
tering data, the interconnecting helix needs to be kinked, bringing the intact
globular domains closer. 93
A putative CaM-binding segment (27 amino acids long) of myosin light-
chain kinase (MLCK), an enzyme activated by CaM, has been identified. 94 The
interaction between the segment peptide ("M13") and CaM has been studied 95
by CD spectroscopy and IH NMR. From these studies it appears that a unique
1: 1 complex is formed, and that secondary and tertiary structural changes occur
not only in the peptide M13 but also in both halves of the CaM molecule.
Further NMR studies 96,97 of the interaction between CaM and naturally occur-
ring peptides (mellitin and mastoparan) that share some structural features of
M13---clusters of basic residues, hydrophobic residues adjacent to the basic res-
idues, and a predicted high a-helical content-show very much the same re-
sults. Based on these results, a model, shown in Figure 3.18, for the interaction
between CaM and M13 has been proposed. In this model the central helix is
kinked at position 81, allowing the two domains to wrap around the assumed
a-helical M13. Preliminary structure calculations of calcium-loaded CaM, based
on NMR data, indicate that the central helix in solution indeed is kinked and
very flexible,99 and comparisons 100 of chemical shifts in calmodulin with and
without M13 complexed supports the model in Figure 3.18. Recent structural
studies using NMR spectroscopy and x-ray diffraction have essentially con-
firmed the general features of this model, although the orientation of the peptide
is found to be reversed. 173
In conclusion, two important features of the protein should be recognized.
(i) The binding of Ca 2 + to CaM (and to its complex with the target protein)
is quite likely cooperative, meaning that the switch from inactive to active con-
formation may occur over a much more narrow Ca 2 + -concentration interval
than otherwise.
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Figure 3.18
A model for the interaction between calmodulin (CaM) and the assumed a-helical (¢ = - 57,
l/J = - 47) peptide M13. To produce this model, the backbone dihedral angles of Ser-81 in the
central a-helix of CaM have been changed (to ¢ = - 54, l/J = + 98), allowing the hydropho-
bic patches of both globular domains (green in Figure 3.17) of CaM to interact with the peptide
simultaneously. Figure kindly provided by R. Kretsinger; see also Reference 98.
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Figure 3.19
Scheme depicting the standard free energies of different states in a system consisting of Ca 2 + ,
calmodulin (CaM), and a target protein (P). p. CaM denotes a complex between calcium-free
CaM and P, P·CaM(Ca 2 +)4 denotes a complex with Ca 2 + -loaded CaM. If the affinity of the
Ca2+ -loaded CaM with the target protein P is higher than that of the Ca 2 + -free form-
i.e., I~GIIII > I~GIII-it follows that the Ca 2+ affinity of the complex p. CaM is higher than
that of CaM itself.
(ii) The effective Ca 2+ affinity will be different in the presence of the target
proteins. To illustrate this second point, consider the standard free energies in
the minimum scheme depicted in Figure 3.19. If the affinity of the Ca 2+-cal-
modulin complex (CaM(Ca)4) for the target protein (P) is greater than that of
Ca 2+ -free calmodulin (CaM)-i.e., ILlGml > ILlGnl-it follows that the Ca 2+
affinity of the complex between P and CaM (p. CaM) must be higher than in
CaM itself. This effect is also found experimentally in model systems. 101
B. Troponin C
The contraction of striated muscle is triggered by Ca2+ ions. Muscle cells are
highly specialized, and contain two types of filaments that may slide past each
other in an energy-consuming process. One of the filaments, the thin filament,
is built up by actin molecules (Mr = 42 kDa) polymerized end-to-end in a dou-
ble helix. In the grooves of this helix runs a long rod-like molecule, tropomyo-
sin; and located on this molecule at every seventh actin, is a complex of three
proteins, troponin. The three proteins in the troponin complex are troponin I
(TnI) , troponin T (TnT), and troponin C (TnC). A schematic picture of the
organization of the thin filament is shown in Figure 3.20.
Troponin C is the Ca 2+ -binding subunit of troponin, and it is structurally
highly homologous to calmodulin. Skeletal-muscle troponin C (sTnC; M r = 18
kDa) can bind four Ca 2+ ions, but cardiac-muscle troponin C (cTnC) has one
of the four calcium sites modified, so that it binds only three Ca2+ ions. The
troponin complex
TnT
actin
I
tropomyosin
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Figure 3.20
Schematic diagram of the organization of skeletal muscle thin filament, showing the position of
tropo-myosin and the troponin complex on the actin filament. The binding of Ca 2+ to TnC, the
calcium-binding subunit of the troponin complex, removes TnI, the inhibitory subunit, from
actin and thus permits an interaction with a specialized protein, myosin, on neighboring thick
muscle filaments (not shown). An ATP-driven conformation change in the myosin head group
makes the thick and thin filaments move relative to one another, so that muscle contraction
occurs.
x-ray structures of sTnC from turkey and chicken skeletal muscle have been
determined to resolutions of 2.8 and 3.0 A, respectively. 102,103 The structure of
turkey sTnC is shown in Figure 3.21. The similarity between the structures of
CaM (Figure 3.17) and sTnC is obvious. In sTnC we again find two domains,
each with two potential Ca 2 + sites, separated by a 9-turn a-helix. The crystals
were grown in the presence of Ca 2 + at a low pH (pH = 5), and only two Ca 2 +
ions are found in the C-terminal domain. The two Ca 2+ -binding sites in this
domain have the same helix-loop-helix motif that is found in CaM, and they
both conform to the archetypal EF-hand structure. The interhelix angles between
helices E and F and between G and H are close to 1100 • By contrast, the helices
in the N-terminal domain, where no Ca 2 + ions are bound, are closer to being
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Figure 3.21
A ribbon backbone representation of the three-dimensional structure of turkey-
skeletal-muscle troponin C according to Herzberg and James. 102 The crystals
were grown at pH 5 in the presence of excess Ca2+, and at this low pH only
Ca 2+ ions bound to the high-affinity domain (the C-terminal domain) are
observed. Note the high structural homology with calmodulin (Figure 3.17).
antiparallel, with interhelix angles of 133° (helices A and B) and 151° (helices
C and D).
Both sTnC and cTnC have two high-affinity Ca 2+ -binding sites (see Table
3.2) that also bind Mg 2 + ions competitively, although with a much lower affin-
ity. These two sites are usually called "the Ca 2 + -Mg 2 + sites." 76,104 In sTnC
there are also two (in cTnC, only one) Ca 2+ -binding sites of lower affinity
(Kjia2 + = 10 5 M - I) that bind Mg 2 + weakly and therefore have been called "the
Ca 2 + -specific sites." Since Ca 2 + binding to the latter sites is assumed to be
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the crucial step in the contractile event, they are often referred to as "the reg-
ulatory sites" (see below). The existence of additional weak Mg 2+ sites
(KB = 300 M -I) on sTnC, not in direct competition with Ca 2+, has also been
inferred. 76,104, 105 Spectroscopic studies have shown that the two strong Ca 2+ -
Mg 2+ sites are located in the C-terminal domain, and the weaker Ca2+-specific
sites in the N-terminal domain of sTnC. 106 This pattern is similar to that ob-
served with CaM. NMR spectroscopic studies strongly suggest that binding of
Ca2+ to both sTnC and cTnC is cooperative. 107 In sTnC the C-terminal domain
binds Mg 2+ much more strongly than the N-terminal domain, by contrast to
CaM, where the reverse is true.
The rates of dissociation of Ca2+ and Mg 2+ from sTnC have been mea-
sured by both stopped-flow and 43Ca NMR techniques. 76,108 As with CaM, the
actual numbers depend on the solution conditions, ionic strength, presence of
Mg 2+, etc. (see Table 3.4). On the rate of Mg 2+ dissociation from the Ca 2+-
Mg2+ sites, quite different results have been obtained by stopped-flow studies 76
of fluorescence-labeled sTnC (k!;lt+ = 8 s - I) and by 25Mg NMR
(k!;lt+ = 800-1000 S -1).109 This apparent discrepancy seems to have been re-
solved by the observation that both binding and release of Mg 2+ ions to the
Ca 2+ _Mg 2+ sites occur stepwise, with k!;lt+ < 20 s -I for one of the ions, and
k!;lt+ ?:: 800 s - I for the other. 110 The rates of dissociation of the Mg 2+ ions
are important, since under physiological conditions the Ca 2+-Mg 2+ sites of
sTnC are likely to be predominantly occupied by Mg 2+ ions, release of which
determines the rate at which Ca2+ can enter into these sites.
Spectroscopic and biochemical data III indicate that upon binding Ca2+, sTnC
and cTnC undergo significant conformation changes. Comparisons of NMR
spectroscopic changes on Ca2+ binding to intact sTnC, as well as to the two
fragments produced by tryptic cleavage (essentially the N-terminal and C-ter-
minal halves of the molecule, just as was the case with CaM), have shown that
the conformation changes induced are mainly localized within the domain that
is binding added ions. llO,112 Thus the central a-helix connecting the domains
seems unable to propagate structural changes from one domain to the other. It
has been suggested that the structural differences found in the x-ray structure of
turkey sTnC between the C-terminal domain, which in the crystal contains two
bound Ca2+ ions, and the N-terminal domain, in which no Ca2+ ions were
found, may represent these conformational changes. 113 This rather substantial
conformational change is schematically depicted in Figure 3.22. However, pre-
liminary structure calculations 114 of the calcium-saturated and calcium-free forms
of calbindin D9k indicate that much more subtle conformational changes take
place upon binding Ca2+ in calbindin D9k . Interestingly, IH NMR spectroscopy
has provided evidence for the concept that the structural change induced by
Mg 2+ binding to the C-terminal domain of sTnC must be very similar to that
induced by Ca2+ ions. Another result obtained by 113Cd NMR studies 108 is that
the cadmium-loaded N-terminal domain of sTnC in solution undergoes a rapid
interchange between two or more conformations, with an exchange rate on the
order of 10 3_10 4 S - I.
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Figure 3.22
Diagrammatic representation of the proposed conformational changes in the N-terminal domain
of troponin C upon Ca 2 + binding. 113 Helices are depicted as cylinders, and I, II denote the
Ca 2+ -binding sites. Helices N, A, and D retain their relative positions, and the relative disposi-
tion of helices Band C are also kept constant. (A) Ca 2+ -free conformation as determined by x-
ray crystallography. 102 (B) Proposed Ca 2 + -saturated conformation based on the structure of the
highly sequence-homologous Ca 2+ -loaded C-terminal. Figure kindly provided by N. C. J. Stry-
nadka and M. N. G. James.
Just as CaM exerts its biological function in complexes with other proteins,
TnC participates in the three-protein troponin complex. It presently appears that
TnC and Tnl form a primary complex that is anchored by TnT to a binding site
on tropomyosin. 115 In the troponin complex the Ca 2+ affinity is increased by a
factor of about ten over that in isolated sTnC, both at the Ca 2 + _Mg 2 + sites and
at the Ca 2 + -specific sites. A similar increase in affinity is found for Mg 2 +.
Given the amounts of "free" Mg 2 + inside muscle cells (1 to 3 mM), it seems
likely that the Ca 2 + _Mg 2 + sites in the resting state of troponin are filled with
Mg 2 +, so that a transitory release of Ca 2 + leads primarily to rapid Ca 2 + bind-
ing to the Ca 2 + -specific sites, and subsequently to conformation change and
contraction.
C. Parvalbumin and Calbindins D9K and D28K
A few intracellular Ca 2 + -binding proteins have been discovered that by se-
quence homology clearly belong to the CaM-TnC family with Ca 2 + sites of the
"EF-hand"-type, but that do not appear to exert a direct regulatory function.
Parvalbumins (Mr = 12 kDa), calbindin D9K (Mr = 8.7 kDa) and calbindin D28K
/
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Figure 3.23
Structure of the Ca 2 + -binding sites ofcarp parvalbumin. The Ca 2 + ions are depicted as regular
octahedra making six ligand contacts with oxygen atoms at each vertex, labeled x, y, z, - x,
- y, - z. The helix-loop-helix structure that forms a Ca 2+ -binding site can be regarded as a
hand with the forefinger representing one helix (e.g., the E-helix) in the plane of the figure, the
thumb oriented perpendicular to the plane representing the second helix (the F-helix), and the
remaining fingers make up the Ca 2+ -binding loop. After Kretsinger and Barry. 118
(Mr = 28 kDa) belong to this group. Parvalbumin(s) exist in two main types,
a and {3, found in large quantities in the white muscle of fish, amphibia, and
reptiles, but also in different mammalian tissues, 116,117 including neurons of the
central and peripheral nervous system. The molecule has two fairly strong Ca 2 + -
binding sites (see Table 3.2). The x-ray structure of carp parvalbumin was solved
in 1973 by Kretsinger et al., 118 and for a decade provided the basis for all
discussions on intracellular Ca 2 + -binding proteins. The concept of the canonical
"EF-hand" Ca 2+ -binding site originated from the parvalbumin work, and the
name "EF" derives from the labeling of the two helices that flank the second
of the two Ca 2 + sites in parvalbumin, as shown in Figure 3.23. If the first Ca 2 +
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Figure 3.24
One consensus EF-hand sequence including residues in the flanking a-helices; x, y, z, -x, -y,
- z denote positions in the octahedral Ca 2 + coordination sphere. E-glutamic acid residue, G-
glycine residues, I-isoleucine residue, n-nonpolar residue, • -a residue with a nonaromatic
oxygen-containing side chain (i.e., Glu, Gin, Asp, Asn, Ser, or Thr), and ·-nonspecific resi-
due.
ligand in the approximately octahedral coordination sphere is given number 1
(or "x") the others come in the order 3( "y"), 5( "z"), 7(" - y"), 9(" - x"),
and 12(" - z"). In the second site of parvalbumin, "-x" is actually a H20
molecule, but in the first site it is the carboxylate of a Glu. Studies 118 of puta-
tive Ca 2+ -binding sites in other proteins with known primary sequences led to
the generalized EF-hand structure-including residues in the flanking a-hel-
ices-shown in Figure 3.24. This sequence, with minor modifications, has been
widely used in searching for "EF-hands" in libraries of amino-acid (or DNA)
sequences of new proteins with unknown properties. In this way, calbindin D28b
a protein with unknown function, initially discovered in chicken intestine, but
later found also in brain, testes, and other tissue, has been shown to have four
EF-hand sites. ll9
Recently two structures of carp parvalbumin, both with a resolution of 1.6 A,
were published. 120 One of these structures is the native calcium-loaded form of
the protein; the second is the structure of parvalbumin in which Ca2+ has been
replaced by Cd 2+. No significant differences are observed upon replacement of
calcium by cadmium. 113Cd has a nuclear spin of I = i, making it much more
amenable to NMR studies than the quadrupolar 43Ca (I = i), This study sup-
ports the use of 113Cd NMR as a tool for the study of calcium-binding pro-
teins. 121
The function of parvalbumin has long been assumed to be that of buffering
Ca2+ in muscle cells, i.e., taking up Ca 2+ ions released from Ca2+-troponin
complexes, thereby ensuring that the cytoplasmic levels of free Ca 2+ are always
kept very low, even during short bursts of muscle activity,122 The widespread
occurrence of parvalbumin in non-muscle tissue indicates that it probably has
other roles as well.
Calbindin D9k (Mr = 8.7 kDa) is another intracellular Ca2+-binding protein
with unknown function. It was briefly mentioned in connection with Ca 2+ up-
take and transport in the intestine and placenta (Section IV.A). Like the avian
calbindin D28b the D9k calbindin has been observed in many types of tissue.
The homology between the D9k and D28k calbindins is much less than the name
suggests; both their syntheses are, however, regulated by vitamin D. The x-ray
structure of bovine calbindin D9k has been determined 123 and refined to a reso-
lution of 2.3 A, and a three-dimensional solution structure of porcine calbindin
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D9k is also available. 124 The average solution structure calculated from NMR
data is shown in Figure 3.25 (See color plate section, page C-lO.)
The protein has four main a-helices and two Ca 2 + -binding loops (I and II).
The interior of the molecule shows a loose clustering of several hydrophobic
side chains; in particular, three phenylalanine rings come ,very close in space.
The Ca 2 + -binding loops constitute the least-mobile parts of the molecule. The
crystallographic temperature factors have pronounced minima in these regions,
with the lowest overall B-factor observed in loop II. Both Ca 2+ ions are roughly
octahedrally coordinated with protein oxygen atoms. There are some striking
differences between the two sites, however. Whereas the C-terminal site (II) has
a general structure very similar to the archetypal "EF-hand," as observed in
CaM, sTnC, and parvalbumin, the N-terminal site (I) has an extra amino-acid
residue inserted between vertices x and y, and z and - y (see Figure 3.24). As
a consequence, the peptide fold in site I is different from that in site II. Three
carboxylate groups are ligands in site II, but in site I there is only one.
Despite this marked difference in charge and peptide fold, the Ca 2 + affinity
of both Ca 2 + sites is remarkably similar, as has been shown in a study in which
site-directed mutagenesis was combined with different biophysical measure-
mentsY Cooperative Ca2 + binding in the native calbindin D9k (the "wild type")
was first demonstrated at low ionic strength by means of the values of the two
stoichiometric Ca 2 + -binding constants, K 1 and K2 , which could be measured
with good accuracy (K1 = 4.4 X 10 8 M -1 and K 2 = 7.4 X 10 8 M -I). The
effects of amino-acid substitutions in Ca 2+ site I were primarily localized to
this site, with virtually no effects on the structure or other biophysical properties
pertinent to site II. The appearance of sequential Ca 2 + binding in some of the
calbindin mutants did allow the identification of 1H NMR resonances that re-
spond primarily to binding of Ca 2+ to either one of the sites. This result in tum
permitted an estimate of the ratio between the site-binding constants (KA and
K B ) in the wild-type protein and in one of the mutant proteins (Tyr-13 ~ Phe).
In this way the reseachers 125 could assess, to within narrow limits, the free
energy of interaction, LlLlG, between the two Ca 2 + sites as 7.7 kJ/mol at low
ionic strength and 4.6 kJ/mol in the presence of 0.15 M KCl. How this site-site
interaction is transmitted on a molecular level is still unknown.
Through a combination of site-specific mutations and biophysical measure-
ments, it has recently been demonstrated that carboxylate groups at the surface
of the protein, but not directly ligated to the bound Ca 2+ ions, have a profound
effect on the Ca 2 + affinity. 126 Neutralization of the surface charges reduces
affinity and increases the stability of the protein toward unfolding by urea. 127
A surprising discovery about the structure of bovine calbindin D9k in solu-
tion has also been made recently. 128 Detailed analysis of the 2D IH NMR spec-
trum of wild-type calbindin has revealed that it exists as a 3: 1 equilibrium
mixture of two forms, corresponding to a trans and cis conformation around the
Gly-42-Pro-43 peptide bond. The global fold appears essentially the same in the
two forms, and structural differences are primarily located in the inter-domain
loop in which Pro-43 is located.
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D. Sarcoplasmic Calcium-Binding Protein from Nereis diversicolor
The calmodulin superfamily of proteins also includes' sarcoplasmic Ca 2 + -bind-
ing proteins (SCPs) that can be found in both vertebrate and invertebrate mus-
cle. 129 The function of SCPs is not yet known, but their sequence h011;lology
with Ca 2+ -binding proteins of known tertiary structure suggests that they orig-
inally contained four helix-loop-helix Ca 2 + -binding domains. Ca 2 + binding has
been preserved in the first and third domains of all known SCPs, but only one,
if any, of domains II and IV is functional. The three-dimensional crystal struc-
ture of an SCP from the sandworm Nereis diversicolor analyzed at 3.0 A
resolution 130 can be seen in Figure 3.26. (See color plate section, page C-ll.)
The C-terminal half (domains III and IV) of the molecule contains two Ca 2 + -
binding EF-hands (green and red in Figure 3.26) similar to calbindin D9k and
the globular domains of troponin C and calmodulin. The N-terminal half is, on
the contrary, markedly different from the normal helix-loop-helix geometry. Do-
main I binds Ca2 + with a novel helix-loop-helix conformation, whereas domain
H lacks calcium-binding capacity. The two halves are packed closely together,
and are not, as in troponin C or calmodulin, connected by a solvent-exposed
a-helix.
E. Membrane Cytoskeleton and Phospholipid Binding Proteins
It has long been suspected that Ca 2+ ions are somehow involved in exocytosis.
Recently several groups 131 have isolated intracellular proteins that associate with
membranes, and/or membrane cytoskeleton proteins, in a Ca 2 + -dependent man-
ner, and that seem able to mediate vesicle fusion or aggregation at Ca 2 + con-
centrations above 200 ILM. These proteins--endonexin, calelectrin, p36, and
pH-have stretches of consensus amino-acid sequences that are also found in a
phospholipase A2 inhibitor protein, lipocortin. 132 It appears that further studies
of this new class of proteins, known as annexins, will lead to new insights into
cell-signaling pathways. Multiple functions have been proposed for the annex-
ins, but no cellular role has yet been defined. 133. The first crystal structure of
an annexin, human annexin V-which in vitro will form voltage-gated Ca2 +
channels-has been determined recently. 172 In annexin, the three Ca2 + -binding
sites are located on the side of the molecule that is involved in membrane bind-
mg.
F. Ca 2 +-Dependent Proteases
An interesting Ca 2+ -activated intracellular protease, sometimes called calpain,
was discovered during the last decade. 134 The ending -pain refers to its relation
with other proteolytic enzymes like papain. It may seem dangerous to have a
proteolytic enzyme loose inside a cell, and it must have rather specialized func-
tions and be under strict control. The complete primary structure of the calcium
protease (My = 80,000) in chicken tissues has recently been deduced from the
nucleotide sequence of cloned DNA. 135,136 The findings are quite unexpected.
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The protein contains four distinct domains. The first and third domains have no
clear sequence homologies with known protein sequences, but the second do-
main has a high homology with the proteolytic enzyme papain, and the fourth
domain is highly homologous to calmodulin. This fourth domain thus has four
EF-hand-type Ca 2 + -binding sites, although the third site has a somewhat un-
usual loqp sequence. Here we apparently are faced with an unusual invention
by Nature: by fusing the gene for a protease with that of the canonical Ca 2 +
receptor, she has created a molecule in which a regulatory protein is covalently
linked to its target enzyme!
G. Protein Kinase C
Before we leave our brief survey of intracellular Ca 2+ -binding proteins, we
must write a few lines about an important Ca 2+ -regulated kinase (a phospho-
rylating enzyme), i.e., protein kinase C (PKC). The activity of this enzyme, or
rather family of enzymes, 137 appears to be regulated by three factors: phospho-
lipids, in particular phosphatidylserine; diacyl-glycerols, one of the products of
inositol lipid breakdown; and Ca 2+ ions. The high-activity form of PKC, which
appears responsible for much of the phosphorylation activity of many cells, is
presumably membrane-bound, whereas the low-activity form may be partly cy-
tosolic (Figure 3.27). The schematic structure of rabbit PKC (Mr = 77 kDa)
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Figure 3.27
Outline of the cellular events that result in the activation of protein kinase C (PKC). The en-
zyme apparently exists in at least two states. Recent sequence work indicates that it has a Ca 2+_
binding site of the EF-hand type. When no Ca 2+ ion is bound, and when the "concentration"
of diacylglycerol (DG) in the inner layer of the plasma membrane is low, the kinase exists in a
low-activity form, possibly dissociated from the membrane. When a hormone binds to a plasma-
membrane receptor (R), cleavage of phosphoinositol into 1,4,5-IP3 and DG is induced. The lat-
ter lipid may bind to and activate the calcium-loaded form of PKC. The active form of protein
kinase C will now phosphorylate other cytoplasmic proteins, and in this way modify their bio-
chemical properties. R = receptor; PL-C = phospholipase C; G = a GTP-binding protein that
is assumed to act as an intermediary between the receptor and the membrane bound PL-C.
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Schematic representation of the structure of rabbit protein kinase C. 138 Three highly homologous
protein kinases C were actually identified with M r = 76,800. The kinase region shows clear
similarity with other kinases. The regulatory domain should contain binding sites for Ca 2 +,
phosphatidyl serine (PS), and diacylglycerol (DG).
according to Ohno et al. 138 is shown in Figure 3.28. The Ca 2 + site(s) are pre-
sumably in the regulatory domain. No typical "EF-hand" pattern has been found
in the amino-acid sequence. A protein kinase that requires Ca 2+ but not phos-
pholipids nor calmodulin for activity has been purified from soybean. From the
amino-acid sequence the protein appears to have a calmodulin-like Ca 2+ -bind-
ing domain, very much as in calpain. 139
H. Summary
Many different biological processes in eukaryotic cells are regulated by intra-
cellular Ca 2 + concentration levels. Examples of such processes are muscle con-
traction, transport processes, cell division and growth, enzyme activities, and
metabolic processes. A link in this regulatory chain is a number of intracellular
Ca 2 + receptors with Ca 2 + affinities such that their binding sites are largely un-
occupied at resting Ca 2 + concentration levels, but are occupied at Ca 2 + levels
reached as a result of some external stimulus. This class of Ca 2+ receptors is
often called the "calmodulin superfamily" and includes the well-known mem-
bers troponin C (regulating muscle contraction in striated muscle) and calmo-
dulin (playing an important role in the regulation of many cellular processes).
Amino-acid sequence determinations as well as x-ray and 2D IH NMR studies
have revealed a strong homology between the regulatory Ca 2+ -binding proteins.
The Ca2 + -binding sites are located in a loop flanked by two helices, and the
Ca 2 + ions are ligated with approximately octahedral or pentagonal bipyramidal
symmetry. The ligands are six or seven oxygen atoms that are furnished by side-
chain carboxylate or hydroxyl groups, backbone carbonyls, and water mole-
cules. Pairs of these Ca 2+ sites, rather than individual sites, appear to be the
functional unit, and a common consequence of their arrangement is cooperative
Ca 2 + binding. Ca 2 + binding to the intracellular receptor proteins is accompa-
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nied by structural changes that expose hydrophobic patches on their surfaces,
thereby enabling them to bind to their target proteins.
VI. EXTRACELLULAR Ca 2 +-BINDING PROTEINS
The Ca 2 + concentration in extracellular fluids is usually orders of magnitude
higher than intracellular concentrations. In mammalian body fluids, the "free"
Ca 2 + concentration is estimated to be 1.25 mM (total Ca 2 + is ~2.45 mM) with
only minor variations. 140 We would thus expect that Ca 2 + ions in extracellular
fluids playa very different role from that inside cells. To ensure Ca 2+ binding
the macromolecular binding sites need have only a modest Ca 2 + affinity
(Kfia2 + = 10 3 to 10 4 M - 1), and since extracellular Ca 2 + does not seem to have
a signaling function, the rates of Ca 2+ association or dissociation in protein-
binding sites need not be very high.
One particularly important aspect of Ca 2 + in mammals is its role in the
blood coagulation system. Here we will meet a new type of amino acid, y-
carboxyglutamic acid ("Gla" )-see Figure 3.29, that seems to have been de-
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Figure 3.29
Chemical structures of two novel amino acids believed to bind
calcium in, e.g., blood-clotting proteins.
signed by Nature as a Ca 2 + ligand with rather special functions. Gla-containing
proteins are also encountered in some mineralized tissues. The formation of
bone, teeth, and other calcified hard structures is an intriguingly complicated
phenomenon that will be dealt with in Section VII. We start, however, with a
brief discussion of the role of Ca 2 + in some extracellular enzymes.
A. Ca 2 +-Binding in Some Extracellular Enzymes
Several extracellular enzymes have one or more Ca 2+ ions as integral parts of
their structure. In a very few of them the Ca 2+ ion is bound at or near the
active cleft, and appears necessary for maintaining the catalytic activity (phos-
pholipase A2 , a-amylase, nucleases), whereas other enzymes show catalytic ac-
tivity even in the absence of Ca 2+ (trypsin and other serine proteases). In the
latter proteins, the Ca 2 + ion is usually ascribed a "structural" role, although
its function may be rather more related to "dynamics" and so be more subtle
and complex.
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Trypsin has one Ca2+-binding site with four ligands (two side-chain and
two backbone oxygens) donated by the protein (Glu-70, Asn-72 , Val-75, and
Glu-80) and two ligating water molecules, making the site roughly octahed-
ral. 141 The binding constant of Ca2+ to trypsin and its inactive precursor
"proenzyme," trypsinogen, has been measured (see Table 3.2). The binding
constant is slightly smaller for the precursor, as is also true for chymotrypsin
and chymotrypsinogen. 142 The Ca 2+ affinities of the serine proteases and their
proenzymes are such that their Ca 2+ sites will be largely occupied in extracel-
lular fluids, but would be unoccupied inside a cell. It has been suggested that
this phenomenon constitutes a safeguard against unwanted conversion of the
proenzymes into the active enzymes as long as they still are inside the cells
where they are synthesized.
The rates of Ca2+ dissociation of the above enzymes and proenzymes have
been measured by 43Ca NMR and stopped-flow techniques,142 and are collected
in Table 3.4. We note that the values of kon and koff are generally much smaller
than in the intracellular regulatory EF-hand proteins discussed in Section VI.
Whereas the latter have dynamic and equilibrium properties similar to those of
flexible low-molecular- weight chelators such as EDTA and EGTA, the serine
proteases are more similar to the more-rigid cryptates, such as the macrobicyclic
amino cryptate [2.2.2] (see Tables 3.2 and 3.4).
As mentioned above, there are a few enzymes in which a Ca 2+ ion is pre-
sent in the active cleft and essential for activity. Pancreatic phospholipase A2
(Mr = 14 kDa) is an enzyme of this type. The x-ray structure is known to high
resolution, and a single Ca 2+ ion is found to be surrounded by six ligands, four
presented by the protein (Tyr-28, Glu-30, Glu-32, and Asp-49) and two water
molecules. 143 A mechanism for the action of phospholipase A2 has been
proposed 144 and is shown in Figure 3.30. This mechanism is based on three
high-resolution x-ray crystal structures of phospholipase A2 with and without
transition-state analogues bound. The binding constant for Ca 2+ together with
the rate of dissociation found from variable-temperature 43Ca NMR studies 145
can be used to calculate kon = 4 X 106 M -I S -I, again lower than in EF-hand
proteins. Recent IH NMR studies indicate that the global structure of the lipase
is very much the same in the Ca 2+-free and the Ca2+-bound forms. Structural
changes upon Ca2+ binding appear primarily located in the region of the bind-
ing site. 112,146
The mammary glands produce, among other substances, a Ca 2+ -binding
enzyme activator, a-lactalbumin, that has about 40 percent sequence identity
with lysozyme. This protein , which is involved in the conversion of glucose
into lactose, is secreted in large quantities, and in human milk constitutes some
15 percent of total protein. The Ca2+-binding constant of bovine or human a-
lactalbumin is on the order of 10 7 M -I under physiological conditions. In ad-
dition to Ca2+, the enzyme also binds Zn 2+. It appears that Ca2+-ion binding
affects enzymatic activity, and somehow controls the secretion process, but the
biological role of metal-ion binding to a-lactalbumin needs to be studied further.
The x-ray structure of a-lactalbumin from baboon milk (Mr = 15 kDa) has been
(A)
(B)
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Figure 3.30
Catalytic mechanism 144 of phospholipase Az. (A) Catalytic attack on substrate bound in a pro-
ductive mode. (B) The tetrahedral intermediate as it collapses into products. (C) Products
formed by "productive collapse" in which three water molecules move into the active site to
replace the products. Two of these water molecules will coordinate the calcium ion. Figure
kindly provided by P. B. Sigler.
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determined 147 to a high resolution (~1.7 A). The Ca2 + -binding site has an in-
teresting structure. The ion is surrounded by seven ox·ygen ligands, three from
the carboxylate groups of aspartyl residues (82, 87, and 88), two carbonyl oxy-
gens (79 and 84), and two water molecules. The spatial arrangement is that of
a slightly distorted pentagonal bipyramid with the carbonyl oxygens at the ap-
ices, and the five ligands donated by the proteins are part of a tight "elbow"-
like tum. The a-lactalbumin site has a superficial structural similarity to an
"EF-hand," although the enzyme presumably has no evolutionary relationship
with the intracellular Ca 2 + -binding regulatory proteins.
Blood clotting proceeds in a complicated cascade of linked events involving
many enzymes and proenzymes. About a decade ago it was shown that several
of these proteins contained a previously unknown amino acid, y-carboxyglu-
tamic acid (Gla), and more recently yet another new amino acid, f3-hydroxyas-
partie acid (Hya), has been discovered (see Figure 3.29). The former is formed
postribosomally by a vitamin-K-dependent process in the liver. 148 Presently the
most-studied Gla protein in the blood-clotting system is prothrombin (Mr = 66
kDa). Ten Gla residues are clustered pairwise in the N-terminal region, essen-
tially lining one edge of the molecule, forming a highly negatively charged
region. 149 A small (48 residues) proteolytic fragment (Fl) that contains all ten
Gla amino acids can be prepared. Prothrombin can bind about 10 Ca 2+ ions,
but Fl binds only 7. Binding studies to Fl show that the Ca 2+ ions bind at
three high-affinity cooperative sites and four noninteracting sites, 150 and that this
binding takes places in conjunction with a spectroscopically detectable confor-
mational change (see Table 3.1).
In the presence of Ca 2 + ions, prothrombin and other vitamin-K-dependent
proteins in the blood-coagulation system will bind to cell membranes containing
acidic phospholipids, in particular, the platelet membrane, which is rich in phos-
phatidylserine. A proposed model for the prothrombin-membrane interaction is
shown in Figure 3.31.
It has long been known that calcium ions are involved in cell-to-cell and
cell-to-extracellular matrix interactions, but the molecular details largely remain
to be unraveled. In the late 1980s a large, adhesive, calcium-binding matrix
glycoprotein (Mr ~ 420 kDa) named thrombospondin was characterized. This
multifunctional adhesion molecule is composed of three polypeptide chains, each
with 38 amino-acid-Iong repeats that are homologous with the calcium-binding
helix-loop-helix sites of the calmodulin superfamily. 152 Each thrombospondin
molecule is reported to bind 12 calcium ions with an affinity of about 104 M -I,
and the removal of calcium is accompanied by a conformational change. 153,154
B. Summary
In higher organisms, the Ca 2+ concentration in extracellular fluids generally is
considerably higher than the intracellular concentrations. In mammalian body
fluids, the Ca 2+ concentration is typically on the order of a few mM. The
Figure 3.31
Proposed features of the interaction between the prothrombinase complex and a membrane lipid
bilayer. lSI K] and K 2 are the kringle domains of prothrombin, and EGFI and EGF2 are the two
epidermal growth factor units of factor Xa' Prothrombin and factor Xaform a heterodimer com-
plex harbored within the membrane protein factor Va- The proposed interaction between pro-
thrombin and factor Xu involves hydrophobic interactions between two helices and bridging by a
Ca 2 + ion between two Gla residues. The N-terminal Gla residues attach the heterodimer com-
plex to the phospholipid surface. Figure kindly provided by C. C. F. Blake.
extracellular concentration levels are highly regulated and undergo only minor
variations. A consequence of these high levels of Ca 2 + in extracellular fluids is
that the binding constant need be only 10 3 to 104 M -1 in order for a protein
site to be highly occupied by Ca 2+. Several extracellular enzymes and enzyme
activators have one or more Ca 2+ ions as integral parts of their structures. Some
Ca 2 + ions are bound at, or near, the active cleft and may take part in the
enzymatic reactions (e.g., phospholipase A2 , a-amylase). In other molecules,
for example, serine proteases like trypsin and chymotrypsin, the Ca 2+ ion is not
essential for enzymatic activity, and may play more of a structural role. Ca 2+
ions are involved in the cascade of enzymatic events that results in blood clot-
ting in mammals. Several of the proteins in this system contain two new amino
acids, y-carboxyglutamic acid (Gla) and {3-hydroxyaspartic acid (Hya) , which
155
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are strongly suspected to be involved as ligands in Ca 2 + binding. In the pres-
ence of Ca 2 + ions, prothrombin and other Gla-containing proteins will bind to
cell membranes containing acidic phospholipids, in particular, the platelet mem-
brane. It appears likely that Ca 2+ ions form a link between the protein and the
membrane surface.
VII. CALCIUM IN MINERALIZED TISSUES
The formation of calcified tissue-shells, bone, and teeth-is a very complex
process that is under strict regulatory control. Despite the obvious importance
of this field, relatively little research has been directed toward elucidation of the
underlying mechanisms, perhaps because the field spans a broad range of sub-
jects, from inorganic solution and solid-state chemistry to cellular physiology. 155
Historically, it was long held that formation of biological minerals such as
bone was simply the nucleation and growth of calcium hydroxyapatite within an
extracellular matrix of collagen. Many proteins other than collagen have now
been discovered in appreciable quantities in bone and other biological minerals.
It is also apparent that the pattern of calcification differs in shells, bone, teeth,
and other mineralized tissues; so it is not likely that there is only one underlying
mechanism. Considering the immensity of the subject, we will here only make
a few brief comments, mainly about bone and teeth.
As was briefly mentioned earlier in this chapter, the inorganic matter of
bone and teeth in many ways resembles apatite minerals (Cas(OH)(P04h). Ta-
ble 3.5 summarizes inorganic solid components of other biominerals. A detailed
Table 3.5
A summary of the main inorganic solid component 8 of the most-common biominerals in
living systems. 148
Anion Formula Crystal form Occurrence Main function
Carbonate CaC03 Calcite Sea corals, molluscs, Exoskeleton; Ca-store; eye
Aragonite and many animals lens
Valerite and plants
Oxalate Ca(COOh . H2O Whewellite Insect eggs; verte- Deterrent; cytoskeleton; Ca
Ca(COO)2· 2H20 Weddellite brate stones store
Phosphate (Ca)IO(P04MOHh Hydroxyapatite Bones; teeth; shells; Skeletal; Ca storage; pres-
(unit cell comp.) intracellular in some sure-transducer (piezo-elec-
bacteria tric)
Sulfate CaS04 'H2O Gypsum Jelly fish; plants Gravity device; Sand Ca
store
a Most real biominerals are actually nonstoichiometric, and contain a number of additional cations (e. g., Mg 2 ') or anions
(e.g., F -). In addition, the inorganic phase may be interpenetrated by a biopolymer.
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analysis 156 shows that, apart from Ca2 + and P04 3 -, many other cations and
. . b M 2 + N + K + S 2 + CO 2 - F - Cl - damons occur III one, e.g., g , a, ,r, 3, , , an
citrate. X-ray diffraction patterns and electron-microscope pictures of bone show
that the inorganic phase is made up of many very small and imperfect crystals.
By contrast, dental enamel is made up of much larger and uniform thin crystals.
Although the solubility product of calcium hydroxyapatite (see Section II) is
such that the equilibrium Ca 2 + concentration should be in the low micromolar
range, bone mineral appears to be in equilibrium with much higher Ca 2+ con-
centrations (0.8 -1 .0 mM). 157 This discussion brings us to the question of how
the inorganic crystallites are formed. Obviously both Ca 2 + and P04 3 - ions
must be concentrated in cells or organelles bordering on the regions where mi-
neralization is to take place. Fresh layers of bone matrix are formed by a con-
tinuously replenished layer of cells called osteoblasts (Figure 3.32A), which, in
addition to apatite crystallites, also secrete collagen, and large specific proteins
called osteonectin, osteocalcin (a Gla protein), proteoglycans, and phosphopro-
teins. In tissues undergoing rapid mineral deposition, the crystallites appear to
be formed in vesicles that may have peeled off from the adjacent cell layers.
These vesicles seem able to concentrate calcium and phosphate in a manner not
well understood.
Bone, unlike diamond, is not forever. It can be remodeled and dissolved.
A serious medical problem, which affects some women after menopause, is
osteoporosis, i.e., the decalcification of bone. This loss of bone mass, which
occurs with increasing age, makes bones more susceptible to breaking under
stress. About 50 percent of American women, and 25 percent of American men,
over 45 years of age are affected by osteoporosis. 158 Whereas osteoblast cells
handle bone formation, another type of cells, osteoclasts, can erode it (Figure
3.32B). These macrophage-like cells can form deep tunnels in a bone matrix,
and the cavities left behind are rapidly invaded by other cells forming blood
vessels and new layers of osteoblasts. The modus operandi of osteoclast cells is
not well understood at present. They may secrete calcium-chelating organic an-
ions, such as citrate, to assist in the solubilization of the bones, as well as
extracellular proteases that degrade the organic part of the matrix.
Summary
Calcium is, along with iron, silicon, and the alkaline earth metals, an important
constituent of mineralized biological tissues. Some Ca 2 + -based biominerals,
like bone or mother-of-pearl, can be regarded as complex composites with mi-
croscopic crystallites embedded in a protein matrix. The formation of calcified
biominerals is a highly regulated process, and human bone, for instance, is
constantly being dissolved and rebuilt. When the rates of these two counteract-
ing processes are not in balance, the result may be decalcification, or osteopo-
rosis, which seriously reduces the strength of the bone.
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Figure 3.32 (facing page)
Schematic diagram depicting the roles of the most important cell types in bone formation. (A)
The osteoblast cells line the bone surface and secrete the inorganic and organic components
(collagen, etc.) that will form new bone. Some osteoblast cells gradually become embedded in
their own secretion. A particular secreted bone-specific protein, osteonectin, forms strong links
between calcium hydroxyapatite and collagen. The bone-forming cells that become trapped in
the bone matrix are now called osteocytes. (B) The osteoclast cells function to remodel compact
bone. A group of cells acting together excavate a tunnel through old bone at a rate of about 50
fLm per day. Behind the advancing osteoclasts follow a contingent of osteoblasts that line the
wall of the tunnel and start to form new bone. Concurrently a capillary vessel is formed along
the center of the tunnel and provides the cells with nutrients. Eventually the tunnel will become
filled with concentric layers of new bone with only a narrow canal remaining. It is apparent that
bone is far from a dull inorganic deposit, and very much a site of continuous activity. It is
estimated that 5 to 10 percent of the bone in an adult mammal is replaced per year. Adapted
from Reference 159.
VIII. Ca 2 +-BINDING PROTEINS IN MICROORGANISMS:
THE SEARCH FOR A PROKARYOTIC CALMODULIN
Since Ca 2 + ions evidently play an important role in regulating a variety of
cellular responses in animals and higher organisms, one may ask whether this
use of Ca 2+ is a recent discovery of Nature, or if it was invented early in
evolution. It now appears well-established that the key intracellular "Ca 2 + -
receptor" protein calmodulin (CaM; see Section V.A) is present in all eukar-
yotic cells. Even in a unicellular eukaryote like common yeast (Saccharomyces
cerevisiae), Ca 2+ has an important regulatory role, and recently yeast CaM, as
well as the single-gene encoding for it, was isolated. 160
The amino-acid sequence of the yeast CaM (147 a.a.; M r = 16.1 kDa) is
60 percent identical with the sequences of all other CaMs known. In fact, if
generally accepted conservative amino-acid replacements are allowed, the ho-
mology increases to 80 percent or more, the most highly conserved portions
being the four putative Ca 2 + -binding sites. Sites I and III match the EF-hand
test sequence (see Figure 3.24) very well; in site a His occurs after the "z"-
ligand instead of the archetypal Gly; and in site IV there is no amino acid
between the residues that usually make up ligands "x" and "y." The effect of
these alterations on the Ca 2+ affinity of yeast CaM is not yet known.
That CaM is essential for the growth of yeast cells was shown by deletion
or disruption of the gene. This constitutes, in fact, the first demonstration in
any organism that CaM is an essential protein. (Deletions of genes in mammals
are ethically questionable research procedures!)
In the biochemically less sophiscated (than eukaryotes) prokaryotic cells, a
regulatory role of Ca 2+ is not well-established. What is known is that calcium
is massively accumulated during sporulation in many bacteria, for example, in
strains of Bacillus, Streptomyces, and Myxococcus. In Myxococcus xanthus a
development-specific protein called protein S assembles at the surface of myxos-
pores in the presence of Ca 2 +. The DNA sequence of the gene that encodes this
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protein has been deciphered. 161 The primary sequence of protein S (175 a.a.,
M r = 19.2 kDa) turns out to closely resemble mammalian CaM. It has four
internally homologous regions with putative Ca 2+ sites. At least two of these
are partly similar to the typical EF-hand, but uncharacteristically there are many
more prolines in the M. xanthus protein than in bovine CaM (12 versus 2); so
it is questionable if the bacterial protein really has the repeated helix-loop-helix
structure found in mammalian CaM. 162
One candidate for a prokaryotic CaM was reported by Leadlay et al. 163 in
Streptomyces erythreaus, the bacterium that produces the well-known antibiotic
"erythromycin." The amino-acid sequence of a low-molecular-weight Ca 2 +-
binding protein, as determined from the gene encoding it, revealed a high ho-
mology with mammalian CaM. The protein is made up of 177 amino acids
(Mr = 20.1 kDa), and has four regions that are predicted to have the helix-
loop-helix secondary structure typical of EF-hand proteins. The aligned se-
quences of the 12 residues in each of the four potential calcium-binding loops
in the S. erythreaus protein are compared with those of human calmodulin in
Table 3.6. The pattern of residues in the S. erythraeus protein is typical of an
EF-hand at least in sites I, III, and IV. Site II is unusual in having Gly at both
positions I and 3. I13Cd NMR studies show that the bacterial protein binds three
metal ions strongly (K :2: 105 M -1) with chemical shifts close to those expected
for EF-hands, and lH NMR studies show that it undergoes a Ca 2 + - dependent
conformational change. 1M
Although the S. erythraeus protein has a homology with eukaryotic CaM, it
has been pointed out that the protein has an even higher homology with a group
of eukaryotic sarcoplasmic Ca 2+ -binding proteins 165 (see Section V.D). The
search for a prokaryotic CaM analogue continues, and the prospect of success
has been improved after recent reports of a 21-amino-acid-Iong polypeptide from
an E. coli heat-shock protein 166 that shows the typical structural features of
CaM-binding domains in other eukaryotic proteins. 167
Table 3.6
Aligned EF-hand sequences for the prokaryotic and human calmodulins.
Ligands 3 5 7 9 12
S. erythraeus protein I D F D G N G A L E R A D
II G V G S D G S L T E E Q
III D K N A D G Q I N A D E
IV D T N G N G E L S L D E
Human calmodulin I D K D G D G T I T T K E
II D A D G N G T I D F P E
III D K D G N G y I S A A E
IV D I D G D G Q V N y E E
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Summary
The role of Ca 2 + ions in the regulation of biological activities of procaryotic
organisms is still largely unsettled. Over the last decade, however, evidence has
gradually accumulated that calcium ions are involved in diverse bacterial activ-
ities, such as chemotaxis and substrate transport, sporulation, initiation of DNA
replication, phospholipid synthesis, and protein phosphorylation. 168 An impor-
tant landmark is the recent demonstration that the intracellular Ca 2 + concentra-
tion in E. coli is tightly regulated to about 100 nM, a level similar to that typical
of resting eukaryotic cells. 169 Furthermore, increasing numbers of calcium-bind-
ing proteins, some of which also have putative EF-hand Ca 2 + sites character-
istic of the calmodulin superfamily of intracellular regulatory proteins, have been
isolated in bacteria. 168
IX. APPENDIXES
A. Definition of Biochemical Terms
Antiport
Basal lateral membrane
Cytosol
Electrogenic
Endocytosis
Endoplasmic reticulum (ER)
Epithelial cells
Erythrocytes
Eukaryotic cells
A transport protein that carries two ions or
molecules in opposite directions across a
membrane.
The membrane in intestinal epithelial cells that
is located on the base of the cells, opposite the
microvilli that face the intestinal lumen.
The unstructured portion of the interior of a
cell-the cell nucleus excluded-in which the
organelles are bathed.
A biological process driven by electric field
gradients.
The process by which eukaryotic cells take up
solutes and/or particles by enclosure in a por-
tion of the plasma membrane to (temporarily)
form cytoplasmic vesicles.
Sheets of folded membranes, within the cyto-
plasm of eukaryotic cells, that are the sites for
protein synthesis and transport.
Cells that form the surface layer of most, if
not all, body cavities (blood vessels, intestine,
urinary bladder, mouth, etc.).
Red-blood corpuscles.
Cells with a well-defined nucleus.
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Exocytosis
Gluconeogenesis
Glycolysis
Hydropathy
Lamina propria mucosae
Mitochondrion
Organelle
Osteoporosis
Phorbol esters
Prokaryotic cells
Sarcoplasmic reticulum
Trophoblasts
Tryptic digest
Uniporter
The process by which eukaryotic cells release
packets of molecules ..(e.g., neurotransmitters)
to the environment by fusing vesicles formed
in the cytoplasm with the plasma membrane.
Metabolic synthesis of glucose.
Metabolic degradation of glucose.
A measure of the relative hydrophobic or hy-
drophilic character of an amino acid or amino-
acid side chain.
The layer of connective tissue underlying the
epithelium of a mucous membrane.
A double-membrane organelle in eukaryotic
cells that is the center for aerobic oxidation
processes leading to the formation of energy-
rich ATP.
A structurally distinct region of the cell that
contains specific enzymes or other proteins that
perform particular biological functions.
Brittle-bone disease.
Polycyclic organic molecules that act as ana-
logues to diacylglycerol and therefore are strong
activators of protein kinase C.
Cells lacking a well-defined nucleus.
The ER of muscle cells.
The cells between the maternal and fetal cir-
culation systems.
Fragmentation of proteins as a result of treat-
ment with the proteolytic enzyme trypsin.
A transport protein that carries a particular ion
or molecule in one direction across a mem-
brane.
B. One-Letter Code for Amino-Acid Residues
A-alanine, C-cysteine, D-aspartate, E-glutamate, F-phenylalanine, G-
glycine, H-histidine, I-isoleucine, K-Iysine, L-Ieucine, M-methionine,
N-asparagine, P-proline, Q-glutamine, R-arginine, S-serine, T-thre-
onine, V-valine, W-tryptophan, Y-tyrosine.
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C. The Activity of a Transport Protein
This is usually described in terms of the classical Michaelis-Menten scheme:
163
v (= transport rate)
where [S] is the concentration of the solute to be transported and Km = (L ]+ k2)1
k] is the Michaelis constant (dimension "concentration") for the reaction
~ k 2E + S +--'- ES ----? P.
k_ 1
Approximated as the reciprocal ratio between on- and off-rate constants rel-
evant to the solute-protein complex, lIKm = k]/k_] may be taken as a lower
limit of the affinity of the protein for the solute.
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I. INTRODUCTION: BIOLOGICAL DIOXYGEN TRANSPORT SYSTEMS
Most organisms require molecular oxygen in order to survive. The dioxygen is
used in a host of biochemical transformations, although most is consumed in
the reaction
(4.1)
that is the terminal (or primary) step of oxidative phosphorylation (Chapters 5
and 6). For some small animals and for plants, where the surface-to-volume
ratio is large, an adequate supply of dioxygen can be obtained from simple
diffusion across cell membranes. The dioxygen may be extracted from air or
water; for plants that produce dioxygen in photosynthesis, it is also available
endogenously. For other organisms, particularly those with non-passive life-
styles, from scorpions to whales, diffusion does not supply sufficient dioxygen
for respiration.
An elegant three-component system has evolved to transport dioxygen from
regions of high abundance-water (at least if free of pollutant reductants) and
air-to regions of relatively low abundance and high demand-the interior cells
of the organism. This process is illustrated in Figure 4.1. 1- 3 The central com-
ponent is a dioxygen-carrier protein. In the three chemically distinct carriers that
have evolved and are found today, the dioxygen-binding site in the protein, that
is, the so-called "active site," is a complex either of copper or of iron. 4- 6 For
hemoglobins, the most widely distributed family of dioxygen carriers, the active 167
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Figure 4.1
Oxygen sequestration and transport in the generalized organism Squarus squorur. The surface
area of lungs or gills is typically 1-2 orders of magnitude greater than the external surface area
of the organism.
site has long been known to consist of an iron porphyrin (heme) group embed-
ded in the protein. Almost all hemoglobins share the basic structure illustrated
in Figure 4.2. 7- 12 Hemocyanin 13-15 and hemerythrin,16-18 the other two biolog-
ical dioxygen carriers, feature pairs of copper atoms and iron atoms, respec-
tively, at the active sites. * Some basic properties of these metalloproteins are
summarized in Table 4.1. 4 - 6
The second component of the dioxygen-transport system facilitates the se-
questration of dioxygen by the dioxygen-carrier protein. Specialized organs, such
as lungs in air-breathing creatures or gills in fish, offer a very large surface area
to the outside environment in order to facilitate diffusion. The third component
is the delivery system. The oxygen carrier is dissolved or suspended in a fluid,
called blood plasma or hemolymph, that is pumped throughout the animal by
* The use of the prefix hem- is confusing. In this context hem connotes blood. Thus, since hemocyanin
and hemerythrin lack a heme group [an iron(II) porphyrin], they are nonheme metalloproteins.
'>----'-.;~
COOH
HOOC
(A) Fe" protoporphyrin IX (heme b)
[hemoglobins and erythrocruorins]
Amine
terminus
(C) Myoglobin
(B) Chloroheme
[chlorocruorin]
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Figure 4.2
Heme groups used in hemoglobin: (A) Protoporphyrin IX (heme b), (hemoglobins and erythro-
cruorins); (B) Chloroheme (chlorocruorin); (C) The encapsulation of the heme molecule in
myoglobin. 11a Reproduced with permission from M. F. Perutz, Nature 228 (1970), 726-737.
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Table 4.1
General features of dioxygen-carrier proteins.
Average
Active site Color change MW MW subunit
Metalloprotein of deoxy deoxy ---i> oxy (Dalton) # Subunits (Dalton)
Hemoglobins
Vertebrate
Human A heme Fell purple ~ red 64,000 4 16,000
Invertebrate
Erythrocruorin heme Fell purple ~ red up to 3.3 X 10 6 192 17,000
(Lumbricus terrestris,
earthworm)
Chlorocruorin chloroheme purple ~ green 3.1 X 10 6 192 15,000
(Eudistylia vancouveri) Fell
Hemocyanins
Mollusc
(Helix pomatia-a, CUI ... CUI colorless ~ blue ~9 x 10 6 160 52,700
edible snail)
Arthropod
(Cancer magister, crab) CUI ... CUI colorless ~ blue ~9 x 10 5 12 76,600
Hemerythrins
(Phascolopsis syn. Fell ... Feu colorless ~ burgundy 108,000 8 13,500
goljingia gouldii)
another specialized organ, the heart, through a network of tubes, the blood ves-
sels. In many organisms an additional dioxygen-binding protein, which stores
dioxygen, is located in tissues that are subject to sudden and high dioxygen
demand, such as muscles. These dioxygen-storage proteins are prefixed myo-
(from the Greek root mys for muscle). Thus for the dioxygen-transport protein
hemerythrin there exists a chemically similar dioxygen-storage protein myoh-
emerythrin. For the hemoglobin family the corresponding storage protein is called
myoglobin. Interestingly, some organisms that use hemocyanin as the dioxygen-
transport protein use myoglobin as the dioxygen-storage protein.
At the center of biological dioxygen transport are transition-metal com-
plexes of iron or copper. To model such systems, chemists have prepared sev-
eral synthetic oxygen carriers, especially of iron and cobalt porphyrins. In this
chapter the structures and properties of biological and nonbiological oxygen car-
riers are described, with particular attention to the hemoglobin family. This
family has been studied in more detail than any other group of proteins, and as
a result a deeper understanding of the relationships among structure, properties,
and biological function (i.e., physiology) exists. The central focus of this chap-
ter is to delineate chemical features that determine the affinity of an active site,
especially an iron porphyrin, for molecular oxygen. In order to develop this
theme, macroscopic (thermodynamic and kinetic) factors associated with diox-
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ygen binding and release are summarized first. The nonbiological chemistry of
iron and copper in the presence of dioxygen is described briefly to elucidate the
key role that the protein plays in supporting oxygen transport by preventing
irreversible oxidation of the binding site or of its ligands. The macroscopic
behavior of the biological systems is related to the microscopic picture that has
been developed over the last 30 years from x-ray crystallographic studies and a
miscellany of spectroscopic probes of the oxygen-binding site. Relationships
between the geometry and charge distribution in the metal-dioxygen moiety and
the nature of the interactions between this moiety and its surroundings are ex-
amined. Nonbiological dioxygen carriers have proved particularly useful in pro-
viding precise and accurate structural information as well as thermodynamic and
kinetic data against which the corresponding data from biological oxygen car-
riers can be contrasted.
The bioinorganic chemistry of the hemoglobin family of oxygen binders is
particularly amenable to study by means of small-molecule model systems: four
of the five ligands that make up the active site are provided by a square-planar
tetradentate ligand, the protoporphyrin IX dianion (Figure 4.2). One axial ligand
in hemoglobin, imidazole from a histidine residue, is provided by the protein,
and the remaining sixth coordination site is available for the exogenous ligand,
e.g., dioxygen or carbon monoxide. Thus a model system that approximates the
stereochemistry of the active site in hemoglobin may be assembled from an
iron(II) porphyrin and a ligand, such as imidazole or pyridine. On the other
hand, in hemocyanin and hemerythrin most of the ligands are supplied by the
protein. Thus the assembly of a model system that provides appropriate ligands
correctly disposed around the pair of metal atoms poses a major synthetic chal-
lenge, especially for hemocyanin, where details on the number, type, and ar-
rangement of ligands have been difficult to establish. Many aspects of the phys-
ical, inorganic, and structural chemistry underlying biological oxygen transport
and utilization (Chapter 5) have been clarified through model systems.
A. Requirements for Effective Oxygen Carriers
In order for dioxygen transport to be more efficient than simple diffusion through
cell membranes and fluids, it is not sufficient that a metalloprotein merely binds
dioxygen. Not only is there an optimal affinity of the carrier for dioxygen, but
also, and more importantly, the carrier must bind and release dioxygen at a
rapid rate. These thermodynamic and kinetic aspects are illustrated in Figure
4.3, a general diagram of energy vs. reaction coordinate for the process
(4.2)
where M is an oxygen carrier, for example hemocyanin or a simple nonbiol-
ogical metal complex. Thermodynamic or equilibrium aspects are summarized
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Figure 4.3
Schematic diagram of energy changes in dioxygen binding.
by !1G in Figure 4.3. As illustrated there, !1G is negative, and thus the forward
reaction, dioxygen binding, is spontaneous. The equilibrium constant (K) is given
by
K = _a-:(_M_O..=2)_
a(M)a(02) , (4.3)
where a is the activity (crudely, concentration) of the component. The equilib-
rium constant is related to the change in free energy by
!1GO = - RTln K. (4.4)
The rate of the forward reaction (k f ) is related to !1G1*; the rate of the reverse
reaction (L 1) is related to !1G!.]. Provided that oxygen binding is effectively a
single-step process, then
K (4.5)
Usually the rates of the forward and reverse reactions are related by the empir-
ical Arrhenius expression to quantities termed the activation energies (Eland
E _ 1) of the reactions, where
k] = A] exp (-E/RT) and L] = A-I exp (-E_J/RT). (4.6)
These quantities are experimentally accessible through the change in rate as
a function of temperature.
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1. Thermodynamic factors 19-20
The equilibrium constant K was defined in Equation (4.3) in terms of the
activity ai of component i. The ai may be expressed as a function of concentra-
tion as
(4.7)
where for species i, )'i is its activity coefficient and [i] is its concentration (strictly
molality, but usually as molarity in mol L-I). At infinite dilution )'i = 1. Pro-
vided that the charge and size of species M and M02 are similar and that O2
forms an ideal solution, then the activities of Equation (4.3) may be approxi-
mated by concentrations to give the expression
(4.8)
However, Equation (4.8) does not permit a direct comparison of the oxygen-
binding behavior of one species in some solvent with that of a second in some
other solvent. First, for a given partial pressure of dioxygen, the concentration
of O2 in the solution varies considerably with temperature and from one solvent
to another. Second, reliable measurements of oxygen solubilities are not always
available, and it is only relatively recently that oxygen electrodes have been
developed to measure directly oxygen concentrations (strictly, activities). How-
ever, oxygen-binding measurements are normally made with a solution of M in
equilibrium with gaseous dioxygen. At equilibrium the molar Gibbs' free ener-
gies (chemical potentials) of the dissolved and gaseous dioxygen are identical-
if they are not, gaseous O2 would dissolve, or dissolved O2 would be released.
Thus the solvent-dependent quantity [02] in Equation (4.8) may be replaced by
the solvent-independent quantity P(02), the partial pressure of dioxygen. Under
almost all experimental conditions the quantity P(02) is a very good approxi-
mation to the gas-phase activity (fugacity) of dioxygen; hence we obtain for the
equilibrium constant*
(4.9)
It is very convenient to express the affinity as the partial pressure of dioxy-
gen required for half-saturation of the species M, Pl/2C02). Under such condi-
tions, [M] = [M02], one obtains
(4.10)
* There has been considerable discussion as to whether K c (4.8) or Kp (4.9) should be used to compare
dioxygen binding under different solvent conditions 21 - 23 We believe that the latter is more appropriate, since
for a system al equilibrium, the chemical potential of gaseous O2 must be identical with that of dissolved 0 2 19
On the other hand, the concentration of O2 varies from one solvent to another.
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where P li2(02) is usually given in Torr or mm Hg.* As will be detailed shortly,
values for Plii02) are typically in the range 0.5 to 40 Torr.
The dioxygen affinity is composed of enthalpic (Mf) and entropic (AS)
components, with
AGO = -RTln K (4.11)
Within a family of oxygen carriers the values of ASo and Mfo are usually simi-
lar. Large deviations (such as a change of sign) are therefore indicative of a
change in the nature of the oxygen-binding process.
a. Non-cooperative Dioxygen Binding If the oxygen-binding sites Mare
mutually independent and noninteracting, as in moderately dilute solutions of
monomeric molecules, then the concentration of species M02 as a function of
the partial pressure of O2 is generally well fit by a Langmuir isotherm. 20 Here a
plot of the fractional saturation of dioxygen binding sites, 0, where
o = [M02]
[M] + [M02]
(4.12)
versus P(02) gives the hyberbolic curve labeled "non-cooperative" in Figure
4.4A. 9 Altematively,24 a plot of log (O/(l - 0)) versus log (P(02)), the so-
called "Hill plot," gives a straight line with a slope of unity and an intercept
of -log P 1I2(02) (Figure 4.4B). A differential form is shown as the dotted line
in Figure 4.4C. Such binding, where the dioxygen sites are independent of each
other, is termed non-cooperative.
b. Cooperative Dioxygen Binding Many dioxygen-binding proteins are not
independent monomers, with only one dioxygen-binding site, but oligomeric
species with the protein comprising two or more similar subunits. The subunits
may be held together by van der Waals' forces or by stronger interactions, such
as hydrogen bonds or salt bridges, or even by covalent bonds. For example,
most mammalian hemoglobins are tetramers, consisting of two pairs [af3h of
myoglobin-like subunits denoted as a and f3. Either none, one, two, three, or
all four sites may be occupied by dioxygen. This situation is illustrated sche-
matically in Figure 4.5, which also shows the statistical weighting of each level
of saturation, treating the a and f3 subunits as identical. Thus the binding or
release of dioxygen at one site may affect the affinity and kinetics of ligand
binding and release at a neighboring site. As a result, the saturation curve be-
comes sigmoidal in shape, as illustrated in Figure 4.4A. The dioxygen binding
is cooperative. When cooperativity is positive, the affinity of a vacant site is
increased by occupancy of an adjacent one.
This behavior, where the binding of one molecule influences the binding of
successive molecules of the same kind, is referred to as a homotropic allosteric
* Many authors use the symbcl P so (corresponding to 50% saturation) for P'/2.
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Figure 4.4
Cooperative and non-cooperative binding of dioxygen: 9 (A) Binding curves;
(B) Hill plot of binding curves; (C) First derivative (slope) of the Hill plots.
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Figure 4.5
Diagram of tetrameric hemoglobin, showing statistical weights
of different saturations (see text).
interaction. A heterotropic allosteric interaction occurs when the interaction with
the protein of a second unlike molecule, for instance, an organic polyphosphate
for human hemoglobins, influences the binding of the first molecule (e.g., diox-
ygen). Such molecules are often termed allosteric effectors. A commonly ob-
served heterotropic allosteric interaction is the Bohr effect, named after the biol-
ogist Christian Bohr, father of physicist Niels Bohr. This effect, which relates
the change in partial pressure of O2 to a change in pH at constant saturation of
binding sites (0), is related thermodynamically to the Haldane effect, which
relates the number of protons released (#H +) with a change in 0 at constant
pH (Equation 4.13). A very large Bohr effect, where O2 affinity decreases sharply
with pH, is often called the Root effect. 25a It is physiologically important for
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fish such as trout, probably in maintaining buoyancy, but its molecular basis in
trout hemoglobin IV remains to be discovered. 25b
(4.13)
The degree of cooperativity can be characterized in a number of ways. By means
of a Hill plot of log (O/(l - 0)) versus log (P(02)), the limiting slopes (which
should be unity) at high O2 pressure and low O2 pressure may be extrapolated
as shown in Figure 4.4B to log «(}/(l 0)) = 0, where 0 = 0.5. Two limiting
values for PI/2(02) are obtained, one characterizing the regime of high partial
pressure of dioxygen, where the O2 affinity is high (for the case illustrated of
positive cooperativity). The other PI/2(02) value characterizes the regime of low
partial pressure of dioxygen, where affinity is relatively low. This difference in
affinities can be converted into a difference between the free-energy change
upon O2 binding in the low-affinity state (K/ ) and the high-affinity state (K/)
[the designations T and R will be described in subsection d]:
- RTIn (K/ /K/). (4.14)
A second way to characterize cooperativity involves fitting the oxygen-binding
data at intermediate saturation (0.2 < 0 < 0.8)-that is, about the inflection
point in a Hill plot-to the Hill equation
or
O/(l - 0)
log (O/(l - 0))
K p pn(02)
-log (P 1/2(02)) + n log (P(02))' (4.15)
The Hill coefficient (n) is an empirical coefficient that has a value of unity for
non-cooperative binding, where Equation (4.15) reduces to the Langmuir iso-
therm, Equation (4.12). Any number greater than unity indicates positive coop-
erativity. If O2 binding is an all-or-nothing affair, where dioxygen binding sites
are either all occupied or all vacant, n equals the number of subunits in the
molecule. The fit is only approximate, since the Hill plot is only approximately
linear about the inflection point, as may be seen in Figure 4.4B. A more precise
value of n may be obtained by plotting the slope in the Hill plot (n') as a
function
n'
d[log (O/(l - 0))]
d[log (P(02)) (4.16)
of log (P(02)) (Figure 4.4C). The maximum value of n' is taken as the Hill
coefficient n. 9 Note that the maximum in this first-derivative plot of the binding
curve will occur at P \/2(02) only if the Hill plot is symmetric about its inflection
point. For tetrameric hemoglobins, a maximum Hill coefficient of around 3.0 is
seen, and for hemocyanins n may be as high as 9. These values, like PI/2(02)
values, are sensitive to the nature and concentrations of allosteric effectors.
178 4 I BIOLOGICAL AND SYNTHETIC DIOXYGEN CARRIERS
c. Benefits of Cooperative Ligand Binding In general, oxygen-carrier pro-
teins, being oligomeric, coordinate dioxygen cooperatively, whereas oxygen-
storage proteins, being monomeric, do not. Oligomerization and cooperative
binding confer enormous physiological benefits to an organism. The first benefit
derives directly from oligomerization. Oxygen carriers either form small oligo-
mers that are encapsulated into cells or erythrocytes (such hemoglobins are re-
ferred to as intracellular hemoglobins) or associate into large oligomers of 100
or more subunits. Such encapsulation and association reduce by orders of mag-
nitude the number of independent particles in the blood, with consequent reduc-
tions in the osmotic pressure of the solution and in strain on vascular mem-
branes.
The second benefit derives from cooperative binding of ligands and the abil-
ities of heterotropic allosteric effectors to optimize exquisitely the oxygen-bind-
ing behavior in response to the external and internal environment. The situation
is illustrated in general terms in Figure 4.6. 9 Most organisms that require O2
live in an environment where the activity of Oz corresponds to about 21 percent
of an atmosphere, that is, to about 160 Torr, although usually the effective
availability, because of incomplete exchange of gases in the lungs, for example,
is around 100 Torr. The concentration of Oz in vertebrate tissues at rest is
equivalent to a partial pressure of about 35-40 Torr dioxygen; lower values
obtain at times of exertion. Now consider a noncooperative oxygen binder with
an affinity expressed as Pl/iOz) of 60 Torr (Figure 4.6, curve a). Then, at 100
Torr the fractional saturation () is 0.625. In other words, in a realm of high Oz
availability, only 62.5 percent of the oxygen-binding capacity is used, which is
not particularly efficient if the organism wished to climb Mt. Everest, where the
partial pressure of Oz is less than half that at sea level. In the tissues, where
P(Oz) = 40 Torr, the fractional saturation is about 40 percent. Thus, only about
one third of the coordinated dioxygen is released to the tissues, and total effi-
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Figure 4.6
Physiological benefits of cooperativity and heterotropic allosteric effectors. 9
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ciency is only 22.5 percent. Consider now a noncooperative oxygen carrier with
a much higher affinity, PI/2(02) = 1.0 Torr (Figure 4.6, curve b). If we assume
the same ambient pressure of O2 in the tissues, the fractional saturation is 97.6
percent. Note that at 100 Torr of O2 the carrier is 99.0 percent saturated. In
other word:(>, only about 1.4 percent of the available oxygen is delivered.
With a, oligomeric protein that binds dioxygen cooperatively, the problem
of inefficient and inflexible oxygen delivery disappears. For example, the tetra-
meric protein hemoglobin has a mean affinity for O2 of P I /2(02) = 26 Torr at
3TC and pH 7.4. If hemoglobin bound O2 noncooperatively, then the hyber-
bolic binding curve (c) in Figure 4.6 would represent the O2 binding. Instead,
the observed binding follows curve (d). Since the partial pressure of dioxygen
in the lungs and arterial blood of vertebrates is around 100 Torr, but in the
tissues and venous blood it is around 40 Torr, then at these pressures a typical
myoglobin (PI/2(02) = 1 Torr) remains effectively saturated. On the other hand,
about 25 percent of the available dioxygen can be delivered, even in the absence
of myoglobin. With venous blood remaining 75 percent oxygenated, hemoglo-
bin has substantial capacity to deliver more O2 at times of exertion or stress
when P(02) in the tissues falls below 40 Torr.
The net result is that whole blood, which contains about 15 g of hemoglobin
per 100 mL, can carry the equivalent of 20 mL of O2 (at 760 Torr) per 100 mL,
whereas blood plasma (no hemoglobin) has a carrying capacity of only 0.3 mL
of O2 per 100 mL. 9
Oxygen binding in vivo is modulated by allosteric effectors that through
interaction with the protein change the affinity and degree of cooperativity. For
hemoglobin A (adult human hemoglobin), naturally occurring allosteric effec-
tors include the proton, carbon dioxide, and 2,3-diphosphoglycerate (2,3-DPG).
Increasing concentrations of these species progressively lower the affinity of
free hemoglobin A, thereby enhancing the release of coordinated O2 (Figure
4.6, curve e). For example, 2,3-DPG is part of a subtle mechanism by which
dioxygen is transferred from mother to fetus across the placenta. The subunits
comprising fetal hemoglobin and adult hemoglobin are slightly different. In the
absence of allosteric effectors (referred to as stripped hemoglobin), the oxygen-
binding curves are identical. However, 2,3-DPG binds less strongly to fetal
hemoglobin than to adult hemoglobin. Thus fetal hemoglobin has a slightly higher
affinity for dioxygen, thereby enabling dioxygen to be transferred. The proton
and carbon dioxide are part of a short-term feedback mechanism. When O2
consumption outpaces O2 delivery, glucose is incompletely oxidized to lactic
acid (instead of CO2). The lactic acid produced lowers the pH, and O2 release
from oxyhemoglobin is stimulated (Figure 4.6, curve e). The CO2 produced in
respiration forms carbamates with the amino terminals, preferentially of deoxy
hemoglobin.
R-NH2 + CO2 :;;::=:::: R-NH-COO - + H +
Thus hemoglobin not only delivers O2 but also facilitates removal of CO2 to the
lungs or gills, where CO2 is exhaled.
180 4 / BIOLOGICAL AND SYNTHETIC DIOXYGEN CARRIERS
d. Models for Cooperativity The binding of Oz to hemoglobin can be de-
scribed as four successive equilibria:
Hb + O2 ~ Hb(02) P1/2(1)(02) = 123 [46] Torr
K(2j
Hb(02), + O2 ~ Hb(Od2 P1/2(2)(02) 30 [16] Torr
~ (4.17)Hb(02b + O2 Hb(02h P1/2(3)(02) 33 [3.3] Torr
Hb(02h + O2 ~ Hb(02)4 P,/2(4)(02) = 0.26 [0.29] Torr
(0.6 mM hemoglobin A, bis(Tris) buffer, pH 7.4, 0.1 M CI-, 2 mM 2,3-DPG, 25°C.
The values in square brackets are affinities in Torr measured in the absence of 2,3-
DPG.)
This simple scheme proposed by Adair z6 assumes that each of the four bind-
ing sites is identical. The Pl/z(Oz) values given come from fitting the binding
curve to this scheme. 27 When 2,3-DPG is removed, the affinity of hemoglobin
for the first three molecules of Oz is substantially increased, and the degree of
cooperativity is lowered (values in square parentheses). For progressively stronger
binding, the following inequalities, reflecting the proper statistical weighting
illustrated in Figure 4.5, should hold:
~K(I) > AK(Z) > JiK(3) > AK(4)
464 1 (4.18)
The ~ ratio, for example, reflects the six equivalent forms of the doubly and the
four equivalent forms of the triply ligated species. In other words, relative to a
noncooperative system, at low Oz availability dioxygen release is facilitated; at
high 02 availability dioxygen binding is facilitated. The scheme is readily ex-
tended to higher orders of oligomerization.
A simple model for analyzing cooperative ligand binding was proposed by
Monod, Wyman, and Changeux in 1965, and is usually referred to as the MWC
two-state concerted model. Z8 Molecules are assumed to be in equilibrium be-
tween two conformations or quaternary structures, one that has a low ligand
affinity and a second that has a high ligand affinity. The low-affinity confor-
mation is often designated the T or tense state, and the high-affinity conforma-
tion the R or relaxed state. The equilibrium between the two conformations is
characterized by the allosteric constant
L o = [Ro]/[To] (4.19)
where the subscript denotes the unliganded Rand T states. The free-energy
change upon binding a ligand to the R state, irrespective of saturation, is as-
sumed to be a constant, and the associated equilibrium constant is designated
KR ; a third constant, K T , characterizes binding to the T state. Figure 4.7 illus-
trates this model, and introduces the terminology conventionally used. To a
reasonable approximation, the cooperative binding of dioxygen can be summa-
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The MWC two-state model for cooperative ligand binding: 4 (A) Free-energy relationships
among Rand T states; (B) Calculation of the allosteric constants from the binding curve.
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rized by these three parameters, L o, KR , and KT . The Adair constants may be
expressed in terms of these parameters:
K(I) = (l + LoC)KT K(2) (l + L OC 2)KT
1 + L o 1 + LoC
K(3) (l + L OC 3)KT K(4) (l + L OC 4)KT
1 + L OC 2 1 + L OC 3
where C = KR / KT' The fractional saturation is given as
a(l + a)3 + LoaC(l + aC)3() = -----,---------.,-(l + a)4 + LoaC(l + aC)4 '
(4.20)
(4.21)
where a = KT[X], and [X] is the concentration of the free ligand (e.g., O2) in
the same units (M or Torr) in which KT is expressed. Figure 4.7B illustrates
how the allosteric parameters, C = KR/K T and L 0 = [Ro]/ [T 0], are extracted
from a plot of saturation (as log [()/(l - ()))) versus partial pressure of dioxygen
(as log [P(02)])' Notice how the two-state model (Figure 4.7B) matches very
closely the form of the binding curve for hemoglobin (Figure 4.4B). Equations
(4.20) and (4.21) may be generalized to an oligomer with n subunits. In the
case of hemoglobin, Perutz and coworkers,1I through the determination of the
crystal structures of a variety of hemoglobin derivatives, have given subse-
quently a sound structural basis to the MWC model of two basic quaternary
states (see below).
A more exact treatment of ligand-binding data would allow for different
affinities for different binding sites (called subunit heterogeneity) and different
intrinsic affinities for ligand binding to the R-state conformation compared with
the T-state conformation, for each level of ligand saturation-that is, for tertiary
structure change within subunits upon ligation. This more exact treatment re-
quires 25 separate equilibrium constants. Statistical thermodynamical ap-
proaches exist. 29 These explicitly incorporate the different types of subunit in-
teractions that structural studies have revealed, and give improved fits to oxygen-
binding data and to the Bohr effect. The key element of two basic quaternary
states is preserved, at least for dioxygen binding. 29b
For some modified hemoglobins, for example [a-Fe(II)h[j3-Mn(III)h, where
in the j3 subunits the heme iron is replaced by Mn(III) , there is now strong
evidence for three quaternary states,29c with the singly and several of the doubly
ligated species having an energy state intermediate between the T (unliganded)
and R (fully, triply, and the other doubly liganded) states.
2. Kinetic factors
It is of little benefit to the organism if its dioxygen carrier, such as hemo-
globin, binds and releases O2 at such slow rates that O2 is not delivered faster
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than it would be by simple diffusive processes. Thus, a binding rate within a
couple of orders of magnitude of the rate of diffusion, together with the high
carrying capacity of O2 that high concentrations of oxygen carrier enable (noted
earlier), and a pumping system ensure adequate O2 supplies under all but the
most physiologically stressful conditions.
Whereas measurements of equilibrium give little or no molecular informa-
tion, rather more molecular information may be inferred from kinetic data. The
processes of binding and release can be examined by a variety of techniques,
with timescales down to the picosecond range. The temperature behavior of the
rates gives information on the heights of energy barriers that are encountered as
dioxygen molecules arrive at or depart from the binding site. The quantitative
interpretation of kinetic data generally requires a molecular model of some sort.
It is because of this multibarrier pathway that the equilibrium constant measured
as kIlL 1 (Equation 4.5) may differ substantially from the thermodynamically
measured value (Equation 4.3).
The simple Adair scheme outlined above is readily adapted to cater to ki-
netic data.
3. Dioxygen reactions
Most biological conversions involving dioxygen require enzymatic catalysis.
It is reasonable then that metals found in the proteins involved in the transport
and storage of O2 also frequently appear, with minor modification of ligands, in
enzymes that incorporate oxygen from dioxygen into some substrate. Dioxygen,
in this case, is not only coordinated, but also activated and made available to
the substrate. In the family of proteins with heme groups, hemoglobin is a diox-
ygen carrier and cytochrome P-450 is an oxygenase. A similar differentiation in
function is also found for hemocyanin and tyrosinase from the family of proteins
with a dinuclear copper complex at the active site. Note that not all enzymes
that mediate the incorporation of oxygen from O2 into some substrate coordinate
and activate dioxygen. For example, lipoxygenase probably catalyzes the con-
version of a 1,4-diene to a 1,3-diene-4-hydroxyperoxy species by activation of
the organic substrate. The active site does not resemble that of any known oxy-
gen-carrier protein. This topic is discussed more fully in Chapter 5.
B. Biological Oxygen Carriers
As noted earlier, three solutions to the problem of dioxygen transport have evolved:
hemoglobin (Hb), hemocyanin (Hc), and hemerythrin (Hr). Their remarkable
distribution over plant and animal kingdoms is shown in Figure 4.8. 15 The
hemoglobins and myoglobins found in plants, snails, and vertebrates all appear
to share a common, very ancient ancestor. There is some evidence now for a
common ancestral hemocyanin. 42c The appearance of hemerythrin in a few an-
nelid worms is an evolutionary curiosity. These few words and the diagram will
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Phylogenetic distribution of oxygen-carrier proteins: Hb, hemoglobin; Mb, myoglobin; Er, ery-
throcruorin; Ch, chlorocruorin; He, hemocyanin; Hr, hemerythrin. 15a Reproduced with permis-
sion from K. E. van Holde and K. I. Miller, Quart. Rev. Biophys. 15 (1982), 1-129.
suffice to give some hints about how respiratory proteins evolved, a subject that
is outside the scope of this book.
1. The hemoglobin family
Hemoglobins are the most evolutionarily diverse family of dioxygen car-
riers. They are found in some plants (e.g., leghemoglobin in the nitrogen-fixing
nodules of legumes), many invertebrates (including some insect larvae), crusta-
ceans, molluscs (especially bivalves and snails), almost all annelid worms, and
in all vertebrates with one possible exception, the Antarctic fish Cyclostomata.
With few exceptions the monomeric and oligomeric hemoglobins all share
a basically similar building block: a single heme group is embedded in a folded
polypeptide with a molecular weight of about 16 kDa (see Figure 4.2), and is
anchored to the protein by coordination of the iron center to an imidazole ligand
from a histidine residue. Mammalian myoglobin is often taken as the archetyp-
ical myoglobin (see Table 4.1). Sperm whale, bovine, or equine myoglobin are
specific examples; the muscle tissue from which they may be extracted is more
available than that from Homo sapiens. The archetypical oligomeric hemoglobin
that shows cooperative binding of O2 is the tetrameric hemoglobin A. It is read-
I. INTRODUCTION: BIOLOGICAL DIOXYGEN TRANSPORT SYSTEMS 185
ily available from the blood of human donors. * In some invertebrate hemoglo-
bins, especially those of annelids, aggregates may contain as many as 192 bind-
ing sites, to give a molecular weight of about 3 x 10 6 Dalton. These and other
high-molecular-weight hemoglobins of arthropods are often referred to as ery-
throcruorins (Er). In a few annelid worms, the otherwise ubiquitous heme b or
protoheme is replaced by chloroheme (see Figure 4.2) to give chlorocruorins
(Ch), which tum green upon oxygenation (chloros, Greek for green). Some
organisms, for example the clam Scapharca equivalvis, feature a dimeric hemo-
globin.
The only known anomalous hemoglobin is Hb Ascaris, which comes from
a parasitic nematode found in the guts of pigs. It has a molecular weight of
about 39 kDa per heme; this value is not a multiple of the myoglobin building
block. 31 Moreover, presumably in response to the low availability of O2 in pigs'
guts, Hb Ascaris has an extraordinarily high affinity for dioxygen, in large part
owing to an extremely slow rate of dioxygen release. 32 Leghemoglobin is an-
other carrier with a high affinity for dioxygen, in this case because of a high
rate of O2 binding. Since O2 is a poison for the nitrogenase enzyme, yet the
nodules also require dioxygen, diffusion of O2 is facilitated, but the concentra-
tion of free dioxygen in the vicinity of nitrogen-fixing sites is minimized. 33
Kinetic and thermodynamic data for dioxygen binding and release from a
variety of hemoglobins are summarized in Table 4.2. 9,10,3I.34-36 Notice that for
the hemoglobin tetramer, which comprises two pairs of slightly dissimilar sub-
units, the a and {3 chains bind O2 with significantly different affinities and rate
constants, especially in the T state. Isolated chains behave like monomeric
vertebrate hemoglobins, such as whale myoglobin, which have affinities close
to those of R-state hemoglobin. The chlorocruorins have a low affinity compared
to other erythrocruorins. Especially for proteins that bind O2 cooperatively, a
range of values is specified, since affinities and rates are sensitive to pH, ionic
strength, specific anions and cations (allosteric effectors), and laboratory. For
example, as we noted above, the O2 affinity of hemoglobin A is sensitive to the
concentration of 2,3-DPG and to pH (Bohr effect). Trout hemoglobin I is insen-
sitive to these species, whereas a second component of trout blood, trout hemo-
globin IV, is so sensitive to pH (Root effect) that at pH < 7 trout hemoglobin
IV is only partially saturated at P(02) = 160 Torr. 4 Note that O2 affinities span
five orders of magnitude. Since heme catabolism produces carbon monoxide,
and since in some environments CO is readily available exogenously, selected
data for CO binding are also presented.
2. The hemocyanin family
Hemocyanins (Hc), the copper-containing dioxygen carriers, are distributed
erratically in two large phyla, Mollusca (for example, octopi and snails) and
* Blood from human donors is also a source for a variety of abnonnal hemoglobins, the most famous of
which is HbS, the hemoglobin giving rise to sickle-cell anemia, It was Pauling and coworkers 30 who first
found that HbS differs from HbA through the single substitution of valine for glutamic acid in each of two of
the four subunits comprising Hb, Sickle-cell anemia was the first condition to be denoted a "molecular
disease. "
Table 4.2
Thermodynamics and kinetics of ligand binding to biological oxygen carriers (at 20-25°C and buffered at pH 6.5-8.5).
Dioxygen binding Carbon-monoxide binding
P1/2(02) !ill !:J.S kon koff PI/2(CO) !:J.H !:J.S kon kotf
Carrier Torr kcallmol eu J1.M I S-l S I Torr kcallmol eu J1.M I s I S - I
Hemoglobins
Hb Ascaris 0.0047 1.5 0.0041 0.063 0.21 0.018
Leg Hb 0.047 - 18.9 156. I. 0.00074 - 13.5 0.012
whale Mb 0.51 -14.9 14. 12. 0.018 -13.5 0.51 0.019
Whale Mb 140. 1600. -
(E7His ---i> Gly)
HbA }a 0.74 - 14.2 -21. 50. 28. 0.0025 4.0 0.013
isolated chains f3 0.42 -16.9 -29. 60. 16. 0.0016 - 4.5 0.008
HbA R achain 29. 10. - 3.2 0.0050.15-1.5 -18. -30.
100. 21.
0.001-0.004
0.009f3 chain 9.8
HbA R aE7His~Gly 220. 620. 19. 0.007
f3E7His~Gly 100. 3. 5.0 0.013
HbA T achain
9-160 12. -35. 2.9
183. 0.10-2.8 0.099 0.09f3 chain 11.8 2500.
Chironimus Mb 0.40 300. 218. 0.0019 - 27. 0.095
Glycera Mb 5.2 190. 1800. 0.00089 27. 0.042
Aplysia Mb 2.7 -13.6 15. 70. 0.013 0.49 0.02
Spirograph is 16-78 4.5
chlorocruorin
CO binding noncooperative since not measurable
-6.0 -2.7 4.1
CO binding noncooperative
Hemocyanins a
Molluscan Hc
Helix pomatia R
Helix pomatia T
Levantina
hierosohimia R
Levantina
hierosohimia T
Arthropod Hc
Panulirus
interruptus R b
P. interruptus
monomer
Leirus quinques-
tris R
Leirus quinques-
tris T
2.7 -11.5 -12.6 3.8 10.
55. -15.4 - 31.1 1.3 300.
3.8 7.5 -1.8
18. +3.1 +31.
1.0 31. 60.
9.3 57. 100.
1.7 -7.4 O.
117. +3.1 +27.
10.
720.
-13.5 -24. 0.66 70.
8100.
Hemerythrins
Phascolopsis
gouldii
Themiste zosteri-
cola 8-mer
T. zostericola
monomer
2.0
6.0
2.2
- 12.4 - 18. 7.4
7.5
78.
56.
82.
315.
not known to bind CO
ex>
--.J
Solubility of O2 in water: 1.86 x 10 .. 6 M/Torr
Solubility of CO in water: 1.36 x 10 -6 M/Torr
a 10 mM Ca 2 + added: necessary for cooperativity.
b CO binding at pH 9.6.
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Arthropoda (for example, lobsters and scorpions). The functional form of hem-
ocyanin consists of large assemblies of subunits. 14,15,37 In the mollusc family
the subunit has a molecular weight of about 50 kDa and contains two copper
atoms. From electron-microscopic observations, hemocyanin molecules are cy-
lindrical assemblies about 190 or 380 A long and 350 A in diameter comprising
10 or 20 subunits, respectively, for a molecular weight as high as 9 x 10 6
Dalton. In the arthropod family, the subunit has a molecular weight of about 70
kDa with two copper atoms. Molecular aggregates are composed of 6, 12, 24,
or 48 subunits. Upon oxygenation the colorless protein becomes blue (hence
cyanin from cyanos, Greek for blue). Spectral changes upon oxygenation, oxy-
gen affinities, kinetics of oxygen binding (Table 4.2),4.5,14,15,38 anion binding,
and other chemical reactions show that the active site in the phylum Arthropoda
and that in Mollusca, although both containing a pair of copper atoms, are not
identical. 4, 14
No monomeric hemocyanins, analogous to myoglobin and myohemerythrin
(next section), are known. For some hemocyanins the binding of dioxygen is
highly cooperative, if calcium or magnesium ions are present, with Hill coeffi-
cients as high as n ~ 9. However, the free energy of interaction per subunit can
be small in comparison with that for tetrameric hemoglobin; 0.9 to 2.5 kcallmol
compared to 3.0 kcallmol. Allosteric effects, at least for a 24-subunit tarantula
hemocyanin, can be separated into those within a dodecamer (12 subunits)-the
major contributor to overall allostery-and those between dodecamers. 39c This
has been termed nested allostery. In contrast to the hemoglobin family, isolated
chains have affinities typical of the T-state conformation for hemocyanin. The
binding of CO, which binds to only one copper atom, is at best weakly coop-
erative. 39
As alluded to above, the distribution of hemocyanins is striking, Among the
molluscs exclusive use of hemocyanin as the respiratory protein occurs only
with the cephalopods (squid, octopi, and cuttlefish), and in the arthropods only
among the decapod (ten-footed) crustaceans (lobsters, shrimp, and crabs). The
bivalve molluscs (for example, oysters and scallops) all use small dimeric or
octameric hemoglobins. The edible gastropod (snail) Helix pomatia uses hemo-
cyanin, whereas the apparently closely related fresh-water snail Planorbis uses
a high-oligomer hemoglobin. Both use a myoglobin as the oxygen-storage pro-
tein. The structure of the active site has been extensively probed by EXAFS
methods,40,41 and the x-ray crystal structure of a hexameric deoxyhemocyanin
is known. 42 Each copper atom is coordinated to three imidazole groups from
histidine residues. The pinwheel arrangement of the six subunits, the domain
structure of a single subunit, and the domain containing the active site are shown
in Figure 4.9.
3. The hemerythrin family
The biological occurrence of hemerythrins (Hr in Figure 4.8), the third class
of dioxygen carriers, is relatively rare, being restricted to the sipunculid family
(nonsegmented worms), a few members of the annelid (segmented worm) fam-
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Figure 4.9
Diagram of the structure of deoxyhemocyanin from Panulirus interruptus at 3.2 Aresolution: 42c
(A) The hexameric arrangement of subunits; (B) The domain structure of one subunit; (C) The
tertiary structure of domain 2, which contains the pair of copper atoms: a-helices are repre-
sented by cylinders; f3-strands by arrows, and copper atoms by diamonds; (D) The active site
and its histidine ligands. Reproduced with permission from B. Linzen, Science 229 (1985),
519-524.
ily, a couple of brachiopods (shrimps), and a couple of priapulids. The oxygen-
binding site contains, like hemocyanin, a pair of metal atoms, in this case, iron.
Upon oxygenation the colorless protein becomes purple-red. Monomeric (myo-
hemerythrin), trimeric, and octameric forms of hemerythrin are known; all ap-
pear to be based on a similar subunit of about 13.5 kDa. When hemerythrin is
extracted from the organism, its oxygen binding is at best only weakly cooper-
ative, with Hill coefficients in the range 1.1 to 2.1. 18 In coelomic cells (the
tissue between the inner membrane lining the digestive tract and the outer mem-
brane of the worm-analogous to flesh in vertebrates), oxygen apparently binds
with higher cooperativity (n ~ 2.5).43 Perchlorate ions have been observed to
induce cooperativity: since CI04 - has no biological role, it appears that in pro-
tein purifications the biological allosteric effector is lost. No Bohr effect occurs.
Dioxygen binding data are accumulated in Table 4.2. 36,44
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The structure of hemerythrin in a variety of derivatives (oxy, azido, met,
and deoxy) is now well-characterized. With three bridging ligands, a distinctive
cofacial bioctahedral stereochemistry is seen (Figure 4.10).45-48
o A
(A)
Figure 4.10
Structure of hemerythrin: (A) The tertiary structure of octameric hemerythrin46b with four (X-
helices (A, B, C, D) of one of the eight subunits. The filled half-circles denote anion binding
sites (e.g., CI04 -); the filled circle the Fe2 site; and the cross-hatched oval the N3 - and SCN-
binding sites (FeIIlh and the O2 binding sites (Fellh. Reproduced with permission from R. E.
Stenkamp, L. C. Sieker, and L. H. Jensen, J. Mol. Bioi. 126 (1978), 457-466. (B) The struc-
ture of the active site of metazidomyohemerythrin,48 showing the cofacial bioctahedral stereo-
chemistry. The structure of oxyhemerythrin is very similar, including the orientations of the
(H)0211Iigand.45 Reproduced with permission from S. Sheriff, W. A. Hendrickson, and J. L.
Smith, 1. Mol. Bioi. 197 (1987), 273-296.
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C. Hazards of Life with Dioxygen
The binding of dioxygen is normally a reversible process:
(4.22)
Under some circumstances, such as in the presence of added nucleophiles and
protons, coordinated dioxygen is displaced as the superoxide anion radical,
O2 -', leaving the metal center oxidized by one electron and unreactive to diox-
ygen: 49,50
(4.23)
For hemoglobin there exists a flavoprotein reductase system, comprising a re-
duced pyridine nucleotide (e.g., NADH), cytochrome b5 reductase, and cyto-
chrome b5 , that reduces the ferric iron back to the ferrous state, so that it may
coordinate dioxygen again. 1,51 In addition, all aerobically respiring organisms
and many air-tolerant anaerobes contain a protein, superoxide dismutase, that
very efficiently catalyzes the dismutation of superoxide ion to dioxygen and
hydrogen peroxide: 52-54
(4.24)
However, the physiological effects of the superoxide moiety remain controver-
sial. 53,54 Finally, there is a third enzyme, the hemoprotein catalase, that converts
the toxic hydrogen peroxide into water and dioxygen: I
(4.25)
This topic is discussed further in Chapter 5.
II. SELECTED CHEMISTRY OF DIOXYGEN, IRON, COPPER,
AND COBALT
Dioxygen is a powerful oxidant, capable of oxidizing all but the noble metals
and of converting many low-valent metal complexes to higher-valent states. As
will be detailed in this section, the binding of dioxygen to metals is most use-
fully considered as an oxidative addition process. The nature of the interaction
is determined by the metal, its oxidation state, and its ligands that modulate the
redox properties of the metal center. In biological and nonbiological oxygen
carriers, several factors allow reversible binding of O2 to occur, even though
this process is metastable with respect to (irreversible) oxidation of the metal,
or its ligands, or other species that may be present. Later in this section the
bioinorganic chemistry of iron, copper, and cobalt is described. For a wider
perspective on the coordination chemistry of these metals, see comprehensive
texts on inorganic chemistry. 56-58
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Many techniques have been used to probe the metal-dioxygen moiety. A
summary of these techniques, key concepts, and results is presented in Table
4.3. 59- 61 UV-visible spectroscopy usually characterizes the oxidation state of the
metal and in favorable cases the number, geometry, and ligand field strength of
ligands. The 0-0 and M-O stretching modes may be investigated with in-
frared spectroscopy, provided that the complex is not a centrosymmetric dimer,
for then the 0-0 stretch for the JL-dioxygen species is infrared-inactive. Res-
onance Raman techniques complement infrared spectroscopy. Not only are the
selection rules different in Raman spectroscopy, but a suitable choice of the
irradiating wavelength (to coincide approximately with an M-L electronic tran-
sition) can amplify those vibrational modes that are coupled, or in resonance,
with the electronic transition. This technique is particularly suited as a probe of
the metal-ligand environment of metalloproteins, since the many solely protein
vibrational modes disappear into background noise. Geometric information on
the orientation of the CO moiety with respect to the heme normal has been
obtained by examining polarization behavior of infrared bands following pho-
tolysis of the Fe-CO bond by linearly polarized light.
Spin and oxidation states of mononuclear iron-porphyrin systems may be
assigned directly from magnetic susceptibility measurements and indirectly from
Mossbauer spectroscopy. Variable temperature susceptibility measurements are
particularly useful for detecting dinuclear systems that share at least one ligand
in common if there is antiferromagnetic (or ferromagnetic) coupling of the elec-
tron spin of one metal center with that of a second.
Definitive characterization of the stereochemistry is usually provided by x-
ray diffraction data when single crystals are available. In general, the level of
resolution and precision available from protein crystal structures leads to tanta-
lizing uncertainties over the geometry of the M-02 species and of the struc-
tural changes occurring on oxygenation that are the origin of cooperativity. Pre-
cise structural data are more readily obtained from small-molecule model systems.
The relevance of these to biological systems is established through congruence
of spectroscopic and functional properties. X-ray diffraction techniques also pro-
vide important information on the environment beyond the immediate surround-
ings of the metal center: this information is usually unobtainable from other
techniques, although recent developments in two-dimensional NMR spectros-
copy can provide this information for diamagnetic systems. Limited information
may be obtained with the use of spin labels or, if the metal center is paramag-
netic, with EPR techniques.
Two other techniques that selectively probe the immediate environment of
the metal center are EXAFS (Extended X-ray Absorption Fine Structure) 60 and
XANES (X-ray Absorption Near-Edge Structure). 61 The former may yield in-
formation on the number and type of bonded atoms and their radial separation
from the metal center. The latter technique may reveal the oxidation state and,
in principle, may yield geometric information, although in its present state of
development some interpretations are contentious. Both techniques have the ad-
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Table 4.3
Techniques used to probe the active sites of oxygen carriers.
Technique Abbrev. Description of technique Description of results
Nuclear NMR Quantized orientation of nuclear Identification of histidine by deuter-
magnetic spin in a magnetic field. Energy ium exchange (N-H vs. N-D) at
resonance separations sampled with radio- or near metal, especially if paramag-
frequency radiation. netic.
Electron EPR Quantized orientation of elec- Location of unpaired electron density
paramagnetic tron spin in a magnetic field. from hyperfine splitting by metals or
resonance Energy separations sampled atoms with nuclear spin.
with X- or Q-band microwave
radiation.
Magnetic Strength of interaction of sam- Identification of spin state, spin-
susceptibility pIe with magnetic field. Solid equilibria, and spin coupling (ferro-
state or solution state by Evans' or antiferromagnetic); identification
NMR method. of FellI-O-FellI moiety.
Infrared IR Vibrational modes involving Classification of 0-0 moiety (su-
spectroscopy change in dipole moment. peroxo vs. peroxo). Identification of
v (M-O) and v(M-O-M)
modes, etc.
Raman and R,RR Vibrational modes involving a Complementary to IR. v(0-0) and
resonance change in polarizability. For v(M-O) especially in metallo-
Raman RR enhancement of modes cou- proteins. In porphyrins, oxidation
pled with electronic transition and spin state.
excited by laser light source.
UV-visible UV-Vis Valence electron transitions. Electronic state of metal from d-d
spectroscopy transitions. Identification of unusual
ligands, e.g., Cu(II}-SR,
FellI-OPh, FellI-O-FellI . Single
crystals and polarized light give geo-
metrical information.
X-ray XPS Inner-shell electron transitions. Oxidation state of metal.
photoelectron (ESCA)
spectroscopy
Mossbauer Excitation of nuclear spin by y Oxidation and spin state. Antifer-
spectroscopy rays. romagnetic coupling (Fe only).
X-ray single- Fourier transform of diffraction Precise three-dimensional structure,
crystal dif- data reveals location of electron bond distances and angles for small
fraction density. molecules. Lower resolution and
precision for proteins.
Extended EXAFS Backscattering of x-rays pro- Number, type, and radial distance of
x-ray absorp- duces interference fringes on ligand donor atoms bonded to the
tion fine absorption curve at energies metal.
structure just greater than metal absorp-
tion edge (Kf3 transition)
X-ray XANES Similar to EXAFS except that As for EXAFS. May give geometric
absorption absorption is monitored at ener- information.
near-edge gies near and below the absorp-
structure tion edge.
194 4 / BIOLOGICAL AND SYNTHETIC DIOXYGEN CARRIERS
vantage of not requiring crystalline material. The structural information is more
reliable if definitive model systems are available for comparison.
X-ray (and, less frequently, neutron) diffraction techniques on single crys-
tals give absolute structural information* and thus provide the basis for interpre-
tation of data obtained from these other techniques that yield relative structural
information.
A. General Aspects of the Chemistry of Dioxygen
1. Redox chemistry of free molecular dioxygen
Dioxygen has a rich redox chemistry that is not explicitly exploited in the
oxygen carriers, but which is central to enzymes that coordinate and activate
dioxygen for subsequent reaction with a substrate. On reduction of dioxygen by
one electron, the superoxide anion radical O2 -. is formed. Concomitant with a
reduction in bond order from 2.0 to 1.5 is an increase in bond length from 1.21
to 1. 30 A. A second reduction step produces the peroxide anion 0 2 2 -; the bond
order is one, and the 0-0 separation is 1.49 A. Each of these reduced spe-
cies, O2 -. and 0/-, has a characteristic 0-0 stretching vibration in the in-
frared region. The free-energy changes and electrochemical potentials for the
reduction of dioxygen at unit activity, pH = 1 (EO), are different from those at
pH 7.0 (EO'), as shown in Figure 4.11. 58 •62 The values at pH 7.0 are more
relevant to physiological conditions. Note that the superoxide anion may func-
tion as either an oxidant or a reductant.
o
2.5
(1.77)
1.36
(1.23)
0.82
(-0.32)
-0.73
o
I'. Go'
kcal/mol
-50
Figure 4.11
Free-energy changes in the aqueous redox chemistry of dioxygen. Standard state P(02) = 1.
Electrode potentials are at pH 7; those in parentheses are at unit activity.
* In favorable situations, sophisticated NMR techniques have been applied successfully to detennine the
polypeptide folding (e.g., in metallothionein).55
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2. Geometry and electronic structure of coordinated dioxygen
In coordinating to metals, dioxygen shows a great variety of geometries and
two formal oxidation states. Many complexes have v(O-O) values in the range
740 to 930 cm -1, and, where known, an 0-0 separation in the range lAO to
1.50 A. By analogy with the peroxide anion, these species are designated per-
oxo, OZl1-. Similarly, the designation superoxo OzI- is applied to those com-
plexes where v(O-O) values are in the range 1075 to 1200 cm -1, and the
0-0 separation is around 1. 30 A.63 Although such 0-0 separations and
vibrations are consistent with coordinated peroxide or superoxide moieties, the
net amount of charge transferred onto the dioxygen ligand from the metal and
its other ligands is difficult to measure experimentally and is probably variable.
Thus the oxidation state of the dioxygen ligand and that of the metal are best
considered in a formal sense rather than literally-hence the use of the termi-
nology OZI to indicate oxidation state I for the Oz moiety as a unit (not each
o atom). Because of the high degree of covalency in the M-O bond, a more
sensible comparison, at least for the peroxo class of compounds, is with organic
peroxides, ROOH or ROOR. The clear separation of coordinated dioxygen into
either the superoxo or the peroxo class is shown in Figure 4.12. 63- 66 Only those
compounds for which both stretching frequencies (v(O-O» and 0-0 sepa-
rations (r (0-0» are available are shown; for the purpose of the plot, non-
coordinated anions and cations, replacement of ethylenendiamine by two am-
monia ligands, and replacement of triphenylphosphine by alkylphenylphosphines
are assumed not to perturb significantly v(O-O) or r(O-O).
1.50
1.40
1.30
1.20
r(O-O)
o
A 1.10
I
I
I
I
I
I
I
I
I
I Hc02
I
I
Na20 2 I •
I
I
I
I
I
I
I
I HrO,
I -
I
I
I
I Hb02
I
o
1.2001,1001,000900
1.00 L--_--L-__--L-_-.l.__---' --L- ----l.L- --'--
700
v(O-O) cm-1
Figure 4.12
Scatter diagram showing the distribution of ° ° stretching frequencies and separations in
ionic superoxides and peroxides (6) and in coordination compounds. An open circle denotes O2
coordinated to one metal; a filled circle denotes O2 bridging two metals. The °- ° stretching
frequencies of oxyhemoglobin, oxyhemocyanin, and oxyhemerythrin are marked by dashed
lines.
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Figure 4.13
Modes of attachment of O2 to metals. P, N, and °denote phosphine,
amine, and oxygen ligands, respectively.
At least seven different geometries have been observed for the coordination
of dioxygen (Figure 4.13),63-66 only three or four of which are currently known
o
to be biologically relevant-the superoxo M - 0/ (for oxyhemoglobin), the
/0 /0
1
",
peroxo M ~ /M or M M (for oxyhemocyanin), and the hydrope-
o "'0/
roxo M_O_M/OOH (for oxyhemerythrin). The geometry is a function of
the metal, its oxidation state, and its ligands. For the late transition metals of
the cobalt and nickel triads, with soft 1T-acid ligands, such as phosphines and
carbonyls, and with an initially low oxidation state of the metal, triangular co-
ordination of a peroxo species with covalent M-02 bonds is common. 63 Con-
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comitant with the formal reduction of dioxygen, the metal center undergoes a
formal two-electron oxidation:
/0
M n+ O
2
----+ Mn+ II \ 11-
"'0
(4.26)
In this example, where the metal has undergone, at least formally, a two-elec-
tron oxidation, the UV-visible properties of the metal-dioxygen complex tend to
resemble those of bona fide Mn +11 rather than Mn species.
Early transition metals (Ti, V, Cr triads) often coordinate several peroxo
species, leaving the metal in formally a very high oxidati~n state (e.g., Cr(02)4 3 -,
a Cr v ion). 63 The M-02 links have more ionic chadcter, with the 1]-peroxo
groups acting as bidentate ligands. Titanium and molybdenum(II) porphyrins
bind, respectively, one and two dioxygen molecules in this manner. 65
With harder u-donor ligand systems, such as those containing nitrogen and
oxygen donors, and the metal center in a normal oxidation state, a formal one-
electron reduction to an end-on coordinated superoxo species occurs with a bent
o
M-O/ bond. Metal-dioxygen species can also be formed by adding the
superoxide anion to the oxidized species: 64
0
'
-
/
M n+ 02 ----+ M n+1 -0 +----- M n+1 + O2 - (4.27)
In the absence of steric constraints, dimerization to a (bridging) fL-peroxo spe-
cies frequently occurs, especially for cobalt-dioxygen complexes:
0
'
-
/
CO III - ° + Co II ----+ Co III
O-CO" 1
";/
°
(4.28)
There are several neutral dicobalt species formulated as fL-peroxo systems that
contain Schiff-base ligands, and for which the 0-0 separation is anomalously
short (e.g., 1.31(2) and 1.338(6) A).66 Few infrared or Raman data for v(O-O)
are available to check whether these compounds, as a result of their delocalized
Co-Schiff base system and their neutrality, fall between the superoxo and per-
oxo classes. The isolated circle in Figure 4.12 is one such example.
These dicobalt species (right-hand side of Equation 4.28) may be oxidized
by one electron to give a fL-superoxo moiety. A clear shortening of the 0-0
bond and concomitant increase in the value of v(O-O) are observed in several
superoxo-peroxo pairs. These and other modes of O2 attachment are illustrated
in Figure 4.13. Some geometries are represented by only one or two examples,
and some geometries, for example, a linear M-O-O species, have never
been observed.
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In binding to metals, Oz effectively functions both as a 1T acid, accepting
into its 1T* orbitals electron density from the filled d orbitals of the metal, and
as a a donor, donating electron density into an empty metal d orbital. Thus
other a donor or 1T acceptor ligands, such as nitric oxide (NO), alkyl isocyan-
ides (R-NC), alkyl nitroso (R-NO), and carbon monoxide (CO), are often
observed to bind to the same metal complexes that bind Oz. The nature of the
metal-dioxygen linkage in biological oxygen carriers and their models will be
examined in more detail later.
B. General Aspects of the Chemistry of Iron
1. Irreversible oxidation
In the presence of dioxygen, iron(II) species are readily oxidized to iron(III)
species. In the presence of water, iron(III) species frequently associate into J.L-
oxodiiron(III) dimers. For iron(II)-porphyrin complexes this process may take
only milliseconds at room temperature. The following mechanism was proposed
in 1968 for the irreversible oxidation of iron(II)-porphyrinato species; 67,68 sub-
sequent work has largely confirmed it. 69-7]
Fe" + O2 ( ) Fe"'-02' (4.29a)
Fe '''-02 ' + Fell ( ) Fe" l - 0 2"--Fe"l (4.29b)
Fe"I-02"···-Fe lll ~ 2Fe IV =O (4,29c)
Fe'V=O + Fell ~ Fe"'-O-Fe'" (4.29d)
In particular, the dimerization reaction (4.29b) may be rendered less favorable
by low temperatures « - 40°C) or by sterically preventing the bimolecular
contact of an FeIlI-OzI - moiety with an Fel! moiety. In the latter case, steri-
cally bulky substituents on the equatorial ligand surround the coordinated O2
ligand and the other axial position, trans to the coordinated dioxygen ligand, is
protected with a nitrogenous base, such as imidazole, or with additional bulky
substituents on the equatorial ligand (Figure 4.14).72 The protein effectively pro-
vides such protection and thus plays a key role in preventing the bimolecular
contact of two hemes. The first observation of reversible binding of dioxygen
to an iron(II)-porphyrin in the absence of protein was made in 1958. 73 In that
pioneering study, a heme group was immobilized on a polymer support specially
modified to contain imidazole functions. The structurally characterizable hemo-
globin or myoglobin species was replaced by a noncrystalline structurally un-
characterized polymer.
Why does this irreversible oxidation not occur analogously for cobalt sys-
tems? Step (4.29c) involves cleavage of the 0-0 bond, which in HzOz has a
bond energy of 34.3 kcal/mol or in NazOz of 48.4 kcal/mol. By way of com-
parison, for O2 the bond energy is 117.2 and for HOz' it is 55.5 kcallmol. 64 A
simple molecular orbital picture gives insight into why an Fe IV =0 species is
stabilized relative to the analogous Co IV =0 species. 74 From Figure 4.15 we
see that for metals with electronic configuration dn , where n ::'S 5, no electrons
----M
I
(N~L N
"
protection on one side:
excess base required
----M
protection on both sides
----M
I
(N"""L N
"
protection on one side:
stoichiometric control
with chelated base
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Figure 4.14
Stylized representation of steric hindrances preventing irreversible oxidation.
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Mn+ 1 Mn+ 1-0-
here Fe d 5
Figure 4.15
Orbital scheme showing the differing stabilities of M-O species,
M = Co(d 6), Fe(d 5); a--bonding of 2pz with 3dz' not shown. 74
occupy the antibonding orbital 7T* for Fe III_O I -. or Fe IV = 0 moieties. For
Co III (d 6) the extra electron goes into the antibonding orbital 7T*. As predicted
by the model, Mn III is observed indeed to behave like Fe III .
A second oxidation pathway does not require the bimolecular contact of two
iron(II)-porphyrins. Coordinated dioxygen may be released not as O2, as in nor-
mal dioxygen transport, but, as noted in Section I.C, as a superoxide radical
anion O2 - . in a process called autoxidation:
(4.30)
This process is assisted by the presence of other nucleophiles that are stronger
than the superoxide anion, such as chloride, and by protons that stabilize the
O2 . anion as HO~:
(4.31)
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The formation of methemoglobin occurs in vivo, probably by the above mech-
anism, at the rate of ~ 3 percent of total hemoglobin per day.
If exogenous reductants are present, then further reduction of dioxygen can
occur:
(4.32)
Such processes are important, for example, in the cytochrome PA50 system.
With suitably small reductants, oxygenase activity also has been observed for
hemoglobin A. This has led to the characterization of hemoglobin as a "frus-
trated oxidase." 75 Note the formal similarity between this process (Equation
4.32) and the bimolecular irreversible oxidation of iron(II) porphyrins: the sec-
ond Fe(II) complex in Reaction (4.29b) functions like the electron in Reaction
(4.32).
2. Spectroscopy of the Feill-O-Fe ill moiety
The end products of the irreversible bimolecular oxidation of Fe II species
contain the Fe1lI-0-Fe III fragment. Given the facile formation of fL-oxodi-
iron(III) species, it is not surprising that the Fe-O-Fe motif is incorporated
into a variety of metalloproteins, including the oxygen-carrier hemerythrin (Fig-
ure 4.10),16-18 the hydrolase purple acid phosphatase,76 the oxidoreductases ri-
bonucleotide reductase 77 and methane monoxygenase,78 an iron-sulfur protein
rubrerythrin,79a and the iron-transport protein ferritin. 79b In ferritin higher-order
oligomers are formed.
This fL-oxodiiron(III) moiety has a distinctive fingerprint that has made it
easy to identify this motif in proteins. 80 Regardless of the number (4, 5, 6, or
7), geometry (tetrahedral, square pyramidal, tetragonally distorted octahedral,
or pentagonal bipyramidal), and type of ligands (halide, RO -, RCOO , ali-
phatic N, or aromatic N) around the iron center, and of the Fe-O-Fe angle,
the magnetic susceptibility at room temperature lies in the range 1.5 to 2.0 Bohr
magnetons per Felll-O-Fe lll group, equivalent to about one unpaired elec-
tron. 81 ,82 In other words, the high-spin (5 = -r) iron centers are strongly anti-
ferromagnetically coupled. Other bridging groups, such as OH -, Cl -, carbox-
ylate, alkoxide, or phenoxide, give very weak coupling. 83-86
The asymmetric Fe-O stretch, vas(Fe-O), lies in the range 730 to
880 cm - 1; in multiply bridged complexes this mode is weak in the infrared
region. The symmetric vibration, vs(Fe-O), forbidden in the infrared region
for linear, symmetric Fe-O-Fe groups, occurs in the range 360 to 545 cm -I.
The symmetric mode is usually,87a but not always,87b observed by resonance
Raman techniques upon irradiating on the low-energy side of the Fe-O charge-
transfer band that occurs at about 350 nm.
Few dinuclear iron(II) complexes are known where the ligands approxi-
mately resemble those believed or known to occur in the family of fL-oxodi-
iron(III) proteins. 88 The dioxygen-binding process in hemerythrin has no close
nonbiological analogue. Although spectroscopically similar to oxyhemerythrin,
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the unstable monomeric purple peroxo complex formed by the addition of hy-
drogen peroxide to basic aqueous Fe III(EDTA) solutions remains structurally
uncharacterized. 89 ,90
3. Oxidation and spin states of iron porphyrins
Iron porphyrins, the active sites of the hemoglobin family, have a rich mag-
netochemistry.91 Iron porphyrins may be octahedral (two axial ligands), square
pyramidal (one axial ligand), or square planar (no axial ligand). The metal d
orbitals, now having partial porphyrin 7T* character, are split, as shown in Fig-
ure 4.16. The radius of the metal atom is much greater when it is high spin
(5 = 2 for Fe II, 5 = -r for Fe 1II) than when it is low spin (5 = 0 for Fe II,
5 = t for Fe III). This difference influences Fe-Nporph separations, porphyrin
conformation, and the displacement of the iron center with respect to the por-
phyrin plane. For iron(II)-porphyrins, two strong-field axial ligands, such as a
pair of imidazoles or an imidazole and carbon monoxide, lead to diamagnetic
complexes (5 = 0) with the six 3d electrons occupying those orbitals of ap-
proximate t2g symmetry. In a classic experiment in 1936, Pauling and Coryell
proved that oxyhemoglobin and carbonmonoxyhemoglobin are diamagnetic. 92*
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Figure 4.16
d-Orbital splitting in metalloporphyrins as a function of number and ligand-field strength
of ligands. 91 Orbital occupancy is illustrated for a d 6 species (Fell or COlli).
* There was a considerable flurry of interest when an Italian group, using a SQUID (Superconducting
Quantum Mechanical Interference Device), reported that at room temperature oxyhemoglobin was significantly
paramagnetic. 93 Not surprisingly, several theoretical papers followed that "proved" the existence of low-lying
triplet and quintet excited states 94- 96 Subsequently, the residual paramagnetism was doubted 97 and shown to
arise from incomplete saturation of hemoglobin by O 2 ; in other words, small amounts of deoxy hemoglobin
remained 98 Since oxygen affinity increases with decreased temperature, the concentration of paramagnetic
impurity decreased with decreasing temperature.
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No axial ligands at all may lead to a spin state of 5 = 1, with unpaired
electrons in the dxy and dzzorbitals. Five-coordinate iron(II)-porphyrinato com-
plexes are commonly high spin, 5 = 2, although strong IT-donor 1T-acceptor
ligands, such as phosphines, carbon monoxide, nitric oxide, and benzyl iso-
cyanide,99 enforce a low-spin state. Five-coordinate iron(II)-porphyrinato com-
plexes with aromatic nitrogenous axial ligands, such as pyridine or I-methylim-
idazole, bind a second such axial ligand 10 to 30 times more avidly than the
first to give the thermodynamically and kinetically (d 6, 5 = 0) stable hemo-
chrome species, a process that is avoided by hemoglobins. That is, the equilib-
rium constant for the following disproportionation reaction is greater than unity,
Fe-N + Fe-N ( ) N-Fe-N + Fe (4.33)
except for bulky ligand N, such as 2-methylimidazole and 1,2-dimethylimida-
zole, for which the five-coordinate species predominates at room temperature
even with a mild excess of ligand: 100
1-Melm 2-Melm
(4.34)
For iron(III)-porphyrinato complexes, strong-field ligands lead to low-spin
(5 = !) complexes. A pair of identical weak-field ligands, such as tetrahydro-
furan, leads to intermediate-spin (5 = ~) species. Five-coordinate species are,
with few exceptions, high-spin (5 = i), with all five 3d electrons in separate
orbitals. Spin equilibria 5 = ! ~ 5 = i and 5 = ~ ~ 5 = i are not unusual.
Specific examples of these spin systems are given in Table 4.4. 65 ,91 Higher
oxidation states are found in some other hemoproteins. Fe(V)-porphyrin systems
actually occur as Fe(IV)-porphyrin cation radical species, and Fe(I)-porphyrin
systems exist as Fe(II)-porphyrin anion radical species.
Substantial structural changes occur upon the addition of ligands and upon
changes in spin state. In one mechanism of cooperativity these changes are the
"trigger" (metrical details are deferred until the next section). Spectral changes
in the UV-visible region are observed also (Figure 4.17) 10 and may be moni-
tored conveniently to evaluate the kinetic and thermodynamic parameters of li-
gand binding to hemoglobin.
Figure 4.17 (facing page)
Spectral changes accompanying the oxygenation and carbonylation of myoglobin. 10 Reproduced
with permission from E. Antonini and M. Brunori, Hemoglobin and Myoglobin in Their Reac-
tions with Ligands, North Holland, 1971.
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Table 4.4
Oxidation and spin states of iron porphyrins and their biological occurrences.
State Fe lJ Felli
6-coord
Fe(TPP)CI } 5-coord
Cytochrome P-450(ox)
[Fe(TPP)(HzOhJ + )
[Fe(OEP)(3-CIPYhJ +(293 K) d
Fe(OEP) (Py)(NCS) 6-coor
MetHb(HzO)
[Fe(TPP) (C(CNh)J"
Fe(TPP)(OCI03) (5 = t ~)
cytochrome c'
High spin
Fell 5 = 2(d 6)
FellI 5 = Hd S )
Intennediate spin
Fell 5 = 1 (d 6 )
FellI 5 = !(d 5)
Low spin
Fell 5 O(d 6 )
FellI 5 = hd 5)
(5 = t Fe-NO adducts)
Fe(PF)(2-Melm)
Hb
Fe (TPP)(THFh
Hb(H20)?
Fe(TPP)
no biol. occurrence
Fe(TPP) (NO)
Hb(NO)' DPG(T)
Fe(PF)(2-MeIm)(02) b
Fe(TPP)(I-Melm)(NO)
Fe(TPP)(Py)(CO)
Fe(TPP)(I-MeImh
Hb(CO), Hb(NO)," Hb(02)b
cytochrome bs, C, C3
} 5-coord
}
} 4-coord
} a 5-coord
6-coord
[Fe(TPP)(Ph)J
[Fe(TPP)(lmhJ +
[Fe(OEP)(3-CI-PyhJ + (98 K)
Fe(TPP) (Py)(CN)
Fe(TPP)(Py)(NCS)C
cytochrome bs, c, C3
metHb (CN)
5-coord
6-coorc
a Could be placed in Fe lll column.
b Could be placed in Fe lll column with spin = O.
C Non-linear Fe-NCS moiety.
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C. General Aspects of the Chemistry of Copper
The chemistry of copper in biological systems is limited to oxidation states I
and II. The Cu I state has electronic configuration d 10. Unless there are ligand
bands or strong ligand-to-copper charge-transfer bands, diamagnetic Cu I species
are colorless. Complexes of Cu II (d 9) are often blue in color. The single un-
paired electron makes Cu II amenable to electron paramagnetic resonance (EPR)
techniques, at least if the electron spins of Cu II centers are independent of one
another. In oxyhemocyanin the spins are so strongly coupled (-J > 600 cm -1)
that at room temperature and below the system is effectively diamagnetic and
the pair of Cu II ions is EPR silent. 14
In aqueous solutions the Cu 1 ion is unstable with respect to disproportiona-
tion to Cu metal and Cu II ion: 62
Cu + + e - ( ) Cu
2Cu j ( ) Cu + Cu II +
EO = 0.3402 V
EO = 0.522 V
EO = 0.182 V
(4.35)
The Cu I state may be stabilized by ligands, especially sulfur-containing ones, or
by immobilization as afforded by a protein matrix, or in nonaqueous solvents,
such as acetonitrile, in the absence of dioxygen. Whereas Cu I thiolate species
are stable, Cu II thiolate species usually are unstable with respect to the dispro-
portionation: 101
2Cu ll -SR~ 2Cu ' + R-S-S-R (4.36)
Again, immobilization may give kinetic stability to Cu II thiolate speCIes, as
occurs in the blue-copper family of electron-transport proteins.
Copper(l) complexes are often two-coordinate with a linear arrangement of
ligands. Three-, four-, and possibly five-coordinate complexes are known.
In the presence of O2 , nonbiological copper(l) [and iron(II)] complexes are
often susceptible to ligand degradation, which may give the illusion of O2 bind-
ing. 102 The mechanisms by which this reaction occurs remain essentially un-
known. Iron-porphyrin systems are rather more robust. Nonetheless, there are
now several well-characterized copper(l) systems that reversibly bind dioxy-
gen,ISb,l03 at least at low temperature. One that has been structurally character-
. /0-...... /cu
Ized features a Cu ° dicopper(II)-peroxo moiety, l03f while a
second, with more properties in common with oxyhemocyanin, features a
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D. General Aspects of the Chemistry of Cobalt
Many parallels exist between the chemistry of Fe II_ and Co II-porphyrinato sys-
tems. Dioxygen binds to many COil complexes to give mononuclear 1: 1 Co:02
complexes with a bent geometry
(4.37)
and dinuclear 2: 1 Co:02 complexes,64,66 analogous to those described for Fe II
systems in Reactions (4.29a) and (4.29b). Indeed, these dinuclear systems were
the first nonbiological oxygen carriers to be isolated. The geometry of the diox-
ygen moiety, spanning two metals, may be cis or trans:
/0-0"
Co Co (4.38)
However, whereas these dinuclear cobalt species are invariably octahedral, din-
uclear copper-peroxo species are tetrahedral or distorted square pyramidal. 40,41
In the late 1960s, 1: 1 Co:02 species were first isolated by use of a combi-
nation of low temperatures and specific Schiff-base ligands. 104 It was found that
cobalt corrins, such as vitamin B12n also formed 1:1 dioxygen adducts,105 al-
though this chemistry is not known to be utilized by living systems. 103 Cobalt(Il)
porphyrins also form 1: 1 adducts but with low O2 affinity, especially in nonpo-
lar, aprotic solvents. Thus hemoglobin and myoglobin may be reconstituted from
a cobaltoheme with preservation not only of dioxygen-binding capabilities but
also of cooperativity. 106 The synthetic 1: 1 Co:02 complexes have proven to be
very useful in increasing our understanding of factors that determine oxygen
affinity for cobalt systems and by extrapolation for iron systems. Two important
differences make COil systems more accessible. First, in contrast to iron sys-
tems, the cleavage reaction (4.29c) and redimerization to a fL-OXO species (Re-
action 4.29d) do not occur (see Figure 4.15). Thus COli complexes of O2 are
stable in solution at room temperature without the need for protection illustrated
in Figure 4.14. Second, for CoII-porphyrinato systems, the equilibrium constant
for the addition of a second axial base, such as pyridine or I-methylimidazole,
is small. Thus the disproportionation to four-coordinate and six-coordinate spe-
cies that occurs for corresponding Fe 11 systems (Reaction 4.33) does not occur.
This difference simplifies the interpretation of spectral changes that are used to
obtain thermodynamic and kinetic parameters of which there are now volumi-
nous examples. 66
Moreover, the 1: 1 Co-02 complexes are paramagnetic. From the small
59CO hyperfine splitting, it is deduced that the single unpaired electron resides
primarily on the dioxygen moiety. 104a,105 From other experiments 107 it is appar-
ent that net transfer of electron density from the metal onto the dioxygen varies
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considerably, from about O.le- to about 0.8e-. For example, it is found for a
given COIl Schiff base, Co(bzacen), that the redox potential of the cobalt-Schiff-
base center LCo, measured by cyclic voltammetry, E1/2 ,
B2LCo 11I + e - ( ) B2LCo"
B = substituted pyridine
(4.39)
is a linear function of log K(02) as the axial base B is varied. The more easily
the COIl center may be oxidized, the higher is the O2 affinity, 103 as illustrated in
Figure 4.18A. The dioxygen affinity also increases as the basicity of the axial
nitrogenous ligand increases. 104a This effect is illustrated in Figure 4.18B. Be-
cause of differing steric requirements, dimethylformamide (DMF) , substituted
imidazole, and piperidine (pip) ligands do not fall on the correlation defined by
the series of substituted pyridine species. Note the synergistic nature of dioxy-
gen binding: in general, the more electron density that is pumped onto the metal
by the axial base, the more electron density is available for donation into the
7T* orbitals of the dioxygen ligand. El/2 and log K(02) are also correlated, al-
though more weakly, for a number of hemoglobins (Figure 4.18C).108 Here the
porphyrin and axial base remain constant, but presumably the surroundings of
the heme group and O2 binding site vary in a manner that is less well-defined
than in the model systems of Figure 4.18A and B. Notwithstanding these var-
ious perturbations to the metal center, the 0-0 stretch occurs at about
1140 cm -1, placing all 1: 1 cobalt and iron-dioxygen complexes of nitrogenous
and other hard ligands into the superoxo class. *
Cobalt(II) porphyrins and their adducts with diamagnetic molecules invari-
ably have spin S = i. (See Figure 4.16, but add one electron.) Thus the struc-
tural changes are less pronounced than for corresponding iron(II) systems. 110,111
From the similarities in geometries and differences in electronic structures be-
tween cobalt- substituted and native hemoglobins and their models, many in-
sights have been gained about the factors that determine oxygen affinity as well
* Because the 0-0 stretch may be coupled with other ligand modes, 109 its value should not be used to
estimate superoxo character, although in a series of fL-superoxo and fL-peroxo complexes of carefully con-
trolled stereochemistry, small changes in 1'(0-0) have been correlated with the pKa of the suite of ligands 66
Figure 4,18 (facing page)
Linear free-energy relationships: (A) Correlation of the O2 affinity at 21°C of Co(bzacen)L
with the COllI ;;::::: COil cyclic voltammetric wave of Co(bzacen)L2 species,I04a (B) Correlation of
ligand affinity with pKa- Squares (0) pertain to the binding of L to Co(PPIX) at 23°e. Circles
(0) pertain to the O2 affinity at - 45°C of Co(PPIX)L species, Filled shapes pertain to substi-
tuted pyridines; the least-squares lines shown are calculated from these data only, 104a (C) Corre-
lation of EO I (from cyclic voltammetry) with affinity for a miscellany of hemoglobins: 108 1,
Aphysia limacina Mb; 2, Physeter macrocephalus Mb; 3, Candida mycoderma Hb; 4, Chirono-
mus thummi Hb; 5, HbM-Hyde Park; 6, HbM-Iwate; 7, Hb a chain; 8, Hb f3 chain; 9, Hb F; 10,
Hb Y chain; 11, HbA; 12, Glycera dibranchiata; 13, IegHb-a; 14, IegHb-c, Reproduced with
permission from A, W. Addison and S. Burman, Biochim. Biophys. Acta 828 (1985), 362-368.
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as how cooperativity might, or might not, work at the molecular level. 112,113
The mechanism of cooperativity has also been probed by the substitution of
other metalloporphyrins into the globin: for example, zinc porphyrins have been
used for their excited triplet-state properties,114 manganese porphyrins for their
EPR activity, 115 and ruthenium porphyrins as a member of the iron triad. 116
E. Other Ligands for Biological Oxygen Carriers
As noted above, a variety of other a-donor or 7T-acceptor ligands will bind to
the active sites of biological oxygen carriers.
1, Carbon monoxide
As documented in Table 4.2, carbon monoxide (CO) generally binds more
strongly to hemoglobin than does dioxygen, hence causing carbon-monoxide
poisoning. In addition to being readily available from car exhausts and tobacco
smoke to convert oxyhemoglobin to carbonmonoxyhemoglobin, CO is produced
in the catabolism of heme molecules. 1I7 Thus under even the most favorable of
conditions, about 3 percent of human hemoglobin is in the carbonmonoxy form.
When CO binds to a single metal atom in nonbiological systems, without excep-
tion it does so through the carbon atom and in a linear manner: 56
Fe-C=O <-- Fell +-C=O+ (4.40)
Model systems for carbonmonoxy (also called carbonyl) hemoglobin show
a geometry similar to that of the Fe-C == 0 group, linear or nearly so and
essentially perpendicular to the porphyrin plane. I 10,118-121 The biochemical lit-
erature is littered with reports that this is not the geometry adopted by CO in
binding to hemoglobins. 122-128 We will return to this topic later in this chapter,
since the physiological consequences are potentially important.
Carbon monoxide binds weakly as a a-donor ligand to four-coordinate co-
balt(II) systems. 129 Despite a bout of artifactual excitement,130 CO has never
been observed to bind significantly to five-coordinate COIl systems with a nitro-
genous axial base to yield octahedral six-coordinate species. 131 The sulfur ana-
logue thiocarbonyl (CS), although not stable as a free entity, binds very strongly
to iron-porphyrin species in a linear manner. 132
2. Nitric oxide
Nitric oxide (NO) binds to hemes even more strongly than CO (and hence
O2),10 so strongly, in fact, that the Fe-N1m bond is very weak and easily
ruptured. II ,III,133 Attachment to the metal is via the nitrogen atom; however,
the geometry of attachment is sensitive to the 7T basicity of the metallopor-
phyrin, and ranges from linear to strongly bent. In binding to COlI the NO
ligand is effectively reduced to NO -, with concomitant oxidation of COIl to
Co III: III
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0
,;;::0 ,;;::0III ;{40 ;(20N N N (4.41)I I I
N=O· Mn Fe Co
v(N-O): 1860 cm- 1 1740 cm- 1 1625 cm- 1 1689 cm- 1
In much the same way that cobalt-dioxygen systems are paramagnetic (5 = t)
and amenable to EPR studies, iron-nitric oxide (also called iron nitrosyl) species
are also paramagnetic and isoelectronic with cobalt-dioxygen species. The un-
paired spin is localized mostly on the NO group.
3. Isocyanide and nitroso species
In contrast to the dioxygen, carbon-monoxide, and nitric-oxide ligands, the
isocyanide and nitroso functions bear an organic tail. Moreover, nitroso ligands
are isoelectronic with dioxygen.
(4.42)R = alkyl or aryl,R N=C R - N~ R = aryl, alkyl
o
Thus, in principle, not only may the steric bulk of the ligand be varied, in order
to probe the dimensions 35 of the dioxygen-binding pocket,* but also the (j-
donor/7T-acceptor properties of the ligands may be varied by appropriate substit-
uents on the aryl ring.
Isocyanide groups may bind to metals in a variety of ways. For 1: I adducts
(Figure 4.19), the isocyanide group is approximately linear, although some flex-
ibility seems to exist in a bis(t-butylisocyanide)iron(Il)tetraphenylporphyrinato
complex. 135 For zerovalent metals with much electron density available for do-
t-Bu
I
N
III
C
~
C
III
N
I
t-Bu
R
/
N
II
C
II
Feo[CN-R14
Figure 4.19
Modes of coordination of isocyanide
and nitroso species.
N-RO~
I
M
R
/O-N
\/
M
* In fact, this classic experiment of 51. George and Pauling established, for the first time and before any
crystallographic data were available, that the heme group and the ligand-binding site in hemoglobin reside at
least partway inside the protein, rather than on the surface. 134
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nation into ligand 77"* orbitals, the isocyanide ligand has been observed to bend
at the N atom. 136 One prediction exists that an isocyanide ligand binds in this
manner to hemoglobin. 137
For 1: 1 adducts of nitroso ligands, side-on, 138 0-, and N-ligated modes are
possible (Figure 4.19). No O-nitroso complexes have been definitively charac-
terized by diffraction methods. For hemoglobin the N-nitroso mode is likely,
since this is the mode found for the nitrosoalkane in Fe(TPP)(amine)(RNO).139
To date isocyanide ligands have not achieved their potential as probes of
the geometry of the ligand-binding pocket in hemoglobin, partly because we
lack structural data on the preferred geometry of attachment of these ligands in
a sterically uncongested environment.
F. Nature of the Metal-Dioxygen Linkage in Biological Systems
Many techniques have been used to probe the geometry and electronic structure
of the metal-dioxygen moiety in biological systems and in synthetic models.
The results form the basis of any understanding of the factors that determine
and modulate oxygen affinity.
1. Oxyhemocyanin and oxyhemerythrin
By resonance Raman techniques, the 0-0 stretch is observed at 744 cm -1
in oxyhemocycanin and at 844 cm -1 in oxyhemerythrin.140-142 Dioxygen is
therefore coordinated as peroxo species. By use of unsymmetrically labeled
dioxygen, 180_ 160, it was established that dioxygen coordinates symmetri-
cally: 141
or
o
,, / "'-Cu "'- Cu"
0/
or
/Ol~Cu" Cu"
~/
o
(4.43)
Carbon monoxide binds to only one of the CUi centers in deoxyhemocyanin,
through the C atom, * apparently blocking the second Cu I siteY Similar behav-
ior is also seen for the nitrosyl adduct.
On the other hand, in an experiment parallel to that just described for hem-
ocyanin, dioxygen was found to bind asymmetrically in oxyhemerythrin: 142
O(H)
I
o
Fe'" / '" Fe'" or
(H)O",
o
I
Fe"' .... Fe'"
(4.44)
* A report 143 that CO binds to the copper center through the 0 atom, an unprecedented mode, has been
challenged. 144
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From single-crystal UV-visible spectroscopy with polarized radiation, an
Fe ... Fe-02 angle of approximately 90° was inferred, which is inconsistent
with the bridging f.L-1, l-(hydro)peroxo geometry. 145 Subsequently, this conclu-
sion was confirmed in a single-crystal x-ray diffraction study of oxyhemerythrin
that revealed, among other things, end-on coordination of dioxygen to only one
iron center (see Figure 4.13).45 This mode of dioxygen coordination remains
unobserved to date in small-molecule synthetic systems. The Orbinding process
is formally very similar to the combinations of Reactions (4.29a) and (4.29b),
except that dioxygen attaches to only one Fe center (bridging carboxylato groups
omitted in Reaction 4.45):
OH
Fe"/ "Fell + O
2
( )
HO"
° °Fe"l/ "~elll (4.45)
The existence and location of the proton, which cannot be proven in the
crystal structure of deoxyhemerythrin or of oxyhemerythrin, are inferred from a
model system for the former that contains a hydroxo group bridging two high-
spin, weakly antiferromagnetically coupled Fell centers (J = - 10 cm -1).88
For oxyhemerythrin (and for one conformation of methydroxohemerythrin), a
small change in the position of the symmetric Fe-O-Fe mode is observed
when H20 is replaced by D20. 146 The strong antiferromagnetic coupling ob-
served for methemerythrin and oxyhemerythrin (-J ~ 100 cm 1) 147 is uniquely
consistent with a bridging oxo moiety between a pair of Fe III centers. 80 Finally,
a Bohr effect (release or uptake of protons) is absent in oxygen binding to
hemerythrin. 16, 18 These observations are consistent with a f.L-oxo group slightly
perturbed by hydrogen bonding to a coordinated hydroperoxo species. An im-
portant role for the protein in hemerythrin is to assemble an asymmetric di-
iron(II) species. Only a few of the myriad of known f.L-oxodiiron(III) complexes
are asymmetric, 81 and the synthesis of realistic asymmetric models remains a
challenge.
Deoxyhemocyanin (CUI d 10) and deoxyhemerythrin (Fell d6) are colorless.
In the oxygenated derivatives there is considerable charge transfer between the
coordinated peroxo groups and the metal centers. This phenomenon makes the
essentially d-d metal transitions more intense than those for the simple aquated
Fe3+ or Cu 2+ ions, and permits facile measurement of oxygen-binding curves.
The spectral changes accompanying oxygenation are shown in Figures 4.20 and
4.21. 5
Nitric oxide binds to deoxyhemocyanin, to deoxyhemerythrin, and to the
mixed valence Felli ... Fell semimethemerythrin. 148 Carbon monoxide binds
to neither form of hemerythrin: apparently the other ligands have insufficiently
strong fields to stabilize the low-spin state for which electron density would be
available for back donation into the CO 7T* orbitals.
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Spectral changes accompanying oxygenation of hemocyanin:
deoxyhemocyanin (---); oxyhemocyanin ( ).5 Reproduced
with permission from A. G. Sykes, in A. G. Sykes, ed.,
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Spectral ehanges accompanying oxygenation of hemerythrin. 5
Reprodueed with permission from A. G. Sykes, in A. G. Sykes,
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2. Oxyhemoglobin
The 0-0 stretch that is observed by difference infrared techniques at around
1105 cm - I for oxyhemoglobin and oxymyoglobin ]49 clearly categorizes the
dioxygen moiety as a superoxo species; that is, the order of the 0-0 bond is
about 1.5. Considerable ink has been spilled about the nature of the Fe-02
fragment since Pauling's original suggestion 150 in 1948 that dioxygen binds to
iron in an end-on bent fashion:
o
/
Fe-O (4.46)
He subsequently reaffirmed this geometry, and proposed that hydrogen bonding
between the coordinated dioxygen and the distal imidazole H- N group was
important in stabilizing the Fe-02 species. 137 In an alternative model Weiss
proposed that a low-spin Fe III center (5 = !) was very strongly antiferromag-
netically coupled to a superoxide anion radical (5 = !).151 A triangular peroxo
mode has also been advanced. 152,153 The problem has been how to resolve the
observed diamagnetism of oxyhemoglobin 92,98 with UV-visible, x-ray absorp-
tion, and resonance Raman spectroscopic characteristics 154 that are distinctly
different from those of Fell systems (such as carbonmonoxyhemoglobin and low-
spin six-coordinated hemochromes, such as Fe(Porph)(Pyh) and from unambig-
uously Fe III systems (such as chloromethemoglobin or cyanomethemoglobin).
Any adequate theoretical treatment must also explain how iron-porphyrin
systems can bind not only O2, but also CO, NO, alkyl isocyanides, and alkyl-
nitroso moieties. A simple qualitative model presented by Wayland and
coworkers 129,155 conveniently summarizes ligand-binding geometries of cobalt
and iron porphyrins. Although a reasonable quantitative theoretical consensus
exists for 1: 1 cobalt-dioxygen species, the same cannot be said yet for iron-
dioxygen systems.
3. A simple model for the electronic structure of Iiganded
hemoglobins
Why does dioxygen bind to iron and cobalt porphyrins in an end-on bent-
bond fashion as in (4.37) and (4.46)? Why does carbon monoxide bind in a
linear manner (Equation 4.40)? Why are six-coordinate dioxygen and carbon-
monoxide adducts more stable than five-coordinate ones? A unified picture of
ligand binding that addresses these questions is important in understanding prop-
erly the specific case of dioxygen binding to hemoglobin and related systems.
The splitting of the metal d orbitals for a four-coordinate metalloporphyrin
is shown in the center of Figure 4.22. These orbitals contain some porphyrin
character and are antibonding with respect to metal-porphyrin bonds. As shown
in Figure 4.16, the primary effect of a single a-donor axial ligand, such as
pyridine or 1-methylimidazole, is to elevate the energy of the antibonding dz2
and lower the energy of the dx 2 _ y2 orbital and hence lead to a high-spin species
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in place of the intermediate-spin four-coordinate one. Thus, for simplicity in
highlighting interaction of the metal center with the diatomic o--donor: 7T-acid
ligands CO, NO, and O2 , the perturbations wrought by primarily o--donor li-
gands, such as 1-methylimidazole, are omitted. For the corresponding cobalt(II)
compound, there is an additional electron. The diatomic ligands of interest share
a qualitatively similar molecular orbital scheme. The filling of orbitals for CO
is shown on the left-hand side. Dioxygen, which is shown on the right-hand
side, has two more electrons than CO; these occupy the doubly degenerate 7T*
orbitals. Quantitative calculations show that the energy of the 7T* orbitals de-
creases monotonically from CO to NO to O2 , indicating increasing ease of re-
duction of the coordinated molecule, a feature that has not been included in the
diagram. Only those interactions of molecular orbitals that have appropriate
symmetry and energy to interact significantly with the metal d orbitals are shown.
Two extremes are shown in Figure 4.22 for the interaction of a diatomic
molecule A-B with the metal center: a linear geometry on the left and a bent
geometry on the right. A side-on geometry is omitted for the binding of O2 to
a COIl or Fell porphyrin, since this would lead to either an MIll side-on superoxo
or an M 1V peroxo species; both these modes of coordination to these metals are
currently without precedent.
Linear diatomic metal bonding maximizes the metal-d7T to ligand-p7T* bond-
ing. When a ligand coordinates in a bent manner, axial symmetry is destroyed,
and the degeneracy of the ligand P7T* orbitals is lifted. One P7T* orbital is now
oriented to combine with the metal dz2 orbital to form a 0- bond, and the other
is oriented to combine with dxz and dyz orbitals to form a 7T bond. A bent ge-
ometry for the diatomic molecule will result when either or both of the metal
dz2 or the ligand P7T* orbitals are occupied, since this geometry stabilizes the
occupied dz2 orbital in the five-coordinate complex. Thus O2 binds in a strongly
bent manner to COIl and Fell porphyrins; NO binds in a strongly bent manner to
COIl porphyrins; CO binds in a linear fashion to Fell porphyrins.
The interaction of NO with Fell porphyrins and CO with COIl porphyrins-
the resultant species are formally isoelectronic-is more complicated. The de-
gree of bending seen in Fell(TPP)(NO) is midway between the two extremes. III
For CO the higher-energy P7T* orbitals lead to a greater mismatch in energy
between the dz2 and P7T* orbitals, and less effective 0- bonding. In EPR experi-
ments the odd electron is found to be localized in a molecular orbital with about
0.87 metal dz2 character for the five-coordinate Co-CO adduct, as expected
for a nearly linear geometry. 129 On the other hand, for the Fe-NO adduct the
metal dz2 character of the odd electron is about 0.4 to 0.5; 155 a somewhat bent
geometry (140°) is observed in the crystal structure of Fe(TPP)(NO). Because
the CO ligand is a very weak 0- donor, the Co-CO species exists only at low
temperatures.
Only qualitative deductions can be made from this model about the extent
of electron transfer, if any, from the metal onto the diatomic ligand, especially
for dioxygen. The higher in energy the metal dz2 orbital is with respect to the
dioxygen P7T* orbitals, the closer the superoxo ligand comes to being effectively
a coordinated superoxide anion. With an additional electron, the dioxygen li-
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A simple general model for ligand binding to metalloporphyrins: 129 AB = CO(17* 0), NO (17* 1),
O2(17*2); M=Co Il(d 7), Fe ll(d 6).
gand in Co-Oz complexes can acquire greater electron density than it can in
Fe-Oz complexes.
From the diagram it may be inferred that a ligand with very strong 7T-accep-
tor properties will lower the energy of the dxz and dyz orbitals through strong
(dw dyz)-7T* interaction. The resultant energy gap between these two orbitals
and the other three metal d orbitals may be sufficient to overcome the energy
involved in spin-pairing, and hence lead to five-coordinate low-spin species, as
happens for complexes containing phosphines and carbon monosulfide.99.13z
G. Role of the Protein in Effecting Biological Oxygen Transport
In our survey of the dioxygen chemistry of iron and copper species in earlier
subsections, three general functions for the protein matrix became apparent: pro-
vision of ligand(s) in an appropriate stereochemistry; protection of the metal-
dioxygen moiety from oxidation and competitive ligands; and modulation of
dioxygen affinity through nonbonded interactions with distal groups.
1. Provision of ligands to the metal
In the hemoglobin family the heme group is anchored in a cleft in the globin
chain by an imidazole ligand from a histidine residue (the proximal histidine).
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The other (distal) side of the heme plane is more or less open to accommodate
a small sixth ligand (see Figure 4.2).
For hemerythrin and hemocyanin the requirements of the protein chain are
more severe. In contrast to the hemoglobin family, all but two of the ligands
are provided by the protein chain, and in addition the metal ions are encapsu-
lated as a pair. The exogenous ligands for hemerythrin are a fL-(hydr)oxo moiety
and dioxygen or anions (depending on oxidation state); for hemocyanin, the
identity of the second exogenous ligand, if there is one at all, is still unclear.
Although hemerythrin has a distinctive cofacial bioctahedral structure (Figure
4.10)46-48 that would appear to be very difficult to assemble in the absence of
the protein, it turns out that with a variety of tridentate ligands the (fL-OXO)bis(fL-
carboxylato)diiron(III) core may be assembled rather easily.82,156,157 Thus, this
core appears to be a thermodynamically very stable structural motif. Such a
synthesis has been termed "self-assembly" and appears to be a common phe-
nomenon in biological systems. 158 The low-temperature assembly of bis-cop-
per(II)-fL-peroxo complexes (models for oxyhemocyanin) from mononuclear
copper(l) compounds provides other examples of this phenomenon. 103f,g
2. Protection of the metal-dioxygen moiety
The immobilization of the heme group inside the protein prevents (i) the
bimolecular contact of an Fe02 species with an Fell species (Reaction 4.29b),
the key step in the irreversible oxidation of Fe II porphyrins; (ii) the facile access
of nucleophiles that would cause autoxidation (Reactions 4.30 and 4.31); (iii)
the oxygenase activity (Reaction 4.32) that is the normal function of other hem-
oproteins, such as cytochrome P-450, horseradish peroxidase, catalase, etc.; and
(iv) the self-oxygenase activity that has been observed in some iron(II) systems
that bind dioxygen, activating it for destruction of the ligand itself. Avoiding
these last two fates also appears to be very important in the active site of hem-
ocyanin. Finally (v), the globin chain serves to restrain the binding of the distal
histidine to give a six-coordinate hemochrome (Reaction 4.33), at least at room
temperature. 159 Thus, unoxygenated hemoglobin is held in a five-coordinate state,
allowing a rapid rate of oxygen binding and greater oxygen affinity-hemo-
chromes such as Fe(TPP)(Py)z are impervious to oxygenation and subsequent
oxidation.
3. Modulation of ligand-binding properties
The protein chain in hemoglobin may place restraints on the iron-to-proxi-
mal histidine bond. On the other side of the heme, the distal histidine and oc-
cluded water molecules may hydrogen-bond to the coordinated dioxygen and
force ligands to adopt geometries that are different from those observed in the
absence of steric hindrances. The conformation of the porphyrin skeleton may
also be perturbed by the protein chain. Clearly, it is the protein chain that be-
stows the property of cooperativity on oligomeric oxygen carriers.
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H. Requirements for a Model System for Hemoglobin
For hemoglobin, the majority of ligands around the iron center are provided by
a fairly rigid macrocycle, the protoporphyrin IX dianion (Figure 4.1), that by
itself enforces a square-planar stereochemistry. Thus, the task of assembling
synthetic analogues of the active site in hemoglobin is simplified. Essentially,
any square-planar, tetradentate ligand containing at least a couple of nitrogen
atoms will suffice: to this end a variety of other porphyrins have been used, as
well as Schiff-base and non-porphyrinato nitrogen-containing macrocycles that
serve to delineate the role of the porphyrin in dioxygen binding. Tetraphenyl-
porphyrin, in place of the naturally occurring porphyrins, has served as the basis
of numerous model systems. It is easily synthesized and derivatized (see below).
Its fourfold symmetry precludes formation of chemical isomers that may arise
if substitution on the asymmetric, naturally occurring porphyrins is attempted.
Moreover, its derivatives can be crystallized. Finally, with the porphyrin meso
positions occupied by phenyl groups, the molecule is less susceptible to pho-
toinduced oxidation.
In order to obtain five-coordinate species, putative models for a deoxy
hemoglobin, access to one side of the porphyrin must be blocked to the coor-
dination of a second axial base (Reaction 4.33), but still must be accessible for
the binding of small molecules (02 , NO, CO, etc). Or second, an axial base
may be attached covalently to the porphyrin, to give so-called "tail-under" or
"chelated" porphyrins. Here the chelate effect ensures an effectively 100 per-
cent five-coordinate complex with only a 1: I stoichiometric ratio of axial base
to porphyrin. These two approaches are illustrated in Figure 4.14. A third means
is to incorporate a sterically bulky substituent in the 2-position of the base, such
as a methyl group, to give 2-methylimidazole (4.34). The formation of the hem-
ochrome Fe(porph)(2-MeImh, where the iron atom is in the center of the por-
phyrin ring, is strongly disfavored relative to the l-methylimidazole analogue,
because the 2-methyl substituents clash with the porphyrin ring. The axial base
needs to be a strong a donor, such as imidazole or pyridine, in order to increase
affinity at the iron (or cobalt) center for dioxygen (Figure 4.18).
Steric hindrance on one side, or on both, provides a pocket for small mol-
ecules to bind and, for O2 , prevents the bimolecular contact of two iron(II)-
porphyrinato species that would lead to irreversible oxidation (Reaction 4.29).
A picturesque collection of substituted porphyrins has been synthesized. Some
of these are illustrated in Figure 4.23. 31 ,72,160-164 The only system that has led
to crystalline dioxygen complexes stable at room temperature is the "picket-
fence" porphyrin. 72* A derivative of this, the "pocket" porphyrin,165 and var-
~~-~-~~-
* The pivalamido pickets (-NH-CO-C(CH3h) of the picket-fence porphyrin are sufficiently bulky
that their free rotation is sterically hindered. Thus the various atropisomers-aaaa, aaaf3, af3aa, aaf3f3,
where a denotes picket "up" and f3 denotes picket "down"--can be separated chromatographically on the
basis of their different polarities. The tail-under picket-fence porphyrin is derived from the aaaf3 atropiso-
mer. 72
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ious "capped" porphyrins,166 provide binding sites with steric hindrance even
to small diatomic molecules.
In the next section the structures of various derivatives of hemoglobin and
its models are presented, and the relationship of structure to ligand-binding
properties is examined. Although there is now a wealth of thermodynamic data
available from model systems, attention is focused primarily on those for which
structural data are also available.
III. STRUCTURAL BASIS OF LIGAND AFFINITIES
OF OXYGEN CARRIERS
The interaction of ligands, such as dioxygen, with metal complexes, such as
iron-porphyrinato systems, and the means by which this interaction is character-
ized, have been covered in broad outline in the previous sections. As noted
earlier, the affinities of hemoglobins for carbon monoxide and dioxygen span a
wide range (see Table 4.2 and Figure 4.24). In this section the active site is
examined in much finer detail than before in order to develop relationships be-
tween perturbations in structure and affinity (and hence function)-so called
structure-function relationships. The reference point is the somewhat hypotheti-
cal situation where the dioxygen binder is in the gas phase and independent of
interactions with solvent molecules, solute molecules, and itself, and where
dioxygen, carbon monoxide, and other small molecules may bind without steric
constraints-in other words, a state where intrinsic affinity is measured. In this
section attention is focused exclusively on the hemoglobin family and on iron-
and cobalt-porphyrinato systems. In recent years structural data on hemoglobin,
myoglobin, and their derivatives have become available with a precision that
permits meaningful comparison with the more precisely determined model or
synthetic systems. In addition, the various hemoglobins and myoglobins, and
especially the naturally occurring mutants of hemoglobin A (human Hb), have
provided a sort of poor man's site-directed mutagenesis. Now the techniques of
molecular biology permit the site of mutation to be selected, the altered gene to
be inserted into E. coli, and the mutant protein to be expressed in large (mg)
quantities. With the conditions for crystallization of hemoglobins now well-es-
tablished, we can discover quite rapidly what structural perturbations are caused
by the substitution of one amino acid for another, and can relate these to the
perturbations in properties, such as cooperativity, dioxygen affinity, and kinetics
of ligand binding.
The principles enunciated here are applicable generally to hemerythrin and
hemocyanin; however, we currently lack the thermodynamic and especially
structural data we would like to have for these systems.
Figure 4.23 (facing page)
A selection of synthetic porphyrins used to probe the dioxygen-binding process.
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A. Ligand Affinities in Hemoglobins and Their Models
The O2 affinities in biological carriers span five orders of magnitude, which at
room temperature corresponds to a difference in the free energy of oxygen bind-
ing
(4.47)
of about 6.0 kcallmol. This wide range of O2 and CO affinities has not yet been
paralleled in synthetic systems; the values for O2 affinity do not exceed those
for R-state human hemoglobin. A selection of values from model systems is
given in Table 4.5. 23 ,31,160-]65 For the flat-open porphyrin system (Figure 4.23)
the dioxygen ostensibly binds in an unconstrained manner, but is actually sub-
ject to solvent influences. In order to obtain thermodynamic constants on these
"unhindered" systems, one must gather data at several low temperatures and
then extrapolate to room temperature, or obtain them from kinetic measure-
ments, K = kon/koff, at room temperature.
For the picket-fence porphyrins, dioxygen binds in a protected pocket that
is deep enough to accommodate it and to prevent the dimerization that leads to
irreversible oxidation, provided that there is a slight excess of base to ensure
full saturation of the coordination sites on the unprotected face of the por-
phyrin. 72 Thus the picket-fence, the capped, and the bis-pocket porphyrins re-
versibly bind dioxygen at room temperature with little oxidation over many cy-
cles. This stability facilitated isolation of crystals of a synthetic iron-dioxygen
species of the picket-fence porphyrin. The capped porphyrin offers a more highly
protected site. The low affinity these latter systems have for dioxygen indicates
that the binding cavity is so small that repulsive steric interactions between
coordinated dioxygen and the cap are unavoidable. The left-hand side of Figure
4.24 depicts on a logarithmic scale the range of O2 affinities. Each power of 10
corresponds to around 1.2 kcallmol at 25°C.
The right-hand side of Figure 4.24 illustrates the range of affinities for CO
binding. For many synthetic systems the CO affinities are orders of magnitude
greater than in the biological systems that have an O2 affinity similar to the
synthetic; for example, see the entries for the picket-fence porphyrin. Compari-
son of the left- and right-hand sides of Figure 4.24 reveals that the strongest O2
binder, hemoglobin Ascaris, is one of the weakest CO binders. The O2 affinity
of the picket-fence porphyrins is very similar to that of myoglobin, but, as will
be detailed shortly, one cannot infer from this that the binding sites are strictly
comparable. Indeed, similar affinities have been observed with a non-porphyrin
iron complex. 121 ,162 Moreover, if the CO affinity of myoglobin paralleled that
of the picket-fence porphyrins, some 20 percent of myoglobin (and hemoglobin)
would be in the carbonmonoxy form (in contrast to the approximately 3 percent
that occurs naturally), a level that could render reading this section while chew-
ing gum physically taxing. 117
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Figure 4.24
CO and O2 affinities of a selection of hemoglobins and model systems. Affinities are given as
PIl2, and the scale is logarithmic. One order of magnitude corresponds to 1.2 kcallmol at 25°C.
Table 4.5
Thermodynamics and kinetics of ligand binding to synthetic oxygen carriers at 20-25°C.
Dioxygen binding Carbon-monoxide binding
P,dOl) !ill 6..5 kon k Off P,dCO) !ill 6..5 kon koff
Carrier Torr kcallmol eu J-LM- 1 S-I S - I Torr kcal/mol eu J-LM I s I S I
Toluene/benzene solvent
Picket fence, pocket
Fe(PF-Im) 0.58 - 16.3 -40 430 2,900 0.000022 36 0.0078
Fe(PF) (l, 2-Me2Im) 38 -14.3 -42 106 46,000 0.0089 1.4 0.14
Fe(Poc-PF) (l-MeIm) 0.36 - 2.2 9 0.0015 0.58 0.0086
Fe(Poc-PF) (l, 2-Mezlm) 12.6 -13.9 -28 1.9 280 0.067 0.098 0.055
Fe(Bis-Poc) (I, 2-Me2IIl1) 508 - 14.4 -47 - 0.0091
Cap
Fe(CzCap) (l-MeIm) 23 -10.5 -28 - - 0.0054 - 0.95 0.05
Fe(C2Cap) (l, 2-MezIIl1) 4,000 9.7 -36 - - 0.20
Strapped
Fe(7, 7-CP) (l, 5-CyzIIl1) 1.4 65 1,000 0.00091 - 6 0.05
Fe(6, 6-CP) (l, 5-CyzIIl1) 700 0.1 800 0.17 - 0.03 0.05
Flat open
Fe(PPIX-IIl1) 5.6 62 4,200 0.00025 - II 0.025
Bis-strapped
Fe(All1ide-1m) 0.29 310 620 0.000017 - 40 0.067
Fe(All1ide-Py) 2.0 360 5,000 0.00009 35 0.03
Fe(Ether-Py) 18 300 40,000 0.0001 68 0.069
H20, alkylammonium micelles, pH 7.3
Fe(PPIX-IIl1) 1.0 -14.0 ~3.5 26 4.7 0.002 -17.5 -34 3.6 0.009
Fe(MPIX-IIl1) 0.57 22 23 0.0013 - II 0.019
Fe(MPIX-Py) 12.2 I 380 0.0021 - 12 0.035
"When available Pli2 are from thermodynamic measurements, otherwise from kon/koff' where solubility of O2 in toluene is 1.02 x 10 5 M/
Torr and of CO in toluene is 1.05 x 10 -2; solubilities in benzene are very similar.
b Some kaff are calculated from K(Ol), kon(CO), and M.
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There is a convenient index to summarize the extent to which CO (or O2)
binding is discriminated against for a given iron-porphyrin system. M is defined
as the ratio of O2 affinity (as P1/2) to CO affinity for a particular system and
experimental conditions:
(4.48)
From Figure 4.24 and from Tables 4.2 and 4.5 the M values calculated may be
somewhat arbitrarily divided into three classes: those where M > 2 X 10 4 (good
CO binder); those where 2 x 10 2 < M < 2 X 104 ; and those where
M < 2 X 10 2 (good O2 binder). An analogous parameter, N, may be defined
to summarize the differences in the O2 affinity between an iron-porphyrin sys-
tem and its cobalt analogue:
(4.49)
For the picket-fence porphyrins and for vertebrate hemoglobins N is in the range
10 to 250, whereas for the flat-open porphyrins and for some hemoglobins that
lack a distal histidine (e.g., hemoglobin Glycera and hemoglobin Aplysia) , N is
at least an order of magnitude larger, indicating for these latter species that the
cobalt analogue binds O2 relatively poorly 167,168 (see Table 4.6).
Note that whereas the O2 binding of the picket-fence porphyrins is similar
to that for myoglobin, the kinetics of the process are very different; the synthetic
system is more than an order of magnitude faster in kl and k_ 1 (often also
referred to as kon and koff)' On the other hand, O2 binding to the pocket por-
phyrin is similar to that for the biological system. The factors by which ligand
affinities are modulated, generally to the benefit of the organism, are subtle and
varied, and their elucidation requires the precise structural information that is
currently available only from x-ray diffraction experiments. Figure 4.25 shows
the structural features of interest that will be elaborated upon in the next subsec-
tions. 110 ,169
B. General Structural Features that Modulate Ligand Affinity
There are many ways in which ligand affinity may be perturbed (Figure 4.25).
It is convenient to divide these into two groups, referred to as distal and proxi-
mal effects. 163 Proximal effects are associated with the stereochemistry of the
metalloporphyrinato moiety and the coordination of the axial base, and thus
their influence on O2 and CO affinity is indirect. Distal effects pertain to non-
covalent interactions of the metal-porphyrinato skeleton and the sixth ligand
(02 , CO, etc.) with neighboring solvent molecules, with substituents, such as
pickets or caps, on the porphyrin, and with the surrounding protein chain. The
distal groups that hover over the Orbinding site engender the most important
Table 4.6
Relative affinities (M) of iron-porphyrinato systems for O2 and CO, and relative affinities (N) for O2 of iron and
cobalt-porphyrinato systems.
P,dFe-CO) PI/2(Fe-0 2) M PI/2(Co-02 ) N
Compound Torr Torr P,dFe-0 2)IP,nCFe-CO) Torr P,nCCo-02)IPI/2CFe-0 2)
H 20, pH 7
Whale Mb 0.018 0.51 28 57 110
Whale Mb 0.0049 6.2 1,300
(E7His---3>Gly)
Aplysia Mb 0.013 2.7 200 50 x CoMb >1,000
Glycera Mb 0.00089 5.2 5,800 50 x CoMb >1,000
Fe(PPIX-Im) 0.002 1.0 500
Toluene/Benzene
Fe(PF-Im)/
Co(PF) (I-Melm) 0.000022 0.58 27,000 140 240
M(PF)(I, 2-Me2Im) 0.0089 38 4,300 900 24
M(Bis-Poc)-
(I, 2-Me2Im) 0.0091 508 55,800
Fe(PPIX-Im)/
Co(PPIX) (I-Melm) 0.00025 5.6 22,000 18,000 3,200
M(CrCap)( I-Melm) 0.0054 23 4,200 140,000 6,100
distal
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N
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Structural parameters and features that determine the affinity of oxygen carriers.
distal effects. For convenience, the effects of crystal packing and the protein
matrix on porphyrin conformation will be discussed among the proximal effects,
although as nonbonded interactions they properly are distal effects.
To a first approximation, the effects of substituents on the porphyrin ring,
as transmitted through bonds to the metal center, do not perturb the ligand bind-
ing properties as much as do distal effects. 170 Thus substituents, such as vinyl
and propionic-acid groups on protoporphyrin IX and o-pivalamidophenyl pick-
ets, are ignored; one porphyrin is much like another. At the end of this subsec-
tion the various ways ligand affinity may be modulated will be summarized in
an augmented version of Figure 4.3.
1. Proximal effects
Few molecules have had their conformational properties characterized as
exhaustively as have metalloporphyrins.
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a. Porphyrin Conformation and M-Np Separations The cyclic aromatic 24-
atom porphyrinato skeleton offers a tightly constrained metal-binding site. The
conformation of least strain is planar, and the radius of the hole of the dianion
is close to 2.00 A,11O leading to metal-porphyrinato nitrogen-atom separations,
M-Np , of 2.00 A if the metal is centered in the square plane defined by the four
porphyrinato nitrogen atoms. Small deviations from planarity are generally ob-
served and attributed to crystal packing effects; large deviations may be induced
by bulky substituents on the porphyrin skeleton, especially at the meso posi-
tions, by the crystal matrix,6s or by the highly anisotropic protein matrix. The
2.00 A radius hole neatly accommodates low-spin (S = 0) and intermediate-
spin (S = 1) iron(II), low-spin (S = !) iron(III), and cobalt(II) and cobalt(III)
ions.9]* With few exceptions the metal is centered in or above the central hole
for mononuclear porphyrin species; only rarely do M-Np bonds show a signifi-
cant (though still small) scatter about their mean value.
b. M ... Porph Displacement For five-coordinate complexes the magni-
tude of the displacement of the metal from the plane of the four nitrogen atoms,
M ... porph, is a consequence of the electronic configuration of MLs com-
plexes. Of course, the effect is augmented if the 3dx2- y 2 orbital (directed along
M-Np bonds, Figure 4.16) is occupied. Compare a displacement of 0.14 A for
Co(TPP)(1,2-Me2Im) (no 3dx2-v2 occupancy)]]] with 0.43 A for Fe(PF)(2-MeIm)
(3dx2- v2 occupied). 169 For six-c~ordinate complexes where the two axial ligands,
L1 and L2, are different, the M . . . porph displacement usually reflects relative
trans influences.
Generally, displacement of the metal from the plane of the porphyrinato-
nitrogen atoms is within 0.04 A of the displacement from the 24-atom mean
plane of the entire porphyrin skeleton. On occasions this second displacement
may be much larger, for example in Fe(TPP)(2-MeIm), where it is 0.15 A largerllO
than it is for Fe(PF)(2-MeIm). This effect is called doming, and it is usually
attributed to crystal packing forces. Interaction of the porphyrin with protein
side chains leads to considerable doming or folding of the heme in vertebrate
hemoglobins.
c. M-L Separations The metal-axial ligand separations, M-L (when more
than one, L] denotes the heterocyclic axial base), are dependent on the nature
of the ligand, L. When L1and L2 are different, the M-L separations are sensitive
to the relative trans influences of L1 and L2 as well as to steric factors. For
* In order to accommodate smaller ions, such as nickel(II), the porphyrin skeleton may contract by ruf-
fling, with little loss of aromaticity; like a pleated skirt the pyrrole rings rotate alternately clockwise and
counterclockwise about their respective M-Np vectors. This distortion leaves the four porphyrinato nitrogen
atoms, Np , still coplanar, Alternatively, the porphyrin skeleton may buckle to give a saddle conformation; the
Np atoms may acquire a small tetrahedral distortion in this process. M-Np bonds as short as 1.92 Ahave been
observed. Metals with one or two electrons in their 3dx2 _ y2 orbital have a radius larger than 2.00 A. In order
to accommodate them in the plane of the porphyrin, the porphyrin skeleton expands. M-Np separations as long
as 2.07 A may occur with the metal still centered in the plane of the Np atoms. 110
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example, for Fe(TPP)(l-Melmh, the Fe-N1m bond length is 2.016(5) A,IIO
whereas for Fe(TPP)(l-Melm)(NO) it is 2.180(4) A.ll1 For sterically active li-
gands, such as 2-methylimidazole compared to I-methylimidazole (4.34), the
longer Co-N1m bond occurs for the 2-Melm ligand because of steric clash
between the 2-methyl group and the porphyrin. III
It is possible that combinations of intrinsic bonding and steric factors may
give rise to a double minimum and two accessible axial ligand conformations
(see Figure 4.26). This situation seems to occur in the solid state for Fe(PF)(2-
/0
°11.90 A
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Figure 4.26
Two arrangements of axial ligands. The right-hand side features
a short L2 and long L I; the left-hand side the opposite.
Melm)(02)' EtOH, where a short Fe-N1m and a long Fe-O bond are ob-
served both from the structure revealed by single-crystal x-ray diffraction meth-
ods and by EXAFS data. On the other hand, for solvate-free Fe(PF)(2-MeIm)(02)
and for Fe(PF)(l,2-Me2Im)(02)' the EXAFS patterns are interpreted in terms of
a short Fe-O and long Fe-1m bond.l?l
d. The Angle <P This parameter is the minimum angle that the plane of the
axial base (e.g., pyridine, substituted imidazole, etc.) makes with a plane de-
fined by the Np , M, and L l atoms (Figure 4.25).65 If there are two axial ligands,
e.g., l-methylimidazole and O2, then, as before, the angle the axial base makes
is denoted <PI and the other angle <P2. For a linear CO ligand bound perpendic-
ularly to the porphyrin plane, <P2 is undefined. Note that the orientation of the
second ligand is influenced by distal effects.
When <P = 0, the axial base eclipses a pair of M-Np bonds; contacts with
the porphyrin are maximized. When <p = 45°, contacts are minimized. Unless
the axial base has a 2-substituent, however, the contacts are not excessively
close for any value of <p. With a 2-methyl substituent, the contacts are suffi-
ciently severe that the M-NL1 vector is no longer perpendicular to the porphyrin
plane, and the imidazole group is rotated so that the M-NL1 vector no longer
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approximately bisects the imidazole C-N-C bond angle, as illustrated III
Figure 4.25. 110,172
2. Distal effects
Distal effects arise from noncovalent interactions of the coordinated dioxy-
gen, carbon monoxide, or other ligand with its surroundings. The protein ma-
trix, the pickets, and the caps are functionally equivalent to an anisotropic sol-
vent matrix that contains a variety of solutes. The limits of this simplification
are illustrated in the following example. The electronically similar cobalt meso-,
deutero-, and protoporphyrin IX complexes bind dioxygen with similar affinities
under identical solvent conditions. When they are embedded in globin, larger
differences in affinity and changes in cooperativity are observed. 170 These ef-
fects are attributed to the slightly different nestling of the porphyrin molecules
in the cleft in hemoglobin or, in the generalization introduced, to slightly dif-
ferent solvation effects.
Interaction of the coordinated O2 or CO molecule with solvent molecules or
with the protein has a profound influence on kinetics and thermodynamics (see
Figure 4.24, and Tables 4.2 and 4.5). As discussed earlier, there is accumula-
tion of negative charge on the dioxygen ligand. The possibility then arises for
stabilization of coordination through hydrogen bonding or dipolar interactions
with solute molecules,175 porphyrin substituents (such as amide groups in the
picket-fence porphyrins 176 and some species of strapped porphyrins 161), or with
protein residues* (such as histidine). 167.177-179
Destabilization of coordinated ligands and lowered affinity can result if the
coordinated ligand is unable, through steric clash, to achieve its optimum ster-
eochemistry or if the closest neighboring groups are electronegative, as are the
ether and ester linkages on capped porphyrins. 31 ,180 We will describe in detail
in the next subsection (III. C) the fascinating variety of means by which ligand
binding is modulated by distal amino-acid residues.
3. Approximate contributions of proximal and distal effects to ligand
affinity
Dissimilar systems may show similar affinities for a ligand as a result of a
different mix of the proximal and distal effects enumerated above. These effects
are not all of equal magnitude, and an attempt is made here to show the incre-
ment in free energy that occurs if the effect is manifest in the deoxy or liganded
state of Figure 4.3. Increasing the free energy of the deoxy state while holding
that of the liganded state constant leads to an increase in affinity. The reference
state is gaseous Fe(TPP)(I-Me1m). The magnitude and sign of these effects are
shown in Figure 4.27. For the coordination of alkylisocyanide molecules to
* For Glycera CoMb02 no change in EPR parameters occurs on substituting D20 for H20.!6S No hydrogen
bond between O2 and a distal group comparable in strength to that in whale CoMb02 was inferred,
free
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Proximal and distal effects on the ligand affinities.
hemoglobin, the steric effects of different alkyl groups have been quantified. 35
Lowered affinity occurs with increasing alkyl chain length, with the exception
of methyl isocyanide.
C. Detailed Structures of Hemoglobins and Model Systems
With thermodynamic background and general structural features relevant to li-
gand affinity enumerated, attention may now be turned to the detailed structural
aspects of the active site and its surroundings. As was shown crudely in Figure
4.3, the ligand affinity of an iron porphyrin may be perturbed either by modu-
lating the structure of the deoxy material or by modulating the structure and
surroundings of the liganded material or both. The model systems provide the
reference points against which the protein structures may be compared.
1. Structures relevant to deoxy hemoglobins
The structure of the picket-fence porphyrin compound, Fe(PF)(2-MeIm), is
shown in Figure 4.28. 172 Minus the pickets, it is essentially a magnified view
of the active site of deoxymyoglobin, shown in Figure 4.29. 181 Some metrical
details of these structures, of a very similar unsubstituted tetraphenylpor-
phyrin, I 10 and of several other deoxyhemoglobins I Ie, 182-185 are listed in Table
4.7. In general they are all similar, but important differences exist.
In all structures, except deoxyerythrocruorin,183 the iron atom is displaced
about 0.4 to 0.5 Afrom the plane of the porphyrin toward the axial base. For
deoxyerythrocruorin the displacement is less than half this, perhaps because the
water molecule is weakly coordinated to the iron center.
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Figure 4.28(A) ,,,,,,OO'ag,,'''' of th< ,wetu", of P<lPFll2-M,\n»'"
(B) Structure of Fe(PF)(I_Melm)(Oz)' \81
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Figure 4.29
Structure of metmyoglobin and deoxymyoglobin at 2.0 Aresolution near the heme. \8\a Solid
bonds are for metmyoglobin; open bonds for deoxymyoglobin. Note the water molecule coordi-
nated to the iron center and hydrogen bonded to the distal imidazole group in metmyoglobin.
Reproduced with permission from T. Takano, J. Mol. Biol. 110 (1977), 569-584.
An imidazole group from a histidine residue-the distal histidine E7 in po-
sition 7 on helix labeled E-hovers over the binding site for most vertebrate
hemoglobins, except for genetically engineered mutants of human hemoglobin
(j3E7His -? Gly), pathological mutant hemoglobins, such as hemoglobin Zurich
(j3E7His -? Arg), and some others, such as elephant hemoglobin. Long be-
lieved to be noncoordinating, this distal histidine may, in fact, coordinate weakly
to the Fe center at low temperature. 159 In the a chains of human deoxyhemoglo-
Table 4.7
Metrical details of deoxyhemoglobins and their models a
Resol. Fe;Np Fe ... Porp DOl!Jing Fe-Nhn </> Tilt
Compound (;\) (A) (;\) (A) (;\) (deg) (deg)
Fe(PF)(2-Melm) 2.072(5) 0.43 0.03 2.095(6) 22.8 9.6
Fe(TPP)(2-Melm) 2.086(6) 0.40 0.13 2.161(5) 7.4 10.3
Mb 1.4 2.03(10) 0.42 0.08 2.22 19 11
Er' .. H2O 1.4 2.02 0.17 -0.06 2.25 7 3
HbA (a' .. H2O) 1.74 2.08(3) 0.40(5) 0.16(6) 2.16(6) 18(1 ) 12(2)
(f3) 2.05(3) 0.36(5) 0.10(6) 2.09(6) 24(1) 11(2)
CoHbb 2.5 0.14(5) 0.13 2.24(6)
Co(TPP)( I-Melm) 1.977(6) 0.13 0.01 2.157(3) 3.8 0
Co(TPP)(I, 2-Me2Im) 1.985(3) 0.15 0.05 2.216(2) 10
a See Figure 4.25 for definition of symbols.
b From a difference refinement of CoHb vs. Hb, where the difference in metal-to-porphyrin-plane separation was
0.24(2);\ and the difference in M-N1m was 0.13(4) A. Doming is similar to Hb.
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bin, hemoglobin A, a water molecule is found in the binding cavity. 182 For
many years the binding cavity has been referred to as the hydrophobic pocket-
literally, water-hating. Although many hydrophobic groups, such as valine, leu-
cine, isoleucine, and phenylalanine are positioned over the porphyrin, the im-
mediate environment around the binding site is, in fact, polar, with the distal
histidine and associated water molecules, as well as the heme group itself. As
will be shown in the next section, the label "hydrophobic pocket" becomes
more misleading when the interaction of coordinated ligands with distal groups
is examined.
The orientation of the axial base, angle 1>1, is similar for Fe(PF)(2-MeIm)
and for several vertebrate deoxyhemoglobins. On the other hand, Fe(TPP)(2-
Melm) and deoxyerythrocruorin have a similar eclipsed axial-base orientation.
At least for five-coordinate species, where the iron center is substantially out of
the porphyrin plane, orientation of the axial base does not invariably induce
structural perturbations, e.g., doming, in the porphyrin skeleton.
The conformation of the protein chain is such that the proximal histidine in
deoxyhemoglobin coordinates in a slightly tilted manner,182,186 comparable to
the tilt that the sterically active 2-methyl substituent induces in the synthetic
systems. 172 Clearly, coordination of the histidine to the heme in a symmetric
manner, as would be expected in the absence of the protein constraints, does
not produce the conformation of lowest free energy for the whole molecule.
2. Structures relevant to liganded hemoglobins
a. Stereochemistry of the Active Site Before the advent of techniques that
enabled the preparation and stabilization of oxyhemoglobin crystals, key infor-
mation on the probable structure of oxyhemoglobin and thence on the mecha-
nism of cooperativity was extrapolated from structures of methemoglobin
derivatives II and from various five- and six-coordinate cobalt-porphyrinato
complexes. llO,112,113 The structures of these met derivatives have proved to be
similar to that of oxyhemoglobin, at least in the stereochemistry of the metal-
loporphyrinato species and for the protein tertiary and quaternary structure as
well.
Tw<, synthetic iron-dioxygen adducts built from the picket-fence porphyrins
have been structurally characterized. 172 ,18? The high, effectively fourfold sym-
metry of the binding pocket in these systems results in fourfold disorder of the
angularly coordinated dioxygen molecule, and precludes the precise and accu-
rate measurements of the Fe-O-O angle and 0-0 separation that are grist
to the theoretical mills. * Figure 4.28B illustrates the stereochemistry for one
conformer. Subsequently, the structures of several dioxygen adducts of biolog-
* On the other hand, very precisely described mononuclear I: I cobalt-dioxygen complexes invariably
have been crystallized from dipolar aprotic solvents. Protic species, especially water, promote dimerization
and, additionally for iron systems, irreversible oxidation. Although several Co-02 structures with tetra-
dentate square-planar Schiff bases are very precisely known, the environment around the dioxygen bears little
resemblance to that in the quasibiological system, Co hemoglobin.
Figure 4.30
Molecular structure of Fe(TPP)(py)(CO), a
model for unhindered coordination of CO. 118
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ical oxygen carriers have been determined.183.188-191 Although the dioxygen moiety
is usually ordered, the precision is tantalizingly just less than that needed to
decide whether the apparently more-linear geometry seen for oxyerythrocruorin 183
and oxyhemoglobin 190 is significantly different from that for oxymyoglobin 188
and therefore attributable to the water molecule or imidazole that is hydrogen-
bonded to the coordinated dioxygen ligand. Nonetheless, several interesting dif-
ferences emerge.
The axial base in oxymyoglobin and oxyhemoglobin is almost eclipsed; that
is, </>1 = 0°. The axial base has moved from a tilted position in deoxyhemoglo-
bin to a symmetric one in oxyhemoglobin. In the absence of steric constraints,
the iron atom is essentially in the center of the porphyrin plane for Fe(PF)( 1-
MeIm)(02), oxymyoglobin, and oxyhemoglobin. For the 2-methyl analogue,
Fe(PF)(2-MeIm)(02), the iron remains significantly out of the plane, as also
appears to occur for oxyerythrocruorin.
In the structure of Fe(TPP)(Py)(CO), Figure 4.30, a model for carbonyl
hemoglobins, the iron atom is in the plane and the Fe-C == 0 bond is linear
and perpendicular, as expected. 118 Not so for carbonyl hemoglobins, where the
blob of electron density that is identified with the coordinated carbon monoxide
lies substantially off the normal to the porphyrin. We return to this point shortly.
In general, with the exception of the coordinated ligand, the structures of six-
coordinate low-spin hemoglobins, whether FeU or Fe III, are similar. Indeed, the
refined structures of oxy- and carbonmonoxyhemoglobin are superimposable within
experimental uncertainties, except in the immediate vicinity of the diatomic li-
gand. Some metrical details are given in Table 4.8. llc ,118,121.172.183,187,188,190-192
Table 4.8
Metrical details of selected liganded hemoglobins and their models a
Resol. Fe:Np Fe-pprph DOf!ling Fe-L, Fe-L2 Fe-XY 0, 02 Tilt
Compound A A A A A A deg. deg. deg. deg.
Dioxygen adducts
Fe(PF)(1- - 1.98(1) -0.03 0.02 2.07(2) 1.75(2) 131(2) 20 45 0
Melm)(02)
Fe(PF)(2- - 1.996(4) 0.09 0.02 2.107(4) 1.898(7) 129(1 ) 22 45 7
Melm)(02)
Mb02 1.6 1.95(6) 0.18(3) 0.01 2.07(6) 1.83(6) 115(4) 1 ~O 4
EXAFS 2.02(2) 2.06(2) 1.80(2) 123(4)
148(8?
Er02 1.4 2.04 0.38 -0.08 2.1 1.8 150 7 3
Hb02 a 2.1 1.99(5) 0.12(8) 0.04 1.94(9) 1.66(8) 153(7) 11 0 3
f3 1.96(6) -0.11(8) 0.11 2.07(9) 1.87(3) 159(12) 27 45 5
EXAFS 1.99(2) 2.05(2) 1.82(2) 122(4)
143(8)b
[a-Fe02Mf3-Feh a 2.1 2.04(4) 0.19(5) 0.17(5) 2.24(10) 1.82(4) 153(4) 6 11
f3 0.3 2.2
Carbonmonoxy adducts
MbCO 1.5 1.97(3) 0.00 0.03 2.2 1.9 140 30
EXAFS 2.01 (2) 2.20(2) 1.93(2) 127(4)
145(8) b
EreO 1.4 2.01 -0.11 -0.10 2.1 2.2 161 (9) 7
HbCO a 2.2 2.02 -0.10 1.95 1.83 175(15)
f3 2.03 0.10 2.20 1.70 171(15)
[a-Nil [f3-FeCO] a 2.6
f3 0.15 0.12 2.23(5)
Fe(TPP)(Py)(CO) 2.02(3) -0.02 -0.02 2.10(2) 1.77(2) 179(2) 45 ~O
EXAFS 2.02(2) - 2.09(2) 1.81 (2) 138(6)
180(II)b
Fe(poc)(1,2-Melm)(CO) 1.973(8) 0.001 2.079(5) 1.768(7) 172.5(6)
Fe(C2Cap)( 1-Melm)(CO) 1.990(7) 0.01 2.043(6) 1.742(7) 172.9(6)
1.988( 13) 0.02 2.041(5) 1.748(7) 175.9(6)
a See Figure 4.25 for definition of symbols.
b Alternative interpretation of EXAFS data.
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b. Interactions of Coordinated Ligands with Distal Groups Without ex-
ception to date (but see footnote 1 in Reference 168), in structurally character-
ized oxyhemoglobins, the coordinated dioxygen ligand is hydrogen-bonded to
the distal histidine or to a water molecule--even though theoretical calculations
show that hydrogen bonding would destabilize M-02 moieties. 192 This univer-
sal observation of hydrogen bonding in these biological systems is consistent
with notions that electron density accumulates on the dioxygen molecule upon
coordination. Given the errors associated with atomic positions (at best, ± 0.20 A)
the x-ray crystallographic evidence could be equivocal, since hydrogen atoms
on the distal imidazole are not observed. There are at least three lines of evi-
dence that support the existence of a specific O2 ... HN interaction. First, the
EPR spectrum of cobalt oxyhemoglobin indicates that the coordinated dioxygen
is hydrogen-bonded to something. 177- 179 Second, and more directly, in the neu-
tron-diffraction structure of oxymyoglobin,189 where hydrogen and especially
deuterium nuclides scatter strongly, the imino hydrogen or deuteron was located
on the nitrogen atom closest to the coordinated dioxygen, as illustrated in Figure
4.31A. In contrast, in the neutron-diffraction structure of carbonmonoxymy-
oglobin, the alternative imidazole tautomer was observed (Figure 4.3IB). 125,189
The absence of hydrogen bonding of the distal imidazole residue with the co-
ordinated CO molecule is consistent with other lines of evidence that there is
little accumulation of electron density on the carbonyl ligand. Third, but less
directly, genetically engineered mutants have been produced in which the distal
histidine has been replaced by glycine-sperm whale Mb E7His-....? Gly, and HbA
Q'E7His-....?Gly and HbA /3E7His-....?Gly.35b,192 For the myoglobin mutant, the O2
binding rate constant at room temperature increases by an order of magnitude,
but the dissociation rate constant increases by two orders of magnitude, leading
to a decrease in affinity of more than an order of magnitude, as derived from
kon/koff' This leads to an estimate of the free energy associated with hydrogen
bonding of
flG [
PlIi0 2)-Native] 15k IRTiog = . ca /mol.
P 1d 0 2)-Mutant
In addition, this mutant myoglobin autooxidizes rapidly compared to the native
one. On the other hand, the affinity for CO is greatly increased, leading to a
value of M for the mutant of 1300, compared to 16 for the native. Thus the
distal histidine stabilizes a coordinated O2 ligand by hydrogen bonding and des-
tabilizes a coordinated CO ligand by steric clash.
A similar discrimination is seen for the Q' chains of the hemoglobin mutant
in the binding of the fourth O2 or CO molecule. For the /3 chains little difference
is seen relative to the native protein: hydrogen bonding between the distal his-
tidine and the coordinated dioxygen ligand appears to be much weaker in /3
chains, as evidenced by longer N(H) ... 0 separations than those seen in the
Q' chains. Comparison of the crystal structures of the native and mutant
Q'2(/3E7His-....? GlYh structures reveals negligible changes in the distal environ-
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Figure 4.31
(A) The hydrogen bonding interaction between coordinated dioxygen and the distal histidine.
(B) The interaction of coordinated carbon monoxide and the distal histidine, showing the ab-
sence of hydrogen bonding. (C) Stereodiagram of a neutron-difference density map for oxymy-
oglobin. The refined structure showing the FeOz and distal histidine moieties is superimposed.
The imidazole deuterium atom is arrowed. 189 Reproduced with permission from S. E. V. Phil-
lips and B. P. Schoenborn, Nature 292 (1981), 81-82.
ment, except for that occasioned by the replacement of -CHZ-C3NzH3 (his-
tidine side chain) by -H (glycine side chain).
Studies of hemoglobin mutants where the nonpolar distal residue ,BValEll
(-CH(CH3h) is replaced by alanine (-CH3), isoleucine (-CH(CH3)CHzCH3),
and leucine (-CHzCH(CH3h) reveal that this valine offers steric hindrance to
oxygen binding in the T state.
III. STRUCTURAL BASIS OF LIGAND AFFINITIES OF OXYGEN CARRIERS 237
(4.50)o4'N-Fe-Cor
Whereas the angularly coordinated O2 ligand fits comfortably around the
distal histidine, a perpendicular and linear CO moiety cannot. Either the distal
histidine rotates out of the way, or the CO tilts off axis, or the Fe-C == 0
group bends, or some combination of these occurs. Notwithstanding the absence
of bent M-CO moieties in the inorganic literature, reports of strongly bent
M-CO groups appear in the biochemical literature. 122-127 The controversy is
illustrative of the synergistic interplay of data from models and proteins, and
the importance of examining a problem with a miscellany of techniques. The
molecular orbital model of ligand-metal interactions presented in Figure 4.22
does not preclude a bent M-C==O moiety on symmetry grounds. Groups re-
lated to CO can bend; the normally linearly coordinated SCN - moiety has been
observed 194 to become strongly bent under severe steric stress, with an
Fe-N-CS of 140°. Unfortunately, the resolution in protein crystal structures
is not sufficient to distinguish unequivocally a linear tilted stereochemistry from
a bent one or from a combination of tilt and bend. Studies by the XANES
technique have been interpreted in terms of a bent Fe-C == 0 moiety (150°)
~o
cY"
/N-Fe
both in MbCO 127 and in the CO adduct of a chelated heme in micelles, the
latter being an especially surprising result. From EXAFS data on a number of
carbonyl adducts, two interpretations were offered: linear or moderately bent
(150°) FeCO moieties for unhindered model systems, and moderately bent or
strongly bent (130°) FeCO moieties for hindered synthetic and biological sys-
tems. 195 In the crystal structure of MbCO at 1.5 Aresolution,122 the CO group
is disordered, and Fe-C == 0 angles of 120° and 140° were proposed, although
the alternative model of tilted, nearly linear Fe-C == 0 stereochemistry could
not be eliminated, and is indeed far more likely to account for the off-axis
nature of the oxygen position. Vibrational spectroscopy confirms the existence
of two major configurations, and indicates a third minor configuration of the
Fe-C == 0 moiety in MbCO. 196 An elegant infrared study of the polarization
of reattached carbon-monoxide molecules following photolysis of MbCO by lin-
early polarized light at 10 K gave tilt angles of the CO vector with respect to
the heme normal of 15(3t, 28(2)°, and 33(4t for the three conformational sub-
states; 196b the former two values were confirmed in a similar study at room
temperature. 196c Note that these studies do not yield the tilt of the Fe-C bond
to the heme normal.
In three synthetic compounds with severe steric hindrance, the extent of
bending and tilting of the Fe-CO moiety is small. In one nonporphyrinic sys-
tem the Fe-C==O group is bent by 9.4(5t and tilted by 4.20.121a In Fe(Poc-
PF)(l,2-Me2Im)(CO) the Fe-C == 0 angle is 172.5(6t and modest tilting of
the Fe-CO group and substantial buckling of the porphyrin ring are appar-
ent. 121b In Fe(C2Cap)((1-MeIm)(CO) the two independent Fe-C==O angles are
172.9(6t and 175.9(6t and modest tilting of the Fe-CO group is again ap-
parent. 121d
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From a detailed analysis of the force constants describing the vibrational
spectroscopy for the Fe-CO moiety, values of 171 Q for the Fe-CO angle,
9.5° for the tilt, and 11° for porphyrin buckling were calculated for MbCO. l21c
These results are particularly important, for in a model complex very closely
related to Fe(Poc-PF)(l,2-Me2Im)(CO), just mentioned, an EXAFS study 195
suggested an Fe-C == 0 bond angle of 127(4t; that same study ascribed an
Fe-C == 0 bond angle of around 130° to MbCO. The structure of carbonmo-
noxyhemoglobin, Hb(CO)4' now is interpreted in terms of a nearly linear tilted
geometry. 192 Clearly the geometry of attachment of CO to hemoglobins is per-
turbed by the surroundings of the ligand-binding site and hence the affinity of
hemoglobins for CO is also perturbed. Unfortunately, a clear resolution of the
geometry of the Fe-CO moiety in MbCO does not exist yet.
D. Stereochemical Changes Upon Ligation
Upon binding a second axial ligand, the iron center together with the axial base
move toward the plane of the porphyrin, initiating a change in spin state from
high-spin to low-spin when the sixth ligand is O2 or CO or any other strong
ligand with an even number of valence electrons. Given these general features,
what are the structural differences between systems that bind O2 with high affin-
ity and those that bind O2 with low affinity? The answers to this question are
relevant to understanding at the molecular level the mechanism of cooperativity,
where a low-affinity conformation, the T state, and a high-affinity conformation,
the R state, are in dynamic equilibrium in one tetrameric molecule. In looking
at crystallographic data one sees a particular conformation frozen in the crystal,
usually the one of lowest free energy among many in equilibrium in the solution
state. The R ~ T equilibrium for hemoglobin is moderately rapid, at 4 x 10 3 S - 1;
hemocyanin also switches quaternary conformations with a similar rate con-
stant.4
Human hemoglobins are a heterogeneous group. Many mutants are known,
and several have been structurally characterized. A structural alteration that af-
fects the equilibrium between Rand T states has a marked effect on ligand
affinity and cooperativity in hemoglobin. If a specific amino-acid substitution
destabilizes the T state, then the transition to the R state will occur earlier in the
ligation process, and the hemoglobin will have an increased oxygen affinity.
Hemoglobin Kempsey is an example. In this mutant an aspartic acid on the f3
chain is replaced by asparagine. Conversely, if the R state is destabilized, then
the hemoglobin will have a lowered oxygen affinity. Hemoglobin Kansas is an
example. Here an asparagine on the f3 chain has been replaced by threonine. 9
1. Structural changes in normal-affinity systems
It was proposed earlier that the molecule Fe(PF)(l-MeIm)(02) in the solid
or solution state was a fair approximation to the reference gas-phase molecule.
The axial base, although not oriented for minimization of contacts with the
porphyrin (i.e., </> = 45°), is well-removed from an eclipsing orientation where
</> = 0 ± 10°; the Fe atom is centered in the plane of a highly planar porphyrin;
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the O2 ligand is oriented' for minimization of contacts with the porphyrin, and
its geometry is largely unconstrained by distal groups (the pickets); no groups
are hydrogen-bonded to the axial base. The major difference from the reference
state is that there is a significant attractive interaction between the electronega-
tive dioxygen moiety and the amide groups on the pickets, and a smaller repul-
sive interaction with the picket t-butyl groups. 176
For the CO adduct, contacts with the pickets are all at ideal van der Waals'
separations and the Fe-CO moiety is free to assume its normal linear geome-
try. For CO binding the reference molecule is again the carbonyl adduct of the
iron picket-fence porphyrinato molecule. In contrast to O2 binding, there are no
specific distal effects, such as hydrogen bonding, by which CO affinity may be
increased; there remain many ways, as with O2 binding, by which CO affinities
may be reduced. Thus, the CO binder with highest affinity is the iron picket-
fence porphyrin.
The O2 affinities of myoglobin, R-state hemoglobin, and the Fe(PF)(l-MeIm)
system are similar. However, the means by which this is achieved are different,
and this difference is reflected most clearly in the kinetics of binding and release
of O2 , which for Mb are much slower. The similarities and differences are
summarized in Table 4.9, which is culled from Tables 4.2, 4.4, and 4.5.
Table 4.9
Comparison of the picket-fence porphyrin system with Mb.
Fe(PF-Im)" Fe(Poc-PF)
Characteristic Mb Fe(PF)(l-Melm) (I-Melm)
P1d02), Torr 0.7 0.58 0.36
P1dCO), Torr 0.018 0.000022 0.0015
kon(02), J.LM -I S-I IS 430 2.2
kofr(0 2), S-I 10 2,900 9
kon(CO), J.LM -I S - 1 0.50 36 0.58
kofrCCO), S-I 0.015 0.0078 0.0086
Solvent H2O/P04 3 - toluene toluene
Loeal environment His (H2O) H-N(amide) H-N (amide)
polar, protic polar, aprotic phenyl
O2 ... distal, A 2.97(18) NH 4.06(5)
CH3 2.67(6)
CO ... distal, A(calc.) 2.7 NH 5.0
CH3 3.3
Fe-N1m(deoxy), A 2.22 2.095(6)
Fe-N1m(oxy), A 2.07(6) 2.07(2)
Fe-O, A 1.83(6) 1.75(2)
<Plm(deoxy), deg 19° 22.8°
<Plm(OXY), deg 1° 20°
<P02' deg ~Oo 45°
Fe ... porph(deoxy), A 0.42 0.43
Fe ... porph(oxy), A 0.18 -0.03
" Solution state studies on Fe(PF-Im). Structural details on Fe(PF)(l-Melm)(02)
and Fe(PF)(2-Melm).
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For the cobalt-dioxygen derivative, the putative hydrogen bonding between
the dioxygen and the amide groups of the pickets assumes greater importance
because the coordinated dioxygen is substantially more negative. Again the picket-
fence porphyrin, being structurally characterized, is the reference system. Al-
though no Co picket-fence porphyrin structures have been determined, the struc-
tures may be predicted with confidence from the iron analogues together with
related structures of COlI and COllI tetraphenylporphyrinato systems. *
2. Structural changes in low-affinity systems
The 2-methyl substituent on 2-methylimidazole is not sterically active in the
five-coordinate structures Fe(PF)(2-MeIm) and Fe(TPP)(2-MeIm), since the iron
atom is displaced from the plane of the porphyrin by the expected amount and
the Fe-N1m bond is unstretched and similar to that in deoxyhemoglobin (low
O2 affinity) and deoxyMb (higher O2 affinity). Moreover, resonance Raman
measurements also indicate little strain t in this bond. 200 In other words, there is
no "tension at the heme," a key concept in early discussions of cooperativity
before structures on model systems and high-resolution, refined protein struc-
tures became available. IIa On moving into the plane of the porphyrin upon oxy-
genation, the 2-methyl substituent prevents the Fe-imidazole group from achiev-
ing its optimum geometry with the iron at the center of the porphyrin hole, as
seen in the structure of Fe(PF)(l-MeIm)(02)' Thus, the sterically active 2-methyl
substituent leads to lowered O2 (and CO) affinity relative to the I-methyl ana-
logue. In metrical terms the lowered affinity is reflected in an increase in the
sum of the axial bond lengths from 1.75 + 2.07 = 3.82 A to
1.90 + 2.11 = 4.01 A.
In the crystal structure of Fe(C2Cap)(l-MeIm)(CO) the cap is about 5.6 A
from the porphryin plane. I2Id Hence, in the crystal structures of the free base
H2(C2Cap)201a and FeCI(C2Cap)20Ib species, in which the cap is screwed down
to approximately 4.0 A from the porphyrin plane, considerable conformational
rearrangement of the cap and the four chains attaching it to the porphyrin is
needed to provide room for a small ligand such as CO. This is even more
pronounced in a Co(C3Cap) complex where the cap is only 3.49 A from the
mean porphyrin plane. 202 Thus not only is affinity for CO lowered, but some
additional discrimination against it is induced, since a linear, perpendicular co-
ordination creates considerable strain energy elsewhere in the molecule.
For the pocket porphyrin (Figure 4.23), structural data are available on the
* For CoHb02 , single-crystal EPR spectra have been interpreted in terms of a nearly triangularly coordi-
nated O2,'97 although a crystal structure of CoMb02 shows a bent CoOO group.'98 There is no precedent for
this triangular arrangement in any Colll-superoxo (02 ' ) system, whereas there are many for angularly coor-
dinated O2 in electronically not dissimilar square-planar Schiff-base systems 66 Regardless of geometry, the
picket amide ... O2 contacts do not change substantially.
t Shortly (10- 9_10- 12 s) after a ligand dissociates, a large difference in v(Fe-N ,m) between Rand T
structures is observed, prior to relaxation to the equilibrium Rand T conformations. 199
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carbonyl adduct. 12lb The CO ligand is unable to achieve the linear perpendicular
geometry seen in the high-affinity picket-fence porphyrin derivative, Fe(PF)(l-
MeIm)(CO), IIO and distortion of the porphyrin core is greater. In the pocket-
porphyrin system, O2 affinity is unaffected, but CO affinity is lowered.
The crystal structure of partially oxygenated hemoglobin, [a-Fe02h[t3-Feh, 191a
reveals that the quaternary structure, except in the immediate vicinity of the a
hemes, which have O2 coordinated, resembles that of T-state deoxyhemoglobin
rather than R-state liganded hemoglobin. In accord with the low affinity of T-
state hemoglobin, the Fe--Nlm bonds for the six-coordinate a-hemes at 2.37 A
are significantly longer than those in fully oxygenated R-state oxyhemoglobin,
[a-Fe02h[l3-Fe02h in the notation above, (1.94 (a-hemes) and 2.06 A (13 hemes»
and that found in oxymyoglobin (2.07 A). In contrast to the R-state structure
and oxyMb, the a-hemes are folded as seen in the deoxy parent, leaving the Fe
still substantially displaced (0.2 A) from the plane of the four pyrrole nitrogen
atoms. The deoxyhemoglobin T-state quaternary structure also has been ob-
served in two other partially liganded hybrid hemoglobins, [a-FeCOh
[f3-Mn(II)h203 and [a-Nih[f3-FeCOh- 191d Again, structural changes upon coor-
dination do not propagate beyond the immediate vicinity of the liganded heme
to the critical alf32 interfaces.
Note that although the crystal structure of hemoglobin A reveals that access
to the binding site for the 13 chains is blocked by groups at the entrance to the
cavity above the iron center, this does not prevent facile access to the binding
site; the rate of O2 binding is slowed by a factor of only five. A similar situation
occurs also for vertebrate myoglobins.
The large structural differences that exist between deoxy (n and oxy (R)
hemoglobin and the much smaller differences between deoxy (n and partially
liganded (n hybrid hemoglobin are shown in Figure 4.32. 203
Because of the steric hindrance afforded by the distal histidine, all biologi-
cal systems have low affinity for CO relative to the picket-fence porphyrins,
with the exception of mutants where the distal histidine has been replaced by
glycine. Thus low affinity to CO is associated primarily with the inability of the
Fe-CO group to achieve its preferred linear geometry perpendicular to the por-
phyrin.
Low-affinity O2binding in the hemoglobins appears to be associated with the
inability of the Fe-proximal histidine unit to move into the plane of the por-
phyrin and less so to distal effects, such as a cavity too small to accommodate
the coordinated ligand. The blocked access to the site affects the kinetics but
not necessarily the thennodynamics of ligand binding, as evidenced by the structure
of T-state [a-Nih[f3-FeCOh- 19Id Some similarities between the structures and
properties of partially oxygenated (T-state) [a-Fe02h[f3-Feh hemoglobin and
Fe(PF)(2-MeIm)(02) are provided in Table 4.10. In the synthetic systems low
O2 affinity can be induced by 2-methyl substituents-a restraint on the move-
ment of the Fe-imidazole moiety analogous to that provided by the protein chain.
A second means is by distal effects, such as caps and straps.
242
(A)
(B)
Figure 4.32
The effects of changes in ligation and in quaternary structure on stereochemistry in the vicinity
of a hemes: 203 (A) Stereodiagram of the large structural differences between deoxy T-state
(heavy lines) and oxy R-state hemoglobin (light lines). (B) Stereodiagram of the small structural
differences between deoxy T-state (heavy lines) and partially liganded T-state la-FeCOhll3-Mnh
hemoglobin (light lines). Reproduced with permission from A. Arnone et al., J. Mol. Biol. 188
(1986),693-706.
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Table 4.10
Comparison of the low-affinity picket-fence porphyrin system with low-affinity
(T-state) partially liganded hemoglobin.
Characteristic
PIl2(02), Torr
P II2(CO), Torr
kon(02), t-LM l S l
kofrC°z), S-l
kon(CO), t-LM - l s l
kofrCCO), s - l
Solvent
Local environment
O2 • • . distal, A
co ... distal, A
Fe-N1m(deoxy), A
Fe-N1m(oxy), A
Fe-O, A
<plm(deoxy), deg
<Plm(OXY), deg
<P02' deg
Fe porph(deoxy), A
Fe porph(oxy), A
HbA T
[a-Fe02h1I3-Feh
46, first O2
~0.7, 1st CO
2.9(a)
I 83(f3)
0.099
0.09
Tris buffer, pH 7,
no 2,3-DPG
histidine
polar
?
2.13(6) (average of a & f3)
2.24(10)
1.82(4)
21(3) (average of a & f3)
~6
?
0.38(5) (average of a & f3)
0.19(5)
Fe(PF)(2-Melm)
Fe(PF)(l ,2-Me2Im)"
38
0.0089
106
46,000
1.4
0.14
toluene
H-N(amide)
polar, aprotic
NH 3.88
CH3 2.77(3)
NH4.9
CH3 3.5
2.095(6)
2.107(4)
1.898(7)
22.8
22.2
45
0.43
0.09
" Ligand binding to Fe(PF)(l,2-Me2Im)
3. Structural changes in high-affinity systems
Few structural data are available for high-affinity oxygen carriers. The crys-
tal structures of two leghemoglobin derivatives, a monomeric myoglobin-like
oxygen carrier found in the nitrogen-fixing nodules of legumes, are known at
2.0 and 3.3 A.Z04,Z05 The binding pocket appears more open, perhaps allowing
HzO to enter and partake in stronger hydrogen bonding than that offered by the
distal imidazole. Consistent with this notion is the more rapid rate of autoxida-
tion observed for oxyleghemoglobin. Aplysia oxymyoglobin, which lacks a dis-
tal histidine, also autoxidizes rapidly,2°4 although a distal arginine further along
the helix E, ElOArg, fulfills the role of the distal histidine by hydrogen bonding
to the sixth ligand, at least in the fluoride derivative, met-MbF.
Although no structural data are available, a tenfold increase in Oz affinity
was observed between an ester-strapped porphyrin, offering no hydrogen-bond-
ing possibilities, and its confonnationally very similar amide analogue. Oz, .. amide
hydrogen bonding was demonstrated by means of NMR shift data (Zn and Fe-CO
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complexes vs. the Fe-02 complex) and from infrared spectroscopy, which
showed shifted amide N-H absorptions. 166
The specific structural features that lead to the extraordinarily high affinity
for O2 and low affinity for CO in hemoglobin Ascaris remain unidentified. This
high affinity is due to an extremely slow dissociation rate of O2 of only 0.Is - 1;
in most hemoglobins the rate is about 10 to 2,500 s ~ 1 (Table 4.2). Dioxygen
binding is thus close to irreversible. Figure 4.27 shows that hydrogen bonding
to the coordinated dioxygen ligand, unrestrained motion of the Fe-proximal his-
tidine group into the plane of the porphyrin, hydrogen bonding to the proximal
histidine, and, in the deoxy form, compression of the Fe-Nrm bond and de-
crease in the out-of-plane displacement of the Fe atom will all increase O2 affin-
ity over that of a system where these effects are absent.
When hydrogen bonding is impossible, as in various synthetic systems (Ta-
ble 4.5) as well as hemoglobin Glycera and Mb(E7His~Gly), O2 affinity is
much lower than when hydrogen bonding can occur (see Table 4.6), especially
for the cobalt analogues. But caution is needed in the absence of complete struc-
tural information: the lowered affinity of Aplysia hemoglobin had been attributed
to the lack of a distal histidine and its attendant hydrogen-bonding capabilities.
However, the crystal structure reveals that an arginine residue, normally di-
rected out into the solution, is capable of folding back into the ligand-binding
pocket and of hydrogen bonding to ligands at the sixth site. In oxyhemerythrin
the hydrogen bonding of the coordinated hydroperoxy group to the oxo bridge
linking the two iron atoms (Figure 4.lOB), described in Section II.F.I, may not
only increase the stability of oxyhemerythrin,146 but also facilitate electron transfer
that occurs in dioxygen binding. 205
IV. DIOXYGEN CARRIERS AND BIOINORGANIC CHEMISTRY
To the student the subject of biological and synthetic molecular-oxygen carriers
offers unusual insights into how bioinorganic chemistry works and what its aims
and uses are. First, consider another bioinorganic problem, that of the nature of
the blue copper proteins. When bioinorganic chemists entered the scene, the
nature, function, and structure of copper blues were largely unknown. To take
a Cu(lI) solution, add a nitrogen base, and obtain a spectrum that "resembled"
that of the proteins was not a contribution to the solution of the biological puz-
zle, although it was the activity of some bioinorganic chemists. The difficulty
here was that too little was known about the protein system. But the challenge
did not diminish once the structure of a blue copper protein was known, for that
structure allowed definition of the active site, one that contained (in the oxidized
form) a Cu(lI) center surrounded by two imidazole, one cysteine, and one me-
thionine residue. Now the bioinorganic chemist was faced with the formidable
(and still incompletely solved) synthetic problem of designing a tetradentate li-
gand that (i) would present two N atoms, one thiolate S atom, and one thioether
SR2 group to a Cu(lI) center and (ii) would remain intact if the Cu(lI) center
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were reduced to Cu(I). If we could prepare such complexes, we would be in a
position to examine in some detail the effects on physical properties, such as
redox potentials or spectra, of chemical substitution. In other words, we could
learn about structure-function relationships in the copper blues. But the risks
involved included the possibility that the specially designed ligand, even if it
could be synthesized, might not bind Cu(Il) or Cu(l) in the desired manner.
Contrast such a situation with that of the oxygen carriers. Hemoglobin 208
and myoglobin 209 were the first crystallized proteins to have their structures
determined. Their functions were well-known. They had been studied by a wide
variety of physical techniques, in part because their structures were known, and
even before that because of their role in human health. The central tetradentate
ligand of the heme group, namely, the porphyrin, was well-defined and much
porphyrin chemistry was known. The structural puzzles that intrigued chemists
and biologists were not answered in the initial, early structural studies of the
proteins; for example, how is O2 bound and why is CO not bound more firmly?
Model chemistry in this area looked as though it would be easy; after all, the
metalloporphyrins were readily synthesized, and all one needed was an axial
base, some spectroscopic equipment, perhaps some single crystals, and then the
structure-function relationships in the biological oxygen carriers would be
understood! Indeed, as often happens, the situation was more complicated than
it appeared. The irreversible oxidation of iron porphyrins was a major stumbling
block to simple modeling. This obstacle was overcome in solution studies through
the use of low temperatures and aprotic solvents; some very useful measure-
ments of O2 and CO binding were made on model systems in such solutions.
But in order to isolate oxygen complexes so that they could be studied by dif-
fraction methods, another approach, that of synthesizing elaborated porphyrins,
such as those in Figure 4.23, was necessary. This task entailed difficult organic
chemistry that ultimately led to successful models that proved to be stable under
ambient conditions. From such models we have learned much about local ster-
eochemistry and, through spectroscopic congruence, about the biological sys-
tems. In short, bioinorganic chemistry has made a major contribution to the
understanding of biological molecular-oxygen carriers, primarily because
knowledge of the biological systems was advanced, the systems "self-assem-
ble," and the goals of the studies were well-defined.
The complementarity of the two approaches continues. There are several
unanswered questions, including:
(1) What is the structural basis for cooperativity? Indeed, is there a struc-
tural basis at all, or is the ~ 6 kcallmol that represents the effect spread
over many interactions, so that there is no obvious structural effect to
be modeled?
(2) Can one design a model where hydrogen bonding to the bound O2 mol-
ecule can be demonstrated by diffraction experiments? How will the
oxygen uptake properties depend on the strength of the hydrogen bond?
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(3) Can one design a "high-affinity" model system? What will this tell us
about the largely ill-defined high-affinity systems that are found in Na-
ture?
There remain many intriguing questions about biological molecular-oxygen
carriers, questions that will be answered by complementary studies on the bio-
logical and model systems. To make and study such model systems is an ex-
ample of the challenge and excitement of this aspect of bioinorganic chemistry.
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I-Melm
1,2-Me2Im
2-Melm
2,3-DPG
3,4-Mer Py
4-t-Bu-Py
4-CN-Py
4-NHr Py
Gj
Arg
B
Ch
E t , E_ 1
EDTA
EO
EO'
Er
EtOH
EXAFS
G
H
Hi6,6-CP)
H2(Poc-PF)
H2Amide-Im
1-methylimidazole
I, 2-dimethylimidazole
2-methylimidazole
2,3-diphosphoglycerate
3,4-dimethylpyridine
4-t-butylpyridine
4-cyanopyridine
4-aminopyridine
activity of component i
arginine
general axial base ligand that binds to a metalloporphyrin
chlorocruorin
activation energy
ethylenediaminetetraacetic acid
electrochemical potential at unit activity and fugacity
electrochemical potential at physiological pH (7.4) and unit pressure
(l atm = 760 Torr)
erythrocruorin
ethanol
extended x-ray absorption fine structure
Gibbs free energy
enthalpy
cyclophane-strapped porphyrin (see Figure 4.23)
pocket picket-fence porphyrin
basket-handle porphyrin: imidazole base covalently attached to por-
phyrin with amide straps; amide straps on other side of porphyrin
(see Figure 4.23)
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H2Bis-Poc
H2bzacen
H2C2Cap
H2Ether-Py
H2MPIX-Im
H2PPIX
H2PPIX-Im
Hb
HbA
HbF
Hc
His
His 203
Hr
1m
k
Kp , Kc
L;
M
M
M
Mb
Me
met
OEP
P
THF
TPP
meso-tetrakis (2, 4, 6-triphenylphenyl) porphyrin
N, N-ethylenebis (benzoylacetoninime)
capped porphyrin; see Figure 4.23
basket-handle porphyrin: as for H2Amide-Im except ether straps and
pyridine base (see Figure 4.23)
mesoporphyrin IX dimethylester with imidazole covalently attached to
porphyrin (see Figure 4.23)
picket fence porphyrin, meso-tetrakis (a, a, a, a-o-pivalamidephenyl)
porphyrin (see Figure 4.23)
protoporphyrin IX dimethylester
protoporphyrin IX dimethylester with imidazole covalently attached to
porphyrin (see Figure 4.23)
hemoglobin
human adult hemoglobin
human fetal hemoglobin
hemocyanin
histidine
position on polypeptide chain (203) of a histidine residue
hemerythrin
imidazole
rate constant
equilibrium constant: concentration of gas expressed in terms of pres-
sure (P) and molarity (M), respectively
allosteric constant: equilibrium constant for conformational change of
protein with i ligands bound
general metalloporphyrinato species
molarity, moles/L
general metal complex
myoglobin
methyl group
oxidized (e.g. met Hb)
2,3,7,8,12, 13, 17, 18-octaethylporphyrinato
pressure, usually in Torr or mm Hg
tetrahydrofuran
5, 10, 15,20-tetraphenylporphyrinato
5
Dioxygen Reactions
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I. INTRODUCTION 1
The major pathway of dioxygen use in aerobic organisms is four-electron reduc-
tion to give two molecules of water per dioxygen molecule: 2
(5.1)
This reaction represents the major source of energy in aerobic organisms when
coupled with the oxidation of electron-rich organic foodstuffs, such as glucose.
Biological oxidation of this type is called respiration, and has been estimated to
account for 90 percent or more of the dioxygen consumed in the biosphere. It
is carried out by means of a series of enzyme-catalyzed reactions that are cou-
pled to ATP synthesis, and the ATP produced is the major source of energy for
the organism. The actual site of the reduction of dioxygen in many organisms
is the enzyme cytochrome c oxidase. 2
Another use of dioxygen in aerobic organisms is to function as a source of
oxygen atoms in the biosynthesis of various molecules in metabolic pathways,
or in conversions of lipid-soluble molecules to water-soluble forms for purposes
of excretion. These reactions are also enzyme-catalyzed, and the enzymes in-
volved are either monooxygenase or dioxygenase enzymes, depending on whether
one or both of the oxygen atoms from dioxygen are incorporated in the final
organic product. Many of these enzymes are metalloenzymes.2~
The advantages of life in air are considerable for an aerobic organism as
compared to an anaerobic organism, mainly because the powerful oxidizing power
of dioxygen can be controlled and efficiently converted to a form that can be
stored and subsequently used. 5 But aerobic metabolism has its disadvantages as
well. The interior of a living cell is a reducing environment, and many of the
components of the cell are fully capable thermodynamically of reacting directly
with dioxygen, thus bypassing the enzymes that control and direct the beneficial
reactions of dioxygen. 6 Luckily, for reasons that are discussed below, these 253
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reactions generally are slow, and therefore represent minor pathways of biolog-
ical dioxygen consumption. Otherwise, the cell would just bum up, and aerobic
life as we know it would be impossible. Nevertheless, there are small but sig-
nificant amounts of products formed from nonenzymatic and enzymatic reac-
tions of dioxygen that produce partially reduced forms of dioxygen, i.e. ,super-
oxide, O2 , and hydrogen peroxide, H20 2 , in aerobic cells. These forms of
reduced dioxygen or species derived from them could carry out deleterious re-
actions, and enzymes have been identified that appear to protect against such
hazards. These enzymes are, for superoxide, the superoxide dismutase enzymes,
and, for peroxide, catalase and the peroxidase enzymes. All of these enzymes
are metalloenzymes. 2-4
Much of the fascination of the subject of biological reactions of dioxygen
stems from the fact that the mechanisms of the biological, enzyme-catalyzed
reactions are clearly quite different from those of the uncatalyzed reactions of
dioxygen or even those of dioxygen reactions catalyzed by a wide variety of
nonbiological metal-containing catalysts. 7 Investigators believe, optimistically,
that once they truly understand the biological reactions, they will be able to
design synthetic catalysts that mimic the 9iological catalysts, at least in repro-
ducing the reaction types, even if these new catalysts do not match the enzymes
in rate and specificity. To introduce this tJpic, therefore, we first consider the
factors that determine the characteristics of ,nonbiological reactions of dioxygen.
II. CHEMISTRY OF DIOXYGEN
A. Thermodynamics
The reduction potential for the four-electron reduction of dioxygen (Reaction
5.1) is a measure of the great oxidizing power of the dioxygen molecule. 8 How-
ever, the reaction involves the transfer of four electrons, a process that rarely,
if ever, occurs in one concerted step, as shown in Reaction (5.2).
e - e ,2H + e - , H + e ,H-j-
02~ O2-~H202~H20 + OH~ 2H20 (5.2)
dioxygen super-
oxide
hydrogen water + hydroxyl water
peroxide radical
Since most reducing agents can transfer at most one or two electrons at a time
to an oxidizing agent, the thermodynamics of the one- and two-electron reduc-
tions of dioxygen must be considered in order to understand the overall mecha-
nIsm.
In aqueous solution, the most common pathway for dioxygen reduction in
the absence of any catalyst is one-electron reduction to give superoxide. But
this is the least favorable of the reaction steps that make up the full four-electron
reduction (see Table 5.l) and requires a moderately strong reducing agent. Thus
II. CHEMISTRY OF DIOXYGEN 255
Table 5.1
Standard reduction potentials for dioxygen species in
water.s
Reaction
O2 + e~ ~ °2 -
O2 - + e - + 2H +~ H20 z
H20 Z + e ~ + H +~ H20 + OH
OH + e - + H +~ H20
O2 + 2e - + 2H +~ H20 2
H20 2 + 2e- + 2H+ ~ 2HzO
O2 + 4H + + 4e - ~ 2HzO
EO, V vs. NHE, pH 7, 25°C
-0.33 a
+0.89
+0.38
+2.31
+0.281"
+ 1.349
+0.815"
" The standard state used here is unit pressure. If unit activity is used
for the standard state of O2 , the redox potentials for reactions of that
species must be adjusted by +0.17 V. 8.9
if only one-electron pathways are available for dioxygen reduction, the low re-
duction potential for one-electron reduction of O2 to O2 - presents a barrier that
protects vulnerable species from the full oxidizing power of dioxygen that comes
from the subsequent steps. If superoxide is formed (Reaction 5.3), however, it
disproportionates quite rapidly in aqueous solution (except at very high pH) to
give hydrogen peroxide and dioxygen (Reaction 5.4). The stoichiometry of the
overall reaction is therefore that of a net two-electron reduction (Reaction 5.5).
It is thus impossible under normal conditions to distinguish one-electron and
two-electron reaction pathways for the reduction of dioxygen in aqueous solu-
tion on the basis of stoichiometry alone.
202 + 2e ~ 202
202 - + 2H +~ H20 2 + O2
O2 + 2e - + 2H +~ H20 2
(5.3)
(5.4)
(5.5)
The thermodynamics of dioxygen reactions with organic substrates is also
of importance in understanding dioxygen reactivity. The types of reactions that
are of particular interest to us here are hydroxylation of aliphatic and aromatic
C- H bonds and epoxidation of olefins, since these typical reactions of oxygen-
ase enzymes are ones that investigators are trying to mimic using synthetic re-
agents. Some of the simpler examples of such reactions (plus the reaction of H2
for comparison) are given in the reactions in Table 5.2. It is apparent that all
these reactions of dioxygen with various organic substrates in Table 5.2 are
thermodynamically favorable. However, direct reactions of dioxygen with or-
ganic substrates in the absence of a catalyst are generally very slow, unless the
substrate is a particularly good reducing agent. To understand the sluggishness
of dioxygen reactions with organic substrates, we must consider the kinetic bar-
riers to these reactions.
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Table 5.2
Examples of hydroxylation and epoxidation reactions.
Reaction
CH4(g) + +02(g) ~ CH30H(g)
C6H6(g) + +02(g) ~ C6HsOH(g)
C6HsOH(g) + +o2(g) ~ C6Hi OH)z(g)
C2H4(g) + +02(g) ~ C2H40(g)
CsHsN(g) + +02(g) ~ CsHsNO(g)
H2(g) + +02(g) ~ H20(g)
B. Kinetics
/:;H in kcallmol
30
-43
42
25
-13
58
Reference
10
11,12
12,13
10
14
10
The principal kinetic barrier to direct reaction of dioxygen with an organic sub-
strate arises from the fact that the ground state of the dioxygen molecule is
triplet, i.e., contains two unpaired electrons. 15,16 Typical organic molecules that
are representative of biological substrates have singlet ground states, i.e., con-
tain no unpaired electrons, and the products resulting from their oxygenation
also have singlet ground states. Reactions between molecules occur in shorter
times than the time required for conversions from triplet to singlet spin. There-
fore the number of unpaired electrons must remain the same before and after
each elementary step of a chemical reaction. For these reasons, we know that it
is impossible for Reaction (5.6) to go in one fast, concerted step.
~ 302 + IX ~ 'XO
it H tt
(5.6)
The arrows represent electron spins: ~ t represents a singlet molecule with all
electron spins paired; t t represents a triplet molecule with two unpaired elec-
trons; and t (which we will see in Reaction 5.13) represents a doublet mole-
cule, also referred to as a free radical, with one unpaired electron. The pathways
that do not violate the spin restriction are all costly in energy, resulting in high
activation barriers. For example, the reaction of ground-state triplet dioxygen,
i.e. ,302 , with a singlet substrate to give the excited triplet state of the oxygen-
ated product (Reaction 5.7) is spin-allowed, and one could imagine a mecha-
nism in which this process is followed by a slow spin conversion to a singlet
product (Reaction 5.8).
~ 302 + 'X ~ 3XO
it H it
(5.7)
(5.8)
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But such a reaction pathway would give a high activation barrier, because the
excited triplet states of even unsaturated molecules are typically 40-70 kcallmol
less stable than the ground state, and those of saturated hydrocarbons are much
higherY
Likewise, a pathway in which O2 is excited to a singlet state that then reacts
with the substrate would be spin-allowed (Reactions 5.9 and 5.10). The high
reactivity of singlet dioxygen, generated by photochemical or chemical means,
is well-documented. 18 ,19 However, such a pathway for a reaction of dioxygen,
which is initially in its ground triplet state, would also require a high activation
energy, since the lowest-energy singlet excited state of dioxygen is 22.5 kcall
mol higher in energy than ground-state triplet dioxygen. 15 •16
302 + 22.5 kcal/mol -----;> '02
tt tt (5.9)
'X ---3> 'xo
H H
(5.10)
Moreover, the products of typical reactions of singlet-state dioxygen with or-
ganic substrates (Reactions 5.1I and 5.12, for example) are quite different in
character from the reactions of dioxygen with organic substrates catalyzed by
oxygenase enzymes (see Section V):
(5.1I)
(5.12)
One pathway for a direct reaction of triplet ground-state dioxygen with a
singlet ground-state organic substrate that can occur readily without a catalyst
begins with the one-electron oxidation of the substrate by dioxygen. The prod-
ucts of such a reaction would be two doublets, i.e., superoxide and the one-
electron oxidized substrate, each having one unpaired electron (Reaction 5.13).
These free radicals can diffuse apart and then recombine with their spins paired
(Reaction 5. 14).
302 + 'X ---3> 202- + 2X +
tt H t t (5.13)
(5.14)
Such a mechanism has been shown to occur for the reaction of dioxygen with
reduced flavins shown in Reaction (5.15).20
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(5.15)
However, this pathway requires that the substrate be able to reduce dioxygen to
superoxide, a reaction that requires an unusually strong reducing agent (such as
a reduced flavin), since dioxygen is not a particularly strong one-electron oxi-
dizing agent (see Table 5.1 and discussion above). Typical organic substrates in
enzymatic and nonenzymatic oxygenation reactions usually are not sufficiently
strong reducing agents to reduce dioxygen to superoxide; so this pathway is not
commonly observed.
The result of these kinetic barriers to dioxygen reactions with most organic
molecules is that uncatalyzed reactions of this type are usually quite slow. An
exception to this rule is an oxidation pathway known as free-radical autoxida-
tion.
c. Free-Radical Autoxidation
The term free-radical autoxidation describes a reaction pathway in which diox-
ygen reacts with an organic substrate to give an oxygenated product in a free-
radical chain process that requires an initiator in order to get the chain reaction
started. 21 (A free-radical initiator is a compound that yields free radicals readily
upon thermal or photochemical decomposition.) The mechanism of free radical
autoxidation is as shown in Reactions (5.16) to (5.21).
Initiation:
Propagation:
Termination:
x2~ 2X'
X' + RH~ XH + R'
R' + O2 ~ ROO'
t tt t
ROO' + RH~ ROOH + R'
R' + ROO'~ ROaR
2ROO'~ ROOOOR~ O2 + ROaR
(5.16)
(5.17)
(5.18)
(5.19)
(5.20)
(5.21)
(plus other oxidized products, such as ROOH, ROH, RC(O)R, RC(O)H). This
reaction pathway results in oxygenation of a variety of organic substrates, and
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is not impeded by the spin restriction, because triplet ground-state dioxygen can
react with the free radical R· to give a free-radical product ROO, in a spin-
allowed process (Reaction 5.18). It is a chain reaction, since R· is regenerated
in Reaction (5.19), and it frequently occurs with long chain lengths prior to the
termination steps, resulting in a very efficient pathway for oxygenation of some
organic substrates, such as, for example, the oxidation of cumene to give phenol
and acetone (Reaction 5.22).22
OOH
o~O~6 (5.22)
When free-radical autoxidation is used for synthetic purposes, initiators are
intentionally added. Common initiators are peroxides and other compounds ca-
pable of fragmenting readily into free radicals. Free-radical autoxidation reac-
tions are also frequently observed when no initiator has been intentionally added,
because organic substrates frequently contain peroxidic impurities that may act
as initiators. Investigators have sometimes been deceived into assuming that a
metal-complex catalyzed reaction of dioxygen with an organic substrate oc-
curred by a nonradical mechanism. In such instances, the reactions later proved,
upon further study, to be free-radical autoxidations, the role of the metal com-
plex having been to generate the initiating free radicals.
Although often useful for synthesis of oxygenated derivatives of relatively
simple hydrocarbons, free-radical autoxidation lacks selectivity and therefore,
with more complex substrates, tends to give multiple products. In considering
possible mechanisms for biological oxidation reactions used in vivo for biosyn-
thesis or energy production, free-radical autoxidation is not an attractive possi-
bility, because such a mechanism requires diffusion of highly reactive free rad-
icals. Such radicals, produced in the cell, will react indiscriminately with
vulnerable sites on enzymes, substrates, and other cell components, causing
serious damage. 6 In fact, free-radical autoxidation is believed to cause certain
deleterious reactions of dioxygen in biological systems, for example the oxida-
tion of lipids in membranes. It is also the process that causes fats and oils to
become rancid (Reaction 5.23).23,24
~COOH---+
HOO
~R R2
1
OOH
r=v---\R R2
1
R1 = -CsH11
R2= -(CH2)7COOH
(5,23)
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D. How Do Enzymes Overcome These Kinetic Barriers?
We see then the reasons that uncatalyzed reactions of dioxygen are usually either
slow or unselective. The functions of the metalloenzymes for which dioxygen
is a substrate are, therefore, to overcome the kinetic barriers imposed by spin
restrictions or unfavorable one-electron reduction pathways, and, for the oxy-
genase enzymes, to direct the reactions and make them highly specific. It is
instructive to consider (1) how these metalloenzymes function to lower the ki-
netic barriers to dioxygen reactivity, and (2) how the oxygenase enzymes redi-
rect the reactions along different pathways so that very different products are
obtained. The first example given below is cytochrome c oxidase. This enzyme
catalyzes the four-electron reduction of dioxygen. It overcomes the kinetic bar-
riers to dioxygen reduction by binding dioxygen to two paramagnetic metal ions
at the dioxygen binding site, thus overcoming the spin restriction, and by reduc-
ing dioxygen in a two-electron step to peroxide, thus bypassing the unfavorable
one-electron reduction to form free superoxide. The reaction occurs in a very
controlled fashion, so that the energy released by dioxygen reduction can be
used to produce ATP. A second example is provided by the catechol dioxygen-
ases, which appear to represent substrate rather than dioxygen activation, and
in which dioxygen seems to react with the substrate while it is complexed to the
paramagnetic iron center. Another example given below is the monooxygenase
enzyme cytochrome PASO, which catalyzes the reaction of dioxygen with or-
ganic substrates. It binds dioxygen at the paramagnetic metal ion at its active
site, thus overcoming the spin restriction, and then carries out what can be
formally described as a multielectron reduction of dioxygen to give a highly
reactive high-valent metal-oxo species that has reactivity like that of the hy-
droxyl radical. Unlike a free hydroxyl radical, however, which would be highly
reactive but nonselective, the reaction that occurs at the active site of cyto-
chrome PASO can be highly selective and stereospecific, because the highly re-
active metal-oxo moiety is generated close to a substrate that is bound to the
enzyme in such a way that it directs the reactive oxygen atom to the correct
position. Thus, metalloenzymes have evolved to bind dioxygen and to increase
while controlling its reactivity.
III DIOXYGEN TOXICITY
A. Background
Before we consider the enzymatically controlled reactions of dioxygen in living
systems, it is instructive to consider the uncontrolled and deleterious reactions
that must also occur in aerobic organisms. Life originally appeared on Earth at
a time when the atmosphere contained only low concentrations of dioxygen,
and was reducing rather than oxidizing, as it is today. With the appearance of
photosynthetic organisms approximately 2.5 billion years ago, however, the
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conversion to an aerobic, oxidizing atmosphere exposed the existing anaerobic
organisms to a gradually increasing level of oxidative stress. 25 ,26 Modem-day
anaerobic bacteria, the descendants of the original primitive anaerobic organ-
isms, evolved in ways that enabled them to avoid contact with normal atmo-
spheric concentrations of dioxygen. Modem-day aerobic organisms, by contrast,
evolved by developing aerobic metabolism to harness the oxidizing power of
dioxygen and thus to obtain usable metabolic energy. This remarkably success-
ful adaptation enabled life to survive and flourish as the atmosphere became
aerobic, and also allowed larger, multicellular organisms to evolve. An impor-
tant aspect of dioxygen chemistry that enabled the development of aerobic me-
tabolism is the relatively slow rate of dioxygen reactions in the absence of cat-
alysts. Thus, enzymes could be used to direct and control the oxidation of
substrates either for energy generation or for biosynthesis. Nevertheless, the
balance achieved between constructive and destructive oxidation is a delicate
one, maintained in aerobic organisms by several means, e.g.: compartmentali-
zation of oxidative reactions in mitochondria, peroxisomes, and chloroplasts;
scavenging or detoxification of toxic byproducts of dioxygen reactions; repair
of some types of oxidatively damaged species; and degradation and replacement
of other species. 6
The classification "anaerobic" actually includes organisms with varying de-
grees of tolerance for dioxygen: strict anaerobes, for which even small concen-
trations of O2 are toxic; moderate anaerobes, which can tolerate low levels of
dioxygen; and microaerophiles, which require low concentrations of O2 for growth,
but cannot tolerate normal atmospheric concentrations, i.e., 21 percent O2, I atm
pressure. Anaerobic organisms thrive in places protected from the atmosphere,
for example, in rotting organic material, decaying teeth, the colon, and gan-
grenous wounds. Dioxygen appears to be toxic to anaerobic organisms largely
because it depletes the reducing equivalents in the cell that are needed for nor-
mal biosynthetic reactions. 6
Aerobic organisms can, of course, live in environments in which they are
exposed to normal atmospheric concentrations of O2. Nevertheless, there is much
evidence that O2 is toxic to these organisms as well. For example, plants grown
in varying concentrations of O2 have been observed to grow faster in lower than
normal concentrations of O2 . 27 E. coli grown under 5 atm of O2 ceased to grow
unless the growth medium was supplemented with branched-chain amino acids
or precursors. High concentrations of O2 damaged the enzyme dihydroxy acid
dehydratase, an important component in the biosynthetic pathway for those amino
acids. 28 In mammals, elevated levels of O2 are clearly toxic, leading first to
coughing and soreness of the throat, and then to convulsions when the level of
5 atm of 100 percent O2 is reached. Eventually, elevated concentrations of O2
lead to pulmonary edema and irreversible lung damage, with obvious damage
to other tissues as well. 6 The effects of high concentrations of O2 on humans is
of some medical interest, since dioxygen is used therapeutically for patients
experiencing difficulty breathing, or for those suffering from infection by anaer-
obic organisms. 6
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B. Biological Targets
The major biochemical targets of O2 toxicity appear to be lipids, DNA, and
proteins. The chemical reactions accounting for the damage to each type of
target are probably different, not only because of the different reactivities of
these three classes of molecules, but also because of the different environment
for each one inside the cell. Lipids, for example, are essential components of
membranes and are extremely hydrophobic. The oxidative damage that is ob-
served is due to free-radical autoxidation (see Reactions 5.16 to 5.21), and the
products observed are lipid hydroperoxides (see Reaction 5.23). The introduc-
tion of the hydroperoxide group into the interior of the lipid bilayer apparently
causes that structure to be disrupted, as the configuration of the lipid rearranges
in order to bring that polar group out of the hydrophobic membrane interior and
up to the membrane-water interface.6 DNA, by contrast, is in the interior of the
cell, and its exposed portions are surrounded by an aqueous medium. It is par-
ticularly vulnerable to oxidative attack at the base or at the sugar, and multiple
products are formed when samples are exposed to oxidants in vitro.6 Since ox-
idation of DNA in vivo may lead to mutations, this type of damage is potentially
very serious. Proteins also suffer oxidative damage, with amino-acid side chains,
particularly the sulfur-containing residues cysteine and methionine, appearing to
be the most vulnerable sites,6
C. Defense and Repair Systems
The biological defense systems protecting against oxidative damage and its con-
sequences are summarized below.
1, Nonenzymatic oxidant scavengers
Some examples of small-molecule antioxidants are a-tocopherol (vitamin E;
5.24), which is found dissolved in cell membranes and protects them against
lipid peroxidation, and ascorbate (vitamin C; 5.25) and glutathione (5.26), which
are found in the cytosol of many cells. Several others are known as well. 6,29
HO
H ,YH3 H .GH3 CH3
CH3
ascorbic acid
(5.24)
(5.25)
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(5.26)
glutathione
2. Detoxification enzymes
The enzymatic antioxidants are (a) catalase and the various peroxidases,
whose presence lowers the concentration of hydrogen peroxide, thereby pre-
venting it from entering into potentially damaging reactions with various cell
components (see Section VI and Reactions 5.82 and 5.83), and (b) the super-
oxide dismutases, whose presence provides protection against dioxygen toxicity
that is believed to be mediated by the superoxide anion, O2 - (see Section VII
and Reaction 5.95).
Some of the enzymatic and nonenzymatic antioxidants in the cell are illus-
trated in Figure 5. I.
vitamin E
~_carote~n/~~
/' /" ~eus" "\ vitamins C and E
,,<I,pl,=I, retiWI"~ DNA v----\ p·w,""",
( Iysosomes )peroxisomes -- GSH
catalase ~ 0 0 cytoplasm /
X\ Cj mitochondrion glutathioneR \Z-+:--l peroxidaseRRRRRtJ ~~~~n ~~~~~~ ~../;---- vitamin C
lipid bilayer of all~/J vitamin E
cellular membranes \ Mn
vitamin E+ SOD + glutathione peroxidase
~-carotene + GSH
Figure 5.1
Cartoon showing some of the antioxidant agents inside the cell. 29
3. Systems for sequestration of redox-active metal ions
Redox-active metal ions are present in the cell in their free, uncomplexed
state only in extremely low concentrations. They are instead sequestered by
metal-ion storage and transport proteins, such as ferritin and transferrin for iron
(see Chapter 1) and ceruloplasmin for copper. This arrangement prevents such
metal ions from catalyzing deleterious oxidative reactions, but makes them
available for incorporation into metalloenzymes as they are needed.
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In vitro experiments have shown quite clearly that redox-active metal ions
such as Fe 2 + /3+ or Cu +/2+ are extremely good catalysts for oxidation of sulfhy-
dryl groups by O2 (Reaction 5.27).30
MH
4RSH + O2 ---3> 2RSSR + 2H20 (5.27)
In addition, in the reducing environment of the cell, redox-active metal ions
catalyze a very efficient one-electron reduction of hydrogen peroxide to produce
hydroxyl radical, one of the most potent and reactive oxidants known (Reactions
5.28 to 5.30).31
M n + + Red ---3> M(n-1)+ + Red
M(n-1)+ + H20 2 ---3> Mn+ + OH + HO'
Red + H20 2 ---3> Red + OH - + HO'
(Red - = reducing agent)
(5.28)
(5.29)
(5.30)
Binding those metal ions in a metalloprotein usually prevents them from enter-
ing into these types of reactions. For example, transferrin, the iron-transport
enzyme in serum, is normally only 30 percent saturated with iron. Under con-
ditions of increasing iron overload, the empty iron-binding sites on transferrin
are observed to fill, and symptoms of iron poisoning are not observed in vivo
until after transferrin has been totally saturated with iron. 32 Ceruloplasmin and
metallothionein may playa similar role in preventing copper toxicity. 6 It is very
likely that both iron and copper toxicity are largely due to catalysis of oxidation
reactions by those metal ions.
4. Systems for the repair or replacement of damaged materials
Repair of oxidative damage must go on constantly, even under normal con-
ditions of aerobic metabolism. For lipids, repair of peroxidized fatty-acid chains
is catalyzed by phospholipase A2 , which recognizes the structural changes at the
lipid-water interface caused by the fatty-acid hydroperoxide, and catalyzes re-
moval of the fatty acid at that site. The repair is then completed by enzymatic
reacylation. 6 Although some oxidatively damaged proteins are repaired, more
commonly such proteins are recognized, degraded at accelerated rates, and then
replaced. 6 For DNA, several multi-enzyme systems exist whose function is to
repair oxidatively damaged DNA. 6 For example, one such system catalyzes rec-
ognition and removal of damaged bases, removal of the damaged part of the
strand, synthesis of new DNA to fill in the gaps, and religation to restore the
DNA to its original, undamaged state. Mutant organisms that lack these repair
enzymes are found to be hypersensitive to O2 , H20 2 , or other oxidants. 6
One particularly interesting aspect of oxidant stress is that most aerobic
organisms can survive in the presence of normally lethal levels of oxidants if
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they have first been exposed to lower, nontoxic levels of oxidants. This phe-
nomenon has been observed in animals, plants, yeast, and bacteria, and suggests
that low levels of oxidants cause antioxidant systems to be induced in vivo. In
certain bacteria, the mechanism of this induction is at least partially understood.
A DNA-binding regulatory protein named OxyR that exists in two redox states
has been identified in these systems. 33 Increased oxidant stress presumably in-
creases concentration of the oxidized form, which then acts to turn on the tran-
scription of the genes for some of the antioxidant enzymes. A related phenom-
enon may occur when bacteria and yeast switch from anaerobic to aerobic
metabolism. When dioxygen is absent, these microorganisms live by fermenta-
tion, and do not waste energy by synthesizing the enzymes and other proteins
needed for aerobic metabolism. However, when they are exposed to dioxygen,
the synthesis of the respiratory apparatus is turned on. The details of this induc-
tion are not known completely, but some steps at least depend on the presence
of heme, the prosthetic group of hemoglobin and other heme proteins, whose
synthesis requires the presence of dioxygen. 34
D. Molecular Mechanisms of Dioxygen Toxicity
What has been left out of the preceding discussion is the identification of the
species responsible for oxidative damage, i.e., the agents that directly attack the
various vulnerable targets in the cell. They were left out because the details of
"-the chemistry responsible for dioxygen toxicity are largely unknown. In 1954,
Rebeca Gerschman formulated the "free-radical theory of oxygen toxicity" after
noting that tissues subjected to ionizing radiation resemble those exposed to
elevated levels of dioxygen. 35 Fourteen years later, Irwin Fridovich proposed
that the free radical responsible for dioxygen toxicity was superoxide, O2 ,
based on his identification of the first of the superoxide dismutase enzymes. 36
Today it is still not known if superoxide is the principal agent of dioxygen
toxicity, and, if so, what the chemistry responsible for that toxicity is. 6
There is no question that superoxide is formed during the normal course of
aerobic metabolism,121 although it is difficult to obtain estimates of the amount
under varying conditions, because, even in the absence of a catalyst, superoxide
disproportionates quite rapidly to dioxygen and hydrogen peroxide (Reaction
5.4) and therefore never accumulates to any great extent in the cell under normal
conditions of pH. 37
One major problem in this area is that a satisfactory chemical explanation
for the purported toxicity of superoxide has never been found, despite much
indirect evidence from in vitro experiments that the presence of superoxide can
lead to undesirable oxidation of various cell components and that such oxidation
can be inhibited by superoxide dismutase. 38 The mechanism most commonly
proposed is production of hydroxyl radicals via Reactions (5.28) to (5.30) with
Red - = O2-, which is referred to as the "Metal-Catalyzed Haber-Weiss Re-
266 5 / DIOXYGEN REACTIONS
action". The role of superoxide in this mechanism is to reduce oxidized metal
ions, such as Cu 2 + or Fe 3+ , present in the cell in trace amounts, to a lower
oxidation stateY Hydroxyl radical is an extremely powerful and indiscriminate
oxidant. It can abstract hydrogen atoms from organic substrates, and oxidize
most reducing agents very rapidly. It is also a very effective initiator of free-
radical autoxidation reactions (see Section II. C above). Therefore, reactions that
produce hydroxyl radical in a living cell will probably be very deleterious. 6
The problem with this explanation for superoxide toxicity is that the only
role played by superoxide here is that of a reducing agent of trace metal ions.
The interior of a cell is a highly reducing environment, however, and other
reducing agents naturally present in the cell such as, for example, ascorbate
anion can also act as Red - in Reaction (5.28), and the resulting oxidation
reactions due to hydroxyl radical are therefore no longer inhibitable by SOD. 39
Other possible explanations for superoxide toxicity exist, of course, but none
has ever been demonstrated experimentally. Superoxide might bind to a specific
enzyme and inhibit it, much as cytochrome oxidase is inhibited by cyanide or
hemoglobin by carbon monoxide. Certain enzymes may be extraordinarily sen-
sitive to direct oxidation by superoxide, as has been suggested for the enzyme
aconitase, an iron-sulfur enzyme that contains an exposed iron atom. 122 Another
possibility is that the protonated and therefore neutral form of superoxide, H02 ,
dissolves in membranes and acts as an initiator of lipid peroxidation. It has also
been suggested that superoxide may react with nitric oxide, NO, in the cell
producing peroxynitrite, a very potent oxidant. 123 One particularly appealing
mechanism for superoxide toxicity that has gained favor in recent years is the
"Site-Specific Haber-Weiss Mechanism." 40,41 The idea here is that traces of
redox-active metal ions such as copper and iron are bound to macromolecules
under normal conditions in the cell. Most reducing agents in the cell are too
bulky to come into close proximity to these sequestered metal ions. Superoxide,
however, in addition to being an excellent reducing agent, is very small, and
could penetrate to these metal ions and reduce them. The reduced metal ions
could then react with hydrogen peroxide, generating hydroxyl radical, which
would immediately attack at a site near the location of the bound metal ion.
This mechanism is very similar to that of the metal complexes that cause DNA
cleavage; by reacting with hydrogen peroxide while bound to DNA, they gen-
erate powerful oxidants that react with DNA with high efficiency because of
their proximity to it (see Chapter 8).
Although we are unsure what specific chemical reactions superoxide might
undergo inside of the cell, there nevertheless does exist strong evidence that the
superoxide dismutases play an important role in protection against dioxygen-
induced damage. Mutant strains of bacteria and yeast that lack superoxide dis-
mutases are killed by elevated concentrations of dioxygen that have no effect
on the wild-type cells. This extreme sensitivity to dioxygen is alleviated when
the gene coding for a superoxide dismutase is reinserted into the cell, even if
the new SOD is of another type and from a different organism. 42,43
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E. Summary of Dioxygen Toxicity
In summary, we know a great deal about the sites that are vulnerable to oxida-
tive damage in biological systems, about the agents that protect against such
damage, and about the mechanisms that repair such damage. Metal ions are
involved in all this chemistry, both as catalysts of deleterious oxidative reactions
and as cofactors in the enzymes that protect against and repair such damage.
What we still do not know at this time, however, is how dioxygen initiates the
sequence of chemical reactions that produce the agents that attack the vulnerable
biological targets in vivo.
IV. CYTOCHROME c OXIDASE
A. Background
Most of the O2 consumed by aerobic organisms is used to produce energy in a
process referred to as "oxidative phosphorylation," a series of reactions in which
electron transport is coupled to the synthesis of ATP and in which the driving
force for the reaction is provided by the four-electron oxidizing power of O2
(Reaction 5.1). (This subject is described in any standard text on biochemistry
and will not be discussed in detail here.) The next to the last step in the electron-
transport chain produces reduced cytochrome c, a water-soluble electron-transfer
protein. Cytochrome c then transfers electrons to cytochrome c oxidase, where
they are ultimately transferred to O2 . (Electron-transfer reactions are discussed
in Chapter 6.)
Cytochrome c oxidase is the terminal member of the respiratory chain in all
animals and plants, aerobic yeasts, and some bacteria. 44- 46 This enzyme is al-
ways found associated with a membrane: the inner mitochondrial membrane in
higher organisms or the cell membrane in bacteria. It is a large, complex, mul-
tisubunit enzyme whose characterization has been complicated by its size, by
the fact that it is membrane-bound, and by the diversity of the four redox metal
sites, i.e., two copper ions and two heme iron units, each of which is found in
a different type of environment within the protein. Because of the complexity
of this system and the absence of detailed structural information, spectroscopic
studies of this enzyme and comparisons of spectral properties with Orbinding
proteins (see Chapter 4) and with model iron-porphyrin and copper complexes
have been invaluable in its characterization.
B. Spectroscopic Characterization
1. Models
Iron-porphyrin complexes of imidazole are a logical starting point in the
search for appropriate spectroscopic models for heme centers in metalloproteins,
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since the histidyl imidazole side chain is the most common axial ligand bound
to iron in such enzymes. Iron-porphyrin complexes with two axial imidazole
ligands are known for both the ferrous and ferric oxidation states. 47
H
t1
N
I
-N-Fe-N-
I
N(J
H
(5.31)
These complexes are six coordinate, i.e., coordinatively saturated, and therefore
do not bind additional ligands unless an imidazole is lost first. Six-coordinate
heme centers with two axial imidazole ligands in metalloproteins are known to
act as electron-transfer redox centers, e.g., in cytochrome bS ,48 but are not ob-
served to coordinate dioxygen or any other substrate under normal conditions,
because they are coordinatively saturated. In the ferrous state, the iron-por-
phyrin complex with two axial imidazole ligands is low-spin d 6 , and thus dia-
magnetic. In the ferric state, it is low-spin d 5, and has one unpaired electron.
Ferric porphyrin complexes with two axial imidazole ligands have EPR spectra
characteristic of low-spin d 5 complexes with axial symmetry,49,50 as shown in
Figure 5.2.
d x2_y 2 -
dz2
dxz' dyz#-#-
dxy #-
-t#-
#-
Fe 1Il P(lmH)2+
S = 1/2
(5.32)
Monoimidazole complexes of iron porphyrins are also known for both the
ferrous and the ferric oxidation states. The design of these model complexes has
been more challenging than for six-coordinate complexes because of the high
affinity of the five-coordinate complexes for a sixth ligand. In the ferrous com-
plex, five coordination has been achieved by use of 2-methylimidazole ligands,
as described in Chapter 4. The ferrous porphyrin binds a single 2-methylimida-
zole ligand, and, because the Fell center is raised out of the plane of the por-
phyrin ring, the 2-methyl substituent suffers minimal steric interactions with the
porphyrin. However, the affinity of the five-coordinate complex for another 2-
methylimidazole ligand is substantially lower, because the Fe II must drop down
into the plane of the porphyrin to form the six-coordinate complexes, in which
case the 2-methyl substitutents on both axial ligands suffer severe steric inter-
actions with the porphyrin. s1 Using this approach, five-coordinate monoimida-
zole complexes can be prepared. They are coordinatively unsaturated, and will
(A)
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Figure 5.2
(A) Frozen solution EPR spectra of Fe III(TPP)(4-Melm) (top) and Fe III(TPP)(4-Melmh-
(bottom) prepared by addition of 4-methylimidazolate anion (4-Melm -) to a solution of
Fe(TPP)(SbF6). The top spectrum is characteristic of a high-spin Fe III-porphyrin complex,
with a resonance at g = 6 (g = 2.7, 2.3, and 1.8 are due to formation of a small amount of
Fe III(TPP)(4-Melmh -). The bottom spectrum is characteristic of a low-spin ferric-porphyrin
bis(imidazole)-type complex. 52 (B) Frozen solution EPR spectrum of Cu II(lmH)4 2 + with
gil = 2.06, All = 183 G, and gl- = 2.256 (courtesy of Dr. J. A. Roe). This type of spectrum
is typical of square-planar Cu II complexes, except that the ligand hyperfine splitting of the g l-
feature is frequently unresolved, especially in copper proteins (for example, see Figure 5.20).
(C) Simulated EPR spectrum of a typical organic free radical with no hyperfine interaction.
Note the narrow linewidth and a g value close to 2.00, i.e., near the g value for a free electron.
bind a second axial ligand, such as O2 and CO. They have been extensively
studied as models for Or binding heme proteins such as hemoglobin and myog-
lobin. Monoimidazole ferrous porphyrins thus designed are high-spin d 6 with
four unpaired electrons. They are even-spin systems and EPR spectra have not
been observed.
Five-coordinate monoimidazole ferric-porphyrin complexes have also been
prepared in solution52 by starting with a ferric porphyrin complex with a very
poorly coordinating anion, e.g., Fe IIIP(SbF6). Addition of one equivalent of
imidazole results in formation of the five-coordinate monoimidazole complex
(Reaction 5.33).
Felll(TPPj(SbFs) + ImH~ [Felll(TPP)(ImH)l + + SbFs- (5.33)
When imidazole is added to ferric-porphyrin complexes of other anionic ligands,
e.g., CI ~, several equivalents of imidazole are required to displace the more
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strongly bound anionic ligand; consequently, only six-coordinate complexes are
observed (Reaction 5.34).
Felll(TPP)CI + 21mH~ [Felll(TPP)(lmHbJ + + CI- (5.34)
Monoimidazole ferric porphyrins are coordinatively unsaturated, readily bind a
second axial ligand, and thus are appropriate models for methemoglobin or
metmyoglobin. The five-coordinate complexes are high-spin d5, but usually be-
come low-spin upon binding another axial ligand to become six-coordinate.
dx2_y2 + +
dz 2 + +
dxz.d yz++ ++ ## -+#
dxy #- + # #
FeIlP(lmH) FeIIlP(lmH)+ FeIlP(lmH)(CO) FeIlIP(lmH)L+
8;2 8; 5/2 8 0 8; 1/2
-;/
(5.35)
HO
O=C
/
H
COOH
heme b
COOH COOH
heme a
COOH
Copper(l) complexes are typically two-, three-, or four-coordinate. 53 The
metal center is d 10, diamagnetic, and thus has no EPR spectrum. Copper(II)
complexes are typically four- or five-coordinate, d9, and have one unpaired
electron. 53 The interaction of the unpaired electron with the nuclear spin of
copper (I = i) causes characteristic hyperfine splitting of gil into four compo-
nents in the EPR, and the value of g~ is found to be near to but greater than
2.00. The EPR signal due to Cu II is thus normally distinguishable from that of
an organic free radical for which g~ = 2.00 (see Figure 5.2).
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2. Spectroscopy of the enzyme
The oxidized form of cytochrome c oxidase contains two Cu II and two Fe III
heme centers. It can be fully reduced to give a form of the enzyme containing
two Cu I and two Fe II heme centers. 44-46 The heme found in cytochrome c
oxidase is different from that found in other heme proteins. It is heme a, closely
related to heme b, which is found in hemoglobin, myoglobin, and cytochrome
P-450, but has one of the vinyl groups replaced by a farnesyl substituent and
one of the methyl groups replaced by a formyl substituent (see 5.35).
Each of the four metal centers has a different coordination environment
appropriate to its function. Cytochrome a and CUA appear solely to carry out an
electron-transfer function without interacting directly with dioxygen. Cyto-
chrome a3 and CUB appear to be part of a binuclear center that acts as the site
for dioxygen binding and reduction. A schematic describing the probable nature
of these four metal sites within cytochrome oxidase is given in Figure 5.3 and
a description of the evidence supporting the formulation of each center then
follows.
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Figure 5.3
Schematic representation of the metal centers in cytochrome c oxidase.
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Cytochrome a in both oxidation states has spectral characteristics that are
entirely consistent with a low-spin ferric heme center with two axial imidazole
ligands. In its oxidized form, it gives an EPR spectrum with g values 44-46 sim-
ilar to those obtained with model ferric-porphyrin complexes with two axial
imidazole ligands 49 ,50 (see above, Section IV.B.l). Moreover, addition of cya-
nide anion to the oxidized enzyme or CO to the reduced enzyme does not per-
turb this center, indicating that cyanide does not bind to the heme, again con-
sistent with a six-coordinate heme. The absence of ligand binding is characteristic
of six-coordinate heme sites found in electron-transfer proteins and suggests
strongly that cytochrome a functions as an electron-transfer center within cyto-
chrome c oxidase.
CUA is also believed to act as an electron-transfer site. It has quite remark-
able EPR spectroscopic characteristics, with g values at g = 2.18, 2.03, and
1.99, and no hyperfine splitting,44-46 resembling more an organic free radical
than a typical CUll center (see Figures 5.2 and 5.4A). ENDOR studies of yeast
cytochrome c oxidase containing 2H-cysteine or 15N-histidine (from yeast grown
with the isotopically substituted amino acids) showed shifts relative to the un-
substituted enzyme, indicating that both of these ligands are bound to CUA. 54
But the linear electric-field effect of CUA did not give the patterns characteristic
of Cu II-histidine complexes, indicating that the unpaired electron is not on the
copper ion. 55 The current hypothesis about this center is that copper is bonded
(Al-ij
(Bl
t
g; 6.0
t
g; 3.03
t
g; 2.00
t
g; 1.6
Figure 5.4
(A) EPR spectrum of oxidized cytochrome c oxidase. The signal at g = 2 is assigned to CU AII
and the signal at g = 3 is assigned to cytochrome a in the low-spin ferric state. No signals
attributable to the other two metal centers, i.e., cytochrome a3 and CUB, are observed (see text).
(B) Spectrum obtained after addition of NO. Binding of NO to CUB II decouples the two metal
ions, and thereby allows the high-spin ferric heme signal of cytochrome a3 at g = 6 to be ob-
served. (From M. Brunori et at., Adv. lnorg. Biochem. 7 (1988), 93-153, adapted from Refer-
ence 56.)
IV. CYTOCHROME c OXIDASE 273
in a highly covalent fashion to one, or more likely two, sulfur ligands, and that
the unpaired electron density is principally on sulfur, i.e., [Cu ll_ - SR~Cu I_
. SR]. Copper-thiolate model complexes with spectroscopic properties similar
to CUA have never been synthesized, presumably because such complexes are
unstable with respect to disulfide bond formation, i.e, 2 RS' ~ RS-SR. In the
enzyme, RS' radicals are presumably constrained in such a way that they cannot
couple to form disulfide bonds.
The other heme center, cytochrome G3, does bind ligands such as cyanide
to the FellI form and carbon monoxide to the Fell form, indicating that it is
either five-coordinate or that it has a readily displaceable ligand. Reaction with
CO, for example, produces spectral changes characteristic of a five-coordinate
ferrous heme binding CO to give the six-coordinate carbonmonoxy product anal-
ogous to MbCO. The cytochrome G3 site is therefore an excellent candidate for
O2 binding within cytochrome oxidase.
The EPR spectrum of fully oxidized cytochrome c oxidase might be ex-
pected to give signals corresponding to two Cu II centers and two ferric heme
centers. In fact, all that is observed in the EPR spectrum of the oxidized enzyme
is the typical low-spin six-coordinate ferric heme spectrum due to cytochrome G
and the EPR signal attributed to CUA (see Figure 5.4A). The fact that signals
attributable to cytochrome G3 and CUB are not observed in the EPR spectrum led
to the suggestion that these two metal centers are antiferromagnetically cou-
pled.44- 46 The measured magnetic susceptibility for the isolated enzyme was
found to be consistent with this hypothesis, suggesting that these two metal
centers consist of an S = i Cu II antiferromagnetically coupled through a bridg-
ing ligand to a high-spin S = i Fe III to give an S = 2 binuclear unit. 45 EXAFS
measurements indicating a copper-iron separation of 3-4 Aas well as the strength
of the magnetic coupling suggest that the metal ions are linked by a single-atom
ligand bridge, but there is no general agreement as to the identity of this bridge. 45,46
The cytochrome GrCUB coupling can be disrupted by reduction of the indi-
vidual metal centers. In this fashion, a g = 6 ESR signal can be seen for cy-
tochrome G3 or g = 2.053, 2.109, and 2.278 signals for CUB' Nitric-oxide bind-
ing to CUB also decouples the metals, allowing the g = 6 signal to be seen 56
(see Figure 5.4B). Mossbauer spectroscopy also indicates that cytochrome G3 is
high-spin in the oxidized as well as the reduced state. 57 ENDOR studies suggest
that CUB has three nitrogens from imidazoles bound to it with water or hydrox-
ide as a fourth ligand. 58 Studies using 15N-labeled histidine in yeast have dem-
onstrated that histidine is a ligand to cytochrome G3. 59 All of these features have
been incorporated into Figure 5.3.
C. Mechanism of Dioxygen Reduction
1. Models
Before we consider the reactions of cytochrome c oxidase with dioxygen, it
is instructive to review the reactions of dioxygen with iron porphyrins and cop-
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per complexes. Dioxygen reacts with ferrous-porphyrin complexes to make
mononuclear dioxygen complexes (Reaction 5.36; see preceding chapter for dis-
cussion of this important reaction). Such dioxygen complexes react rapidly with
another ferrous porphyrin, unless sterically prevented from doing so, to form
binuclear peroxo-bridged complexes 60.61 (Reaction 5.37). These peroxo com-
plexes are stable at low temperature, but, when the temperature is raised, the
0-0 bond cleaves and two equivalents of an iron(IV) oxo complex are formed
(Reaction 5.38). Subsequent reactions between the peroxo-bridged complex and
the Fe IV oxo complex produce the j.L-oxo dimer (see Reactions 5.39-5.40).
3Fe"(P) + 302 ----? 3Fe(P)(02)
3Fe(P)(02) +3Fe"(P) ----? 3(P)Felll-0-0-Felll(p)
(P)Fe"I-O-O-Felll(p) ----? 2FeIV(p)(0)
2FeIV(p)(0) +2(P)Fe"I-0-0-Felll(p) ----i>
2(P)Felll-0-Felll(p) +2Fe(P)(02)
2Fe(P)(02) ----? 2Fell(p) +202
(5.36)
(5.37)
(5.38)
(5.39)
(5.40)
(5.4 l)
The reaction sequence (5.36) to (5.40) thus describes a four-electron reduc-
tion of O2 in which the final products, two oxide, 0 2 , ligands act as bridging
ligands in binuclear ferric-porphyrin complexes (Reaction 5.41).
Copper(l) complexes similarly react with dioxygen to form peroxo-bridged
binuclear complexes. 62 Such complexes do not readily undergo 0-0 bond
cleavage, apparently because the copper(III) oxidation state is not as readily
attainable as the Fe(IV) oxidation state in an iron-porphyrin complex. Neverthe-
less, stable peroxo complexes of copper(II) have been difficult to obtain, be-
cause, as soon as it is formed, the peroxo complex either is protonated to give
free hydrogen peroxide or is itself reduced by more copper(l) (Reactions 5.42
to 5.46).
2Cu I + O2 ----? Cu II_O-O-Cu II
Cu II_O-O-Cu II + 2H + ----? 2Cu II + H20 2
2Cu I + H20 2 + 2H + ----? 2Cu II + 2H20
or Cu II_O-O-Cu II + 2Cu I + 4H + ----? 4Cu II + 2H20
(5.42)
(5.43)
(5.44)
(5.45)
(5.46)
Recently, however, examples of the long-sought stable binuclear copper(II) per-
oxo complex have been successfully synthesized and characterized, and inter-
estingly enough, two entirely different structural types have been identified, i.e.,
j.L-1,2 and j.L_YJ2:YJ2 dioxygen complexes 63 ,64 (see 5.47)
11-1 ,2
/O~LnCu~ I/CULn
o
ll-r(112
(5.47)
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2. Mechanistic studies of the enzyme
A single turnover in the reaction of cytochrome c oxidase involves (1) re-
duction of the four metal centers by four equivalents of reduced cytochrome c,
(2) binding of dioxygen to the partially or fully reduced enzyme, (3) transfer of
four electrons to dioxygen, coupled with (4) protonation by four equivalents of
protons to produce two equivalents of water, all without the leakage of any
substantial amount of potentially harmful partially reduced dioxygen byproducts
such as superoxide or hydrogen peroxide. 44- 46 At low temperatures, the reaction
can be slowed down, so that the individual steps in the dioxygen reduction can
be observed. Such experiments are carried out using the fully reduced enzyme
to which CO has been bound. Binding of CO to the Fell heme center in reduced
cytochrome c oxidase inhibits the enzyme and makes it unreactive to dioxygen.
The CO-inhibited derivative can then be mixed with dioxygen and the mixture
cooled. Photolysis of metal-CO complexes almost always leads to dissociation
of CO, and CO-inhibited cytochrome c oxidase is no exception. Photolytic dis-
sociation of CO frees the Fell heme, thereby initiating the reaction with dioxy-
gen, which can then be followed spectroscopically. 44-46 Dioxygen reacts very
rapidly with the fully reduced enzyme to produce a species that appears to be
the dioxygen adduct of cytochrome a3 (Reaction 5.48). Such a species is pre-
sumed to be similar to other mononuclear oxyheme derivatives. The dioxygen
ligand in this species is then rapidly reduced to peroxide by the nearby CUB,
forming what is believed to be a binuclear /-L-peroxo species (Reaction 5.49).
These steps represent a two-electron reduction of dioxygen to the peroxide level,
and are entirely analogous to the model reactions discussed above (Reactions
5.36 to 5.46), except that the binuclear intermediates contain one copper and
one heme iron. The /-L-peroxo FellI - (02 2 -) - CUll species is then reduced
by a third electron, resulting in cleavage of the 0-0 bond (Reaction 5.50).
One of the oxygen atoms remains with iron in the form of a ferryl complex,
i. e., an Fe IV oxo, and the other is protonated and bound to copper in the form
of a Cu II aquo complex. 65 Reduction by another electron leads to hydroxo com-
plexes of both the Fe III heme and the Cu II centers (Reaction 5.51).65 Protonation
then causes dissociation of two water molecules from the oxidized cytochrome
a3-CuB center (Reaction 5.52).
1--1 I I
(cyt aa)Fe" Cus' + O2~ (cyt aa)Fe"'(02-) Cus'
I I I I
(cyt aa)Fell '(02 -) CUs'~ (cyt aa)Fell'-(022 )-Cusil
I I 1----1
(cyt aa)Fell'-(O/ )-Cus" + e - + 2H +~ (cyt aa)Fe'V = 0 H20-CUsll
I I I I(cyt aa)Fe'v=O H20-Cus"+e-~ (cyt aa)Fe'Il-(OH-) (HO-)-Cusll
I I I-I
(cyt aa)Felll-(OH-) (HO-)-Cusll+2 H+ ~ (cyt aa)Felll Cusll+2 H20
(5.48)
(5.49)
(5.50)
(5.51)
(5.52)
Several important questions remain to be resolved in cytochrome c oxidase
research. One is the nature of the ligand bridge that links cytochrome a3 and
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CUB in the oxidized enzyme. Several hypotheses have been advanced (imida-
zolate, thiolate sulfur, and various oxygen ligands), but then discarded or dis-
puted, and there is consequently no general agreement concerning its identity.
However, EXAFS measurements of metal-metal separation and the strength of
the magnetic coupling between the two metal centers provide evidence that a
single atom bridges the two metals. 45 ,46 Another issue, which is of great impor-
tance, is to find out how the energy released in the reduction of dioxygen is
coupled to the synthesis of ATP. It is known that this occurs by coupling the
electron-transfer steps to a proton-pumping process, but the molecular mecha-
nism is unknown. 46 Future research should provide some interesting insights
into the mechanism of this still mysterious process.
V. OXYGENASES
A. Background
The oxygenase enzymes catalyze reactions of dioxygen with organic substrates
in which oxygen atoms from dioxygen are incorporated into the final oxidized
product. 2-4 These enzymes can be divided into dioxygenases, which direct both
atoms of oxygen into the product (Reaction 5.53), and monooxygenases, where
one atom of oxygen from dioxygen is found in the product and the other has
been reduced to water (Reaction 5.54):
Dioxygenase: substrate + *02-----'>substrate(*Oh
Monooxygenase: substrate + *02+ 2H + + 2e - -----'>substrate(*O) + H2*0
B. Dioxygenases
(5.53)
(5.54)
Dioxygenase enzymes are known that contain heme iron, nonheme iron, copper,
or manganese. 66,67 The substrates whose oxygenations are catalyzed by these
enzymes are very diverse, as are the metal-binding sites; so probably several,
possibly unrelated, mechanisms operate in these different systems, For many of
these enzymes, there is not yet much detailed mechanistic information. How-
ever, some of the intradiol catechol dioxygenases isolated from bacterial sources
have been studied in great detail, and both structural and mechanistic informa-
tion is available. 66,67 These are the systems that will be described here.
1. Intradiol catechol dioxygenases
The role of these nonheme iron-containing enzymes is to catalyze the deg-
radation of catechol derivatives to give muconic acids (Reaction 5.55, for ex-
ample). The enzymes are induced when the only carbon sources available to the
bacteria are aromatic molecules. The two best-characterized members of this
class are catechol 1,2-dioxygenase (CTD) and protocatechuate 3,4-dioxygenase
(PCD),
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R := H, cis,cis-muGonic acid;
Enz =catechol 1,2-dioxygenase
O OHI ~ +02R OH ~ {:eOOH~ eOOHR
R = COO-, p-carboxy cis,cis-muconic acid;
Enz = protocatechuate 3,4-dioxygenase
(5.55)
a. Characterization of the Active Sites Even before the x-ray crystal struc-
ture of PCD was obtained, a picture of the active site had been constructed by
detailed spectroscopic work using a variety of methods. The success of the spec-
troscopic analyses of these enzymes is a particularly good example of the im-
portance and usefulness of such methods in the characterization of metallopro-
teins. The two enzymes referred to in Reaction (5.55) have different molecular
weights and subunit compositions,66 but apparently contain very similar active-
site structures and function by very similar mechanisms. In both, the resting
state of the enzyme contains one Fe III ion bound at the active site. EPR spectra
show a resonance at g = 4.3, characteristic of high-spin Fe III in a so-called
rhombic (low symmetry) environment,66 and the Mossbauer parameters are also
characteristic of high-spin ferric. 66-68 Reactions with substrate analogues (see
below) cause spectral shifts of the iron chromophore, suggesting strongly that
the substrate binds directly to the iron center in the course of the enzymatic
reaction.
It is straightforward to rule out the presence of heme in these enzymes,
because the heme chromophore has characteristic electronic-absorption bands in
the visible and ultraviolet regions with high extinction coefficients, which are
not observed for these proteins. Likewise, the spectral features characteristic of
other known cofactors or iron-sulfur centers are not observed. Instead, the dom-
inant feature in the visible absorption spectrum is a band with a maximum near
460 nm and a molar extinction coefficient of 3000 to 4000 M - Jcm - 1 per iron
(see Figure 5.5). This type of electronic absorption spectrum is characteristic of
a class of proteins, sometimes referred to as iron-tyrosinate proteins, that con-
tain tyrosine ligands bound to iron(III) in their active sites, and which conse-
quently show the characteristic visible absorption spectrum due to phenolate-to-
iron(III) charge-transfer transitions. This assignment can be definitively proven
by examination of the resonance Raman spectrum, which shows enhancement
of the characteristic tyrosine vibrational modes (typically ~1170, 1270, 1500,
and 1600 cm 1) when the sample is irradiated in the charge-transfer band de-
scribed above. Ferric complexes of phenolate ligands may be seen to give al-
most identical resonance Raman spectra (see Figure 5.6). These bands have
been assigned as a C-H bending vibration and a C-O and two C-C stretch-
ing vibrations of the phenolate ligand. 69 In addition, NMR studies of the relax-
ation rates of the proton spins of water indicate that water interacts with the
paramagnetic Fe III center in the enzyme. This conclusion is supported by the
broadening of the Fe III EPR signal in the presence of Hz 170, due to interaction
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with the I = i nuclear spin of 170. Thus numerous spectroscopic studies of the
catechol dioxygenases led to the prediction that the high-spin ferric ion was
bound to tyrosine ligands and water. In addition, EXAFS data, as well as the
resemblance of the spectral properties to another, better characterized iron-ty-
rosinate protein, i.e., transferrin (see Chapter 1), suggested that histidines would
also be found as ligands to iron in these proteins. 66 ,67
Preliminary x-ray crystallographic results on protocatechuate 3,4-dioxygen-
ase completely support the earlier predictions based on spectroscopic studies. 70
The Fe IlI center is bound to two histidine and two tyrosine ligands and a water,
the five ligands being arranged in a trigonal bipyramidal arrangement, with a
tyrosine and a histidine located in axial positions, and with the equatorial water
or hydroxide ligand facing toward a cavity assumed to be the substrate-binding
cavity. The cavity also contains the positively charged guanidinium group of an
arginine side chain, in the correct position to interact with the negatively charged
carboxylate group on the protocatechuate substrate (see Figure 5.7).
Figure 5.7
A view of the active site of protocatechuate 3,4-dioxygenase based on the results of the x-ray
crystal structure. 70 The Fe III center is approximately trigonal bipyramidal, with Tyr-147 and His-
162 as axial ligands, and Tyr-108 and His-160 in the equatorial plane along with a solvent mol-
ecule (not shown) in the foreground. 66
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b. Mechanistic Studies As mentioned above, substrates and inhibitors that
are substrate analogues bind to these enzymes and cause distinct changes in the
spectral properties, suggesting strongly that they interact directly with the Fe III
center. Nevertheless, the spectra remain characteristic of the Fe IIl oxidation state,
indicating that the ferric center has not been reduced. Catecholates are excellent
ligands for Fe III (see, for example, the catecholate siderophores, Chapter 1) and
it might therefore be assumed that the catechol substrate would bind to iron
using both oxygen atoms (see 5.56).
0=0I 'Fe(lll)~ 0 (5.56)
However, the observation that phenolic inhibitors p-X-C6H4-OH bind strongly
to the enzymes suggested the possibility that the substrate binds to the iron
center through only one oxygen atom (see 5.57).
~O-Fe(lll)
~OH (5.57)
Paramagnetic NMR studies have been invaluable in distinguishing these two
possibilities. 67 The methyl group of the 4-methylcatecholate ligand is shifted by
the paramagnetic ferric ion to quite different positions in the lH NMR spectra,
depending on whether the catecholate is monodentate or bidentate. Comparison
of the positions of the methyl resonances in the lH NMR spectra of the model
complexes with those of the substrate 4-methylcatechol bound to the enzymes
CTD and PCD indicates quite clearly that the substrate is bound to CTD in a
monodentate fashion and to PCD in a bidentate fashion (see Figure 5.8). These
Figure 5.8 (facing page)
(A) Paramagnetically shifted IH-NMR spectra of Fe(salen) complexes with 4-methylphenolate
and 4-methylcatecholate ligands. Starred resonances are assigned to methyl groups. The top
spectrum is of the ferric-salen complex of the monodentate 4-methylphenolate ligand. The
middle spectrum is of the ferric-salen complex of the monoprotonated 4-methylcatecholate li-
gand. Note that two isomers are present, because the two oxygen atoms on the ligand are ine-
quivalent, and either may be used to make the monodentate complex. The bottom spectrum is of
the ferric-salen complex of the fully deprotonated 4-methylcatecholate ligand, which binds to the
iron in a bidentate fashion. Note the smaller span of isotropic shifts, which has been demon-
strated to be diagnostic of bidentate coordination. (B) Paramagnetically shifted IH-NMR spectra
of enzyme-substrate complexes of the dioxygenase enzymes catechol 1,2-dioxygenase (CTD)
and protocatecholate 3,4-dioxygenase (PCD). Note the resemblance between the position of the
methyl resonance in the complex of 4-methylcatechol with CTD and that of one of the methyl
resonances in the middle spectrum in (A), indicating that 4-methylcatechol binds to the ferric
center in CTD in a monodentate fashion through the 0-1 oxygen only. By contrast, the spec-
trum of 4-methylcatechol with PCD resembles the bottom spectrum in (A), indicating that here
the 4-methylcatecholate ligand is bidentate.66
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results contradict an early hypothesis that the mode of substrate binding, i.e.,
monodentate versus bidentate, might be a crucial factor in activating the sub-
strate for reaction with dioxygen. 67
Spectroscopic observations of the enzymes during reactions with substrates
and substrate analogues have enabled investigators to observe several interme-
diates along the catalytic pathway. Such studies have led to the conclusion that
the iron center remains high-spin Fe III throughout the entire course of the reac-
tion. This conclusion immediately presents a problem in understanding the na-
ture of the interaction of dioxygen with the enzyme, since dioxygen does not in
general interact with highly oxidized metal ions such as Fe III. The solution seems
to be that this reaction represents an example of substrate rather than dioxygen
activation.
Studies of the oxidation of ferric catecholate coordination complexes have
been useful in exploring mechanistic possibilities for these enzymes. 71 A series
of ferric complexes of 3,5-di-t-butyl-catechol with different ligands L have been
found to react with Oz to give oxidation of the catechol ligand (Reaction 5.58).
°t-BUY:0\ 0 t-BU-qI FeL ~ 0
~ 0 ~
t-Bu t-Bu 0
The relative reactivities of these complexes appear to vary with the donating
properties of the ligand L. Ligands that are the poorest donors of electron den-
sity tend to increase the reactivities of the complexes with Oz. These results
suggest that the reactivity of these complexes with Oz is increased by an in-
crease in the contribution that the minor resonance form B makes to the ground
state of the complex (see Figure 5.9) and that complexes of ligands that are
poor donors tend to favor electron donation from catechol to Fe III, thus increas-
ing the relative amount of minor form B. It should be noted that the spectro-
scopic characteristics of these complexes are nevertheless dominated by the ma-
jor resonance form A, regardless of the nature of L.
All these studies of the enzymes and their model complexes have led to the
mechanism summarized in Figure 5.9. 66 In this proposed mechanism, the ca-
techol substrate coordinates to the ferric center in either a monodentate or a
bidentate fashion, presumably displacing the water or hydroxide ligand. The
resulting catechol complex then reacts with dioxygen to give a peroxy derivative
of the substrate, which remains coordinated to Fe Ill. The subsequent rearrange-
ment of this peroxy species to give an anhydride intermediate is analogous to
well-characterized reactions that occur when catechols are reacted with alkaline
hydrogen peroxide. 72 The observation that both atoms of oxygen derived from
Oz are incorporated into the product requires that the ferric oxide or hydroxide
complex formed in the step that produces the anhydride does not exchange with
external water prior to reacting with the anhydride to open it up to the product
diacid.
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Figure 5.9
Proposed mechanism for catechol dioxygenases (modified from Reference 45). The major form
A is shown here with the catechol bound in a monodentate fashion. It may sometimes be bound
in a bidentate fashion as well (see text).
It is interesting to consider how the intradiol dioxygenase enzymes over-
come the kinetic barriers to oxidations by dioxygen, and why this particular
mechanism is unlikely to be applicable to the monooxygenase enzymes. The
first point is that the ferric catechol intermediate is paramagnetic, with resonance
forms that put unpaired electron density onto the carbon that reacts with dioxy-
gen. The spin restriction is therefore not a problem. In addition, the catechol
ligand is a very good reducing agent, much more so than the typical substrates
of the monooxygenase enzymes (see next section). It is possible, therefore, that
the reaction of dioxygen with the ferric catechol complex results in a concerted
two-electron transfer to give a peroxy intermediate, thus bypassing the relatively
unfavorable one-electron reduction of O2 .
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C. Monooxygenases
Metal-containing monooxygenase enzymes are known that contain heme iron,
nonheme iron, or copper at their active sites. 2 For most of these enzymes, there
is only limited information about the nature of the active site and the mode of
interaction with dioxygen or substrates. But there are three monooxygenase en-
zymes that strongly resemble well-characterized reversible dioxygen-carrying
proteins (see preceding chapter), suggesting that dioxygen binding to the metal-
loenzyme in its reduced state is an essential first step in the enzymatic mecha-
nisms, presumably followed by other steps that result in oxygenation of sub-
strates. The enzymes are:
(1) cytochrome P-450,73 a heme-containing protein whose active site resem-
bles the dioxygen-binding sites of myoglobin or hemoglobin in many
respects, except that the axial ligand to iron is a thiolate side chain from
cysteine rather than an imidazole side chain from histidine;
(2) tyrosinase,74 which contains two copper ions in close proximity in its
active site and which has deoxy, oxy, and met states that closely resem-
ble comparable states of hemocyanin in their spectroscopic properties;
and
(3) methane monooxygenase,75,76 which contains two nonheme iron ions in
close proximity and which resembles hemerythrin in many of its spec-
troscopic properties.
In addition to these three, there are also monooxygenase enzymes contain-
ing single nonheme iron 77 or copper ions,78 or nonheme iron plus an organic
cofactor such as a reduced pterin at their active sites. 79 Just as with the dioxy-
genase enzymes, we do not know how similar the mechanisms of the different
metal-containing monooxygenase enzymes are to one another. The enzyme for
which we have the most information is cytochrome P-450, and we will therefore
focus our discussion on that system. Speculations about the mechanisms for the
other systems are discussed at the end of this section.
1. Cytochrome P-450
Cytochrome P-450 enzymes are a group of monooxygenase enzymes that
oxygenate a wide variety of substrates. 73 Examples of such reactions are:
(1) hydroxylation of aliphatic compounds (Reaction 5.59);
(2) hydroxylation of aromatic rings (Reaction 5.60);
(3) epoxidation of olefins (Reaction 5.61);
(4) amine oxidation to amine oxides (Reaction 5.62);
(5) sulfide oxidation to sulfoxides (Reaction 5.63); and
(6) oxidative dealkylation of heteroatoms (for example, Reaction 5.64).
-t-H~ -t-OH
I I
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Ph-D-CH3~ Ph-OH + HCHO
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(5.59)
(5.60)
(5.61)
(5.62)
(5.63)
(5.64)
Some of these reactions have great physiological significance, because they rep-
resent key transformations in metabolism, as in lipid metabolism and biosyn-
thesis of corticosteroids, for example. 73 Cytochrome P-450 is also known to
catalyze the transformation of certain precarcinogens such as benzpyrene into
their carcinogenic forms. 73
Many of the P-450 enzymes have been difficult to characterize, because
they are membrane-bound and consequently relatively insoluble in aqueous so-
lution. However, cytochrome P-450cam ' which is a component of the camphor
5-monooxygenase system isolated from the bacterium Pseudomonas putida, is
soluble and has been particularly useful as the subject of numerous spectro-
scopic and mechanistic studies, as well as several x-ray crystallographic struc-
ture determinations. 80 This enzyme consists of a single polypeptide chain, mainly
a-helical, with a heme b group (Fe-protoporphyrin IX) sandwiched in between
two helices, with no covalent attachments between the porphyrin ring and the
protein. One axial ligand complexed to iron is a cysteinyl thiolate. In the resting
state, the iron is predominantly low-spin FellI, probably with a water as the
other axial ligand. When substrate binds to the resting enzyme, the spin state
changes to high-spin, and the non-cysteine axial ligand is displaced. The en-
zyme can be reduced to an FeU state, which is high-spin, and resembles deox-
yhemoglobin or myoglobin in many of its spectroscopic properties. This ferrous
form binds dioxygen to make an oxy form or carbon monoxide to make a car-
bonyl form. The CO derivative has a Soret band (high-energy 7T-7T* transition
of the porphyrin ring) at 450 nm, unusually low energy for a carbonyl derivative
of a heme protein because of the presence of the axial thiolate ligand. This
spectroscopic feature aids in the isolation of the enzyme and is responsible for
its name.
a. "Active Oxygen" Camphor 5-monooxygenase is a three-component
system, consisting of cytochrome P-450cam and two electron-transfer proteins, a
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flavoprotein, and an iron-sulfur protein (see Chapters 6 and 7). The role of the
electron-transfer proteins is to deliver electrons to theP-450 enzyme, but these
may be replaced in vitro by other reducing agents. The reaction sequence is in
Figure 5.10.
For cytochrome P-450, the question that is possibly of greatest current in-
terest to the bioinorganic chemist is just what mechanism enables activation of
dioxygen and its reaction with substrate. It seems clear that dioxygen binds to
substrate, e-
substrate (0)
'--_----.J N- Fe"'- NI'--_--J
OX
'--_---'I N - Fe"- N L..-I__-,
substrate
o
II,V~N-Fe -Nl--_-'
X
"peroxide shunt"
(OX ~ OIPh, RC03H, etc.) substrate
substrate
OOH
I
'--_----'I N - Fe"'- N '--_----.J
Figure 5.10
Proposed mechanism for cytochrome P-450. The resting enzyme is shown at the top of the cy-
cle. Substrate binds to the enzyme at a position close to the iron center, but it is not directly
coordinated to the metal ion. The enzyme-substrate complex is then reduced to the ferrous form.
Dioxygen then binds to form an oxy complex (not shown). The oxy complex is then reduced by
another electron and protonated, giving a ferric-hydroperoxy complex shown at the bottom of
the cycle. The ligand bound here to the Felli center is H02-, i.e. deprotonated hydrogen perox-
ide. The ferric hydroperoxy form of the enzyme-substrate complex then undergoes heterolytic
0-0 bond cleavage, giving a high-valent Fe IV oxo center, with the porphyrin ligand oxidized
by one equivalent (see text). This species then transfers a neutral oxygen atom to the bound
SUbstrate, which is then released, giving the oxygenated product and regenerating the resting
form of the enzyme. The "peroxide shunt" refers to the mechanism proposed for the cyto-
chrome PA50-catalyzed oxygenation of substrates by single-oxygen-atom donors (see text). It is
believed that the same high-valent iron-oxo intermediate is generated in these types of reactions
as well.
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the ferrous state of the enzyme-substrate complex, and that the resulting oxy
ligand, which presumably is similar to the oxy ligand in oxyhemoglobin and
oxymyoglobin, is not sufficiently reactive to attack the bound substrate. The
oxy form is then reduced and the active oxidant is generated, but the nature of
the active oxidant has not been deduced from studies of the enzyme itself, nor
has it been possible to observe and characterize intermediates that occur between
the time of the reduction and the release of product. Three species are potential
candidates for" active oxygen," the oxygen-containing species that attacks the
substrate, in cytochrome P-450. They are:
(1) a ferric peroxo, la, or hydroperoxo complex, lb, formed from one-
electron reduction of the oxy complex (Reaction 5.65);
(2) an iron(1V) oxo complex, 2, formed by homolytic 0-0 bond cleavage
of a ferric hydroperoxo complex (Reaction 5.66); and
(3) a complex at the oxidation level of an iron(V) oxo complex, 3, formed
by heterolytic 0-0 bond cleavage of a ferric hydroperoxo complex
(Reaction 5.67).
The hydroxyl radical, HO', although highly reactive and capable of attacking
P-450 substrates, is considered to be an unlikely candidate for "active oxygen"
because of the indiscriminate character of its reactivity.
e- H+
FeIlP+02 ---i> FeP02~ [FeIl1P(Ol-W --7 Fe1IlP(02H-)
1a 1b
FeIlIP(02H)~ FeIVP(O)+HO'
1b 2
FeIl1P(02W )~ [FeV(P2-)(O)+<---->Fe1v(P-)(O)+]+HO-
1b 3
(P2- = porphyrin ligand; P- = one-electron oxidized porphyrin ligand)
(5.65)
(5.66)
(5.67)
An iron(V) oxo complex (or a related species at the same oxidation level),
3, formed via Reaction (5.67), is the favored candidate for "active oxygen" in
cytochrome P-450. 81 This conclusion was initially drawn from studies of reac-
tions of the enzyme with alkylhydroperoxides and single-oxygen-atom donors.
Single-oxygen-atom donors are reagents such as iodosylbenzene, 01Ph, and per-
iodate, 104 ,capable of donating a neutral oxygen atom to an acceptor, form-
ing a stable product in the process (here, iodobenzene, 1Ph, and iodate, 103 -).
It was discovered that ferric cytochrome P-450 could catalyze oxygenation re-
actions using organic peroxides or single-oxygen-atom donors in place of diox-
ygen and reducing agents. Usually the same substrates would give the identical
oxygenated product. This reaction pathway was referred to as the "peroxide
shunt" (see Figure 5.10). The implication of this discovery was that the same
form of "active oxygen" was generated in each reaction, and the fact that sin-
gle-oxygen-atom donors could drive this reaction implied that this species con-
tained only one oxygen atom, i.e., was generated subsequent to 0-0 bond
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cleavage. The mechanism suggested for this reaction was Reactions (5.68) and
(5.69).
Fe(III)P + + ox ---i> 3 + X
3 + substrate ---i> Fe(III)P + + substrate(O)
(5.68)
(5.69)
b. Metalloporphyrin Model Systems Studies of the reactivities of synthetic
metalloporphyrin complexes in oxygen-transfer reactions and characterization of
intermediate species observed during the course of such reactions have been
invaluable in evaluating potential intermediates and reaction pathways for cyto-
chrome P-450. Logically, it would be most desirable if one could mimic the
enzymatic oxygenation reactions of substrates using iron porphyrins, dioxygen,
and reducing agents. However, studies of such iron-porphyrin-catalyzed reac-
tions have failed to produce meaningful results that could be related back to the
P-450 mechanism. This is perhaps not surprising, since the enzyme system is
designed to funnel electrons into the iron-dioxygen-substrate complex, and thus
to generate the active oxidant within the confines of the enzyme active site in
the immediate proximity of the bound substrate. Without the constraints im-
posed by the enzyme, however, iron porphyrins generally will either (1) cata-
lyze the oxidation of the reducing agent by dioxygen, leaving the substrate un-
touched, or (2) initiate free-radical autoxidation reactions (see Section II.C). A
different approach was suggested by the observation of the peroxide shunt re-
action (Reactions 5.68 and 5.69) using organic peroxides or single-oxygen-atom
donors, and the earliest successful studies demonstrated that Fe(TPP)CI
(TPP = tetraphenylporphyrin) would catalyze the epoxidation of olefins and the
hydroxylation of aliphatic hydrocarbons by iodosylbenzene 81(Reactions 5.70 and
5.71).
IPh
OH
0"OIPh '"""'''. 6" IPh
0+ OIPh Fe(TPP)CI, 0 0 +IPh
(5.70)
(5.71)
Reactions (5.70) and (5.71) were postulated to occur via an iron-bound ox-
idant such as 3 in Reaction (5.67). This hypothesis was tested by studying the
reaction of dioctyl Fe(PPIX)CI with iodosylbenzene, which resulted in 60 per-
cent hydroxylation at positions 4 and 5 on the hydrocarbon tail (see 5.72), po-
sitions for which there is no reason to expect increased reactivity except for the
fact that those particular locations are predicted from molecular models to come
closest to the iron center when the tail wraps around the porphyrin molecule.82
~4
~
o 5,,----,
O~F'{I"J_
Rooe
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(5.72)
The nature of the species produced when single-oxygen-atom donors react
with Fe III-porphyrin complexes has been deduced from studies of an unstable,
bright-gr,een porphyrin complex produced by reaction of FeIlI(TMP)CI
(TMP = 5,1O,15,20-tetramesitylporphyrin) with either iodosylbenzene or per-
oxycarboxylic acids in solution at low temperatures. 81 ,83 Titrations of this green
porphyrin complex using I - as a reducing agent demonstrated that this species
is readily reduced by two electrons to give the ferric complex FeIlI(TMP) + ,
i.e., that the green complex is two equivalents more oxidized than Fe III. A
logical conclusion would be that the green species is Fe V(p2-)(02-) +. How-
ever, spectroscopic studies of this species have led to the conclusion that it is,
in fact, an Fe lV oxo porphyrin-radical complex, FeIV(p' -)(0 2-) +, and that
this formulation is the best description of 3, the product formed from heterolytic
cleavage of the hydroperoxy intermediate in Reaction (5.67).81,83 EXAFS stud-
ies indicate that the green porphyrin complex contains iron bonded to an atom
at an unusually short distance, i.e., 1.6 A, in addition to being bonded to the
porphyrin nitrogens at 2 A. This short Fe-O distance is consistent with the
formulation of the complex as a "ferryl" complex, i.e., Fe IV = O. In such a
complex, the oxo ligand, 0 2-, is bonded to the Fe IV center by a combination
of a and 1T bonding, the latter because of overlap of the filled ligand
p-orbitals with the partially filled dxz and dyz orbitals of the metal. Confirmation
that the oxidation state of iron is indeed Fe IV comes from comparison of the
Mossbauer parameters (Ope = 0.06 and flEQ = 1.62) with those of other known
Fe IV-porphyrin complexes (see Figure 5.11).83
Visible absorption spectra of porphyrin complexes are due largely to 1T-1T*
transitions of the porphyrin ligand. The bright green color is unusual for iron-
porphyrin complexes, which are usually red or purple. (However, this green
color has been seen for compound I of catalase and peroxidases; see Section VI
below.) The unusually long-wavelength visible absorption bands that account
for the green color result from the fact that the porphyrin ring has been oxidized
by one electron. Similar visible absorption bands can be seen, for example, in
other oxidized porphyrin complexes, such as CoIlI(p' -) +, formed by two-elec-
tron oxidation of Co lI(p2-)(see 5.73).84
(5.73)
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Figure 5.11
Comparative Mossbauer data for iron-porphyrin complexes: • high-spin Fe lIl , D low-spin Fe lIl ,
• intermediate-spin (admixed) Fe lIl , 0 high-spin Fell, 6. low-spin Fell, • oxo- and imido-Fe IV,
* dimethoxyiron(IV)TMP. Insert shows the zero-field Mossbauer spectrum of 57Fe-dimethoxyi-
ron(IV)TMP at 4.2 K. (From Reference 83.)
Oxidized porphyrin ligands also give characteristic proton NMR spectra, which
are seen for the green porphyrin complex as well. 81 ,83
Magnetic measurements indicate that the green porphyrin complex contains
three unpaired electrons. Detailed analysis of the Mossbauer spectra has indi-
cated that the two unpaired electrons on the Fe IV ion are strongly ferro-
magnetically coupled to the unpaired electron on the porphyrin, accounting for
the resulting S = ! state. 81 ,83
S=1
++
-it
+
p'-
S=1/2
gives S=3/2
(5.74)
Studies of the reactions of this species with P-4S0-type substrates demonstrate
that this species is reactive enough to make it an attractive candidate for" active
oxygen" in the enzymatic mechanism. 81,83
Synthetic analogues for two of the other candidates for "active oxygen"
have also been synthesized and their reactivities assessed. For example, FellI
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and MnIII-porphyrin peroxo complexes analogous to 1a in Reaction (5.65) have
been synthesized. The x-ray crystal structure of the Mn complex shows that the
peroxo ligand is bound to the metal in a triangular, side-on fashion (see 5.75).
The Fe complex is believed to have a similar structure.85 ,86
0-0
\ /
Fe
--l ~
(5.75)
Studies of this species indicate that 1a in Reaction (5.65) would not have the
requisite reactivity to be a candidate for "active oxygen" in the cytochrome P-
450 mechanism, since it will not even oxidize triphenylphosphine, PPh3 , to
triphenylphosphine oxide, OPPh3 , one of the more facile oxygenation reactions
known. 87 Attempts to examine the protonated form, 1b in Reaction (5.65), how-
ever, indicate that it is highly unstable, and its reactivity has not yet been thor-
oughly examined. 87 Fe IV-oxo-porphyrin complexes analogous to 2 in Reaction
(5.66) have also been prepared in solution and characterized by NMR. 60,61 Such
complexes will react with PPh3 to give OPPh3 , but are relatively unreactive with
olefins and totally unreactive with saturated hydrocarbons. Thus 2 is also ruled
out as a candidate for "active oxygen" in PA50 mechanisms.
These reactivity studies, and the observation of the peroxide shunt described
above, indicate that Fe V(p2-)(0) + or FelV(p )(0) + is the most likely candi-
date for "active oxygen." These two formulations are, of course, isoelectronic,
and it is tempting to conclude that the latter is the more likely formulation of
the enzymatic intermediate. However, it is important to remember that the model
systems lack the axial cysteinylligand present in cytochrome P-450. The effect
of the relatively easily oxidized sulfur ligand on the electron distribution within
that intermediate is not known, since model systems for high-valent iron-oxo
complexes containing axial thiolate ligands have not been synthesized.
The mechanism of reactions of the high-valent oxo complex 3 in Reaction
(5.67) with a variety of substrates is an area of active interest. 81 ,88 Such studies
are generally carried out by generation of the species in situ from the reaction
of a ferric porphyrin with a single-oxygen-atom donor, such as a peracid or
iodosylbenzene. 89 In hydroxylation reactions of aliphatic hydrocarbons, the ini-
tial step appears to be abstraction of a hydrogen atom from the substrate to form
a substrate radical and an Fe IV hydroxide complex held together in a cage cre-
ated by the enzyme active site so that they cannot diffuse away from each other
(Reaction 5.76). This step is then followed by recombination of the OH frag-
ment with the substrate radical to make the hydroxylated product (Reaction 5.77).
This mechanism is referred to as the "oxygen rebound mechanism." 83
I· /
X - Fe 'v = 0 + H - C - --->
1 "
1 IV /X - Fe - OH + . C - --->
1 "
1 IV /X-Fe -OH+ 'C-
1 "
1 III /X-Fe + HO-C-
1 "
(5.76)
(5.77)
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The radical character of the intermediates formed in this reaction is supported
by the observation that such reactions carried out using synthetic porphyrins and
single-oxygen-atom donors in the presence of BrCCh give substantial amounts
of alkyl bromides as products, a result that is consistent with radical intermedi-
ates and inconsistent with either carbanion or carbonium-ion intermediates.83
In the enzymatic reactions themselves, there is also strong evidence to sup-
port a stepwise mechanism involving free-radical intermediates. For example,
cytochrome P-450cam gives hydroxylation of d-camphor only in the 5-exo posi-
tion, but deuterium-labeling studies show that either the 5-exo or the 5-endo
hydrogen is lost (Reaction 5.78).88
(5.78)
D
Such results are obviously inconsistent with a concerted mechanism in which
the oxygen atom would be inserted into the 5-exo C-H bond in one step; so
there would be no chance for the hydrogens in the two positions to exchange.
(Remember that alcohol protons exchange rapidly with water and therefore are
not expected to remain deuterated when the reaction is carried out in H20.)
The crystal structure of reduced cytochrome P-450cam with CO bound to the
iron and the substrate camphor bound 90 adjacent to it has been examined and
compared with the crystal structure of the oxidized enzyme with camphor bound.
The former is expected to be similar in structure to the less-stable oxy complex.
The comparison shows that the substrate camphor is closer to the iron center in
the oxidized enzyme. It is therefore possible that a similar movement of the
substrate occurs during the catalytic reaction after either a 5-exo or a 5-endo
hydrogen is abstracted, and that the new position of the camphor molecule then
restricts the hydroxylation step to the 5-exo position. It is interesting to note that
the 5-exo position on the camphor that is hydroxylated is held in very close
proximity to the Fe III center, and therefore to the presumed location of the oxo
ligand in the high-valent oxo intermediate in the structure of the ferric enzyme
plus camphor derivative (Figure 5.12). Crystal structures of the ferric form of
cytochrome P-450cam with norcamphor and adamantanone bound in place of
camphor have also been determined. 90 These alternative substrates are smaller
than camphor, and appear to fit more loosely than camphor. It is therefore rea-
sonable to assume that they "rattle around" to a certain extent in the substrate
__~ V3~
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Figure 5.12
Edge-on view of the P-450 active-site region with the substrate camphor molecule bound. 80 The
substrate camphor is located in a hydrophobic pocket directly above the heme and is oriented by
a hydrogen bond between the carbonyl oxygen of the camphor and Tyr-96. The position that is
hydroxylated in the oxygenation reaction, i.e., the 5-exo position, is the closest point of ap-
proach of the substrate to the expected position of the oxygen atom bound to iron in the high-
valent iron-oxo intermediate.
binding site, which probably accounts for the less-specific pattern of hydroxy-
lation observed for these alternative substrates.
Mechanisms for olefin epoxidations catalyzed either by the enzyme or by
model porphyrin complexes are not as well understood as those for hydroxyla-
tion of aliphatic hydrocarbons. Some of the possibilities that have been
proposed 88.91 are represented schematically in Figure 5.13.
c. 0-0 Bond Cleavage The evidence is persuasive that the "active oxy-
gen" species that attacks substrate in cytochrome P-450 is a high-valent iron-
oxo complex. However, the mechanism of formation of that species in the cat-
alytic reaction with dioxygen is less well-understood. Heterolytic 0-0 bond
cleavage of a ferric porphyrin hydroperoxide complex, Ib (Reaction 5.67), is
the logical and anticipated route, but it has not yet been unequivocally demon-
strated in a model complex. 92,93 The catalase and peroxidase enzymes catalyze
heterolytic 0-0 bond cleavage in reactions of hydrogen peroxide, but in them
the active sites contain amino-acid side chains situated to facilitate the devel-
[Fe]
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Figure 5.13
Schematic representation of possible mechanistic pathways for olefin epoxidation by 3.
The mechanisms described are, from right to left, concerted addition of oxygen to the
double bond, reaction via a metallocylic intermediate, reaction via a ring-opened radical
intermediate, and reaction proceeding via an initial electron-transfer step.91
oping charge separation that occurs in heterolytic cleavage (see Section VI). The
crystal structure of cytochrome P-450cam shows no such groups in the active-
site cavity, nor does it give any clue to the source of a proton to protonate the
peroxide ligand when it is produced. 8o Also, we have little experimental evi-
dence concerning possible roles that the cysteinyl sulfur axial ligand might play
in facilitating 0-0 bond cleavage. These issues remain areas of active interest
for researchers interested in cytochrome P-450 mechanisms.
2. Other metal-containing monooxygenase enzymes
As mentioned above, much less is known about the structural characteristics
and mechanisms of the nonheme metal-containing monooxygenase enzymes. From
the similarities of the overall stoichiometries of the reactions and the resem-
blance of some of the enzymes to dioxygen-binding proteins, it is likely that the
initial steps are the same as those for cytochrome P-450, i.e., dioxygen binding
followed by reduction to form metal-peroxide or hydroperoxide complexes. It is
not obvious that the next step is the same, however (i.e., 0-0 bond cleavage
VI. CATALASE AND PEROXIDASE 295
to form a high-valent metal-oxo complex prior to attack on substrate). The prob-
lem is that such a mechanism would generate metal-oxo complexes that appear
to contain metal ions in chemically unreasonable high-oxidation states, e.g.,
Fe v, Cu III , or Cu IV (Reactions 5.79-5.81).
(Felli - 00H)2+---> (Fe VO)3+ + OH
(CUll - OOH) + ---> (CU IVO)2+ + OH ~
(CUll 00 CUll) 2+ ---> 2 (CuIllO) +
(5.79)
(5.80)
(5.81)
An alternative mechanism is for the peroxide or hydroperoxide ligand to attack
the substrate directly; i.e., 0-0 bond cleavage could be concerted with attack
on substrate. Another possibility is that the oxygen atom is inserted in a metal-
ligand bond prior to transfer to the substrate. Neither of these alternative mech-
anisms has been demonstrated experimentally. These various possibilities re-
main to be considered as more information about the monooxygenase enzymes
becomes available.
VI. CATALASE AND PEROXIDASE
A. Description of the Enzymes
Catalase and peroxidase are heme enzymes that catalyze reactions of hydrogen
peroxide.94,95 In catalase, the enzymatic reaction is the disproportionation of
hydrogen peroxide (Reaction 5.82) and the function of the enzyme appears to
be prevention of any buildup of that potentially dangerous oxidant (see the dis-
cussion of dioxygen toxicity in Section III).
(5.82)
Peroxidase reacts by mechanisms similar to catalase, but the reaction catalyzed
is the oxidation of a wide variety of organic and inorganic substrates by hydro-
gen peroxide (Reaction 5.83).
peroxidase
H20 2 + AH2~ 2H20 + A (5.83)
(The catalase reaction can be seen to be a special case of Reaction 5.83 in which
the substrate, AH2, is hydrogen peroxide.) Some examples of peroxidases that
have been characterized are horseradish peroxidase, cytochrome c peroxidase,
glutathione peroxidase, and myeloperoxidase. 94,95
X-ray crystal structures have been determined for beef-liver catalase 80 and
for horseradish peroxidase 96 in the resting, high-spin ferric state. In both, there
is a single heme b group at the active site. In catalase, the axial ligands are a
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phenolate from a tyrosyl residue, bound to the heme on the side away from the
active-site cavity, and water, bound to heme within the cavity and presumably
replaced by hydrogen peroxide in the catalytic reaction. In horseradish peroxi-
dase, the axial ligand is an imidazole from a histidyl residue. Also within the
active-site cavity are histidine and aspartate or asparagine side chains that appear
to be ideally situated to interact with hydrogen peroxide when it is bound to the
iron. These residues are believed to play an important part in the mechanism by
facilitating 0-0 bond cleavage (see Section VI.B below).
Three other forms of catalase and peroxidase can be generated, which are
referred to as compounds I, II, and III. Compound I is generated by reaction of
the ferric state of the enzymes with hydrogen peroxide. Compound I is green
and has spectral characteristics very similar to the FeIV(p' -)(0) + complex pre-
pared at low temperatures by reaction of ferric porphyrins with single-oxygen-
atom donors (see Section V.c.1.a). Titrations with reducing agents indicate that
it is oxidized by two equivalents above the ferric form. It has been proposed
(see 5.84) that the anionic nature of the tyrosinate axial ligand in catalase may
serve to stabilize the highly oxidized iron center in compound I of that en-
zyme,80 and furthermore that the histidyl imidazole ligand in peroxidase may
deprotonate, forming imidazolate,52,97 or may be strongly hydrogen bonded,98
thus serving a similar stabilizing function for compound I in that enzyme.
o
II
--N-Fe-N--
I
o
6
tyrosinate
o
II
--N Fe-N--
I
N
L)
imidazolate
o
II
--N-Fe-N--
I
N
LJ
"H
"
"x
H-bonded imidazole
(5.84)
Reduction of compound I by one electron produces compound II, which has
the characteristics of a normal ferryl-porphyrin complex, analogous to 2, i.e.,
(L)FeIV(p)(O). Reaction of compound II with hydrogen peroxide produces com-
pound III, which can also be prepared by reaction of the ferrous enzyme with
dioxygen. It is an oxy form, analogous to oxymyoglobin, and does not appear
to have a physiological function. The reactions producing these three forms and
their proposed formulations are summarized in Reactions (5.85) to (5.88).
Felll(P)++H20 2~ FeIV(P'~)(O)++H20
ferric form Compound I
FeIV(p'~)(O)+ +e-~ FeIV(p)(O)
Compound I Compound II
FeIV(P)(O)+H20 2~ Fe(P)02+ H20
Compound II Compound III
(5.85)
(5.86)
(5.87)
B. Mechanism
Fell(P}+02~ Fe(P}02
ferrous form Compound III
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(5.88)
The accepted mechanisms for catalase and peroxidase are described in Reactions
(5.89) to (5.94).
catalase:
peroxidase:
Felll(p} + + H202~Felll(P)(H20d +~ FeIV(p' ~·)(O} + + H20
Compound I
FeIV(p' -)(0)+ + H202~ Felll(p)+ + H20 + O2
Compound I
FeIV(p' -}(O) + + AH2~ FeIV(p}(O} + HA" + H'
Compound I Compound II
FeIV(p)(O} + AH2~Felll(p)+ + HA" + OH-
Compound II
2HA"~A + AH2
or 2HA"~ HA - AH
(5.89)
(5.90)
(5.91)
(5.92)
(5.93)
(5.94)
In the catalase reaction, it has been established by use of HZI80 Z that the
dioxygen formed is derived from hydrogen peroxide, i.e., that 0-0 bond
cleavage does not occur in Reaction (5.90), which is therefore a two-electron
reduction of compound I by hydrogen peroxide, with the oxo ligand of the
former being released as water. For the peroxidase reaction under physiological
conditions, it is believed that the oxidation proceeds in one-electron steps (Re-
actions 5.91 and 5.92), with the final formation of product occurring by dispro-
portionation (Reaction 5.93) or coupling (Reaction 5.94) of the one-electron
oxidized intermediate. 94.95
C. Comparisons of Catalase, Peroxidase, and Cytochrome P-450
The proposal that these three enzymes all go through a similar high-valent oxo
intermediate, i.e., 3 or compound I, raises two interesting questions. The first
of these is why the same high-valent metal-oxo intermediate gives two very
different types of reactions, i.e., oxygen-atom transfer with cytochrome P-450
and electron transfer with catalase and peroxidase. The answer is that, although
the high-valent metal-oxo heme cores of these intermediates are in fact very
similar, the substrate-binding cavities seem to differ substantially in how much
access the substrate has to the iron center. With cytochrome P-450, the substrate
is jammed right up against the location where the oxo ligand must reside in the
high-valent oxo intermediate. But the same location in the peroxidase enzymes
is blocked by the protein structure so that substrates can interact only with the
heme edge. Thus oxidation of the substrate by electron transfer is possible for
catalase and peroxidase, but the substrate is too far away from the oxo ligand
for oxygen-atom transfer. 99 ,lz4
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The second question is about how the the high-valent oxo intermediate forms
in both enzymes. For catalase and peroxidase, the evidence indicates that hydro-
gen peroxide binds to the ferric center and then undergoes heterolysis at the
0-0 bond. Heterolytic cleavage requires a significant separation of positive
and negative charge in the transition state. In catalase and peroxidase, analysis
of the crystal structure indicates strongly that amino-acid side chains are situated
to aid in the cleavage by stabilizing a charge-separated transition state (Figure
5.14). In cytochrome P-450, as mentioned in Section V.C.1, no such groups
o
,.----, II IV ,----,
L-_-lIN-Fe -NI • +
Figure 5.14
Schematic representation of the mechanism for heterolytic 0-0 bond cleavage to fonn Com-
pound I in peroxidase, as proposed in Reference 96. The histidyl imidazole aids in transfer of a
proton from the oxygen atom of hydrogen peroxide that is bound to the iron to the departing
oxygen atom, while the positive charge of the arginyl side chain stabilizes the developing nega-
tive charge on the departing oxygen, thus facilitating heterolytic 0-0 bond cleavage.
are found in the hydrophobic substrate-binding cavity. It is possible that the
cysteinyl axial ligand in cytochrome P-450 plays an important role in 0-0
bond cleavage, and that the interactions found in catalase and peroxidase that
appear to facilitate such cleavage are therefore not necessary.
VII. COPPER-ZINC SUPEROXIDE DISMUTASE
A. Background
Two families of metalloproteins are excellent catalysts for the disproportionation
of superoxide (Reaction 5.95).
(5.95)
These are (1) the copper-zinc superoxide dismutases, CuZnSOD,100-102 found in
almost all eukaryotic cells and a very few prokaryotes, and (2) the manganese
and iron superoxide dismutases, MnSOD and FeSOD, the former found in the
mitochondria of eukaryotic cells, and both found in many prokaryotes. 103 Re-
cent studies of bacterial 104 and yeast 105 mutants that were engineered to contain
no superoxide dismutases demonstrated that the cells were unusually sensitive
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to dioxygen and that the sensitivity to dioxygen was relieved when an SOD
gene was reintroduced into the cells. These results indicate that the superoxide
dismutase enzymes playa critical role in dioxygen metabolism, but they do not
define the chemical agent responsible for dioxygen toxicity (see Section III).
B. Enzymatic Activity
Several transition-metal complexes have been observed to catalyze superoxide
disproportionation; in fact, aqueous copper ion, Cu 2 +, is an excellent SOD
catalyst, comparable in activity to CuZnSOD itselfp7 Free aqueous Cu 2 + would
not itself be suitable for use as an SOD in vivo, however, because it is too toxic
(see Section III) and because it binds too strongly to a large variety of cellular
components and thus would not be present as the free ion. (Most forms of
complexed cupric ion show much less superoxide dismutase activity than the
free ion.) Aside from aqueous copper ion, few other complexes are as effective
as the SOD enzymes.
Two mechanisms (Reactions 5.96 to 5.99) have been proposed for catalysis
of superoxide disproportionation by metal complexes and metalloenzymes. 37
Mechanism I:
2H+
M(n~1)++02~ ---? Mn+(Ol~) ---? Mn++H20 2
Mechanism II:
Mn+ + O2~ ---? Mn+ (02 ~)
2H+
Mn+(02~)+02~ ---? Mn+(022~) ---? Mn+H20 2
+02
(5.96)
(5.97)
(5.98)
(5.99)
In Mechanism I, which is favored for the SOD enzymes and most redox-active
metal complexes with SOD activity, superoxide reduces the metal ion in the
first step, and then the reduced metal ion is reoxidized by another superoxide,
presumably via a metal-peroxo complex intermediate. In Mechanism II, which
is proposed for nonredox metal complexes but may be operating in other situa-
tions as well, the metal ion is never reduced, but instead forms a superoxo
complex, which is reduced to a peroxo complex by a second superoxide ion. In
both mechanisms, the peroxo ligands are protonated and dissociate to give hy-
drogen peroxide.
Analogues for each of the separate steps of Reactions (5.96) to (5.99) have
been observed in reactions of superoxide with transition-metal complexes, thereby
establishing the feasibility of both mechanisms. For example, superoxide was
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shown to reduce Cu II(phen)z2+ to give Cul(phen)z + (phen = 1,1O-phenanthro-
line),106 a reaction analogous to Reaction (5.96). On the other hand, superoxide
reacts with CU II(tet b) 2+ to form a superoxo complex 107 (a reaction analogous
to Reaction 5.98), presumably because CU II(tet b) 2+ is not easily reduced to
the cuprous state, because the ligand cannot adjust to the tetrahedral geometry
that Cu 1 prefers. 53
H~HI" 1 I)
c: :~
/1 I",H~H
tet b
(5.100)
Reaction of superoxide with a reduced metal-ion complex to give oxidation of
the complex and release of hydrogen peroxide (analogous to Reaction 5.97) has
been observed in the reaction of FeIIEDTA with superoxide. 108 Reduction of a
Co III superoxo complex by free superoxide to give a peroxo complex (analogous
to Reaction 5.99) has also been observed. 109
If a metal complex can be reduced by superoxide and if its reduced form
can be oxidized by superoxide, both at rates competitive with superoxide dis-
proportionation, the complex can probably act as an SOD by Mechanism I.
Mechanism II has been proposed to account for the apparent catalysis of super-
oxide disproportionation by Lewis acidic nonredox-active metal ions under cer-
tain conditionsY However, this mechanism should probably be considered pos-
sible for redox metal ions and the SOD enzymes as well. It is difficult to
distinguish the two mechanisms for redox-active metal ions and the SOD en-
zymes unless the reduced form of the catalyst is observed directly as an inter-
mediate in the reaction. So far it has not been possible to observe this interme-
diate in the SOD enzymes or the metal complexes.
C. Structure
The x-ray crystal structure of the oxidized form of CuZnSOD from bovine
erythrocytes shows a protein consisting of two identical subunits held together
almost entirely by hydrophobic interactions.loo-I02 Each subunit consists of a
flattened cylindrical barrel of {3-pleated sheet from which three external loops of
irregular structure extend (Figure 5.15). The metal-binding region of the protein
binds Cu II and Zn II in close proximity to each other, bridged by the imidazolate
ring of a histidyI side chain. Figure 5.16 represents the metal-binding region.
The Cu II ion is coordinated to four histidyl imidazoles and a water in a highly
distorted square-pyramidal geometry with water at the apical position. The Zn II
ion is coordinated to three histidyl imidazoles (including the one shared with
Figure 5.15
Schematic drawing of the polypeptide backbone of one of the two subunits
of bovine CuZnSOD. The strands of the f3 structure are shown as arrows.
The active-site channel provides access to the copper site from the direction
of the viewer. (From J. A. Tainer et al., J. Mol. Bioi. 160 (1982), 181-217.)
Figure 5.16
Representation of the metal-binding region of bovine CuZnSOD.
copper) and an aspartyl carboxylate group, forming a distorted tetrahedral ge-
ometry around the metal ion.
One of the most unusual aspects of the structure of this enzyme is the oc-
currence of the bridging imidazolate ligand, which holds the copper and zinc
ions 6 Aapart. Such a configuration is not unusual for imidazole complexes of
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metal ions, which sometimes form long polymeric imidazolate-bridged struc-
tures.
F\ F\ F\
M-N' - 'N-M-N' - 'N-M-N' - 'N-M
"'7 "'7 "'7 (5.101)
However, no other imidazolate-bridged bi- or polymetallic metalloprotein has
yet been identified.
The role of the zinc ion in CuZnSOD appears to be primarily structural.
There is no evidence that water, anions, or other potential ligands can bind to
the zinc, so it is highly unlikely that superoxide could interact with that site.
Moreover, removal of zinc under conditions where the copper ion remains bound
to the copper site does not significantly diminish the SOD activity of the en-
zyme. J10 However, such removal does result in a diminished thermal stability,
i.e., the zinc-depleted protein denatures at a lower temperature than the native
protein, supporting the hypothesis that the role of the zinc is primarily structural
in nature. JJJ
The copper site is clearly the site of primary interaction of superoxide with
the protein. The x-ray structure shows that the copper ion lies at the bottom of
a narrow channel that is large enough to admit only water, small anions, and
similarly small ligands (Figure 5.17). In the lining of the channel is the posi-
tively charged side chain of an arginine residue,S Aaway from the copper ion
Figure 5.17
Schematic diagram of a cross section of the active-site channel in CuZnSOD. The diameter of
the channel narrows as the Cu II center is approached, and only small ligands can actually reach
that site. In addition to the positively charged Cu II ion at the bottom of the channel, the posi-
tively charged side chain of Arg-141 is part of the walls of the channel. Two positively charged
lysine side chains, not shown in this diagram, are close to the mouth of the channel. (From E.
D. Getzoff, R. A. Hallewell, and J. A. Tainer, in M. Inouye, ed., Protein Engineering: Appli-
cations in Science, Industry, and Medicine, Academic Press, 1986, pp. 41-69.)
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and situated in such a position that it could interact with superoxide and other
anions when they bind to copper. Near the mouth of the channel, at the surface
of the protein, are two positively charged lysine residues, which are believed to
play a role in attracting anions and guiding them into the channel. lIZ Chemical
modification of these lysine or arginine residues substantially diminishes the
SOD activity, supporting their role in the mechanism of reaction with superox-
ide.100-10Z
The x-ray structural results described above apply only to the oxidized form
of the protein, i.e., the form containing CUll. The reduced form of the enzyme
containing Cu I is also stable and fully active as an SOD. If, as is likely, the
mechanism of CuZnSOD-catalyzed superoxide disproportionation is Mechanism
I (Reactions 5.96-5.97), the structure of the reduced form is of critical impor-
tance in understanding the enzymatic mechanism. Unfortunately, that structure
is not yet available.
D. Enzymatic Activity and Mechanism
The mechanism of superoxide disproportionation catalyzed by CuZnSOD is gen-
erally believed to go by Mechanism I (Reactions 5.96-5.97), i.e., reduction of
Cu II to Cu I by superoxide with the release of dioxygen, followed by reoxidation
of CUI to CUll by a second superoxide with the release of HOz- or HzOz. The
protonation of peroxide dianion, Oz z-, prior to its release from the enzyme is
required, because peroxide dianion is highly basic and thus too unstable to be
released in its unprotonated form. The source of the proton that protonates per-
oxide in the enzymatic mechanism is the subject of some interest.
Reduction of the oxidized protein has been shown to be accompanied by the
uptake of one proton per subunit. That proton is believed to protonate the bridg-
ing imidazolate in association with the breaking of the bridge upon reduction of
the copper. Derivatives with Co II substituted for Zn II at the native zinc site have
been used to follow the process of reduction of the oxidized Cu II form to the
reduced Cu1form. The COIl in the zinc site does not change oxidation state, but
acts instead as a spectroscopic probe of changes occurring at the native zinc-
binding site. Upon reduction (Reaction 5.102), the visible absorption band due
to Co II shifts in a manner consistent with a change occurring in the ligand
environment of Co II. The resulting spectrum of the derivative containing Cu I in
the copper site and COIl in the zinc site is very similar to the spectrum of the
derivative in which the copper site is empty and the zinc site contains COlI. This
result suggests strongly that the imidazolate bridge is cleaved and protonated
and that the resulting imidazole ligand is retained in the coordination sphere of
COIl (Reaction 5.102).101
I F\ I
Cu(lI) - NVN - Co(ll)
I F\ I
Cu(l) H-NV N-Co(lI)
(5.102)
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The same proton is thus an attractive possibility for protonation of peroxide as
it is formed in the enzymatic mechanism (Reactions 5; 103 and 5. 104).
I F\ I
Cu(II)-NVN-Zn(ll) + 02-
I
Cu(l) H
I
Zn(ll) + 02 (5.103)
I F\ I
Cu(l) H-NvN-Zn(ll) + O2
I F\ I
--+ Cu(II)-N
V
N-Zn(lI) + H02- (5.104)
Attractive as this picture appears, there are several uncertainties about it.
For example, the turnover of the enzyme may be too fast for protonation and
deprotonation of the bridging histidine to occur. 113 Moreover, the mechanism
proposed would require the presence of a metal ion at the zinc site to hold the
imidazole in place and to regulate the pKa of the proton being transferred. The
observation that removal of zinc gives a derivative with almost full SOD activity
is thus surprising and may also cast some doubt on this mechanism. Other crit-
icisms of this mechanism have been recently summarized. 102
Studies of CuZnSOD derivatives prepared by site-directed mutagenesis are
also providing interesting results concerning the SOD mechanism. For example,
it has been shown that mutagenized derivatives of human CuZnSOD with major
differences in copper-site geometry relative to the wild-type enzyme may none-
theless remain fully active. 114 Studies of these and similar derivatives should
provide considerable insight into the mechanism of reaction of CuZnSOD with
superoxide.
E. Anions as Inhibitors
Studies of the interaction of CuZnSOD and its metal-substituted derivatives with
anions have been useful in predicting the behavior of the protein in its reactions
with its substrate, the superoxide anion, O2 - . 101.102 Cyanide, azide, cyanate,
and thiocyanate bind to the copper ion, causing dissociation of a histidyl ligand
and the water ligand from the copper. 115 Phosphate also binds to the enzyme at
a position close to the Cu II center, but it apparently does not bind directly to it
as a ligand. Chemical modification of Arg-141 with phenylglyoxal blocks the
interaction of phosphate with the enzyme, suggesting that this positively charged
residue is the site of interaction with phosphate.11 6
Electrostatic calculations of the charges on the CuZnSOD protein suggest
that superoxide and other anions entering into the vicinity of the protein will be
drawn toward and into the channel leading down to the copper site by the dis-
tribution of positive charges on the surface of the protein, the positively charged
lysines at the mouth of the active-site cavity, and the positively charged arginine
and copper ion within the active-site region. 112 Some of the anions studied, e.g.,
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CN -, F -, N3 ,and phosphate, have been shown to inhibit the SOD activity
of the enzyme. The source of the inhibition is generally assumed to be compe-
tition with superoxide for binding to the copper, but it may sometimes result
from a shift in the redox potential of copper, which is known to occur some-
times when an anion binds to copper. 100,101
F. Metal-Ion Substitutions
1. SOD activity
In the example described above, studies of a metal-substituted derivative
helped in the evaluation of mechanistic possibilities for the enzymatic reaction.
In addition, studies of such derivatives have provided useful information about
the environment of the metal-ion binding sites. For example, metal-ion-substi-
tuted derivatives of CuZnSOD have been prepared with Cu II, Cu I, Zn II, Ag I,
Ni ll , or COli bound to the native copper site, and with Zn ll , CUll, CuI, COli,
HgII, Cd ll , Ni ll , or Ag I bound to the native zinc site. 100, 101, 117 The SOD activ-
ities of these derivatives are interesting; only those derivatives with copper in
the copper site have a high degree of SOD activity, whereas the nature of the
metal ion in the zinc site or even its absence has little or no effect. 100,101
2. Spectroscopy
Derivatives of CuZnSOD are known with Cu II ion bound either to the native
copper site or to the native zinc site. The electronic absorption spectra of these
derivatives indicate that the ligand environments of the two sites are very dif-
ferent. Copper(1I) is a d 9 transition-metal ion, and its d-d transitions are usually
found in the visible and near-IR regions of the spectrum. 53 Copper(1I) com-
plexes with coordinated nitrogen ligands are generally found to have an absorp-
tion band between 500 and 700 nm, with an extinction coefficient below
100 M -Icm -I. Bands in the absorption spectra of complexes with geometries
that are distorted away from square planar tend to be red-shifted because of a
smaller d-d splitting, and to have higher extinction coefficients because of the
loss of centrosymmetry. Thus the optical spectrum of CuZnSOD with an ab-
sorption band with a maximum at 680 nm (14,700 cm -I; see Figure 5.18A)
and an extinction coefficient of 155 M -Icm -I per Cu is consistent with the
crystal structural results that indicate that copper(II) is bound to four imidazole
nitrogens and a water molecule in a distorted square-pyramidal geometry. Metal-
substituted derivatives with Cu II at the native copper site but with CO II, Cd II,
Hg II, or Ni II substituted for Zn II at the native zinc site all have a band at 680 nm,
suggesting that the substitution of another metal ion for zinc perturbs the copper
site very little, despite the proximity of the two metal sites. The absorption
spectra of native CuZnSOD and these CuMSOD derivatives also have a shoul-
der at 417 nm (24,000 cm -I; see Figure 5.18A), which is at lower energy than
normal imidazole-to-Cu II charge-transfer transitions, and has been assigned to
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Figure 5.18
Vis-UV spectra of (A) CuZnSOD, (B) copper-only SOD (zinc site empty), and (C) AgICuSOD,
In all three spectra, the low-energy band is the CUll d-d transition. Note that the spectrum of
CuZnSOD contains a shoulder at 24,000 cm-I (417 nm) that is assigned to the imidazolate-to-
copper(II) charge-transfer transition. This shoulder is not present in the copper-only derivative.
For AgICuSOD, the d-d transition is red-shifted because of the change in the ligand geometry
when CUll is moved from the copper site to the zinc site (see text), (From M. W. Pantoliano, L.
A. Nafie, and J. S. Valentine, J. Am. Chern. Soc. 104 (1982),6310-6317.)
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an imidazolate-to-Cu 1I charge transfer, indicating that the imidazolate bridge
between Cu II and the metal ion in the native zinc site is present, as observed in
the crystal structure of CuZnSOD. Derivatives with the zinc site empty, which
therefore cannot have an imidazolate bridge, are lacking this 417 nm shoulder.
Small but significant changes in the absorption spectrum are seen when the
metal ion is removed from the zinc site, e.g., in copper-only SOD (Figure 5.18B).
The visible absorption band shifts to 700 nm (14,300 cm -1), presumably due
to a change in ligand field strength upon protonation of the bridging imidazolate.
In addition, the shoulder at 417 nm has disappeared, again due to the absence
of the imidazolate ligand.
The spectroscopic properties due to copper in the native zinc site are best
observed in the derivative Ag1CuSOD, which has Ag 1 in the copper site and
Cu II in the zinc site (see Figure 5.18C), since the d 10 Ag 1 ion is spectroscopi-
cally silent. In this derivative, the dod transition is markedly red-shifted from
the visible region of the spectrum into the near-IR, indicating that the ligand
environment of Cu II in that site is either tetrahedral or five coordinate. The EPR
properties of Cu II in this derivative are particularly interesting (as discussed
below).
The derivative with CUll bound at both sites, CuCuSOD, has a visible-near
IR spectrum that is nearly a superposition of the spectra of CuZnSOD and
Ag1CuSOD (see Figure 5.19), indicating that the geometry of CUll in each of
these sites is little affected by the nature of the metal ion in the other site.
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Figure 5.19
Comparison of the visible absorption spectrum of CuCuSOD, --------, with that of Cu-
ZnSOD, ---, and of Ag1CuSOD, A digital addition of the spectra of Cu-
ZnSOD and of Ag1CuSOD generated the other spectrum, -'-'-'-'. Note that the spectrum of
CuCuSOD, which has CUll ions in both the copper and the zinc sites, closely resembles a super-
position of the spectra of CuZnSOD, which has CUll in the copper site, and Ag1CuSOD, which
has CUll in the zinc site. (From M. W. Pantoliano, L. A. Nafie, and J. S. Valentine, J. Am.
Chern. Soc. 104 (1982), 6310-6317.)
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EPR spectroscopy has also proven to be particularly valuable in character-
izing the metal environments in CuZnSOD and derivatives. The EPR spectrum
of native CuZnSOD is shown in Figure 5.20A. The gil resonance is split by the
hyperfine coupling between the unpaired electron on CUll and the I = i nuclear
spin of copper. The All value, 130 G, is intermediate between the larger All
(A)
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magnetic field (gauss)
Figure 5.20
Frozen solution EPR spectra of (A) CuZnSOD, (B) copper-only SOD (zinc site empty), and
(C) Ag1CuSOD. See text for discussion. (Adapted from References 100 and 101.)
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typical of square-planar Cu II complexes with four nitrogen donor ligands and
the lower All observed in blue copper proteins (see Chapter 6). The large line-
width seen in the g -l region indicates that the copper ion is in a rhombic (i.e.,
distorted) environment. Thus, the EPR spectrum is entirely consistent with the
distorted square-pyramidal geometry observed in the x-ray structure.
Removal of zinc from the native protein to give copper-only SOD results in
a perturbed EPR spectrum, with a narrower g1- resonance and a larger All value
(142 G) more nearly typical of CUll in an axial N4 environment (Figure 5.20B).
Apparently the removal of zinc relaxes some constraints imposed on the geom-
etry of the active-site ligands, allowing the copper to adopt to a geometry closer
to its preferred tetragonal arrangement.
The EPR spectrum due to Cu II in the native Zn II site in the Ag ICuSOD
derivative indicates that Cu II is in a very different environment than when it is
in the native copper site (Figure 5.20C). The spectrum is strongly rhombic, with
a low value of All (97 G), supporting the conclusion based on the visible spec-
trum that copper is bound in a tetrahedral or five-coordinate environment. This
type of site is unusual either for copper coordination complexes or for copper
proteins in general, but does resemble the CUll EPR signal seen when either
laccase or cytochrome c oxidase is partially reduced (see Figure 5.21). Partial
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Relationship between gil and All for naturally occurring copper proteins and copper-substituted
metalloproteins. Points labeled a-f are for laccases (a and b), cytochrome c oxidase (c), Cu-
ZnSOD (d), Ag1CuSOD (e), and CUICuIISOD (f). See text for discussion. (From M. W. Panto-
liana, L. A. Nafie, and J. S. Valentine, J. Am. Chern. Soc. 104 (1982),6310-6317.)
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reduction disrupts the magnetic coupling between these Cu II centers that makes
them EPR-silent in the fully oxidized protein.
The EPR spectrum of CuCuSOD is very different from that of any of the
other copper-containing derivatives (Figure 5.22) because the unpaired spins on
I I I I I I I I
1,400 1,800 2,200 2,600 3,000 3,400 3,800 4,200
magnetic field (gauss)
Figure 5.22
Frozen-solution EPR spectrum of CuCuSOD. Note the very different appearance of this spec-
trum from those shown in Figure 5.20. These differences are due to the fact that the two Cu 1I
centers are magnetically coupled across the imidazolate bridge. 100
the two copper centers interact and magnetically couple across the imidazolate
bridge, resulting in a triplet EPR spectrum. This spectrum is virtually identical
with that of model imidazolate-bridged binuclear copper complexes. 101
Electronic absorption and EPR studies of derivatives of CuZnSOD contain-
ing Cu II have provided useful information concerning the nature of the metal
binding sites of those derivatives. IH NMR spectra of those derivatives are gen-
erally not useful, however, because the relatively slowly relaxing paramagnetic
Cu II center causes the nearby proton resonances to be extremely broad. This
difficulty has been overcome in two derivatives, CuCoSOD and CuNiSOD, in
which the fast-relaxing paramagnetic COIl and Ni II centers at the zinc site inter-
act across the imidazolate bridge and increase the relaxation rate of the Cu II
center, such that well-resolved paramagnetically shifted IH NMR spectra of the
region of the proteins near the two paramagnetic metal centers in the protein
can be obtained and the resonances assigned. 1l8 ,119
The use of IH NMR to study CuCoSOD derivatives of CuZnSOD in com-
bination with electronic absorption and EPR spectroscopies has enabled inves-
tigators to compare active-site structures of a variety of wild-type and mutant
CuZnSOD proteins in order to find out if large changes in active-site structure
have resulted from replacement of nearby amino-acid residues. 120
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I. ELECTRON TRANSFERS IN BIOLOGY
A. Biological Redox Components
Three types of oxidation-reduction (redox) centers are found in biology: protein
side chains, small molecules, and redox cofactors. The first class is frequently
overlooked by mechanistic enzymologists. The sulfhydryl group of cysteine is
easily oxidized to produce a dimer, known as cystine:
-2e
2R-SH ---J> R-S-S-R
-2H +
(6.1)
This type of interconversion is known to occur in several redox proteins, includ-
ing xanthine oxidase, mercuric ion reductase, and thioredoxin. Other enzyme
systems display spectral evidence pointing to the presence of a protein-based
radical in at least one intermediate. EPR spectroscopy provides a powerful tool
in studying such systems; the observation of a g = 2.0 signal that cannot be
attributed to impurities or an organic redox cofactor is generally taken to be
evidence for a protein-based radical. Radicals localized on tyrosine (e.g., in
photosystem II and the B2 subunit of ribonucleotide reductase 1) and tryptophan
(e.g., in yeast cytochrome c peroxidase 2) have been unambiguously identified
using EPR techniques together with protein samples containing isotopically la-
beled amino acids (e.g., perdeuterated Tyr) or single amino-acid mutations (e.g.,
Trp ~ Phe).
A variety of small molecules, both organic and inorganic, can function as
redox reagents in biological systems. Of these, only the nicotinamide and qui- 315
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Figure 6.1
Reduction of NAD + to NADH.
none coenzymes are found throughout the biosphere. Nicotinamide adenine di-
nucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP)
participate in a wide variety of biological redox reactions. The 4-position of the
pyridine ring is the reactive portion of both molecules (Figure 6.1). Both typi-
cally function as 2-electron redox reagents.
In contrast, quinones may function as either 1- or 2-electron carriers:
e-- HT e- H+
Q ( , ) QH' ( , ) QH 2 (6.2)
Free-radical semiquinone (QH') intermediates have been detected by EPR spec-
troscopy in some electron transfers. Coenzyme Q, also called ubiquinone be-
cause it occurs in virtually all cells, contains a long isoprenoid tail that enables
it to diffuse through membranes rapidly. This quinone derivative, which occurs
in both free and protein-bound forms, is called ubiquinol when reduced (Figure
6.2). Other types of quinones are less frequently found in cells.
o
H3
C0x)CH3I I CH3
H3CO [CH2 - CH = 6- CH2 -t,; H
o n=6-10
Figure 6.2
Reduction of coenzyme Q (ubiquinone) to ubiquinol.
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Metalloproteins containing a single type of redox cofactor can be divided
into two general classes: electron carriers and proteins involved in the transport
or activation of small molecules. Adman 3 has identified some of the factors that
seem to be characteristic of electron-transfer proteins (these proteins are some-
times called "electron transferases"): (a) possession of a suitable cofactor to
act as an electron sink; (b) placement of the cofactor close enough to the protein
surface to allow electrons to move in and out; (c) existence of a hydrophobic
shell adjacent to, but not always entirely surrounding, the cofactor; (d) small
structural changes accompanying electron transfer; and (e) an architecture that
permits slight expansion or contraction in preferred directions upon electron
transfer.
Proteins that function as electron transferases typically place their prosthetic
groups in a hydrophobic environment and may provide hydrogen bonds (in ad-
dition to ligands) to assist in stabilizing both the oxidized and the reduced forms
of the cofactor. Metal-ligand bonds remain intact upon electron transfer to min-
imize inner-sphere reorganization 4 (discussed in Section III). Many of the com-
plex multisite metalloenzymes (e.g., cytochrome c oxidase, xanthine oxidase,
the nitrogenase FeMo protein) contain redox centers that function as intramole-
cular electron transferases, shuttling electrons to/from other metal centers that
bind exogenous ligands during enzymatic turnover.
There are four classes 3,5 of electron transferases, each of which contains
many members that exhibit important structural differences: flavodoxins, blue
copper proteins, iron-sulfur proteins, and cytochromes.
The flavodoxins 6 are atypical in that they contain an organic redox cofactor,
flavin mononucleotide (FMN; see Figure 6.3). These proteins have molecular
Figure 6.3
Reduction of FMN,
weights in the 8-13 kDa range, and are found in many species of bacteria and
algae. The FMN cofactor is found at one end of the protein, near the molecular
surface, but only the dimethylbenzene portion of FMN is significantly exposed
to the solvent (Figure 6.4). FMN can act as either a 1- or a 2-electron redox
center. In solution, the semiquinone form of free FMN is unstable, and dispro-
portionates to the quinone (oxidized) and hydroquinone (reduced) forms. Hence,
free FMN functions in effect as a 2-electron reagent. FMN in flavodoxins, on
the other hand, can function as a single-electron carrier. This is easily discerned
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Figure 6.4
Stereo view of the structure of a clostridial f1avodoxin. See R. D. Andersen et al., Proc. Natl.
Acad. Sci. USA 69 (1972),3189-3191. Figure kindly provided by M. L. Ludwig.
by comparing reduction potentials for free and protein-bound FMN (Table 6.1).
Clearly, the protein medium is responsible for this drastic alteration in oxida-
tion-state stability. From an NMR study 7 of the M. elsdenii flavodoxin quinone/
semiquinone and semiquinone/hydroquinone electron self-exchange rates, it was
concluded that the latter is approximately 300 times faster than the former, in
keeping with the view that the physiologically relevant redox couple is semiqui-
none/hydroquinone.
The blue copper proteins are characterized by intense S(Cys) .......,. Cu charge-
transfer absorption near 600 nm, an axial EPR spectrum displaying an unusually
small hyperfine coupling constant, and a relatively high reduction potentia1.4 ,8-10
With few exceptions (e.g., photosynthetic organisms), their precise roles in bac-
terial and plant physiology remain obscure. X-ray structures of several blue
copper proteins indicate that the geometry of the copper site is approximately
trigonal planar, as illustrated by the Alcaligenes denitrijicans azurin structure
(Figure 6.5).11,12 In all these proteins, three ligands (one Cys, two His) bind
tightly to the copper in a trigonal arrangement. Differences in interactions be-
tween the copper center and the axially disposed ligands may significantly con-
tribute to variations in reduction potential that are observed 12 for the blue copper
Table 6.1
Reduction potentials of FMN couples.
Free FMN
C.M.P. f1avodoxin
238 mY
92 mY
-172 mY
-399 mY
Abbreviations: Q, quinone; SQ, semiquinone; HQ,
hydroquinone.
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Figure 6.5
Structure of the blue copper center in azurin. 11
electron transferases. For example, EO' = 276 mV for A. denitrijicans azurin,
whereas that of P. vulgaris plastocyanin is 360 mY. In A. denitrijicans azurin,
the Cu-S(Met) bond is 0.2 Alonger than in poplar plastocyanin, and there is a
carbonyl oxygen 3.1 A from the copper center, compared with 3.8 A in plas-
tocyanin. These differences in bond lengths are expected to stabilize CUll in
azurin to a greater extent than in plastocyanin, and result in a lower EO' value
for azurin.
The iron-sulfur proteins play important roles 13.14 as electron carriers in vir-
tually all living organisms, and participate in plant photosynthesis, nitrogen fix-
ation, steroid metabolism, and oxidative phosphorylation, as well as many other
processes (Chapter 7). The optical spectra of all iron-sulfur proteins are very
broad and almost featureless, due to numerous overlapping charge-transfer tran-
sitions that impart red-brown-black colors to these proteins. On the other hand,
the EPR spectra of iron-sulfur clusters are quite distinctive, and they are of great
value in the study of the redox chemistry of these proteins.
The simplest iron-sulfur proteins, known as rubredoxins, are primarily found
in anaerobic bacteria, where their function is unknown. Rubredoxins are small
proteins (6 kDa) and contain iron ligated to four Cys sulfurs in a distorted tetra-
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hedral arrangement. The EO I value for the FeIII/I1 couple in water is 770 mY;
that of C. pasteurianum rubredoxin is - 57 mV. The reduction potentials of
iron-sulfur proteins are typically quite negative, indicating a stabilization of the
oxidized form of the redox couple as a result of negatively charged sulfur li-
gands.
The [2Fe-2S] ferredoxins (10-20 kDa) are found in plant chloroplasts and
mammalian tissue. The structure of Spirulina platensis ferredoxin 15 confirmed
earlier suggestions, based on EPR and Mossbauer studies, that the iron atoms
are present in a spin-coupled [2Fe-2S] cluster structure. One-electron reduction
(EO I ~ -420 mY) of the protein results in a mixed-valence dimer (Equation
6.3):
+8'-
[Fe2S2(SR)41 2- ( '[Fe2S2(SR)4P-
-e-
Fd"d
Fe(II) + Fe(III)
(6.3)
The additional electron in Fdred is associated with only one of the iron sites,
resulting in a so-called trapped-valence structure. 16 The [Fe2S2(SR)4] 4- cluster
oxidation state, containing two ferrous ions, can be produced in v itro when
strong reductants are used.
Four-iron clusters [4Fe-4S] are found in many strains of bacteria. In most
of these bacterial iron-sulfur proteins, also termed ferredoxins, two such clusters
are present in the protein. These proteins have reduction potentials in the
- 400 mV range and are rather small (6-10 kDa). Each of the clusters contains
four iron centers and four sulfides at alternate comers of a distorted cube. Each
iron is coordinated to three sulfides and one cysteine thiolate. The irons are
strongly exchange-coupled, and the [4Fe-4S] cluster in bacterial ferredoxins is
paramagnetic when reduced by one electron. The so-called "high-potential iron-
sulfur proteins" (HiPIPs) are found in photosynthetic bacteria, and exhibit
anomalously high (~350 mY) reduction potentials. The C. vinosum HiPIP (10
kDa) structure demonstrates that HiPIPs are distinct from the [4Fe-4S] ferredox-
ins, and that the reduced HiPIP cluster structure is significantly distorted, as is
also observed for the structure of the oxidized P. aerogenes ferredoxin. In ad-
dition, oxidized HiPIP is paramagnetic, whereas the reduced protein is EPR-
silent.
This bewildering set of experimental observations can be rationalized in
terms of a "three-state" hypothesis (Le., [4Fe-4S(SR)4] n - clusters exist in three
physiological oxidation states). 17 This hypothesis nicely explains the differences
in magnetic behavior and redox properties observed for these iron-sulfur pro-
teins (Equation 6.4):
+e +e[4Fe-4S(SR)41- ( '[4Fe-4S(SR)4F- ( '[4Fe-4S(SR)4P- (6.4)
-e- ~e-
HiPIPox HiPIP,ed
Ferredoxinox
Ferredoxin"d
a b
Figure 6.6
Structures of hemes G, b, and c.
(protein)
S-Cys
c
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The bacterial ferredoxins and HiPIPs all possess tetracubane clusters containing
thiolate ligands, yet the former utilize the - 2/ - 3 cluster redox couple, whereas
the latter utilize the - II - 2 cluster redox couple.
The protein environment thus exerts a powerful influence over the cluster
reduction potentials. This observation applies to all classes of electron transfer-
ases-the factors that are critical determinants of cofactor reduction potentials
are poorly understood at present but are thought t8 to include the low dielectric
constants of protein interiors (~4 for proteins vs. ~78 for H20), electrostatic
effects due to nearby charged amino-acid residues, hydrogen bonding, and geo-
metric constraints imposed by the protein.
As a class, the cytochromes t9-22 are the most thoroughly characterized of
the electron transferases. By definition, a cytochrome contains one or more heme
cofactors. These proteins were among the first to be identified in cellular ex-
tracts because of their distinctive optical properties, particularly an intense ab-
sorption in the 410-430 nm region (called the Soret band). Cytochromes are
typically classified on the basis of heme type. Figure 6.6 displays the three most
commonly encountered types of heme: heme a possesses a long phytyl "tail"
and is found in cytochrome c oxidase; heme b is found in b-type cytochromes
and globins; heme c is covalently bound to c-type cytochromes via two thioether
linkages. Cytochrome nomenclature presents a real challenge! Some cyto-
chromes are designated according to the historical order of discovery, e.g., cy-
tochrome C2 in bacterial photosynthesis. Others are designated according to the
Amax of the a band in the absorption spectrum of the reduced protein (e.g.,
cytochrome C55]).
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Figure 6.7
Structure of tuna cytochrome c.
Cytochromes c are widespread in nature. Ambler 23 divided these electron
carriers into three classes on structural grounds. The Class I cytochromes c
contain axial His and Met ligands, with the heme located near the N-terrninus
of the protein. These proteins are globular, as indicated by the ribbon drawing
of tuna cytochrome c (Figure 6.7). X-ray structures of Class I cytochromes c
from a variety of eukaryotes and prokaryotes clearly show an evolutionarily
conserved "cytochrome fold," with the edge of the heme solvent-exposed. The
reduction potentials of these cytochromes are quite positive (200 to 320 mV).
Mammalian cytochrome c, because of its distinctive role in the mitochondrial
electron-transfer chain, will be discussed later.
Class II cytochromes c (EO I ~ - 100 mV) are found in photosynthetic bac-
teria, where they serve an unknown function. Unlike their Class I cousins, these
c-type cytochromes are high-spin: the iron is five-coordinate, with an axial His
ligand. These proteins, generally referred to as cytochromes c' , are four-ex-helix
bundles (Figure 6.8). The vacant axial coordination site is buried in the protein
interior.
Finally, Class III cytochromes c, also called cytochromes C3, contain four
hemes, each ligated by two axial histidines. These proteins are found in a re-
stricted class of sulfate-reducing bacteria and may be associated with the cyto-
plasmic membrane. The low molecular weights of cytochromes C3 (~14.7 kDa)
require that the four hemes be much more exposed to the solvent than the hemes
of other cytochromes (see Figure 6.9), which may be in part responsible for
their unusually negative ( - 200 to - 350 mV) reduction potentials. These pro-
teins possess many aromatic residues and short heme-heme distances, two prop-
erties that could be responsible for their anomalously large solid-state electrical
conductivity. 24
Figure 6.8
Structure of cytochrome c' .
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Figure 6.9
Structure of cytochrome C3'
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B. Energy Storage and Release
Electron-transfer reactions play key roles in a great many biological processes,
including collagen synthesis, steroid metabolism, the immune response, drug
activation, neurotransmitter metabolism, nitrogen fixation, respiration, and pho-
tosynthesis. The latter two processes are of fundamental significance-they pro-
vide most of the energy that is required for the maintenance of life. From the
point of view of global bioenergetics, aerobic respiration and photosynthesis are
complementary processes (Figure 6.10). The oxygen that is evolved by photo-
synthetic organisms is consumed by aerobic microbes and animals. Similarly,
the end products of aerobic respiratory metabolism (C02 and H20) are the major
nutritional requirements of photosynthetic organisms. The global C, H, and 0
cycles are thus largely due to aerobic respiration and photosynthesis.
The extraction of energy from organic compounds, carried out by several
catabolic pathways (e.g., the citric-acid cycle), involves the oxidation of these
compounds to CO2 and H20 with the concomitant production of water-soluble
reductants (NADH and succinate). These reductants donate electrons to com-
ponents of the mitochondrial electron-transfer chain, resulting in the reduction
of oxygen to water:
(6.5)
In aerobic organisms, the terminal oxidant is, of course, oxygen. However,
some species of bacteria respire anaerobically and are able to use inorganic
oxyanions (nitrate or sulfate) as terminal oxidants. The translocation of protons
across the inner mitochondrial membrane accompanies the electron transfers that
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Aerobic respiration and photosynthesis.
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Figure 6.11
Redox components in mitochondria.
ultimately lead to the reduction of O2; these protons, in turn, activate ATP
synthase, which catalyzes the phosphorylation of ADP to ATP (a process known
as oxidative phosphorylation). Because the hydrolysis of ATP is very exoer-
gonic (i.e., ;)..G < 0), the newly synthesized ATP is used as a molecular energy
source to drive thermodynamically unfavorable reactions to completion.
The rediscovery of cytochromes by Keilin 25 in 1925 led him to propose that
the reduction of O2 is linked to the oxidation of reduced substrates by a series
of redox reactions, carried out by cellular components collectively referred to as
the respiratory electron-transport chain. Progress toward a molecular under-
standing of these redox reactions has been painfully slow. Most of the compo-
nents are multisubunit proteins that reside in the inner mitochondrial membrane
(Figure 6.11). These proteins (Complexes I-IV) are quite difficult to purify with
retention of in vivo properties, and they do not crystallize well.
The components 26-28 of the respiratory chain contain a variety of redox
cofactors. Complex I (NADH-Q reductase; > 600 kDa) contains five iron-sulfur
clusters and FMN. Complex II (succinate-Q reductase; 150 kDa) contains sev-
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Electron flow from NADH to O2 in the mitochondrial electron-transport chain.
eral iron-sulfur clusters, FAD (flavin adenine dinucleotide), and cytochrome bS68 .
Complex III (ubiquinol-cytochrome C reductase; 250 kDa) contains a [2Fe-2S]
iron-sulfur center and cytochromes bS62 ' bS66 ' and Ct. Complex IV (cytochrome
C oxidase; 200 kDa) contains at least two copper ions and cytochromes a and
a3; Q denotes coenzyme Q, which may be bound to hydrophobic subunits of
Complexes I, II, and/or III in vivo. Cytochrome c (cyt c in Figure 6.11) is a
water-soluble protein (12.4 kDa) that is only peripherally associated with the
inner mitochondrial membrane; it has been so thoroughly studied that it is gen-
erally regarded as the prime example of an electron transferase.
More than 20 redox centers are involved in the electron-transport chain.
Figure 6.12 depicts a simplified view of the flow of electrons from NADH to
O2 via this series of electron carriers. Electron flow through Complexes I, III,
and IV is associated with the release of relatively large amounts of energy,
which is coupled to proton translocation by these complexes (and therefore ATP
production). The redox potentials of the electron carriers thus appear to playa
role in determining the pathway of electron flow through the electron-transport
chain.
Approximately 50 percent of the surface area of the inner mitochondrial
membrane is lipid bilayer that is unoccupied by membrane proteins and through
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which these proteins, in principle, are free to diffuse laterally. Kinetic (laser
photobleaching and fluorescence recovery) and ultrastructural (freeze-fracture
electron microscopy) studies 29,30 indicate that Complexes I-IV diffuse indepen-
dently and laterally over the inner membrane, whereas cytochrome c diffuses in
three dimensions (i.e., through the intramembrane space). Respiratory electron
transport has been shown to be a diffusion-coupled kinetic process. 29,30 The
term "electron-transport chain" is thus somewhat misleading, because it implies
a degree of structural order that does not exist beyond the level of a given
protein complex.
In view of these observations, why are all of the electron transfers associ-
ated with mitochondrial respiration required? For example, why is cytochrome
c needed to shuttle electrons in Figures 6.11 and 6.12 when the cofactor reduc-
tion potentials of Complex III are more negative than those of Complex IV?
Evidently, factors other than b..Go are of importance-these will be discussed in
Sections III and IV.
Photosynthesis could be viewed as the most fundamental bioenergetic pro-
cess. Biological reactions are driven by an energy flux, with sunlight serving as
the energy source. Photosynthesis 31-36 is the process by which radiant solar
energy is converted into chemical energy in the form of ATP and NADPH,
which are then used in a series of enzymatic reactions to convert CO2 into
organic compounds. The photosynthetic algae that appeared on Earth two mil-
lion years ago released oxygen into the atmosphere and changed the environ-
ment from a reducing to an oxidizing one, setting the stage for the appearance
of aerobically respiring organisms.
Photosynthesis is initiated by the capture of solar energy, usually referred
to as "light harvesting." A large number of organic pigments, including chlo-
rophylls, carotenoids, phycoerythrin, and phycocyanin (in green plants and al-
gae) are clustered together in pigment-protein complexes called photosystems.
These pigments collectively absorb most of the sunlight reaching the Earth-
their absorption spectra are displayed in Figure 6.13. Light is transformed into
chemical energy in pigment-protein complexes called reaction centers. The con-
centration of reaction centers within a photosynthetic cell is too small to offer a
suitable absorption cross section for sunlight. Hence, hundreds of these light-
harvesting pigments function as molecular antennas; an x-ray structure 35 of one
subunit of a bacteriochlorophyll-protein complex is displayed in Figure 6.14.
Absorption of a photon by an antenna pigment promotes the pigment into
an electronically excited state, which can return to the ground state by a variety
of relaxation processes, including fluorescence or resonance transfer of excita-
tion energy to a nearby pigment at picosecond rates. As much as 100 ps may
elapse between the photon absorption and the arrival of the light energy at a
reaction center. During this time, the energy may "migrate" in a random-walk
fashion among hundreds of pigments.
The energy of the excited state is converted into electrochemical potential
energy at the reaction center, which contains a primary electron donor P that
transfers an electron to a nearby acceptor Al within the same protein (and P
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Absorption spectra of the photosystem pigments.
Figure 6.14
Structure of a subunit of a bacteriochlorophyll-protein complex. Reproduced with permission
from Reference 35.
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becomes oxidized to P+):
(6.5)
This charge separation is of paramount importance. The key problem is main-
taining the charge separation, which involves minimization of the energy-wast-
ing back reaction. Reaction centers contain an ordered array of secondary elec-
tron acceptors (AI, Az, A3 "') that optimize the ilGo that occurs at each step:
(6.6)
Thus, the back reaction is circumvented by optimizing forward electron transfers
that rapidly remove electrons from A I -. As the acceptors are separated by greater
and greater distances from P +, the probability of the back electron transfer to
P + decreases. Put another way, the overlap of P + and each acceptor orbital
decreases in the order P + fA I > P + fA z - > P + fA 3 - .
Photosynthetic bacteria contain only one type of reaction center (l00 kDa).
The solution of the x-ray structure (at 2.9 A resolution) of the Rps. viridis re-
action center was reported 36 in 1984, providing conclusive proof that electrons
can "tunnel" over 10-20 A distances through protein interiors. The reaction-
center protein contains many cofactors (Figure 6.15): two bacteriochlorophylls
(BChl) in close proximity (the so-called "special pair"), two further bacterio-
chlorophylls that are spectroscopically identical, two bacteriopheophytins (BPh),
two quinones (QA and QB), and one iron center. (QB was lost during isolation
of the Rps. viridis reaction center and thus does not appear in Figure 6.15.) The
reaction center contains an approximate two-fold rotation axis. Despite this
strikingly high symmetry in the reaction center, one pathway of electron flow
predominates, as the cartoon in Figure 6.16 indicates.
C. Coupling Electron Transfers and Substrate Activation
Electron transfers are key steps in many enzymatic reactions involving the oxi-
dation or reduction of a bound substrate. Relevant examples include cytochrome
c oxidase (Oz ~ 2HzO) and nitrogenase (Nz~ 2NH3). To reinforce the claim
that electron-transfer steps are of widespread importance, several other redox
systems, representative of diverse metabolic processes, will be mentioned here.
Xanthine oxidase (275 kDa; <Xz dimer) catalyzes the two-electron ox-
idation 37-39 of xanthine to uric acid (Equation 6.7).
xanthine
+ H20
o
~HHN N~ I }-OHo N N
H
uric acid
(6.7)
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Figure 6.15
Structure of the Rps. viridis photosynthetic reaction-center cofactors. The black dots delineate
the outward (0)- and inward (I)-facing portions of the membrane. Adapted from Reference 36.
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Electron flow in the bacterial photosynthetic reaction center.
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Representation of the cofactors in
one subunit of xanthine oxidase.
This enzyme, which plays a prominent role in the biodegradation of purines, is
the target of drugs administered to patients suffering from gout (joint inflam-
mation, due to precipitation of sodium urate). Figure 6.17 displays the cofactors
in a subunit: a Mo-pterin, termed MoCo; two [2Fe-2S] centers; and one FAD.
The binuclear iron-sulfur sites serve to shuttle electrons between the reduced
substrate (XH) and O2 ,
The first step in the biosynthesis of DNA involves the reduction of ribonu-
cleotides (Equation 6.8) catalyzed by ribonucleotide reductase. 4o The E. coli
enzyme is an (X2{32 tetramer composed of a B1 protein (160 kDa) and a B2
protein (78 kDa). The BI protein (a dimer) contains redox-active dithiol groups,
binding sites for ribonucleotide substrates, and regulatory binding sites for nu-
cleotide diphosphates. Protein B2, also a dimer, possesses a phenolate radical
(Tyr-122) that is stabilized by an antiferromagnetically coupled binuclear iron
center (Figure 6.18). This radical is essential for enzyme activity, and is ~10 A
from the protein-B lIprotein-B2 interface. Hence it cannot directly participate in
an H-atom abstraction from the substrate (bound to protein B1). Instead, the x-
ray structure of the B2 protein 41 suggests that a long-range electron transfer
from the Tyr radical to a residue (perhaps Trp-48) on the B1 protein is operative
during enzyme turnover.®:v-a-v""
OH OH
_
__--. ®:V-O-CQH20 base
ribonucleotide
•
reductase
OH H
(6.8)
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Figure 6.18
Schematic of the binuclear iron center and Tyr-122 radical in
the B2 protein of E. coli ribonucleotide reductase. 41
Most of the presently known metal-containing mono- and dioxygenases are
multicomponent, requiring the involvement of additional proteins (electron
transferases) to shuttle electrons from a common biological reductant (usually
NADH or NADPH) to the metallooxygenase. Cytochrome P-450, whose sub-
strate oxidation chemistry was discussed in detail in Chapter 5, serves as an
excellent example. Figure 5.10 presented a catalytic cycle for cytochrome
P-450-dependent hydroxylations 42 that begins with substrate (RH) binding to the
ferric enzyme (RH is camphor for Pseudomonas putida cytochrome P-450). To
hydroxylate the camphor substrate, the monooxygenase must be reduced via the
electron-transport chain in Equation (6.9).
NADH) 0(OX)~ €(red)~+H+
[FAD] [2Fe-2S]
Ferredoxin P t"d d "
reductase U I are oXln
NAD+ (red) (ox)
(
(OX)) (R-OH,HP
[Heme] (6.9)
P-450
(red) RH, O2
The ferredoxin reductase receives two electrons from NADH and passes them
on, one at at time, to putidaredoxin, a [2Fe-2S] iron-sulfur protein. Thus, two
single-electron-transfer steps from reduced putidaredoxin to cytochrome P-450
are required to complete one enzyme turnover.
The activity of the enzyme appears to be regulated at the first reduction
step.43 In a 1: 1 putidaredoxin-cytochrome P-450 complex, the reduction poten-
tial of putidaredoxin is - 196 mV, but that of cytochrome P-450 is - 340 mV
in the absence of camphor; reduction of the cytochrome P-450 is thus thermo-
dynamically unfavorable (k ~ 0.22 s ~ I). Upon binding camphor, the reduction
L ELECTRON TRANSFERS IN BIOLOGY 333
potential of cytochrome P-4S0 shifts to - 173 mV, and the electron-transfer rate
in the protein complex accordingly increases to 41 s -1. "Costly" reducing
equivalents are not wasted, and there are no appreciable amounts of noxious
oxygen-reduction products when substrate is not present.
In the third step, molecular oxygen binds to the camphor adduct of ferrous
cytochrome P-4S0. This species, in the presence of reduced putidaredoxin, ac-
cepts a second electron, and catalyzes the hydroxylation of the bound camphor
substrate. The turnover rate for the entire catalytic cycle is 10-20 s -I, and the
second electron-transfer step appears to be rate-determining. 44
The bulk of the interest in electron-transfer reactions of redox proteins has
been directed toward questions dealing with long-range electron transfer and the
nature of protein-protein complexes whose structures are optimized for rapid
intramolecular electron transfer. Before we undertake a discussion of these is-
sues, it is worth noting that studies of the reactions of redox proteins at elec-
trodes are attracting increasing attention. 45- 47 Direct electron transfer between a
variety of redox proteins and electrode surfaces has been achieved. Potential
applications include the design of substrate-specific biosensors, the development
of biofuel cells, and electrochemical syntheses. An interesting application of
bioelectrochemical technology is the oxidation of p-cresol to p-hydroxybenzal-
dehyde (Figure 6.19).48
CHO
¢
OH
electrode
surface
AZax ENZax
Q
OH
Figure 6.19
Enzyme-catalyzed electrochemical oxidation of p-cresol to p-hydroxybenzaldehyde.
AZ is azurin, and ENZ is p-cresol methylhydroxylase.48
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II. ELECTRON-TRANSFER RATES
A. Overview
Measurements of the rates of oxidation-reduction reactions began in the late
1940s. A great deal of the early experimental work was carried out by inorganic
chemists, and by the 1970s the reactivity patterns of many complexes had been
uncovered. 49- 51 Chemists studying the mechanisms of metalloprotein electron-
transfer reactions frequently seek parallels with the redox behavior of less-com-
plicated inorganic complexes.
In examining biological electron transfers, it is important to remember that
metalloproteins are more than just metal ions in disguise. Virtually every prop-
erty of a protein (excluding its amino-acid sequence) depends on the solution
pH. Redox proteins are very large polyelectrolytes whose redox prosthetic groups
are typically buried in the protein interior. One important distinction between
redox reactions of proteins and redox reactions of small transition-metal com-
plexes is the magnitude of the electron donor-to-acceptor distance. The relevant
distance for small molecules, unlike redox proteins, is generally taken to be van
der Waals contact. Within the last ten years, it has been convincingly demon-
strated that electrons can "tunnel" at significant rates across distances of 15 A
or more in protein interiors. 52-58
Experimental investigation of the factors that control the rates of biological
redox reactions has not come as far as the study of the electron transfers of
metal complexes, because many more variables must be dealt with (e.g., asym-
metric surface charge, nonspherical shape, uncertain details of structures of pro-
teins complexed with small molecules or other proteins). Many experimental
approaches have been pursued, including the covalent attachment of redox re-
agents to the surfaces of metalloproteins.
B. Self-Exchange and Cross Reactions
The simplest reactions in solution chemistry are electron self-exchange reactions
(Equation 6.10), in which the reactants and products are the same (the asterisk
is used to identify a specific isotope). The only
*Aox + Ared~ *Ared + Aox (6.10)
way to establish chemically that a reaction has taken place is to introduce an
isotopic label. There is no change in the free energy (LlGo = 0) for this type of
reaction. As will become evident later on, the reason why these types of reac-
tions are studied is because self-exchange rates and activation parameters are
needed to interpret redox reactions in which a net chemical change occurs. The
experimental measurement 58 of self-exchange rates is tedious and usually only
results in an order-of-magnitude estimate of the rate constant (as inferred from
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Table 6.2
Experimental timescales in seconds.
Laser flash photolysis
Pulse radiolysis
Mossbauer spectroscopy (57Fe)
EPR (transition metals)
Temperature-jump spectrometry
NMR CH)
Chemical mixing
~IO -14
~1O-9
10 -9_10- 6
10-9_10- 8
~1O-8
~1O-5
~1O-3
the experimental timescale; see Table 6.2). Most of the protein self-exchange
rates reported to date have been measured by NMR line-broadening studies.
Other potentially useful methods, such as Mossbauer spectroscopy and EPR,
have not been widely used.
An elegant example of the measurement of an electron self-exchange rate
of a redox protein was reported by Dahlin et ai. 59 The copper ion of stellacyanin
was removed and then replaced with either 63CU or 65CU. Oxidized [63CU] stel-
lacyanin was allowed to react with reduced [65CU] stellacyanin for various times
(10 ms to 7 min) at 20°C, after which the reaction was quenched by lowering
the solution temperature to - 120°C using a rapid-freeze apparatus:
(6.11)
Subtle differences in the EPR spectra (Figure 6.20) of the two isotopic forms of
stellacyanin (due to a small difference in the nuclear magnetic moments of the
two isotopes) were used to monitor the progress of the reaction, yielding a rate
constant of 1.2 x 10 5 M - 1 S - I .
Much more common are cross reactions (Equation 6.12), where Aox is the
oxidized reactant, Bred is the reduced reactant, Ared is the reduced product, and
Box is the oxidized product.
(6.12)
For these reactions, fiGo 7"=- O. The experimental measurement of cross-reaction
rates is generally more straightforward than the measurement of self-exchange
rates. Either the reactants are simply mixed together, or a thermodynamically
unstable system is generated rapidly (via pulse radiolysis, flash photolysis, or
temperature-jump relaxation) to initiate the redox reaction. Absorption spectros-
copy has almost always been used to monitor the progress of protein cross re-
actions. The primary goal of theory, as will become evident, is to provide a
relationship between fiGo and fiG+ for cross reactions.
Both self-exchange and cross reactions can be broadly classified as inner-
sphere or outer-sphere reactions. In an inner-sphere reaction, a ligand is shared
between the oxidant and reductant in the transition state. An outer-sphere reac-
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Figure 6.20
Frozen-solution EPR spectra of
stellacyanin (20 K, 9.25 GHz):
(A) 65CU; (B) 63CU; (C) Differ-
ence spectrum (A - B). 59
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magnetic flux density (T)
tion, on the other hand, is one in which the inner coordination shells of both
the oxidant and the reductant remain intact in the transition state. There is no
bond breaking or bond making, and no shared ligands between redox centers.
Long-range electron transfers in biology are all of the outer-sphere type.
III. ELECTRON-TRANSFER THEORY
A. Basic Concepts
The simplest electron transfer occurs in an outer-sphere reaction. The changes
in oxidation states of the donor and acceptor centers result in a change in their
equilibrium nuclear configurations. This process involves geometric changes,
the magnitudes of which vary from system to system. In addition, changes in
the interactions of the donor and acceptor with the surrounding solvent mole-
cules will occur. The Franck-Condon principle governs the coupling of the elec-
tron transfer to these changes in nuclear geometry: during an electronic transi-
tion, the electronic motion is so rapid that the nuclei (including metal ligands
and solvent molecules) do not have time to move. Hence, electron transfer oc-
curs at a fixed nuclear configuration. In a self-exchange reaction, the energies
of the donor and acceptor orbitals (hence, the bond lengths and bond angles of
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the donor and acceptor) must be the same before efficient electron transfer can
take place.
The incorporation of the Franck-Condon restriction leads to the par-
titioning 60-65 of an electron-transfer reaction into reactant (precursor complex)
and product (successor complex) configurations. The steps in Equations (6.13)
to (6.15) go from reactants to products: K is the equilibrium constant for the
formation of the precursor complex [Aox , Bred], and ket is the forward electron-
transfer rate to produce the successor complex [Ared , Boxl.
Aox + Bred ( K ) lAox, Bred]
IAox, Bred]~ IAred. Box]
(6.13)
(6.14)
(6.15)
Marcus pioneered the use of potential energy diagrams as an aid in describ-
ing electron-transfer processes. 60 For the sake of simplicity, the donor and ac-
ceptor are assumed to behave like collections of harmonic oscillators. Instead of
two separate potential energy surfaces being used for the reactants, they are
combined into a single surface that describes the potential energy of the precur-
sor complex as a function of its nuclear configuration (i.e., the sum of the
translational, rotational, and vibrational degrees of freedom of the reactant mol-
ecules and the molecules in the surrounding solvent-3N coordinates, where N is
the number of nuclei present). Similarly, a single potential energy (3N-dimen-
sional) surface is used to describe the potential energy of the successor complex
as a function of its nuclear configuration. It has become conventional to simplify
such potential energy diagrams by using one-dimensional slices through the reactant
and product surfaces in order to visualize the progress of a reaction, as illus-
trated in Figure 6.21.
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Figure 6.21
Potential energy diagrams: (A) self-exchange reaction; (B) cross reaction. Point S represents the
activated complex. ER and Ep are the reactant and product surfaces, respectively.
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The intersection of the reactant and product surfaces (point S) represents the
transition state (or "activated complex"), and is characterized by a loss of one
degree of freedom relative to the reactants or products. The actual electron-
transfer event occurs when the reactants reach the transition-state geometry. For
bimolecular reactions, the reactants must diffuse through the solvent, collide,
and form a precursor complex prior to electron transfer. Hence, disentangling
the effects of precursor complex formation from the observed reaction rate can
pose a serious challenge to the experimentalist; unless this is gone, the factors
that determine the kinetic activation barrier for the electron-transfer step cannot
be identified with certainty.
The surfaces depicted in Figure 6.21 presume that the electrons remain lo-
calized on the donor and acceptor; as long as this situation prevails, no electron
transfer is possible. Thus some degree of electronic interaction, or coupling, is
required if the redox system is to pass from the precursor to the successor com-
plex. This coupling removes the degeneracy of the reactant and product states
at the intersection of their respective zero-order surfaces (points S in Figure
6.21) and leads to a splitting in the region of the intersection of the reactant and
product surfaces (Figure 6.22). If the degree of electronic interaction is suffi-
ciently small, first-order perturbation theory can be used to obtain the energies
of the new first-order surfaces, which do not cross. The splitting at the intersec-
tion is equal to 2HAB , where HAB is the electronic-coupling matrix element.
The magnitude of HAB determines the behavior of the reactants once the
intersection region is reached. Two cases can be distinguished. First, HAB is
very small; for these so-called "nonadiabatic" reactions, there is a high proba-
bility that the reactants will "jump" to the upper first-order potential energy
surface, leading to very little product formation. If the electronic interaction is
sufficiently large, as it is for "adiabatic" reactions, the reactants will remain on
the lower first-order potential energy surface upon passage through the transi-
tion-state region.
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Figure 6.22
Potential energy diagrams: (A) RAB = 0, K = °(no transfer); (B) RAB small, K « 1 (nonadi-
abatic transfer); (C) RAB large, K = 1 (adiabatic transfer). The arrows indicate the relative prob-
ability of crossing to the product surface (ER to Ep).
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The tenn adiabatic (Greek: a-dia-bainein, not able to go through) is used in
both thermodynamics and quantum mechanics, and the uses are analogous. In
the former, it indicates that there is no heat flow in or out of the system. In the
latter, it indicates that a change occurs such that the system makes no transition
to other states. Hence, for an adiabatic reaction, the system remains on the same
(i.e., lower) first-order electronic surface for the entire reaction. The probability
of electron transfer occurring when the reactants reach the transition state is
unity. The degree of adiabaticity of the reaction is given by a transmission
coefficient, K, whose value ranges from zero to one. For systems whose H AB is
sufficiently large (>kBT, where k B is the Boltzmann constant), K = l. This
situation occurs when the reacting centers are close together, the orbital sym-
metries are favorable, and no substantial changes in geometry are involved. The
transmission coefficient is generally very small (K < 1) for electron-transfer re-
actions of metalloproteins, owing to the long distances involved.
B. Marcus Theory
In classical transition-state theory, the expression for the rate constant of a bi-
molecular reaction in solution is
k = KlJn exp ( - dG*IRT ), (6.16)
where lJ", the nuclear frequency factor, is approximately 10 11 M - I S - 1 for small
molecules, and dG* is the Gibbs-free-energy difference between the activated
complex and the precursor complex. This theoretical framework provides the
starting point for classical electron-transfer theory. Usually the transmission
coefficient K is initially assumed to be unity. Thus, the problem of calculating
the rate constant involves the calculation of dG*, which Marcus partitioned into
several parameters:
(6.17)
(6.18)
Here w r is the electrostatic work involved in bringing the reactants to the mean
reactant separation distance in the activated complex, and wP is the analogous
work term for dissociation of the products. These terms vanish in situations
where one of the reactants (or products) is uncharged. dGo is the Gibbs-free-
energy change when the two reactants and products are an infinite distance apart,
and dGo i is the free energy of the reaction when the reactants are a distance r
apart in the medium; dGo is the standard free energy of the reaction, obtainable
from electrochemical measurements (the quantity - dGo is called the driving
force of the reaction).
The reorganization energy A is a parameter that contains both inner-sphere
(Ai) and outer-sphere (A o) components; A = Ai + Ao . The inner-sphere reorga-
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nization energy is the free-energy change associated with changes in the bond
lengths and angles of the reactants. The Ai term can be evaluated within the
simple harmonic-oscillator approximation:
Ai = m2:kj (Lli)2,
J
(6.19)
where kj values are normal-mode force constants, and the Lll:j values are differ-
ences in equilibrium bond lengths between the reduced and oxidized forms of a
redox center.
The outer-sphere reorganization energy reflects changes in the polarization
of solvent molecules during electron transfer:
(6.20)
d is the distance between centers in the activated complex, generally taken to
be the sum of the reactant radii rA and rB; Dop is the optical dielectric constant
of the medium (or, equivalently, the square of the refractive index); and Ds is
the static dielectric constant. This simple model for the effect of solvent reor-
ganization assumes that the reactants are spherical, and that the solvent behaves
as a dielectric continuum. (Sometimes the latter approximation is so rough that
there is no correspondence between theory and experiment.)
Variations in A can have enormous effects on electron-transfer rates, Some
of the possible variations are apparent from inspection of Equation (6.20). First,
Ao decreases with increasing reactant size. Second, the dependence of the reac-
tion rate on separation distance attributable to Ao occurs via the lid term. Third,
Ao decreases markedly as the solvent polarity decreases. For nonpolar solvents,
Ds = Dop = 1.5 to 4.0. It is significant to note that protein interiors are esti-
mated to have Ds = 4, whereas, Ds = 78 for water. An important conclusion
is that metalloproteins that contain buried redox cofactors need not experience
large outer-sphere reorganization energies.
The key result of Marcus theory is that the free energy of activation displays
a quadratic dependence on LlGo and A (ignoring work terms). Hence, the reac-
tion rate may be written as
(6.21)
For intramolecular re<j.ctions, the nuclear frequency factor (vn) is ~10 13 S - 1.
One of the most striking predictions of Marcus theory follows from this equa-
tion: as the driving force of the reaction increases, the reaction rate increases,
reaching a maximum at - LlGo = A; when - LlGo is greater than A, the rate
decreases as the driving force increases (Figure 6.23). Two free-energy regions,
depending on the relative magnitudes of - LlGo and A, are thus distinguished.
The normal free-energy region is defined by - LlGo < A. In this region, LlG*
decreases if - LlGo increases or if A decreases. If - LlGo = A, there is no free-
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Figure 6.23
Plot of log ket as a function of increasing driving force (- LlGO). Three LlGo
regions are indicated: nonnal ( - LlGo < ~); activationless ( - LlGo = A);
and inverted (- LlGo > ~). The corresponding two-well (ER , Ep ), diagrams
also are shown. The dashed curve (kdiff) is for a bimolecular reaction. The
predicted behavior of a unimolecular reaction (kun;) is given by the solid
curve; here the rate could be as high as 10 13 S ~ I, because it is not masked
by diffusional processes.
energy barrier to the reaction. In the inverted region, defined by -IlGo > A,
IlG* increases if A decreases or if -IlGo increases.
Another widely used result of Marcus theory deals with the extraction of
useful kinetic relationships for cross reactions from parameters for self-exchange
reactions. Consider the cross reaction, Equation (6.22), for which the rate
(6.22)
and equilibrium constants are k12 and K 12 , respectively. Two self-exchange re-
actions are pertinent here:
A,(ox) + A,(red)~ A, (red) + A,(ox),
A2(ox) + A2(red)~ Adred) + A2(ox).
(6.23a)
(6.23b)
These reactions are characterized by rate constants k 11 and kn , respectively.
The reorganization energy (Ad for the cross reaction can be approximated as
the mean of the reorganization energies for the relevant self-exchange reactions:
(6.24)
Substitution of Equation (6.24) into Equation (6.17) leads to the relation
(6.25a)
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where
(6.25b)
When the self-exchange rates k11 are corrected for work terms or when the latter
nearly cancel, the cross-reaction rate kl2 is given by the Marcus cross relation,
(6.26a)
where
(6.26b)
This relation has been used to predict and interpret both self-exchange and cross-
reaction rates (or even Kd, depending on which of the quantities have been
measured experimentally. Alternatively, one could study a series of closely re-
lated electron-transfer reactions (to maintain a nearly constant A12) as a function
of ~G12; a plot of In kl2 vs. In K12 is predicted to be linear, with slope 0.5 and
intercept 0.5 In (k ll k22). The Marcus prediction (for the normal free-energy re-
gion) amounts to a linear free-energy relation (LFER) for outer-sphere electron
transfer.
1. Cross reactions of blue copper proteins
Given the measured self-exchange rate constant for stellacyanin (kll ~
1.2 X 10 5 M -I S -I), the Marcus cross relation (Equation 6.26a) can be used
to calculate the reaction rates for the reduction of euII-stellacyanin by Fe(EDTA) 2
and the oxidation of Cul-stellacyanin by Co(phenh3+. EO(Cu 2 +/+) for stella-
cyanin is 0.18 V vs. NHE, and the reduction potentials and self-exchange rate
constants for the inorganic reagents are given in Table 6.3. 66,67 For relatively
small ~Eo values, 112 is ~1; here a convenient form of the Marcus cross relation
is log k12 = 0.5[log kll + log k22 + 16.9~E12]' Calculations with kll , k22 , and
~E12 from experiments give k12 values that accord quite closely with the mea-
sured rate constants.
Cu"S! + Fe(EDTA)2-~ CUIS! + Fe(EDTA)-
kdcalc.) = 2.9 x 10 5 M -I s-I
kdobs.) = 4.3 x 105 M -1 s-I
(~ET2 = 0.06 V)
CUIS! + Co(phenh 3 +~ Cu"S! + Co(phenh2+
k12(calc.)
kdobs.)
1.4 X lOsM- 1 S-l
1.8 x 105 M- 1 s-I
(~ET2 = 0.19 V)
The success of the Marcus cross relation with stellacyanin indicates that the
copper site in the protein is accessible to inorganic reagents. The rate constants
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Table 6.3
Reduction potentials and self-exchange rate
constants for inorganic reagents.
Reagent
Fe(EDTA) -!2~
Co(phenh3+!2+
0.12
0.37
6.9 X 10 4
9.8 X 10 1
for the reactions of other blue copper proteins with inorganic redox agents show
deviations from cross-relation predictions (Table 6.4).68 These deviations sug-
gest the following order of surface accessibilities of blue copper sites: stellacy-
anin > plastocyanin > azurin. Rate constants for protein-protein electron trans-
fers also have been subjected to cross-relation analysis. 69
Table 6.4
Reactions of blue copper proteins with inorganic reagents.
Protein Reagent k,2(obs.)" ~E~2' V kll(obs.)" kll(calc.)"
Stellacyanin Fe(EDTA)2- 4.3 X 10 5 0.064 1.2 X 10 5 2.3 X 105
Co(phenh3+ 1.8 X 10 5 0.186 1.2 X 10 5 1.6 X 10 5
Ru(NH3)sPy 3+ 1.94 X 10 5 0.069 1.2 X 10 5 3.3 X 10 5
Plastocyanin Fe(EDTA)2- 1.72 X 105 0.235 -10 3_10 4 7.3 X 10 1
Co(phen)33 + 1.2 X 10 3 0.009 -10 3_10 4 1.1 X 104
Ru(NH3)spy 3 + 3.88 X 10 3 -0.100 -10 3 _10 4 4.9 X 10 4
Azurin Fe(EDTA)2- 1.39 X 10 3 0.184 2.4 X 106 2.8 X 10 -2
Co(phenh H 2.82 X 10 3 0.064 2.4 X 106 7.0 X 10 3
Ru(NH3)spy 3+ 1.36 X 10 3 0.058 2.4 X 106 l.1x 10 3
aM I S -I.
IV. LONG-RANGE ELECTRON TRANSFER IN PROTEINS
A. Electronic Coupling
The electron-transfer reactions that occur within and between proteins typically
involve prosthetic groups separated by distances that are often greater than 10 A.
When we consider these distant electron transfers, an explicit expression for the
electronic factor is required. In the nonadiabatic limit, the rate constant for re-
action between a donor and acceptor held at fixed distance and orientation is: 70-73
(6.27)
The electronic (or tunneling) matrix element HAB is a measure of the electronic
coupling between the reactants and the products at the transition state. The mag-
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nitude of RAB depends upon donor-acceptor separation, orientation, and the na-
ture of the intervening medium. Various approaches have been used to test the
validity of Equation (6.27) and to extract the parameters RAB and A. Driving-
force studies have proven to be a reliable approach, and such studies have been
emphasized by many workers. 73,74
In the nonadiabatic limit, the probability is quite low that reactants will
cross over to products at the transition-state configuration. 72 This probability
depends upon the electronic hopping frequency (determined by RAB ) and upon
the frequency of motion along the reaction coordinate. 75 In simple models, the
electronic-coupling strength is predicted to decay exponentially with increasing
donor-acceptor separation (Equation 6.28): 72,76
o [-13 0]HAB = HAB exp "2 (d-d ) (6.28)
In Equation (6.28), R~B is the electronic coupling at close contact (dO), and {3
is the rate of decay of coupling with distance (d). Studies of the distance depen-
dence of electron-transfer rates in donor-acceptor complexes, and of randomly
oriented donors and acceptors in rigid matrices, have suggested 0.8:s
{3:s 1.2 A-1.73,74,77,78
Analysis of a large number of intramolecular electron-transfer rates has sug-
gested a {3 value of 1.4 A-1 for protein reactions (Figure 6.24).79,80 Assigning
a single protein {3 implies that the intervening medium is homogenous. At best
this is a rough approximation, because the medium separating two redox sites
in a protein is a heterogenous array of bonded and nonbonded interactions. 81- 86
Beratan and Onuchic have developed a formalism that describes the medium in
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Figure 6.24
Maximum electron-transfer rate (kmax ) vs. edge-to-edge distance (d)
for proteins. Photosynthetic reaction center rates are shown as circles
and 3ZnP* to Ru3 + rates in modified myoglobins and cytochromes c
are shown as triangles. Adapted from Reference 80.
9
10
A
Figure 6.25
Example of a tunneling pathway. 79 The donor is coupled to the bonded
pathway through bond I and the acceptor through bond 10. There are
three bonded segments and two through-space jumps (between orbitals
4 and 5 and between orbitals 6 and 7).
terms of "unit blocks" connected together to form a tunneling pathway. 84-86 A
unit block may be a covalent bond, a hydrogen bond, or a through-space jump,
each with a corresponding decay factor. Dominant tunneling pathways in pro-
teins are largely composed of bonded groups (e.g., peptide bonds), with less
favorable through-space interactions becoming important when a through-bond
pathway is prohibitively long (Figure 6.25).84 The tunneling pathway model has
been used successfully in an analysis of the electron-transfer rates in modified
cytochromes c (Section IV.D.I).
1. Binding sites on the plastocyanin molecular surface
Plastocyanin cycles between the Cu II and Cu I oxidation states, and transfers
electrons from cytochrome f to the P700 component of photosystem I in the
chloroplasts of higher plants and algae. 87- 89 The low molecular weight (l0.5
kDa) and availability of detailed structural information 90 have made this protein
an attractive candidate for mechanistic studies, which, when taken to-
gether,87,91-94 point to two distinct surface binding sites (i.e" regions on the
plastocyanin molecular surface at which electron transfer with a redox partner
occurs). The first of these, the solvent-exposed edge of the Cu ligand His-87
(the adjacent site A in Figure 6.26), is ~6 A from the copper atom and rather
nonpolar. The second site (the remote site R in Figure 6.26) surrounds Tyr-83,
and is much farther (~15 A) from the copper center. Negatively charged car-
boxylates at positions 42-45 and 59-61 make this latter site an attractive one
for positively charged redox reagents.
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Figure 6.26
Structure of poplar plastocyanin illustrating the adjacent
(A) and remote (R) surface binding sites.
Bimolecular electron-transfer reactions are typically run under pseudo-first-
order conditions (e.g., with an inorganic redox reagent present in ~ IS-fold ex-
cess):
Rate = k[plastocyanin] [complex] = kobs[plastocyanin]. (6.29)
For some reactions [e.g., Co(phenh 3 + oxidation of plastocyanin (CUI)] the ex-
pected linear plot of kobs vs. [complex] is not observed. Instead, the rate is
observed to saturate (Figure 6.27).95 A "minimal" model used to explain this
behavior involves the two pathways for electron transfer shown in Equation
(6.30).
(6.30)
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Figure 6.27
Dependence of first-order rate constants kobs (25°C) on [Co(phenh3+]
for the oxidation of plastocyanin PCut at pH 7.5. Key: ., spinach;
and A, parsley.95
Surprisingly, the rate ratio kremotelkadjacent is 7.
Calculations 81 indicate that, despite the significant differences in distances,
HAB for the remote site is ~15 percent of HAB for the adjacent site. This figure
is much higher than would be expected from distance alone, suggesting that the
value of the decay parameter f3 in Equation (6.28) depends strongly on the
structure of the intervening medium.
B. Modified Metalloproteins
Chemical modification of structurally characterized metalloproteins by transi-
tion-metal redox reagents has been employed 52,53,96-98 to investigate the factors
that control long-range electron-transfer reactions. In these semisynthetic multi-
site redox systems, the distance is fixed, and tunneling pathways between the
donor and acceptor sites can be examined.
1. Ruthenium-modified myoglobin
Sperm-whale myoglobin can be reacted with (NH3)5Ru(OH2)2+ and then
oxidized to produce a variety of ruthenated products,52,99-101 including a His-48
derivative whose Ru ~ Fe tunneling pathway is depicted in Figure 6.28. Elec-
trochemical data (Table 6.5) indicate that the (NH3)sRu 3+ group does not sig-
nificantly perturb the heme center, and that equilibrium (i.e., k obs = k l + L 1)
should be approached when a mixed-valent intermediate is produced by flash-
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His-48
Figure 6.28
Electron-tunneling pathway for myoglobin modified at His-48.
The pathway moves along the protein backbone from His-48 to
Arg-45, and then to the heme via an H-bond (=) to the heme
propionate. The His-48 to heme edge-edge distance is 12.7 A. 101
photolysis techniques:
fast(NH3)sRu 3 +-Mb(Fe 3 +)~ (NH3)sRu 21 -Mb(Fe 3 +)
e
k ,( ) (NH3)sRu h -Mb(Fe 2 +)
k-,
(6.31)
This kinetic behavior was observed,52 and both the forward (k l ) and reverse
(k _I) reactions were found to be markedly temperature-dependent: k) =
0.019 S -I (25°C), Mit = 7.4 kcallmol, L 1 = 0.041 s -) (25°C), Mit =
19.5 kcallmol. X-ray crystallographic studies 102 indicate that the axial water
ligand dissociates upon reduction of the protein. This conformational change
does not control the rates, since identical results were obtained when a second
flash-photolysis technique 99 was used to generate (NH3)5Ru3+ -Mb(Fe 2+) in or-
der to approach the equilibrium from the other direction.
Cyanogen bromide has been used 103 to modify the six-coordinate metmy-
oglobin heme site, causing the coordinated water ligand to dissociate. The CNBr-
Table 6.5
Thermodynamic parameters for the reduction of (NH3)sRu 3 + and the heme
site in native and modified myoglobin (Mb).a
Modified Mb
Thennodynamic parameter
EO, mY vs. NHE (25°C)
!:leo, kcal mol - 1 (25°C)
!:lSo, e.u.
Mio, kcal mol - 1 (25°C)
Native Mb
Fe3-+/2+
58.8 ± 2
-1.26 ± 0.05
-39.2 ± 1.2
- 13.0 ± 0.4
Fe 3 +!2+
65.4 ± 2
1.51 ± 0.05
-37.6 ± 1.2
-12.7 ± 0.4
85.8 ± 2
- 1.98 ± 0.05
4.2 ± 1.2
-0.7 ± 0.4
a pH 7.0, /h = O. J M phosphate buffer.
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modified myoglobin heme site is thus five-coordinate in both oxidation states.
As expected, the self-exchange rate increased from ~ I M ~ I S ~ I to
~104 M ~I S ~I.
Recent efforts in modeling biological electron transfers using chemically
modified redox proteins 104--106 point the way toward the design of semisynthetic
redox enzymes for catalytic applications. An intriguing example, termed flavo-
hemoglobin, was produced by reaction of hemoglobin with a flavin reagent de-
signed to react with Cys-93 of the ,B-chain (i.e., the hemoglobin molecule was
modified by two flavin moieties).107 The resulting derivative, unlike native
hemoglobin, accepts electrons directly from NADPH and catalyzes the para-
hydroxylation of aniline in the presence of O2 and NADPH.
C. Protein-Protein Complexes
In physiologically relevant precursor complexes, both redox centers are fre-
quently buried in protein matrices. Characterization of such protein-protein com-
plexes is clearly important, and several issues figure prominently:
(1) What are the "rules" that govern complex formation? How important
are protein-dipole/protein-dipole interactions, intermolecular hydrogen
bonding, and hydrophobic interactions?
(2) Are the water (and small solute) molecules associated with protein sur-
faces "squeezed" out of the interfacial region upon complex formation?
(3) Within a given complex, is there a high degree of structural order, or
do the proteins retain some independent mobility?
Most of our knowledge about the structures of protein-protein complexes
comes from crystallographic studies 108-110 of antigen-antibody complexes and
multisubunit proteins; such systems generally exhibit a high degree of thermo-
dynamic stability. On the other hand, complexes formed as a result of bimolec-
ular collisions generally are much less stable, and tend to resist attempts to grow
x-ray-quality crystals; the high salt conditions typically used in protein crystal-
lizations often lead to dissociation of such complexes.
1. Cytochrome b5-cytochrome c
One of the most widely studied protein-protein complexes is that formed
between mammalian cytochrome bs and cytochrome c. Using the known x-ray
structures of both proteins, Salemme III generated a static computer graphics
model of this electron-transfer complex by docking the x-ray structures of the
individual proteins. Two features of this model and its revision 112 by molecular
dynamics simulations (Figure 6.29 See color plate section, page C-12.) are
noteworthy: (1) several Lys residues on cytochrome c and carboxylate-contain-
ing groups on cytochrome bs form "salt bridges" (i.e., intermolecular hydrogen
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Figure 6.30
Job plot of the ehange in absorbance at 416 nm due to complex formation
between cytochrome bs and cytochrome c (25°C, pH 7.0 (phosphate),
f.L = 1 mM, 10.54 f.LM total protein concentration).114
bonds); and (2) the hemes are nearly coplanar and are ~17 A (Fe-Fe) apart.
This distance was confirmed by an energy-transfer experiment 113 in which the
fluorescence of Zn-substituted cytochrome c was quenched by cytochrome b5 .
Spectroscopic studies 114.115 have verified the suggestion that these proteins form
a I: I complex at low ionic strength (Figure 6.30). In addition, chemical
modification 116 and spectroscopic analyses 117-119 are all in agreement with the
suggestion Ill, 112 that the complex is primarily stabilized by electrostatic inter-
actions of the (-NH3+ ... -02C-) type. The effect of ionic strength on the
reduction of cytochrome c by cytochrome b5 is also in accord with this pic-
ture: 120 lowering the ionic strength increases the reaction rate, as expected for
oppositely charged molecules.
2. Hybrid hemoglobins
A common 52,55,57,121,122 experimental strategy for studying electron transfers
between proteins uses a metal-substituted heme protein as one of the reactants.
In particular, the substitution of zinc for iron in one of the porphyrin redox
centers allows facile initiation of electron transfer through photoexcitation of the
zinc porphyrin (ZnP). The excited zinc porphyrin, 3ZnP* in Equation (6.32),
may decay back (kd ~ ]02 S -I) to the ground state or transfer an electron to an
acceptor.
(6.32)
[ZnP, Acceptoroxl
Figure 6.31
Structure of the 0'1 and /32 subunits of hemoglobin.
The edge-edge separation of the two hemes is 20 A.
The ZnP + cation radical produced in the kf step is a powerful oxidant; back
electron transfer (kb) will thus occur and regenerate the starting material.
The reactions shown in Equation (6.32) have been investigated in mixed-
metal [Zn, Fe] hemoglobins. 123- 125 A hemoglobin molecule can be viewed as
two independent electron-transfer complexes, each consisting of an al-f32 sub-
unit pair (Figure 6.31), since the al-a2, f31-f32, and al-f31 distances are prohib-
itively long (> 30 A).
Both [a(Zn), f3(Fe)] and [a(Fe), f3(Zn)] hybrids have been studied. The ZnP
and FeP are nearly parallel, as in the cytochrome b5-cytochrome c model com-
plex. Long-range electron transfer eZnP* ~ Fe3+) between the al and f32 sub-
units has been observed (the heme-edge/heme-edge distance is ~20 A). The
driving force for the forward electron-transfer step is ~0.8 eV, and kf (see
Equation 6.32) is ~100 S -I at room temperature, but decreases to ~9 s -I in
the low-temperature region (Figure 6.32). Below 140-160 K the vibrations that
induce electron transfer "freeze out"; nuclear tunneling is usually associated
with such slow, temperature-independent rates. A complete analysis of the full
temperature dependence of the rate requires a quantum-mechanical treatment 126,127
of A.i rather than that employed in the Marcus theory. It is interesting to note
that the heme b vinyl groups (see Figure 6.6) for a given [al(Fe), f3iZn)]
hybrid point toward each other and appear 125 to facilitate electron transfer.
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Temperature dependence of the forward electron-transfer rate, kf ,
for [a(Zn), I3(Fe lllHzO»); adapted from Reference 124.
D. Cytochrome c
Cytochrome c occupies a prominent place in the mitochondrial electron-trans-
port chain. Its water solubility, low molecular weight (12.4 kDa), stability, and
ease of purification have allowed many experiments, which, when taken to-
gether, present a detailed picture of the structure and biological function of this
electron carrier. 128-133
X-ray structures 134 of oxidized and reduced tuna cytochrome c are very
similar; most of the differences are confined to changes in the orientations of
the side chains of some surface-exposed amino acids and sub-Angstrom adjust-
ments of some groups in the protein interior. Upon reduction, the heme active
site becomes slightly more ordered (Figure 6.33). Two-dimensional NMR
studies 135-137 confirm this interpretation of the x-ray data, and further establish
that the crystal and solution structures of cytochrome c differ in only minor
respects.
Cytochrome c exhibits several pH-dependent conformational states. In par-
ticular, an alkaline transition with a pKa ~ 9.1 has been observed for ferricy-
tochrome c. This transition is believed to be associated with the dissociation of
Met-80; the reduction potential decreases dramatically, 138 and the 695-nm ab-
sorption band, associated with a sulfur......,. iron charge-transfer transition, dis-
appears. The 2H NMR resonance due to CZH3C-) Met-80 in deuterium-enriched
ferricytochrome c disappears from its hyperfine-shifted upfield position without
line broadening, and reappears coincident with the CZH3C-)Met-65 resonance. 139
In contrast, ferrocytochrome c maintains an ordered structure over the pH range
4 to 11. 140 The heme iron in ferricytochrome c remains low-spin throughout this
Figure 6.33
Side-chain motion in the vicinity of the heme of cytochrome c. Heavy lines
indicate the reduced molecule, and light lines the oxidized molecule. 134
transition, and a new strong-field ligand must therefore replace Met-80. It has
been suggested that an e-amino nitrogen of a nearby Lys provides the new donor
atom, but this has not been confirmed. However, it is clear that reduction of
ferricytochrome c at alkaline pH values below 11 causes a drastic conforma-
tional change at the heme site. The unknown sixth ligand must be displaced by
Met-80 in order for the reduced protein to assume a structure similar to the one
at neutral pH. This structural change is accompanied by a decrease in the rate
of reduction of ferricytochrome c by hydrated electrons,141 as expected.
How does the protein control the reduction potential of the iron center in
cytochrome c? Factors that appear to play a role include the nature of the axial
ligands, the stability and solvent accessibility of the heme crevice, and the hy-
drophobicities of the amino acids that line the heme crevice. These issues have
been addressed theoretically 142,143 and experimentally 144-149 using cytochrome c
variants engineered by protein semisynthesis or site-directed mutagenesis. Re-
sults for horse heart cytochrome c are set out in Table 6.6. Point mutations at
either of positions 78 or 83 do not significantly alter E0 1 ; however, the double
mutant (Thr-78 ~ Asn-78; Tyr-83 ~ Phe-83) exhibits a substantially lower re-
dox potential. Evidently, the results of such changes are not necessarily addi-
tive; great care must be taken in drawing conclusions about structure-function
relations in engineered proteins. Finally, the ~ 310mV difference between the
values for the heme octapeptide and the native protein (the axial ligands are the
same in both) provides a dramatic illustration of protein environmental effects
on the redox potential: shielding the heme from the solvent is expected to sta-
bilize Fell and therefore result in an increase in E0 1 •
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Table 6.6
Reduction potentials a of horse heart cytochrome c.
Cytochrome
Native
Met-80 ~ His-80
Tyr-67 ~ Phe-67
Thr-78 ~ Asn-78
Tyr-83 ~ Pro-83
Thr-78, Tyr-83 ~ Asn-78, Pro-83
Heme octapeptide b
" pH 7.0, 25°C.
b In 2M N-acetyl-DL-methionine.
EO'(mV vs. NHE)
262
41
225
264
266
235
-50
Reference
138
144
145
145
145
145
146
During the last fifteen years, much has been learned about the interaction of
cytochrome c with its redox partners. 128- 133 Cytochrome c is a highly basic
protein (pI = 10.05); lysine residues constitute most of the cationic amino acids.
Despite the indication from the x-ray structures that only ~1 percent of the
heme surface is solvent-exposed, the asymmetric distribution of surface charges,
particularly a highly conserved ring of Lys residues surrounding the exposed
edge of the heme crevice, led to the suggestion that electron-transfer reactions
of cytochrome c (and other Class I cytochromes as well) occur via the exposed
heme edge.
Chemical modification of the surface Lys residues of cytochrome c has af-
forded opportunities to alter the properties of the surface E-amino groups sus-
pected to be involved in precursor complex formation. Margoliash and
coworkers 133,150,151 used a 4-carboxy-2,6-dinitrophenol (CDNP) modification of
the Lys residues to map out the cytochrome c interaction domains with various
transition-metal redox reagents and proteins. These experiments have shown that
cytochrome c interacts with inorganic redox partners near the exposed heme
edge.
Numerous studies 129,152,153 of cytochrome c with physiological reaction part-
ners are in accord with electrostatic interactions featured in the model cyto-
chrome c/cytochrome b5 complex discussed earlier. Similar types of interactions
have been proposed for cytochrome c/flavodoxin 154 and cytochrome c/cyto-
chrome c peroxidase complexes. 155 (Recent x-ray crystal structure work 155b has
shed new light on this problem.) Theoretical work 156 additionally suggests that
electrostatic forces exert torques on diffusing protein reactants that "steer" the
proteins into a favorable docking geometry. However, the domains on cyto-
chrome c for interaction with physiological redox partners are not identical, as
Figure 6.34 illustrates.
Reactions between cytochrome c and its physiological redox partners at low
ionic strength generally are very fast, ~10 8 M -I S 1, even though the ther-
modynamic driving force may be as low as 20 mV, as it is for the reduction of
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Figure 6.34
Domains on cytochrome c for interaction with physiological redox partners. The heme edge is
represented by the shaded rectangle. The number of circles around a given Lys residue is pro-
portional to the percentage of the observed inhibition in redox assays when the corresponding
CDNP-modified cytochrome c is used. 151
cytochrome a in cytochrome c oxidase. Such rates are probably at the diffusion-
controlled limit for such protein-protein reactions. 157.158 A more detailed under-
standing of these reactions will require studies that focus on the dynamical (rather
than static) features of complexes of cytochrome c with other proteins. For ex-
ample, there is evidence 159 that a cytochrome c conformational change in the
vicinity of the heme edge accompanies the formation of the complex with cy-
tochrome c oxidase. Studies of the influence of geometry changes on activation
energies 52,60, 160 are of particular importance in elucidating the mechanisms of
protein-protein reactions.
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1. Ruthenium-modified cytochrome c
Intramolecular electron transfer in cytochrome c has been investigated by
attaching photoactive Ru complexes to the protein surface. 98 ,161 Ru(bpyh(C03)
(bpy = 2,2' -bipyridine) has been shown to react with surface His residues to
yield, after addition of excess imidazole (im), Ru(bpyh(im)(His)2+. The pro-
tein-bound Ru complexes are luminescent, but the excited states (*Ru2+) are
rather short lived (1":5 100 ns). When direct electron transfer from *Ru2+ to
the heme cannot compete with excited-state decay, electron-transfer quenchers
(e.g., Ru(NH3)63+) are added to the solution to intercept a small fraction
(I-I0%) of the excited molecules, yielding (with oxidative quenchers) Ru3+.
If, before laser excitation of the Ru site, the heme is reduced, then the Fe2+ to
Ru3+ reaction (ket ) can be monitored by transient absorption spectroscopy. The
ket values for five different modified cytochromes have been reported: (Ru(His-
33), 2.6(3) x 106; Ru(His-39), 3.2(4) x 106; Ru(His-62), 1.0(2) x 104; Ru(His-
72),9.0(3) x 105; and Ru(His-79), > 108 S-I).162,163
According to Equation (6.27), rates become activationless when the reaction
driving force (- ~GO) equals the reorganization energy (A), The driving force
(0.74 eV) is approximately equal to the reorganization energy (0.8 eV) esti-
mated for the Ru(bpyh(im)(His)-cyt c reactions. 161 The activationless (maxi-
mum) rates (kmax) are limited by Hh, where HAB is the electronic matrix ele-
ment that couples the reactants and products at the transition state. Values of
kmax and HAB for the Fe2+ to Ru3+ reactions are given in Table 6.7.
Calculations that explicitly include the structure of the intervening medium 81-
86,164-169 have been particularly helpful in developing an understanding of distant
electronic couplings. As discussed in Section IV.A, the couplings in proteins
can be interpreted in terms of pathways comprised of covalent, H-bond, and
through-space contacts. An algorithm has been developed 85,170 that searches a
Table 6.7
Electron-transfer parameters163 for Ru(bpYb(im)(His-X)-
cytochromes c.
HAB (cm-')
X kmax (5-') [Fe2+ _Ru3t ] d (A) nef/ crl(A)
79 > 1.0 x 108 >0.6 4.5 8 (8C) 11.2
39 3.3 x 106 0.11 12.3 14.0 (l1C) 19.6
(lH)
33 2.7 x 106 0.097 11.1 13.9 (11C) 19.5
(lH)
72 9,4x 105 0.057 8,4 17.6 (7C) 24.6
(lS)
62 1.0 x 104 0.006 14.8 20.6 (l6C) 28.8
(2H)
ac covalent bond, H hydrogen bond, S = space jump.
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(A) Electronic coupling pathways to the heme from Ru-modified residues in native (His-33 horse
heart, His-39 yeast), genetically engineered (His-62 yeast), and semisynthetic (His-n, His-79
horse heart) cytochromes c. Solid lines are covalent bonds; dashed lines are hydrogen bonds;
and the dotted line (His-n pathway) is a space jump. (B) The left half of the diagram (a) shows
maximum electron-transfer rate vs. d minus 3 A(van der Waals contact). Exponential-decay
line with I x 1013 S - 1 intercept and 1.4 A-I slope. The right half of the diagram (b) shows
maximum rate vs. al: 0.71 A-I slope; 3 x 1012 S -1 intercept. Adapted from References 162 and
163.
protein structure for the best pathways coupling two redox sites (the pathways
between the histidines (33, 39, 62, 72, 79) and the heme are shown in Figure
6.35). A given coupling pathway consisting of covalent bonds, H-bonds, and
through-space jumps can be described in terms of an equivalent covalent path-
way with an effective number of covalent bonds (neff)' Multiplying the effective
number of bonds by 1.4 A/bond gives a-tunneling lengths (al) for the five
pathways (Table 6.7) that correlate well with the maximum rates (one-bond
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limit set at 3 x 1012 S -I; slope of 0.71 A-I) (Figure 6.35). The 0.71 A-I decay
accords closely with related distance dependences for covalently coupled donor-
acceptor molecules. 73,77
E. Bacterial Photosynthetic Reaction Centers
Photosynthetic bacteria produce only one type of reaction center, unlike green
plants (which produce two different kinds linked together in series), and are
therefore the organisms of choice in photosynthetic electon-transfer research. 171-
176 As indicated in Section LB, the original reaction center structure (Figure
6.15) lacked a quinone (QB)' Subsequent structures for reaction centers from
other photosynthetic bacteria 177,178 contain this quinone (Figure 6.36 See color
plate section, page C-13.). The Rps. sphaeroides reaction center contains ten
cofactors and three protein subunits. (Note that the Rps. viridis structure con-
tains a cytochrome subunit as well.) The cofactors are arrayed so that they
nearly span the 40-A-thick membrane (Figure 6.37 See color plate section, page
C-13.). The iron atom is indicated by the red dot near the cytoplasmic side of
the membrane (bottom). In spite of the near two-fold axis of symmetry, electron
transfer proceeds along a pathway that is determined by the A branch. In partic-
ular, BChlB and BPheB do not appear to play an important role in the electron
transfers.
It was demonstrated long ago that (BChlh is the primary electron donor and
that ubiquinone (or metaquinone) is the ultimate electron acceptor. Transient
flash photolysis experiments indicate that several electron-transfer steps occur in
order to translocate the charge across the membrane (Figure 6.38). Curiously,
the high-spin ferrous iron appears to play no functional role in the QA to QB
electron transfer. 179 In addition, the part played by BChlA is not understood-it
may act to promote reduction of BPheA via a superexchange mechanism. 180,181
Cytochromes supply the reducing equivalents to reduce the special pair (BChlh + .
Estimated rate constants for the various electron-transfer steps, together with
approximate reduction potentials, are displayed in Figure 6.39. For each step,
the forward rate is orders of magnitude faster than the reverse reaction. The
rapid rates suggest that attempts to obtain x-ray structures of intermediates (es-
pecially the early ones!) will not be successful. However, molecular dynamics
methods are being explored in computer simulations of the structures of various
intermediates. 182,183 Within a few years we may begin to understand why the
initial steps are so fast.
y'BChl),B?h"a,a,~
(BChl)2BPheA0A (BChl)2+BPheA-OAOsa,H'1
(BChl)2BPheA0A-0S-
,-\ ,BChl),B?h',a,a,-
(BChl)2+BPheAOA-OS- /
~ /hU
(BChl)2+BPheA-OAOS-
Figure 6.38
Forward electron transfer through the reaction center. Note that two charge translocations must
occur in order for the (labile) quinol QBH2 to be produced. Once QBHz dissociates from the RC
and is replaced by another, oxidized, QB, the cycle can begin anew.
~
-0.4
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Figure 6.39
Electron-transfer rates (for forward and reverse reactions) and reduction
potentials for RC intermediates.
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Ferredoxins, Hydrogenases, and
Nitrogenases: Metal-Sulfide Proteins
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Transition-metal/sulfide sites, especially those containing iron, are present in all
forms of life and are found at the active centers of a wide variety of redox and
catalytic proteins. These proteins include simple soluble electron-transfer agents
(the ferredoxins), membrane-bound components of electron-transfer chains, and
some of the most complex metalloenzymes, such as nitrogenase, hydrogenase,
and xanthine oxidase.
In this chapter we first review the chemistry of the Fe-S sites that occur in
relatively simple rubredoxins and ferredoxins, and make note of the ubiquity of
these sites in other metalloenzymes. We use these relatively simple systems to
show the usefulness of spectroscopy and model-system studies for deducing
bioinorganic structure and reactivity. We then direct our attention to the hydro-
genase and nitrogenase enzyme systems, both of which use transition-metal-
sulfur clusters to activate and evolve molecular hydrogen.
I. IRON-SULFUR PROTEINS AND MODELS
Iron sulfide proteins involved in electron transfer are called ferredoxins and rub-
redoxins. * The ferredoxins were discovered first, and were originally classified
as bacterial (containing Fe4S4 clusters) and plant (containing FezSz clusters) fer-
redoxins. This classification is now recognized as being not generally useful,
since both FezSz and Fe4S4 ferredoxins are found in plants,14,15 animals,Z,6,16
and bacteria.4 Ferredoxins are distinguished from rubredoxins by their posses-
sion of acid-labile sulfide; i.e., an inorganic Sz- ion that forms HzS gas upon
denaturation at low pH. Rubredoxins have no acid-labile sulfide, and generally
have a single iron in a more or less isolated site. Despite their lack of acid-
labile sulfide, rubredoxins are included in this chapter because they have se-
* For review articles, see References I-II. For a discussion of nomenclature, see References 12 and 13. 365
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quences much like those of the ferredoxins, and because their simple mononu-
clear Fe 2+ and Fe 3+ sites provide convenient illustrations of key structural and
spectroscopic features.
In most ferredoxins, and in all rubredoxins, the protein ligands are cys-
teines, which provide four thiolate donors to the IFe, 2Fe, or 4Fe center. Ad-
ditionally, the existence of 3Fe centers and of Fe-S sites that contain a second
metal (i.e., heteronuclear clusters) make the Fe-S class a broad and multifunc-
tional one.
Simple cytochromes and simple iron-sulfide proteins are similar, in that both
can undergo one-electron transfer processes that are generally uncoupled from
proton-, atom-, or group-transfer processes. Some of these proteins, such as
cytochrome C3 from Desulfovibrio with four hemes 17 or ferredoxin from Clos-
tridium pasteurianum with two Fe4S4 centers,6 can transfer more than one elec-
tron, because they have multiple copies of a one-electron transfer group. The
cytochromes were discovered in 1886 by McMunn,18 and their role in metabo-
lism was discovered in the 1920s by Keilin (Chapter 6). The intense optical
absorbance of these heme-containing proteins contributed singularly to their dis-
covery and biochemical characterization. In contrast, the iron-sulfur proteins,
although red to red-brown, absorb far more weakly in the visible region than do
the cytochromes. Their presence is sometimes obscured by the cytochromes,
and their frequent air instability made their initial recognition and isolation more
difficult. It was not until the early 1960s that discoveries by several research
groups 19 led to the isolation, recognition, and characterization of the ferredox-
ins. The use of EPR spectroscopy and its application to biological systems had
a profoundly stimulating effect on the field (see below).
Although cytochromes were discovered first, the ferredoxins are likely to be
the older proteins from an evolutionary perspective. 20 Ferredoxins have rela-
tively low-molecular-weight polypeptide chains, require no organic prosthetic
group, and often lack the more complex amino acids. In fact, the amino-acid
composition in clostridial ferredoxin is close to that found in certain meteo-
rites. 21
The various Fe-S sites found in electron-transfer proteins (ferredoxins) are
also found in many enzymes,6,11,22.23 where these centers are involved in intra-
or interprotein electron transfer. For example, sulfite reductase contains a siro-
heme and an Fe4S4 center,24 which are strongly coupled and involved in the six-
electron reduction of S032- to H2S. Xanthine oxidase (see Figure 7.1) has two
identical subunits, each containing two different Fe2S2 sites plus molybdenum
and FAD sites. In xanthine oxidase, the Mo(VI) site carries out the two-electron
oxidation of xanthine to uric acid, being reduced to Mo(IV) in the process. 25
The Mo(VI) site is regenerated by transferring electrons, one at a time, to the
Fe2S2 and flavin sites, thereby readying the Mo site for the next equivalent of
xanthine. Although the Fe2S2 sites do not directly participate in substrate reac-
tions, they are essential to the overall functioning of the enzyme system. The
Fe2S2 centers in xanthine oxidase play the same simple electron-transfer role as
the Fe2S2 ferredoxins play in photosynthesis.
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Figure 7.1
A schematic drawing of xanthine oxidase illustrating the Mo, flavin, and FezSz sites
and interaction of the enzyme with substrate and oxidant(s).
Structurally, all the iron-sulfur sites characterized to date are built up of
(approximately) tetrahedral iron units (see Figure 7.2). In rubredoxins the single
iron atom is bound in tetrahedral coordination by four thiolate ligands provided
by cysteine side chains. In two-iron ferredoxins the Fe2S2 site consists of two
tetrahedra doubly bridged through a pair of sulfide ions, i.e., Fe2(JLrSh, with
the tetrahedral coordination of each Fe completed by two cysteine thiolates. In
four-iron or eight-iron ferredoxins, the 'thiocubane' Fe4S4 cluster consists of
four tetrahedra sharing edges with triply bridging S2- ions, i.e., FeiJLrS)4'
with each Fe completing its tetrahedron by binding to a single cysteine thiolate.
Finally, for Fe3S4 clusters, which are now being found in more and more pro-
teins, the well-established structure has one triply bridging and three doubly
bridging sulfide ions, Fe3(JLrS)(JLrSh. The Fe3S4 unit can be thought of as
derived from the 'thiocubane' Fe4S4 unit by the removal of a single iron atom.
In what follows we will introduce these structures in the order IFe, 2Fe,
4Fe, and 3Fe. For each, we will first discuss the physiological role(s) of the
particular proteins, then the structural features, followed by the spectroscopic
properties and model systems.
A. Rubredoxin: A Single-Fe Tetrathiolate Protein
The physiological role of rubredoxins (sometimes abbreviated as Rd) is not al-
ways known with certainty. In particular, although rubredoxin was first identified 26
in the anaerobe Clostridium pasteurianum, its role in anaerobic metabolism re-
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Figure 7.2
Structural systematics of Fe-S units found in proteins:
(A) rubredoxin single Fe center; (B) FezSz unit;
(C) Fe4S4 unit; (d) Fe3S4 unit.
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Figure 7.3
Diagram illustrating the redox changes that occur in the rubredoxin-dependent w-hydroxylase of
Pseudomonas oleovoransY
mains obscure. Some rubredoxins, such as that from the aerobe Pseudomonas
oleovorans, participate in fatty acid w-hydroxylation, i.e., hydroxylation at the
end of the hydrocarbon chain farthest from the carboxylic acid. 27 Like the Fe2S2
proteins putidaredoxin 28 and adrenodoxin,29 the rubredoxin provides electrons
to the hydroxylase, which acts as a monooxygenase forming the w-alcohol prod-
uct and water (see Figure 7.3). In a reaction catalyzed by rubredoxin reductase,
rubredoxin is reduced by NADH to the ferrous state and reoxidized by the
w-hydroxylase to the ferric form during the catalytic cycle.
Most rubredoxins contain a single Fe atom, which can exist in the ferrous
or ferric state. For the rubredoxin from Clostridium pasteurianum,26 the E0 1
value is - 57 mY, which is much more positive than that of ferredoxins from
the same organism (see below). The 6-kDa clostridial protein has only 54 amino
acids in its polypeptide chain, and has a very low isoelectric point of 2.93. The
rubredoxin from P. oleovorans 27 has one or two iron atoms in a single polypep-
tide chain of MW ~ 20 kDa. Its redox potential is - 37 mY for the Fe3+/2+
couple. Rubredoxins as a class show considerable sequence identity, and the
larger 2Fe members of the class show evidence, involving internal-sequence
homology, that they may have. evolved through gene duplication.
A protein from Desulfovibrio gigas, called desulforedoxin,30,31 appears to
resemble rubredoxins in some respects, but the two Fe atoms in the 7.6-kDa
protein appear to be spectroscopically and structurally distinct from the Fe atoms
in rubredoxins. 31 A protein from Desulfovibrio vulgaris called ruberythrin has a
single rubredoxin site as well as a strongly coupled 2Fe site resembling that of
hemerythrin. Its physiological function is unknown. Table 7.1 lists some of the
known rubredoxins and their properties.
The x-ray crystal structures of the rubredoxins from C. pasteurianum 32 and
D. vulgaris 33 have been determined. 33a The C. pasteurianum protein structure
is known to a resolution of 1.2 A, placing it among the metalloproteins whose
structures are known with greatest precision. The individual Fe and S atoms are
clearly resolvable. As shown in Figure 7.4, the single iron is coordinated by
four S ligands provided by Cys-6, Cys-9, Cys-39, and Cys-42. The sequence
Cys-x-y-Cys is a common one in Fe-S proteins, because it allows both cysteine
residues to bind to the same metal site or cluster. The Fe-S distances and angles
Table 7.1
Properties of some iron-sulfur proteins.
Molecular Redox
weight Fe-S potential EPR
Protein source (subunits) composition mY (pH) g values References
Rubredoxins
Clostridium pasteurianum 6,000 Fe - 58 (7) 9.3 4.3 26
Pseudomonas oleovorans 6,000 Fe 9.42 0.9 1.25 a 44
4.02 4.77 4.31
Fe2S2 proteins
Spinach ferredoxin 11,000 [2Fe-2S] 420 (7.0) 2.05 1.96 1.89 350, 351
Parsley ferredoxin 11,000 [2Fe-2S] 2.05 1.96 1.90 352
Euglena ferredoxin 11,000 [2Fe-2S] 2.06 1.96 1.89 352
Adrenal cortex ferredoxin (pig) 16,000 [2Fe-2S] -270 (7.0) 2.02 1.93 1.93 352,353
[Adrenodoxin]
Pseudomonas putida ferredoxin 12,500 [2Fe-2S] -240 (7.0) 2.02 1.93 1.93 352, 353
[Putidaredoxin]
Clostridium pasteurianum 25,000 [2Fe-2S] - 300 (7.5) 2.00 1.96 1.94 354
Xanthine Oxidase 280,000 (2) 2 x [2Fe-2S] I - 343 (8.2) 2.02 1.94 1.90 355, 356
II - 303 (8.2) 2.12 2.01 1.91
Thermus thermophilus Rieske 20,000 2 x [2Fe-2S] + 150 (7.8) 2.02 1.90 1.80 93,357
Fe4S4 proteins
Clostridium pasteurianum 6,000 2 x [4Fe-4S] 420 (8.2) 2.06 1.92 1.89 b 115
Bacillus stearothermophilus 9,100 [4Fe-4S] -280 (8.0) 2.06 1.92 1.89 358
Desulfovibrio gigas ferredoxin I 18,000 (3) [4Fe-4S] -455 (8.0) 2.07 1.94 1.92 359
Aconitase (beef heart) [active] 81,000 [4Fe-4S] 2.06 1.93 1.86
Chromatium vinosum HiPIP 10,000 [4Fe-4S] + 356 (7.0) 2.12 2.04 2.04 353
Paracoccus sp. 10,000 [4Fe-4S] + 282 (7.0) 353
Azotobacter vinlandii Fd I 14,500 [3Fe-4S]
[4Fe-4S] 645 (8.3) 2.06 1.93 1.89 c 360
Thermus aquaticus 10,500 [3Fe-4S]
[4Fe-4S] -550 (9.0) 2.06 1.93 l.92 c 353, 361
Fe3S4 proteins
Desulfovibrio gigas Fd II 6,000 (4) [3Fe-4S] 130 (8.0) 2.02 359
Azotobacter vinlandii Fd I 14,500 [3Fe-4S] 450 (8.3) 2.01 360
[4Fe-4S]
Thermus aquaticus 10,500 [3Fe-4S] 260 (9.0) 2.02 1.99 1.94 d 353, 361
[4Fe-4S]
Aconitase (beef heart) [inactive] 81,000 [3Fe-4S] 2.01
a g'-tensors for ± ! and ±~ Kramers doublets, respectively, of the 5 = ~ system. The values of 0.9 and 1.25 are calculated (not
observed) 44
b The fully reduced protein has a complex spectrum due to magnetic coupling between the two identical Fe4S4 clusters. The g-values are
those for partly reduced samples, and represent a magnetically isolated cluster.
c The reported spectrum is complex because of magnetic interaction with the reduced Fe3S4 cluster.
d Recent evidence suggests that Thermus thermophilus and Thermus aquaticus are actually the same species. 362 EPR parameters of the
homologous Thermus thermophilus ferredoxin estimated from computer simulations. 361 In this protein a signal originating from the Fe3S4
cluster at g' = 12, attributable to f).M, = ± 4 transitions, is observed for the reduced (5 = 2) cluster.
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Figure 7.4
The x-ray crystal structure of rubredoxin from Clostridium pasteurianum. 32
in the clostridial rubredoxin are shown in Table 7.2. The range of distances and
angles reveals a slightly distorted tetrahedral structure.
The initial structural results on C. pasteurianum rubredoxin were reported
at a slightly lower resolution than those displayed in Table 7.2. In fact, the
early study 34 reported a range of Fe-S distances from 2.05 to 2.34 A. Prior to
the higher-resolution refinement, a synchrotron-radiation x-ray-absorption spec-
troscopy study of the iron-absorption edge of rubredoxin was reported. 35 ,36 Us-
ing the technique of Extended X-ray A bsorption Fine Structure,* EXAFS, the
average Fe-S distance was found 35 ,36 to be 2.26 A, in agreement with the av-
erage distance from the x-ray crystallographic study. However, the EXAFS in-
dicated a much narrower permissible range of Fe-S distances than did the early
crystallographic study. The later, more highly refined crystallographic treatment 32
agreed nicely with the EXAFS result, illustrating the importance of applying
more than one technique to the elucidation of key parameters. Here, as with the
3Fe proteins we will discuss later, EXAFS proved a useful complementary tech-
nique to x-ray crystallography.
The tetrahedral iron sites in rubredoxins offer an interesting glimpse of li-
gand-field theory in action, and illustrate the use of various physical methods in
* X-ray absorption spectroscopy is most commonly (and conveniently) used with the K-edges of transition-
metal ions, such as Fe or Mo. It can be split up into two distinct types; X-ray Absorption Near-Edge Structure
(or XANES), and Extended X-ray Absorption Fine Structure (or EXAFS) spectroscopy. The former consists
of features near the absorption edge itself, which are due to transitions of the photoelectron to bound states
and also to other, more complex, phenomena (e.g., the so-called shape resonances). Although the spectra are
highly dependent on the nature of the site, they are quite difficult to interpret, and most analyses are based
upon simple comparisons with spectra from model compounds. The EXAFS are oscillations of the absorption
coefficient at rather higher x-ray energies, and arise from scattering of the emitted photoelectron by surround-
ing atoms. In contrast to the XANES, EXAFS spectra are relatively simple to interpret in a quantitative
manner, yielding a local radial structure. With proper interpretation of the spectra, very accurate interatomic
distances (e.g., to ± 0.02 A), plus more approximate ligand coordination numbers and atomic numbers can
be obtained.
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Table 7.2
Bond distances and bond angles around
Fe in rubredoxin from Clostridium
pasteurianum (W1 ).32
Fe-S[Cys(6)]
Fe-S[Cys(9)]
Fe-S[Cys(39)]
Fe-S[Cys(42)]
S-Fe-S[Cys(6)-Fe-Cys(9)]
S-Fe-S[Cys(6)-Fe-Cys(39)]
S-Fe-S[Cys(6)-Fe-Cys(42)]
S-Fe-S[Cys(9)-Fe-Cys(39)]
S-Fe-S[Cys(9)-Fe-Cys(42)]
S-Fe-S[Cys(39)-Fe-Cys(42)]
Distance (A)
2.333 (11)
2.288 (15)
2.300 (15)
2.235 (12)
Angle (0)
113.8 (4)
109.0 (4)
103.8 (4)
103.7 (4)
114.3 (5)
112.4 (5)
deducing electronic structure and coordination geometry. The four sulfur ligands
are expected to split the iron 3d orbitals into e and t2 sets, with the e set lower
as shown in Figure 7.5. The small tetrahedral splitting causes the 3ds Fe 3+ ion
to have five unpaired electrons, (e)2(t2)3, 6A1. Consistent with this configura-
tion, the magnetic susceptibility of rubredoxin gives a f..Leff of 5.85 Bohr mag-
netonsY No spin-allowed ligand-field transitions are expected, and the red color
is caused by S ~ Fe charge-transfer transitions in the visible region. 38 ,39
In contrast, the 3d 6 Fe 2+ state, with one additional electron, has four un-
paired electrons, as confirmed by its magnetic moment of 5.05 Bohr magnetons.
In exact tetrahedral symmetry, a single, low-energy, low-intensity d-d absorp-
tion of designation 5E ~ 5T [(e) 3(t2)3~ (e)2(t2)4] is expected for the high-spin
ferrous site (Figure 7.5). Indeed, reduced rubredoxin displays a band in the
near-infrared region at 6,250 cm -I that arises as a component of the 5E~ sT2
transition.40 This band stands out particularly vividly in the low-energy circular
dichroism (CD) spectrum of reduced rubredoxin. 41 Moreover, magnetic circular
dichroism (MCD) has proven valuable in dissecting electronic transitions in sev-
eral rubredoxins and metal-sulfide proteins. 38,39,42,43
t 2 -cD-CD-CD- -cD-CD-CD-
e ----<D-CD- ---<D-®--
(A) (B)
Figure 7.5
Splitting of the 3d orbitals of Fe by the tetrahedral ligand field
of four coordinated cysteine residues: (A) Fe 3 +; (B) Fe 2+ .
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The EPR spectrum of oxidized rubredoxin (Figure 7.6) shows characteristic
peaks at g = 4.31 and 9.42 (P. oleovorans) , which have been assigned 44 to
transitions within excited and ground-state Kramers doublets, respectively, of a
nearly completely rhombic 5 = i site, with D = 1.8 and E = 0.5 cm -I. These
values for the mononuclear Fe 3+ ion stand in sharp contrast to those for other
iron-sulfur proteins, which are usually 5 = ! (when reduced) and have g values
close to 2. The even-electron Fe 2+ state (5 = 2) in reduced rubredoxin has no
detectable EPR when conventional instruments are used. *
Mossbauer spectroscopy has proven to be a particularly powerful comple-
mentary tool to EPR in probing the iron sites in Fe-S proteins. 3,37,51,52 It is a
nuclear spectroscopy that can give valuable information not available from other
techniques. t Unlike EPR, where only paramagnetic centers are "seen," every
57Fe atom in the sample will contribute to the Mossbauer spectrum. For rubre-
doxin, the high-spin nature of the ferric and ferrous sites are clearly seen in the
Mossbauer spectra. 53 The high-spin Fe 3+ sites show a small quadrupole split-
ting of roughly 0,7-0.8 mm/s due to the almost spherical distribution of the five
d electrons in the five d orbitals (Figure 7,7A). In contrast, the high-spin Fe 2+
ion with an additional d electron has a significant asymmetry, and thus displays
* But see Reference 45. EPR spectroscopy uses magnetic fields to split the electron spin states into levels
that differ by energy in the microwave region of the spectrum. For an S = ! system, the g value (and its
anisotropy) and the a values (hyperfine splitting from various nuclei and their anisotropy) are the major
parameters reported. EPR spectroscopy has played a role in the development of Fe-S biochemistry akin to the
role played by optical spectroscopy in the development of the biochemistry of the cytochromes,46-49 particu-
larly for mitochondria 47 and chloroplasts,50 where the g = 1.9 EPR signal has facilitated the monitoring of
electron flow through these redox systems. Although EPR has been a powerful tool, it does have some
important limitations. A necessary but not sufficient condition for EPR is that the center to be observed must
be in a paramagnetic state. Fortunately, this condition is met for at least one member of each one-electron
redox couple, i.e., the odd-electron species. However. even when the even-electron species is paramagnetic,
it is usually not observed in the EPR, because of the presence of large zero-field splittings. Moreover, relax-
ation effects and/or the population of excited states often cause the EPR of proteins to be unobservable at
room temperature. necessitating the use of liquid N2 or liquid He temperatures to observe the signals in the
frozen state. The need to freeze samples prior to observation can lead to artifacts involving the observation of
nonphysiological states and processes. On the positive side, the low temperature increases the signal intensity
by altering the Boltzmann distribution of the spin population, and allows various quenching techniques to be
used with EPR to evaluate kinetic and electrochemical parameters. Nevertheless, one cannot usually observe
real-time kinetics or be certain that one is observing a physiologically relevant state. Despite these caveats,
EPR has proven a valuable and, in some cases, indispensable tool for identification and monitoring of Fe-S
sites. Recently, the advanced EPR techniques ENDOR (Electron Nuclear Double Resonance) and ESEEM
(Electron Spin Echo Envelope Modulation) have allowed the extraction of additional information from the
EPR signal.
t Mossbauer spectroscopy measures nuclear absorption of light at y-ray energies, and can be used to probe
nuclear energy levels (usually of 57Fe). The splitting of these levels is influenced by the (s) electron density
at the nucleus, and by the electric-field gradient that is set up by nearby atoms. These factors affect the isomer
shift and the quadrupole splitting of the Mossbauer spectrum, respectively. Information on nuclear hyperfine
couplings is also available when experiments are conducted in the presence of an external (usually applied)
magnetic field. Fortunately, the nucleus most commonly (and easily) studied by this technique is present in
all the proteins discussed in this chapter, although the level of 57Fe (2 percent natural abundance) must be
increased by isotopic enrichment to achieve a high-enough signal-to-noise ratio. For spectra containing one
type of site, the spectra are relatively straightforward to interpret. For multisite systems deconvolution is
required to get data on individual centers. When possible, selective labeling of sites with 57Fe is extremely
helpful in the deconvolution process.
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Figure 7.6
EPR spectra of various Fe-S proteins:
(A) oxidized Desulfovibrio gigas
rubredoxin; (B) reduced spinach
ferredoxin [Fe2SZ] +; (C) reduced
Bacillus stearothermophilus ferredoxin
[Fe4S4] +; (D) oxidized Thermus
aquaticus ferredoxin [Fe3S4] + ;
(E) oxidized Chromatium vinosum
HiPIP [Fe4S4P+. (Spectra courtesy
of S. J. George.)
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Figure 7.7
Mossbauer spectra of various Fe-S sites: (A) oxidized and (B) reduced Fe(SR)4
(Fe3+ and Fe z+, respectively) rubredoxin models (data from Reference 347);
(C) oxidized and (D) reduced Scenedesmus FezSz ferredoxin (2Fe3+ and [Fe 3+ ,
Fe 2 +], respectively, data from Reference 348); (E) oxidized and (F) reduced
Desulfovibrio gigas Fe3S4 ferredoxin II (3Fe3+ and [2Fe3+, Fe z+], respectively,
data from Reference 158); (G) oxidized and (H) reduced Bacillus sterother-
mophilus Fe4S4 ferredoxin (data from Reference 349).
a large and quite characteristic quadrupole splitting of 3.1-3.4 mm/s (Figure
7.7B). The isotope shift also distinguishes between Fe 2 + and Fe 3+, although
not as dramatically. 37 Finally, the observation 53 of magnetic hyperfine interac-
tion in the Mossbauer spectrum at low temperature in the Fe 3 + state directly
reveals the presence of unpaired electrons, i.e., magnetic coupling with a hy-
perfine field of 370 ± 3 kG. Although in rubredoxins with a single Fe atom,
this observation of magnetic coupling does not reveal any new information,
similar magnetic coupling is particularly useful in unraveling the Fe sites in
more complex multiiron proteins.
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NMR studies on both the oxidized and the reduced states of rubredoxins
have been reported. The strongly paramagnetic iron atoms have a profound ef-
fect on the NMR spectra of protons in the vicinity of the iron. The iron drasti-
cally affects the relaxation behavior of such protons, causing line-broadening,
sometimes so much that the protons become nonobservable. If observed, the
protons are shifted far from the values found in diamagnetic proteins by com-
binations of Fermi contact (through overlap/through bond) and pseudo-contact
(through space/dipolar) coupling. 54,55 In the rubredoxins, the reduced state shows
resolved spectra, 37 ,56 which can be assigned 56 with the help of data from model
systems.*
Resonance Raman spectroscopy provides information involving molecular
vibrations that is not dependent on either nuclear or magnetic properties. Elec-
tronic excitation of bands involving S --? Fe charge transfer often leads to res-
onance enhancement of Fe-S stretching modes. In rubredoxin, 57 ,57a the Fe-S
stretching vibrations are located between 300-400 cm - 1. Deviations of the ex-
pected two-band tetrahedral pattern (T2 and Al modes) are attributable to cou-
pling of the Fe-S vibrations with S-C-C bending modes. This coupling makes
for greater variability, and the detailed vibrational assignment is thus more dif-
ficult for bands involving the cysteinyl sulfur atoms. In contrast, for sites con-
taining inorganic S 2~, the Fe-S vibrations involving the inorganic core are less
variable and therefore more characteristic of the core type. 57
In theory, each of the spectroscopic techniques applied to rubredoxins can
give useful information about the other iron-sulfur proteins. In practice, some
techniques have proven more useful than others in particular situations, and
combined use of several techniques is necessary to draw meaningful conclu-
sions.
Chemical studies of rubredoxins have led to the replacement of the Fe 2+
with an Fe4S4 center,58 with C0 2 +, and with Ni2+. The C0 2 + replacement of
Fe 2 +, in P. oleovorans rubredoxin, leads to a stable protein that displays re-
duced (but not trivial) reactivity in the w-hydroxylation reaction. 59,60 The spec-
tral properties of the cobalt(II) site show the expected changes in d-d bands and
the expected shifts in charge-transfer transitions. 59 Interestingly, when Ni 2+ is
substituted into rubredoxins from desulfovibrio species, the resultant proteins
show hydrogenase activity.61
B. Rubredoxin Model Systems
The simple mononuclear tetrahedral site of Rd has been chemically modeled in
both its reduced and its oxidized forms. The bidentate o-xylyl-a,a'-dithiolate
ligand forms bis complexes of Fe(II) and Fe(III) that have spectroscopic features
* NMR is a technique whose great utility in the study of low-molecular-weight proteins and model systems
has not (yet) carried over to the study of larger proteins. Slower tumbling rates, rapid electronic relaxation,
multiple paramagnetic sites, large numbers of protons, and more dilute solutions conspire to make the obser-
vation and/or interpretation of NMR spectra a daunting task in multisite redox proteins of > 50 kDa.
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quite similar to those of the protein. 62 ,63 The preparative procedure is relatively
straightforward (Equation 7. 1).
.....----CH2X)HS ~ NaOEIFeCI~- + I Etc5H
HS---"""' CH b2
(
CH ~2-S.....---- 2 ~
Fe ::: IS'____CH,X) ,
(7.1)
The UV-visible-NIR spectra, Mossbauer spectra, and magnetic susceptibility differ
only slightly from those of oxidized and reduced rubredoxins.
The monodentate benzenethiolate (thiophenolate) ligand, C6HsS - , similarly
forms the ferrous Fe(SC6Hs )4 2 - complex. 64,6s Although for some time it was
felt that the oxidized form, Fe(SC6Hs)4 , was inherently unstable, the sterically
hindered monothiolate ligand 2,3,5,6-tetramethylbenzenethiolate was found to
form 66-68 a stable, quite symmetric Fe(III) tetrathiolate anion. Armed with this
information, the preparation of the tetrakis(benzenethiolate) Fe(III) complex was
reinvestigated, and the complex successfully synthesized 67 (Equation 7.2).
The Fe(III) and Fe(II) tetrathiolate species now serve as excellent structural models
for the Fe sites of both oxidized and reduced Rd. 69
The structural parameters for the oxidized rubredoxin analogues are very
similar to those of the oxidized Rd iron site. The reduced complexes reveal a
lengthening of the average Fe-S bond from 2.27 to 2.36 A, consistent with the
change in oxidation state from ferric to ferrous. The addition of an electron has
a more profound structural effect in this single-iron center than in some of the
multiiron clusters, where electrons are more delocalized.
Clearly, for the single-Fe sites, the dominant structural feature is their near-
tetrahedral tetrathiolate coordination. The dominant electronic structural feature
is the presence of high-spin Fe3+ and Fe 2 + sites. The important mode of chem-
ical reactivity is a simple one-electron transfer. Each of these features carries
over to the 2Fe, 4Fe, and 3Fe sites discussed below.
C. FezSz Ferredoxins
The simple 2Fe-2S proteins are sometimes referred to as "plant" or "plant-
type" ferredoxins. The protein from spinach, which serves as an electron accep-
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tor in the photosynthetic apparatus,14,15,50,70 was among the first to be well-
characterized and widely studied, and could be considered the prototypical
2Fe-2S ferredoxin, However, 2Fe-2S proteins are also well-known in bacteria.4
The protein from the cyanobacterium (blue-green alga) Spirulina platensis has
been structurally elucidated by x-ray crystallography. 47 Putidaredoxin, from
Pseudomonas putida, which serves as a donor to the P-450 camphor monooxy-
genase system, has been extensively studied. 28 Fe2S2 centers are also well-estab-
lished in mammalian proteins. Adrenodoxin 29 serves as the electron donor to
the P-450 monooxygenase system that carries out the 11-f3-hydroxylation of
steroids, The so-called "Rieske proteins" are found in the bel complex of
mitochondria 47 as well as in the bd complex of the photosynthetic apparatus of
plants. 71 In addition, Fe2S2 centers are well-known constituents of such redox
proteins as xanthine oxidase,25,72 CO oxidase,25 succinate dehydrogenase,73-75
and putidamonooxin. 76 Table 7.1 lists some of the Fe2S2 proteins and their prop-
erties.
The x-ray crystal structure of only the single 2Fe-2S protein mentioned above
has been determined; 70a the 2Fe-2S ferredoxin from the blue-green alga Spiru-
lina platensis 6,22,47,77,78 shows significant sequence identity with chloroplast fer-
redoxins typical of higher plants. 79 ,80 As Figure 7.8 shows, the Fe2S2 unit in
this ll-kDa protein is bound by Cys-41, Cys-46, Cys-49, and Cys-79, The
binuclear iron cluster is found in a largely hydrophobic region of the protein,
but is within 5 A of the protein surface. 6 The sulfur atoms of the cluster, both
inorganic and cysteinyl, are hydrogen-bonded to six peptide NH groups and one
serine OH group, which presumably stabilize the cluster/protein complex, The
serine involved in the H-bonding, Ser-40, is conserved in all plant and algal
2Fe-2S ferredoxins sequenced, which implies that it plays a crucial structural or
functional role.
The structure of the 2Fe-2S core in Figure 7,2 reveals a tetrahedron of S
ligands surrounding each Fe atom. The two tetrahedra share an edge defined by
the two bridging sulfide ions, and the core structure is designated Fe2(JLTSh.
Fe-S distances and angles cannot be measured accurately in the structure at the
present 2.5-A resolution; 70a so we will later discuss these details in terms of
model compounds.
The Fe2S2 center shows nicely how spectroscopy can be used to deduce the
structure of an active site. Indeed, in this case the now well-established active-
site structure was deduced by a combination of chemical, spectroscopic, and
magnetic methods, and the site was successfully modeled long before the first
protein crystallographic study was reported.
The presence of acid-labile, inorganic sulfide is a key feature of both the
Fe2S2 and the Fe4S4 centers. The 1: 1 stoichiometry between iron and acid-labile
sulfide was eventually established analytically for Fe2S2 centers.9- 11 Care must
be taken to ensure that both the protein and its active-site complement are ho-
mogeneous. Although protein homogeneity is usually established by electropho-
retic methods, these methods may not distinguish between pure proteins and
those with absent or incomplete active centers. Fortunately, absorption at 420 run
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Figure 7.8
The x-ray crystal structure of the FezSz ferredoxin from Spirulina platensis. 70a
is due solely to the Fe2S2 cluster, whereas the 275-nm absorption is dominated
by the protein. Therefore a good criterion for active-site saturation and homo-
geneity is the ratio of the absorbances at 420 and 275 nm, A420 nm/Am nm, which
is ~ 0.48 for pure spinach ferredoxin. 81 Once homogeneous protein is obtained,
the Fe2S2 composition of the "plant" ferredoxins can be correctly deduced an-
alytically.
The Fe2S2 center displays two redox states that differ by a single electron.
The potential range for the couple is - 250 to - 420 mV, revealing the highly
reducing nature of the ferredoxin. The correct structure of the Fe2S2 center was
first proposed in 1966 based on EPR studies. 82 The reduced state of the cluster
shows a rhombic EPR signal with g values of 1.88, 1.94, and 2.04 (Figure
7.6B) characteristic of an S = t center. The oxidized state is EPR-silent. The
weakness of the sulfur ligand field causes the iron atoms to be high-spin. But
how can two sulfur-ligated iron atoms, each with a tendency to be high-spin,
produce a state with a single unpaired electron?
The individual Fe atoms in the Fe2S2 cluster resemble those in rubredoxin
quite closely. The two redox states of the Fe2S2 protein correspond to an Fe 3 + -
Fe3+ and an Fe 3+ -Fe 2+ pair, respectively, as shown in Figure 7.9. In the all-
Figure 7.9
Redox states of FezSz proteins: (A) reduced; (B) oxidized.
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ferric oxidized state, the two Fe 3+ sites are antiferromagnetically coupled; i.e.,
the spins of the five d electrons on the two iron atoms are oppositely aligned,
such that their pairing produces an effective S = 0, diamagnetic ground state.
In the reduced form, a single unpaired electron is present, because the S = i
Fe 3+ and S = 2 Fe 2+ sites are antiferromagnetically coupled, leaving one net
unpaired spin and an S = ! ground state. The profound difference between the
electronic properties of rubredoxin and Fe2S2 ferredoxin arises because the latter
has two Fe atoms in close proximity, which allows for their magnetic coupling.
Strong support for the spin-coupling model in Fe2S2 ferredoxins comes from
a detailed analysis of their absorption and circular dichroism spectra. 83 As with
rubredoxin (see Figure 7.5), we expect no low-energy spin-allowed dod bands
for the ferric site in either the oxidized or the reduced state. Indeed, the oxidized
state containing all Fe 3+ shows no low-energy bands; the reduced state contain-
ing a single Fe 2+ displays low-energy, low-intensity bands in the region 4,000-
9,000 em 1, in close analogy to the situation in reduced rubredoxin. The com-
bined EPR and optical spectra leave little doubt about the structural assignment:
two coupled high-spin ferric ions in the oxidized state, and coupled high-spin
ferric and ferrous ions in the reduced state. Moreover, the spectra are consistent
only with a localized model, i.e., one in which the Fe(II) site is associated with
a single iron. 83 ,83a The Fe2S2 site is inherently asymmetric, and inequivalence
of the Fe(llI) sites is spectroscopically detectable in the all-ferric oxidized form. 84
In fact, the localized valence trapping is present in reduced model compounds
that contain no ligand asymmetry.
M6ssbauer spectra provide additional and striking confirmation of the struc-
tural assignment. The spectrum of the oxidized ferredoxin (Figure 7.7) resem-
bles strongly that of oxidized rubredoxin, indicating the presence of high-spin
Fe3+, even though the net spin is zero. In the reduced form, the M6ssbauer
spectrum involves the superposition of signals from a high-spin Fe2+ and a
high-spin Fe3+, i.e., a reduced and an oxidized rubredoxin, respectively. Clearly,
the simplest interpretation of this result consistent with the S = ! spin state
required by the EPR is the localized Fe2+-Fe3+ antiferromagnetic coupling model
discussed above.
NMR studies of oxidized Fe2S2 proteins reveal broad isotropically shifted
resonances for the CH2 protons of the cysteine ligands. 85 Despite the coupling
of the irons, the net magnetism at room temperature is sufficient to lead to large
contact shifts (- 30 to - 40 ppm downfield from TMS). The assignment of the
resonance was confirmed with the synthesis and spectroscopic analysis of model
compounds. 86 Extensive NMR studies of the Fe2S2 proteins have been re-
ported. 87 .87a
Resonance Raman spectra of Fe2S2 sites 88,89,90 reveal many bands attribut-
able to Fe-S stretching. Detailed assignments have been presented for the four
bridging and four terminal Fe-S modes. A strong band at ~ 390 em 1, which
shifts on 34S sulfide labeling, is assigned to the A1g "breathing" mode; another
band at 275 em - 1 is assigned to B3u symmetry in point group D2h .57 ,88 Spectro-
scopic differences in the terminal, Fe-S(Cys) stretches between plant ferredoxins
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and adrenodoxin (which also differ somewhat in redox potential) seem to reflect
different conformations of the cysteine ligands in the two classes. Evidence for
asymmetry of the iron atoms is found in the intensity of the resonance enhance-
ment of certain modes.
D. Rieske Centers
Within the class of Fe2S2 ferredoxins there is a subclass called the Rieske pro-
teins, or the Rieske centers. 47 ,91.92 The Rieske iron-sulfur centers are found in
proteins isolated from mitochondria and related redox chains. 47 .92 In addition,
the phthalate dioxygenase system from Pseudomonas cepacia 93 ,94 contains one
Fe2S2 Rieske center as well as one additional nonheme Fe atom. Although the
Rieske centers appear to contain an Fe2S2 core, there is extensive evidence for
nonsulfur ligands coordinated to at least one of the Fe atoms. The proposed
model in Scheme (7.3) has two imidazole ligands bound to one Fe atom. The
nitrogen atoms are seen in ENDOR (Electron Nuclear Double Resonance) ex-
periments,93 and are manifest in EXAFS spectra, which are consistent with the
presence of a low-Z (atomic number) ligand bound to iron. 94 The potentials for
the Rieske proteins range from + 350 to - ISO mV, 47 in contrast to the plant-
type Fe2S2 centers, which range from - 250 to - 450 mV. The strong depen-
dence of redox potential on pH 95 suggests a possible role in coupling proton-
and electron-transfer processes.
H
cys Nil~s ~ J-hiS
~F/S~ /N
e Fe
/ ~S/ ~
S N/ (~hiS
cys N.-!J
H
(7.3)
Although spectroscopic studies led to the correct deduction of the structure of
the Fe2S2 core, the synthesis of model compounds containing this core provided
unequivocal confirmation. The model compounds allowed detailed structural
analysis unavailable for the proteins. Moreover, by using a uniform set of pe-
ripheral ligands, properties inherent to the Fe2S2 core could be discerned.
The Fe2S2 core has been synthesized by several routes 86,96,96a,b,c.d (see Fig-
ure 7.10). For example, the reaction of Fe(SR)42-, the ferrous rubredoxin model,
with elemental sulfur produces the complex Fe2S2(SR)42 -. In this reaction the
sulfur presumably oxidizes the Fe 2+ to Fe 3+, being reduced to sulfide in the
process. The Fe2S2 core has been prepared with a variety of peripheral S-donor
ligands. Metrical details for Fe2SiSC6H4-p-CH3)/- are given in Table 7.3.
Notable distances are the Fe-S (bridging) distance of 2.20 A, the Fe-S (terminal)
distance of 2.31 A, and the Fe-Fe distance of 2.69 A.
Figure 7.10
Preparative schemes leading to complexes containing the FezSz core. 128
Table 7.3
Structural parameters for
Fe2S2(SCsH4-p-CH3)4 2~· .
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Atoms a
Fe-Fe
Fe-S I (bridge)
Fe-S2 (bridge)
Fe-S3
Distance A
2.691 (I)
2.200 (I)
2.202 (I)
2.312 (I)
Atoms'
Fe-S-Fe
S-Fe-S
S-Fe-S
S-Fe-S
Angle 0
75.3
104.6
115.1
105.4
a Data from Reference 211.
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To date, all analogue systems structurally characterized contain the Fe3+-
Fe3+ fully oxidized form. Attempts to isolate the Fe3 +-Fe2+ form have so far
failed. However, the mixed-valence Fe2S2 form can be generated and trapped
by freezing for spectroscopic examination. 97 ,98 Mossbauer spectroscopy reveals
the presence of distinct Fe2+ and Fe3+ ions, as found in the proteins, clearly
showing that "trapped" valence states are an inherent characteristic of the FeZS22+
core and are not enforced by the protein.97 ,98
The existence of noncysteine-bound Fe2S2 cores in Rieske-type proteins has
led to attempts to synthesize complexes with oxygen and nitrogen ligands. 99- 101
Characterized species include Fe2S2(OC6Hs)42-, Fe2S2(OC6H4-P-CH3)42-,
Fe2Sz(C4H4N)42-, and Fe2S2(L)z2-, where L is a bidentate ligand.
<{ 0
0- -0
The potentially tridentate ligand
sOCco, (7.4)
(7.5)
acts in a bidentate fashion, binding through Sand 0 but not N.
No Fe2S2 complexes containing mixed S,N terminal ligands, such as those
suggested for the Rieske site, have been prepared. The Se 2- bridged analogue
has been prepared for some of the compl~xes. 102,103
F. Fe4S4 Ferredoxins (including HiPIPs)
We now turn our attention to proteins containing the Fe4S4 center. Historically,
within this class a strong distinction was made between the "ferredoxins," which
are low-potential (as low as - 600 mV in chloroplasts) iron-sulfur proteins, and
the "HiPIPs" = High Potential Iron Proteins, which have positive redox po-
tentials (as high as +350 mV in photosynthetic bacteria). Although the HiPIP
designation is still useful, proteins of both high and low potential are considered
ferredoxins, whose key defining feature is the presence of iron and acid-labile
sulfide. 13
The Fe4S4 proteins participate in numerous electron-transfer functions in
bacteria, and in some organisms (such as Clostridium) are the immediate elec-
tron donors for the nitrogenase and/or hydrogenase enzymes. The function of
the HiPIPs seems obscure at present. In addition, Fe4S4 centers have been shown
or postulated to occur in numerous microbial, plant, and mammalian redox en-
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zymes, including nitrate reductase,104 sulfite reductase,24 trimethylamine dehy-
drogenase,105 succinate dehydrogenase ,73, 106 hydrogenase, and, possibly, in al-
tered forms, nitrogenase. Table 7.1 lists some of the Fe4S4 ferredoxins and their
properties.
In the Fe2S2 ferredoxins, combined spectroscopic, analytical, and model-
system work led to an unequivocal assignment of the structural nature of the
active site long before the crystallography was done. In contrast, for Fe4S4 sys-
tems and in particular the 8Fe-8S = 2Fe4S4 systems from bacteria, the initial
chemical suggestions were fallacious, and even the number and stoichiometry
of the clusters were in doubt. In these cases, crystallography provided the defin-
itive structural information.
The first indication of the presence of the "thiocubane" structure came in
1968, when a 4-A resolution study 107 indicated a compact cluster of potentially
tetrahedral Fe4 shape in the HiPIP from Chromatium vinosum. This finding did
not lead to much excitement, since it was not yet appreciated that HiPIPs and
ferredoxins were structurally similar. In 1972, the high-resolution structure so-
lution of both Chromatium HiPIP 108 and the 8Fe ferredoxin from Peptococcus
aerogenes (formerly Microbacter aerogenes) 101 confirmed the presence of vir-
tually identical thiocubane clusters in the two proteins. 108 Moreover, the struc-
tures for both oxidized and reduced HiPIP were deduced, and these revealed
that the Fe4S4 cluster remained intact during the redox interconversion. l09 Sub-
sequently, four-iron clusters have been crystallographically confirmed in an Fe4S4
ferredoxin from Bacillus thermoproteolyticus,IIO,1l0a in Azotobacter vinelandii
ferredoxin I (also previously called Shethna Fe-S protein II), which also con-
tains a 3Fe-4S cluster,IIl,112 in the active form of aconitase,1l3 and in sulfite
reductase, where the cluster is probably bridged by cysteine sulfur to a siro-
heme.
In all the proteins characterized to date, the Fe4S4 clusters adopt the thio-
cubane structure,108 which is discussed at greater length in the section on models.
The clusters are usually bound to their proteins by four cysteine residues. As
shown in Figure 7.11, in the P. aerogenes protein the two Fe4S4 clusters are
bound by cysteines numbered 8, 11, 14, 18, 35, 38,41, and 45. 101 ,114 The
presence of the Cys-x-x-Cys unit is again apparent. However, this sequence
seems prominent in all Fe-S proteins, and so is not specific for a particular
Fe-S site. At first glance one might expect one cluster to be bound by cysteines
8,11,14, and 18, the other by cysteines 35, 38, 41, and 45. Actually, one clus-
ter is bound by cysteines 8, 11, 14, and 45, the other by cysteines 35, 38, 41,
and 18. The binding of a given cluster by cysteine residues from different por-
tions of the polypeptide chain apparently helps stabilize the tertiary structure of
the protein and brings the two clusters into relatively close proximity, the cen-
ter-center distance being 12 A.114
The C. pasteurianum protein displays weak magnetic coupling, which leads
to an unusual EPR spectrum 115 consistent with the 12-A cluster-cluster separa-
tion. However, the redox potentials for the two sites seem virtually identical at
- 412 mV, thus allowing the 8Fe ferredoxin to deliver two electrons at this low
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Figure 7.11
The x-ray crystal structures of (A) Chromatium vinosum HiPIP 108 and (B) the 8Fe-8S ferredoxin
from Peptococcus aerogenes. 101
redox potential. 115 Significant sequence identity indicates the likelihood that other
8Fe ferredoxins, such as the well-studied one from C. pasteurianum, 116-118 have
quite similar structures.
The thiocubane unit of Fe4S4 proteins can exist in proteins in at least three
stable oxidation states. This so-called three-state modeI74.I09.I19.IZO contrasts dra-
matically with the situation for Rd(lFe), FezSz, and Fe3S4 systems, in which
only two oxidation states are accessible through simple electron transfer for each
center. For the thiocubane structure, the three accessible states can be desig-
nated Fe4S43 +, Fe4S4Z+, and Fe4S4 +, corresponding to [Fe(IIIhFe(II)l,
[Fe(III)zFe(II)z], and [Fe(III)Fe(IIhl valence-state combinations, respectively. It
is crucial to note that, in sharp contrast to the FezSz and Fe3S4 sites, the oxida-
tion states are not localized in the Fe4S4 clusters. In most cases, each Fe atom
behaves as if it had the same average oxidation level as the other Fe atoms in
the cluster. The redox interconversion of the Fe4S4 sites is shown in Figure
7.12. The Fe4S43+ ~ Fe4S4z+ couple is the high-potential redox couple char-
acteristic of HiPIPs; the Fe4S4 z+ ~ Fe4S4 + couple is responsible for the low-
potential process characteristic of the classical ferredoxins. In any given protein
under physiological conditions, only one of the two redox couples appears to be
accessible and functional.
Both the Fe4S4 + and the Fe4S43 + states of the thiocubane cluster are para-
magnetic and display characteristic EPR spectra (Figure 7.6C,D). The Fe4S43+
Fe4S~+ < e '> Fe4S~+ < e '> Fe4 S;
-e -e
[Fe(III)3 Fe (II)] [Fe (III) 2Fe (II) 2] [Fe (III) Fe(II)3]
(A) (B) (C)
Figure 7.12
The redox interconversions of Fe4S4 sites illustrating the three-state model. The states are found
in (A) oxidized HiPIP; (B) reduced HiPIP and oxidized ferredoxin; (C) reduced ferredoxin.
site in reduced ferredoxins 46.48.49,119 displays a rhombic EPR signal (Figure 7.6C)
with g = 1.88, 1.92, and 2.06. The oxidized form of low-potential ferredoxins
is EPR-silent, and attempts to "superoxidize" it to achieve the Fe4S43+ state
invariably lead to irreversible cluster decomposition, probably through a 3Fe-4S
structure. The Fe4S43+ signal is usually referred to as the HiPIP signal (Figure
7.6D) and shows distinct g values at 2.04(g.l) and 2.10(gll); it is present in
oxidized HiPIP but absent in reduced HiPIP.46,119 Reduction of HiPIP to a "super-
reduced" state apparently occurs under partially denaturing conditions in aqueous
DMSO. 108 The observed axial EPR signal with g = 1.94 and 2.05 is assigned
to the Fe4S4 + state characteristic of reduced ferredoxins. This result 108 is con-
sistent with structural and spectroscopic identity of the HiPIP and Fd sites, as
required by the three-state model of the Fe4S4 proteins (Figure 7.12).
In Fe4S4 centers at each level of oxidation, electronic transitions give rise
to characteristic visible and UV spectra, although the delocalized nature of the
electronic states makes detailed assignment difficult. MCD spectra of clusters in
the three states of oxidation are clearly distinguishable from each other and from
MCD of Fe2S2 clusters. 43 ,119 MCD, magnetic susceptibility, and M6ssbauer spectra
provide evidence that the S = t state, whose EPR signal is so distinct in re-
duced ferredoxins, may coexist at higher T with S = i and perhaps even higher
spin states. Indeed, recent studies with model systems 121,122 and theoretical
treatments 123,124 clearly support the ability of the Fe4S4 cluster to display a num-
ber of spin states that are in labile equilibria, which are influenced, perhaps
quite subtly, by local structural conditions. The iron protein of nitrogenase also
displays this behavior.
The M6ssbauer spectra of Fe4S4 centers of ferredoxins reveal the equiva-
lence of the Fe sites, and quadrupole splittings and isomer shifts at averaged
values for the particular combination of oxidation states present. 3,51 ,52 Represen-
tative spectra are shown in Figure 7.7. Magnetic coupling is seen for the para-
magnetic states.
Resonance Raman spectra (and IR spectra) have been extensively investi-
gated in C. pasteurianum ferredoxin and in model compounds. 57 ,125 Selective
labeling of either thiolate sulfur or sulfide sulfur with 34S allows modes associ-
ated with the Fe4S4 core to be distinguished from modes associated with the Fe-
SR ligands. The band at 351 cm - 1 is assigned to Fe-SR stretching, and Fe4S4
modes occur at 248 and 334 cm - I in reduced ferredoxin from C. pasteurianum.
There is little difference between the oxidized and reduced spectra, although an
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extra band at 277 cm 1 seems present in the oxidized protein. The Fe4Se4 sub-
stituted protein has also been studied. 125
As in the IFe and 2Fe proteins, 1H NMR spectra reveal resonances from
contact-shifted -CHr groups of cysteinyl residues. 125a However, unlike the other
proteins, where all states are at least weakly magnetic, only the reduced ferre-
doxin and the oxidized HiPIP states show contact shifts. 87a,125a,b,c
EXAFS studies on proteins and on model compounds clearly identify the
Fe-S distance of ~2.35 Aand an Fe-Fe distance of 2.7 A. These distances, as
expected, vary only slightly with state of oxidation. 125d
Judging from the ease with which models of Fe4S4 are prepared under a variety
of conditions and their relative stability, the Fe4S42 + core structure seems to be
a relatively stable entity, a local thermodynamic minimum in the multitude of
possible iron-sulfide-thiolate complexes. The initial preparation and structural
characterization 126,127 of the models showed that synthetic chemistry can dupli-
cate the biological centers in far-simpler chemical systems, which can be more
easily studied in great detail.
The general synthetic scheme for Fe-S clusters is shown in Figure 7.13.
Many different synthetic procedures can be used to obtain complexes with the
Fe4S4 core. 126~138,138a,b The multitude of preparative procedures is consistent with
the notion that the Fe4S42 + core is the most stable entity present and "sponta-
neously self-assembles" when not limited by stoichiometric constraints.
~T"O,/RI"
7)
2 RGOGI 2/ "'TRI' ~ ",S,CI,
Fe 4 (SR),~-
[S] = S8 or RSSSR
Figure 7.13
Preparative schemes leading to complexes containing the Fe4S4 core. 128
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Table 7.4
Structural parameters for Fe4S4(SCH2C6Hs)42-.
Number
Atoms a Average distances of bonds
Fe(1)-S(3) 2.310(3) 8
Fe(1 )-S(2) 2.239 (4) 4
Fe(1 )-S(5) 2.251 (3) 4
Fe(1 )-Fe(2) 2.776 (10) 2
Fe-Fe(other) 2.732 (5) 4
Number
Atoms a Average angle of bonds
Fe-S-Fe 73.8 (3) 12
S-Fe-S 104.1 (2) 12
S-Fe-S 111.7-117.3 12
a Data from References 126 and 127.
Type
Sulfide
Sulfide
Thiolate
Type
Sulfide-Fe-Sulfide
Sulfide-Fe-Thiolate
The thiocubane structure can be viewed as two interpenetrating tetrahedra
of 4Fe and 4S atoms. The 4S tetrahedra are the larger, since the S-S distance is
~3.5 A, compared with the Fe-Fe distance of ~2.7 A. The S4 tetrahedron
encloses ~2.3 times as much volume as does the Fe4 tetrahedron. 128 Key dis-
tances and angles for Fe4S4(SCH2C6Hs)42 given in Table 7.4 are extremely
similar to those found in oxidized ferredoxin and reduced HiPIP centers in pro-
teins. 127
The idealized symmetry of Fe4S42+ model systems is that of a regular tet-
rahedron, i.e., Td. Though the distortion of the cube is quite pronounced, all
known examples of the Fe4S/+ core show distortion, which lowers the sym-
metry at least to D2d . In most Fe4S/+ core structures, this distortion involves a
tetragonal compression, which leaves four short and eight long Fe-S bonds.
Complexes with non-S-donor peripheral ligands have been prepared
and studied. The halide complexes Fe4S4X42 - (X = CI -, Br -, I -) have
been prepared, and serve as useful starting points for further syntheses. 129-133
The complex Fe4SiOC6Hs)42- can be prepared 134 from the tetrachloride (or
tetrathiolate) thiocubane by reaction with NaOC6Hs (or HOC6Hs). There
are a few examples of synthetic Fe4S42 + cores in which the ,peripheral ligands
are not identical. For example, Fe4S4Cl2(OC6Hsh2- and Fe4S4Ch(SC6Hsh2-
have structures characterized by D2d symmetry. 13S The complexes
Fe4SiSC6Hsh[S2CN(C2Hshh2 and Fe4S4(SC6H40H)42- are similarly asym-
metric, containing both four- and five-coordinate iron. 136- 138 The presence of
five-coordinate iron in the Fe4S4 cluster is notable, since it offers a possible
mode of reactivity for the cluster wherever it plays a catalytic role (such as in
aconitase). Complexes with Fe4Se/+ and Fe4Te42+ cores have also been pre-
pared. 138c,d
One structural analysis of Fe4S4(SC6Hs)43 -, which contains the reduced
Fe4S4 + core, revealed a tetragonal elongation 139 in the solid state. In contrast,
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analysis of Fe4S4(SCH2C6Hs)43~ revealed a distorted structure possessing C2v
symmetry.102 It would appear that the Fe4S4 + clusters maintain the thiocubane
structure, but are nevertheless highly deformable. Interestingly, when the solid-
state C2v structure, Fe4S4(SCH2C6HS)43~ , is investigated in solution, its spectro-
scopic and magnetic behavior change to resemble closely those of the
Fe4SiSC6Hs)43~ cluster,140 which does not change on dissolution. The simplest
interpretation assigns the elongated tetragonal structure as the preferred form for
Fe4S4 + cores with deformation of sufficiently low energy that crystal packing
(or, by inference, protein binding forces) could control the nature of the distor-
tions in specific compounds. 128 The elongated tetragonal structure has four long
and eight short bonds in the core structure. The terminal (thiolate) ligands are
0.03-0.05 A longer in the reduced structure, consistent with the presence of
3Fe(ll) and lFe(III) in the reduced form, compared to 2Fe(II) and 2Fe(III) in
the oxidized form. There is no evidence for any valence localization. 128
The oxidized Fe4S43 + core defied isolation and crystallization in a molecular
complex prior to the use of sterically hindered thiolate ligands. With 2,4,6
tris(isopropyl)phenylthiolate, the Fe4S4L4 ~ complex could be isolated and char-
acterized. 141 The structure is a tetragonally compressed thiocubane with average
Fe-S and Fe-SR distances 0.02 and 0.04 A shorter than the corresponding dis-
tances in the Fe4S4L42~ complex. Again, there is no evidence for Fe inequival-
ence or more profound structural distortion in this 3Fe(III)-IFe(II) cluster. Clearly,
the Fe4S4 clusters have highly delocalized bonding.
Evidence from model systems using sterically hindered thiolate ligands in-
dicates the existence of an Fe4S44+, i.e., all-ferric fully oxidized cube. 142 The
existence of the complete series Fe4S4[(CyhC6H2Sn (Cy =cyclohexyl; n = 0,
-1, -2, -3) is implied by reversible electrochemical measurements. Clearly,
five different states of the Fe4S4 core-including the (at least) transient fully
oxidized state and the all-ferrous fully reduced state-may have stable exis-
tence. Although only the central three states have been shown to exist in biolog-
ical contexts, one must not rule out the possible existence of the others under
certain circumstances.
Recently, specifically designed tridentate ligands have been synthesized that
bind tightly to three of the four Fe atoms in the thiocubane structure. 143.143a.b
The remaining Fe atom can then be treated with a range of reagents to produce
a series of subsite-differentiated derivatives and variously bridged double-cu-
bane units. These derivatives illustrate the potential to synthesize complexes that
mimic the more unusual features of Fe4S4 centers that are bound specifically and
asymmetrically to protein sites. The recently synthesized complex ion
[(Cl3Fe4S4hS]4~, containing two Fe4S4 units bridged by a single S2- ligand,
illustrates the potential coupling of known clusters into larger aggregates. 143c
The model-system work has made an important contribution to our under-
standing of the Fe4S4 centers. The existence of three states, the exchange of
ligands, the redox properties, the metrical details of the basic Fe4S4 unit, and
the subtleties of structural distortion can each be addressed through the study of
models in comparison with the native proteins.
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H. Core Extrusion/Cluster Displacement Reactions
Synthetic model-system work led to the realization that the cluster cores can
exist outside the protein and undergo relatively facile ligand-exchange reac-
tions. 128 This behavior of the purely inorganic complexes allowed core extrusion
reactions 128,144 to be developed. The basic assumption behind these reactions is
that the cluster core retains its integrity when it is substituted by low-MW thio-
lates, especially aryl thiolates, which replace the cysteinyl ligands that bind it
to the protein. In order to free the cluster from the protein, one must at least
partially denature the protein, usually by using ~80 percent aqueous solution of
a polar aprotic solvent, such as DMSO or HMPA. The resulting inorganic clus-
ters can be identified and quantified by measurement of their characteristic elec-
tronic absorption or NMR spectra. An alternative approach involves transferal
of the unknown cluster in question to an apoprotein that binds a cluster of known
type. 145
Since the IFe, 2Fe, and 4Fe sites are each usually bound to the protein by
four cysteine residues, it is perhaps not surprising that there have been reports 58
of interconversion of cluster types bound to a given protein. Specifically, in 90
percent aqueous DMSO, the single Fe site in rubredoxin from C. pasteurianum
is converted to an Fe4S4 cluster by the addition of sodium sulfide, ferrous chlo-
ride, and ferric chloride in ratio 4: 2: 1. Presumably the spacing and geometric
disposition of the cysteines are suitable to bind a single Fe or the Fe4S4 cluster,
which is readily formed under the reaction conditions. Another example of clus-
ter rearrangement involves the three-iron center discussed below that does not
extrude as an Fe3S4 center. Rather, at least under certain conditions, the Fe3Sx
center rearranges to form Fe2S2 centers. 146 The facile interconversion of the Fe
clusters demonstrated the lability of Fe-S systems, and indicates that caution
must be exercised in interpreting the results of cluster-displacement reactions.
Three-iron centers are a comparatively recent finding,119,146 and the full scope
of their distribution is not yet known. Although they have now been confirmed
in dozens of proteins, it often remains uncertain what physiological role these
centers play. Indeed, since Fe3S4 centers can be produced as an artifact upon
oxidation of Fe4S4 centers, it has been suggested that 3Fe centers may not be
truly physiological, and could be side products of aerobic protein isolation. This
caveat notwithstanding, the 3Fe sites are being found in more and more proteins
and enzymes. Their physiological raison d' etre may be more subtle than that of
their 1, 2, and 4Fe cousins; we should certainly try to find out more about them.
Some proteins containing Fe3S4 centers are listed in Table 7.1.
The 3Fe center was first recognized 147 in the protein ferredoxin I from the
anaerobic nitrogen-fixing bacterium Azotobacter vinelandii. The protein is called
Av FdI for short. It is instructive to sketch historically the evolution of our
understanding of this protein. Av ferredoxin I was reported to have 6 to 8 Fe
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atoms and was first thought to resemble the clostridial 8Fe ferredoxins. How-
ever, unlike the clostridial protein, the Av FdI clusters appeared to have two
quite different redox couples at + 320 and - 420 mV. Although it might have
been thought that this protein contained one HiPIP-type and one Fd- or "ferre-
doxin" -type Fe4S4 cluster, the protein as isolated had an EPR signal with
g = 2.01, which differed significantly (Figure 7.6) from that of an oxidized
HiPIP or a reduced Fd. 148 Cluster extrusion reactions also seemed to indicate
the presence of an unusual cluster type. 149
Fortunately, the protein was crystallized, and could be studied by x-ray
diffraction. Unfortunately, the initial conclusions 150 and subsequent revisions 151,152
of the crystal-structure analysis have proven to be wrong, teaching us in the
process that protein x-ray crystallography, taken alone, does not always provide
definitive results. Specifically, the first crystallographic report suggested the
presence of a conventional Fe4S4 cluster and a smaller packet of electron density
that was assigned as a 2Fe-2S center. 150 However, upon further refinement, and
following the formulation of the 3Fe center by M6ssbauer spectroscopy, 147 a
3Fe-3S center was identified and refined. 151,152 The "refined" Fe3S3 center was
a six-membered alternating iron-sulfide ring with an open, almost flat, twisted-
boat conformation (Figure 7. 14). The Fe-Fe separation of 4. 1 Aand the struc-
(A)
(8)
Figure 7.14
Fe3Sn structures: (A) open Fe3S3 structure
proposed from initial x-ray studies (now
shown to be in error); (B) the thiocubane
fragment structure believed present in most
Fe3S4 proteins; (C) open Fe3S4 structure
(not found to date).
(e)
o
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tural type was unprecedented, and did not agree with the results of resonance
Raman spectroscopy, 153 with x-ray absorption spectroscopy on the native pro-
tein or on samples from which the Fe4S4 center was removed,103 or even with
stoichiometry, which eventually led to the reformulation 154 of the cluster as
Fe3S4. The x-ray absorption studies (EXAFS) clearly led to the assignment of a
2.7-A Fe-Fe distance for the 3Fe cluster. 103
In parallel with the studies on Av FdI, two additional proteins played key
roles in the resolution of the nature of the Fe3 cluster. These are FdII from
Desulfovibrio gigas and aconitase from beef heart. Each contains (under certain
conditions) only Fe3S4 sites, thus enabling more definitive structural, stoichio-
metric, and spectral information to be acquired. Studies on these proteins using
EXAFS,155 Mossbauer,52,156,157 EPR,146 and resonance Raman (to which we will
return briefly) clearly favor the closed structure shown in Figure 7. 14C. Indeed,
x-ray crystallography on aconitase by the same group that did the initial x-ray
work on Av FdII revealed the compact structure in agreement with the spectros-
copy.20
In 1988 the structural error in the crystallography of Av FdI was found by
two groups, and a new refinement in a corrected space group led to a structure
in agreement with the spectroscopy. 111,112 The Fe3S4 cluster has the apoFe thio-
cubane structure, with each iron atom bound to the protein by a single cysteinyl
thiolate. Clearly, even x-ray crystallography is potentially fallible, and its find-
ings must be critically integrated with the data from other techniques in arriving
at full structural definition of metalloenzyme sites.
The studies on the ferredoxins from D. gigas present an interesting lesson
on the lability of the Fe-S cluster systems. Two distinct proteins from D. gigas,
FdI and FdII, contain the same polypeptide chain (6 kDa) in different states of
aggregation, 158,159 Whereas FdI is a trimer containing three Fe4S4 clusters, FdII
is a tetramer that contains four Fe3S4 clusters. The ferredoxins differ in their
redox potentials and appear to have different metabolic functions in D. gigas.
The oxidation of D. gigas FdI with Fe(CN)63- leads to FdII, and treatment of
FdII with iron salts leads to FdI. The D. gigas system reveals the lability and
interconvertibility of Fe-S clusters. The recently reported 160 crystal structure of
D. gigas FdII shown in Figure 7.15 confirms the partial (apoFe) thiocubane
Fe3S4 center. The iron atoms are ligated by three cysteinyl residues from protein
side chains. The cube missing an iron is now firmly established as a viable
structural type.
The aconitase system presents yet another fascinating story. 159a Aconitase is
a key enzyme in the Krebs cycle, catalyzing the conversion of citrate and iso-
citrate through the intermediacy of cis-aconitate, as shown in Equation (7.6).
H COO-
H
"c/ HI I
H-e-eOO- II Ho-e-eOO- (7.6)I -H 2O C -H2O I
Ho-e-eOO- ----> /
"
( ) H-e-cOO-<--- H CH2I H2O / H2O ICH2-COO COO CH2-eOO
citrate cis-aconitate isocitrate
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Figure 7.15
The x-ray crystal structure of D.gigas FdII, illustrating the Fe4S4
and Fe3S4 centers in this protein. l60
This is a hydrolytic nonredox process, and for some time it was thought that
aconitase was a simple Fe 2+ protein wherein the ferrous iron was involved in
the Lewis-acid function of facilitating the hydrolytic reaction. Indeed, aconitase
is inactive when isolated from mitochondria, and requires the addition of Fe 2+
to achieve activity.
Surprisingly, the isolated aconitase was found by analysis and Mossbauer
spectroscopy to possess an Fe3S4 site in its inactive form. 161 Low-resolution
crystallographic study supports the presence of an apo-Fe thiocubane, Fe3S4
structure in aconitase. 162 Resonance Raman 163 and EXAFS 103,155 studies clearly
fingerprint the Fe3S4 cluster. The current hypothesis for aconitase activation in-
volves the Fe3S4 thiocubane fragment reacting with Fe2+ to complete the cube,
which is the active form of the enzyme. l64 Recent crystallographic studies 113
confirm the presence of a complete cube in the activated aconitase. The dimen-
sions and positioning of the Fe3S4 and Fe4S4 centers in the cube are virtually
identical. The added Fe 2+ iron atom is ligated by a water (or hydroxide) ligand,
consistent with the absence of any cysteine residues near the exchangeable iron.
Since this water (or a hydroxide) is also present in the Fe3S4 system, one won-
ders whether a small ion such as Na + might be present in the Fe3S4 aconitase
system.
Questions of detailed mechanism for aconitase remain open. ENDOR spec-
troscopy 165 shows that both substrate and water (or OH -) can bind at the clus-
ter. Does one of its Fe-atom vertices play the Lewis-acid role necessary for
aconitase activity? Is the Fe3S4 ~ Fe4S4 conversion a redox- or iron-activated
switch, which works as a control system for the activity of aconitase? These
and other questions will continue to be asked. If aconitase is indeed an Fe-S
enzyme with an iron-triggered control mechanism, it may be representative of a
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large class of Fe3/Fe4 proteins. Other hydrolytic enzymes containing similar
Fe-S centers have recently been reported. 166,166a
Spectroscopically, the Fe3S4 center is distinct and clearly distinguishable
from IFe, 2Fe, and 4Fe centers. The center is EPR-active in its oxidized form,
displaying a signal (Figure 7.6) with g = 1.97, 2.00, and 2.06 (D. gigas FdII).158
The Mossbauer spectrum (Figure 7.7) shows a single quadrupole doublet with
LlQ = 0.53 nmIs and isomer shift of 0.27 nm, suggesting the now familiar high-
spin iron electronic structure. 158.159 In its reduced form, the center becomes EPR-
silent, but the Mossbauer spectrum now reveals two quadrupole doublets of
intensity ratio 2: 1. The suggestion of the presence of a 3Fe center was first
made based on this observation. 147 The picture of the reduced Fe3S4 state that
has emerged involves a coupled, delocalized Fe 2+ /Fe 3+ unit responsible for the
outer doublet, with a single Fe 3+ unit responsible for the inner doublet of half
the intensity. The oxidized state contains all Fe 3+ ions, which are coupled in
the trinuclear center.
EXAFS studies were consistent and unequivocal in finding an Fe-Fe dis-
tance of ~2.7 Ain all putative Fe3S4 proteins. 103.155,167 Resonance Raman spec-
tra compared with those of other proteins and of model compounds with known
structures 168,169 for other metals also favored the structure of Figure 7.14B.
Clearly, what has been termed the spectroscopic imperative 170 has been crucial
in the successful elucidation of the 3Fe structure.
An interesting excursion has led to isolation of what are presumed to be
ZnFe3S4, CoFe3S4, and NiFe3S4 thiocubane structures by adding Zn 2+, C0 2+,
or Ni 2+, respectively, to proteins containing reduced Fe3S4 cores. 170a,b,c These
modified proteins provide interesting electronic structural insights and, poten-
tially, new catalytic capabilities.
J. Fe3 Model Systems
To date, the Fe3S4 center is the only structurally characterized biological iron-
sulfide center that does not have an analogue in synthetic Fe chemistry. In fact,
the closest structural analogue21 ,170d is found in the M03S44+ or V3S43+ core in
clusters such as M03S4(SCH2CH2Sh2-, whose structure is shown in Figure 7.16.
Figure 7.16
The x-ray crystal structure of M03S4(SCH2CH2S)3 2- .
(From Reference lOa.)
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The resonance Raman spectrum 169 of this complex bears a close resemblance to
that of the D. gigas ferredoxin II. Since the vibrational bands responsible for
the resonance Raman spectrum are not strongly dependent on the electronic
properties, it is not surprising that an analogue with a different metal can be
identified using this technique.
In synthetic Fe chemistry, although there is no precise structural analogue,
it is instructive to consider three types of trinuclear and one hexanuclear center
in relation to the three-iron biocenter.
The trinuclear cluster Fe3S[(SCH2hC6H4h2 is prepared 171,172 by the reac-
tion of FeCI3, C6H4(CH2SHh, Na +OCH3~, and p-CHr C6H4-SH in CH30H.
As shown in Figure 7.17A, this cluster has, like the biocluster, a single triply
bridging sulfide ion but, unlike the biocluster, it uses the sulfur atoms of the
ethane 1,2-dithiolate as doubly bridging, as well as terminal, groups. The inor-
ganic ring Fe3(SRhS63~(X = CI, Br) has a planar Fe3(SRh core, which resem-
bles the now-discredited structure for Av FdI 173 (Figure 7. 14A).
The complex Fe3S4(SR)43- is prepared 174,175 by reaction of Fe(SR)42- with
sulfur. The x-ray-determined structure reveals two tetrahedra sharing a vertex
with the linear Fe-Fe-Fe array shown in Figure 7.17B. This complex has dis-
tinctive EPR, Mossbauer, and NMR spectra that allow it to be readily identi-
fiedY4,175,175a Interestingly, after the complex was reported, a study of (dena-
tured) aconitase at high pH (>9.5) revealed that the thiocubane fragment Fe3S4
site in that enzyme rearranged to adopt a structure that was spectroscopically
almost identical with that of the linear complex. 176 Although the state may not
have any physiological significance, it does show that Fe-S clusters different
Figure 7.17
The x-ray crystal structures of trinuclear Fe complexes: (A) Fe3SiSR)43 -;
(B) Fe3S[(SCH2hC6H4h2-. (Data from References 171, 172, 174, 175.)
Figure 7.18
The x-ray crystal structure 176a,b of Fe6S9(SRh4- .
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from the common (conventional) ones already discussed could be important in
proteins under certain physiological conditions or in certain organisms; i.e., iron
centers first identified synthetically may yet prove to be present in biological
systems.
A synthetic cluster that displays features related to the biological Fe3S4 clus-
ter is the hexanuclear cluster Fe6S9(SRh4- shown in Figure 7.18. This cluster
contains two Fe3S4 units bridged through their diiron edges by a unique quad-
ruply bridging S2- ion (,u4-S2-) and by two additional ,urS2- bridges. The
inability of synthetic chemists to isolate an Fe3S4 analogue may indicate that in
proteins this unit requires strong binding. Significant sequestration by the pro-
tein may be needed to stabilize the Fe3S4 unit against oligomerization through
sulfide bridges or, alternatively, rearrangement to the stable Fe4S4 center.
K. Fe-S Chemistry: Comments and New Structures
The first successful model system for an iron-sulfur protein was an analogue of
the Fe4S4 system, i.e., the system with the largest presently established biolog-
ical Fe cluster. The reactions used to synthesize the cluster shown in Figure
7.13 are said to involve self-assembly, meaning that starting materials are sim-
ply mixed together, and thermodynamic control causes the cluster to assemble
in its stable form. Interestingly, the Fe4S4-containing proteins, such as those of
C. pasteurianum, are considered to be among the most ancient of proteins.
Perhaps on the anaerobic primordial Earth, Fe-S clusters self-assembled in the
presence of protein ligands to form the progenitors of the modem ferredoxins.
Much progress has been made in synthetic chemistry, and it is clear that
both understanding and control of Fe-S chemistry are continuing to grow. New
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preparations for known clusters continue to be found, and new clusters continue
to be synthesized, Although many of the new clusters appear to be abiological,
we should not ignore them or their potential. They add to our understanding of
Fe-S chemistry in general, and serve as starting points in the study of hetero-
nuclear clusters, There is also the distinct possibility that one or more of these
synthetic clusters represent an existing biological site that has not yet been iden-
tified in an isolated system.
Among the "nonbiological" structures that have been synthesized are com-
plexes with Fe6S63+/2+ cores 177,178 including the thioprismanes, 108,109,177~179 the
octahedron/cube Fe6S83+ cores,180,181 the Fe6Sl- cores 176a,b discussed above,
the adamantane-like Fe6(SR)104- complexes related to Zn and Cu structures in
metallothioneins,182 basket Fe6S62+ /Fe6S6 + cores,182a,b,c,d monocapped pris-
matic Fe7S63+ cores,183 the cube/octahedron Fe8S65 + cores,179 and the circular
Na+-binding Fe18S301O- unit. 183a,b Representative ions are shown in Figure 7.19.
Some of these cores are stabilized by distinctly nonbiological phosphine ligands.
Nevertheless, one should not a priori eliminate any of these structures from a
possible biological presence. Indeed, recently a novel, apparently six-iron pro-
tein from Desulfovibio gigas has been suggested 183c to have the thioprismane
core structure first found in model compounds.
L. Detection of Fe-S Sites
Several recent reviews have concentrated on the ways in which the various Fe-
S centers can be identified in newly isolated proteins. 5,6, 184 It is instructive to
summarize the central techniques used in the identification of active sites. Op-
tical spectra are usually quite distinctive, but they are broad and of relatively
low intensity, and can be obscured or uninterpretable in complex systems. MCD
spectra can give useful electronic information, especially when the temperature
dependence is measured. EPR spectra, when they are observed, are distinctive,
and are usually sufficiently sharp to be useful even in complex systems. M6ss-
bauer and resonance Raman spectroscopies have each been applied with good
effect when they can be deconvoluted, and NMR and magnetic susceptibility
have given important information in some simple, lower-MW protein systems.
X-ray absorption spectra, especially EXAFS, give accurate Fe-S and Fe-Fe dis-
tances when a single type of Fe atom is present. Analytical and extrusion data
complement the spectroscopic and magnetic information. Extrusion data must
be viewed with considerable caution, because of possible cluster-rearrangement
reactions. Even x-ray crystallography has led to incorrect or poorly refined
structures. In general, no one technique can unequivocally identify a site except
in the very simplest systems, and there is continued need for synergistic and
collaborative application of complementary techniques to a given system.
M. Redox Behavior
Figure 7.20 shows the ranges of redox behavior known for Fe-S centers. Clearly,
the Fe-S systems can carry out low-potential processes. The rubredoxins cover
the mid-potential range, and the HiPIPs are active in the high-potential region.
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Figure 7.19
Structures of "to date nonbiological" Fe-S clusters: (A) the thioprismane structure; 177 (B) bas-
ket-handle structure; 182a (C) monocapped prismatic structure; 183 (D) adamantane structure; 182 (E)
circular FelSS30 1O~ core unit. 183a,b
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Figure 7.20
A schematic diagram of the redox potential of the various FeS centers in comparison with other
known redox centers.
The lack of extensive Fe-S proteins in the positive potential region may reflect
their instability under oxidizing conditions and their preemption by Mn, Cu, or
heme-iron sites (such as in cytochrome c), which function in this region.
II. MULTISITE REDOX ENZYMES
In making the transition from the relatively simple electron-transfer proteins to
the far more complex Fe-S-containing enzymes, we must recognize that the
difference in our degree of understanding is enormous. Not only are the catalytic
proteins ten to twenty times larger than the redox proteins, but they often also
have several subunits and multiple copies of prosthetic groups. Moreover, very
few crystal structures are known for the redox enzymes, and none is known at
high resolution. In the absence of three-dimensional protein structural informa-
tion, we do not know the arrangement, relative separation, or orientation of the
prosthetic groups. Finally, studies on model systems have not yet approached
the sophisticated state that they have for the structurally known centers.
In general, multicomponent redox enzyme systems appear to be organized
in two distinct ways to effect their substrate reactions. In the first mode, the
enzyme is designed to bring the oxidant and reductant together so that they may
directly interact. For example, oxygenases bring O2 and an organic molecule
together, and activate one or both of these reactants to cause them to react
directly with each other. This mode can be called proximation, as the reactants
are brought near each other by the enzyme catalyst.
In contrast to proximation, many redox enzymes keep the oxidant and re-
ductant well-separated, and use rapid (usually long-distance) internal electron
transfer to bring electrons from the reductant to the oxidant. We can term their
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mode of action electrochemical. The oxidant and reductant are separated spa-
tially. The enzyme provides the "anode" site to interact with the reductant, the
"cathode" site to interact with the oxidant, and the wire to allow electronic
flow between the "anode" and "cathode" sites. Hydrogenases and nitrogenases
adopt the electrochemical mode of redox activation. In hydrogenases, the elec-
tron acceptor, even if it must formally take up hydrogen (e.g., NAD + --;> NADH),
does not interact at the same site as the Hz. There is no direct transfer of H -
from Hz to NAD +. Rather, Hz reduces the enzyme at one site, and NAD + or
other acceptors, such as methylene blue, retrieve the electrons at other sites
following internal electron transfer. For nitrogenase, the redox partners are even
more removed, as a separate protein, the Fe protein, delivers electrons to the
FeMo protein, that eventually end up at the FeMoco site ready to reduce Nz to
NH3 . These enzymes work much like electrochemical cells.
A. Hydrogenase and Nitrogenase
Hydrogenase is the enzyme responsible for the uptake or evolution of Hz. Nitro-
genase is the enzyme that catalyzes the ATP-dependent reduction of Nz to NH3 ,
with concomitant evolution of Hz.
The relationship between Hz and Nz in biology is intricate. 184 Metabolically,
Hz use and Nz use are tightly coupled in many nitrogen-fixing organisms, with
Hz serving indirectly as the reductant for Nz. Moreover, Hz and Nz react in
related ways with various transition-metal complexes, which are at present the
closest (albeit quite imperfect) models of the enzyme active sites. The biological
fixation of molecular nitrogen is dependent on iron-sulfide proteins that also
contain molybdenum or vanadium. The biological production or uptake of Hz
depends on the presence of iron-sulfide proteins, which often also contain nickel
and sometimes selenium. Spectroscopic and model-system studies, which have
played such a key role in advancing the understanding of simple Fe-S sites, are
now helping to foster an understanding of these more complex enzyme sites,
although we have much yet to learn about structure and mechanism in these
enzymes. The remainder of this chapter seeks to convey the state of our rapidly
evolving knowledge.
B. Hydrogenases
1. Physiological significance
Molecular hydrogen, Hz, is evolved by certain organisms and taken up by
others. For either process, the enzyme responsible is called hydrogenase. The
raison d' etre for hydrogenases in particular organisms depends on the metabolic
needs of the organism. Properties of some representative hydrogenases are given
in Table 7.5. 184.184a-g
Hydrogenases are found in a wide variety of anaerobic bacteria, such as the
eubacterial C. pasteurianum and Acetobacterium woodii and the archaebacterial
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Table 7.5
Properties of some representative hydrogenases.
MW Approximate
Organism (designation) (subunits) composition Reference
Clostridium pasteurianum 60,000 (1) 12Fe 191
(Hydrogenase I) 22Fe 194
Clostridium pasteurianum 53,000 (1) 8Fe 191
(Hydrogenase II) 17Fe 194
Acetobacterium woodii 15,000 Fe 192
Megasphaera elsdenii 50,000 (1) 12Fe 188
Desulfovibrio vulgaris 56,000 (2) 12Fe 171
(periplasmic)
Desulfovibrio gigas 89,000 (2) llFe, INi 363
Desulfovibrio africanus 92,000 llFe, INi 364
Methanobacterium Fe, INi 145
thermoautotrophicum 200,000
Methanosarcina barkeri 60,000 8-lOFe, INi 77
Methanococcus vanielli 340,000 Fe, Ni, ISe, FAD 365
Desulfovibrio baculatus 85,000 (2) 12Fe, INi, ISe 365
Methanosarcina barkerii. Interestingly, C. pasteurianum sometimes evolves H2
during its growth on sugars. This H2 evolution is required for continued metab-
olism, since it allows the organism to recycle (reoxidize) cofactors that are re-
duced in the oxidation of sugars (or their metabolic descendants, lactate or ethanol).
In effect, H + is acting as the terminal oxidant in clostridial metabolism, and H2
is the product of its reduction. In contrast, methanogens such as methanosarcina
take up H2 and in effect use it to reduce CO2 to CH4 and other carbon products.
Clearly, either H2 uptake or H2 evolution may be important in particular anaer-
obic metabolic contexts. The hydrogenases of the anaerobic sulfate-reducing
bacteria of the genus Desulfovibrio have been particularly well-studied (see Ta-
ble 7.5).
In nitrogen-fixing organisms, H2 is evolved during the nitrogen-fixation pro-
cess, and hydrogenase is present to recapture the reducing equivalents, which
can then be recycled to fix more nitrogen. In Nrfixing organisms, such "up-
take" hydrogenases can make an important contribution to the overall efficiency
of the nitrogen-fixation process. In fact, certain species of rhizobia lacking the
hydrogen-uptake system (hup - strains) can be made more efficient by geneti-
cally engineering the hup activity into them.
Aerobic bacteria such as Azotobacter vinelandii, Alcaligenes eutrophus, and
Nocardia opaca, and facultative anaerobes, such as Escherichia coli and various
species of Rhizobium and Bradyrhizobium (the symbionts of leguminous plants),
also contain hydrogenase, as do photosynthetic bacteria such as Chromatium
vinosum, Rhodobacter capsulatus (formerly Rhodopseudomonas capsulata), and
Anabaena variabilis (a filamentous cyanobacterium). The thermophilic hydro-
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gen oxidizer Hydrogenobacter thermophilus, which grows in alkaline hot springs
above 70°C, obviously has a critical requirement for hydrogenase.
In certain aerobic organisms, such as hydrogenomonas, H2 and O2 are caused
to react (but not directly) according to the Knallgas reaction 185
54.6 kcal/mol (7.7)
These organisms break up this thermodynamically highly favorable redox pro-
cess by using intermediate carriers, thereby allowing the large negative free-
energy change to be captured in biosynthetic capacity.
Hydrogenases seem to be especially prevalent in anaerobic, nitrogen-fixing,
and photosynthetic organisms. However, although hydrogenases are obviously
found widely among prokaryotes, unlike nitrogenase, their domain is not re-
stricted to prokaryotes. Eukaryotic green algae such as Chlorella fusca and
Chlamydomonas reinhardtii possess hydrogenase. The anaerobic protozoan Tri-
chomonas vaginalis, which lacks typical aerobic organelles, such as mitochon-
dria and peroxisomes, has an organelle called a hydrogenosome, whose function
is to oxidize pyruvate to acetate, producing H2, via hydrogenase, in the process.
The various hydrogenase enzymes are all transition-metal sulfide proteins.
However, before we discuss these enzymes, we tum briefly to the dihydrogen
molecule and its physical and chemical properties.
2. Dihydrogen: the molecule
Diatomic H2 has a single H-H bond formed by overlap of the two Is
orbitals of the two hydrogen atoms. In molecular orbital terms, this overlap
forms bonding u and antibonding u* orbitals, shown in the energy-level dia-
gram in Figure 7.21A and displayed spatially in Figure 7.21B. The H-H dis-
tance is 0.74 A, and the bond dissociation energy is 103.7 kcallmole. The iso-
topes of hydrogen IHj, 2H1 = 2Dj, 3H1 = 3T1 are called protium (a designation
seldom used), deuterium, and tritium, respectively. Deuterium, at natural abun-
dance of 0.015 percent, is a stable isotope with nuclear spin I = 1, whereas
both IH and 3T have nuclear spin I = !. NMR has been fruitfully applied to all
the hydrogen isotopes, including tritium. Tritium is radioactive, decaying to
3He2 by f3 ~ emission with a half-life of 12 years. The nuclear properties of
deuterium and tritium make them useful as labels to probe structure and mech-
anism in hydrogen-containing compounds. "Exchange" reactions involving the
formation of HD or HT have played a significant role in mechanistic studies of
both hydrogenase and nitrogenase.
In molecular hydrogen, the existence of nuclear-spin energy levels is re-
sponsible for the distinction between ortho and para hydrogen, which corre-
spond to the triplet and singlet (i.e., parallel and antiparallel) orientations, re-
spectively, of the two nuclei in H2. Because of the coupling of the rotational
and spin levels, ortho and para hydrogen differ in specific heat and certain other
properties. The correlated orientation of the nuclear spins in para H2 has re-
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Molecular orbital scheme for binding in Hz: (A) energy-level diagram;
(B) bonding and antibonding orbitals.
cently been shown to constitute a powerful mechanistic probe, wherein NMR
may be used to trace the relative fate of the two H nuclei in the original mole-
cule.186.187 Although this technique has not yet been applied to any enzyme
systems, hydrogenase is known to catalyze the interconversion of the artha and
para forms of Hz (as does the hydrogenase analogue Pd).
Dihydrogen is a reducing agent. The Hz/H + couple at [H +] = I M defines
the zero of the potential scale. At pH = 7 the hydrogen half-reaction
H2 ~ 2H+ + 2e- (7.8)
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has E~ = - 420 mV. Dihydrogen is therefore one of the strongest biological
reductants.
Although many hydrogenases are reversible, some "specialize" in the up-
take of H2. One hydrogenase has been reported 188 to specialize in the evolution
of H2. This "specialization" seems curious, since it appears to contradict the
notion of microscopic reversibility, and seems to violate the rule that catalysts
increase the speed of both forward and backward reactions without changing the
course (direction) of a reaction. In fact, there is no contradiction or violation,
since the overall reactions catalyzed by the various types of hydrogenases are
fundamentally different. The electron acceptor in uptake hydrogenases differs
from the electron donor/acceptor in the reversible hydrogenases. The difference
involves structure and, more importantly, redox potential. The reaction cata-
lyzed by the uptake hydrogenase involves an acceptor of such high positive
redox potential that its reaction with H2 is essentially irreversible. The enzyme
appears to be designed so that it can transfer electrons only to the high potential
acceptor.
A selection of hydrogenases from various organisms is given in Table 7.5.
All hydrogenases contain Fe-S centers. The hydrogenases from more than 20
organisms 189 have been found to contain Ni by analysis and/or spectroscopy.
Many more Ni hydrogenases are likely to be found, given the nutritional
requirements 189 for hydrogenase synthesis or growth on H2. Hydrogenases may
be cytoplasmic (as in C. pasteurianum) , membrane-bound (as in E. coli), or
located in the periplasmic space (as in Desulfovibrio vulgaris). The isolation of
hydrogenases is sometimes complicated by their air sensitivity or membrane-
bound nature. Many hydrogenases have now been isolated and studied in detail;
they can be divided into two categories, the iron hydrogenases and the nickel-
iron hydrogenases.
3. Iron hydrogenases
The iron hydrogenases 189a generally have higher activities than the NiFe
enzymes, with turnover numbers approaching 10 6 min -1. Iron hydrogenases
from four genera of anaerobic bacteria have been isolated: Desulfovibrio, 190
Megasphaera,188 Clostridium,191 and Acetobacterium. 192 Of these, the enzymes
from Desulfovibrio vulgaris, Megasphaera elsdenii, Clostridium pasteurianum
(which contains two different hydrogenases), and Acetobacterium woodii 192 have
been well-characterized (especially the D. vulgaris and C. pasteurianum en-
zymes). Although Acetobacterium and Clostridium are closely related, the other
organisms are only distant cousins. 193 Nevertheless, their hydrogenases display
significant similarities; all contain two different types of iron-sulfur cluster, called
F and H clusters,194 and carbon monoxide is a potent inhibitor (although this
has not been reported for the M. elsdenii enzyme). The F clusters are thought
to be of the Fe4S4 +/2+ thiocubane type, and give S = t EPR signals when the
enzyme is in the reduced form. On the other hand, the H cluster, which is
thought to be the hydrogen-activating site, gives an EPR signal only when the
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enzyme is in the oxidized form. The H-cluster EPR signals of all the enzymes
are quite similar (g = 2.09, 2.04, 2.00), and are quite unlike the signals from
other oxidized iron-sulfide clusters (such as Fe3S4 clusters and HiPIPs), in that
they are observable at relatively high temperatures (> 100 K). Inhibition of the
D. vulgaris and both C. pasteurianum enzymes by carbon-monoxide yields a
photosensitive species that has a modified H-cluster EPR signal. l95 ,196
The two different hydrogenases of C. pasteurianum, called hydrogenase I
and II, have both been quite extensively studied, and can be regarded as proto-
typical iron-only hydrogenases. Hydrogenase I is active in catalyzing both H2
oxidation and H2 evolution, whereas hydrogenase II preferentially catalyzes H2
oxidation. 188 The two enzymes differ in their iron contents: hydrogenase I con-
tains about 20 iron atoms, 16 of which are thought to be involved in four F
clusters,194 while the remainder presumably constitute the H cluster, which may
contain six Fe atoms. 194 Hydrogenase II contains about 14 iron atoms as two F
clusters and one H cluster. 194 These estimates of iron content result from a
recent reappraisal of the metal contents (based on amino-acid analysis) that in-
dicated a rather higher Fe content than previously realized. 188.194 It is important
to note that much of the spectroscopic work, which will be discussed below,
was initially interpreted on the basis of the earlier, erroneous, iron analysis. Of
particular interest is the possibility (first suggested 197 for the D. vulgaris en-
zyme) that the H cluster contains six iron atoms.
Carbon-monoxide treatment of the D. vulgaris and both C. pasteurianum
enzymes yields a photosensitive species that has a modified H cluster EPR sig-
nal. 195.196 Interestingly, the C. pasteurianum enzymes also form complexes with
O2, in a process that is distinguishable from the deactivation of hydrogenase by
O2, which results from a much more prolonged exposure to O2 than that re-
quired to form the O2 complex. The O2 complexes have (photosensitive) EPR
signals much like those of the CO complex. 196 It is important to note that al-
though CO, when in excess, is a potent inhibitor of the enzymes, the hydroge-
nase I-CO complex is actually quite active. 196 With hydrogenase II, the CO
complex is dissociated on exposure to H2, restoring the "active" enzyme. 196
The EPR spectrum of reduced hydrogenase I is typical of (interacting) Fe4S4 +
clusters, and integrates to 3 or 4 spins/protein. 194,198 Electrochemical studies 199
show that these clusters possess indistinguishable reduction potentials. Recently,
MCD and EPR spectroscopies have been used to demonstrate the presence of
significant quantities of an S = ~ species in reduced hydrogenase 1. This signal
apparently integrates to about one spin per molecule, and probably originates
from an S = ~ state of an Fe4S4 cluster. 198 No information is yet available on
the reduction potential of the S = ~ species. However, based on analogy with
the nitrogenase iron protein,200 we might expect the S = ~ form to have electro-
chemistry indistinguishable from the S = ! form. EPR signals with high g val-
ues (g = 6.1 and 5.0) have also been observed in C. pasteurianum hydrogenase
I, and in the D. vulgaris enzyme. 198,201 Since there is some uncertainty about
the nature and origin of these signals,198 we will not discuss them further. The
F clusters of hydrogenase II, on the other hand, give two different EPR signals
that integrate to one spin each per protein molecule, and that correspond to sites
with different redox potentials. 194,198,199 This suggests that hydrogenase II con-
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Figure 7.22
Redox schemes illustrating proposed action of Fe hydrogenases: (A) Clostridium pasteurianum
hydrogenase I; (B) Clostridium pasteurianum hydrogenase II. 189a, 199
tains two different F clusters, called F and F' (note that the presence of F' was
in fact first suggested by Mossbauer spectroscopy 202). The EPR spectrum from
the F' cluster is unusually broad. The H-cluster EPR signals of active hydroge-
nase I and II are quite similar and have essentially identical redox potentials. 199
The redox behavior of the F and H centers in hydrogenases I and II is nicely
consistent with their respective modes of function. As shown in Figure 7.22,
the F clusters are presumed to transfer electrons intermolecularly with the exter-
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nal electron carrier and intramolecularly with the H center. In the reversible
hydrogenase I, the F and H centers have the same redox potentials (about
- 400 mV at pH 8), similar to that of the hydrogen electrode (- 480 mV at
pH 8). Thus, electrons may flow in either direction when a mediator such as
methyl viologen (E 0' = - 440 mV at pH 8) is used as the external electron
acceptor (methyl viologen is the 4,4' -bipyridinium ion). On the other hand, for
hydrogenase II, the F clusters have EO' (pH 8) = - 180 mV and
EO' > - 300 mV for F and F', respectively. In hydrogenase II, therefore, elec-
trons can only move favorably from H2 to the H cluster, through F' and F, and
then to a lower-potential acceptor, such as methylene blue [for which EO'
(pH 8) = 11 mY].
Mossbauer spectroscopic studies of both hydrogenase I and II have been
reported. 202 ,203 Our discussion focuses primarily on the H cluster. The results
are similar for the two enzymes, but better defined for hydrogenase II because
of the smaller number of clusters. The H cluster apparently contains only two
types of iron, in the ratio of 2: 1, with quadrupole splittings reminiscent of Fe3S4
clusters. The oxidized cluster is confirmed to be an S = t system, also reminis-
cent of Fe3S4 clusters, and the reduced H cluster is an S = 0 system; this con-
trasts with reduced Fe3S4 clusters, which have S = 2. In agreement with the
Mossbauer studies, ENDOR spectroscopy of 57Fe-enriched protein indicates at
least two different types of iron in the H cluster, with metal hyperfine couplings
of about 18 and 7 MHz in hydrogenase II. Rather-less-intense ENDOR features
were also observed at frequencies corresponding to couplings of about 11 and
15 MHz. 204 The H-cluster EPR signals of hydrogenase II and hydrogenase I
change on binding carbon monoxide. Although the signals of the uncomplexed
enzymes are quite similar, the signals of the CO-bound species are very differ-
ent (note, however, that C. pasteurianum CO-bound hydrogenase I has EPR
similar to that of the CO-bound D. vulgaris enzyme), When produced with 13C_
enriched CO, the EPR signal of hydrogenase II shows resolved 13C hyperfine
coupling (Aav = 33 MHz) to a single 13C nucleus, indicating that only a single
CO is bound, presumably as a metal carbonyl. A slightly smaller coupling of
20 MHz was obtained using ENDOR spectroscopy for the corresponding species
of hydrogenase 1. 205
Recent ESEEM spectroscopy of hydrogenase I indicates the presence of a
nearby nitrogen, which may be a nitrogen ligand to the H-cluster. This nitrogen
possesses an unusually large nuclear electric quadrupole coupling and a rather
novel structure, involving an amide amino-acid side chain connected to an
H-cluster sulfide via a bridging proton ligand, has been suggested for it. 206 Al-
though the nitrogen in question must come from a chemically novel species, the
proposed proton bridge might be expected to be exchangeable with solvent water.
The ENDOR-derived result 205 that there are no strongly coupled exchangeable
protons in the oxidized H cluster may argue against such a structure.
Rather weak MCD 198,207 and resonance Raman spectra 208 have also been
reported for iron hydrogenases. The lack of an intense MCD spectrum 198,207
contrasts markedly with results for other biological FeS clusters. The resonance
Raman spectra of hydrogenase I resemble, in some respects, spectra from Fe2S2
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sites. Z08 These results further emphasize that the hydrogenase H clusters are a
unique class of iron-sulfur clusters.
Perhaps most tantalizing of all are the recent EXAFS results on hydrogenase
II. Z09 It is important to remember that for enzymes with multiple sites, the
EXAFS represents the sum of all sites present (i.e., the iron of the F, F' , and
H clusters). Despite this complication, useful information is often forthcoming
from these experiments. The EXAFS of oxidized hydrogenase I showed both
iron-sulfur and iron-iron interactions; the latter, at about 2.7 A, is at a distance
typical of FezSz, Fe3S4, and Fe4S4 clusters, and thus is not unexpected. The
reduced enzyme, however, gave an additional, long Fe-Fe interaction at 3.3 A.
This Fe-Fe separation is not found in any of the FeS model compounds reported
to date. z09 The appearance of the 3.3-A interaction indicates a change in struc-
ture on reduction of the H cluster, again revealing a cluster of unique structure
and reactivity. The large structural change of this H cluster on Hz reduction is
likely to have significant mechanistic implications.
4. Nickel-iron hydrogenases
The presence of nickel in hydrogenases has only been recognized relatively
recently. Purified preparations of the active enzymes were the subject of quite
intensive studies for years before the Ni content was discovered by nutritional
studies (see Reference 189 for a history). Some workers even tried (in vain) to
purify out "impurity" EPR signals that were later found to be from the Ni. In
contrast to the Fe hydrogenases discussed in the previous section, the Ni en-
zymes possess a variety of compositions, molecular weights, activation behav-
ior, and redox potentials. 189,ZIO,ZII As Table 7.5 shows, some of the Ni hydro-
genases contain selenium, likely in the form of selenocysteine, some contain
flavin (FMN or FAD), and all contain iron-sulfur centers, but in amounts rang-
ing from 4 to 14 iron atoms per Ni atom.
Among the different Ni hydrogenases there is a common pattern of protein
composition, to which many, but not all, seem to conform (especially those
enzymes originating from purple eubacteria). There are two protein subunits, of
approximate molecular masses 30 and 60 kDa, with the nickel probably residing
in the latter subunit. The hydrogenase of the sulfate-reducing bacterium Desul-
fovibrio gigas is among the best investigated, and we will concentrate primarily
on this enzyme. D. gigas hydrogenase contains a single Ni, two Fe4S4 clusters,
and one Fe3S4 cluster. Of primary interest is the Ni site, which is thought to be
the site of Hz activation. 189 ,Z10,Zll
EPR signals attributable to mononuclear Ni [as shown by enrichment with
61Ni (I = I)] have been used in numerous investigations of the role of Ni in
hydrogenases. 189,ZIO,ZI1 Three major Ni EPR signals are known, which are called
Ni-A, Ni-B, and Ni-C. The principal g values of these signals are: 2.32, 2.24,
and 2.01 for Ni-A; 2.35, 2.16, and 2.01 for Ni-B; and 2.19, 2.15, and 2.01 for
Ni-C. Of these, Ni-C is thought to be associated with the most active form of
the enzyme (called active); the other two are thought to originate from less-
active enzyme forms. 189,ZIO
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In the enzyme as prepared (aerobically) the Ni-A EPR is characteristically
observed. On hydrogen reduction the Ni-A EPR signal disappears, and the en-
zyme is converted into a higher-activity form (Ni-B arises from reoxidation of
this form). Further progressive reduction of the enzyme gives rise to the Ni-C
EPR signal, which also finally disappears. These redox properties show that
Ni-C arises from an intermediate enzyme oxidation state. Although the Ni-A
and Ni-B EPR signals 189,210-212 almost certainly originate from low-spin Ni(III),
the formal oxidation state of Ni-C is rather less certain. Both an Ni(I) site 189,210
and an Ni(III) hydride 213 have been suggested, with the former alternative cur-
rently favored because of the apparent absence of the strong proton hyperfine
coupling expected for the latter. In the fully reduced enzyme, Ni-C is converted
to an EPR-silent species. This has variously been suggested to be Ni(O), Ni(II),
or an Ni(II) hydride. 214 One possible reaction cycle 189,210 is shown in Figure
7.23.
Information on the coordination environment of the nickel has been obtained
from both x-ray absorption spectroscopy and EPR spectroscopy. The Ni K-edge
EXAFS of several different hydrogenases,215-218 and EPR spectroscopy of 33S
enriched Wolinella succinogenes hydrogenase,219 clearly indicate the presence
of sulfur coordination to nickel. A recent x-ray absorption spectroscopic inves-
tigation of the selenium-containing D. baculatus hydrogenase, using both Ni
and Se EXAFS, suggests seienocysteine coordination to Ni. 216
ESEEM spectroscopy of the Ni-A and Ni-C EPR signals 220,221 indicate the
presence of 14N coupling, which probably arises from a histidine ligand to Ni.
Ni(lil)
[Fe-S]2+ Ni(lli)[Fe-S]2+
Ni(ll)
[Fe-S]2+ ~(H
EPR-silent A 2
H2
reaction cycle
/
Ni(I)·H+
[Fe-SrW
Figure 7.23
Proposed activation/reactivity scheme for Ni hydrogenases. 189
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Interestingly, Ni-C, but not Ni-A, shows coupling to a proton that is exchange-
able with solvent water. Although this coupling is too small to suggest a nickel-
hydride (consistent with conclusions drawn from EPR), the proton involved could
be close enough to the Ni to playa mechanistic role.
Despite the extensive studies reported to date, there are still many unan-
swered questions about the mechanism of the NiFe hydrogenases, which remain
as exciting topics for future research. Despite our lack of detailed knowledge of
enzyme mechanism, it is nevertheless not premature to seek guidance from in-
organic chemistry.
5. Insights from inorganic chemistry
Recent years have brought insights into the way dihydrogen can be bound
at a transition-metal site. Unexpectedly, it has been shown that molecular Hz
forms simple complexes with many kinds of transition-metal sites.zzz-zz4 This
finding contrasts with the classical situation, in which Hz interacts with a tran-
sition-metal site by oxidative addition to form a dihydride complex. Z3 The H-H
bond is largely maintained in the new/nonclassical structures. The dihydrogen
and dihydride complexes can exist in simple equilibrium,ZZ4 as in Equation (7.9).
H
M~I
H
H
/( ) M
"'H
(7.9)
The bonding of dihydrogen to a metal occurs via the (Tb orbital of the H-H
bond acting as a donor, with the (T* level of Hz acting as a weak acceptor. If
the back donation is too strong, sufficient electron density will build up in the
u* level to cause cleavage of the H-H bond, leading to the formation of a
dihydride. Dihydrogen complexes therefore require a delicate balance, in which
the metal coordination sphere facilitates some back-bonding, but not too much.
The proclivity of a metal center to form Hz complexes can be judged by the
stretching frequency of the corresponding Nz complexes: Nz can usually dis-
place Hz from the Hz complex to form an Nz complex without changing the
remainder of the coordination sphere. If v(N==N) is between 2060 and
2160 cm -1, Hz complexes form upon replacement of Nz. If v(N==N) is less
than 2060 cm -1, indicative of electron back-donation from the metal center,
a dihydride complex should form. For example, v(N==N) = 1950 cm- 1
in MoNz(PCY3)s and MoHz(PCY3h is a dihydride complex, but v(N==N) =
2090 cm - 1 in Mo(PhzPCHzCHzPPhzhCO(Nz) and Mo(PhzPCHzCHzPPhz)Hz(COh
is a dihydrogen complex. By comparison, Mo(EtzPCHzCHzPEtzh(CO)(Nz) has
v(N==N) = 2050 cm -1 and forms a dihydride complex, Mo(EtzPCHzCHz_
PEtz)zHiCO). The correlation between v(N==N) and the type of hydrogen
complex formed seems quite useful.
Since Fe-S and Ni-S sites are implied for hydrogenase, the reactivity of
transition-metal/sulfide systems with Hz may also be relevant. Interestingly, Hz
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can react with metal-sulfide systems at S instead of at the metal site. For ex-
ample,225 (Cp')zM02S4 reacts with H2 to form (Cp')zM02(SHk Here the dihy-
drogen is cleaved without any evidence for direct interaction with the metal
center, and the resulting complex contains bridging SH groups and no direct
metal-H bonding. 225 In recent work,226 the binuclear rhodium-sulfur complex
{RhS[P(C6H5)zCH2CH2hCHh was reported to react with two equivalents of di-
hydrogen to yield the complex {Rh(H)(SH)[P(C6H5)zCH2CH2hCHh, in which
two SH groups bridge the two Rh centers, each of which contains a single
hydrido ligand. Figure 7.24 illustrates the possibilities for hydrogen activation.
Each of these types of reactivity must be considered as possibilities for the
hydrogen activation process of hydrogenase.
a b c d
dihydrogen dihydride thio/-hydride dithio/
/H /H SI-;l SH
M I
/ /M M M M M
"'H "'H "'H '"SH
1
M-N_N:
Figure 7.24
Possible modes of Hz/H bonding at a transition-metal sulfide site.
Recently, a great deal of attention has been given to the chemistry of nickel-
sulfur systems, inspired in part by the results showing that many hydrogenases
are nickel-sulfur proteins. 227-230 A particularly interesting finding is that Ni thiolates
can react with O2 to produce sulfinate complexes. 231 ,232 The oxygenated thiolate
can be regenerated, thus providing a potential model for the O2 inactivation of
Ni hydrogenases.
C. Nitrogenases
Nitrogen fixation is a key reaction of the biological nitrogen cycle. 233 Fixed
nitrogen, in which N is in molecules other than N2, is frequently the limiting
factor in plant growth. 234 Since natural systems often cannot provide enough
fixed nitrogen for agriculture or animal husbandry, industrial processes have
been developed to "fix nitrogen" chemically. The major process in use, often
referred to as ammonia synthesis, is the Haber-Bosch process, in which N2 and
H2 are reacted at temperatures between 300-500°C and pressures of more than
300 atm, using catalysts (usually) based on metallic iron. 235 Hundreds of mas-
sive chemical plants are located throughout the world, some producing more
than 1,000 tons of NH3/day. In contrast, in the biological process, N2 is reduced
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locally as needed at room temperature and ~ 0.8 atm by the enzyme system
called nitrogenase (variously pronounced with the accent on its first or second
syllable).
1. The scope of biological nitrogen fixation
Biological nitrogen fixation occurs naturally only in certain prokaryotic or-
ganisms (sometimes called diazotrophs). Although the majority of bacterial spe-
cies are not nitrogen fixers, the process of nitrogen fixation has been confirmed
in at least some members of many important phylogenetic groups. Nitrogen
fixation occurs in strict anaerobes such as Clostridium pasteurianum, in strict
aerobes such as Azotobacter vinelandii, and in facultative aerobes such as Kleb-
siella pneumoniae. Much of the established biochemistry of N2 reduction has
been gleaned from studies of these three species. However, nitrogen fixation
has a far broader range, occurring in archaebacterial methanogens such as Meth-
anobacillus omelianskii, which produce methane, and eubacterial methanotrophs
such as Methylococcus capsulatus, which oxidize methane. Photosynthetic or-
ganisms ranging from the purple bacterium Rhodobacter capsulatus (formerly
Rhodopseudomonas capsulata) to the cyanobacterium (blue-green alga) Ana-
baena cylindrica fix nitrogen. Nitrogen fixation occurs mostly in mesophilic
bacteria (existing between 15 and 40°C), but has been found in the thermophilic
archaebacterial methanogen Methanococcus thermolithotrophicus at 64°C.
Many organisms fix N2 in nature only symbiotically. Here the most studied
systems are species of Rhizobium and Bradyrhizobium, which fix nitrogen in the
red root nodules of leguminous plants such as soybeans, peas, alfalfa, and pea-
nuts. The red color inside the nodules is due to leghemoglobin, a plant Or
binding protein analogous to animal myoglobins and hemoglobins (Chapter 4).
Other symbioses include that of blue-green algae such as Anabaena azollae with
Azola (a water fern); actinomycetes such as Frankia with trees such as alder;
and Citrobacter freundii, living in the anaerobic hind gut of termites. The
distribution of nitrogenase clearly points to its adaptability as a metabolic option
for species occupying widespread ecological niches.
The absence of nitrogen fixation in eukaryotes therefore seems somewhat
puzzling. There would appear to be no fundamental limitation to the existence
of nitrogen fixation in higher organisms. Indeed, nif genes have been transferred
to yeast, where they work effectively under anaerobic conditions. Furthermore,
the problem of the simultaneous presence of nitrogen fixation and aerobiosis has
been solved effectively by aerobic bacteria such as Azotobacter, Gleocapsa, and
Anabaena. Indeed, the lack of a fundamental limitation has encouraged re-
searchers to propose the construction of nonsymbiotic nitrogen-fixing plants (whose
niche to date is limited to the grant proposal).
Due to the mild conditions under which it occurs, the biological nitrogen-
fixation process may seem inherently simpler than the industrial one. However,
it is not; the biological process displays a complexity 235,235a that belies the sim-
plicity of the chemical conversion of N2 ---.,. 2NH3 . Genetic analysis reveals that
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Nif genes required for nitrogen fixation as arranged in Klebsiella pneumoniae,
and their respective gene products. The numbers on the top are the molecular
weights in kilodaltons of the respective gene products.
at least twenty genes are required for nitrogen fixation in the bacterium Klebsi-
ella pneumoniae.236.237 These nij genes (illustrated in Figure 7.25) specify pro-
teins that are involved in regulation (nijA and L), pyruvate oxidation/flavin
reduction (nij J), electron transfer (nij F for flavodoxin), the subunits of the
structural proteins of the nitrogenase (nif H, D, K), Fe-S cluster assembly (nij M)
and biosynthesis of the iron-molybdenum cofactor, FeMoco (nijN, B, E, Q,
V, H). 238 The last two functions specify proteins that are responsible for the
incorporation of unusual transition-metal sulfide clusters into the nitrogenase
proteins. These clusters have allowed nitrogenase to be studied by biophysical
and bioinorganic chemists to establish aspects of its structure and mechanism of
action.
We will first discuss the N2 molecule and focus on its reduction products,
which are the presumed intermediates or final product of nitrogen fixation. We
then present what has been called 239,240 the "Dominant Hypothesis" for the
composition, organization, and function of molybdenum-based nitrogenases. Until
1980, it was thought that molybdenum was essential for nitrogen fixation. How-
ever, work starting in 1980 led finally in 1986 to the confirmation of vanadium-
based nitrogen fixation. The newly discovered vanadium-based nitrogenases dif-
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fer in reactivity from the Mo-based enzyme in having "alternative" substrate
specificity. The distinct reaction properties of the different nitrogenases point to
the importance of the study of alternative substrate reactions in probing the
mechanism of nitrogen fixation.
2. Dinitrogen: The molecule and its reduced intermediates
The N2 molecule has a triple bond with energy 225 kcallmole, a v(N==N)
stretch of 2331 cm -I, and an N==N distance of 1.098 A. The stable isotopes
of nitrogen are 14N(I = 1) with natural abundance of 99.64 percent and 15N(I = !)
with an abundance of 0.36 percent.
The challenge to which nitrogenase rises is to break and reduce at a reason-
able rate the extremely strong N==N triple bond. The kinetic inertness of N2 is
highlighted by the fact that carrying out reactions "under nitrogen" is con-
sidered equivalent to doing the chemistry in an inert atmosphere. Despite this
kinetic inertness, thermodynamically the reduction of N2 by H2 is a favorable
process,
and at pH 7 the reaction
(7.10)
N2 + 8H + + 6e -~ 2NH4 + EO' = -280 mV (7.11)
has an E 0 1 value that makes it easily accessible to biological reductants such as
the low-potential ferredoxins discussed earlier in this chapter.
What, then, is the cause of the kinetic inertness of the N2 molecule? The
thermodynamically favorable reduction of N2 to 2NH3 is a six-electron process.
Unless a concerted 6e ,6H + process can be effected, intermediates between
N2 and NH3 must be formed. However, all the intermediates on the pathway
between N2 and NH3 are higher in energy than either the reactants or the prod-
ucts. The EO' values for the formation of N2H2 (= diimine, diazene, diamide)
or N2H4 (hydrazine) are estimated 241 as
N2 + 2H+ + 2e- ~ N2H2
N2 + 5H + + 4e - ~ N2Hs+
EO' ~ -1000 to -1500 mV
EO' = 695 mV
(7.12)
(7.13)
Clearly, these potentials are sufficiently negative that the normal biological re-
ductants cannot effect the reaction. The difficulty of reaching these intermedi-
ates is indicated in Figure 7.26.
Several factors may allow this barrier to be overcome. First, the six-electron
reduction might be carried out in a concerted or near-concerted manner to avoid
the intermediates completely. Alternatively, the intermediates could be com-
pIexed at metal centers to stabilize them to a greater extent than either the reac-
tants or products. Finally, the formation reaction for the unfavorable intermedi-
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Energetics of N2 , NH3 , and some potential intermediates along
the reaction pathway for their interconversion.
ate could be coupled with ATP hydrolysis or with the evolution of dihydrogen,
each a favorable process, so that the overall process is favorable. Which of the
above strategies is used by nitrogenase is unknown, but it seems likely that
some combination of the last two of these is used to effect the difficult reduction
of N2 to NH3 . To probe the possibilities, a variety of complexes of N2, di-
azenes, and hydrazines has been prepared and chemically characterized, and
these are discussed toward the end of this section.
3. The Dominant Hypothesis for molybdenum
nitrogenase 239,240,242,243
The action of the Mo-nitrogenase enzyme involves the functioning of two
separately isolatable component proteins, as sketched in Figure 7.27A. The larger
of the two proteins, sometimes incorrectly244 designated 245 dinitrogenase has,
in the past, been called molybdoferredoxin, azofermo, or component 1. More
often this protein is called the MoFe or FeMo protein ([MoFe] or [FeMo]). The
smaller protein, formerly called azoferredoxin or component II, is sometimes
incorrectly 244 referred to 245 as dinitrogenase reductase. * This protein is properly
, The nomenclature proposal 245 that [FeMo] be designated as dinitrogenase and [Fe] as dinitrogenase
reductase, although sometimes used in the literature, is incorrect or, at best, premature. 244 The suggested
nomenclature implies that both [FeMo] and [Fe] are enzymes. However, neither protein can function catalyt-
ically in the absence of the other. [FeMo] will not reduce N2 or C2H2 or evolve H2 in the absence of [Fe].
The iron protein will not hydrolyze MgATP in the absence of [FeMo]. Nitrogen fixation requires the simul-
taneous presence of both proteins. Although mechanistic considerations 255 point to [FeMo] as the substrate
binding and reducing protein, and [Fe] as the ATP binding locus, catalytic reactions characteristic of this
enzyme system have never been consumated by one protein in the absence of the other (but see later for the
uptake of H2). In this chapter, we use the [FeMo] and [Fe] designations in accord with most workers in the
field.
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Table 7.6
Properties of some representative nitrogenases.
Organism Component MW Metal content Reference
Azotobacter vinelandii [MoFe] 234,000 2Mo, 34-38Fe, 26-285 366,367
[Fe] 64,000 3.4Fe, 2.85
Azotobacter chrococcum [MoFe] 227,000 2Mo, 22Fe, 205 366, 368
[Fe] 65,400 4Fe, 3.95
Clostridium pasteurianum [MoFe] 221,800 2Mo, 24Fe, 245 366, 369
[Fe] 55,000 4Fe, 45
Klebsiella pneumoniae [MoFe] 229,000 2Mo, 32Fe, 245 366
[Fe] 66,800 4Fe, 3.85
Anabaena cylindrica [MoFe] 223,000 2Mo, 20Fe, 205 370
[Fe] 60,000
Rhodospirillum rubrum [MoFe] 215,000 2Mo, 25-30Fe, 19-225 371
[Fe] 60,000
called the Fe protein or [Fe]. A useful nomenclature for discussions of kinetics
and comparative biochemistry designates the FeMo protein as Xyl, where X and
y are the first letters of the first and second name of the bacterial source, re-
spectively. For example, Cpl is the FeMo protein from Clostridium pasteu-
rianum. Similarly, for the Fe protein the designation Xy2 is given; for example,
the Fe protein of Azotobacter vinelandii is called A v2. This system will be used
where appropriate to distinguish the protein source. Properties of representative
Mo nitrogenases are given in Table 7.6.
The schematic diagram in Figure 7.27 shows some of the compositional and
functional relationships of the nitrogenase proteins. The iron protein contains
two identical subunits of MW ~ 30 kDa. The subunits are products of the nif H
gene. 246 A single Fe4S4 center is present in the protein and appears to be bound
between the subunits. 246a A recent x-ray structure 246b of the iron protein con-
firms this picture. As shown in Figure 7.27A, the single Fe4S4 center is located
at one end of the molecule, in the only region of significant contact between the
two subunits. In vivo, the Fe protein is reducible by ftavodoxin or ferredoxin.
In vitro, artificial reductants such as dithionite or viologens are generally used.
The single Fe4S4 center undergoes a single one-electron redox process, wherein
the reduced form is EPR-active and the oxidized form is diamagnetic. As such,
this center resembles four-iron-cluster-containing ferredoxins. Its redox potential
is dependent on the ATP or ADP level in the solution. For example, Cp2 (the
Fe protein from Clostridium pasteurianum) shows p' = -294 mV in the ab-
sence and - 400 mV in the presence of MgATP. 247 Two equivalents of MgATP
and MgADP each bind to [Fe].
Until recently there was a major mystery over the number of Fe4S4 centers
in [Fe] as deduced by EPR quantitation of the Fe4S4 centers compared to the
number derived analytically or by extrusion experiments. 239,248 However, it has
now 9,200,249,250 been clearly established that the single Fe4S4 center can exist in
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Figure 7.27
(A) Preliminary x-ray crystal structure of the Azotobacter vinelandii nitrogenase Fe protein. 246b
(B) Schematic of the nitrogenase proteins illustrating their composition and mode of action.
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this protein in two spin states, S = t and S i Only that part of the EPR
signal corresponding to the S = t form, with its g values near 2, was con-
sidered in earlier spin quantitations. When the S = i center, with g values be-
tween 4 and 6, is included, the EPR spin integration shows one paramagnetic
site per Fe4S4 unit. Model systems 121,122 and theoretical studies 123,124,251 strongly
support the ability of Fe4S4 to exist in various spin states. During enzyme turn-
over, the single Fe4S4 of the Fe-protein center transfers electrons to the FeMo
protein in one-electron steps. There is no evidence for any difference in redox
behavior between the S = t and S = i states of the protein. 200
The Fe protein binds two molecules of MgATP. 252 The recent structure 246b,378
suggests that a cleft between the two subunits may serve as the ATP binding
site. As the enzyme system turns over, a minimum of two molecules of MgATP
are hydrolyzed to MgADP and phosphate in conjunction with the transfer of
each electron to the FeMo protein. 253 The ATP/2e - ratio is generally accepted
to have a minimum value of 4. Higher numbers represent decreased efficiency,
often attributed to "futile cycling," where back electron transfer from [FeMo]
to [Fe] raises the effective ratio.248.253 Except for an as-yet-unconfirmed report
of reduction by thermalized electrons produced by pulse radiolysis, 254 there is
no evidence that the FeMo protein can be reduced to a catalytically active form
without the Fe protein present.
Even though [Fe] must be present for catalysis to take place, the Dominant
Hypothesis 239 designates [FeMo] as the protein immediately responsible for sub-
strate reduction, and genetic/biochemical evidence supports this view. The FeMo
protein contains an (X2{32 subunit structure, where (X and {3 are coded by the
nif D and nif K genes,15,229 respectively. The overall molecular weight of about
230 kDa reflects the 50- to 60-kDa MW of each of its four subunits. In addition
to protein, a total of 30 Fe, 2 Mo, and 30 S2-, all presumed to be in the form
of transition-metal sulfide clusters, add relatively little to the molecular weight,
but are presumed to be major parts of the active centers of the protein. Figure
7.27, which is highly schematic, displays the cluster types in accord with the
Dominant Hypothesis.
4. Protein purity and active sites
It has been almost 20 years since the first relatively pure preparations of
nitrogenase became available. Indeed, homogeneous preparations are a sine qua
non for progress in our understanding of the chemical nature and reactivity of
any active site. In metalloproteins, there are two levels of homogeneity. The
first involves purity with respect to the protein/subunit composition. This type
of purity is achieved by conventional protein-purification techniques, and can
be monitored by gel electrophoresis under native and denaturing conditions. In
the language of polymer science, the macromolecular portion of the protein can
be said to be monodisperse, corresponding to a single molecular weight for the
polypeptide chain(s). However, even if the protein is homogeneous by this cri-
terion, it may be inactive or only partially active because it does not have a full
420 7 / FERREDOXINS, HYDROGENASES, AND NITROGENASES: METAL-SULFIDE PROTEINS
complement of active metal sites. The metal sites may be empty, filled with the
wrong metals, or otherwise imperfect. Often the apo or inactive enzyme has
chromatographic, electrophoretic, and centrifugal behavior very much like that
of the holo protein, and therefore copurifies with it. Therefore, purification to
electrophoretic homogeneity is only the first step. It is then necessary to ensure
the chemical homogeneity of the active site. Very often activity is the major
criterion for the approach toward such purity; i.e., the most homogeneous prep-
arations are usually those in which the activity is highest. Several studies done
on preparations that lacked active-site homogeneity were, as a result, not mean-
ingful.
The two types of centers present in the nitrogenase FeMo protein are des-
ignated P clusters and FeMoco (or M) centers. Both types of centers display
unique spectroscopic properties, but only FeMoco continues to display most of
those properties when it is extracted from the protein.
5. FeMoco
The presence of the FeMo cofactor within the FeMo protein of nitrogenase,
i.e., the M center, is revealed through spectroscopic and redox studies. 239 In the
resting state of [FeMo], as isolated in the presence of dithionite, the M center
has a distinct S = i EPR signal, which is discussed below (see Figure 7.28).
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Figure 7.28
EPR spectra: (A) the S = ~ M center in Clostridium pasteurianum nitrogenase FeMo protein;
and (B) the FeMoco extracted into NMF from the protein. (Spectra courtesy of R. Bare and G. N.
George.)
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When the enzyme is turning over the EPR signal essentially disappears, leaving
an EPR-silent state in which the FeMoco site is super-reduced to what is pre-
sumed to be its catalytically active form. In addition, a third state in which the
S = ~ EPR signal disappears is produced upon oxidation under non-turnover
conditions. Thus the M center within the protein shows three states of oxidation,
and these appear to have been reproduced in the FeMoco extracted from the
protein: 255a
e e
FeMoco (OXidized)~ FeMoco (reduced)~ FeMoco (super-reduced) (7.14)
The detailed characterization of the FeMoco site has involved parallel stud-
ies of the site within the protein and in its extracted form. The authentication of
the extracted FeMoco involves the production and use of mutant organisms that
make an inactive FeMo protein that contains all subunits and P clusters, but
lacks the FeMoco sites. 172,256 A mutant of Azotobacter vinelandii called UW-45
(UW = University of Wisconsin) was first used to assay for isolated Fe-
Moco. 257 Since several genes are involved in specifying FeMoco biosynthesis,
mutants lacking these genes produce FeMo protein either lacking FeMoco or
having a defective version of FeMoco. Mutants such as Nif B - of Klebsiella
pneumoniae 172 lack cofactor, and an inactive "apo" protein can be isolated
from them,
The breakthrough in this field 257 came in 1976, when FeMoco was extracted
from [FeMo] into N-methylformamide 258 after the protein was acidified and
then neutralized, The acidification removes most of the acid-labile P clusters,
and partially denatures the protein. Reneutralization precipitates the protein (near
its isoelectric point) and the precipitated denatured protein can then be extracted.
It has been shown that FeMoco can be extracted into many organic sol-
vents, 10,257,259-259b provided proper combinations of cations and anions 259a are
present in the solvent. The role of the cation is to balance the charge of the
negatively charged cofactor. The role of the anion is to displace the cofactor
from anion-exchange columns, such as DEAE cellulose or TEAE cellulose, to
which the cofactor and/or its protein source had been adsorbed. The ability to
dissolve cofactor in such solvents as CH3CN, acetone, THF, and even benzene
should facilitate attempts at further characterization and crystallization, 259,259a
The biochemical authenticity of FeMoco has been assayed by its ability to
activate the FeMo protein from the cofactor-less mutant organism. 258 The stoi-
chiometry of the cofactor is MoFe6_8S7_1O, with the variability likely due to
sample inhomogeneity. The extracted cofactor resembles the M-center unit spec-
troscopically and structurally as shown in Table 7.7, The differences are pre-
sumed to result from differences in the peripheral ligands of the metal-sulfide
center between the protein and the organic solvent. 260
Strong evidence to support FeMoco as the site of substrate binding and
reduction comes from the study of nif V mutants.261-263 (The V designation is
somewhat unfortunate, as nifV has nothing to do with vanadium.) The NifV
mutants do not fix nitrogen in vivo, and have altered substrate specificity in
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vitro. Dihydrogen evolution by isolated nif V nitrogenase is inhibited by CO, in
contrast to the wild type, where H2 evolution is insensitive to CO. FeMoco can
be extracted from the nif V protein and used to reactivate the FeMoco-deficient
mutants, such as nif B or UW-45. Remarkably, the reconstituted FeMo protein
has CO-sensitive H2 evolution, which is characteristic of nif V; i.e., the nif V
phenotype is a property of FeMoco and not of the protein. 263 This result clearly
implicates the FeMoco site as an important part of the substrate reactions of the
nitrogenase enzyme complex.
Recently, a heat-stable factor called the V-factor has been discovered that
restores the wild-type phenotype when added to nif V mutants during in vitro
FeMoco assembly reactions. 264 The V-factor has been shown to be homocitrate
(see Scheme 7.15) and 14C labeling strongly suggests that homocitrate (or a part
of it) is a component of the cofactor center. Interestingly, the far more meta-
bolically common citrate appears to be present in the nif V mutant. 265a Replace-
ment of homocitrate by analogues that differ in structure or stereochemistry
yields modified FeMoco sites that have altered substrate specificities. 265b
Thus, as is true for many cofactors (e.g., heme = porphyrin + iron;
B12 = corrin + cobalt; F430 corphin + nickel; Moco, the molybdenum
cofactor = Mo + molybdopterin), both inorganic and organic components are
present in FeMoco.
Hamacitrate
CH2-GOOH
I
Ho-e-eOOH
I
CH2-GOOH
Citrate
(7.15)
The biosynthesis of the cofactor and its insertion into [FeMo] apparently
requires the presence of [Fe] and ATP in A. vinelandii. 266,266a Whether this
involves redox or conformational change in [FeMo] induced by [Fe] is un-
known, but the fact that inactive versions of [Fe] are effective would seem to
favor the nonredox mechanism. An attractive idea 266 is that [Fe]' MgATP binds
to [FeMo], producing a state that is conformationally accessible for cofactor
insertion.
Recently, site-directed mutagenesis studies 266b,c have shown that cysteine
residues are involved in binding FeMoco to the subunits of [FeMo]. Moreover,
these studies again implicate FeMoco in the substrate-reducing site.
6. The P-clusters
Evidence has been presented 229 for the presence of four Fe4S4-like clusters
(designated as P-clusters) in [FeMo]. The P-clusters are, however, by no means
ordinary Fe4S4 clusters, and may not be Fe4S4 clusters at all. P-clusters are
manifest 239,248 in electronic absorption and, especially, MCD and Mossbauer
spectra of [FeMo]. These spectra are clearly not conventional; i.e., they are not
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like those found in ferredoxins and have not yet been seen in model compounds.
In their oxidized forms, the P-clusters are high-spin, probably S = t according
to EPR studies. 267 M6ssbauer spectra reveal decidedly inequivalent Fe popula-
tions,268,269 indicating that the putative Fe4S4 clusters are highly distorted or
asymmetric. The four P-clusters do not appear to behave identically under many
circumstances, and it is clear that they form at least two subsets. There is open
disagreement over the redox behavior of these sets. 239 ,270,271 Furthermore, an
additional M6ssbauer signal sometimes designated as S may also be part of the
P-cluster signal. 268
Although spectroscopic studies of the P-clusters do not unequivocally reveal
their structural nature, extrusion of these clusters from the protein leads to the
clear identification of three or four Fe4S4 clusters. 248,272 As discussed previously,
the extrusion technique has inherent uncertainties, because it may be accompa-
nied by cluster rearrangement. Nevertheless, the experimental result does sup-
port the Dominant Hypothesis, which designates the P centers as highly unusual
Fe4S4 clusters.* The P-clusters are thought to be involved in electron storage
and transfer, and presumably provide a reservoir of low-potential electrons to
be used by the M center (FeMoco) in substrate reduction. Attractive as it may
seem, there is no direct evidence to support this notion.
7. EPR, ENDOR, and ESEEM studies
The FeMoco or M center has been identified spectroscopically within the
FeMo protein;239,248,273 it has a distinctive EPR signal with effective g values of
4.3, 3.7, and 2.0 I, and originates from an S = i state of the M center. The
signal arises from transitions within the ±! ground-state Kramers doublet of
the S = i system (D = +5.1 cm -1, EID = 0.04). The isolated cofactor
(FeMoco) gives a similar EPR signal, but with a rather larger rhombicity
(EID = 0.12). Spectra from the C. pasteurianum nitrogenase and cofactor are
shown in Figure 7.28, and comparative data are given in Table 7.7. The
M-center EPR signal has proved useful in characterizing the nature of the site,
especially when more sophisticated magnetic resonance techniques, such as EN-
DOR or ESEEM, are used.
Extensive ENDOR investigations 274,275.275a have been reported using protein
samples enriched with the stable magnetic isotopes 2H, 33S, 57Fe, 95Mo, and
97Mo. The 57Fe couplings have been investigated in the most detail. Individual
hyperfine tensors of five coupled 57Fe nuclei are discernible, and were evaluated
by simulation of the polycrystalline ENDOR spectrum. 275 The data from 33S and
95Mo were analyzed in less detail; 33S gave a complex ENDOR spectrum, evi-
dently with quite large hyperfine couplings, although no quantification was at-
tempted because of the complexity of the spectrum. 274 On the other hand, 95Mo
was shown to possess a small hyperfine coupling, indicating that the molybde-
*Recent x-ray crystallographic results show that, if Fe4S4 clusters are present, they are very close together
in two pairs,379.380 which may account for their unusual properties.
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Table 7.7
Comparison of the FeMo protein and isolated FeMoco. a
EPR
g'values
EXAFS"
Mo-S
Mo-Fe
Mo-O or N
Fe-S
Fe-Fe
Fe-Mo
Fe-O or N
XANES
M003S3 fits best f
FeMo protein
(M center)
4.27
3.79
2.01
2.36 (4)b
2.69 (3)b
2.18(l)b
FeMoco
(inNMF)
4.8
3.3
2.0
2.37 (3.1)C
2.70 (2.6)C
2.10 (3.I)C
2.25 (3A)d 2.20 (3.0)°
2.66 (2.W 2.64 (2.2)e
3.68 (0.8)"
2.76 (OA)d 2.70 (0.8)C
1.81 (1.2)d
a Distance in A with number of atoms in parentheses.
b From 287; earlier study reported in 286.
C Data from 373; earlier study reported in 372.
d Data from 290.
e Data from 291.
f Data from 288, 289.
num possesses very little spin density (although the quantitative aspects of the
conclusions of the 95Mo ENDOR study have recently been shown to be in error276).
Although no nitrogen splittings were reported in any of the ENDOR studies,
evidence for involvement of nitrogen as a cluster component has been forthcom-
ing from ESEEM spectroscopy. 277-279 14N modulations are observed in the ESEEM
of the M center. The observed 14N is not from the substrate (N2) , or from an
intermediate or product of nitrogen fixation, because enzyme turnover using 15N
as a substrate does not change the ESEEM spectrum. The isolated cofactor
(FeMoco) does not show the modulation frequencies observed for the M center
in the protein. These experiments suggest that the M-center 14N ESEEM arises
from a nitrogen atom that is associated with the M center, and probably from
an amino-acid side chain (most likely a histidine) ligated to the cluster. 279 Re-
cent evidence from site-directed mutagenesis of the Azotobacter vinelandii
protein 280 provides strong support for the presence of histidine ligation, and
points specifically to His-195 of the Q' subunit as the N ligand.
8. M6ssbauer studies
Extensive Mossbauer investigations of nitrogenase 271,281-283 and FeMoc0 283a
have been reported. Unlike EPR and EPR-based spectroscopies, which can be
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used to investigate only the EPR-active S = ~ oxidation state, all three available
M-center oxidation states are accessible to Mossbauer spectroscopy. The fully
reduced site was found to be diamagnetic with S = 0 (but see Reference 284),
whereas the oxidized site was found to have S 2:: I. The zero-field spectrum of
reduced C. pasteurianum nitrogenase is shown in Figure 7.29; the spectrum is
comprised of four quadrupole doublets, one of which was concluded to originate
from the M site. 282 Mossbauer spectra taken in the presence of applied magnetic
fields were used to deduce the presence of four types of 57Fe hyperfine coupling;
these were called sites AI, A2, and A3, which have negative hyperfine cou-
plings, and B sites, which have positive hyperfine couplings. The A sites were
quantitated as a single Fe each; the B sites were estimated to contain three irons.
These conclusions were largely confirmed and extended by later ENDOR inves-
tigations,274 although the B sites were resolved as two inequivalent, rather than
three equivalent, sites. ENDOR is rather more sensitive to the nature of the
hyperfine couplings than Mossbauer, although it cannot usually be used to count
numbers of exactly equivalent sites. Thus the number of iron atoms in the M
center is minimally five, although larger numbers cannot be excluded. Note also
that some of the quantitative aspects of the earlier Mossbauer investigations
have been criticized. 285
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Figure 7.29
Mossbauer spectrum of C. pasteurianum nitrogenase FeMo protein,282 indicating the various
components (quadrupole doublets) and their assignments. The doublet labeled M is the cofactor
signal; those labeled D, S, and Fe 2+ are attributed to the P-clusters.
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9. X-ray absorption studies
One of the early triumphs of biological x-ray absorption spectroscopy was
the deduction that the nitrogenase M center is an Mo-Fe-S cluster. 286 (It is also
worth noting that nitrogenase was the first enzyme to be studied by x-ray ab-
sorption spectroscopy.) Early work on lyophilized protein samples indicated the
presence of two major contributions to the Mo K-edge EXAFS, which were
attributed to Mo-S ligands, plus a more distant Mo-Fe contribution. 286 Subse-
quently, these conclusions have been confirmed and extended, using samples in
solution and with much more sensitive detection systems.
Most EXAFS studies to date have been on the molybdenum K-edge of the
protein or of FeMoco, and indicate a very similar Mo environment in both
(Table 7.7, Figure 7.30). A consensus of the best available analyses287 indicates
that Mo is coordinated by three or four sulfur atoms at 2.4 A, one to three
oxygens or nitrogens at 2.2 A, with approximately three nearby iron atoms at
2.7 A. Of these, the EXAFS evidence for the oxygen/nitrogen contribution is
weakest. However, comparison of Mo K_edge 288 and Mo L-edge XANES 289
spectra with model compounds indicates strong similarities with MoFe3S4 thio-
cubane model compounds possessing MOS30 3 coordination, and provides some
support for the presence of O/N ligands.
The iron EXAFS of FeMoco has been independently examined by two
groups. 290,291 Both groups agree that the iron is coordinated largely to sulfur at
about 2.2 A, with more distant Fe-Fe interactions at about 2.6 A. They differ,
however, concerning the presence of short (l.8 A) Fe-O interactions. Such in-
teractions were apparently observed in the earlier study,290 but not in the later
study.291 One possible explanation for this discrepancy is that the short Fe-O
interactions of the earlier study were due to extraneous iron coordinated to sol-
vent, contaminating the FeMoco preparation. 291 A final resolution of this dis-
cord must, however, await the results of further experiments. Interestingly, a
long Fe-Fe interaction at 3.7 A was also observed in the later study. 291
Largely on the basis of the Mo K-edge EXAFS results and model studies
discussed below, several proposals for the structure of the M center have been
put forward. These are illustrated in Figure 7.31.
The MoFe proteins from Clostridium pasteurianum 292 and from Azotobacter
vinelandii 293 have been crystallized. For the former protein, crystals of space
group P21 are obtained, with two molecules per unit cell of dimensions
70 X 151 X 122 A. There is good evidence for a molecular two-fold axis,
which presumably relates equivalent sites in the two af3 dimers that make up
the protein molecule. 294 Preliminary refinement reveals that the two FeMoco
units per protein are about 70 A apart and the four P clusters are grouped in
two pairs.
Single crystal EXAFS studies 295 have provided important structural infor-
mation on the molybdenum site. For different crystal orientations (relative to
the polarized x-ray beam), the amplitude of the Mo-Fe EXAFS changes by a
factor of 2.5, but the Mo-S EXAFS changes only slightly. Analysis of the an-
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Figure 7.30
Mo K-edge EXAFS spectrum (left panel) and EXAFS Fourier transform (right panel) of Klebsiella pneumoniae nitrogenase MoFe protein.
The solid line is the processed experimental spectrum and the dashed line a calculated one. 287
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Figure 7.31
Proposed models for FeMoco. (Compare with the recent model from the x-ray structure on
page 444.)
isotropy of the Mo-Fe EXAFS using the available crystallographic infonnation 294
is consistent with either a tetrahedral MoFe3 geometry such as that found in
thiocubanes (Figure 7.32) or a square-based pyramidal MoFe4 arrangement of
metals. This interpretation tends to rule out some of the structural proposals
shown in Figure 7.33. The observed orientation-dependence of the iron ampli-
tudes is too small for clusters containing a linear or planar arrangement of iron
and molybdenum (e.g., Figure 7.33B,C), and too large for arrangements that
involve regular disposition of iron about molybdenum. Moreover, the lack of
anisotropy of the sulfur EXAFS (which was apparently not considered in the
original interpretation 295) argues against an MoS3 (O/Nh model that has molyb-
denum coordinated by sulfur atoms that bridge only to Fe atoms disposed to
one side of the molybdenum. Significant anisotropy for the Mo-S EXAFS (of
opposite polarization, and smaller than that for Mo-Fe) would be expected for
(A)
(8)
(e)
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Figure 7.32
Structures of thiocubanes that display Mo-S and Mo-Fe distances similar to FeMoco:
(A) (Fe3MoS4h(SR)93~; (B) (MoFe3S4hFe(SR)123~/4~; (C) MoFe3SiSEth(cat)CN3~.
(Data on A and B from References 328, 330a; data on C from References 331, 332.)
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Figure 7.33
FeMoS and FeWS structures of potential interest with respect to nitrogenase. 331 ,332,332a-j
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such an arrangement of sulfur atoms. However, the cubane model of Figure
7.33, which provides the best model of both geometric and electronic structure,
remains viable if one of the nonbridging ligands to molybdenum is a sulfur atom
(rather than oxygen or nitrogen) with a bond length similar to that of the bridg-
ing sulfides.
10. Substrate reactions
The two-component Mo-nitrogenase enzyme catalyzes the reduction of N2
to 2NH4 + as its physiological reaction. Concomitant with the reduction of N2 ,
H2 evolution occurs, with electrons supplied by the same reductants that reduce
N2 . The limiting stoichiometry appears to be
N2 + 1OH + + 8e ...~ 2NH4 + + H2 (7.16)
CHz
+ 2e - + 2H + ~ CH2 =CH-CH3 + A.
H2C--CHz
If N2 is omitted from the assay, all the electrons go to H2 evolution. Indeed, to
a first approximation the rate of electron flow through nitrogenase is independent
of whether the enzyme is producing only H2 , producing both NH4 + and H2 , or
reducing most of the alternative substrates.
As displayed in Table 7.8, many alternative substrates are known for this
enzyme. 240 ,243,296 The most important of these from a practical perspective is
Table 7.8
Nitrogenase substrate reactions.296,374-376
Two-electron reductions
2e- + 2H+ ~ Hz
C2H2 + 2e + 2H+ ~ CZH4
N3 + 2e - + 3H + ~ NH3 + N2
NzO + 2e - + 2H + ~ H20 + N2
CH2
HC!\H
Four-electron reductions
HCN + 4e + 4H +~ CH3NH2
RNC + 4e- + 4H+ ~ RNHCH3
Six-electron reductions
Nz + 6e- + 6H+ ~ 2NH3
HCN + 6e- + 6H+ ~ CH4 + NH3
HN3 + 6e- + 6H+ ~ NH3 + N2H4
RNC + 6e- + 6H+ ~ RNH2 + CH4
RCN + 6e- + 6H+ ~ RCH3 + NH3
NCNH2 + 6e - + 6H +~ CH3NH2 + 2NH3
N02 + 6e + 6H + ~ NH3
Multielectron reductions
RNC ~ (CZH6 , C3H6 , C3Hs) + RNHz
NCNHz + 8e- + 8H+ ~ CH4 + 2NH3
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acetylene, C2H2, which is reduced by the Mo nitrogenase exclusively to ethyl-
ene, C2H4 . Acetylene can completely eliminate H2 evolution by nitrogenase.
Many of the substrates in Table 7.8 have a triple bond. Indeed, the only triple-
bonded molecule not reduced by nitrogenase is CO, which nevertheless inhibits
all substrate reactions, but not H2 evolution (in the wild type). Triple-bonded
molecules such as acetylene (H-C==C-H) are useful probe molecules for
related reactivity as discussed below for simple inorganic systems. All substrate
reductions involve the transfer of two electrons or multiples thereof (i.e.,
4,6,8 ...). Multielectron substrate reductions may involve the stepwise execu-
tion by the enzyme of two-electron processes. Further, about as many protons
as electrons are usually transferred to the substrate. One way of viewing the
nitrogenase active site is that it can add the elementary particles (H + and e -)
of H2 to the substrate. This may have mechanistic implications. 297
It is potentially fruitful to pursue the intimate connection between H2 and
the N2 binding site in nitrogenase. It has been shown unequivocally298,299 that
one H2 is evolved for each N2 "fixed" even at 50 atm of N2, a pressure of N2
well above full saturation. Moreover, H2 is a potent inhibitor of N2 fixation,
and under D2, HD is formed, but only in the presence of N2. These complex
relationships between N2 and H2(D2) have elicited a variety of interpreta-
tions. 255 ,300-302
Recently, it has been demonstrated that the FeMo protein alone acts as an
uptake hydrogenase. 303 Dihydrogen in the presence of [FeMo] causes the reduc-
tion of oxidizing dyes such as methylene blue or dichlorophenolindophenol in
the absence of Fe protein. This is the only known catalytic reaction displayed
by the FeMo protein alone. The hydrogen evolution and uptake by [FeMo] sug-
gest that understanding hydrogen interaction with transition-metal/sulfur centers
may be crucial to understanding the mechanism of nitrogenase action.
11. The role of ATP
ATP hydrolysis appears to be mandatory, and occurs during electron trans-
fer from [Fe] to [FeMo]. Dissociation of [Fe] and [FeMo] following electron
transfer is probably the rate-limiting step in the overall turnover of the en-
zyme. 255 The fact that reductant and substrate levels do not affect turnover rates
is consistent with this finding.
The role of ATP on a molecular level remains one of the great mysteries of
the mechanism of nitrogen fixation. As discussed above, the overall thermody-
namics of N2 reduction to NH3 by H2 or by its redox surrogate flavodoxin or
ferredoxin is favorable. The requirement for ATP hydrolysis must therefore arise
from a kinetic necessity. This requirement is fundamentally different from the
need for ATP in other biosynthetic or active transport processes, wherein the
free energy of hydrolysis of ATP is needed to overcome a thermodynamic lim-
itation.
What is the basis for the kinetic requirement of ATP hydrolysis in nitrogen
fixation? To answer this question, we again look at the potential reduction prod-
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ucts of the N2 molecule. Of these, only N2H2 (diimide, three potential isomers),
N2H4 (hydrazine and its mono and dications), and NH3 (and its protonated form,
NH4 +) are isolable products. (In the gas phase, other species such as N2H,
N2H3 , or NH2 also have a "stable" existence.) In the presence of H2 , only the
formation of ammonia is thermodynamically favored (Figure 7.26). Clearly, the
formation of the intermediate species in the free state cannot occur to any rea-
sonable extent. However, this does not mean that nitrogenase must form NH3
directly without the formation of intermediates. It is possible for these reactive
intermediates to be significantly stabilized by binding to a metal-sulfur center or
centers.
Detailed kinetic studies 255,304 have suggested a scheme in which intermedi-
ates with bound and probably reduced nitrogen are likely to be present. Rapid
quenching experiments in acid solution lead to the detection of hydrazine during
nitrogenase turnover. 305 Likewise, studies of inhibition of N2 fixation by H2 and
the formation of HD under D2 have been interpreted in terms of a bound diimide
intermediate. 306,307 Although a bound "dinitrogen hydride" is likely to be pre-
sent, its detailed structure remains unknown.
D. The Alternative Nitrogenases
1. Vanadium nitrogenase
The "essentiality" of molybdenum for nitrogen fixation was first reported
by Bortels in 1930. 308 This finding led ultimately to the characterization of the
molybdenum nitrogenases discussed in the preceding section. Bortels' work has
been cited many times, and is often referred to without citation. Following this
seminal work, many other Mo-containing enzymes were subsequently sought
and found. 25 ,309 At present more than a dozen distinct Mo enzymes are known,
and new ones are continually being discovered.
In addition to the classic 1930 paper, Bortels 310 reported in 1935 that va-
nadium stimulated nitrogen fixation. In contrast to the 1930 paper, the 1935
paper languished in obscurity. Then, starting in the 1970s, attempts were made
to isolate a vanadium nitrogenase. In 1971, two groups reported isolating a
vanadium-containing nitrogenase from A. vinelandii. 311 ,312 The interesting no-
tion at this time was that V might substitute for Mo in nitrogenase, not that
there was a separate system. The isolated enzyme was reported to be similar to
the Mo enzyme, but had a lower activity and an altered substrate specificity.
One of the groups carefully reinvestigated their preparation, and found small
amounts of molybdenum, which were presumed to be sufficient to account for
the low activity, although the altered selectivity was not addressed. 313 The van-
adium was suggested to play a stabilizing role for [FeMo], allowing the small
amount of active Mo-containing protein to be effectively isolated. Apparently
the possibility was not considered that a truly alternative nitrogenase system
existed, whose protein and metal centers both differed from that of the Mo
nitrogenase.
434 7 I FERREDOXINS, HYDROGENASES, AND NITROGENASES: METAL-SULFIDE PROTEINS
The unique essentiality of molybdenum for nitrogenase fixation went un-
challenged until 1980, when it was demonstrated 314 that an alternative nitrogen-
fixation system could be observed in A. vinelandii when this organism was starved
for molybdenum. 315 Despite skepticism from the nitrogenase research commu-
nity, it was eventually shown that even in a mutant from which the structural
genes for the Mo nitrogenase proteins (nif H, D, and K) had been deleted, the
alternative system was elicited upon Mo starvation. In 1986, two groups316-321
isolated the alternative nitrogenase component proteins from different species of
Azotobacter, and demonstrated unequivocally that one component contained
vanadium and that neither component contained molybdenum.
One of the two components of the V-nitrogenase system is extremely similar
to the Fe protein of nitrogenase. This similarity is evident in the isolated pro-
teins from A. vinelandii 316 and in the genetic homology between nif H (the gene
coding for the subunit of the Fe protein in the Mo-nitrogenase system) and
nif H* (the corresponding gene in the V-based system). Both Fe proteins have
an (Y2 subunit structure, and contain a single Fe4S4 cluster that is EPR-active in
its reduced state.
The FeV proteins from Azotobacter vinelandii and Azotobacter chroococ-
cum each have an (Y2f3202 subunit structure. 322 Metal composition and spectro-
scopic comparisons between the FeMo and FeV proteins are shown in Table
7.9. Although there is the major difference involving the presence of V instead
of Mo in the FeV protein and in the probable presence of the small 0 subunits
(13 kDa), the two nitrogenase systems are otherwise quite similar. 322 In each, a
system of two highly oxygen-sensitive proteins carries out an ATP-dependent
N2 reduction with concomitant H2 evolution. The Fe proteins have the same
subunit structure and cluster content, and are spectroscopically very similar. The
V versions of the larger protein have somewhat lower molecular weights than
their Mo analogues, and by MCD spectroscopy seem to contain P-like clus-
ters. 318 The FeV site still may be an S = i center (by EPR, although its EPR
differs significantly from that of the FeMo center). 323 The V-S and V-Fe dis-
tances as measured by EXAFS 324,325 are similar to those in thiocubane VFe3S4
clusters and to Mo-S and Mo-Fe distances like those in [FeMo], which are in
tum similar to those in MoFe3S4 thiocubanes. Likewise, XANES 324,325 indicates
VS30 3 type coordination in [FeV] nitrogenase similar to the MoS30 3 coordina-
tion suggested by XANES for FeMoco. The "FeV cofactor" is extractable into
NMF, and can reconstitute the nif B -, FeMoco-deficient mutant of the Mo
system. 326 Despite the substitution of V for Mo, the proteins and their respective
M-Fe-S sites do not differ drastically. However, the compositional changes do
correlate with altered substrate reactivity.
A major difference between the V and Mo enzymes lies in substrate speci-
ficity and product formation. 321 As is clearly shown in Table 7.9, the FeV nitro-
genase has a much lower reactivity toward acetylene than does the Mo system.
Furthermore, whereas the FeMo system exclusively produces ethylene from
acetylene, the FeV system yields significant amounts of the four-electron reduc-
tion product, ethane. 321 The detection of ethane in the acetylene assay may
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Table 7.9
Comparison of alternative nitrogenase proteins a
Property Avl 47 Avl '47 Ad '50
Molecular weight 240,000 200,000 210,000
Molybdenum b 2 <0.05 <0.06
Vanadium b 0.7 2
Iron b 30-32 9.3 23
Activity'
H+ 2200 1400 1350
CZH2 2000 220 608
N2 520 330 350
EPR g values 4.3 5.31 5.6
3.7 4.34 4.35
2.01 2.04 3.77
1.93 1.93
a Avl is the FeMo protein of Azotobacter vinelandii, Avl* is the FeV
protein of A. vinelandii and Ad* is the FeV protein of A. chroococcum.
Data from References 317,377, and 319, respectively.
b Atoms per molecule.
C nmol product/min/mg of protein.
prove a powerful technique for detecting the presence of the V nitrogenase in
natural systems. 322 Moreover, this reactivity pattern is found in the nif B - mu-
tant reconstituted with FeVco, indicating that the pattern is characteristic of the
cofactor and not the protein. 326 The reactivity change upon going from Mo to
V in otherwise similar protein systems clearly adds weight to the implication of
the M-Fe-S center (M = V or Mo) in substrate reduction.
2. The all-iron nitrogenase 322
The first sign that there is yet another alternative nitrogenase again came
from genetic studies. A mutant of A. vinelandii was constructed with deletions
in both nif HDK and nif H*D*K*, i.e., the structural genes for the Mo and V
nitrogenases, respectively. Despite lacking the ability to make the two known
nitrogenases, the mutant strain nevertheless was able to fix nitrogen, albeit poorly.
Moreover, this mutant strain's nitrogenase activity was clearly inhibited when
either Mo or V was present in the culture medium. Preliminary studies indicate
that the nitrogenase proteins produced by this organism are closely related to
those previously isolated. A 4Fe-4S Fe-protein nif H t and a protein due to nif D t
was produced. The latter appeared to contain no stoichiometric metal other than
iron. Symmetry of nomenclature would suggest calling this the FeFe protein
and its cofactor FeFeco. Interestingly, this nitrogenase seems to be the poorest
of the set in reducing N2 and makes ethane from ethylene. The finding of the
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all-iron nitrogenase, if fully confirmed, will add significantly to the comparative
biochemistry of nitrogen fixation. Speculatively, one l11ight suggest that the con-
comitant absence of V and Mo suggests that nitrogen fixation need not directly
involve the noniron heterometal in the cofactor cluster. This result may explain
the lack of direct implication of Mo in the nitrogen fixation mechanism, despite
many years of intense effort by workers in the field. (The above discussion
should be taken cum grana salis until the existence of the all-iron nitrogenase
is confirmed.)
3. Model systems
Three types of model systems for nitrogenase may be considered. First,
there are transition-metal sulfide clusters that resemble the FeMoco or FeVco
centers of the active proteins. Although there has been significant progress, there
are not yet any definitive models (as there are for Fe2S2 and Fe4S4). A second
approach uses the reactions of N2 and related substrates or intermediates with
metal centers in order to gain insights into the way in which transition-metal
systems bind N2 and activate it toward reduction. Here to date the most reactive
systems bear little direct chemical resemblance to the nitrogenase active sites.
Nevertheless, these systems carry out bona fide nitrogen fixation from which
one may learn the various ways in which N2 can be activated. Finally, there are
other inorganic systems that display some of the structural and possibly some of
the reactivity characteristics of the nitrogenase active sites without binding or
reducing N2 or precisely mimicking the active center. We may nevertheless be
able to learn effectively about nitrogenase reactivity from these interesting chemical
systems.
a. Transition-Metal Sulfide Models for Nitrogenase Sites Although there
has been great activity in synthetic Fe-S cluster chemistry, there is to date no
example of a spectroscopic model for the P-cluster sites in nitrogenase. If the
P-clusters are indeed asymmetrically bound high-spin Fe4S4 clusters, then the
recent work on high-spin versions of Fe4S4 clusters 327 and site-selectively deri-
vatized Fe4S4 centers 143 may hint that appropriate model systems are forthcom-
mg.
b. Fe-Mo-S Cluster Models for FeMoco Despite the importance of P-clus-
ters, the modeling of the FeMoco center has properly received the most atten-
tion. The significant structural parameters that any model must duplicate are the
Mo-S and Mo-Fe distances detennined by EXAFS. Spectroscopically, the S = i
EPR signal provides a stringent feature that model systems should aspire to
mImIC.
Many FeMoS clusters have been prepared in the quest to duplicate the FeMoco
center, but none of the chemically synthesized clusters can reactivate the (UW-
45 or Nif B -) cofactor-less mutants, perhaps because of their lack of homoci-
trate, which only recently has been discovered as a key component of FeMoco.
Undoubtedly, new FeMoS clusters containing homocitrate will be prepared, and
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perhaps these will activate the mutant proteins, thereby revealing a close or full
identity with FeMoco.
Despite the absence of homocitrate, some interesting model systems have
been investigated. It is beyond the scope of this chapter to give a comprehensive
account of FeMoS chemistry. We concentrate on the so-called "thiocubane"
model systems. Heterothiocubane models were first synthesized using self-as-
sembly approaches analogous to those used for the simpler Fe-S model systems.
The reaction 3ZS-330a
uses tetrathiomolybdate, MoS4z ,as the source of Mo, and leads to the double
cubane structures shown in Figure 7.32A,B. The Fe7MozSs structure proved
particularly interesting, since it was possible to complex the central ferric iron
atom with substituted catecholate ligands 331,33Z and eventually isolate a single
thiocubane unit (Figure 7.32C). Significantly, the single unit has S = ~ and
Mo-S and Mo-Fe distances that match precisely those found by EXAFS for the
M center of nitrogenase. Single cubes with VM03S4 cores have also been pre-
pared. 160,160a Although the single thiocubanes display spectroscopic similarity
and distance identity with FeMoco, they are not complete models. They are
stoichiometrically Fe and S deficient, lack homocitrate, and most importantly,
fail to activate the UW-45 and Nif B - mutants.
Other interesting FeMoS (and FeWS) clusters with structurally distinct prop-
erties are shown in Figure 7.33. These include the "linear" (MoS4)zFe 3- ion,
the linear (WS4)zFe[HCON(CH3hhz- ion, the linear ClzFeSzMSzFezCI/-
(M = Mo, W), the "linear" (MoS4)zFezSz4- ion, the trigonal (WS4hFe3Sz4-,
the capped thioprismane Fe6S6X6[M(COhh3- (X = CI, Br, I; M = Mo, W),
and the organometallic clusters MoFe6S6(CO)16z-, MoFe3S6(COMPEt3h, and
MoFe3S6(CO)6z-. Structures suggested for FeMoco based on these and other
chemically synthesized transition metal sulfides and on spectroscopic studies of
the enzyme are shown in Figure 7.31.
E. N2 and Related Complexes
The triple bond of Nz has one cr and two 1T components. Each nitrogen
atom has a lone pair oriented along the N-N direction. The two lone pairs allow
Nz to bind in an end-on fashion in either a terminal or a bridging mode. Both
modes of binding are illustrated in the binuclear zirconium complex 333 shown
in Figure 7.34. In this and in many other Nz complexes, the N-N bond is not
significantly lengthened and is therefore presumed to be insignificantly weak-
ened in the complex. Interestingly, the complex in Figure 7.34, despite not
having long N-N distances, forms hydrazine quantitatively upon protonation.
Only one of the three Nz molecules is reduced, and all four electrons required
come from the two Zr(III) by presumed internal electron transfer. The related
,u-Nz complex [We1Js-CsMes)Mez(SC6HzMe3)h(,u-Nz) is one of the few dinitro-
gen complexes to contain an S donor ligand. 333a
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Figure 7.34
The x-ray crystal structure 333 of (Cp'hZr(N2)(,uT N2)Zr(N2)(Cp')2'
In addition to the N lone pairs, the 1T components of the N==N triple bond
can serve as donor-acceptor orbitals in the Dewar-Chatt-Duncanson (olefin bind-
ing) manner. This less-common mode of N2 binding is illustrated by the struc-
ture of the Ti complex 334 shown in Figure 7.35. Here, as in the few other
known side-on bound N2 complexes,335 the N-N bond is significantly length-
ened. The lengthened bond at 1.30 Ais presumed to be sufficiently weakened
[v(N-N) = 1280 cm - I] that it is susceptible to further lengthening and reduc-
tion. As the N-N distance lengthens, it is more appropriate to consider the li-
gand as a deprotonated diimide or hydrazine.
Complexes that have proven particularly useful are bis(dinitrogen)phosphines
of Mo(O) and W(O) such as M(N2MPh2PCH2CH2PPh2h and M(N2MPPh2Mek
Figure 7.35
The structure of a multiply bound dinitrogen titanium compound. 334
Figure 7.36
Structure and reactions of M(Nz)z(PhzPCH2CH2PPhzh (M == Mo, W)
and related complexes. Not all of the intermediates in this scheme have
been isolated in anyone particular system. 336 ,337,337. The phosphine
ligands are not shown.
As shown in Figure 7.36, treatment of the complexes 336-337a with acid leads to
the formation of the diazenido(-H) and hydrazido(-2H) complexes, and some-
times to the production of ammonia. The finding of a bound N2H2 2 - species is
consistent with the proposed presence of similar bound species in nitrogenase.
The complexes of reduced dinitrogen intermediates are stabilized by multiple
M-N binding. Further protonation of these intermediates or treatment of the
original complex with strong acid leads to the formation of NH3 from the bound
nitrogen. Here the Mo(O) starting complex has enough electrons [six from the
Mo(O) ~ Mo(VI) conversion] to reduce one N2 molecule in conjunction with
its protonation from the external solution.
In a general sense this reaction may be telling us something about nitrogen-
ase. The enzyme may be able to deliver six reducing equivalents to N2 , and
protonation, perhaps carefully orchestrated by neighboring amino-acid or hom-
ocitrate groupings, may facilitate the process. However, it is virtually certain
that the Mo in nitrogenase is not able to change its oxidation state by six units.
In the enzyme the multimetal, multisulfur FeMoco site may serve the equivalent
function, by providing multiple sites at which reduced intermediates can simul-
taneously bind.
Only a few of the known N2 complexes contain S-donor ligands. One of
these, Mo(N2h(S(CH2C(CH3hCH2Sh), shown in Figure 7.37, has four thioether
S-donor atoms bound to Mo(O). This Mo(O) complex shows reactivity reminis-
cent of the related phosphine complexes. 337a A remarkable complex (Figure 7.38)
has been isolated 338 in which two lone pairs of trans-diimide bind to two Fe,
concomitantly with H-binding of the two diimide hydrogen atoms to coordinated
sulfur atoms. The ability of an Fe-S system to stabilize the very reactive trans-
N2H2 grouping adds support to the notion that similar metal-sulfide sites of
nitrogenase may stabilize related intermediates along the N2 ~ 2NH3 reaction
path.
Most of the model systems involving N2 do not lead to NH3 formation.
Moreover, many systems that do form NH3 are not catalytic. However, certain
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Figure 7.37
The structure of Mo(Nz)zL (L is a tetrathiacyc!ohexadecane)337b,C
Figure 7.38
The structure 338 of FeL(NzHz)FeL (L = SC6H4SCHzCH2SCHCH2SC6H4S),
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V-based and Mo-based systems can catalytically reduce N2 to N2H4 or NH3
using strong reducing agents. 339 Although kinetic studies indicate the possibility
of intermediates, little structural information is available at present on these
interesting systems.
F. Insights from Relevant Inorganic Reactivity
Certain studies on inorganic systems that do not model the nitrogen-fixation
process can nevertheless potentially give insight into nitrogenase action. Two
categories of relevant chemistry are acetylene binding/reactivity and dihydrogen
binding/activation. Modes of dihydrogen activation on sulfide systems have pre-
viously been discussed in the section on hydrogenase.
Acetylene has long been known to bind to metal centers using its 7T and 7T*
orbitals as, respectively, a-donor and 7T-acceptor orbitals. Even when the metal
is predominantly sulfur-coordinated, 340, 341 such side-on bonding of RC2R is well
known 340,341 as in MOO(S2CNR2h(RC==CR) and MO(S2CNR2h(RC==CRh.
The direct interaction of acetylene with the metal center must be considered as
a potential binding mode for nitrogenase substrates.
A totally different, sulfur-based mode of acetylene binding is now also well
established. For example, (Cp'hM02S4 reacts with acetylene 342,225 to produce
(7.18)
containing a bridging ethylene-l,2-dithiolate (dithiolene). The acetylene binds
directly to the sulfur atoms by forming S-C bonds. Acetylenes or substituted
(activated) acetylenes are able to displace ethylene from bridging or terminal
1,2-dithiolate ligands 225,341 to produce the 1,2-dithiolenes. In these reactions the
sulfur rather than the metal sites of the cluster are reactive toward these small
unsaturated molecules. Clearly, for nitrogenase, where we do not know the mode
of binding, sulfur coordination might be a viable possibility. The (Cp'hM02S4
systems that bind H2 and C2H2, wherein bound C2H2 can be reduced to C2H4
and displaced by C2H2, are potential models for substrate reduction by nitrogen-
ase. 225 ,342
The versatility of transition-metal sulfur systems is further illustrated by the
observation that activated acetylene can insert into a metal-sulfur bond in
M020 2S2(S2h 2- , forming a vinyl-disulfide-chelating ligand
s-s
/ \
M" -7C- R
C
I
R
(7.19)
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Figure 7.39
Possible modes of acetylene binding to metal-sulfur sites.
on an MozOzSzz- core. In this case the acetylene is bound by both metal and
sulfur atoms. Figure 7.39 shows three possible modes of CzHz binding, each of
which is possible for the nitrogenase system.
It has recently been suggested 343 that the presence of a dihydrogen complex
is required for Hz to be displaced by Nz to form a dinitrogen complex. This
reaction would explain the required stoichiometry of Nz reduction and Hz evo-
lution. Such an explanation had been suggested previously with dihydride com-
plexes acting as the Nz-binding and Nz-displacing site. 18Z Clearly, this new sug-
gestion is an interesting embellishment of potential Nz/Hz relationships.
At present, the activation process that is at work in the enzyme is unknown.
We need greater structural definition of the active site, which should be forth-
coming through the continued application of sophisticated diffraction and spec-
troscopic probes. Diffraction alone, however, will be incapable of locating pro-
tons and possibly other low-molecular-weight ligands. Therefore, spectroscopic
probes such as ENDOR10 and ESEEM,277-Z79,344 which are based on EPR spec-
troscopy, and x-ray-based techniques, such as EXAFS and XANES, will remain
crucial in elucidating mechanistically significant structural details.
III. REPORT ON THE NITROGENASE CRYSTAL STRUCTURE378-381
A significant breakthrough has occurred in the crystallographic analysis of the
iron-molybdenum protein of nitrogenase. The overall distribution of the metal
clusters in the protein is shown in Figure 7.40. The distance between the two
FeMoco units is fully consistent with each cofactor acting as an independent
active site. On the other hand, the closeness of the P cluster and FeMoco centers
in each unit is indicative of their likely cooperation in the Nz fixation reaction.
The proposed structure of the P cluster, shown in Figure 7.41, involves a
doubly bridged, double cubane unit consisting of one normally bound Fe4S4
cluster with all cysteine ligands and one Fe4S4 cluster that contains an unusual
cysteine/serine (S/O) ligand pair on one of its two nonbridged Fe positions.
Such five-coordinate iron in an Fe4S4 cluster is not unprecedented. 138 The two
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Figure 7.40
A schematic representation of the spatial arrangement of the metal sulfur
clusters bound to Cpl as determined by the x-ray anomalous scattering
studies described in the text. The representation of the large, "8-Fe"
cluster with a P symbol indicates only that it must contain the Fe atoms
normally assigned to P-c1usters.
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Figure 7.41
Proposed P-cluster pair in A. vinelandii FeMo protein.
Fe4S4 clusters are disposed to produce a face-sharing arrangement with two cys-
teine ligands bridging the two sets of Fe atoms. An interesting feature of the
structure is a disulfide unit linking the two clusters; this unit potentially could
be redox-active during nitrogenase turnover.
Most striking of the new results is the proposed structure of FeMoco shown
in Figure 7.42. The cluster core of composition Fe7MoSg can be viewed as two
halves bridged by two S2- ions and an unknown ligand (designated Y in the
figure). The MoFe3S3 half of the core is in the shape of a thiocubane fragment
missing one fJ-rS2- ion. The Mo is six coordinate; the ligands are three fJ-rS2-
ions, which bridge to the three Fe ions, an a-His-442 nitrogen, and two oxygen
donors (the hydroxyl and central carboxylate) of the homocitrate ligand. Inter-
estingly, the second half of FeMoco is a similar thiocubane fragment, Fe4S3,
also missing a fJ-3-S2 ion. This unit has a single noncore ligand, a-Cys-275,
which is bound to the terminal Fe atom of the cluster. The two thiocubane
444
Figure 7.42
Proposed cofactor cluster in A. vinelandii FeMo protein.
fragments (MoFe3S3 and Fe4S3) are bridged by three ligands in a face-sharing
mode with the two Fe3 faces eclipsed with respect to each other. The eight metal
ions display a bis(end-capped) trigonal prismatic arrangement with three bridges
on the edges of the prism, which connect the two thiocubane fragments. The
two sulfide bridges between the thiocubane halves are clearly defined in the
structure, but the third bridge is not, suggesting the possibility that this is in
fact part of the Nrbinding site. Interestingly, a-His-195, identified as essential
for Nz fixation by mutagenesis and ESEEM studies, does not appear to be cov-
alently bound, although it is close to the FeMoco unit.
Clearly, this structure is not the same as any of those previously proposed
(Figure 7.31), although it does possess many features that were identified in
model studies. While it is tempting to speculate that the central bridge of the
cluster (the Y ligand) is the site of Nz reduction, this is in no way established
at present.
The structural definition of the nitrogenase proteins is now progressing at a
rapid rate. Many of the physical measurements will have to be reexamined in
light of the new data. Through further experimentation involving physical meth-
ods, mutagenesis, and kinetic/mechanistic studies, much more information about
the role of ATP, the activation of hydrogen, and the binding, activation, and
reduction of Nz and other nitrogenase substrates should be obtained.
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I. INTRODUCTION
The interest of the bioinorganic community in the field of metal/nucleic-acid
interactions has burgeoned in the last decade. This interest and the resulting
progress have come about primarily because of the tremendous advances that
have occurred in nucleic-acid technology. We can now isolate, manipulate, and
even synthesize nucleic acids of defined sequence and structure, as we would
other molecules that chemists commonly explore. Furthermore, as may be evi-
dent already in other chapters of this book, bioinorganic chemistry has itself
been evolving from a field focused on delineating metal centers in biology to
one that includes also the application of inorganic chemistry to probe biological
structures and function. In the past decades it has become clear that nucleic
acids, structurally, functionally and even remarkably in terms of catalysis, play
active and diverse roles in Nature. Transition-metal chemistry, both in the cell
and in the chemist's test tube, provides a valuable tool both to accomplish and
to explore these processes.
There are also many practical motivations behind the study of how metal
ions and complexes interact with nucleic acids. Heavy-metal toxicity in our
environment arises in part from the covalent interactions of heavy-metal ions
with nucleic acids. In addition, these heavy metals interfere with metalloregu-
latory proteins and in so doing disrupt gene expression. We need to understand
the functioning of the natural metalloregulators of gene expression and we need
to design new metal-specific ligands, which, like the proteins themselves, cap-
ture heavy metals before their damage is done. Heavy-metal interactions with
nucleic acids indeed have provided the basis also for the successful application
of cisplatin and its derivatives as anticancer chemotherapeutic agents (see Chap-
ter 9). The design of new pharmaceuticals like cisplatin requires a detailed un-
derstanding of how platinum and other metal ions interact with nucleic acids
and nucleic-acid processing. Furthermore, we are finding that metal complexes
can be uniquely useful in developing spectroscopic and reactive probes of nu- 455
456 8 / METAUNUCLEIC-ACID INTERACTIONS
cleic acids, and hence may become valuable in developing new diagnostic agents.
Finally, Nature itself takes advantage of metal/nucleic~acidchemistry, from the
biosynthesis of natural products such as bleomycin, which chelates redox-active
metal ions to target and damage foreign DNA, to the development of basic
structural motifs for eukaryotic regulatory proteins, the zinc-finger proteins, which
bind to DNA and regulate transcription. In all these endeavors, we need first to
develop an understanding of how transition-metal ions and complexes interact
with nucleic acids and how this chemistry may best be exploited.
In this chapter we first summarize the "basics" needed to consider the in-
teractions of metal ions and complexes with nucleic acids. What are the struc-
tures of nucleic acids? What is the basic repertoire of modes of association and
chemical reactions that occur between coordination complexes and polynucleo-
tides? We then consider in some detail the interaction of a simple family of
coordination complexes, the tris(phenanthroline) metal complexes, with DNA
and RNA to illustrate the techniques, questions, and applications of metal/nu-
cleic-acid chemistry that are currently being explored. In this section, the focus
on tris(phenanthroline) complexes serves as a springboard to compare and con-
trast studies of other, more intricately designed transition-metal complexes (in
the next section) with nucleic acids. Last we consider how Nature uses metal
ions and complexes in carrying out nucleic-acid chemistry. Here the principles,
techniques, and fundamental coordination chemistry of metals with nucleic acids
provide the foundation for our current understanding of how these fascinating
and complex bioinorganic systems may function.
II. THE BASICS
A. Nucleic-Acid Structures 1
Figure 8.1 displays a single deoxyribonucleotide and the four different nucleic-
acid bases. As may be evident, each mononucleotide along a nucleic-acid pol-
ymer contains a variety of sites for interactions with metal ions, from electro-
static interactions with the anionic phosphate backbone to soft nucleophilic in-
teractions with the purine heterocycles. The different nucleic-acid bases furthermore
offer a range of steric and electronic factors to exploit. Coordination of a metal
complex to the N7 nitrogen atom of a purine, for example, would position other
coordinated ligands on the metal center for close hydrogen bonding to the 06
oxygen atom of guanine, but would lead to clashes with the amine hydrogen
atoms of adenine.
The monomeric units strung together in a polynucleotide furthermore pro-
vide an array of polymeric conformers. Figure 8.2A (See color plate section,
pages C-14, C-15.) shows three crystallographically characterized structures of
double-helical DNA 01igonucleotides,2-4 Figure 8.2B a schematic illustration of
other conformations of DNA, and Figure 8.2C the crystal structure 5 of yeast
tRNA Phe. In double-helical DNA, I the two antiparallel polynucleotide strands
adenine
guanine
cytosine
thymine
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Figure 8.1
Illustration of a mononucleotide unit. Arrows indicate the various torsional angles within each
unit that together generate the wide range of conformations available in the polymer. Also
shown are the individual bases as well as the commonly employed numbering scheme.
are intertwined in a helix, stabilized through Watson-Crick hydrogen bonding
between purines and pyrimidines, and through 7r-7r stacking interactions among
the bases arranged in the helical column. There are electrostatic repulsions be-
tween the anionic phosphate backbones of the polymer, causing a stiffening;
each double-helical step has two formal negative charges. An atmosphere of
metal ions condensed along the sugar-phosphate backbone serves partially to
neutralize these electrostatic interactions. In the B-DNA conformation, the bases
are stacked essentially perpendicular to the helical axis, and the sugars are puck-
ered in general, with a C2'-endo geometry (the C2' carbon is to the same side
as the C5' position relative to a plane in the sugar ring defined by the CI', C4',
and 0 atoms). This conformer yields a right-handed helix with two distinct,
well-defined grooves, termed the major and minor. The A-form helix, while
still right-handed, is distinctly different in structure. The sugar rings are puck-
ered generally in the C3' -endo conformation, causing the bases to be pushed
out from the center of the helix toward the minor groove, and tilted relative to
the helix perpendicular by almost 20°. What results is a shorter and fatter helix
than the B-form; the helical pitch is 28.2 Ain A-DNA for an ll-residue helix
and 33.8 Afor a la-residue helix in B-DNA. The A-form helical shape is best
characterized by the very shallow minor groove surface; what was the major
groove in the B-form has been pulled deeply into the interior of the A-conformer
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and is really not accessible to binding by small molecules in solution. Transi-
tions to the A-conformation are promoted by hydrophobic solvents or solutions
of high ionic strength. The Z-conformation is perhaps most distinctive, owing
to its left-handed helicity.4 The conformer was dubbed Z-DNA because of the
zig-zag in the helix. Alternations both in sugar puckering, between C2' -endo
and C3'-endo, and in the rotation of the base about the glycosidic bond, anti or
syn relative to the sugar, are evident, and lead to a dinucleoside repeating unit
versus a mononucleoside repeat in the A- and B-helices. Alternating purine-
pyrimidine sequences have the highest propensity to undergo transitions into the
Z-form. It is actually this syn conformation of purines that leads to the left-
handed helicity of the polymer. But it is not only its left-handedness that distin-
guishes the Z-conformation. The polymer is long and slender (the pitch is 45 A
for a 12-residue helix), and the major groove is a shallow and wide, almost
convex, surface, whereas the minor groove is narrowed into a sharp and small
creVIce.
These crystal structures, shown in Figure 8.2A (see color plate section, page
C-15), in fact each represent a family of conformations. The bases in a base
pair often do not lie in the same plane, but are instead propeller-twisted with
respect to one another. The local unwinding of the helix and tilting of the base
pairs furthermore tend to vary with the local nucleic-acid sequence so as to
maximize stacking or hydrogen-bonding interactions among the bases. Hence
there is a variety of structures within each conformational family. Our under-
standing of these structural variations as a function of solution conditions and
importantly of local sequence is still quite poor. But surely these structural var-
iations affect and are affected by the binding of metal ions and complexes.
Even less defined structurally are other conformations of DNA, some of
which are illustrated schematically in Figure 8.2B (see color plate section, page
C-15). Double-helical DNA can bend,6 form loops and cruciforms,7 and fold
back on itself into intramolecular triple helices, termed H-DNA. 8 At the ends
of chromosomes, four strands may even come together in a unique conforma-
tion. These structures, characterized thus far by means of biochemical tech-
niques, arise because of sequence and local torsional stress, or supercoiling.
Many of these structures are stabilized by the binding of highly charged metal
ions, probably because the highly charged metal center in a small volume can
neutralize the electrostatic repulsions between polyanionic strands that are bun-
dled together. Metal complexes can furthermore be extremely useful in targeting
and characterizing these structures, as we will see. In chromosomes the DNA
is packaged by histone proteins into even tighter bundles, with helical segments
wrapped about the basic proteins to form superhelical nucleosomal units which
are then arranged like beads on a string of more loosely packed DNA. 9
This complexity in DNA structure is in fact small compared to that of RNA.
Figure 8.2C (see color plate section, page C-15) shows the first crystallograph-
ically characterized structures of an RNA polymer, yeast tRNA Phe. Ostensibly
single-stranded RNAs do not exist as random coils, but instead fold up into
well-defined three-dimensional structures, much like proteins. The structural va-
riety, of course, bears some resemblance to that found in DNAs. Double-helical
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regions in the tRNA are A-like in conformation; helices fold together as one
might imagine to occur in cruciforms, and even triple-helical segments are evi-
dent where three strands fold together in the polymer. But overall our ability to
characterize structures of RNA thus far is lower than that with DNAs. RNAs
are less stable in solution than is DNA, and fewer chemical as well as enzymatic
tools are available for structural characterization. Yet the recent discovery of
ribozymes,1O the finding that RNAs can indeed catalyze nucleolytic reactions,
makes our need to understand these structures even greater. Again transition-
metal chemistry may participate in stabilizing, promoting, and probing these
structures.
B. Fundamental Interactions with Nucleic Acids
Metal ions and complexes associate with DNA and RNA in a variety of ways,
as illustrated in Figure 8.3. Both strong covalent interactions and weak nonco-
valent complexes are observed. 11 Each may yield a significant perturbation in
the nucleic acid and/or may be exploited to obtain a site-specific response. Clearly
there are some general guidelines, based on principles of coordination chemis-
try, that may be helpful in sorting out these interactions.
1. Coordination
Most prevalent among covalent complexes with DNA are those involving
coordination between soft metal ions and nucleophilic positions on the bases.
The structure 12 of cis-(NH3hPt-dGpG is an example: its platinum center coor-
dinates to the N7 position of the guanine bases. In terms of interactions with
the full polynucleotide, it is likely that the cis-diammineplatinum center, with
two coordination sites available, would yield an intrastrand crosslink between
neighboring guanine residues on a strand (see Chapter 9). Other nucleophilic
sites targeted by soft metal ions on the bases include the N7 position of adenine,
the N3 position on cytosine, and the deprotonated N3 position on thymine and
uracil. 12,13 Some additional covalent binding to the Nl positions of the purines
has also been observed. Indeed, coordination by the metal to one site on the
heterocyclic base lowers the pKa and increases the metal-binding affinity to sec-
ondary sites. It is noteworthy, however, that in base-paired double-helical DNA
only the N7 positions on the purines are easily accessible in the major groove
of the helix. Base binding at the purine N7 position is, of course, not limited to
soft metal ions such as Pt(II), Pd(II), and Ru(II). Coordination at these sites has
been evident also with first-row transition-metal ions such as Cu(IT) and Zn(II).13
For these, as is consistent with basic coordination chemistry, the lability of
complexes formed is higher.
Transition-metal ions with decreasing softness are capable of coordinating
also to the phosphate oxygen atoms. The ionic versus covalent character of these
complexes clearly depends on the metal ions involved. In a classic study, ex-
amining the melting temperature of double-helical DNA in the presence of dif-
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Figure 8.3
Covalent and noncovalent binding modes of metal complexes with DNA. (A) Representative
covalent interactions. Shown schematically are examples of coordination to the DNA base,
sugar, and phosphate moieties given by the covalent binding of cis-(diammine)platinum to the
N7 nitrogen atom of neighboring guanine residues, the formation of an osmate ester with ribose
hydroxyl groups, and the primarily electrostatic association between Mg(H20)62+ and the gua-
nosine phosphate, respectively. (B) Noncovalent intercalative stacking of a metal complex.
Shown is the crystal structure 20b of (terpyridyl)(2-hydroxyethanethiolate)platinum(II) intercalated
and stacked above and below the base-paired dinucleotide d(CpG). (C) An illustration of hydro-
gen bonding of coordinated ligands. Shown is a partial view of the crystal structure 19 of Z-form
d(CG)3 with Co(NH3)63+ hydrogen-bonded both to the guanine base (G 10) and phosphate back-
bone (P9).
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Figure 8.4
The effects of various metal ions on the melting temperature (Tm ) of calf thymus DNA. 14
Reproduced with permission from Reference 14.
ferent metal ions and as a function of their concentration, Eichhorn and cowork-
ers established the preference of the metal ions for base versus phosphate binding
(Figure 8.4).14 The preference for phosphate over base association was found
to decrease in the order Mg(II) > Co(II) >Ni(II) >Mn(II) >Zn(II) >Cd(II) >
Cu(II). This series arises from examination of DNA helix-melting temperatures,
since base interactions in general should destabilize the helical form [except
where interstrand crosslinking occurs, as may happen with Ag(I)], whereas
phosphate coordination and neutralization would increase the helix stability and
hence the melting temperature.
Also of interest, but less common, are covalent interactions with the sugar
moiety.15,16 Although the pentose ring in general provides a poor ligand for
metal ions, osmate esters can form quite easily across the C2'-C3' positions in
ribose rings. This particular interaction has been suggested as a basis for heavy-
metal staining of RNA. In fact, OS04 is not restricted in its reactivity with the
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sugar positions. Cisoid osmate esters form as well upon reaction of OS04 across
the electron-rich C5-C6 double bonds of accessible pyrimidines on DNA.
2. Intercalation and hydrogen bonding
But important interactions of metal complexes with polynucleotides are not
restricted to those involving direct coordination of the metal center to the poly-
mer. Instead, an abundance of highly selective interactions arise from an ensem-
ble of weaker noncovalent interactions between the ligands of coordinatively
saturated metal complexes and the nucleic acid. Two primary examples of non-
covalent association are given by metallointercalation and hydrogen-bonding in-
teractions of coordinated ligands. 17,18 Planar aromatic heterocyclic ligands such
as phenanthroline and terpyridine can stack in between the DNA base pairs,
stabilized through dipole-dipole interactions. Here, depending on the complex
and its extent of overlap with the base pairs, the free energy of stabilization can
vary from ~2 to 10 kcal. Nonintercalative hydrophobic interactions of coordi-
nated ligands in the DNA grooves also can occur, as we will see. Hydrogen-
bonding interactions of coordinated ligands with the polynucleotide are quite
common, and arise in particular with the phosphate oxygen atoms on the back-
bone. With cobalt hexaammine, for example, hydrogen bonding to an oligonu-
cleotide occurs between the ammine hydrogens and both phosphate oxygen atoms
and purine bases. 19
A mix of covalent and noncovalent interactions is also possible. With cis-
diammineplatinum(II) coordinated to the guanine N7 position, the ammine li-
gands are well-poised for hydrogen-bonding interactions with the phosphate
backbone. 12 The steric constraints on the molecule must be considered, how-
ever. With Pt(terpy)CI +, both intercalation of the terpy ligand and direct coor-
dination of the platinum center (after dissociation of the coordinated chloride)
are available, but not simultaneously; coordination of the platinum to the base
would likely position the terpyridylligand away from the base stack in the DNA
major groove, precluding intercalation. 2o Sigel and coworkers 21 have studied the
thermodynamics of noncovalent interactions coupled to direct coordination of
simple first-row transition-metal complexes with mononucleotides, and these re-
sults illustrate well the interplay of weak noncovalent interactions and direct
coordination in generating geometric specificity in complex formation.
C. Fundamental Reactions with Nucleic Acids
The reactions of transition-metal complexes with polynucleotides generally fall
into two categories: (i) those involving a redox reaction of the metal complex
that mediates oxidation of the nucleic acid; and (ii) those involving coordination
of the metal center to the sugar-phosphate backbone so as to mediate hydrolysis
of the polymer. Both redox and hydrolytic reactions of metal complexes with
nucleic acids have been exploited with much success in the development of tools
for molecular biology.
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1. Redox chemistry
The simplest redox reaction with polynucleotides one might consider as an
illustration is the Fenton reaction, which indirectly promotes DNA strand scis-
sion through radical reactions on the sugar ring. The reaction with Fe(EDTA)2-
is shown in Figure 8.5A. As do other redox-active divalent metal ions, ferrous
ion, in the presence of hydrogen peroxide, generates hydroxyl radicals, and in
the presence of a reductant such as mercaptoethanol, the hydroxyl radical pro-
duction can be made catalytic. Although ferrous ion itself does not appear to
interact appreciably with a nucleic acid, especially when chelated in an anionic
EDTA complex and repelled by the nucleic-acid polyanion, the hydroxyl radi-
cals, produced in appreciable quantities catalytically, attack different sites on
the sugar ring, indirectly yielding scission of the sugar-phosphate backbone.
One such reaction that has been characterized in some detail is that involving
(A) Fe(ll) + H202 --+ Fe(lll) + 10H·1 + ow
Fe(lll) + e --+ Fe(lI)
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Figure 8.5
An illustration of DNA strand cleavage mediated by hydroxyl radicals produced by the Fenton
reaction (A) of Fe(EDTA)2- with hydrogen peroxide. The cleavage scheme (B) shows the prod-
ucts obtained as a result of initial C4'-H abstraction by the hydroxyl radicals.
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hydroxyl radical reaction at the C4' position, the position most accessible to the
diffusible radical in the minor groove of the helix. 22 As illustrated in Figure
8.5B, the products of this reaction include a 5'-phosphate, a mixture of 3'-
phosphate and phosphoglycolates, and a mixture of free bases and base propen-
also Reactions of the hydroxyl radical at other sites on the sugar ring are now
being identified as well by isotope-labeling studies. Comparable reactions with
RNA have also been described. 23
The application of this Fenton chemistry to promote site-specific or se-
quence-neutral cleavage of DNA was first demonstrated 24 by Dervan and co-
workers, and has provided the basis for the design of a tremendous range of
new and valuable DNA cleavage agents. The development of this chemistry was
originally based on modeling Fe-bleomycin, a natural product with antitumor
and antibiotic activity, which binds and cleaves DNA. 25 The chemistry mediated
by Fe-bleomycin, as we will discuss later, is likely to be far more complex,
however, involving direct reaction of an intimately bound ferryI intermediate
species with the nucleic acid, rather than net oxidation of the sugar mediated by
a diffusing hydroxyl radical. Other metal ions such as Cu(Il) can also promote
redox-mediated cleavage of DNA26,27 through reactions on the sugar ring; whether
the oxidizing radical is still coordinated to the metal or is a dissociated and
diffusing species is a topic of much debate. 26
Metal ions can also be used to generate other oxidizing intermediates in
aerated aqueous solution, such as superoxide ion and singlet oxygen. DNA strand-
cleavage reactions mediated by superoxide have not thus far been demonstrated,
however. Singlet oxygen may be produced by photosensitization of Ru(phenh 2+,
and indeed photolysis of Ru(phenh 2+ bound to DNA yields oxygen-dependent,
alkaline-sensitive strand cleavage. 28 ,29 For singlet oxygen, the oxidation occurs
on the nucleic-acid base rather than on the sugar ring. As such, the reaction
varies with base composition; guanine residues are most reactive. Furthermore,
since the primary lesion is that of a base modification, piperidine treatment, or
other weakly basic conditions, are needed to convert the base lesion into a strand-
scission event.
Another scheme for oxidative cleavage of DNA mediated by metal com-
plexes involves formation of a coordinated ligand radical bound to the helix that
directly abstracts a hydrogen atom from the sugar ring. The photoreaction of
Rh(phenhphP + (phi = 9, lO-phenanthrenequinone diimine) exemplifies this
strategy.30 Here photolysis promotes a ligand-to-metal charge transfer with for-
mation of a phi-centered radical. Isotope-labeling studies and product analysis
have shown that this phi radical bound intercalatively in the major groove of
DNA directly abstracts the C3'-H (which sits in the major groove of the he-
lix); 31 subsequent hydroxylation or dioxygen addition at this position promotes
DNA strand scission without base treatment.
Some potent photooxidants can also produce outer-sphere electron transfer
from the DNA. Here it is the guanine bases, likely those stacked with neigh-
boring purines, that are most easily oxidized and hence most susceptible to
attack. Again, this base modification requires alkaline treatment to convert the
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lesion to a strand breakage. Ilb,n The DNA double helix can furthermore also
mediate electron-transfer reactions between bound metal complexes. The DNA
polymer has, for example, been shown to catalyze photoinduced electron-trans-
fer reactions between Ru(phenh 2 + and Co(phenh3+ bound along the DNA
strand. 32 Table 8.1 summarizes different redox reactions of metal complexes
bound to DNA.
2. Hydrolytic chemistry
Hydrolysis reactions of nucleic acids mediated by metal ions are important
elements in natural enzymatic reactions; chemists would like to exploit them in
the design of artificial restriction endonucleases. 33 Hydrolysis reactions of the
phosphodiester linkage of polynucleotides appear preferable to redox-mediated
cleavage reactions, since in the hydrolytic reaction all information is preserved.
In redox cleavage by sugar oxidation, for example, both a sugar fragment and
free nucleic-acid base are released from the polymer, and, in contrast to hydro-
lytic chemistry, the direct religation of the fragments becomes practically im-
possible.
Table 8.1
Examples of metal complexes that cleave DNA through redox chemistry.
Complex Target" Chemistryb Diffusibility' DNA Bindingd Site Selectivity'
Fe(EDTA)2- sugar OH', Fenton diffusible none none
MPE-Fe(II) sugar OH', Fenton diffusible sequence-neutral none
(C4'-H)
Co(NH3)63+ * base photoelectron hydrogen-bonding 5'-G-pur-3'
transfer
Cu(phenh + sugar Cu 2+-OH' slight AT-rich AT-rich
Mn-Porphyrin sugar M=O none AT-rich AT-rich
U(02)(N03h* f diffusible none
Ru(TMP)32+ * base 102 diffusible A-form A-form, G
Ru(phen)/+ * base 102 diffusible sequence-neutral G
CO(DIP)33 + * sugar ligand radical none Z-form (non-B) Z-form (non-B)
Rh(DIP)33+ * sugar ligand radical none Z, cruciforms Z, cruciforms
Rh(phenhphi 3+ * sugar ligand radical none open major groove 5' -pyr-pyr-pur-3'
(C3'-H)
Rh(phihbpy3+ * sugar ligand radical none sequence-neutral none
(C3'-H)
a DNA may be modified by attack either at the sugar or at the nucleotide base position.
b The reactive species involved in DNA cleavage, if known.
C Some reactive species are diffusible, producing broad patterns of DNA damage along the strand. Others are nondiffusi-
ble, resulting in cuts at single discrete sites.
d The site of metal complex binding to DNA, if known.
e The sites cleaved by the metal complex.
I Not known.
* Indicates an excited-state reaction requiring photoactivation.
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Metal ions can be effective in promoting hydrolysis of the phosphodiester,
since they can function as Lewis acids, polarizing the phosphorus-oxygen bond
to facilitate bond breakage, and can also deliver the coordinated nucleophile to
form the pentacoordinate phosphate intermediate. Figure 8.6 illustrates one crys-
tallographically characterized model system developed by Sargeson and cowork-
ers, where hydrolysis of a model phosphodiester was enhanced dramatically by
taking advantage of both the acidic and the nucleophilic characteristics of the
bound cobalt(III) species. 34 A whole series of model systems utilizing both co-
balt and zinc ions has been designed to explore the hydrolytic reactions of sim-
ple phosphodiesters. 35 This strategy coupled to a DNA binding functionality has
also been exploited, albeit inefficiently, in the hydrolytic cleavage of double-
helical DNA by Ru(DIPhMacro with Zn 2 +, Cd 2 +, or Pb 2 + added in situ. 36 In
this complex (see Figure 8.6), the central portion of the molecule, held together
by the ruthenium(II), is responsible for DNA binding. Tethered onto the coor-
dinatively saturated ruthenium complex are two diethylenetriamine functionali-
ties (in the Macro ligand), however, and these serve to coordinate hydrolytically
active metal ions such as Zn(II) and Co(II) , which promote DNA hydrolysis
once delivered to the sugar-phosphate backbone by the DNA-binding domain.
Perhaps simpler and certainly better understood are the hydrolytic reactions
of RNAs mediated by metal ions. More than twenty years ago Eichhorn and
coworkers showed that simple metal ions such as Zn(II) and Pb(II) promote the
hydrolysis of RNA. 37 Figure 8.6 illustrates also the crystallographically charac-
terized site-specific hydrolyis in tRNA by plumbous ion. 38 In tRNA, Pb(II) oc-
cupies three quite specific high-affinity binding sites, and at one of these sites,
the metal ion becomes poised to promote strand cleavage. The crystal structure
with bound Pb 2 + suggests that the lead-coordinated hydroxide ion deprotonates
the 2'-hydroxyl of one residue, so that the resulting 2'-oxygen nucleophile may
attack the phosphate to give a pentavalent intermediate that decays to form the
2' ,3' -cyclic phosphate and, after reprotonation, the 5' -hydroxide. This very spe-
cific cleavage reaction is already being used by biologists as a tool in probing
structures of mutant tRNAs, since the reaction is exquisitely sensitive to the
stereochemical alignment of the nucleic-acid residues, phosphate backbone, and
associated metal ion. In hydrolytic reactions on RNA, it is commonly con-
sidered, though certainly not established, that the job of the metal ion may be
simpler than with DNA, since the ribose provides a nearby nucleophile already
in the 2'-hydroxide. The reaction of tRNA with Pb(II) nonetheless illustrates
how a metal ion may be utilized in promoting highly specific chemistry on a
nucleic-acid polymer.
Last, it must be mentioned that metal coordination to the purine N7 position
can also indirectly promote strand cleavage, although not through direct hydro-
lytic reaction on the sugar-phosphate backbone. Metal ions such as Pd 2+ and
Cu 2+ , through coordination at N7, promote depurination. The depurinated site
then becomes easily susceptible to hydrolysis upon treatment with mild base.
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Hydrolysis reactions catalyzed by metal ions and complexes. (A) Illustration of a phosphate es-
ter hydrolysis in a binuclear model complex catalyzed by coordinated cobaltic ions, with one
metal ion functioning as a Lewis acid and the other functioning to deliver the coordinated hy-
droxide. 34 (B) Ru(DIPhMacro, a metal complex constructed to contain a central DNA-binding
domain (Ru(DIP)32+) with two tethered amine arms to chelate additional metal ions (Zn 2 +) to
deliver to the sugar-phosphate backbone and promote hydrolytic strand cleavage. 36 (C) RNA
site-specificially hydrolyzed by lead ion. Diagram of the proposed mechanism of sugar-phos-
phate backbone cleavage between residue D17 and GI8 in yeast RNA Phe.38
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III. A CASE STUDY: TRIS(PHENANTHROLlNE) METAL COMPLEXES
Now we may examine in detail the interaction of one class of metal complexes
with nucleic acids, how these complexes bind to polynucleotides, the techniques
used to explore these binding interactions, and various applications of the com-
plexes to probe biological structure and function. Tris(phenanthroline) metal
complexes represent quite simple, well-defined examples of coordination com-
plexes that associate with nucleic acids. Their examination should offer a useful
illustration of the range of binding modes, reactivity, techniques for study, and
applications that are currently being exploited and explored. In addition, we
may contrast these interactions with those of other transition-metal complexes,
both derivatives of the tris(phenanthroline) family and also some complexes that
differ substantially in structure or reactivity.
A. Binding Interactions with DNA
Tris(phenanthroline) complexes of ruthenium(II), cobalt(III), and rhodium(III)
are octahedral, substitutionally inert complexes, and as a result of this coordina-
tive saturation the complexes bind to double-helical DNA through a mixture of
noncovalent interactions. Tris(phenanthroline) metal complexes bind to the dou-
ble helix both by intercalation in the major groove and through hydrophobic
association in the minor groove. ll b,40 Intercalation and minor groove-binding
are, in fact, the two most common modes of noncovalent association of small
molecules with nucleic acids. In addition, as with other small molecules, a non-
specific electrostatic interaction between the cationic complexes and the DNA
polyanion serves to stabilize association. Overall binding of the tris(phenanthroline)
complexes to DNA is moderate (log K = 4).41
The extent of intercalative versus groove binding is seen to depend upon
environmental conditions, such as temperature and ionic strength, the charge of
the metal center, and the DNA base sequence; groove binding is favored at
AT-rich sequences. 41 Second-generation mixed-ligand derivatives of the
tris(phenanthroline) series have been prepared, and their interactions with DNA
have provided useful insight into the factors important for promoting either in-
tercalation or groove binding. 42 Aromatic heterocyclic ligands with increased
surface areas that are planar bind DNA with increasing avidity through interca-
lation, irrespective of the charge on the metal center. Intercalative binding con-
stants greater than 10 7 M ~ 1 can be easily achieved with planar heterocyclic
ligands that jut out from the metal center. Not surprisingly, complexes contain-
ing ligands of increasing hydrophobicity that are not planar favor minor-groove
binding. 28
Critically important as well in determining the binding mode is the chirality
of the metal complex. 40 Intercalation into the right-handed helix favors the Ll-
isomer, whereas groove binding favors the A-isomer. Figure 8.7 illustrates these
symmetry-selective interactions. In intercalation, we consider that one phenan-
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Figure 8.7
Enantiomeric discrimination in binding to DNA. Shown above is the basis for the preference for
Ll-Ru(phenh 2 + upon intercalation and A-Ru(phen)3 2 + for surface binding against a right-handed
helix. With intercalation (top) the symmetry of the metal complex matches the symmetry of the
helix; steric interactions preclude a close association of the A-isomer. With groove binding (bot-
tom), where the metal complex binds against the minor-groove helical surface, complementary
symmetries are required, and it is the A-isomer that is preferred.
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throline inserts and stacks in between the base pairs, essentially perpendicular
to the helix axis. For the ~-isomer, once intercalated, the ancillary non-inter-
calated ligands are aligned along the right-handed groove of the helix. For the
A-isomer, in contrast, with one ligand intercalated, the ancillary ligands are
aligned in opposition to the right-handed groove, and steric interactions become
evident between the phenanthroline hydrogen atoms and the phosphate oxygen
atoms. Increasing the steric bulk on these phenanthrolines furthermore increases
the enantioselective preference for intercalation of the ~-isomer. 40,43 For inter-
calation, then, the chiral discrimination depends on matching the symmetry of
the metal complex to that of the DNA helix. For groove binding, where the
metal complex is thought to bind against the helix, instead it is a complemen-
tary symmetry that is required. In our model for groove binding of the
tris(phenanthroline) metal complex, two phenanthroline ligands are likely bound
against the right-handed helical groove, stabilized through hydrophobic associ-
ation. For the A-isomer, bound in this fashion, the ligands lie against and com-
plement the right-handed groove; with the ~-isomer, the ligands oppose the
groove, and no close surface contacts are made.
Intercalation of metal complexes in DNA is not uncommon. Lippard and
coworkers first established metallointercalation by Pt(II) complexes in the
1970s. 18.20 Square-planar platinum(II) complexes containing the terpyridyl li-
gand were shown to intercalate into DNA. In an elegant series of x-ray diffrac-
tion experiments on DNA fibers, Lippard illustrated the requirement for planar-
ity in the complex. 18,44 Although (phen)Pt(en)2+ and (bpy)pt(en)2+ were shown
to intercalate into the helix, (pyrhPt(en)2+ , with pyridine ligands rotated out of
the coordination plane, could not. Complex planarity is in itself insufficient to
promote intercalation, however. Cis-(NH3hPtCI2 or even cis-(NH3hPt(en)2+ does
not appear to intercalate into a helix, despite full planarity. Instead, aromatic
heterocyclic ligands must be included in order to promote dipole-dipole inter-
actions with the heterocyclic bases stacked in the helix. Indeed, planarity of the
full complex is not required. Intercalation is not restricted to coordination com-
plexes that are square planar. The tris(phenanthroline) complexes represented
the first examples of "three-dimensional intercalators" and illustrated that oc-
tahedral metal complexes could also intercalate into the helix. 40,45,46 Here one
can consider the partial intercalation of one ligand into the helix, providing the
remaining ligands on the complex an opportunity to enhance specificity or reac-
tivity at a given site.
Curiously, one unique and apparently general characteristic of metallointer-
calators is their preference for intercalation from the major groove of the helix.
Most small molecules associate with DNA from the minor groove, but metal-
lointercalators, both those that are square planar, such as (terpyri-
dyl)platinum(II) complexes, and those that are octahedral, such as the
tris(phenanthroline) metal complexes, appear to intercalate into the major groove.
This then mimics quite well the association of much larger DNA-binding pro-
teins with the helix; DNA regulatory proteins generally appear to target the
major groove. The reason why metallointercalators favor major groove associa-
tion is still unclear.
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Figure 8.8
Some metal complexes that bind DNA noncovalently primarily through intercalation
(top) or binding in the minor groove (bottom). Some metalloporphyrins also primarily
associate via intercalation.
Transition-metal complexes with aromatic ligands also generally associate
by minor-groove binding or through the mix of intercalative and groove-bound
interactions. Cu(phenh + , a tetrahedral complex, appears to favor minor-groove
binding over intercalation. 26 Perhaps the tetrahedral coordination does not per-
mit appreciable overlap of the phenanthroline ring with the bases in an interca-
lative mode. Metalloporphyrins, despite their large expanse and the presence
commonly of nonplanar substituents, appear to bind to double-helical DNA both
by intercalation and by minor-groove binding at AT-rich sequences. 47 Occupa-
tion of the porphyrins by transition-metal ions, such as Cu(II), which bind axial
ligands, leads to the favoring of groove binding over intercalation. Figure 8.8
illustrates some of the complexes that bind DNA noncovalently.
The tris(phenanthroline) metal complexes themselves do not offer an illus-
tration of hydrogen-bonding interactions with the helix, since these ligands lack
hydrogen-bonding donors and acceptors, but as mentioned already, hydrogen
bonding of coordinated ligands to the helix can add some measure of stabiliza-
tion, comparable to, but likely no greater in magnitude than, that provided by
intercalative stacking, hydrophobic, or dispersive interactions. Indeed, mixed-
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ligand derivatives of the phenanthroline complexes have been prepared that in-
clude hydrogen-bonding groups (amides, hydroxyls, and nitro substituents) on
the ancillary phenanthroline ligands, and these have shown no greater avidity
for double-helical DNA than their counterparts with hydrophobic substituents. 42
A large number of weak hydrogen-bonding interactions to DNA by one complex
can be stabilizing, however, as with, for example, hexaamminecobalt(III) or
hexaaquoterbium(III) .
Tris(phenanthroline) metal complexes also do not offer an opportunity to
explore covalent binding interactions with the helix in greater detail, but these
interactions are, in fact, a major focus of Chapter 9, concerned with the mode
of action of cisplatin. One derivative of the tris(phenanthroline) series,
Ru(phenhClz, has been shown to bind to DNA covalently.48 In aqueous solution
the dichlororuthenium(II) complex undergoes hydrolysis to form an equilibrium
mixture of bis(phenanthroline) diaquo and chloroaquo species. These species
bind covalently to DNA, with preferential reactivity at guanine sites. It is inter-
esting that the same structural deformations in the DNA evident upon bind-
ing cis-diammineplatinum units become apparent upon coordination of
bis(phenanthroline)ruthenium(II). It is also noteworthy that the chiral preference
in coordination is for the A-isomer. As with groove binding, direct coordination
to base positions requires a complementary symmetry, with the the A-isomer
binding against the right-handed groove. This preference for the A-isomer re-
affirms that, rather than noncovalent intercalation (which would favor the ~­
isomer), covalent binding dominates the interaction. The energetic stabilization
in direct coordination of the ruthenium(II) center is certainly more substantial
than the weaker stabilization derived from intercalation. Rh(phenhCl2+ and its
derivatives have also been shown to bind covalently to DNA but only upon
photoactivation, since light is needed to promote dissociation of the coordinated
chloride and substitution of the nucleic acid base as a ligand. 49
B. Techniques to Monitor Binding
Many of the same techniques employed in studying the basic chemistry of co-
ordination complexes can be be used in following the binding of transition-metal
complexes to nucleic acids, but biochemical methods, with their often exquisite
sensitivity, become valuable aids as well in delineating specific binding inter-
actions. Tris(phenanthroline) metal complexes are particularly useful to illustrate
this point, since here the metal center in the complex is selected in terms of the
technique used for examination.
Coordination complexes are often visibly colored, and these colorations pro-
vide a useful and sensitive spectroscopic handle in following fundamental reac-
tions. This notion holds as well with tris(phenanthroline) metal complexes in
their interactions with nucleic acids. Ru(phenh 2+ and its derivatives are highly
colored because of an intense metal-to-ligand charge-transfer band (Amax = 447 nm,
E = 1.9 X 104 M -Icm -I). Furthermore, the complexes are highly photolumi-
nescent (Aem = 610 nm, T = 0.6 f.LS in aerated aqueous solution). On binding
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to nucleic acids these transitions are perturbed. Hypochromism is observed in
the charge-transfer band, and intercalation leads to an increase in lifetime of the
charge-transfer excited state. 43 ,46 Indeed, single-photon counting experiments show
a biexponential decay in emission from Ru(phenh 2+ bound to double-helical
DNA. The longer-lived component (T = 2 fLS) has been assigned as the inter-
calated component and the shorter-lived 0.6 fLS component has been attributed
to a mixture of free and groove-bound species. These spectroscopic perturba-
tions permit one to define equilibrium-binding affinities for the different com-
ponents of the interaction as a function of metal-center chirality and under dif-
ferent solution conditions. 41 One can also follow the polarization of emitted
light from the complexes after excitation with polarized light, and these studies
have been helpful in describing the dynamics of association of the complexes
on the helix. 41 ,43 Mixed-ligand complexes of ruthenium(II) show similar spec-
troscopic perturbations, and these have been used to characterize binding affin-
ities and chiral preferences, as well as the extent of intercalation versus groove
binding as a function of ligand substitution on the metal center. 42 The spectro-
scopic handle of the metal center therefore affords a range of experiments to
monitor and characterize the binding of the metal complexes to polynucleotides.
Binding interactions of metal complexes with oligonucleotides can also be
followed by NMR, and here as well the metal center offers some useful char-
acteristics to exploit. As with organic DNA-binding molecules, shifts in the 1H_
NMR resonances of both the DNA-binding molecule and the oligonucleotide
become apparent as a function of increased association with the helix. These
shift variations can be used empirically to watch the dynamics of association
and to gain some structural insights into the binding modes of the complexes on
the helix. These kinds of experiments have been performed with
tris(phenanthroline) complexes of ruthenium(II) and rhodium(III), where it was
observed that the double-helical oligonucleotide is an exceedingly good chiral-
shift reagent to separate resonances in an enantiomeric mixture of the
tris(phenanthroline) complexes. 50 For covalent binding molecules, such as cis-
diammineplatinum(II), furthermore, the lowering of the pKa of purine positions
and therefore shifting of resonances as a function of coordination to an alternate
site has been helpful as well in assigning the sites of covalent binding on the
oligonucleotide. 51 But also in NMR experiments, special advantage can be taken
of the metal center. For tris(phenanthroline) metal complexes, 1H-NMR
experiments 52 were performed on the paramagnetic analogues, Ni(phenh 2+ and
Cr(phenh 3+. It was reasonable to assume the binding characteristics would be
identical with their respective diamagnetic analogues, Ru(II) and Rh(III); yet
paramagnetic broadening by the metal complexes of nearby resonances on the
oligonucleotide would allow one to deduce where along the helix the complexes
associate. Using this method the groove-binding interaction of the complexes
was identified as occurring in the minor groove of the helix. Figure 8.9 illus-
trates the monitoring of DNA binding by tris(phenanthroline) metal complexes
using both the luminescence characteristics of ruthenium(II) complexes and the
paramagnetic characteristics of nickel(II).
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There are numerous other classic techniques of inorganic chemistry that have
been or could be applied in studying the binding of metal complexes to nucleic
acids. Coordination complexes have invariably been used in x-ray diffraction
experiments because of the high electron density of the metal center. The
tris(phenanthroline) metal complexes have not yet been applied in this context,
but, as mentioned already, platinum metallointercalators were examined by fiber
diffraction to delineate intercalation requirements. In fact, many nucleic-acid
crystal structures have required specific metal ion additions for isomorphous
heavy-metal derivatives to solve the structure. Such has certainly been true for
the crystal structure of tRNA Phe, where heavy-metal ions such as platinum, os-
mium, and mercury were targeted to specific base positions, and lanthanide ions
were used to label phosphate positions around the periphery of the molecule. 53
Other techniques can also be exploited to monitor and characterize binding. A
recent novel illustration is one from electrochemistry, which has been applied
in monitoring the binding of Co(phenh3+ to DNA. 54 Surely other techniques,
from EXAFS to scanning tunneling microscopy, will be exploited in the future.
Biochemistry also provides very sensitive techniques that have been invalu-
able in characterizing interactions of metal complexes with nucleic acids. First
are simply gel electrophoresis experiments, which permit an assessment of changes
in the nucleic-acid conformation, through its changes in gel mobility, as a func-
tion of metal binding. A classic illustration is that of the unwinding of super-
helical DNA as a function of intercalation. Closed circular DNA has much the
same topological constraints on it as does a rope or a telephone cord; the DNA
helices can wind up in coils. We define the duplex turning in a double helix as
the secondary helical turns, and turns of the helices about one another as the
supercoils or tertiary turns. As long as a DNA double helix is closed in a circle
(form I), the total winding, that is, the total number of secondary and tertiary
turns, is fixed. Molecules with differing extents of winding have different su-
perhelical densities. In a circular molecule with one strand scission, what we
call form II (nicked) DNA, the topological constraints are relaxed, and no su-
percoils are apparent. The same, by analogy, can be said of a telephone cord
Figure 8.9 (facing page)
An illustration of two spectroscopic techniques used to probe DNA. (A) The variation in lumi-
nescence characteristics of Ru(phenh 2 + with DNA binding. Shown is the emission spectrum
of free Ru(phen)3 2 + (----), A-Ru(phenh 2 + in the presence of DNA ( ..... ), and
Il-Ru(phenh 2 + in the presence of DNA (--) illustrating the spectroscopic perturbation with
DNA binding as well as the associated enantioselectivity in binding of the complexes to the
helix. As is evident from the greater luminescence of the Il isomer on binding, it is this
Il-isomer that intercalates preferentially into the right-handed helix. (B) An application of para-
magnetic broadening by metal complexes in NMR experiments to obtain structural information
on their association with nucleic acids. Shown is the IH-NMR spectrum of d(GTGCACh with
increasing amounts of A-Ni(phen)3 2 + . Note the preferential broadening of the adenine AH2 res-
onance (7.8 ppm), indicating the association of this enantiomer in the minor groove of the helix.
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off the phone receiver, which can turn about itself to relax its many supercoils.
Now let us consider a DNA unwinding experiment, monitored by gel electro-
phoresis. Supercoiled form I DNA can be distinguished from nicked DNA (form
II) in an agarose gel because of their differing mobilities; the wound-up super-
coiled molecule moves easily through the gelatinous matrix to the positive pole,
whereas the nicked species is more floppy and thus is inhibited in its travels
down the gel. A closed circular molecule with no net supercoils ( form 10)
comigrates with the nicked species. Consider now the supercoiled molecule in
the presence of an intercalator. Since the intercalator unwinds the DNA base
pairs, the number of secondary helical turns in the DNA is reduced. In a nega-
tively supercoiled, closed circular DNA molecule, the number of supercoils must
be increased in a compensatory fashion (the total winding is fixed); hence the
total number of negative supercoils is reduced, and the molecule runs with slower
mobility through the gel. As the intercalator concentration is increased still fur-
ther, the mobility of the supercoiled species decreases until no supercoils are
left, and the species comigrates with the nicked form II DNA. Increasing the
bound intercalator concentration still further leads to the positive supercoiling
of the DNA and an increase in mobility. Figure 8.10 illustrates the experiment
with tris(phenanthroline)ruthenium(II) isomers. 46 This kind of unwinding exper-
iment is an example of the sensitivity with which DNA structural changes can
be monitored using biochemical methods; only low quantities «J-Lg) of mate-
rials are needed to observe these effects.
DNA strand scission can also be sensitively monitored, and even more im-
portantly the specific nucleotide position cleaved can be pinpointed by biochem-
ical methods. This methodology has been applied successfully in monitoring
both the efficiency of DNA strand scission by metal complexes and the specific
sites cleaved, and hence where the complexes are specifically bound on the
helical strand.
Relative extents of cleavage of DNA by different metal complexes can be
easily assayed in an experiment that is an extension of the unwinding experi-
ment described above. One simply measures the conversion of supercoiled form
I DNA to nicked form II species. One strand cleavage on the DNA circle re-
leases the topological constraints on the circular molecule and relaxes the super-
coils. Two cleavage events within 12 base pairs on opposite strands will convert
the DNA to a linear form (III), which also has a distinguishable gel mobility.
Photoactivated cleavage of DNA by tris(phenanthroline) complexes of co-
balt(lIl) and rhodium(III) was first demonstrated using this assay. 55.56 Given the
high sensitivity of this assay, redox-mediated cleavage of DNA by a wide range
of metal complexes can be easily demonstrated. However, other techniques are
required to analyze whether appreciable and significant cleavage results, and, if
so, what products are obtained. Since the assay can monitor, in a short time
using little sample, a single nick in a full 4,000-base-pair plasmid, reactions of
very low, almost insignificant yield can be detected. The assay provides, how-
ever, a simple scheme to assess relative extents of cleavage by different metal
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Figure 8.10
The application of DNA supercoiling to probe metal-complex interactions with DNA. (A) A
schematic representation of supercoiled DNA (form I), nicked DNA (form II) that, as a result of
the single-strand scission, relaxes to a circular form lacking supercoils, and linear (form III)
DNA. (B) Plots of the relative electrophoretic mobilities of form I (.) and form II (0) DNA as
a function of increasing concentration of A-(top) and A-(bottom) Ru(phen)3 2 + in the gel. 46 In-
creasing concentrations of bound intercalator unwind the negatively supercoiled DNA. Given the
higher intercalative binding affinity of the A-isomer, slightly lower concentrations of this isomer
are needed to unwind the plasmid to a totally relaxed state (where form I and II comigrate).
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complexes, as well as a first indication that a cleavage reaction by a given metal
complex occurs at all.
More informative are experiments on 32P-labeled DNA fragments using high-
resolution polyacrylamide gel electrophoresis, since these experiments allow one
to find the exact nucleotide where the complexes break the sugar-phosphate
backbone. Consider a cleavage reaction by a given metal complex on a DNA
fragment of 100 base pairs in length that has been labeled enzymatically with
32p on one end of one strand. If the metal complex cleaves the DNA at several
different sites, then one can arrive at conditions where full cleavage is not ob-
tained, but instead a population of molecules is generated where single cleavage
events per strand are obtained, and cleavage at each of the sites is represented.
After denaturation of the fragment, electrophoresis through a high-density poly-
acrylamide gel, and autoradiography, only f~agments that are radioactively end-
labeled are detected, and hence the population of sites cleaved is determined.
The denatured cleaved fragments move through the gel according to their mo-
lecular weight. By measuring their length, using molecular-weight markers, one
can find the specific position cleaved relative to the end of the fragment. By this
route the specific sites cleaved by a molecule that binds and cleaves DNA, or
end-labeled RNA, at unique positions may be identified. In a complementary
experiment, using footprinting, where a molecule cleaves DNA nonspecifically
at all sites along a fragment, one can find the binding positions of other mole-
cules such as DNA-binding proteins. In this experiment, cleavage with the se-
quence-neutral cleaving reagent is carried out both in the presence and in the
absence of the other binding molecule. In the absence of the protein, cleavage
ideally occurs at all sites; hence a ladder of cleaved fragments is apparent on
the autoradiograph. If cleavage is carried out in the presence of the protein,
however, those sites that are bound by the protein are protected from cleavage
by steric considerations, producing a shadow or footprint of the protein-binding
site on the gel. Both the site-specific and footprinting experiments are illustrated
schematically in Figure 8.11. This very powerful technology was first applied
by Dervan and coworkers in demonstrating the application of methidium-propyl-
FeEDTA (MPE-Fe) as a chemical footprinting reagent. 22 ,S? Tris(phenanthroline)
metal complexes have been shown to cleave DNA nonspecifically, and their
derivatives have been applied either as sensitive photofootprinting reagents, or
as site-specific cleaving molecules, as we will see.
IV. APPLICATIONS OF DIFFERENT METAL COMPLEXES
THAT BIND NUCLEIC ACIDS
Both the spectroscopy and the chemical reactivity of transition-metal complexes,
coupled to biochemical assays, can therefore be exploited to obtain a wide range
of useful reagents to probe nucleic acids. Here some specific applications are
described.
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Figure 8.11
DNA cleavage by metal complexes. Shown schematically is the method used with single-base
resolution to discover the sites where metal complexes are bound on double helical DNA. After
the metal complex is bound to several sites on a radioactively end-labeled (*) DNA fragment
and activated to permit strand cleavage at the binding sites, the nicked DNA is denatured and
electrophoresed on a high-resolution polyacrylamide gel, and the gel submitted to autoradiogra-
phy. From the molecular weights of the end-labeled denatured fragments, the positions of cleav-
age and therefore binding by the metal complex may be deduced. The results in lane A show
the cleavage pattern observed for a metal complex that binds to a specific site. The results in
lane B show cleavage observed for a nonspecifically bound metal complex that binds and there-
fore cleaves at every base site. Lane C illustrates a footprinting experiment. When protein is
bound to DNA at a specific site, it protects the DNA from cleavage by the metal complex at its
binding site, thus producing a "footprint" in the gel: the absence of end-labeled fragments of
those lengths that are protected from cleavage as a result of protein binding.
A. Spectroscopic Probes
As discussed above, the tris(phenanthroline)ruthenium(II) complexes offer a novel
spectroscopic probe of nucleic acids, since their luminescence is increased upon
intercalation into the double helix. As a result the complexes provide a simple
luminescent stain for DNA in fluorescent microscopy experiments. More inter-
esting, perhaps, is the conformational selectivity of derivatives of tris(phenanthro-
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line)ruthenium. Ru(DIPh 2 + (DIP = 4,7-diphenyl-l,1O-phenanthroline) shows
enantiospecificity in binding to B-form DNA. 40 Because of the steric bulk of
the phenyl rings, detectable binding is seen only with the ~-isomer in a right-
handed helix; no binding is evident with the A-isomer. But with the left-handed
Z-form helix, both isomers bind avidly.40,58 The shallow left-handed major groove
can accomodate the two enantiomers, A left-handed but more B-like helix shows
selectivity instead for the A-isomer. Spectroscopic experiments that measure the
chiral selectivity of Ru(DIPh 2 + isomers in binding to a given DNA then pro-
vide a novel probe for helical handedness. Indeed, A-Ru(DIPh 2+ was the first
spectroscopic probe for Z-DNA (or other alternate conformations that are suffi-
ciently unwound to permit binding by the bulky left-handed isomer).58
Another set of derivatives of the tris(phenanthroline) metal complexes that
may become exceedingly useful as spectroscopic probes are Ru(bpYhdppz 2+
and Ru(phenhdppz 2+ (dppz = dipyridophenazine).59 In these complexes the
metal-to-ligand charge transfer is preferentially to the electron-accepting dppz
ligand. In nonaqueous solutions, the complexes luminesce. However, in aqueous
solution at pH 7, no luminescence is observed, likely because hydrogen bonding
by water to the phenazine nitrogen atoms quenches the charge-transfer excited
state. But the dppz ligand is also an expansive, aromatic heterocyclic ligand,
and as a result both Ru(bpyhdppz 2+ and Ru(phenhdppz 2+ bind avidly to DNA
by intercalation. Once intercalated, the phenazine ligand is protected from water.
Therefore these complexes are luminescent when intercalated into DNA, whereas
no luminescence is apparent from the complexes in the absence of DNA in
aqueous solution. The enhancement factor is > 104 with DNA. One might con-
sider the ruthenium complexes as true "molecular light switches" for DNA.
Both simpler bipyridyl and phenanthroline derivatives as well as dppz com-
plexes of ruthenium are currently being tethered onto other DNA binding moie-
ties, in particular onto oligonucleotides, so as to develop new, nonradioactive
luminescent probes for DNA sequences. These transition-metal complexes may
provide the basis for the development of new families of DNA diagnostic agents,
and many industrial laboratories are currently exploring routes to accomplish
these goals. Figure 8.12 illustrates A-Ru(DIPh 2+ and Ru(bpYhdppz 2+, two
complexes whose luminescence properties can be employed to probe nucleic
acids.
Other transition-metal complexes besides those of ruthenium have shown
some promise in spectroscopic applications with nucleic acids. Lanthanide ions
have been applied both in NMR experiments and in luminescence experiments
to probe tRNAs, and more recently with synthetic DNAs of differing sequence
and structure. 60 Lanthanide ions have been exceedingly useful in probing Ca 2+
binding sites in proteins, and one would hope that a parallel utility would be
achieved with nucleic acids. Their poor absorptivity have made luminescent
experiments difficult, however, requiring relatively high concentrations of ma-
terial. Nonetheless, the sensitivity of luminescent lifetimes to coordination and
indeed solvation is providing a novel spectroscopic handle to explore binding
sites and structures of the macromolecules. Another quite novel luminescent
2+
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Figure 8.12
Two spectroscopic probes of nucleic acids: A-Ru(DIP)/+ and Ru(bpYhdppz2+.
handle has been phenanthroline and diphenylphenanthroline complexes of cop-
per(I).61 These complexes are extremely valuable cleavage probes, as we will
see later; to characterize better their interactions with the helix, luminescence
experiments are being explored. A problem here has been the nonphysiological
conditions necessary to achieve detectable luminescence. Nonetheless, studies
with the copper complexes demonstrate how the whole range of transition-metal
chemistry and spectroscopy is beginning to be applied in sorting through nu-
cleic-acid interactions.
B. Metallofootprinting Reagents
Probably the most widespread application of metal nucleic-acid chemistry in the
biology community has been the utilization of metal complexes for chemical
footprinting. The footprinting technique (Figure 8.11) was developed by
biologists 62 as a means of locating protein-binding sites on DNA. 32P-end-la-
beled double-stranded DNA fragments could be digested with a nuclease, such
as DNAse, in the presence or absence of DNA-binding protein. After electro-
phoresis of the denatured digests and autoradiography, one would find a "foot-
print," that is, the inhibition of cleavage by DNAse, at the spot bound by
protein, in comparison to a randomly cleaved pattern found on the DNA in the
absence of binding protein. Although DNAse is still widely used, this footprint-
ing reagent has some disadvantages: (i) the nuclease is not sequence-neutral in
its cleavage, resulting in lots of noise in the footprinting background; and (ii)
since the nuclease is itself a large protein, its ability to provide high-resolution
footprinting patterns of smaller molecules is quite limited.
Several metal complexes now serve as high-resolution, sequence-neutral
chemical footprinting reagents. Some of these reagents are shown in Figure
8.13. The first, as mentioned previously, was MPE-Fe(II)Y The complex con-
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Figure 8.13
Examples of metallofootprinting reagents. Rh(phihbpy3+, a photofootprinting intercalator, and
MPE-Fe(II), a sequence-neutral intercalating agent.
tains a sequence-neutral DNA binding moiety, the intercalator methidium, and
a tethered DNA redox cleaving moiety, Fe(EDTA). The methidium, in binding
nonspecifically to DNA, delivers the hydroxyl radicals, generated via Fenton
chemistry at the Fe(II) center in the presence of peroxide and a reducing agent,
to the DNA backbone in a random manner. Since the complex is small, high
resolution can be achieved. Indeed, MPE-Fe(II) has been shown to footprint
small natural products that bind to DNA, in addition to footprinting much larger
DNA-binding peptides and proteins.
Perhaps simpler still and now very widely used as a footprinting reagent is
Fe(EDTA)2- itself. 63 The concept here is that Fe(EDTA)2- , as a dianion, is
unlikely to associate at all with the DNA polyanion. Hence hydroxyl radicals,
generated via Fenton chemistry at a distance from the helix, would likely diffuse
to the helix with a uniform concentration along the helix and provide a com-
pletely sequence-neutral pattern of cleavage. Tullius and coworkers have
demonstrated 63 this to be the case. The resolution is furthermore extremely high
since the hydroxyl radical is sufficiently small that it can even diffuse within
the DNA-binding protein to delineate binding domains. Some difficulties are
found, however, with the high concentrations of activating reagents needed to
activate a cleavage reagent that does not bind to the helix, and problems of
course arise in trying to footprint metalloproteins. Nonetheless, Fe(EDTA)2- ,
a reagent easily found on the biologist's shelf, is now finding great utility in
labs as a chemical substitute for DNAse.
Other transition-metal complexes are also finding applications in chemical
footprinting. Both Cu(phenh + and manganese porphyrins have been used to
footprint DNA-binding proteins. 64,65 These complexes likely cleave DNA through
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either Fenton chemistry or direct reaction of a coordinated metal-oxo interme-
diate with the sugar-phosphate backbone. The complexes, however, appear to
bind DNA predominantly along the surface of the DNA minor groove, and with
some preference for AT-rich regions. The patterns obtained are actually quite
similar to those found with DNAse, and thus the lack of high sequence neutral-
ity is somewhat limiting. Furthermore, the complexes are most sensitive to bind-
ing moieties in the minor groove, rather than those in the major groove, where
proteins bind. Intercalators such as MPE-Fe(II) can sense binding species in
both grooves. Cu(phen)z + has nonetheless proved to be quite effective in de-
tecting hyperreactivities in the minor groove, owing to DNA structural pertur-
bations that arise from protein binding in the major groove. Whether this sen-
sitivity emanates from the intimate interaction of Cu(phen)z + in the minor groove
of the helix, or because of the characteristics of the reactive radical formed, is
not known.
Inorganic photochemistry has also been applied in developing metal com-
plexes as photofootprinting reagents. Uranyl acetate, for example, at high con-
centrations, upon photolysis, promotes DNA cleavage. 66 It is thought that the
ions interact with the phosphates, generating some excited-state radical chemis-
try, although no detailed characterization of this chemistry has been undertaken.
The cleavage reaction is nonetheless remarkably sequence-neutral and therefore
shows some promise for photofootprinting applications. In fact, the applicability
of uranyl acetate typifies how simple coordination chemistry and now even pho-
tochemistry may be helpful in the design of a variety of reagents that interact
and cleave DNA, both nonspecifically and specifically. The biochemical tech-
niques used to monitor such processes are sufficiently sensitive that even quite
inefficient reactions in solution can be harnessed in developing useful reagents.
The better our understanding of the chemistry of the coordination complex, the
more effectively it may be utilized.
The best derivative of a tris(phenanthroline) metal complex currently being
applied in footprinting experiments is Rh(phi)zbpy3+, a second-generation de-
rivative of the tris(phenanthroline) series67 that binds DNA avidly by intercala-
tion and in the presence of light promotes direct strand cleavage by hydrogen-
atom abstraction at the C3'-position on the sugar. 31 Since no diffusing interme-
diate is involved in this photocleavage reaction, the resolution of the footprint-
ing pattern is to a single nucleotide. Here the excited-state transition-metal
chemistry involves a ligand-to-metal charge transfer, producing a phi cation rad-
ical that directly abstracts the hydrogen from the sugar at the intercalated site.
The high efficiency of this photoreaction and high sequence-neutral binding of
the complex to double-stranded DNA add to the utility of this reagent in foot-
printing studies. Indeed, both DNA-binding proteins, bound in the major groove,
and small natural products, associated with the minor groove, have been foot-
printed with Rh(phi)zbpy 3 + to precisely that size expected based upon crystal-
lographic results. One may hope that this and other photofootprinting reagents
will soon find applications for footprinting experiments in vivo.
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C. Conformational Probes
Metal complexes are also finding wide application in probing the local variations
in conformation that arise along nucleic-acid polymers. X-ray crystallography
has been critical in establishing the basic conformational families of double-
helical DNA, and to some extent how conformations might vary as a function
of nucleic-acid sequence. Yet many conformations have still not been described
to high resolution, and only a few oligonucleotides have been crystallized. Other
techniques are therefore required to bridge the small set of oligonucleotide crys-
tal structures that point to plausible structures and the large array of structures
that arise as a function of sequence on long helical polymers. Furthermore, only
a very small number of RNA polymers has been characterized crystallographi-
cally; hence other chemical methods have been needed to describe the folding
patterns in these important biopolymers. Metal complexes, mainly through spe-
cific noncovalent interactions, appear to be uniquely useful in probing the struc-
tural variations in nucleic acids.
1. Nonspecific reactions of transition-metal complexes
Hydroxyl radical cleavage with Fe(EDTA) 2- illustrates again how simple
metal complexes can be used in characterizing nucleic acids. One example in-
volves efforts to describe the local structural variations in "bent" DNA. Bio-
chemists had found that DNA fragments containing runs of adenines, such as in
the tract dAAAAAA, possessed unusual gel-electrophoretic mobilities. Indeed,
kinetoplast DNA isolated from mitochondria of trypanosomes showed a remark-
able lacework pattern of structure, with loops and circles of DNA; these struc-
tures were found to be governed by the placement of these d(A)6 tracts. By
constructing a series of oligonucleotides with adenine runs positioned either in
or out of phase relative to one another, researchers found that the adenine tracts
caused a local bending of the DNA toward the minor groove. 6 But what were
the detailed characteristics of these bent sites? Using hydroxyl radical cleavage
of DNA, generated with Fe(EDTA)2- , Tullius and coworkers found a distinc-
tive pattern of cleavage across the adenine tracts, consistent with a locally per-
turbed structure. 6S Here the notion again was that Fe(EDTA)2- in the presence
of peroxide would generate hydroxyl radicals at a distance from the helix, and
thus careful densitometric analysis of the cleavage across 32P-end-Iabeled DNA
fragments would reveal any differential accessibility of sugar residues to cleav-
age mediated by the radicals caused by the bending. The cleavage patterns sug-
gested a smooth bending of the DNA across the tract and indicated furthermore
an asymmetry in structure from the 5'- to 3'-end of the adenine run.
The reactivities of other transition-metal reagents have also been used ad-
vantageously in probing nucleic-acid structures. As described in Section II, OS04
reacts across the 5,6 position of accessible pyrimidines to form a cis-osmate
ester. Upon treatment with piperidine, this base modification can yield scission
of the sugar-phosphate backbone. Hence DNAs containing unusual local con-
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formations with prominent solvent-accessible pyrimidines can be probed with
OS04. The junction regions of Z-DNA, the single-stranded loops in cruciform
structures, and a segment of the dangling third strand in H-DNA, have all been
probed by means of the differential reactivity of osmium tetroxide with DNA
sites dependent upon their accessibility. 7 ,8, 16,69 Surely other transition-metal
chemistry will become similarly applicable.
2. Transition-metal complexes as shape-selective probes
Transition-metal complexes have also been designed with three-dimensional
structures that target complementary structures along the helical polymer. This
recognition of DNA sites, based upon shape selection, has proved to be ex-
tremely useful both in demarcating and in characterizing structural variations
along the polymer and in developing an understanding of those factors important
to the recognition of specific polynucleotide sites. Complexes, basically deriva-
tives of the tris(phenanthroline) metal series, have been designed that specifi-
cally target A- and Z-form helices, cruciforms, and even subtle variations such
as differential propeller twisting within B-form DNA. lie By appropriate substi-
tution of the metal at the center of the coordinatively saturated complex, com-
plexes that cleave the DNA at the binding site are obtained. Figure 8.14 shows
some of these shape-selective conformational probes.
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Figure 8.14
Shape-selective probes that target local DNA conformations. Rh(DIPh3+, which with photo-
activation promotes double-stranded cleavage at cruciform sites; Ru(TMPh 2 +, a photoactivated
probe for A-like conformations; and Rh(phenhphi 3 +, which targets openings in the DNA major
groove.
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One example of this shape-selective cleavage is apparent in reactions of
Ru(TMPh 2 + (TMP = 3,4,7 ,8-tetramethylphenanthroline) , a probe of the
A-conformation. 28 ,29 The complex was designed by incorporating methyl groups
about the periphery of each phenanthroline ligand to preclude intercalative bind-
ing of the complex to the helix, owing to the bulkiness of the methyl groups,
and at the same time to promote hydrophobic groove binding, Importantly, how-
ever, this hydrophobic groove binding could not occur against the minor groove
of B-DNA, given the width and depth of the groove versus the size of the
complex. Instead, the shape of the complex was matched well to the shallow
minor-groove surface of an A-form helix. Binding studies with synthetic poly-
nucleotides of A, B, and Z-form were consistent with this scheme. Photolysis
of the ruthenium complex, furthermore, as with Ru(phenh 2 +, leads to the sen-
sitization of singlet oxygen, and hence, after treatment with piperidine, to strand
cleavage. Thus, photocleavage reactions with Ru(TMPh 2 + could be used to
delineate A-like regions, with more shallow minor grooves, along a helical pol-
ymer. At such sites, Ru(TMPh 2 + would bind preferentially, and upon photo-
lysis, generate locally higher concentrations of singlet oxygen to mediate cleav-
age of the sugar-phosphate backbone. This scheme revealed that homopyrirnidine
stretches along the helix adopt a more A-like conformation. 29
The targeting of altered conformations such as Z-DNA has been described
earlier58 in the context of a spectroscopic probe, A-Ru(DIPh 2 +. Substitution of
a photoredox-active metal into the core of the tris(diphenylphenanthroline) unit
leads also to a complex that both binds and, with photoactivation, cleaves at the
altered conformation. 55 Both Co(III) polypyridyl and Rh(III) polypyridyl com-
plexes have been shown to be potent photooxidants. Coupled to site-specific
DNA binding, these metal complexes, with photoactivation, become conforma-
tionally selective DNA cleavage agents. Co(DIPh3+, for example, has been
shown to cleave specifically at Z-form segments inserted into DNA plas-
mids. 55 ,70 Perhaps even more interesting, on both natural plasmids and viral
DNAs, the various sites cleaved by Co(DIPh3+, corresponding both to Z-form
sites and to other locally altered non-B-conformations, coincide with function-
ally important regions of the genome, e.g., regulatory sites, gene termination
sites, and intron-exon joints. 70,71 The altered structures recognized by the metal
complexes, therefore, appear to mark biologically important sites, those presum-
ably recognized also by cellular proteins. Cleavage studies with these metal
complexes, therefore, are providing some insight also into how Nature specifi-
cally targets and accesses the sequence information encoded along the DNA
polymer, sequence information encoded indirectly through local structure.
The most striking example of the specificity to be derived from shape-selec-
tive targeting has been given by the double-stranded cleavage induced by
Rh(DIPh 3 + at cruciforms. 72 Rh(DIPh3+, like its Co(III) and Ru(II) congeners,
binds to locally unwound, non-B-conformations such as Z-DNA, but interest-
ingly this potent photooxidant yields the specific cleavage of both DNA strands
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at cruciform sites. Lacking any crystallographic information, our understanding
of the local structure of a cruciform is poor. In these palindromic sites, a tor-
sionally strained DNA extrudes two intrastrand hydrogen-bonded helices from
the main helix (see Figure 8.2B). Clearly the structure is grossly altered and
locally unwound. Rh(DIP)33+ appears to bind into a pocket generated by the
folding of the extruded helix onto the main helix. The recognition is of this
intricately folded structure, not of the sequence used to generate the cruciform.
Studies with the transition-metal complex on different cruciforms should be use-
ful in helping to characterize this interesting tertiary DNA structure.
Shape-selective transition-metal probes have also been useful in delineating
more subtle variations in structure, such as the propeller twisting and tilting
evident in B-form DNA. 30,73 Rh(phenhphi3+ was found to target preferentially
sites in the major groove where the DNA base pairs are more open; this pref-
erential recognition arises from the steric constraints at more-closed intercalation
sites because of the bulkiness of the ancillary phenanthroline ligands above and
below the intercalation plane. Two straightforward structural perturbations that
lead to an opening of the major groove involve the propeller twisting of bases
with respect to one another and the tilting of base pairs along the helix. Chiral
discrimination in cleavage by Rh(phen)2phj3+ is now being used quantitatively
to discriminate among these structural parameters. The goal in these studies is
to use cleavage results with the shape-selective metal complexes to describe the
three-dimensional structure of a long double-helical DNA sequence in solution.
Probing structurally well-defined sequences with a whole family of shape-selec-
tive metal complexes may provide a route to this goal.
As mentioned above, describing the three-dimensional structures of RNAs
is an even more complicated task than it is for double-stranded DNAs. Only a
few tRNAs have been characterized crystallographically to high resolution, and
for other larger RNA structures, such as 5S RNA, or any of the catalytic inter-
vening-sequence RNAs, little is known about their folding characteristics. To
understand the regulation and catalytic functions of these biopolymers, we need
to develop chemical tools to explore these structures. Figure 8.15 shows the
results of cleavage studies using the variety of transition-metal probes on tRNA Phe.
Hydroxyl-radical cleavage mediated by Fe(EDTA)2- reveals the protection of
solvent-inaccessible regions, the "inside" of the molecule. 23 MPE-Fe(II) ap-
pears to demarcate the double-helical regions,74 Cu(phen)2 + shows the looped-
out single-stranded segments,75 and Rh(phenhphi 3+ seems to delineate those
regions involved in triple-base interactions, the sites of tertiary folding. 76 Taken
together, the full structure of the tRNA can be described based upon cleavage
data with transition-metal complexes. It therefore seems as if this full family of
coordination complexes might be generally useful in delineating RNA struc-
tures. Still more work is needed quantitatively to compare the patterns obtained
with the few well-characterized structures. Nonetheless, an important role for
these and possibly other transition-metal reagents is indicated.
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Figure 8.15
The diversity of cleavage sites for metal complexes on tRNA Phe. In (A) is shown cleavage by
probes that primarily detect features of RNA secondary structure. Cu(phenh + (arrows), detect-
ing single-stranded regions and MPE-Fe(II) (black dots), detecting double-helical segments. In
(B) are shown probes that detect protected or more complex structures on tRNA. Inaccessible
sites protected from OR· after treatment with Fe(EDTA)2- are shown as shaded portions of the
molecule, and specific cleavage by Rh(phen)z(phi)3+ at tertiary folds is indicated by the cir-
cles. llh
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D. Other Novel Techniques
Transition-metal ions can also be used advantageously tethered onto peptides,
proteins, oligonucleotides, and other natural products, to provide a chemical
probe for their binding interactions with nucleic acids. This strategy, termed
affinity cleavage, was developed by Dervan and coworkers in preparing and
characterizing distamycin-Fe(II)EDTA. 24 Distamycin is a known natural product
that binds in the minor groove of DNA at AT-rich sequences. By tethering
Fe(II)EDTA onto distamycin, the researchers converted the DNA-binding moiety
into a DNA-cleaving moiety, since, as with MPE-Fe(1I), in the presence of
peroxide and a reductant, hydroxyl radical chemistry would be delivered to the
distamycin binding site. Unlike MPE-Fe(II) , however, the distamycin moiety
shows preferential binding at some sites along the polymer, and hence only at
those sites would the local hydroxyl-radical concentration be increased and
cleavage be obtained. As a result the tethered Fe(EDTA)2- could be used as a
cleavage probe, marking sites of specific binding.
Affinity cleaving has been generalized so that now Fe(EDTA)2 - can be
tethered onto both oligonucleotides and peptides to follow their interactions with
nucleic acids. The sequence-specific binding of oligonucleotides to double-heli-
cal DNA through triple-helix formation is but one of many examples where the
tethering of Fe(EDTA)2- has been applied advantageously. 77
Other redox-active metals can be incorporated into DNA-binding moieties
as well. Schemes have been developed to functionalize accessible lysine resi-
dues on DNA-binding repressor proteins with phenanthrolines, so that in the
presence of copper ion, peroxide, and a reductant, the phenanthroline-bound
copper on the protein would induce DNA strand cleavage. Through this scheme,
again the conversion of a DNA-binding moiety into a cleaving moiety by incor-
poration of a redox-active metal, the specific binding sites of repressor proteins
can be readily identified (far more quickly on large DNA than through footprint-
ing).78
Another scheme, which perhaps takes advantage more directly of bioinor-
ganic chemistry, involves engineering redox metal-binding sites into DNA-bind-
ing proteins and peptides. The DNA-binding domain of the protein Hin recom-
binase was synthesized chemically, and first, to examine the folding of the peptide
on the DNA helix, EDTA was tethered onto the peptide for Fe(II) cleavage
experiments. 79 But as is illustrated repeatedly in these chapters, Nature has al-
ready provided amino-acid residues for the chelation of metal ions into proteins.
Thus the DNA-binding domain of Hin recombinase was synthesized again, now
including at its terminus the residues Gly-Gly-His, a known chelating moiety
for copper(II).80 This chemically synthesized peptide, with now both DNA-binding
and DNA-cleaving domains, as illustrated in Figure 8.16, specifically promotes
cleavage at the Hin recombinase binding site in the presence of bound copper
and ascorbate. Interestingly, the addition of nickel(II) also leads to specific strand
cleavage, without diffusible intermediates. Using this approach, taking advan-
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Figure 8.16
A schematic of a synthetic DNA-cleaving peptide bound to DNA that was constructed by syn-
thesis of the DNA-binding domain of Hin Recombinase with Gly-Gly-His at the N-terminus to
coordinate copper. 80 Reproduced with permission from Reference 80.
tage of the chelating abilities of amino acids and the cleaving abilities of differ-
ent metal ions, one may prepare new synthetic, functional metalloproteins that
bind and react with DNA.
V. NATURE'S USE OF METAL/NUCLEIC-ACID INTERACTIONS
In the context of what we understand about the fundamental interactions and
reactions of metal ions and complexes with nucleic acids, and also in compari-
son to how chemists have been exploiting these interactions in probing nucleic
acids, we can also consider how Nature has taken advantage of metal ions in
the construction of metalloproteins, nucleic-acid assemblies, and smaller natural
products containing metal ions that interact with DNA and RNA.
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A. A Structural Role
One of the chief functions attributed to metal ions in biological systems is their
ability to provide a structural center to direct the folding of a protein. Just as
shape-selective recognition has been helpful in targeting metal complexes to
specific sites on DNA, it appears that one element of the recognition of sites by
DNA regulatory proteins may also involve the recognition of complementary
shapes. Furthermore, metal ions appear to be used in these proteins to define
the shape or folding pattern of the peptide domain that interacts specifically with
the nucleic acid.
The DNA-binding metalloproteins that have received the greatest attention
recently have been the "zinc-finger" regulatory proteins. It was discovered in
1983 that zinc ions played a role in the functioning of the nucleic acid-binding
transcription factor IlIA (TFIIIA) from Xenopus laevis, which binds specifically
both DNA, the internal control region of the 5S rRNA gene, and RNA, the 5S
RNA itself. 81 The protein (actually the 7S storage particle) was found to contain
two to three equivalents of zinc ion. Dialysis removed both the associated zinc
ions and the nucleic-acid-binding ability of the protein. Importantly, treatment
with zinc ion, or in later studies with higher concentrations of Co 2+ , restored
the specific binding ability. Hence, zinc ion was shown to be functionally im-
portant in these eukaryotic regulatory proteins.
The notion of a "zinc-finger structural domain" was first provided by Klug
and coworkers, after examination of the amino-acid sequence in TFIIIA. 82 It
was found that TFIIIA contained nine imperfect repeats of a sequence of ap-
proximately 30 amino acids, and furthermore that each repeat contained two
cysteine residues, two histidine residues, and three hydrophobic residues, in
conserved positions. In addition, subsequent metal analyses were revealing higher
zinc contents (7 to 11 equivalents) associated with the protein, and protein-
digestion experiments indicated that several repeated structural domains existed
in the protein. The two cysteine thiolates and two histidine imidazoles in each
repeated domain could certainly serve to coordinate a zinc ion. Thus it was
proposed that each peptide repeat formed an independent nucleic-acid-binding
domain, stabilized in its folded structure through coordination of a zinc ion. The
peptide unit was termed a "zinc finger," which is illustrated schematically in
Figure 8.17. TFIIIA was therefore proposed to contain nine zinc fingers, which
would cooperatively bind in the internal control region of the 5S RNA gene.
An enormous number of gene sequences from a variety of eukaryotic regu-
latory proteins was then found to encode strikingly similar amino-acid se-
quences,83 and many were dubbed zinc-finger proteins. The bioinorganic chem-
ist, however, should be aware that chemical analyses supporting such assignments
are first required. Nonetheless, several legitimate examples of eukaryotic nu-
cleic-acid-binding zinc-finger proteins containing multiple zinc-binding peptide
domains have emerged since the first study of TFIIIA, including the proteins
Xfin from Xenopus, the Kruppel protein from Drosophila, the Spi transcription
factor, and human testes-determining factor. It has therefore become clear that
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Figure 8.17
(A) A schematic of a zinc-finger peptide domain. 82 (B) The proposed schematic structure of a
zinc-finger domain based on comparisons to other structurally characterized metalloproteins 85
the zinc-jinger domain represents a ubiquitous structural motif for eukaryotic
DNA-binding proteins. 84
What is the structure of a zinc finger, and how is this structure important
for binding a specific nucleic-acid site? Based on a search of crystallographic
databases for metalloproteins and an examination of the consensus sequence
emerging for zinc fingers (that is, which residues were truly conserved and com-
mon to the different putative zinc fingers), Berg proposed a three-dimensional
structure for a zinc finger, shown schematically in Figure 8.17. 85 The proposed
structure included the tetrahedral coordination of zinc by the two cysteine and
histidine residues at the base of the finger and an a-helical region running al-
most the length of the domain. EXAFS studies also supported the tetrahedral
zinc site. Since this proposal, two detailed two-dimensional NMR studies have
been reported that are consistent with the tetrahedral zinc coordination and the
a-helical segment. 86 More recently, a crystal structure of a three-finger binding
domain associated with an oligonucleotide was determined. 87 The zinc fingers
lie in the major groove of DNA, the a-helical region being within the groove.
Not surprisingly, given basic coordination chemistry, the zinc does not interact
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directly with the nucleic acid. Instead, the zinc ion must serve a structural role,
defining the folding and three-dimensional structure of the protein scaffolding
about it. This structure, defined by the metal at its center, like other coordina-
tion complexes, is able to recognize its complementary structure on the nucleic-
acid polymer.
It should also be noted that this zinc-finger structural motif is not the only
metal-containing or even zinc-containing structural motif important in nucleic-
acid-binding proteins. 88 A clearly different domain is evident in the protein GAlA,
a transcription factor required for galactose utilization in S. cerevisiae. 88a A
recent crystal structure of the protein bound to an oligonucleotide shows the
protein to bind to DNA as a dimer; each monomer contains a binuclear zinc
cluster with two zinc ions tetrahedrally coordinated by six cysteines (two cys-
teines are bridging), not dissimilar from proposed structures in metallothionein.
Still another structural motif is found in the glucocorticoid receptor DNA-bind-
ing domain. Crystallography 89 has revealed that this domain also binds DNA as
a dimer; here each monomer contains two zinc-nucleated substructures of dis-
tinct conformation. The zinc ions are each tetrahedrally coordinated to four cys-
teine residues. Likely this too represents another structural motif for proteins
that bind nucleic acids, and one again in which the metal serves a structural
role.
Lastly, one might consider why zinc ion has been used by Nature in these
nucleic-acid binding proteins. Certainly, the natural abundance of zinc is an
important criterion. But also important is the absence of any redox activity as-
sociated with the metal ion, activity that could promote DNA damage [as with
Fe(II) or Cu(II), for example]. In addition, other softer, heavier metal ions might
bind preferentially to the DNA bases, promoting sequence-specific covalent in-
teractions. Zinc ion, therefore, is clearly well-chosen for the structural center of
these various nucleic-acid-binding proteins.
B. A Regulatory Role
Metalloregulatory proteins, like the transcription factors described above, affect
the expression of genetic information through structural interactions that depend
upon the metal ions, but unlike the zinc-finger proteins, metalloregulatory pro-
teins act as triggers, repressing or activating transcription given the presence or
absence of metal ion. In some respects, even more than zinc fingers, these
systems resemble the Ca 2 + -activated proteins described in Chapter 3.
Consider the biological system that must respond to changing intracellular
metal concentrations. At high concentrations many metal ions become toxic to
the cell; hence, a full system of proteins must be synthesized that will chelate
and detoxify the bound-metal-ion pool. In order to actively engage these pro-
teins, the genes that encode them must be rapidly transcribed. But at the same
time, the DNA itself must be protected from the high concentrations of metal
ion. Hence the need for these metalloregulatory proteins, which bind DNA in
the absence of metal ion, usually repressing transcription, but in the presence of
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metal ion bind the metal ion tightly and specifically, and as a consequence
amplify transcription.
Perhaps the best-characterized metalloregulatory system thus far is the MerR
system, regulating mercury resistance in bacteria. 90 An inducible set of genes
arranged in a single operon is under the control of the metal-sensing MerR
protein, and it is this system that mediates mercury resistance. Mercury resis-
tance depends upon the expression of these genes to import toxic Hg(lI), reduce
Hg(II) to the volatile Hg(O) by NADPH, and often additionally to cleave organ-
omercurials to their corresponding hydrocarbon and Hg(II) species. The MerR
protein regulates mercury resistance both negatively and positively. As illus-
trated in Figure 8.18, MerR in the absence of Hg(II) binds tightly and sequence-
specifically to the promoter. In so doing, MerR inhibits binding to the promoter
by RNA polymerase. When Hg 2 + is added at low concentrations, the metal ion
binds specifically and with high affinity to the DNA-bound MerR, and causes a
DNA conformational change detectable by using other metal reagents as confor-
mational probes. This conformational change now facilitates the binding of RNA
polymerase and hence activates expression of the gene family.
What are the structural requirements in the metal-binding site? Certainly one
requirement is Hg(II) specificity, so that other metal ions will not also trigger
transcriptional activation. Another is high metal-binding affinity to protect the
DNA from direct coordination of the Hg(lI). The MerR protein is dimeric, and
contains four cysteine residues per monomer. Site-directed mutagenesis studies 91
have indicated that three of these four cysteine residues are needed for Hg(II)
binding, and EXAFS studies 92 have been consistent with tricoordinate ligation,
clearly a well-designed system for Hg(1I) specificity. Perhaps even more inter-
esting, the site-directed mutagenesis studies 91 on heterodimers (a mixture of
mutant and wild-type monomers) have indicated that the coordinated Hg(II) bridges
the dimer, ligating two cysteines of one monomer and one cysteine of the other.
This scheme may provide the basis also for the kinetic lability needed in a
rapidly responsive cellular system.
Model systems are also being constructed to explore metal modulation of
DNA binding. One system involves the assembly of two dipeptides linked by a
central acyclic metal-binding polyether ligand, with Fe(EDTAf tethered to
one end to mark site-specific binding. 93 In the presence of alkaline earth cations,
which induce a conformational change that generates a central macrocycle, the
linked peptides become oriented to promote sequence-specific binding in the
minor groove. In the absence of the alkaline earth ion, no site-specific binding,
or cleavage of DNA, is evident. One might consider this system as a simple,
first-order synthetic model for the metalloregulatory proteins.
MerR is clearly only one natural metalloregulatory system. Other metal ions
bind regulatory factors to mediate the regulation of gene expression in a metal-
specific manner. Two examples include the Fe(II)-binding Fur protein from enteric
bacteria 94 and the copper-binding protein ACElICUP2 from S. cerevisiae. 95 Both
copper and iron are essential trace elements for which high concentrations are
toxic; for nucleic acids this toxicity is certainly the result of redox-mediated
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Figure 8.18
A model for MerR metalloregulation. 90a In the absence of MerR, RNA polymerase binds and
transcribes the MerR promoter. In the presence of MerR, the preferential binding of MerR to the
promoter is observed that inhibits transcription by the polymerase. The addition of Hg 2 + then
leads to a conformational change that promotes binding of the polymerase, substantially increas-
ing transcription. Reproduced with permission from Reference 90a.
strand damage. Other metal-specific regulatory systems are surely present as
well. Both the MerR and the synthetic system may exemplify how these various
systems function, how Nature might construct a ligand system to facilitate toxic-
metal-specific binding in the presence of DNA that then alters or triggers how
other moieties bind and access the nucleic acid.
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C. A Pharmaceutical Role
With the exception of cisplatin (see Chapter 9), most pharmaceuticals currently
being used as DNA-binding agents were first isolated as natural products from
bacteria, fungi, plants, or other organisms. For the most part they represent
complex organic moieties, including peptide and/or saccharide functionalities,
and often a unique functionality, such as the ene-diyne in calichimycin. These
natural products bind DNA quite avidly, through intercalation, groove binding,
or a mixture thereof. Often the efficacy of these antitumor antibiotics stems from
subsequent alkylation or DNA strand-cleavage reactions that damage the DNA.
Among the various natural products used clinically as antitumor antibiotics
are bleomycins, a family of glycopeptide-derived species isolated from cultures
of Streptomyces. 25 •96 The structure of bleomycin A2 is shown schematically in
Figure 8.19. The molecular mode of action of these species clearly involves
binding to DNA and the promotion of single-stranded cleavage at GT and GC
sequences. Importantly, as demonstrated by Horwitz, Peisach, and coworkers,
this DNA cleavage requires the presence of Fe(II) and oxygen. 97 Thus, one
might consider Fe-bleomycin as a naturally occurring inorganic pharmaceutical.
What is the role of the metal ion in these reactions? As one might imagine,
based upon our earlier discussions of metal-promoted DNA cleavage, the iron
center is essential for the oxidative cleavage of the strand through reaction with
the sugar moiety. The reaction of Fe(II)-bleomycin can, however, clearly be
distinguished from the Fe(EDTA)2 reactions discussed earlier in that here no
diffusible intermediate appears to be involved. Instead of generating hydroxyl
radicals, the Fe center must be positioned near the sugar-phosphate backbone
and activated in some fashion to promote strand scission directly.
Despite extensive studies, in fact little is known about how Fe(II)-bleomycin
is oriented on the DNA. Indeed, the coordination about the metal is the subject
of some debate. The structure of Cu(II)-P-3A,98 a metallobleomycin derivative,
is also shown in Figure 8.19. On the basis of this structure and substantive
spectroscopic studies on Fe-bleomycin itself, it is likely that, as with Cu(II), in
the Fe(II)-bleomycin complex the metal coordinates the {3-hydroxyimidazole ni-
trogen, the secondary amine of {3-aminoalanine, and the Nl nitrogen of the
pyrimidine. Whether in addition the primary amines of the amino alanine and
of the histidine coordinate the metal is still not settled. Possibly bithiazole co-
ordination or some coordination of the sugar moieties is involved. Nonetheless,
given five different coordination sites to the bleomycin, the sixth axial site is
available for direct coordination of dioxygen. How is this Fe-02 complex ori-
ented on the DNA? It is likely that at least in part the complex binds against the
minor groove of the helix. There is some evidence that suggests that the bith-
iazole moiety intercalates in the helix. It is now becoming clear, however, that
the structure of the metal complex itself, its three-dimensional shape, rather than
simply the tethered bithiazole or saccharide, is needed for the sequence selectiv-
ity associated with its mode of action.
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Although the coordination and orientation of the metal complex are still not
understood, extensive studies have been conducted concerning the remarkable
chemistry of this species. 96•99 The overall mechanism of action is described in
Figure 8.19. In the presence of oxygen, the Fe(Il) O2 species is formed and is
likely rapidly converted to a ferric superoxide species. The one-electron reduc-
tion of this species, using either an organic reductant or another equivalent of
Fe(II)-bleomycin, leads formally to an Fe(III)-peroxide, which then undergoes
0-0 bond scission to form what has been termed "activated bleomycin."
This species might be best described as Fe(V) = 0 (or [Fe 0] 3+). This species
is comparable in many respects to activated cytochrome P-450 or perhaps even
more closely to the Fe center in chloroperoxidase (see Chapter 5). Like these
systems, activated bleomycin can also epoxidize olefins and can generally func-
tion as an oxo transferase. In contrast to these systems, Fe-bleomycin clearly
lacks a heme. How this species can easily shuttle electrons in and out, forming
and reacting through a high-valent intermediate, without either the porphyrin
sink or another metal linked in some fashion, is difficult to understand. In fact,
understanding this process, even independently of our fascination with how the
reaction is exploited on a DNA helix, forms the focus of a substantial effort of
bioinorganic chemists today.
What has been elucidated in great detail is the reaction of activated bleo-
mycin with DNA. It has been established that the activated species promotes
hydrogen abstraction of the C4'-H atom, which is positioned in the minor groove
of the helix (Figure 8.19). Addition of another equivalent of dioxgen to this
C4'-radical leads to degradation of the sugar to form a 5'-phosphate, a
3'-phosphoglycolate, and free base propenal. Alternatively, oxidation of the
C4'-radical followed by hydroxylation in the absence of oxygen yields, after
treatment with base, a 5'-phosphate, an oxidized sugar phosphate, and free base.
Other metals such as copper and cobalt can also activate bleomycins, al-
though their mechanistic pathways for strand scission are clearly different from
that of Fe(II)-bleomycin. Whether other natural products that bind DNA also
chelate metal ions and exploit them for oxidative strand cleavage is not known,
but several systems provide hints that they do. Furthermore, such a fact would
not be surprising given our understanding of the utility of metal ions in promot-
ing this chemistry. An even more detailed understanding of this chemistry might
lead to the development of second-generation synthetic transition-metal phar-
maceuticals that specifically and efficiently target and cleave DNA sites.
D. A Catalytic Role
In addition to serving structural and modulating roles in proteins which bind
nucleic acids, metal ions also appear to be essential to the functioning of various
complex enzymes that act on nucleic acids. At this stage our understanding of
the participation of the metal ion in the catalytic chemistry of these enzymes is
somewhat sketchy, and we are relying more on our current understanding of the
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(A) The structure of bleomycin A2 . (B) The crystallographically determined structure 98 of a copper derivative of bleomycin, P3A.
(C) A scheme to generate "activated bleomycin." (D) The proposed mechanism of action of activated Fe-bleomycin.
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possible roles where metal ions may prove advantageous. These remain areas of
biochemical focus where the inorganic chemist could make a major contribu-
tion.
For example, zinc ion appears to be essential to the functioning of both
RNA polymerases and DNA topoisomerases. 100-102 These multisubunit en-
zymes perform quite complex tasks. RNA polymerase must bind site-specifi-
cally to its DNA template, bind its nucleotide and primer substrates, and form
a new phosphodiester bond in elongating the growing RNA. Two zinc ions
appear to be involved. One may be involved in orienting the nucleotide sub-
strate, and the other structurally in template recognition. It would not be sur-
prising, however-indeed, it might be advantageous-if one or both metal ions
also participated in the polymerization step. Our mechanistic understanding of
how topoisomerases function is even more cursory. These complex enzymes
bind supercoiled DNA, sequentially break one strand through hydrolytic chem-
istry, move the strand around the other (releasing one tertiary turn), and religate
the strand. Again, the zinc ion might participate in the hydrolytic chemistry, the
ligation step, or both; alternatively, the metal might again serve a structural role
in recognition of the site of reaction.
We do have some understanding of the role of metal ions in several endo-
nucleases and exonucleases. As discussed in Section II.C, metal ions may ef-
fectively promote phosphodiester hydrolysis either by serving as a Lewis acid
or by delivering a coordinated nucleophile. Staphylococcal nuclease 103 is an
extracellular nuclease of Staphylococcus aureus that can hydrolyze both DNA
and RNA in the presence of Ca 2+. The preference of the enzyme is for single-
stranded DNA, in which it attacks the 5' -position of the phosphodiester linkage,
cleaving the 5'-P-O bond to yield a 5'-hydroxyl and 3'-phosphate terminus.
Ca 2+ ions are added as cofactors and are strictly required for activity. The
structure of staphylococcal nuclease, determined by x-ray crystallography and
crystallized in the presence of Ca2+ and the enzyme competitive inhibitor pdTp,
as well as subsequent NMR and EPR studies on mutant enzymes using Mn 2+
as a substitute for the Ca2+ ion, have provided the basis for a detailed structural
analysis of the mechanism of this enzyme. In this phosphodiester hydrolysis,
the metal ion appears to function primarily as an electrophilic catalyst, polariz-
ing the P-O bond, and stabilizing through its positive charge the evolving neg-
ative charge on the phosphorus in the transition state. The base is thought here
not to be directly coordinated to the metal; instead, action of a general base is
invoked.
Metal ions also participate in the functioning of other nucleases, although
the structural details of their participation are not nearly as established as those
for staphylococcal nuclease. DNAse I also requires Ca2+ for its catalytic activ-
ity.104 Sl endonuclease, mung bean nuclease, and Physarum polycephalem nu-
clease require zinc ion either as cofactors or intrinsically for nuclease activity,
and the restriction enzyme EcoRI may also require intrinsically bound zinc ion. 33
In terms of how the zinc ion might function in these enzymes, one can look
both to staphylococcal nuclease and to bacterial alkaline phosphatase 105 for some
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illustrations. One would expect that this metal ion could serve both as an elec-
trophilic catalyst and also in the delivery of a zinc-coordinated hydroxide, as it
does in alkaline phosphatase, directly attacking the phosphate ester. More work
needs to be done to establish the mechanisms by which zinc ion promotes phos-
phodiester hydrolysis in these enzymatic systems.
Probably most intriguing and mysterious at this stage is the metal partici-
pation in the very complex DNA-repair enzyme endonuclease III from E. coli
(similar enzymes have also been isolated from eukaryotic sources). This enzyme
is involved in the repair of DNA damaged by oxidizing agents and UV irradia-
tion, and acts through an N-glycosylase activity to remove the damaged base,
and through an apurinic/apyrimidinic endonuclease activity to cleave the phos-
phodiester bond adjacent to the damaged site. Although more complex in terms
of recognition characteristics, this enzyme functions in hydrolyzing the DNA
phosphodiester backbone. What is so intriguing about this enzyme is that it
contains a 4Fe-4S cluster (see Chapter 7) that is essential for its activity! 106 We
think generally that Fe-S clusters best serve as electron-transfer agents. In the
context of this repair enzyme, the cluster may be carrying out both an oxidation
and a reduction, to effect hydrolysis, or alternatively perhaps a completely new
function for this metal cluster will emerge. (Fe-S clusters may represent yet
another structural motif for DNA-binding proteins and one which has the poten-
tial for regulation by iron concentration.) Currently the basic biochemical and
spectroscopic characterization of the enzyme is being carried out. Understanding
this very novel interaction of a metal center and nucleic acid will require some
new ideas, and certainly represents one new challenge for the bioinorganic chemist.
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I. INTRODUCTION AND OVERVIEW
Metal ions are required for many critical functions in humans. Scarcity of some
metal ions can lead to disease. Well-known examples include pernicious anemia
resulting from iron deficiency, growth retardation arising from insufficient di-
etary zinc, and heart disease in infants owing to copper deficiency. The ability
to recognize, to understand at the molecular level, and to treat diseases caused
by inadequate metal-ion function constitutes an important aspect of medicinal
bioinorganic chemistry.
Metal ions can also induce toxicity in humans, classic examples being heavy-
metal poisons such as mercury and lead. Even essential metal ions can be toxic
when present in excess; iron is a common household poison in the United States
as a result of accidental ingestion, usually by children, of the dietary supplement
ferrous sulfate. Understanding the biochemistry and molecular biology of natu-
ral detoxification mechanisms, and designing and applying ion-specific chelating
agents to treat metal overloads, are two components of a second major aspect
of the new science that is evolving at the interface of bioinorganic chemistry
and medicine.
Less well known than the fact that metal ions are required in biology is their
role as pharmaceuticals. Two major drugs based on metals that have no known
natural biological function, Pt (cisplatin) and Au (auranofin), are widely used
cis-diamminedichloroplatinum(II)
(cisplatin, or cis-DDP)
OAc
~S-AuPEt3OAcAcO
OAc
2,3,4,5-tetra-O-acetyl-1-1-~-D­
thioglucose(triethylphosphine)gold(I)
(auranofin) 505
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for the treatment of genitourinary and head and neck tumors and of rheumatoid
arthritis, respectively. In addition, compounds of radioactive metal ions such as
99mTc and complexes of paramagnetic metals such as Gd(III) are now in wide-
spread use as imaging agents for the diagnosis of disease. Many patients admit-
ted overnight to a hospital in the U.S. will receive an injection of a 99mTc
compound for radiodiagnostic purposes. Yet, despite the obvious success of
metal complexes as diagnostic and chemotherapeutic agents, few pharmaceutical
or chemical companies have serious in-house research programs that address
these important bioinorganic aspects of medicine.
This chapter introduces three broad aspects of metals in medicine: nutri-
tional requirements and diseases related thereto; the toxic effects of metals; and
the use of metals for diagnosis and chemotherapy. Each area is discussed in
survey form, with attention drawn to those problems for which substantial chemical
information exists. Since there is only a primitive understanding at the molecu-
lar level of the underlying biochemical mechanisms for most of the topics, this
field is an important frontier area of bioinorganic chemistry. The major focus of
this chapter is on the platinum anticancer drug cisplatin, which is presented as
a case study exemplifying the scope of the problem, the array of methodologies
employed, and the progress that can be made in understanding the molecular
basis of a single, if spectacular, metal complex used in medicine today.
II. METAL DEFICIENCY AND DISEASE1
A. Essential Metals
Four main group (Na, K, Mg, and Ca) and ten transition (V, Cr, Mn, Fe, Co,
Ni, Cu, Zn, Mo, and Cd) metals are currently known or thought to be required
for normal biological functions in humans. Table 9.1 lists these elements, their
relative abundances, and the medical consequences of insufficient quantities where
known. The nutritional requirements for selected members of the essential met-
als are discussed in the following sections.
B. Anemia and Iron 2
Anemia results from insufficient oxygen supply, often because of a decrease in
hemoglobin (Hb) blood levels. Approximately 65 to 70 percent of total body
iron resides in Hb. In the U.S., many foods, especially those derived from flour,
are enriched in iron. In third-world countries, however, scarcity of dietary iron
is a major contributor to anemia. This information illustrates one important fact
about disease that results from metal deficiency, namely, the need for an ade-
quate supply of essential metals in food. A related aspect, one of greater interest
for bioinorganic chemistry, is the requirement that metals be adequately ab-
sorbed by cells, appropriately stored, and ultimately inserted into the proper
environment to carry out the requisite biological function. For iron, these tasks,
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Table 9.1
Essential metals and medical consequences resulting from their
deficiency.a
Abundance
Diseases resulting
Sea Water Earth's Crust from
Metal mg/l (ppm) mg/l (ppm) metal deficiency
Na 1.05 X 104 2.83 X 104
K 380 2.59 X 104
M- 1.35 x 103 2.09 X 104
Ca 400 3.63 X 104 bone deterioration
V 2 X 10 -3 135
Cr 5 X 10 -5 100 glucose tolerance (?)
Mn 2 X 10 -3 950
Fe 1 X 10 -2 5.00 X 104 anemia
Co 1 x 10 -4 25 anemia
Ni 2 x 10 -3 75
Cu 3 x 10 -3 55 brain disease, anemia, heart disease
Zn 1 x 10- 2 70 growth retardation, skin changes
Mo 1 x 10 -2 1.5
Cd 1.1 x 10- 4 0.2
a Data taken from E.-i. Ochiai, Bioinorganic Chemistry, Allyn & Bacon, 1977, p. 6.
among others, are performed by specific iron-chelating agents, the storage pro-
tein ferritin and the transport protein transferrin, the bioinorganic chemistry of
which is extensively discussed in Chapter 1.
Another cause of anemia exists in individuals who have a mutant variety of
hemoglobin, HbS, in which valine has been substituted for glutamic acid in the
sixth position of the f3 subunits. 3 Interestingly, extensive studies have shown
that this phenomenon, which leads to sickling of the red blood cells, does not
result from failure of the protein to bind heme or from changes in the O2 binding
constant of the iron atom. Rather, deoxy HbS polymerizes into soluble, ordered
fibrous structures that lower the ability of blood to carry oxygen effectively to
the tissues. These results illustrate the importance of structural features remote
from the metal-binding domain in determining the functional characteristics of
a metalloprotein.
C. Causes and Consequences of Zinc Deficiency 4-6
The average adult contains ~ 2 g of zinc and requires a daily intake of 15 to
20 mg, only half of which is absorbed, to maintain this level. Although food in
many technologically advanced societies contains sufficient zinc to afford this
balance, zinc deficiencies occur in certain populations where there is either an
unbalanced diet or food that inhibits zinc absorption. An especially interesting
example of the latter phenomenon is found in certain villages in the Middle East
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where phytates, organic phosphates present in unleavened bread, chelate zinc
ion and render it inaccessible. Zinc deficiency produces growth retardation, tes-
ticular atrophy, skin lesions, poor appetite, and loss of body hair. Little is known
about the biochemical events that give rise to these varied consequences, al-
though the three most affected enzymes are alkaline phosphatase, carboxypep-
tidase, and thymidine kinase. About 30 percent of zinc in adults occurs in skin
and bones, which are also likely to be affected by an insufficient supply of the
element. Zinc deficiency is readily reversed by dietary supplements such as ZnS04,
but high doses (>200 mg) cannot be given without inducing secondary effects
of copper, iron, and calcium deficiency.
D. Copper Deficiency 7
More copper is found in the brain and heart than in any other tissue except for
liver, where it is stored as copper thionein and released as ceruloplasmin or in
the form of a complex with serum albumin. The high metabolic rate of the heart
and brain requires relatively large amounts of copper metalloenzymes including
tyrosinase, cytochrome c oxidase, dopamine-{3-hydroxylase, pyridoxal-requiring
monamine oxidases, and Cu-Zn superoxide dismutase. Copper deficiency, which
can occur for reasons analogous to those discussed above for Fe and Zn, leads
to brain disease in infants, anemia (since cytochrome oxidase is required for
blood formation), and heart disease. Few details are known about the molecular
basis for copper uptake from foods.
E. Summary
From the above anecdotal cases, for which similar examples may be found for
the other metals in Table 9. I, the biological consequences of metal deficiency
are seen to result from a breakdown in one or more of the following steps:
adequate supply in ingestible form in foodstuffs; absorption and circulation in
the body; uptake into cells; insertion into critical proteins and enzymes requiring
the element; adequate storage to supply needed metal in case of stress; and an
appropriate mechanism to trigger release of the needed element under such cir-
cumstances. Only for iron, and to a lesser extent copper and zinc, is there a
reasonably satisfying picture of the molecular processes involved in this chain
of events. The elucidation of the detailed mechanisms of these phenomena, for
example, the insertion of iron into ferritin, remains an exciting challenge for the
bioinorganic chemist (see Chapter I).
III. TOXIC EFFECTS OF METALS
A. Two Classes of Toxic Metal Compounds
As intimated in the previous section, the presence of excess quantities of an
essential metal can be as deleterious as insufficient amounts. This situation can
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arise from accidental ingestion of the element or from metabolic disorders lead-
ing to the incapacitation of normal biochemical mechanisms that control uptake
and distribution phenomena. These possibilities constitute one major class of
metal toxicity. The other broad class results from entry of nonessential metals
into the cell through food, skin absorption, or respiration. The toxicities asso-
ciated with this latter class have received much recent attention because of the
public health risks of chemical and radioisotopic environmental pollutants.
In this section, we survey examples of both categories, and discuss ways in
which bioinorganic chemistry can contribute to the removal of toxic metals and
restoration of normal function. One way involves chelation therapy, in which
metal-specific chelating agents are administered as drugs to complex and facili-
tate excretion of the unwanted excess element. The use of desferrioxamine to
treat iron poisoning is one example of this approach. A second role of bioinor-
ganic chemistry is to identify fundamental biological mechanisms that regulate
metal detoxification, and to apply the principles that emerge to help control the
toxic effects of metal ions in the environment. Recent studies of mercury resis-
tance and detoxification in bacteria provide an elegant example of the way in
which biochemistry and molecular biology can be used to elucidate events at
the molecular level. This work, which has uncovered the existence of metallo-
regulatory proteins, is described in some detail in Section III.F below. It repre-
sents a benchmark by which other investigations into the mechanisms of metal-
detoxification phenomena may be evaluated.
B. Copper Overload and Wilson's Disease 8
Wilson's disease results from a genetically inherited metabolic defect in which
copper can no longer be tolerated at normal levels. The clinical manifestations
are liver disease, neurological damage, and brown or green (Kayser-Fleischer)
rings in the cornea of the eyes. Patients suffering from Wilson's disease have
low levels of the copper-storage protein ceruloplasmin; the gene and gene prod-
ucts responsible for the altered metabolism have not yet been identified. Chela-
tion therapy, using K2Ca(EDTA), the Ca 2 + ion being added to replenish body
calcium stores depleted by EDTA coordination, 2,3-dimercaptopropan-I-ol (BAL,
British Anti-Lewisite), or d-penicillamine to remove excess copper, causes the
symptoms to disappear. The sulfhydryl groups of the latter two compounds
presumably effect removal of copper as Cu(I) thiolate complexes. Wilson's dis-
ease offers an excellent opportunity for modem methodologies to isolate and
clone the gene responsible for this altered Cu metabolism, ultimately providing
a rational basis for treatment.
C. Iron Toxicity9
Chelation therapy is also used to treat iron overload. Acute iron poisoning, such
as that resulting from accidental ingestion of FeS04 tablets, results in corrosion
of the gastrointestinal tract. Chronic iron poisoning, or hemochromatosis, arises
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from digestion of excess iron usually supplied by vessels used for cooking. A
classic case of the latter is siderosis induced in members of the Bantu tribe in
South Africa, who consume large quantities of beer brewed in iron pots and
who suffer from deposits of iron in liver, kidney, and heart, causing failure of
these organs. The chelating agent of choice for iron toxicity is the siderophore
desferrioxamine, a polypeptide having a very high affinity for Fe(III) but not for
other metals. Ferrioxamine chelates occur naturally in bacteria as iron-transport
agents. Attempts to mimic and improve upon the natural systems to provide
better ligands for chelation therapy constitutes an active area of bioinorganic
research (see Chapter 1).
D. Toxic Effects of Other Essential Metals 10,11
When present in concentrations above their normal cellular levels, most of the
other metals listed in Table 9.1 are toxic. Calcium levels in the body are con-
trolled by vitamin D and parathyroid hormones. Failure to regulate Ca2+ leads
to calcification of tissue, the formation of stones and cataracts, a complex pro-
cess about which little is understood (see Chapter 3). Chronic manganese poi-
soning, which can occur following ingestion of metal-oxide dust, e.g., among
miners in Chile, produces neurological symptoms similar to Parkinson's disease.
Neuron damage has been demonstrated. Although Zn toxicity is rare, it can lead
to deficiencies in other essential metals, notably calcium, iron, and copper. Co-
balt poisoning leads to gastrointestinal distress and heart failure. Metal poison-
ing by those elements has been treated by chelating agents, most frequently
CaNaiEDTA), but the selectivity offered by the ferrioxamine class of ligands
available for iron has not even been approached. Fortunately, there are few
cases involving these metals.
E. Plutonium: A Consequence of the Nuclear Age 12
Some of the chelating agents developed to treat iron toxicity have found appli-
cation as therapeutics for plutonium poisoning. Diethylenetriaminepentaacetic
acid (DTPA) salts and siderophores are especially effective. Some improvement
over the naturally occurring chelates has been made by tailoring the ligand to
encapsulate completely the eight-coordinate Pu(IV) center. Although few indi-
viduals have been affected, ingestion of 239pU, for example, as small particles
of PU02' at nuclear-reactor sites can have dire consequences. 239pU emits high
energy ex particles, leading to malignancies of bone, liver, lung and lymph nodes,
to which tissues it is transported by transferrin. With a maximum tolerated dose
of only 1.5 JLg, plutonium is among the most toxic metals known. We turn now
to other, more classic examples of such industrial pollutants.
F. Mercury Toxicity 13 and Bacterial Resistance 14-17
Mercury is released into the environment as Hg(II) ions through weathering of
its most common ore, HgS, red cinnabar. Organomercurials of general formula
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RHgX used in agriculture have also entered the environment as toxic waste.
Both RHgX and HgX2 compounds bind avidly to sulfhydryl groups in proteins,
which can lead to neurological disease and kidney failure. Metallothionein is a
favored protein target, which may help to limit mercury toxicity. A highly pub-
licized case occurred in 1953 at Minimata, Japan, where 52 people died after
eating mercury-contaminated fish and crustaceans near a factory waste outlet.
The volatile, elemental form of mercury, Hg(O) , is reportedly nontoxic, but its
conversion to alkylmercury compounds by anaerobic microorganisms utilizing a
vitamin B-12 biosynthetic pathway constitutes a serious health hazard.
Because of the high affinity of mercury for sulfur-donor ligands, mercury
poisoning is treated by BAL; N-acetylpenicillamine has also been proposed.
Recently, a very interesting natural detoxification system has been discovered
in bacteria resistant to mercury; this system, when fully elucidated, might pro-
vide important strategies for treating heavy-metal poisoning in humans.
Presumably under environmental pressure, bacteria have developed mecha-
nisms of resistance to HgX2 and RHgX compounds in which mercury is recycled
back to Hg(O). At least five gene products are involved in the bacterial mercury-
resistance mechanism. MerT and MerP mediate the specific uptake of mercury
compounds. MerB, organomercury lyase, and MerA, mercuric reductase, cata-
lyze two of the reactions, given in Equations (9.1) and (9.2). Plasmids encoding
the genes for these two proteins have been isolated. A typical arrangement of
genes in the mer operon
RHgX + H + + x-
organomercury
lyase ) HgX2 + RH (9.1)
mercuric
Hg(SRh + NADPH + H +~ Hg(O) + NADP + + 2RSH (9.2)
region of these plasmids is shown in Figure 9.1. The most thoroughly studied
gene product is MerR, a metalloregulatory protein that controls transcription of
the mer genes. In the absence of Hg(II) the MerR protein binds to DNA as a
repressor, preventing transcription of the merT, P, A, and B genes (Figure 9.1)
and negatively autoregulating its own synthesis. When Hg(I1) is present, tran-
scription of these genes is turned on. Interestingly, the MerR protein remains
bound to the same site on DNA whether acting as an activator in the presence
R A ~-~ B
R, regulatory protein A, Hg(ll) - Hg(O)
MerR reductase
T, transport protein B, R-HgX - RH + Hg(lI)
lyase
P, periplasm-
binding protein
Figure 9.1
Arrangement of genes in mer operon of a gram negative bacterium
(adapted from Figure 1, Reference 14).
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of Hg(II) or as a repressor in its absence. Random and site-specific mutagenesis
studies implicate several cysteine residues in the carboxyl terminal region of the
protein as candidates for the mercury-binding site.
Organomercury lyase, encoded by the merB gene, achieves the remarkable
enzymatic step of breaking Hg-C bonds (Equation 9.1). It is a 22-kDa protein
with no metals or cofactors. Two cysteine-sulfhydryl groups on the protein have
been postulated to effect this chemistry, as depicted in Equation (9.3). Stereo-
chemical studies of the Hg-C bond cleavage revealed retention of configuration,
indicating that cleavage of the Hg-C bond probably does not proceed by a rad-
ical pathway. A novel concerted SE2 mechanism has been suggested. The en-
zyme turnover numbers, ranging from 1 min -1 for CH3HgCl to 240 min -1 for
butenylmercuric chloride, although slow, are ~105-108-fold faster than the no-
nenzymatic rate.
1l
~H RHgXSH ~SHe ~-
Hg(SR)2ll
1~2 RSH
ES\g ~ EtS\9---R: ::B RH B----H
(9.3)
Mercuric ion reductase, the FAD-containing merA gene product, has several
pairs of conserved cysteines. From site-specific mutagenesis studies, cysteine
residues in the sequence 134-Thr-Cys-Val-Asn-Val-Gly-Cys-140 are known to
comprise a redox-active disulfide group; in addition, a redox-inactive pair of
cysteines near the carboxyl terminus is also required for the selective reduction
of Hg(II). Exactly how the enzyme achieves the chemistry shown in Equation
(9.2) is currently uncertain, but the redox activities of the flavin and disulfide/
thiol centers are undoubtedly involved. This enzyme serves both to detoxify
mercury supplied directly from the environment as Hg(II) salts and to complete
clearance of Hg 2 + generated by the MerB protein from RHgX compounds.
Clearly, Nature has invented a remarkable system to detoxify mercury in this
fascinating class of Hg-resistant bacteria.
G. Cadmium and Lead Toxicity18
Gastrointestinal, neurological, and kidney toxicity are among the symptoms ex-
perienced by acute or chronic exposure to these heavy metals. The use of un-
leaded gasoline and the removal of lead-containing pigments from paint have
substantially diminished the quantity of this element released to the environment
each year. Cadmium sources include alkaline batteries, pigments, and plating.
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Lead poisoning can be treated by chelation therapy using CaNaz(EDTA) (acute)
or penicillamine (chronic). Although both Cd(II) and Pb(II) bind to sulfhydryl
groups in thionein, we have little information at the molecular level on the
mechanisms by which these elements induce toxicity.
H. Metals as Carcinogens 19,20
Although most metal ions have been reported to be carcinogenic, the three most
effective cancer-causing metals are Ni, Cr, and, to a lesser extent, Cd. Nickel
subsulfide, NizS3 , found in many nickel-containing ores, has been extensively
studied and shown to be carcinogenic in humans and other animals. In short-
term bioassays including mutagenesis, enhanced infidelity of gene replication in
vitro and altered bacterial DNA repair were observed. Chromium is most car-
cinogenic as chromate ion (cr04 Z-), which enters cells by the sulfate uptake
pathway and is ultimately reduced to Cr(III) via a Cr(V)-glutathione intermedi-
ate species. The latter complex binds to DNA to produce a kinetically inert and
potentially damaging lesion. Despite the fact that much information is available
about metal-DNA interactions, molecular mechanisms of metal-induced carcin-
ogenesis have not been elucidated. Two aspects of the problem are tumor initi-
ation and tumor development, which are likely to involve different pathways.
As new methods become available for studying the molecular events responsible
for cancer (oncogenesis), it should be possible for bioinorganic chemists to un-
ravel details of how metals act as carcinogens and as mutagens. Since cancer
has genetic origins, metal/nucleic-acid chemistry is likely to be prominent in
such mechanisms. As discussed later, metal-DNA interactions are an important
aspect of the antitumor drug mechanism of cis-[Pt(NH3hClz].
I. Summary
Toxicity can arise from excessive quantities of either an essential metal, possi-
bly the result of a metabolic deficiency, or a nonessential metal. Both acute and
chronic exposure can be treated by chelation therapy, in which hard-soft acid-
base relationships are useful in the choice of chelating agent. Since chelates can
also remove essential metals not present in toxic amounts, ligands with high
specificity are greatly desired. The design and synthesis of such ligands for
chelation therapy remains an important objective for the medicinal bioinorganic
chemist. Until recently, studies of the toxic effects of metals and their removal,
sometimes categorized under "environmental chemistry," have been empirical,
with little insight at the molecular level. Application of the new tools of molec-
ular biology to these problems has the potential to change this situation, as
illustrated by rapid progress made in cloning the genes and studying the gene
products of the mercury-resistance phenotype in bacteria. The discovery of such
resistance phenomena in mammalian cells, and even the remote prospect of
transferring Hg-resistant genes from bacteria to humans, are exciting possibili-
ties for the future.
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Radiodiagnostic r;.n,onl,,,,21,22
Metal complexes having radioactive nuclei find many applications in medicine,
such as in organ, and tissue imaging, Early detection of cancer, for
example, by selective and imaging of the tumor using a radioactive metal
compound can facilitate surgical removal or chemotherapeutic treatment before
the disease reaches an advanced stage. radioisotopes used for diagnostic
purposes be emit low-energy y and no a or f3
particles. Table 9.2 lists the radionuclides most commonly employed for
purpose in nuclear medicine. Among these, 99mTc is perhaps the most desir-
able,23 for it gives off a 140-keV y ray that is detected scintillation
cameras and produces clear images. radionuclide is prepared from an alu-
mina column loaded with 99Mo042 -, which decays to form 99mTc04 -, which
in tum may be selectively eluted from the column with saline owing
to its lower charge. treatment with a reducing agent in the presence
of the appropriate ligands produces radiopharmaceuticals with de-
sired water stability, and properties. Such com-
plexes may be injected at concentrations of 10 -6_10 -8 M. For example, iso-
cyanide complexes such as [Tc(CNR)6] + = t-Bu, CH2C02But, etc.) have
been found to be taken up selectively into heart tissue and thus have the poten-
tial to be used as heart-imaging agents. Figure 9.2 displays bone as
imaged a 99mTc bone agent. The dark correspond to surface areas of
metabolic which can be used to diagnose or disease. One
Table 9.2
Radionuclides most commonly
employed in diagnostic nuclear
medicine.a
Radionuclide Half-Life Energy (keV)
57CO 271 d 836
67Ga 78 h 1,001
99mTc 6h 140
lilln 67 h 172,247
113mln 104 m 392
1231 13 1,230
169Yb 32 d 207
197Hg 64h 159
201TI 72h 135, 167
a Data are from Table of the Isotopes in D.
R. Lide, ed., CRC Handbook of Chemistry and
Physics, CRC Press, 71 st ed., 1990-91, pp.
11-33 ff.
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Figure 9.2
Human skeleton (bone) imaged with 99mTc. Both anterior (left)
and posterior (right) views are shown.
goal of research in this field is to images of myocardial in-
farcts or clogged arteries for physicians who can watch the patient's heart on a
video surgery. Although chemical details responsible for the
selective tissue of Tc isocyanide, and other complexes are
largely synthetic modifications are and have many
new compounds for evaluation.
Among the few known to be absorbed selectively tumor cells
is the ,24,25 the structure of which is por-
trayed in Figure 9.3. binds most radioactive metal ions, but the
57Co(III) complex has the best tumor-to-blood ratio. Unfortunately,
the long 57CO 9.2) has limited its clinical Attempts to
prepare 99mTc complexes of BLM with selective uptake properties ap-
proaching that of the cobalt have not yet been successful, although the
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Figure 9.3
Structure of bleomycin and its proposed iron complex (reproduced by permission
from Reference 25).
target molecule would be a most valuable radiodiagnostic agent. One imagina-
tive solution 26 to this problem was achieved by covalent attachment of an EDTA
moiety to the terminal thiazole ring of BLM (Figure 9.3). The resulting Co(III)
BLM-EDTA molecule was radiolabeled with lIlIn3+ and found to be useful for
diagnosis of cancer in humans. Also used for tumor imaging are 99mTc and 67Ga
citrate complexes, the latter being the agent of choice for many applications.
Again, there is little known at the molecular level about the mechanism of tu-
mor-cell specificity.
An alternative approach to radionuclide-based tumor-imaging agents for di-
agnosis of disease is to modify, with metal chelating agents, antibodies raised
against a biological substance, such as a tumor-cell antigen, hormone, or other
target. Antibodies are proteins that are synthesized by specialized cells of the
immune system in response to an external stimulant, or antigen. The high spec-
ificity and affinity of antibodies for the antigen can be used to target the anti-
body to a particular biological site, such as a site on the membrane of a partic-
ular cell type. Chelating agents are now routinely attached to antibodies and
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used to bind radioactive metal ions. The resulting radionuclide-labeled products
are currently under extensive study in diagnostic medicine. 26
B. Magnetic Resonance Imaging (MRI)27
Nuclear magnetic resonance (NMR) spectroscopy can be used to image specific
tissues of biological specimens because of differences in the relaxation times of
water proton resonances, usually brought about by paramagnetic metal ions. An
early, pioneering example was the demonstration that Mn(lI) salts localize in
normal heart-muscle tissue in dogs rather than in regions affected by blocked
coronary arteries. Since the paramagnetism of the d 5 Mn(lI) ions alters the re-
laxation rate of nearby water protons, the normal and diseased tissue could be
distinguished. Of the various metal ions surveyed in attempts to provide clini-
cally useful NMR images in humans, Gd(III) , Fe(III) , and Mn(lI) were found
to give the best proton-relaxation enhancements. The gadolinium complex
[Gd(DTPA)(H20)f ,an agent currently used in the clinic, has been success-
fully employed to image brain tumors. Ferric chloride improves gastrointestinal
tract images in humans and, as already mentioned, manganous salts can be used
for heart imaging. NMR imaging methodologies have advanced to the stage
where increases as small as 10 to 20 percent in T I -I, the inverse nuclear-spin
relaxation time, can be detected. As with radionuclide labeling, the complexes
must be soluble and stable in biological fluids and relatively nontoxic, and are
of greatest value when able to target a specific tissue. Even more important than
targeting, however, is that proton relaxivity be maximally enhanced, an objec-
tive that depends not only upon the local binding constant but also upon large
magnetic moments, long electron-spin relaxation (Tie) values, access to and the
residence lifetime in the inner and outer coordination spheres by water mole-
cules, and the rotational correlation time of the complex at its binding site. An
obvious advantage of paramagnetic NMR over radioisotopic imaging agents is
that there is no possibility of radiation damage; on the other hand, the need for
10-100 pM concentrations at the site of imaging is a distinct drawback. Both
methods are likely to continue to be used in the future, and both will benefit
from the design of new stable chelates that are selectively absorbed by the tissue
to be diagnosed.
C. Lithium and Mental Health 28- 31
One in every 1,000 people in the United States currently receives lithium, as
Li2C03 , for the treatment and prophylaxis of manic-depressive behavior. Doses
of 250 mg to 2 g per day are administered in order to maintain a 0.5 to 2.0 mM
concentration window, outside of which the drug is either toxic or ineffective.
The detailed molecular mechanism by which Li + ion brings about its remark-
able chemotherapeutic effects is largely unknown, but there are various theories.
One theory proposes that lithium binds to inositol phosphates, inhibiting their
breakdown to inositol, and so reducing inositol-containing phospholipids. A
consequence of this chain of events would be disruption of the neurotransmis-
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sion pathway based on inositol I ,4,5-triphosphate and 1,2-diacylglycerol, reduc-
ing neuronal communication, which is most likely hyperactivated in the manic
state. This theory does not account for the antidepressive action of the drug,
however. An alternative explanation is that lithium inhibits cyclic adenosine
monophosphate (AMP) formation, again interfering with neurotransmission by
intercepting this key intracellular signaling molecule. Recent experiments indi-
cate that lithium affects the activation of G-proteins, a class of guanosine tri-
phosphate (GTP)-binding proteins involved in information transduction. Possi-
bly these effects result from displacement by Li + of Mg 2+ from GTP and/or
from protein-binding sites normally required for activation. Use of 7Li NMR
spectroscopy to study lithium transport in human erythrocytes suggests that it
might be possible to apply this method to unravel details of the bioinorganic
chemistry of lithium associated with the management of manic depression.
D. Gold and Rheumatoid Arthritis 23,32,33
Gold compounds have been used in medicine for centuries, an application known
as chrysotherapy. Since 1940, however, complexes of gold have been used most
successfully to treat arthritic disorders in humans and other animals. Au(I) com-
pounds are currently the only class of pharmaceuticals known to halt the pro-
gression of rheumatoid arthritis.
Until recently, gold compounds used to treat arthritis were painfully admin-
istered as intramuscular injections. Included were colloidal gold metal, colloidal
gold sulfides, Na3[Au(S203h] (Sanocrysin), gold thiomalate and its sodium and
calcium salts (Myochrisin), and polymeric gold thioglucose (Solganol, approved
by the FDA). It was discovered, however, that triethylphosphinegold(l) tetra-O-
acetylthioglucose (auranofin, Figure 9.4, approved by the FDA) was equally
effective against rheumatoid arthritis and could be orally administered. The
availability of this compound has sparked many studies of its biodistribution,
stability, and possible metabolism that lead to antiarthritic activity. The mode
cis-DDP (cisplatin) carboplatin
spirogermanium
Figure 9.4
Structures and trivial names of metal-based antitumor drugs.
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of action of antiarthritic gold drugs is largely unknown, but it may involve
binding of Au(I) to protein thiol groups, a process that inhibits the formation of
disulfide bonds, and could lead to denaturation and subsequent formation of
macroglobulins .
E. Anticancer Drugs
1. Platinum ammine halides 34,35
The discovery that cis-diamminedichloroplatinum(Il), cis-DDP or cisplatin
(Figure 9.4), has anticancer activity in mice, and its subsequent clinical success
in the treatment of genitourinary and head and neck tumors in humans, consti-
tutes the most impressive contribution to the use of metals in medicine. Given
in combination chemotherapy as an intravenous injection together with large
amounts of saline solution to limit kidney toxicity, cisplatin treatment results in
long-term (>5 yr) survival for more than 90 percent of testicular cancer pa-
tients. In a typical course, ~ 5 mg/kg body weight of the drug is administered
once a week for four weeks. Extensive studies of platinum ammine halide ana-
logues led to a series of empirical rules governing their chemotherapeutic poten-
tial. Specifically, it was concluded that active compounds should:
(1) be neutral, presumably to facilitate passive diffusion into cells;
(2) have two leaving groups in a cis configuration;
(3) contain nonleaving groups with poor trans-Iabilizing ability, similar to
that of NH3 or organic amines;
(4) have leaving groups with a "window of lability" centered on chloride.
These early structure-activity relationships have had to be modified somewhat,
however, since chelating dicarboxylate ligands such as I, I-dicarboxylatocyclo-
butane can replace the two chloride ions, and since cationic complexes with
only one labile ligand, specifically, cis-[Pt(NH3hCI(4-X-py)] +, where X = H,
Br, CH3 , etc., showed activity in some tumor screens. The two compounds
shown in Figure 9.4, cisplatin and carboplatin (Figure 9.4), were the first to be
approved for clinical use. Of particular interest to the bioinorganic chemist is
that complexes having a trans disposition of leaving groups are inactive in vivo.
This difference suggests the presence of a specific cellular receptor that, when
identified, should facilitate the design of new, metal-based anticancer drugs.
Present evidence strongly points to DNA as being the relevant cellular target
molecule. Section V of this chapter expands on this topic in considerable detail.
2. Metallocenes and their halides: Ti, V, Fe 36,37
Several compounds in this category, including [(CsHshTiX2] (X = CI, Br,
02CCh), [(CsHshVCh]' [(CsHshNbCh], [(CsHshMoChJ, and [(CsHshFe] + salts,
exhibit significant activity against experimental animal tumors. Higher quantities
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(200 mg/kg) of these compounds than of cis-DDP can be tolerated with fewer
toxic side effects, but their failure in two mouse leukemia screens commonly
used to predict the success of platinum anticancer agents appears to have de-
layed their introduction into human clinical trials. Studies of Ehrlich ascites
tumor cells treated with [(CsHshVCh] in v itro revealed selective inhibition of
incorporation of radiolabeled thymidine, versus uridine or leucine, indicating
that the complex blocks DNA replication. Unlike cisplatin, however, metallo-
cene halides undergo rapid hydrolysis reactions in aqueous media, forming oxo-
bridged and aqua complexes that may have a higher affinity for phosphate oxy-
gen atoms than the heterocyclic nitrogen atoms of the bases in DNA. 38 Exactly
how the ferrocenium ion might bind to DNA is even more obscure, although
partial metallointercalation and groove binding are more likely than covalent
attachment of the chemically unmodified cation. From the limited information
available, metallocenes and their halides appear to behave fundamentally differ-
ently from platinum antitumor compounds. As a class, they provide a promising
new opportunity to expand the scope of metal complexes used in cancer che-
motherapy.
3. Gold and other metal phosphines 39
Following the successful entry of the soluble gold-phosphine complex au-
ranofin (Figure 9.4) into the metal-based pharmaceuticals industry, several gold-
phosphine complexes were examined for possible anticancer activity. Although
auranofin itself was active in only a small fraction of the mouse tumor models
tested, biological activity approaching that of cisplatin was discovered for many
analogues, most notably the diphosphine bridged complex [ClAu(PPh2CH2CH2
PPh2)AuCI]. Attempts to replace the phosphine with As or S donor ligands, to
increase or decrease the length of the 2-carbon bridge, or to replace the phenyl
with alkyl groups all led to diminished activity. Most noteworthy is that the
diphosphine ligands themselves have activity very similar to that of their gold
complexes, and that Ag(I) and Cu(I) analogues are also effective. These results
strongly imply that the phosphine ligands are the chemical agents responsible
for the anticancer properties of these compounds. Coordination to a metal pre-
sumably serves to protect phosphines against oxidation to the phosphine oxides,
which independent investigations have proved to be ineffective. A possible role
for the metal in the cytotoxicity of the compounds cannot be ruled out, however.
4. Other main group and transition-metal compounds 36,40,41
Several main group metal complexes exhibit anticancer activity. Gal-
lium(III) nitrate is active against human lymphomas, but with dose-limiting side
effects on the kidneys and gastrointestinal tract. Tin complexes of general for-
mula R2L2SnX2, where R = alkyl or phenyl, L2 = PY2, bpy, or phen, and
X2 = two cis-oriented halide or pseudohalide leaving groups, are active against
the mouse P388 leukemia tumor. The cis disposition of the leaving groups sug-
gests a possible mechanism analogous to that of cisplatin (see below). Organo-
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gennanium compounds are also active, notably the derivative spirogermanium
shown in Figure 9.4. Nothing is known about the mechanism of action of any
of these compounds.
Following the discovery of activity for cisplatin, several thousand platinum
and nearly 100 other transition-metal complexes have been screened in various
tumor model systems in the hope of achieving better activity against a broader
range of tumors. Among the classes of nonplatinum compounds showing some
activity are ruthenium complexes cis-[RuCh(DMSO)4], [Ru(NH3)s(Asc)](CF3S03),
where Asc is ascorbate dianion, and jac-[Ru(NH3hCh] , all of which are be-
lieved to bind to DNA; binuclear rhodium complexes [Rh2(02CR)4L2]; octahe-
dral Pd(IV) complexes such as cis-[Pd(NH3hCI4]; and such miscellaneous mol-
ecules as the iron(II) complex of 2-formylpyridine thiosemicarbazone, the site
of action of which is thought to be ribonucleotide reductase. These examples
illustrate the broad scope encompassed by this field, which has a potential for
developing fundamental infonnation about metal-biomolecule interactions as well
as novel anticancer drugs. Much remains to be explored.
F. Miscellaneous Metals in Medicine
Numerous other anecdotal and some fairly elaborate studies have been reported
for metal complexes as medicinal agents. The use of zinc applied topically to
promote the healing of wounds dates back to around 1500 B.C., and silver is
now commonly applied to prevent infection in bum patients. 42 ,43 Osmium car-
bohydrate polymers have been reported to have antiarthritic activity.44 Transi-
tion-metal complexes have a long history of use as antibacterial and antiviral
agents; for example, Zn2+ is used to treat herpes, possibly by inhibiting the
viral DNA polymerase. 45 Early transition-metal (e.g., tungsten) polyoxoanions
have been employed to treat AIDS patients. 46 Numerous reports have appeared
detailing the anti-inflammatory, antiulcer, and analgesic activities of copper car-
boxylate complexes. 7 As in the previous section, these reports and others like
them require more serious attention from bioinorganic chemists to elucidate the
molecular events responsible for such a fascinating menu of biologically active
metal complexes.
G. Summary and Prospectus
The clinical successes of platinum anticancer and gold antiarthritic drugs have
changed the attitudes of many who doubted that heavy-metal compounds, no-
torious for their deleterious effects on human health, would ever playa serious
role in chemotherapy. Indeed, we have seen that Hg 2 +, Pb 2 +, and Cd 2+ are
toxic elements. Even essential metals can be highly toxic if present in excess,
either because of chronic or acute poisoning or because of metabolic defects
that deregulate their control in the cell. An important common theme running
throughout this discussion is selectivity. For a drug to be effective, it must be
selectively toxic to diseased tissue while leaving nonnal tissue alone; or it must
selectively kill harmful microorganisms at levels where it fails to deplete helpful
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ones. For a chelating agent to be useful in the toxic effects of llll:;ldl1>,
it must bind as selectively as possible to the deleterious ion while coordinating
only weakly, if at to others. For a diagnostic metal complex to be it
must be taken up (or excluded) selectively from diseased cells relative to normal
ones, or to one tissue type versus another. Rarely has such selectivity been
designed in advance of the discovery of a useful metal-based pharmaceutical,
although spectacular advances in biology, such as monoclonal antibodies, may
be hastening the day when such an objective be common. Interestingly,
the successes of such unlikely as cis-[Pt(NH3hCh] and
[(Et3P)Au(OAc4-thioglucose)] in chemotherapy were driven by the personal in-
volvement of individuals like B. Rosenberg for the former and B. Sutton for
the latter. Like Hollywood producers, these men mustered every conceivable
resource to promote the compounds for testing, introduction into human clinical
trials, and eventually approval by the FDA. Such zeal requires years, usually
more than a decade, of sustained personal effort, and may be the reason why
other metal complexes, such as those mentioned above, have not had
the impact of a cisplatin or an auranofin. On average, only one of 7,000 such
compounds makes it from the laboratory bench to the patient, at an average cost
of 250 million dollars and a time interval of 13 years.
Another component of the evolving field of metals in medicine,
however, is that, once a has proved its in the clinic, how does
it work? This question is deceptively for coordination chemistry in viva,
and the of cells to respond to unnatural external stimuli such as metal
complexes, are matters about which we are beginning to
learn. As progress is made in this latter area, it should become possible to
design drugs in a rational way to achieve the required selectivity.
The remainder of this chapter focuses on a case study where some
progress in unraveling the molecular mechanism of a metal-based drug, cispla-
is being made. If nothing else, this discussion will elucidate strategic guide-
lines that may be employed to attack similar questions about other chemothera-
peutic metal compounds discussed earlier in this section. Unfortunately, there is
very little information available about the molecular mechanisms of these other
complexes. At this transition in our discussion, we move from gen-
eral considerations to a specific, analysis. The reader must here take
time to become familiar with the biological aspects of the new material.
A
the Discovery47
cis-[Pt(NH3hCh], a molecule known since the mid-19th century, has been a
subject of considerable importance in the of inorganic stereochem-
istry and substitution reaction kinetics. 48 Its biological was discovered
by accident. In the mid-1960s, biophysicist Barnett Rosenberg, at Michigan
State University, was studying the effects of electric fields on the growth of
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I<~('hpn,..hln coli cells in culture. They had cell divi-
SlOn, the orientation of the mitotic be affected by local electric
which they hoped to perturb. Instead, observed growth without cell
the being elongated, spaghetti-like bacterial approach-
ing I cm in After much detective work, realized that small amounts
of from the electrodes used to apply the electric fields had reacted with
NH4CI in their to produce various ammine halide compounds.
Two of these, cis-[Pt(NH3hChl and cis-[Pt(NH3hCI4l, were capable of inducing
filamentous growth in the absence of any electric field. Since chemicals that
onJdllCe filamentation in bacteria had been known to exhibit activity,
Rosenberg was eager to have his compounds tested. Unable to con-
vince existing agencies like the National Cancer Institute to credit
later spearheaded the of that a heavy-metal complex could
actually be beneficial to the Michigan State group set up their own
anlm;dHlUrnor screens. The results were short of spectacular. Injection
of cis-DDP into the cavity of mice into which a Sar-
coma-ISO tumor had been led within a few days to a blackening
(necrosis), in size, and eventual of the tumor (Figure
9.5). The cured mouse enjoyed a normal From these and other animal
Figure 9.5
Photographic demonstration of the dramatic ability of cisplatin to cure a Sarcoma-ISO murine
tumor (reproduced by permission from Reference 47).
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studies, physicians became convinced that administering compounds
to cancer patients might be and a new field involving bioinorganic
chemistry and cancer chemotherapy was born. The drug, marketed as Platinol
with the generic name cisplatin, received FDA approval in 1979 and is today
one of the leading anticancer agents.
B.
1. Strategic considerations
There are two general routes to the development of inorganic complexes,
and indeed most chemical compounds, as drugs. One, illustrated by cisplatin,
arises from an observation of biological activity followed by attempts
to the efficacy through investigations of structure-activity re-
lationships (SAR). The goals are to minimize toxicity, to develop cell culture
and animal screens for testing related compounds, and ultimately to elucidate
the mechanism. Knowledge of the molecular mechanism might even-
lead to a rational strategy for designing better drugs.
The second general approach to drug design begins with known biochemis-
try. For example, ribonucleotide reductase is required in the first step
in the biosynthesis of DNA, the conversion of ribo- to deoxyribonucleoside
dir)hclsphat.es. The mammalian enzyme contains a binuclear non-heme iron cen-
ter required for activity. Compounds that would selectively inhibit this enzyme
by destroying this center are useful as antiviral or agents.
Another example is the enzyme reverse Iranscriptase, encoded by the HIV (AIDS)
virus and for its integration into the genome of the host cell. Com-
pounds like 3' -azidothymidine (AZT) are accepted by the enzyme as substrates
but, when added to the growing DNA chain, cannot be linked to the next nu-
cleotide. termination therefore occurs and the replication process becomes
permanently Attempts to find organic molecules or inorganic com-
plexes that are more effective chain terminators than AZT constitute a rational
strategy for developing new anti-AIDS drugs.
In the remainder of this we describe research that has evolved fol-
lowing the discovery of biological activity for cisplatin. Although the initial
breakthrough was serendipitous, subsequent studies have revealed many aspects
of the molecular mechanism. From this known biochemistry we may one day
be in a position to design more effective anticancer drugs and therapies based
upon the bioinorganic of cisplatin.
("I i r1 i(,,~::I1 trials 49
Predicting the chemotherapeutic of an inorganic compound such as
cis-DDP prior to its introduction into human cancer patients is an ImpolrtaJllt
objective. Compounds are most easily tested for their cytotoxic effects on bac-
terial or mammalian cells in culture. Shown in Figure 9.6 are results for the
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Figure 9.6
Differential toxicity of cis- (II) and trans-DDP C,,) on HeLa cells
growing in culture (reproduced by permission from Reference 51).
survival of cultured Ll210 cells in the presence of increasing amounts of cis-
or trans-DDp. 50 ,51 The data reveal the markedly greater toxicity of the cis iso-
mer, which is a much better anticancer agent than its stereoisomer. Unfortu-
nately, no single assay has yet been found that can predict the chemotherapeutic
potential of compounds in humans. The best that can be obtained are
results relative to those for cis-DDP, in which case at low dose is usu-
ally scored positive.
The next level of testing, often employed directly without first examining
cell-culture results, involves animal (usually excluding
screens. 49 Among the most popular measures of the actiVIty
of compounds has been their to prolong the survival of mice
bearing the LI210 or P388 leukemia. A suspension of cells is inoculated intra-
peritoneally (i.p., in the abdominal cavity), producing a leukemia eventu-
ally progresses to the generalized disease. In one used protocol,
inum compounds are dissolved in physiological saline (0.85 percent NaCl) or
sterile H20 and injected 24 5, 9, and 13 days after inoculation of the
leukemia cells. Several indices of antitumor and toxicity have been de-
fined. The percent I.L.S., or increased measures the mean survival of
treated versus control animals that were given no drug. A related index
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is the median survival, percent T/C (Test/Control), which is 100 + percent I.L.S.
The LOso value measures toxicity as mean lethal dose,the amount of drug (usu-
ally in mg/kg body weight) required to kill half the animals. Potency is defined
by lOgo, the inhibiting dose at which 90 percent of the tumor cells are killed.
From these values, a therapeutic index (TI) = LOso/IOgo is sometimes defined,
which should be substantially greater than one. Typical values for cis-OOP are
85 percent I.L.S. at 8 mglkg for the LI210 tumor, 13.0 mglkg LOso, and 1.6 mg/
kg lOgo resulting in a TI of 8. 1.
In addition to being tested in mice, cisplatin and related compounds have
been screened in other mammals, specifically dogs and monkeys, mainly to look
for possible dose-limiting side effects. Severe vomiting, once thought to be an
insurmountable obstacle, was monitored by using ferrets. None of the animal
screens can substitute for the ultimate test, however, which is human clinical
trials. In 1972, such trials were initiated using terminally ill cancer patients. It
was determined that intravenous (i.v.) injection, rather than i.p. or oral admin-
istration, was the preferred method for giving the drug. Further details of the
clinical development of cisplatin are discussed in a later section.
From the animal screens emerged the set of structure-activity relationships
enumerated earlier (Section IV.E.l). Both cisplatin and carboplatin conform to
these rules, and to date no compounds with demonstrably better antitumor activ-
ity have been tested in humans. The decision to move an experimental drug into
the clinic is a difficult one, however, and it may be that molecules such as cis-
[Pt(NH3h(4-Br-py)Cl]Cl (see Section V.0.7.c) would be effective for tumors
that are refractive to cisplatin chemotherapy. In any case, the foregoing chain
of events, from studying the effects of a compound on cells in culture through
animal screens and eventually to humans, constitutes the principal route for
introducing a new anticancer drug. The process can take more than a decade.
3. Mechanism of action studies
Once a class of compounds has been identified as biologically active, stud-
ies to elucidate the molecular mechanism of action can be undertaken. A first
step is to identify the major cellular target or targets responsible for the chem-
otherapeutic properties of the drug. These investigations must also focus on
chemical transformations that might take place in the solutions being adminis-
tered and in the biological fluids that transport the drug to its ultimate target
site. The next major step is to characterize the adduct or family of adducts made
with the biological target molecule. The structure and kinetic lifetime of these
adducts need to be investigated. Once this information is in hand, the effect of
the adducts on the structure, stability, and function of the biological target mol-
ecule must be studied. Here many powerful new methodologies of modern mo-
lecular biology, genetics, and immunology can be brought to bear on the prob-
lem. The ultimate goals are to translate the molecular events elucidated into a
realistic mechanism for how the drug molecule brings about its toxic effects
selectively at the sites responsible for the disease and to use this information to
design even better drugs.
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Having progressed this far, we next need to bridge the gap between funda-
mental knowledge gained in studies of the mechanism of action and the SAR
gleaned through pre-clinical and clinical trials. Whether such a happy situation
can be reached for cisplatin remains to be seen, but there are encouraging signs,
as we hope to demonstrate in the following discussion.
C. Clinical Picture for Cisplatin and Carboplatin 49,52
1. Responsive tumors and combination chemotherapy
It was an early observation that the best responses to cisplatin occurred in
patients with genitourinary tumors. For testicular cancer, once a leading cause
of death for males of age 20-40, cisplatin cures nearly all patients with stage A
(testes alone) or B (metastasis or retroperitoneal lymph nodes) carcinomas. Plat-
inum is usually given in combination with other drugs, commonly vinblastine
and bleomycin for testicular cancer. This combination chemotherapy, as it is
known, has several objectives. Some tumors have a natural or acquired resis-
tance to one class of drugs and, by applying several, it is hoped that an effective
reduction in tumor mass can be achieved. In addition, various drugs are known
to affect different phases of the cell cycle, so several are applied simultaneously
to allow for this possibility. Finally, synergism, where the response is greater
than expected from simple additive effects, can occur, although it is rare. In
addition to testicular cancer, platinum chemotherapy has produced responses in
patients with ovarian carcinomas (>90 percent), head and neck cancers, non-
small-cell lung cancer, and cervical cancer. Cisplatin is also effective when
combined with radiation therapy.
2. Dose-limiting problems; toxicology
An early and quite worrisome adverse side effect of cisplatin was kidney
toxicity. This problem, not commonly encountered with the older cancer drugs,
nearly prevented its widespread use and eventual FDA approval. The major
breakthrough here was made by E. Cvitkovic, who, while working at Sloan-
Kettering Memorial Hospital in New York, administered large quantities of water
by intravenous injection to patients, together with an osmotic diuretic agent such
as D-mannitol. The rationale was that such hydration could ameliorate kidney
toxicity by flushing out the heavy-metal complex. This simple idea worked, and
the dose of the platinum compound could be increased threefold without accom-
panying nephrotoxicity. Hydration therapy is now commonly employed when
cisplatin is administered. Among the other toxic effects encountered in cisplatin
chemotherapy are nausea and vomiting, but this problem has also been con-
trolled by use of antiemetic agents. Patients have also been known to experience
bone-marrow suppression, a ringing in the ears, and occasional allergic reac-
tions.
More recently, attempts have been made to extend cisplatin treatment to
other broad classes of tumors by raising the dose above the ~ 5 mg/kg body
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weight levels given by i. v. injection every few weeks. Direct injection into the
peritoneal cavity has been employed for refractory ovarian tumors. These more
aggressive therapeutic protocols have been frustrated by drug resistance, a phe-
nomenon by which cells learn to tolerate a toxic agent and for which many
mechanisms exist, and by the return of the usual cisplatin side effects, most
notably kidney toxicity and neurotoxicity. In order to combat toxic effects to
the kidneys, chemoprotector drugs have been introduced. Based on the known
affinity of platinum(II) complexes for sulfur-donor ligands, sodium diethyldi-
thiocarbamate (DDTC) has been given both to experimental animals and to hu-
mans by i. v. infusion over about an hour following cisplatin administration. 53
DDTC inhibits many of the toxic side effects, particularly to the kidneys and
bone marrow, without itself producing long-term side effects or apparently in-
hibiting the antitumor properties of cis-DDP. Similar efforts have been made to
reduce the toxic effects of cisplatin with other sulfur-containing compounds in-
cluding thiosulfate and the naturally occurring biomolecules glutathione, cys-
teine, and methionine. The relative amounts of the latter three molecules can be
controlled by drugs that affect their normal cellular concentrations.
Another approach to reducing cisplatin toxicity is to develop new classes of
platinum drugs or different routes of their administration. Carboplatin (Figure
9.4) is one result of these efforts. The bidentate chelating dicarboxylate leaving
group in carboplatin presumably retards the rates of reactions leading to toxicity,
but does not adversely interfere with the chemistry required for antitumor activ-
ity. Recently, promising platinum compounds for oral administration have been
developed. 54 In Pt(IV) complexes of the kind cis, trans, cis-[Pt(NH3)(C6HlI NH2)
. (02CCH3hCh], where C6HllNH2 is cyclohexylamine, have been found to be
effective in preclinical screens. The greater kinetic inertness of these complexes
apparently renders them sufficiently stable to the chemically harsh environment
of the gastrointestinal tract. Once absorbed into the bloodstream, these com-
pounds are metabolized to the Pt(II) analogues, cis-[Pt(NH3)(C6HllNH2)Ch],
which are presumed to be the active form of the drug. The Pt(IV) compound
has recently entered clinical trials.
Although impressive inroads have been made in the management of human
tumors by platinum chemotherapy, the fact remains that, apart from testicular
and to a lesser extent ovarian cancer, the median survival times are measured
in months. Clearly, there is much room for improvement.
3. Pharmacology49,52
Solutions of cisplatin are usually given in physiological saline (NaCl), since
hydrolysis reactions occur that can modify the nature of the compound and its
reactions in vivo (see below). Cisplatin is rapidly cleared from the plasma after
injection, 70-90 percent of the platinum being removed within the first 15 min-
utes. It has been found that more than half the platinum binds to serum proteins
and is excreted. Most of the platinum exits the body via the urine within a few
days. These results account for the use of multiple-dose chemotherapy at inter-
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vals of several weeks. Animal studies employing cis-DDP labeled with 195mpt,
a 99 keV y-emitter with a 4. I-day half-life, reveal retention half-times in var-
ious tissues of 8.4 (kidney), 6.0 (ileum), 4.1 (liver), 2.8 (tumor), and 1.9 (serum)
days following a single dose. Platinum distributes widely to all tissue, with
kidney, uterus, liver, and skin having the most, and muscles, testes, and brain
the least amount of the compound. There is no evidence for selective uptake
into normal versus tumor cells.
D. Bioinorganic Chemistry of Platinum Anticancer Drugs;
How Might They Work?
The material in this section constitutes the major portion of this chapter. One
important goal of the discussion is to illustrate, by means of an in-depth analysis
of a single case history, the questions that must be addressed to elucidate the
molecular mechanism of an inorganic pharmaceutical. Another is to introduce
the techniques that are required to answer these questions, at least for the chosen
case. The inorganic chemist reading this material with little or no biological
background may find the experience challenging, although an attempt has been
made to explain unfamiliar terms as much as possible. It is strongly advised that
material in Chapter 8 be read before this section. Toward the end of this section,
the results obtained are used to speculate about a molecular mechanism to ac-
count for the biological activity of the drug. Experiments directed toward eval-
uating the various hypotheses are delineated. Once the mechanism or mecha-
nisms are known, it should be possible to design new and better antitumor drugs
which, if successful, would be the ultimate proof of the validity of the hy-
potheses. This topic is discussed in the next and final section of the chapter.
Such an analysis could, in principle, be applied to probe the molecular mecha-
nisms of the other metals used in medicine described previously. In fact, it is
hoped that the approach will prove valuable to students and researchers in these
other areas, where much less information is currently available at the molecular
level.
The material in this section has been organized in the following manner.
First we discuss the relevant inorganic chemistry of platinum complexes in bi-
ological media. Next we summarize the evidence that DNA is a major target of
cisplatin in the cancer cell, responsible for its antitumor activity. The chemical,
physical, and biological consequences of damaging DNA by the drug are then
described, followed by a presentation of the methodologies used to map its
binding sites on DNA. The detailed structures of the DNA adducts of both
active and inactive platinum complexes are then discussed, together with the
way in which the tertiary structure of the double helix can modulate these struc-
tures. Finally, the response of cellular proteins to cisplatin-damaged DNA is
presented, leading eventually to hypotheses about how tumor cells are selec-
tively destroyed by the drug. Together these events constitute our knowledge of
the' 'molecular mechanism," at least as it is currently understood.
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1. Reactions of cis-DDP and related compounds in aqueous,
biological, and other media
cis-Diamminedichloroplatinum(II) is a square-planar d8complex. As such,
it belongs to a class of compounds extensively investigated by coordination
chemists. 55 Typically, such compounds are relatively inert kinetically, do not
usually expand their coordination numbers, and undergo ligand substitution re-
actions by two independent pathways with the rate law as given by Equation
(9.4). The rate constants k1 and k2 correspond to first-order (solvent-assisted) and
second-order (bimolecular) pathways;
Rate = (k1 + k2[YD [complex] (9.4)
[Y] is the concentration of the incoming ligand. Usually, k1 < < k2 by several
orders of magnitude. In biological fluids, however, the concentration of a poten-
tial target molecule could be ~1O -6 M, in which case k1 2: k2[y]. Substitution
of ligands in cis-DDP, required for binding to a cellular target molecule, is
therefore likely to proceed by the solvent-assisted pathway. Such a pathway is
assumed in the ensuing discussion.
For the hydrolysis of the first chloride ion from cis- or trans-DDP,
(9.5)
the k1values at 25°C are 2.5 x 10 - 5 and 9.8 x 10 - 5S - 1, respectively. 55 These
hydrolyzed complexes can undergo further equilibrium reactions, summarized
by Equations (9.6) to (9.9).
[Pt(NH3hCI(OH2)J +~ [Pt(NH3hCI(OH)1 + H +
[Pt(NH3hCI(OHdl + + H20~ [Pt(NH3h(OH2hj2+ + CI-
[Pt(NH3h(OH2h1 2 +~ [Pt(NH3h(OH2)(OH)] + + H +
[Pt(NH3h(OH2)(OH)J +~ [Pt(NH3h](OHh] + H +
(9.6)
(9.7)
(9.8)
(9.9)
The formation of dimers such as [Pt(NH3h(OH)h 2 + and higher oligomers can
also occur,56,57 but such reactions are unlikely to be important at the low plati-
num concentrations encountered in biological media, Reactions (9.5) to (9.9),
which depend on pH and the chloride-ion concentrations, have been followed
by 195pt (I = i, 34.4 percent abundance) and 15N (using enriched compounds)
NMR spectroscopy. The latter method has revealed for the cis-diammine com-
plexes pKa values of 6.70 ± 0.10 at 25°C for Reaction (9.6) and of 5.95 ± 0.1
and 7.85 ± 0.1 at 5°C for Reactions (9.8) and (9.9), respectively.58
The effects of pH and Cl - ion concentration on the species distribution of
platinum compounds have been used to fashion the following plausible argu-
ment for the chemistry of cis-DDP in vivo. 59 With the use of thermodynamic
data for the ethylenediamine (en) analogue [Pt(en)ChL the relative concentra-
tions of hydrolyzed species at pH 7.4 were estimated (see Table 9.3) for blood
plasma and cytoplasm (Figure 9.7). The higher chloride ion concentration in
Table 9.3
Distribution of various adducts formed between cis-DDP or [3H][Pt(en)Clda and DNA in vitro and in vivo.118-122
Adducts formed
Total Mono-
incubation functional Remaining
DIN ratio time cis-[PtA2{d(pGpGl}lb cis-[PtA2{d(pApGl}lb cis-[PtA2{d(GMPlhlb adducts platinum C
In vitro
0.055< 5 h (50°C) 47-50% 23-28% 8-10% 2-3% 10%
0.022d 5 h (50°C) 60-65% 20% ~4% ~2% 9-14%
O.Ol e 16 h (37°C) 62% 21% 7% 10%
ef 30 ill (37°C) 36% 3% 8% 40% 13%
ef 2 h (37°C) 54% 9% 9% 14% 14%
ef 3 h (37°C) 57% 15% 9% 4% 15%
In vivo
dg 1 h (37°C) 35.9 ± 4.7%h <34%' 3.1 ± 1.6%h 38.5%i ~22%
dg 25 h (37°C) 46.6 ± 6.8%h <48%i 3.0 ± 0.9%h <14.5%i ~50%
a A radiolabeled analogue of cis-DDP, [3Hldichloroethylenediamineplatinum(IIl.
b A2 represents either (NH3h or ethylenediamine.
< By difference.
d Percentage of adducts based on total amount of platinum eluted from the separation column.
e Percentage of adducts based on total amount of radioactivity eluted from the separation column.
f Not given.
g Chinese hamster ovary cells treated with 83 ILM cis-DDP.
h Results from ELISA.
i Results from AAS. Where the signal was too weak for reliable quantitation, the maximal amount possible is given. Adapted from Table
I in Reference 8I.
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Figure 9.7
Hydrolysis reactions of antitumor platinum complexes and an estimate of the species
present in plasma and cytoplasm (reproduced by permission from Reference 51).
plasma preserves the complex as the neutral molecule cis-DDP, which passively
diffuses across cell membranes. The lower intracellular chloride ion concentra-
tion facilitates hydrolysis reactions such as Equations (9.5) to (9.9), thereby
activating the drug for binding to its biological target molecules. There is, of
course, a reasonable probability that cis-DDP and species derived from it will
encounter small molecules and macromolecules in vivo that divert it from this
route to the target. We have already seen such cases; cisplatin binds to serum
proteins, and there is good evidence that intracellular thiols react with the drug. 60
Glutathione, for example, is present in millimolar concentrations in cells. How,
one might ask, does cisplatin swim through such a sea of sulfur donors to find
its target in the tumor cell? Is it possible that a modified form of the drug, in
which a Pt-CI bond has been displaced by thiolate to fonn a Pt-S bond, is the
actual species responsible for its activity? Although these questions have not yet
been satisfactorily answered, there is reason to believe that such reactions are
not directly involved in the molecular mechanism of action. As evident from
structure-activity relationship studies, the most active compounds have two la-
bile ligands in cis positions. If Pt-S bonds were required, then compounds al-
ready having such linkages would be expected to exhibit activity and they do
not. Rather, it seems most likely that the antitumor activity of cisplatin results
from surviving species of the kind written in Equations (9.5) to (9.9) that find
their way to the target molecule, and that the induced toxicity must arise from
a significantly disruptive structural consequence of drug binding. Since only cis
complexes are active, it is reasonable for the coordination chemist to infer that
the stereochemistry of this interaction is of fundamental importance.
Reactions of platinum compounds with components in media used to dis-
solve them can give and undoubtedly have given rise to misleading results, both
in fundamental mechanistic work and in screening studies. A particularly note-
worthy example is dimethylsulfoxide (DMSO), which even recently has been
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used to dissolve platinum compounds, presumably owing to their greater solu-
bility in DMSO compared to water. As demonstrated by 195pt NMR spectros-
copy, both cis- and trans-DDP react rapidly (1112 = 60 and 8 min at 37°C, re-
spectively) to form [Pt(NH3hCI(DMSO)] + complexes with chemical and biological
reactivity different from those of the parent ammine halides. 61
2. Evidence that DNA is the target
Two early sets of experiments pointed to interactions of cisplatin with DNA,
rather than the many other possible cellular receptors, as an essential target
responsible for cytotoxicity and antitumor properties. 62,63 Monitoring the uptake
of radiolabeled precursors for synthesizing DNA, RNA, and proteins, showed
that [3H]thymidine incorporation was most affected by therapeutic levels of cis-
platin for both cells in culture and Ehrlich ascites cells in mice. Since indepen-
dent studies showed that cis-DDP binding to DNA polymerase does not alter its
ability to synthesize DNA, it was concluded that platination of the template and
not the enzyme was responsible for the inhibition of replication.
In a second kind of experiment demonstrating that DNA is a target of cis-
platin, hydrolyzed forms of the drug in low concentrations were added to a
strain of E. coli K12 cells containing a sex-specific factor F. 64,65 After free
platinum was removed, these F + cells were conjugated with a strain of E. coli
K12 cells lacking this factor that had previously been infected with lambda
bacteriophage. Addition of cis-DDP, but not trans-DDP, directly to the latter
infected F - cells had been shown in a separate study to accelerate cell lysis.
Conjugation with the platinum-treated F + cells produced the same effect, strongly
suggesting that Pt had been transferred from the F + to the F cells. Since only
DNA is passed between the F + and F - strains, it was concluded that Pt was
attached to the DNA and that this modification was essential for the observed
lysis of the cell. Further studies showed a good correlation between cell lysis
by platinum compounds and their antitumor properties.
Various other observations are consistent with the notion that platinum bind-
ing to DNA in the cell is an event of biological consequence. 66 The filamentous
bacterial growth observed in the original Rosenberg experiment is one such piece
of evidence, since other known DNA-damaging agents, for example, alkylating
drugs and x-irradiation, also elicit this response. Another is the greater sensitiv-
ity toward cis-DDP of cells deficient in their ability to repair DNA. Finally,
quantitation of the amount of platinum bound to DNA, RNA, and proteins re-
vealed that, although more Pt was bound to RNA per gram biomolecule, much
more Pt was on the DNA when expressed as a per-molecule basis. In the ab-
sence of any selective interaction of Pt with a specific molecule, only one out
of every 1,500 protein molecules (average M.W. ~ 60 kDa) in a cell will con-
tain a single bound platinum atom, whereas hundreds or thousands of Pt atoms
are coordinated to DNA (M.W. ~ 1011). If the replication apparatus cannot
bypass these lesions, then cell division will not occur, and tumor growth is
inhibited.
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Although these and other results all point to DNA as an important cellular
target of cisplatin, most likely responsible for its anticancer activity, this infor-
mation does not explain why tumor cells are more affected by cis-DDP than
non-tumor cells of the same tissue. Moreover, why is trans-DDP, which also
enters cells, binds DNA, and inhibits replication, albeit at much higher doses
(see discussion below), not an active anticancer drug? What causes cisplatin to
kill cells and not merely to arrest tumor growth? The latter can be explained by
DNA synthesis inhibition, but not necessarily the former. Very recent studies
have begun to address these questions using powerful new methodologies of
molecular and cell biology, as described in subsequent sections of this chapter.
The results, although preliminary, continue to point to DNA as the most impor-
tant cellular target of cisplatin.
3. Aspects of platinum binding to DNA
Given that DNA is a major target of platinum binding in cells, it is incum-
bent upon the bioinorganic chemist to investigate the nature of these interactions
and their biological consequences. Of all the ligands studied in coordination
chemistry, DNA is surely among the most complex. In the ensuing discussion,
we first present experiments that delineate the chemical steps involved in cis-
and trans-DDP binding to DNA as well as the chemical consequences of the
adducts formed. We next describe the physical changes in the double helix that
accompany platinum binding, and then we discuss the biological consequences
that attend the platination of DNA. Subsequent sections describe the major ad-
ducts formed, in other words the regiospecificity of the drug, the three-dimen-
sional structures of the adducts, and the way in which different structures within
DNA can modulate platinum binding. Finally, we consider the response of the
cell to Pt-DNA adducts, including studies with site-specifically modified DNA,
and speculate about how this chemistry might relate to the antitumor drug mech-
anism.
a. Kinetics of Platinum Binding to DNA The binding of cis- and trans-
DDP to DNA has been studied 67 by 195pt NMR spectroscopy with the use of
isotopically enriched 195Pt, which has a nuclear spin I = !. The DNA used in
this experiment was obtained from chicken red blood cell chromosomes that had
been enzymatically degraded to relatively small pieces ranging from 20 to 60
base pairs in length (molecular-weight range 13 to 30 kDa). Since the 195Pt
chemical shifts are very sensitive to chemical environment, this NMR study
provided important details about the kinetics and mechanism of platinum bind-
ing to the biopolymer. The rate-determining step in platination of the DNA is
loss of chloride ion (Equation 9.5) to form the monoaqua complex, which rap-
idly coordinates to a nitrogen donor on the nucleic acid. The identification of
the coordinating atom as nitrogen was possible because the 195pt chemical shift
is characteristic of species having one chloride and three nitrogen ligands bound
to Pt(II).67 The spectroscopic changes that accompany the formation of the fam-
ily of monofunctional adducts are shown in Figure 9.8. Subsequent hydrolysis
cis-DDP
monofunctional
adducts
o(ppm)
bifunctional
adducts
Figure 9.8
Time course of the reaction between double-stranded chicken erythrocyte DNA and
cis-[Pt(NH3h<HzO)CI] + at a DIN = 0.07, in 3 mM NaCl and I mM NaHzP04 , 37°C, pH 6.5.
Each spectrum consists of 200,000 transients. The inset shows the sum of the individual spectra
(reproduc;ed by permission from Reference 67).
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of the second chloride ion leads to the formation of a second bond with DNA.
This sequence of events affords bifunctional adducts and is similarly accompa-
nied by discrete 195pt spectral changes (Figure 9.8). From the 195pt chemical-
shift range of the final products, it was apparent that the cis-{Pt(NH3hP+ moiety
is bound primarily to two nitrogen donors on the nucleic acid. This chemistry
is summarized in Equation (9.10), together with the half-lives for the mono-
-CI- + DNA[Pt(NH3lP2] = [Pt(NH3l2CI(Hpl] ------
cis- or trans-DDP
[Pt(NH3)pJ-DNA
monofunctional adducts
[Pt(NH3l2]=DNA
bifunctional adducts (9.10)
~ ~
[Pt(NH3l2(H20l]-DNA
t l /2: cis-DDP, 1.9 h; trans-DDP, 2.0 h
functional adducts. The half-lives were calculated from a kinetic analysis of the
time-dependence of the 195pt spectral changes. As can be seen, the rates of
closure of mono- to bifunctional adducts for the two isomers are quite similar,
suggesting that their different biological properties are not a consequence of the
kinetics of binding to DNA.
The next logical question to address is what donor atoms on DNA are co-
ordinating to platinum in the mono- and bifunctional adducts. This important
issue is discussed in considerable detail in Sections V.DA and V.D.S. As will
be shown, the N7 atoms of the purine bases adenine and guanine are the prin-
cipal binding sites. Alkylation of DNA at these positions facilitates depurina-
tion. Platinum binding to N7 atoms of purines (Figure 9.9), however, stabilizes
the glycosidic (N9-C1') linkage. 68- 7o Presumably the positive charge is better
distributed over the platinum atom and its ligands in the adduct than over a
purine alkylated at N7. On the other hand, platinum binding to N7 of guanine
does perturb the charge distribution in the purine ring, as evidenced by the
lowering of the pKa of NI by = 2 units from its value in the unplatinated nu-
cleotide (usually from pKa = 10 to pKa = 8).71,72 This effect has been used to
assign platinum binding sites in DNA fragments, as discussed below.
What are the chemical changes at the platinum center when cis-DDP binds
to DNA? Both chloride ions are lost from the coordination sphere, as already
indicated. Platinum EXAFS studies of calf-thymus DNA modified with cis-DDP
revealed no chlorine backscattering features characteristic of Pt-CI bonds. 73 The
spectra were consistent with the presence of four Pt-N/O linkages, since the
technique is unable to distinguish between the two low-Z elements oxygen and
nitrogen. Various studies reveal that, under most circumstances, the NH3ligands
are not lost from DNA upon the binding of platinum ammine halides. For ex-
ample, when 14C-Iabeled cis-[Pt(NH2CH3hChJ was allowed to bind to T7 (47
percent GC content) or M. luteus (73 percent GC content) DNA, no loss of
radiolabel was found to accompany platinum binding. 74 In vivo, however, loss
of amine ligands has been observed. Injection of 195mpt and l4C doubly labeled
adenine
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Figure 9,9
Structural components of DNA. The left panel shows a schematic of the DNA backbone, in-
cluding the deoxyribose ring numbering scheme and torsion angles. The center panel gives the
two main classes of sugar pucker and base orientations. The right panel gives the bases in their
Watson-Crick, A-T, and G-C pairs and the base numbering scheme, viewed down the helix
axis, with the major grooves pointing toward the top of the figure and the minor grooves toward
the bottom.
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[Pt(en)CI2] into tumor-bearing mice resulted in unequal distribution of the two
labels in various biochemical fractions, but there is no reason to believe that
this result is relevant to the antitumor mechanism. 75 Metabolic inactivation of
the drug could occur in a variety of ways unrelated to anticancer activity. The
best evidence that ammine loss does not occur at the critical biological target of
cisplatin is the finding, by using antibodies specific for cis-{Pt(NH3hP+ nucleo-
tide complexes (see Section V.D.4.c), that DNA, extracted from cells in culture
or from human cancer patients treated with cis-DDP and subsequently degraded,
contains intact Pt-NH3 Iinkages. 76
Once bonds are made between Pt and its targets on DNA, they are relatively
inert kinetically. Platinum-DNA complexes can be subjected to various physical
methods of separation and purification, including gel electrophoresis, ethanol
precipitation, centrifugation, and chromatography, as well as to enzymatic and
even chemical degradation procedures that digest the DNA, without releasing
the platinum. Platinum can be removed, however, either by use of cyanide ion,
to form the very stable (K ~ 10 41 ) [Pt(CN)4]2- complex, or by excess thi-
ourea. 77,78 These properties have proved to be extremely valuable in facilitating
localization and characterization of the major cis- and trans-DDP binding sites
on DNA.
Although Pt-DNA linkages are, generally speaking, kinetically inert, some-
times a particular adduct will rearrange into a more stable linkage isomer. One
interesting example is the product of the reaction of trans-DDP with the dode-
canucleotide 5' -d(TCTACGCGTTCT). 79 Initially the platinum coordinates to the
two guanosine residues, forming a trans-[Pt(NH3h{d(GCG)}] 1,3-intrastrand
crosslink. This complex rearranges to a more stable trans-[Pt(NH3h{d(CGCG)}]
1,4-intrastrand crosslink with a half-life of 129 h at 30°C or 3.6 h at 62°C. In
this rearrangement product the platinum is coordinated to a cytosine and a guan-
osine residue.
As just described, the binding of bifunctional platinum complexes to DNA
proceeds in a stepwise fashion. The second step is sufficiently slow (a few
hours), however, that various reagents such as NH3 , nucleobases, and low con-
centrations of thiourea can coordinate to the fourth site and trap the monoad-
ducts. Generally speaking, however, given sufficient time both cis- and trans-
DDP will bind DNA in a bifunctional manner. As such, they bear some resem-
blance to organic alkylating agents, such as the nitrogen mustards, which have
been employed as anticancer agents. 80
b. Crosslinking Reactions of Platinum Complexes There are three broad
classes of DNA adducts that can be made by bifunctional platinum complexes.
As illustrated for cis-DDP in Figure 9.10, they are DNA-protein crosslinks,
interstrand DNA-DNA crosslinks, and intrastrand crosslinks,81 A fourth possi-
bility for platinum complexes is bidentate chelate ring formation utilizing two
donor atoms on a nucleotide. For many years, a favored such postulated mode
of binding was chelation by the N7-06 positions of the guanine base (Figure
9.9), since this structure could be formed only by cis- and not by trans-DDp.82,83
interstrand crosslink intrastrand crosslink
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DNA-protein crosslink bifunctional binding to guanine
Figure 9.10
Possible bifunctional binding modes of cis-DDP with DNA
(reproduced by permission from Reference 81).
Such a structure has never been observed for cis-DDP binding to DNA, how-
ever. DNA-protein and interstrand crosslinks formed by platinum complexes
have been the focus of many attempts to explain cytotoxicity and antitumor
behavior. 84 The technique of alkaline elution, in which crosslinked DNA-DNA
strands or DNA-protein molecules bind to filter paper following denaturation
under basic conditions, sensitively and easily reveals such adducts. trans-DDP
forms such adducts more rapidly than the cis isomer, perhaps because of its
faster chloride-ion hydrolysis rates (see above) and a more favorable geometry,
but they also seem to be repaired more rapidly in cells. As will be shown,
interstrand and DNA-protein crosslinks are a small minority of adducts formed
by cisplatin, and their contribution to the cytotoxic and anticancer properties of
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the drug remains to be established. In studies of SV40 replication in vivo, DNA-
protein crosslinking by cis- and trans-DDP was shown not to be correlated with
the inhibition of DNA replication. 85
What proteins form crosslinks to DNA? One possibility is the histones that
make up the spools around which DNA is wound when packaged into chromatin
in the nucleus. Studies 86 of cis- and trans-DDP binding to nucleosome core
particles (each particle made up of eight histone proteins; around each particle
is wound a 146-bp piece of DNA in a shallow superhelix of 1.75 turns) revealed
the DNA binding to be little affected by the protein core. Both DNA-protein
and specific histone crosslinked species were observed; from the latter it was
suggested that DDP complexes might be useful crosslinking probes of biological
structures. Other proteins likely to form crosslinks to DNA in the presence of
platinum complexes are DNA-processing enzymes, or enzymes requiring a DNA
template for normal function. In the in vivo SV40 study, for example, T antigen
was one of the proteins found to be crosslinked to SV40 DNA by cisplatin. 85
Other nuclear proteins such as the high-mobility group (HMG) class are also
crosslinked to DNA in the presence of cis-DDP. In all cases so far, DNA-
protein crosslinking has occurred when platinum was added to cells. There is as
yet no evidence that transfection of platinated DNA into cells results in such
crosslinking or that crosslinks form during in vitro enzymatic digestions of plat-
inated DNAs.
c. Physical Effects of Platinum-DNA Binding
(i). Unwinding, shortening, and bending of the double helix Early studies
of cis- and trans-DDP binding to DNA employed closed and nicked circular
plasmids. 87 As was described in more detail in Chapter 8, closed circular DNAs
are topologically constrained such that any change in the number of helical turns
must result in an equal and opposite number of superhelical turns. Any reagent
that unwinds the double helix reduces the number of helical turns. Consider, for
example, a stretch of DNA that is 360 base pairs (bp) long. Normal B-DNA
has =10.5 bp per turn or a helical winding angle of = 34.3° per bp. Suppose
the DNA is unwound, so that there are now 12 bp per turn or a winding angle
of = 30°. Instead of 34.3 helical turns (360 -;- 10.5), the DNA now has only
30 (360 -;- 12). If this DNA molecule were in the form of a covalently closed
circle, the helical unwinding of -4.3 turns would be accompanied by a super-
helical winding of +4.3 turns.
Planar organic dyes such as ethidium bromide (EtdBr) and inorganic com-
plexes such as [Pt(terpy)(HET)] + (Figure 9.11) bind to DNA by intercalation,
inserting between the base pairs and unwinding the double helix by ~ 26° per
molecule bound (Figure 9.12).88 This unwinding can be measured by monitoring
changes in the superhelicity of closed circular DNA. This kind of DNA is sub-
jected to certain topological constraints that lead to the formation of supercoils
and superhelical winding that dramatically alter the hydrodynamic properties of
the DNA. Either gel electrophoresis or analytical ultracentrifugation can be used
to measure this phenomenon. The platinum complexes cis- and trans-DDP also
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Organic (top) and inorganic (bottom) intercalators.
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Schematic representation of double-stranded DNA without (left)
and with (shaded area, right) a bound intercalator (reproduced
with permission from Reference 51).
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Figure 9.13
Electrophoresis in I percent agarose gels of nicked and closed circular PSMI DNA incubated
with (a) cis- and (b) trans-[Pt(NH3hClz] as function of time. After electrophoresis, gels were
stained with ethidium bromide. Reproduced with permission from Reference 51.
produce changes in the superhelix density when bound to closed circular DNA. 87
As shown in Figure 9.13, increasing concentrations of platinum bound per nu-
cleotide on the DNA first retard its mobility and then increase its mobility through
the gel. These interesting alterations in gel mobility occur because the nega-
tively coiled superhelix unwinds first into an open, or untwisted, form and then
into a positively supercoiled form. The conformational changes, which are de-
picted in Figure 9.14, are directly proportional to the drug-per-nucleotide, or
(DlNh, ratio. In addition to superhelical winding, both platinum complexes in-
crease the mobility of nicked circular DNA in the gels (Figure 9.13). Nicked
DNA has one or more breaks in the sugar-phosphate backbone, which relieve
the topological constraint and prohibit the DNA from twisting into superhelical
structures.
What could be the cause of these physical changes in the DNA structure
upon cis- or trans-DDP binding? Intercalation can be excluded, not only be-
cause the compounds do not have the aromatic character normally associated
with intercalators (Figure 9.11), but also through studies of the manner by which
these and other platinum complexes inhibit the intercalative binding of EtdBr to
DNA. 89,90 Platinum metallointercalators such as [Pt(terpy)(HET)] + are compet-
itive inhibitors of EtdBr binding, as measured by fluorescence Scatchard plots,
whereas the non-intercalators cis- and trans-DDP are not. Moreover, intercala-
tion tends to lengthen and stiffen the double helix, whereas the mobility changes
of nicked circular DNAs upon binding of cis- or trans-DDP were shown by
electron microscopy experiments to arise from a pronounced shortening of the
DNA with increased Pt binding.
One manner by which cis- or trans-DDP might produce these physical al-
terations in DNA structure is by kinking the double helix at or near the binding
site. Such an effect could be produced by the bidentate attachment of platinum;
the monofunctional [Pt(dien)Cl] + complex does not have these pronounced ef-
Negatively supercoiled DNA
j 1
Relaxed DNA
j 1
Positively supercoiled DNA
Figure 9.14
Topological fonns of closed circular DNA.
fects on DNA secondary structure. 91 Recently, it has been demonstrated that cis-
DDP binding to DNA does indeed produce a pronounced bend in the helix
axis. 92,93 The proof employed a gel-electrophoretic method of analysis that had
previously been used to study DNA bending at naturally occurring specific se-
quences called A-tracts, consisting of five or six adenosine nucleosides in a row
followed by about the same number of thymidine residues. 94 When these d(AsTsh
sequences are positioned in the center of a DNA restriction fragment of, say,
150 bp, the mobility of the DNA through polyacrylamide electrophoresis gels is
greatly retarded compared to that of a similar DNA fragment where the A-tract
is at the end. For the former fragment, the bent molecules presumably cannot
snake their way through the pores of the polyacrylamide as well as the mole-
cules whose bends are at the ends and have little effect on the linear structure.
It was further shown that A-tracts bend the duplex toward the minor groove of
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the DNA. Moreover, in a DNA containing multiple A-tracts, the bends must be
separated by integral numbers of helical turns (~ 10.5 bp) or else the effect will
cancel and the gel mobility will be that of normal DNA of similar length. This
latter phenomenon has been referred to as phasing.
With this background information in mind, we can now discuss the experi-
ments with cis-DDP that demonstrated bending. 92•93 By methods described in
Section V.D.8, a 22-bp oligonucleotide (22-mer) containing self-complementary
overhanging ends ("sticky ends") was synthesized with a single cis-diammi-
neplatinum(II) moiety linking adjacent guanosine residues (Figure 9.15A). A
22-mer was chosen since it has approximately two helical turns, accounting for
some platinum-induced unwinding, and will thus have phased bends when po-
lymerized. This platinated DNA was then labeled with 32p and treated with the
enzyme DNA ligase, which seals the ends, producing oligomers of the 22-mer
having lengths 22, 44, 66, 88, 110, etc., bp. In these oligomers, the platinum
atoms are spaced apart approximately by integral numbers of helical turns. As
shown in Figure 9.15, studies of this family of oligomers by gel electrophoresis
revealed a pronounced retardation compared to the mobility of unplatinated DNA
oligomers of comparable size (line P22 in Figure 9.15B). The plots in this figure
show the relative mobilities (Rd of the different length multimers, compared to
a control in which the top strand is not platinated, as a function of the length in
base pairs. From the resulting curves may be extracted the extent of cooperative
bending. When oligomers of a platinated DNA fragment in which the metal
atoms were spaced apart by 27 bp were examined, their relative mobilities were
found to be nearly the same as unplatinated control molecules (line P27 in Fig-
ure 9.15B). These experiments unequivocally established that platinum kinks
the double helix. As with A-tract-induced bends, the platinum atoms must be
phased in order to induce cooperative bending. Comparison of the magnitudes
of the gel mobility changes made it evident that cis-{Pt(NH3h}2+ binding pro-
duces a bend comparable to that of two A-tracts, = 34°.
In a related series of experiments,93 the platinated 22-mer was copolymer-
ized with various A-tract-containing Il-mers to produce ladders of oligomers in
which the phasing of Pt with respect to the center of the A-tract was varied, but
the Pt atoms were always in phase. The results of these studies showed that
maximum gel-mobility retardation occurred when the Pt and A-tract center were
spaced apart by half-integral numbers of helical turns (Figure 9.15C). Since A-
tracts bend the DNA into the minor groove, this result implies that platinum
bends the DNA into the major groove. Only when phased by nl2 (n = integer)
turns will copolymers of species situated alternatively in the major and minor
grooves of DNA exhibit such cooperative bending. It will be shown later that
helix bending of cis-DDP-DNA adducts into the major groove is in accord with
their known structures.
The ability to prepare site-specifically platinated oligonucleotides (see Sec-
tion V.D.8) has provided a means for measuring the extent to which cis-DDP
produces local unwinding of the double helix. 95 When the platinum atoms are
positioned with respect to one another, or phased, by exactly integral numbers
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Experiment to demonstrate that cis-lPt(NH3h{d(pGpG)}] intrastrand crosslinks bend duplex DNA
by =34°. Panel A shows the platinated 22-mer sequence, panel B the effect of platination on the
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Figure 9.16
Plot showing the relative mobility (RL ) versus actual length curves
for the oligomers cis-GG-20, cis-GG-21, cis-GG-22, and cis-GG-23,
denoted as 20,21,22, and 23, respectively.
of helical turns, the retardation of the DNA multimers in the gel is maximized.
This phenomenon is illustrated in Figure 9.16, where the RL values are plotted
as a function of the interplatinum spacing for oligonucleotides containing the
cis-{Pt(NH3hd(GpG)} intrastrand crosslink. When the resulting curve was ana-
lyzed, the maximum was found to occur at 21.38 bp. Since normal B-DNA has
a helical repeat of 10.5 bp, one can compute the effect of platination from the
expression [(21.38 - 2(10.5)] bp = 0.38 bp. From the fact that one helical
tum of DNA comprises 360° and 10.5 bp, the unwinding of the DNA double
helix due to the presence of a single cis-{Pt(NH3hd(GpG)} intrastrand crosslink
can be calculated as
(0.38110.5) x 360 = 13°.
Similar studies of DNA platinated with trans-DDP have been carried out.
In these, oligonucleotides containing the 1,3-trans-{Pt(NH3hd(GpNpG)} intra-
strand crosslink were examined. The electrophoresis gels of polymerized 15-
mers and 22-mers containing this adduct showed cooperative bending. This re-
sult indicates that bends at the sites of platination by trans-DDP are not phase
sensitive, and has been interpreted to imply the formation of a "hinge joint" at
these positions. 92•95 The directed bends and local unwinding of DNA produced
by cisplatin could be an important structural element that triggers a response by
cellular proteins. This subject is discussed in greater detail in Section V.D.7.d.
d. Biological Consequences of Platinum-DNA Binding
(i). Inhibition of replication Binding of cis-DDP to DNA inhibits replica-
tion both in vivo and in vitro, as shown by a variety of assays. Inhibition of
replication of SV40 viral DNA in African green monkey cells as a function of
the concentration of added cis-DDP is shown in Figure 9.17. When SV40 virus
infects monkey cells, it does not integrate its DNA into the genome of the host.
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SV40 DNA replication in CV-l cells as a function of platinum concentration in the medium
(panel A) or DIN (panel C). In panel B, DIN is plotted as a function of platinum concentration
in the medium. SV40-infected cells were treated with cis-DDP (e) or trans-DDP (0) at the indi-
cated concentrations for 40 h. SV40 DNA replication relative to control (untreated) cells was
measured by incorporation of [3H]thymidine, added after the first 24 h of platinum treatment,
and Pt in isolated SV40 chromosomes was measured by AAS. The data shown are from a repre-
sentative experiment. Experiments were carried out in quadruplicate. Reproduced by permission
from Reference 85.
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Instead, it forms its own chromosomes in the cell nucleus. These so-called mini-
chromosomes consist of = 20 nucleosomes, fundamental chromosome building
blocks. SV40 has its own life cycle, using virally encoded and cellular proteins
to replicate and, ultimately, reassemble virus particles before lysing the cell and
departing to infect neighboring cells.
In the experiment shown in Figure 9.17, the SV40-infected cells were treated
with cisplatin. After 24 h, [3H]thymidine was added and, after 24 more hours,
the cells were harvested, and SV40 DNA was isolated; the amount of DNA
synthesis was recorded by comparing incorporated radiolabel with results from
control experiments where no platinum was present. The data show that, when
25 pM platinum was present, SV40 DNA replication was reduced to about 5
percent of control. Quantitation reveals that, at =2 platinum atoms bound per
thousand nucleotides (drug-per-nucleotide, or (DlNh, = 0.002), synthesis is only
10 percent that of control.
Recently, a related series of experiments has been carried out that can mon-
itor DNA synthesis from templates platinated in vitro. 96 In this work, DNA
plasmids containing the SV40 origin of replication are added to cellular extracts
prepared from human kidney cells previously infected with adenovirus. In the
presence of large T antigen, a virally encoded protein required for replication,
SV40 DNA is synthesized from the plasmid templates. Synthesis can be con-
veniently monitored by P2p]dATP incorporation. At a (D/Nh ratio of only
1.7 X 10 -3, DNA synthesis is about 5 percent of control, in agreement with
the results of the in vivo study.
The binding of cis-DDP to DNA has also been measured for normal and
tumor cells implanted in nude mice and in cells obtained from the ascites fluid
of patients with ovarian carcinoma 24 h after their last dose. 97 The data for
mouse bone marrow and a human pancreatic tumor xenograft show that, at a
dose of 10 mg/kg, (D/Nh platinum binding levels of 3.3 x 10 -6 and
1.82 x 10 -6 reduce survival to 20 and 10 percent of control, respectively. These
ratios are in good accord with platinum levels required to inhibit DNA synthesis
in mammalian cells, as revealed by various studies, but substantially less than
that needed for replication inhibition in the SV40 experiments described above.
The difference can be readily explained, illustrating an important point. The
SV40 genome, like most other DNAs of viral or plasmid origin, consists of
only 15,000 nucleotides whereas the nuclear DNA of mammals has about 10 9
nucleotides. Thus, (D/Nh levels of ~ 10 -6 would leave 99 out of 100 SV40
DNA molecules with no platinum at all, and replication would hardly be af-
fected. For the mammalian genome, (D/Nh values of 10 -6 place 103platinum
atoms on each DNA genome, sufficient to inhibit replication and reduce cell
survival. Platinum-DNA binding levels of this magnitude are found for ovarian
ascites cells taken from patients receiving cisplatin chemotherapy.97
(ii). Mutagenesis and repair Apart from inhibition of DNA synthesis, what
are the other biological consequences of cisplatin binding to DNA? One such
consequence is mutagenesis, in which a normal base in the sequence is replaced
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by a different base. This phenomenon has been demonstrated for cis-DDP-treated
cells in a variety of studies. What brings about such mutagenesis? There are
several possibilities. One is that errors are introduced in DNA strands during
attempts of the replication apparatus to synthesize past a platinum lesion. An-
other is that the platinum-damaged DNA is recognized by cellular repair systems
that, in attempting to eliminate the platinated stretch of DNA, incorporate one
or more incorrect nucleotides. Platinum-induced mutagenesis can lead to dele-
terious long-term health problems in patients treated with cisplatin. It is there-
fore important to understand the mechanism by which cellular DNA becomes
mutated following platination, and to devise strategies for minimizing or elimi-
nating this mutagenesis.
The foregoing considerations bring up another biological consequence of
cis-DDP binding, namely, DNA repair. Removal of platinum from DNA by
cellular repair mechanisms has been demonstrated by several groups. For ex-
ample, in studying cis-DDP-treated human fibroblast cells in culture, it was
found that the amount of bound platinum per nucleotide decreased according to
first-order kinetics, from (D/Nh of 2.3 x 10 -5 to 3.3 x 10 -6 over a six-day
period. Since Pt-DNA adducts are stable with respect to dissociation from DNA
under physiological conditions (see above discussion), loss of platinum was at-
tributed to DNA repair. 98
How does the cell remove platinum from DNA? One mechanism is by a
process known as excision repair, whereby the sugar-phosphate backbone on the
platinated strand is hydrolyzed (' 'nicked") on either side of the damage and the
remaining, unplatinated strand is used as a template for new DNA synthesis.
The platinated oligonucleotide is displaced and the resulting gap filled in. In
support of this picture is the fact that, in xeroderma pigmentosum (XP) human
fibroblast cells, known to be deficient in excision repair, there is very little
removal of platinum during post-treatment incubation. 99 Recent studies of in
vitro repair of cisplatin-DNA adducts by a defined enzyme system, the ABC
excision nuclease of E. coli, have provided some details at the molecular level
about the process. lOO •101 [ 32P]-Labeled double-stranded DNA fragments contain-
ing {Pt(NH3hP+ or {Pt(en)p+ adducts at random or defined sites were incu-
bated with the enzyme. Cleavage of the platinated strand occurred at the 8th
phosphodiester bond 5', and the 4th phosphodiester bond 3', to the GG or AG
intrastrand crosslink. Further details about the identification and construction of
such specific crosslinks will be given later in this chapter.
(iii). Drug resistance Another biological consequence of DNA-platinum
interactions, probably related to the repair phenomenon, is resistance. Resis-
tance of a cell to a chemotherapeutic agent, which can be inherent or acquired,
is a phenotypical ability of the cell to tolerate doses of a drug that would be
toxic to normal, or parent, cells. 102 Resistance is often acquired by prolonged
exposure of cells in culture to the drug or, in patients, to repeated doses of drug
therapy. There is not yet any direct proof that platinum-DNA interactions are
responsible for acquired resistance to cisplatin. Studies of sensitive and resistant
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tumors in rats have shown, however, that after intravenous injection of 10 mg/
kg of the drug, the platinum levels were the same after an hour, but after 24
hours a larger proportion of adducts had been removed in the resistant cells. 103
Similar results have been found for studies of Pt-DNA adducts in cultured LI210
cells of varying levels of resistance to cisplatin where, in the 18 h following a
6-hour incubation with the drug, the resistant cells had up to fourfold more
platinum removed than the sensitive cells. 104
Experiments have also been carried out showing that cis-DDP binding to
DNA inhibits transcription, the formation of RNA from a gene, and that this
phenomenon is less efficiently reversed for parent versus resistant Ll210 cells
in culture. 105 The assay involves transfection (the process whereby free or viral
DNA or RNA is taken into a cell) of pRSVcat plasmid DNA into LI210 cells.
The plasmid contains the bacterial cat gene in a position that permits its expres-
sion in mammalian cells. The cat gene encodes the enzyme chloroamphenicol
acyltransferase (CAT), an activity readily measured following lysis of the cells.
Transfection of the cis-DDP-damaged plasmid into resistant LI210 cells showed
that up to eight times the amount of platinum was required in the resistant versus
sensitive cells to produce a mean lethal hit (63 percent reduction in activity).
This result is consistent with greater repair of platinum-DNA adducts in the
resistant cells.
These results should not be construed to mean that DNA repair is the only
mechanism of cisplatin resistance. There is evidence that relative amounts of
glutathione are increased in cisplatin-resistant cells. 106 Glutathione presumably
uses its thiol moiety to coordinate platinum and diminish the amount that can
bind to DNA. Reduced influx or increased efflux of a drug constitutes additional
mechanisms by which cells become resistant. Further studies are required to
ascertain which of these possibilities is most important for the cisplatin resis-
tance phenomenon.
The discovery that cells can become resistant to cisplatin by repairing DNA
lesions suggests a way to explain the selectivity of the drug for certain tumor
tissue, and even the selective cytotoxicity of the drug for tumor versus normal
cells of the same tissue. Tumor cells that cannot repair platinum-DNA adducts
would be most affected by cis-DDP. This idea forms one of the central hy-
potheses about the molecular mechanism of action of cis-DDP, details of which
can be probed by bioinorganic chemists. Specifically, it is important to inquire
what DNA adducts formed by cis-DDP are both cytotoxic and repairable, what
enzymes are responsible for such repair in mammalian cells, by what mecha-
nisms these enzymes operate, and how this knowledge can be used to design
better metal-based antitumor drugs and chemotherapeutic protocols.
(iv). DNA-protein interactions Most of the phenomena discussed in this
section, inhibition of replication, DNA repair, drug resistance, and mutagenesis,
probably involve interaction of a protein or group of proteins with platinated
DNA. These interactions are clearly important in determining the biological
consequences of DNA templates containing bound platinum. Very recent exper-
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iments have uncovered the existence of proteins from a variety of mammalian
sources that bind specifically to DNA platinated with cis- but not trans-DDp. 107
Identifying the nature and function of these factors may provide important clues
about the mechanisms of antitumor activity, drug resistance, or repair. Study of
protein-DNA-drug interactions is an essential feature of the bioinorganic chem-
istry of platinum chemotherapeutic agents.
4. Mapping the major adducts of cis- and trans-DDP on DNA;
sequence specificity
As we have seen, the antitumor activity of cisplatin is most likely the result
of its DNA-binding properties. But what are the adducts? The human genome
has more than a billion nucleotides. Does platinum recognize any special re-
gions of the DNA or any particular sequences? In other words, is binding simply
random or is there at least a regioselectivity? In this section, we discuss the best
strategies for answering these questions, strategies that evolved in pursuit of
learning how cis-DDP binds to DNA. We also illustrate their power in elucidat-
ing the DNA-binding properties of other metal complexes of interest to bio-
inorganic chemists.
a. Early Strategic Approaches The first experiments to imply the se-
quence preferences of cis-DDP binding to DNA employed synthetic poly-
mers. 108,109 Specifically, the buoyant density of poly(dG)' poly(dC), poly(dG' dC),
and their cis-DDP adducts was studied in the analytical ultracentrifuge. The
greatest shift in buoyant density was seen for the platinum adducts of
poly(dG) .poly(dC) , from which it was concluded that platinum forms an intra-
strand crosslink between two neighboring guanosine nucleosides on the same
strand. This interpretation was suggested by the known preference of metal ions,
and especially platinum, for binding at the N7 position on the guanine base
(Figure 9.9), information available from model studies of metal-nucleobase
chemistry. Although other interpretations of the buoyant-density shift were pos-
sible, especially since the amount of platinum bound was not quantitated, the
conclusion proved to be correct, as confirmed by later investigations. Interest-
ingly, trans-DDP did not selectively increase the buoyant density of
poly(dG)' poly(dC).
Following these initial experiments, the regioselectivity of cis-DDP binding
was investigated by studying the inhibition of enzymatic digestion of platinated
DNA. For example, the platinum complex inhibits the cleavage of DNA by
restriction enzymes that recognize specific sequences and cut both strands of the
double helix. ItO The resulting fragments are readily identified on electrophoresis
gels. One such restriction enzyme is Bam HI. As shown by the arrows in Scheme
(9.11), Bam HI cleaves a six-bp palindromic sequence at the phosphodiester
bonds between two guanosine nucleosides. Formation of an intrastrand crosslink
between the two adjacent guanosine nucleosides inhibits digestion by the en-
zyme. Another method, termed exonuclease mapping, involves digestion of the
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strands of duplex DNA from its 3' _ends. 111 ,112 When the enzyme encounters a
bound platinum atom, it is unable to proceed further. Analysis of the digestion
products by gel electrophoresis reveals the presence of discrete bands caused by
the inhibition of digestion by bound platinum at specific sequences. Results
from experiments of this kind were the most definitive at this time in demon-
strating the profound regioselectivity of cisplatin for adjacent guanosines, and
strongly supported the earlier conclusion that the drug was making an intrastrand
d(GpG) crosslink.
5' t 3'
-G GAT C C-
-C C TAG G-
3' t 5'
(9.11)
A third enzymatic strategy for exploring the regioselectivity of cis- and trans-
DDP binding to DNA is outlined in Figure 9.18. Platinum is first bound to a
single-stranded DNA template, in this example from bacteriophage M13mp18,
to which is next annealed a short, complementary oligonucleotide termed a
"primer" for DNA synthesis. Addition of the large (Klenow) fragment of E.
coli DNA polymerase I and deoxynucleoside triphosphates, one of which bears
a 32p label, [a- 32P]dATP, initiates replication. When the enzyme encounters a
platinum adduct, the chain is terminated. By running out the newly synthesized
DNA strands on a sequencing gel, the sites of platinum binding can be detected
by comparing the positions of the radiolabeled fragments with those obtained
from sequencing ladders. The results of this procedure, which has been termed
"replication mapping," confirmed that cis-DDP binds selectively to (dG)n (n ;:: 2)
sequences. In addition, they showed that trans-DDP blocks replication, in a
much less regioselective manner, in the vicinity of sequences of the kind
d(GpNpG), where N is an intervening nucleotide. These data afforded the first
clear insight into the sequence preferences for trans-DDP on DNA. A control
experiment run with DNA platinated by the monofunctional complex [Pt(dien)CI] +
gave the interesting result that DNA synthesis was virtually unaffected.
In yet another approach to the problem, DNA containing cis- or trans-DDP
adducts was electrostatically coupled to bovine serum albumin, to enhance its
replication mapping
~primer
denature
~
32p
large ~
fragment
DNA polymerase I
32P-NTP
gel
~
electrophoresis
Figure 9.18
Diagram illustrating the replication mapping experiment. To a single-stranded, platinated tem-
plate is annealed a short primer for DNA synthesis using DNA polymerase I (Klenow fragment)
and radiolabeled nucleotides. Sites of platinum binding are revealed as bands on gel electropho-
resis where chain termination occurs (see text for details).
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antigenicity, and injected into rabbits. 113,114 The resulting antisera and antibodies
were then studied for their ability to recognize and bind specifically to platinated
DNAs having defined sequences, such as poly(dG)' poly(dC) and
poly[d(GC)]' poly[d(GC)].
From experiments of this kind, the major cis-DDP adduct recognized by the
antibody was found to be cis-[Pt(NH3Md(GpG)}], in accord with the findings
of the enzymatic mapping experiments. Unplatinated DNA was not recognized,
nor was DNA platinated with trans-DDP. On the other hand, the antibody rec-
ognized DNA platinated with antitumor-active compounds [Pt(en)Clz] and
[Pt(DACH)(CP)], where DACH = 1,2-diaminocyclohexane and CP = 4-car-
boxyphthalate. This result revealed that the antibody recognized the structural
change in DNA that accompanies formation of d(GpG) intrastrand crosslinks,
irrespective of the diamine ligand in the coordination sphere of the platinum
atom. The antibody is also capable of distinguishing adducts formed by active
versus inactive platinum complexes. Most importantly, DNA isolated from the
cells of mice bearing the LI210 tumor five hours after cisplatin injection, was
recognized. 113, 115 Subsequent studies 116 revealed that these antibodies could de-
tect cisplatin-DNA adducts formed in the white blood cells of patients receiving
platinum chemotherapy. Thus, the antibody work linked the regiospecificity of
platination chemistry in vitro with that occurring in vivo and in a clinically
relevant manner.
Additional studies with monoclonal antibodies generated using DNA platin-
ated with cis- or trans-DDP further confirmed and extended these results. 117 This
later work indicated that intrastrand crosslinked d(ApG) and d(GpG) sequences
possess a common structural determinant produced by cis-DDP platination, and
that carboplatin is also capable of inducing the same DNA structure. For trans-
DDP-platinated DNA, a monoclonal antibody was obtained that appeared to
have the intrastrand d(GpTpG) adduct as its major recognition site. In all these
studies, the primary structural determinant appears to be DNA duplex opposite
the site of platination, since fairly major stereochemical changes could be made
in the amine ligands with no appreciable effect on antibody binding.
b. Degradation, Chromatographic Separation, and Quantitation of DNA
Adducts Experiments in which DNA platinated with cis-DDP is degraded to
chromatographically separable, well-defined adducts have been invaluable in re-
vealing the spectrum of products formed. In a typical experiment, platinated
DNA is digested with DNAse I, nuclease PI, and alkaline phosphatase. These
enzymatic digestions degrade DNA into nucleosides that can be readily sepa-
rated by high-performance liquid chromatography (HPLC). Detection of the ad-
ducts can be accomplished by the UV absorption of the nucleoside bases at
260 nm or, for platinum complexes containing a radioactively labeled ligand
such as [14C]ethylenediamine, 118 by monitoring counts. In addition to peaks
corresponding to dA, dC, dG, and dT, the chromatographic trace contains ad-
ditional peaks corresponding to specific platinum nucleobase adducts such as
cis-[Pt(NH3MdGh]. The precise nature of these adducts was established by
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comparison with chemically synthesized compounds structurally characterized
by NMR spectroscopy. 118-121 An alternative method for identifying the adducts
employed antibodies raised against specific platinum-nucleobase complexes. 122
This approach has revealed the relative amounts of various adducts formed
by a variety of platinum complexes; selected results are summarized in Table
9.4. Usually, for cisplatin, the relative amounts of the various adducts formed
varies according to the series cis-[Pt(NH3)z{d(pGpG)}]>cis-[Pt(NH3h{d(pApG)}]
> cis-[Pt(NH3)2{d(GMP)}z] > monofunctional adducts. Only when the total in-
cubation time was short, less than an hour, were the monofunctional adducts
more prevalent, as expected from the kinetic studies of cis-DDP binding to
DNA discussed previously. It is noteworthy that no d(pGpA) adducts were de-
tected. This result, which is consistent with information obtained by enzymatic
mapping, can be understood on stereochemical grounds. 123 If the guanosine nu-
cleoside N7 position is the most-preferred binding site on DNA, closure to make
an N7,N7 intrastrand crosslink between two adjacent purine nucleotides is more
feasible in the 5' direction along the helix backbone (N7' .. N7 distance of = 3 A)
than in the 3' direction (N7' .. N7 distance = 5 A). In addition, molecular-me-
Table 9.4
Geometric features of the platinum coordination spheres of cis-
[Pt(NH3h{d(pGpG)}].
Bond distances and angles a
Molecule 1 Molecule 2 Molecule 3 Molecule 4
Pt-NI 2.03(2) 2.01(2) 2.08(2) 2.08(2)
Pt-N2 2.03(3) 2.09(2) 2.04(3) 2.06(3)
Pt-N7A 2.01(2) 2.02(2) 1.91(3) I.93(3)
Pt-N7B 2.05(2) I.95(3) 2.00(3) 2.06(3)
N7A-Pt-NI 88.6(9) 90.3(9) 91.0(1) 88.4(9)
N7A-Pt-N2 179(1 ) 173.3(8) 178(1) 177(1)
N7A-Pt-N7B 89.1(9) 90.0(1) 85(1) 89(1)
NI-Pt-N2 92(9) 90.8(9) 91( 1) 93(1)
qNI-Pt-N7B 176.5(9) 179.0(1) 173(1) 175(1)
N2-Pt-N7B 90.3(9) 89.0(1) 93(1) 89(1)
Dihedral anglesb
Molecule 3' -Gua/5' -Gua 5' -Gua/PtN4 3'-Gua/PtN4
1 76.2(5) 110.6(5) [3.30(3)] 86.1(5)
2 81.0(5) 110.8(5) [3.49(3)] 95.5(5)
3 86.8(6) 81.0(6) 58.0(6) [3.11(4)]
4 80.6(5) 76.6(6) 59.6(6) [3.18(4)]
a Bond distances are in Angstroms and angles are in degrees.
b Conventions used for assigning Base/Base and Base/PtN4 dihedral angles can be
found in J. D. Orbell, L. G. Marzilli, and T. J. Kistenmacher, 1. Am. Chern. Soc.
103 (l981), 5126. The numbers in square brackets refer to the corresponding
N(ammine)'" 06 distance, in A (see text).
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chanics modeling studies 124 indicate that a highly unfavorable steric clash oc-
curs between the 6-amino group of the 3'-adenosine residue in a d(pGpA) cross-
link and the platinum ammine ligand, whereas in the platinated d(pApG) sequence,
the 6-oxo group forms a stabilizing hydrogen bond to this ligand. A 28 kJ mol - 1
preference of cis-DDP for binding d(pApG) over d(pGpA) was calculated.
There are two likely sources of cis-[Pt(NH3h{d(GMP)}z] in the spectrum of
adducts. This species could arise from long-range intrastrand crosslinks, where
the two coordinated guanosines are separated by one or more nucleotides. In
support of this possibility is the fact that digestion of chemically synthesized
cis-[Pt(NH3h{d(GpNpG)}], where N = C or A, led to cis-[Pt(NH3h{d(Gua)}-
{d(GMP)}] and mononucleotides. 118 ,119,121 The other source of this product is
interstrand crosslinked DNA, known to occur from the alkaline elution studies.
As indicated in Table 9.4, in all the experiments there was platinum that
was unaccounted for in the quantitation procedures, which employed either an-
tibodies, platinum atomic absorption spectroscopy, or a radiolabeled ethylene-
diamine ligand. Some of this material was assigned to oligonucleotides having
high platinum content, resistant to enzymatic degradation.
Two important points emerge from the quantitation of adducts by this method.
One is that intrastrand d(GpG) and d(ApG) crosslinks constitute the major ad-
ducts (>90 percent of total platination) made by cisplatin on DNA in vivo.
Because they were identified by an antibody specific for their structures, no
chemical change brought about by cellular metabolism has occurred. Secondly,
the preponderance of these adducts far exceeds the frequency of adjacent gua-
nosine or guanosine/adenosine nucleosides in DNA. This latter result implies a
kinetic preference for, or recognition of, d(pGpG)- and d(pApG)-containing se-
quences by cisplatin.
c. Postscript: A Comment on Methodologies With few exceptions, none
of the experimental studies described in this section could have been carried out
in 1969, when Rosenberg first demonstrated the anticancer activity of cis-DDP.
The techniques of DNA sequencing, monoclonal antibody formation, oligonu-
cleotide synthesis, HPLC, FPLC, and many of the higher resolution gel electro-
phoresis methodologies employed were the result of later developments driven
by rapid advances in the fields of molecular biology and immunology. Future
progress in elucidating the molecular mechanisms of action of cisplatin and other
inorganic pharmaceuticals will no doubt benefit from new technological discov-
eries and inventions of this kind yet to come.
5. Structure of platinum-DNA complexes
a. NMR Studies of Platinated Oligonucleotides Once the major spectrum
of adducts formed by cis- and trans-DDP with DNA began to emerge, it was
of immediate interest to learn to what positions on the nucleobases the platinum
atom was coordinated. Proton NMR spectroscopy soon proved to be an invalu-
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able tool for obtaining this information. 71 ,125,126 Several ribo- and deoxyribooli-
gonucleotides containing GG, AG, or GNG sequences were synthesized, and
allowed to react with cis-DDP or its hydrolysis products, and the resulting com-
plexes were purified by chromatography. All GG-containing oligomers formed
intrastrand crosslinks with the {Pt(NH3hP+ moiety coordinated to the N7 atoms.
This structure was deduced from several criteria. Most frequently studied were
the nonexchangeable base protons H8 and H2 of adenine, H6 of thymine, H8
of guanine, and H5 and H6 of cytosine (Figure 9.9). Coordination of platinum
to N7 of guanine causes a downfield shift of the H8 proton resonance. More
importantly, however, it also lowers the pKa of the NI proton by ~ 2 units,
because platination adds positive charge to the base. Thus, titration of the pla-
tinated oligonucleotide over a pH range, and comparison of the results to those
obtained for the unplatinated oligomer, reveals a difference in the midpoint of
the transition in chemical shift of the H8 proton by ~ 2 pH units if coordination
occurs at N7. This effect is illustrated in Figure 9. 19 for the adduct cis-
[Pt(NH3h{d(ApGpGpCpCpT)}N7-G(2),N7-G(3)], where the pKa of Nl is seen
to shift from ~ 10 to ~ 8 upon platination. 71 The pH titration in this example
also reveals the pH-dependent chemical shift of the cytosine 1H resonances at a
pH of ~ 4.5, corresponding to protonation of the N3 atoms. The protonation of
adenine N7 (pKa ~ 4) is also frequently observed in these studies. These results
conclusively demonstrate platinum coordination at N7 of the two guanosine nu-
cleosides.
Although several of the oligonucleotides studied have self-complementary
sequences, such that they can form a double helix when unplatinated, in no
such case was a duplex observed for their platinated forms. The presence of the
platinum-induced crosslink presumably decreases the stability of the double-
stranded form of the oligonucleotide. Another interesting result is that all intra-
strand {Pt(NH3hP+ adducts of d(GpG) or d(ApG) have an altered deoxyribose-
sugar ring conformation. In normal, unplatinated form, these single-stranded or
duplex oligonucleotides have a C2'-endo sugar pucker (Figure 9.9). Upon plat-
ination, the 5' -nucleotide switches to C3' -endo. This change is readily moni-
tored by the ring proton-coupling constants JHI '-H2' and JHI '-H2". These protons
constitute an ABX spin system such that the sum, 2:,3J = 3J1'2' + 3J1'2'" is
most easily measured as the separation between the outermost peaks in the mul-
tiplet. For the C2'-endo conformation, a pseudotriplet occurs with 2:,3J = 13.6 Hz,
and for C3'-endo, 2:,3J = 7.5 Hz. The 3'-guanosines in the adducts show greater
conformational flexibility, having ~ 70 to 80 percent C2' -endo sugar puckers,
depending upon the temperature.
Another conformational feature that could be deduced from 1H NMR studies
of all cis-DDP-platinated oligonucleotides containing an embedded d(GpG) se-
quence is that both guanosine nucleosides retain the anti orientation of the base
around the Cl'-N9 glycosidic linkage (Figure 9.9). This result was deduced
from the lack of a pronounced nuclear Overhauser effect (NOE) between H8
and the HI' protons, such as would occur in the syn conformation. An NOE
between H8 resonances on the two coordinated nucleosides was observed for
Figure 9.19
Chemical shift (0) vs. pH* of the
nonexchangeable base protons of D20
solutions of [d(ApGpGpCpCpT)h
(3.5 mM, 35°C) and its cis-DDP
adduct (2.5 mM, 70°C). The pyrimi-
dine resonances of the latter sample
show no chemical shift changes
with temperature over the range
35 < T < 70°C while the purine
resonances show a slight temper-
ature-dependent chemical shift
change of up to 0.1 ppm. Tetra-
methylammonium chloride was
used as the internal standard (0
3.180). Reproduced by permission
from J. C. Caradonna, S. J. Lippard,
M. J. Gait, and M. Singh, J. Am.
Chern. Soc. 104 (1982), 5793.
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adducts of d(ApTpGpG) and d(CpGpG), indicating that the two bases are in a
head-to-head orientation with respect to the platinum coordination plane. In other
words, both 06 atoms lie on the same side of that plane. Two oligonucleotides
containing cis-[Pt(NH3MApG)] adducts have been examined; their structural
properties closely resemble those of the (GpG) adducts, with platinum coordi-
nated to N7 of both purine bases.
In order to study double-stranded DNAs platinated on one strand, it was
necessary to adopt a special strategy. First, the desired oligonucleotide is syn-
thesized. It is preferable that the DNA strands not be self-complementary, since
the affinity of such an oligomer for itself is so much greater than that for its
platinated form that the desired, singly platinated duplex will not form. After
the platinated single strand is synthesized and purified, the complementary strand
is added. Several duplex oligonucleotide-containing cis-[Pt(NH3h{d(pGpG)}]-
embedded adducts prepared in this manner have been studied by 1H NMR
spectroscopy. With the use of two-dimensional and temperature-dependent tech-
niques, both the nonexchangeable base and sugar protons as well as the ex-
changeable (guanine Nl and thymine N3) N-H (imino) proton resonances were
examined. The last are useful, since they give some measure of the extent to
which the double helix remains intact. When not base-paired to their comple-
ments in the other strand, these protons exchange more rapidly with solvent
(water) protons, leading at moderate exchange rates to broadening of the reso-
nances and, at high exchange rates (> 107 s -I), disappearance of the signals.
Several interesting results were obtained in these studies. In all of them, platin-
ation of the d(GpG) sequence brought about the same C2'-endo ----i> C3'-endo
sugar-ring pucker switch for the 5' -guanosine as seen in the single-stranded
adducts. Head-to-head, anti conformations were also observed. At low temper-
atures, below the melting transition temperature, above which the duplex be-
comes single-stranded, the imino proton resonances were observed. This result
was interpreted to mean that normal, Watson-Crick base pairs can still exist
between the cis-DDP d(GpG) adduct and the d(CpC) sequence on the
complementary strand. In the case of [d(TpCpTpCpG *pG *pTpCpTpC)]'
[d(GpApGpApCpCpGpApGpA)], where the asterisks refer to the sites of platin-
ation, the imino proton resonances were assigned with the assistance of NOE
experiments. 125 Temperature-dependent studies showed that, in the range
- 4° < T < 46°C, the imino resonances of the coordinated guanosine nucleo-
sides broadened first with increasing temperature. Apparently the base pairs of
the intrastrand crosslinked, platinated duplex DNA are disrupted, or "melted,"
outward from the point of platination as well as from the ends. Since the amino
hydrogen atoms involved in base pairing were not observed in this study, a
completely definitive structural analysis was not possible. Nevertheless, the au-
thors proposed that the duplex would be kinked by an angle of ~ 60° at the cis-
DDP binding site in order to preserve full duplex character.
Another useful NMR nucleus for monitoring cis-DDP-DNA interactions is
195Pt, which is 34 percent abundant with I = t. When used in conjunction with
15N (I = "!) enriched NH3 ligands, 195pt NMR resonances provide a powerful
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means for characterizing complexes in solution. The 19Spt and 15N chemical
shifts are both sensitive to the ligand trans to the NH3 group, as is the 195Pt_ 15N
coupling constant. 127 195pt NMR studies of cis-DDP binding have been carried
out using nucleobases, small oligonucleotides, and even double-stranded frag-
ments of 20 to 40 bp in length, as previously described (Section V.D.l). The
major contribution of this method is to show whether platinum coordinates to a
nitrogen or an oxygen donor atom on the DNA, since the 195pt chemical shift is
sensitive to this difference in ligation.
b. X-ray Structural Studies In recent years several oligonucleotide du-
plexes have been crystallized and characterized by x-ray diffraction methods.
The probability of forming suitable single crystals of DNA fragments is disap-
pointingly low, however, with only I in 10 such attempts being successful.
Correspondingly, it has been difficult to crystallize platinated oligonucleotides.
An alternative approach has been to soak nucleic-acid crystals of known struc-
ture with the platinum reagent in the hope of forming an isomorphous de-
rivative, the structure of which could be obtained by using the changes in
phases from the native material. In attempts to characterize a cis-DDP nucleic
acid adduct, crystals of tRNA Phe and the self-complementary dodecamer
d(CpGpCpGpApApTpTpCpGpCpG) were soaked with cisplatin solutions in the
hope of obtaining useful metric information. 123,128,129 These efforts have thus far
failed to produce a high-resolution structure, although they confirm the predilec-
tion for platinum to coordinate to the N7 position of purine rings. Addition of
cis-DDP tends to disorder the crystal, with platinum going to several sites of
partial occupancy.
A more fruitful approach has been to crystallize a purified oligonucleotide
containing the coordinated cis-{Pt(NH3hP+ moiety. The first x-ray structure to
be deciphered through such a strategy was that of cis-[Pt(NH3h{d(pGpG)}].13°
This compound crystallizes with water solvent and glycine buffer molecules in
the lattice. The crystals were grown at pH 3.8, where the terminal phosphate is
monoprotonated in order to provide a neutral complex of diminished solubility.
Two crystalline forms have been obtained, and both structures solved, one to
0.94 A resolution. The latter contains four crystallographically independent
molecules, which, although complicating the structure solution, afforded four
independent views of the major adduct formed by cis-DDP with DNA. The four
molecules form an aggregate, held together by hydrogen bonding and intermo-
lecular base-base stacking interactions (Figure 9.20). There are two conforma-
tionally distinct classes that comprise molecules I and 2, and molecules 3 and
4; within each class, the molecules are related by an approximate C2 symmetry
aXIS.
The molecular structure of molecule 1 is displayed in Figure 9.21; geomet-
ric information about all four molecules is contained in Table 9.4. As expected
from the NMR studies, platinum coordinates to N7 atoms of the guanine bases,
which are completely destacked (dihedral angles range from 76.2 to 86.7°), to
form a square-planar geometry. The bases have a head-to-head configuration
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Figure 9.20
Stereoview of aggregate of four cis-[Pt(NH3h{d(pGpG)}]
molecules (reproduced by permission from Reference 130).
03" B
Figure 9.21
Molecular structure of cis-[Pt(NH3Md(pGpG)}].
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and conformational angles X (Table 9.4 and Figure 9.9) that fall in the anti
range. The sugar puckers of the 5'-deoxyribose rings for all four molecules have
a C3' -endo conformation, and some of the 3'-sugar carbon atoms exhibit large
thermal parameters suggestive of a less well-ordered structure. These results
further demonstrate the similarity of the structure as detected in the solid state
by x-ray diffraction and in the solution state by NMR spectroscopy.
An interesting additional feature of the cis-[Pt(NH3h{d(pGpG)}] crystal
structure is a hydrogen bonding interaction between an ammine ligand and the
oxygen atom of the terminal phosphate group (OPIA'" Nl, Figure 9.21). This
intramolecular hydrogen bond is prominent in three of the four molecules in the
asymmetric unit. Although the relevance of this hydrogen bonding interaction
to the solution structure and molecular mechanism of cisplatin is presently un-
known, it is interesting to note that the antitumor activity of platinum amine
halide complexes is reduced when protons on coordinated NH3 are replaced by
alkyl groups. 34
A second cis-DDP-oligonucleotide adduct characterized by x-ray crystallog-
raphy is the neutral molecule cis-[Pt(NH3h{d(CpGpG)}].131 Here again, there
are several (three) molecules in the asymmetric unit. Although determined at
lower resolution, the structure is similar in most respects to that of cis-
[Pt(NH3h{d(pGpG)}] except for the presence of some weak NH3·· '06(guanosine)
intramolecular hydrogen bonding interactions and a few unusual sugar-phos-
phate backbone torsional angles. Also, no NH3(H)'" phosphate(O) hydrogen
bonds were observed.
From the foregoing discussion, it is apparent that adequate x-ray structure
information is available for the cis-{Pt(NH3h}2+ /d(pGpG) intrastrand crosslink.
What is needed now are structures of the minor adducts and, most importantly,
of adducts in double-stranded DNA. Very recently, dodecanucleotide duplexes
containing cis-{Pt(NH3hP+/d(pGpG) adducts have been crystallized, the struc-
tures of which are currently being investigated. 132
c. Molecular Mechanics Calculations on Platinated Duplexes As a sup-
plement to x-ray structural information on double-stranded oligonucleotides con-
taining an embedded cis-[Pt(NH3h{d(pGpG)}] adduct, several models have been
constructed by using a molecular mechanics approach. 133 In this work, a set of
coordinates was first obtained by amalgamation of structural information about
standard double-helical DNAs and the platinated d(pGpG) fragment. Various
starting structures were assumed, both linear and bent. The models were then
refined according to various charge and stereochemical constraints built into the
calculation. The results, which can reveal only what is feasible and not neces-
sarily what actually happens, for both linear and bent structures are depicted in
Figure 9.22 for two of the duplex sequences studied. In the linear model, the
5' -coordinated guanosine is rotated out of the stack, and its hydrogen bonding
to the cytosine on the complementary strand is seriously disrupted. The imino
N-H group is still involved in H-bonding, however; so this structure is not in-
consistent with the NMR results. Two classes of kinked platinated duplex struc-
tures were encountered, with bending angles of 61 and 50°. In one of these, all
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Watson-Crick hydrogen bonds remain intact. These kinked structures are sup-
ported most strongly by the gel-electrophoresis experiments discussed in Section
V.D.3.b.v.
Molecular mechanics and the related molecular dynamics calculations are a
potentially valuable tool for the bioinorganic chemist interested in how metal
complexes might perturb the structures of biopolymers. Analysis of the results
for cisplatin-DNA binding reveals that, compared with the sum of all contribu-
tions from the biopolymer, the Pt-DNA interactions constitute a small part of
the overall energy. For the most accurate results, it is important to know the
charge distributions on the metal and its ligands as well as the effects of solvent
interactions. Much work needs to be done in these areas before the results of
molecular mechanics and dynamics calculations can be used reliably to predict
or analyze structures. At present, however, they are far superior to examination
of space-filling molecular models, for example, and produce quantitatively re-
vealing structural diagrams.
d. Platinum-Nucleobase Model Complexes Several studies have been car-
ried out of the cis-diammineplatinum(II) moiety coordinated to nucleobases in
which the N9 (purine) or N3 (pyrimidine) positions either have been alkylated,
to simulate the glycosidic linkages, or in which the actual nucleotide (AMP,
dGMP, etc.) is employed. 134 These investigations are in many respects analo-
gous to the synthesis and characterization by bioinorganic chemists of model
complexes for the active site of a metalloenzyme. Their purpose is to simplify
the problem, revealing kinetic, thennodynamic, and structural preferences of the
primary building blocks involved in the metallodrug-biopolymer interaction,
without the profound stereochemical constraints of the latter. Early studies of
cis- and trans-DDP adducts with nucleobases (i) revealed the kinetic preferences
for platinum binding to GMP and AMP, (ii) mapped out the preferred sites of
platination (N7 of A and G; NI of A; N3 of C; no N7-06 chelate; no ribose or
deoxyribose binding; only rare binding to phosphate oxygen atoms), (iii) dem-
onstrated that Pt-N7 binding to G lowered the pKa of NI-H by ~ 2 units, and
(iv) led to the discovery of interesting new classes of coordination complexes
such as the cis-diammineplatinum pyrimidine blues and metal-metal bonded di-
platinum(III) complexes.
Figure 9.22 (facing page)
(A) Stereoscopic view of the unkinked, platinated model of duplex
d(TpCpTpCpG*pG*pTpCpTpC) from molecular-mechanics calculations. Counter ions
used to stabilize the negative charge of the phosphates are not shown. (8) Stereoscopic view
of the "high-salt" kinked, platinated model of duplex d(GpGpCpCpG*pG*pCpC) from
molecular-mechanics calculations. Counter-ions are not depicted, with the exception of the
bridging ion. (C) Stereoscopic view of the "low-salt" kinked, platinated model of duplex
d(GpGpCpCpG*pG*pCpC). Counter-ions are not depicted. Reproduced with
permission from Reference 133.
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Attempts to model the intrastrand d(GpG) crosslink with nucleobases have
met with only moderate success. Usually the 06 atoms of the two guanosine
rings are on opposite sides of the platinum coordination plane ("head-to-tail"
isomer). Only for cis-[Pt(NH3h<9-EtGh] 2+ was the correct isomer obtained.
Nucleobase complexes of the cis-diammineplatinum(II) moiety have been valu-
able for testing the controversial proposal of N7,06 chelate formation, which to
date has not been observed. Several interesting discoveries of metal-nucleobase
chemistry are that metal binding can stabilize rare tautomers, for example, the
4-imino, 2-oxo form of cytosine, through N4 binding, that coordination of plat-
inum often produces unusual base pairing, and that metal migration from one
donor site to another on an isolated nucleobase can occur. These model studies
will continue to provide valuable insights into the possible chemistry of plati-
num antitumor drugs with DNA.
e. trans-DDP-DNA Adducts Because trans-DDP is biologically inactive,
it has received less attention than the cis isomer. Nevertheless, knowledge of its
binding to DNA is important to have as a reference point for mechanistic com-
parison with the active compounds. Shortly after replication mapping experi-
ments established that trans-DDP binds preferentially to d(GpNpG) and d(ApNpG)
sequences,135 several synthetic oligonucleotides containing such sequences were
prepared and used to investigate reactions with the trans isomer. 136-138 Kinetic
studies of trans-DDP with d(GpCpG) and d(ApGpGpCpCpT) revealed the pres-
ence of, presumably monofunctional, intermediates that closed to form both
intra- and interstrand products. In the reaction with d(GpCpG), the 1,3-intra-
strand G-G chelate accounted for 70 percent of the product, and 21 percent of
the remaining material was unreacted oligonucleotide. Proton NMR studies of
purified trans-[Pt(NH3h{d(GpCpG)}] as well as the d(GpTpG) analog estab-
lished platinum binding to N7 positions of the two trans guanosine nucleosides.
As with the cis-[Pt(NH3Md(pGpG)}] adducts, the 5'-guanosine residue no longer
retained the normal B-DNA type conformation; instead, the sugar ring pucker
switched to C3' -endo. A fairly detailed lH NMR characterization of trans-
[Pt(NH3h{d(ApGpGpCpCpT)-N7-A(l),N7-G(3)}] revealed very similar fea-
tures. This example nicely illustrates the different stereoselectivity of cis- and
trans-DDP binding to DNA. The cis isomer forms exclusively an intrastrand
d(GpG) crosslink, whereas the trans isomer makes a 1,3-d(A*pGpG*) adduct.
A schematic depiction of the trans-{Pt(NH3hP+ adduct is shown in Figure 9.23.
As can be seen, the two purine rings enclose a large, 23-membered ring, the
central guanosine residue is "bulged out," and the 5'-residue has a C3' -endo
sugar pucker. This structure may be compared with that of cis-[Pt(NH3h{d(pGpG)}]
(Figure 9.21), where the platinum is part of a smaller, 17-membered ring. Both
space-filling model building studies and molecular mechanics calculations reveal
that it would be stereochemically very unfavorable for the trans-{Pt(NH3hP+
fragment to replace the cis analogue in an intrastrand crosslinked d(GpG) struc-
ture of the kind shown in Figure 9.21. Thus, for bidentate adducts, it seems
clear that the important difference between cis- and trans-DDP binding to sin-
oH-<~NHNAN~NHo 2
H
H
Figure 9.23
Structure of the intrastrand 1,3-d(A*pGpG*) crosslink formed in the reaction of trans-DDP
with d(ApGpGpCpCpT). Reproduced by permission from Reference 136.
gle-stranded DNA is revealed by the structures shown in Figures 9.21 and 9.23,
respectively.
Information about trans-DDP binding to double-stranded DNA is scanty,
but very recent studies indicate that the trans-[Pt(NH3Md(GpApG)-N7-G(1),N7-
G(3)}] intrastrand crosslinked fragment can be embedded in duplex dodeca-
mers. 139 Interestingly, for one sequence the melting temperature (TM) of this
duplex is not reduced over that of the unplatinated DNA fragment, in contrast
to results for cis-DDP intrastrand d(GpG) adducts. This intriguing result, which
agrees with earlier TM studies of DNA platinated by trans-DDP, does not yet
have a structural rationale. It is possibly relevant to the processing of bifunc-
tional trans-DDP-DNA adducts in vivo.
f Effects of Platination on DNA Structure It is valuable to summarize at
this stage all that has been learned concerning the changes in DNA structure
that occur upon cis- or trans-DDP binding. cis-DDP intrastrand crosslinks result
in unstacking of neighboring bases and a switch in the sugar pucker of the 5'-
nucleoside from C2'-endo, the standard B-DNA conformation, to C3'-endo, a
conformation encountered in A-DNA. These various forms of DNA have al-
ready been introduced in the previous chapter. Watson-Crick base pairing, al-
though weakened, is probably maintained. Evidence that base pairing is altered
comes from studies with antinucleoside antibodies that bind appreciably better
to DNA platinated with cis-DDP than to unmodified DNA. These antibodies
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recognize the nucleobases much better in platinated than in unplatinated DNA,
presumably because platination disrupts the double helix. Additional support for
base-pair disruption comes from gradient gel-denaturation experiments using site-
specifically platinated DNA (see Section V.D.8.b). Intrastrand crosslinking by
cis-DDP also bends the helix by about 34° and unwinds the duplex by 13°.
When trans-DDP forms 1,3-intrastrand crosslinks, the nucleotides situated be-
tween the platinated residues may be bulged out; consistent with this picture is
the fact that they present an especially good target for antinucleoside antibodies.
In 1,3-intrastrand d(GpNpG) or d(ApNpG) adducts, the 5'-nucleoside sugar pucker
is altered to C3 I -endo. Intrastrand crosslink formation by trans-DDP also leads
to DNA bending, but the platinum serves as the locus for a hinge joint and not
for cooperative bending. These different effects of platination on DNA structure
brought about by the two isomers are likely to be related to their different bio-
logical activities.
6. Effects of DNA structure on platinum binding
a. A-, B-, and Z-DNA 140 As discussed in more detail in Chapter 8, double-
helical DNA can adopt different polymorphic forms depending on the conditions
in solution or polycrystalline fiber. Even within a given DNA molecule, there
can be sequence-dependent local secondary and tertiary structural differences
that constitute important signals for cellular DNA binding and processing mol-
ecules. An example already discussed is the recognition of palindromic se-
quences by type II restriction endonucleases. As shown in Figure 9.24, three
such DNA polymorphs are the right-handed A- and B- and the left-handed Z-
forms. Most commonly encountered in solution is B-DNA, characterized by
well-classified major and minor grooves designated by arrows in Figure 9.24.
The targets of platinum binding, guanine N7 atoms, are situated in the major
groove.
To what extent do sequence-dependent local structural modulations affect
platinum binding? Although no general answer to this question can be given,
there are several interesting anecdotal pieces of information worth mentioning.
Z-DNA, a form favored by alternating purine-pyrimidine sequences such as in
poly d(GC), does not constitute a particularly good target for cis-DDP binding.
For one thing, it lacks the preferred d(GpG) or d(ApG) sequences. The mono-
functional [Pt(dien)CI] + complex, however, facilitates the B-DNA ---?> Z-DNA
conformational transition, as demonstrated by circular dichroism and 31p NMR
spectroscopic data. 141 In Z-DNA, the guanosine nucleoside adopts the syn con-
formation (Figure 9.9), which is presumably favored by placing a bulky
{Pt(dien)p+ moiety on N7. Moreover, the local charge density on DNA is greater
in Z- than B-DNA, owing to the closer proximity of the phosphate groups, and
the former is presumably stabilized by the +2 charge on the platinum complex.
b. Effects of Local Sequence and of Free and Linked Intercalators on Plat-
inum Binding Of more interest perhaps to anticancer drug-DNA interactions is
the fact that some d(GpG), d(ApG), and even d(GpA) targets for cis-DDP bind-
A- DNA B- DNA
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Figure 9.24
Representations of side (above) and top (below) views of three major classes of double-stranded
DNA. For B-DNA, arrows near the top and bottom of the helix designate the minor and major
grooves, respectively. Reproduced with permission from Reference 140.
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Figure 9.25
Autoradiograph of Exo III mapping results for cis-DDP
binding to a l65-bp DNA restriction fragment. The
Ptlnucleotide ratio is 0.05. Lanes 8-12 contain DNA
platinated in the presence of 0,0.012,0.057,0.12,
and 0.23 Etd/nucleotide, respectively. For more details,
see Reference 142.
ing are very sensitive to the sequences in which they are embedded. This phe-
nomenon was first discovered during exonuclease III mapping studies of cispla-
tin binding to a 165-bp restriction fragment from pBR322 DNA. 142 Although
cis-DDP binding stops the enzyme at G3 , Gs, and GAGGGAG sequences, at a
(D/Nh ratio of 0.05 there is little evidence for coordination to an apparently
favored G6CG2 sequence (Figure. 9.25, lane 8). When platination was carried
out in the presence of the DNA intercalator EtdBr (Figure 9.11), however, the
G6CG2 sequence became a Pt binding site (Figure 9.25, lanes 9-12). A more
extensive exonuclease III mapping study of this phenomenon suggested that
d(CGG)-containing sequences in general are less well platinated by cis_DDP. 143,144
Moreover, only EtdBr, and not other acridine or phenanthridinium type inter-
calators, was able to promote an enzyme-detectable cis-DDP binding to these
sequences. A suggested explanation for these results is that local d(purCGG)
sequences might have an A-DNA-type structure (Figure 9.24) in which the ma-
jor groove is narrow, inhibiting access of platinum to N7 of guanosine nucleo-
sides. In the presence of the intercalator EtdBr, the local DNA structure might
be altered in such a manner as to permit binding. 143,144
In accord with this interpretation, and further to delineate a possible reason
why acridines and deaminated ethidium cations do not promote cisplatin binding
to d(purCGG) sequences, NMR studies were performed that revealed the mean
NME2
Figure 9.26
Structure of AO-Pt in which the {Pt(en)C12} moiety is
linked by a hexamethylene chain to acridine orange.
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residence time of EtdBr on DNA to be 6 to 21 times longer than that of any of
the other intercalators examined. 144 Thus, for these latter intercalators, the local
DNA structure presumably can relax back to one unfavored for cisplatin binding
before it can diffuse to the site. Moreover, when acridine orange (AO), one of
the five intercalators studied that does not promote cisplatin binding to excluded
sites, was covalently attached to dichloroethylenediamineplatinum(ll) (Figure 9.26)
via a hexamethylene linker chain, the resulting AO-Pt molecule was able to bind
to all d(CpGpG) sites, as determined by exonuclease III mapping. In the teth-
ered molecule, the high local concentration near the intercalator bind-
ing site facilitates attachment of the {Pt(en)}2+ moiety to DNA before the acri-
dine orange fragment can diffuse away and the structure can relax to reform the
excluded site.
Subsequently, the excluded site phenomenon was found for cis-DDP bind-
ing, as assayed by the 3'-5' -exonuclease activity of T4 DNA polymerase. 145
Enzyme stopping sites were observed at all d(GpG) sequences, but
only weakly when at a d(GTGGTC) site. Similarly, d(ApG) was not modltled
when embedded in pyGAGCpy and pyGAGCA sequences. Although most d(GpA)
sequences were not platinated, as detected by T4 mapping, a few were. These
results further underscore the importance of local sequence modulation of cis-
binding to DNA.
c. DNA-Promoted Reaction Chemistry In the EtdBr-enhanced binding of
cis-DDP to DNA, a small fraction «5 percent) of the intercalator is strongly
bound and can be dialyzed out only very slowly. 145 The detailed structure of
this DNA-cisplatin-EtdBr ternary complex has been established, and involves
cis-{Pt(NH3h}2+ binding to the exocyclic amino groups of ethidium as well as
to donor sites on DNA. 146 This assignment was proved by synthesizing cis-
[Pt(NH3hCEtd)CI] 2+ complexes in dimethylformamide solution and then allow-
ing them to react with DNA. The optical spectra of the resulting adducts were
identical to that of the ternary complex. The reaction of cis-DDP, and
DNA to form the ternary complex is promoted by the favorable orientation of
the exocyclic amino group of intercalated Etd with respect to the coordination
plane of bound to the double helix. The N-8 exocyclic amino group
of ethidium, bound intercalatively at a site adjacent to a purine N-7 coordinated
cis-{Pt(NH3hCI} + moiety, is positioned above the platinum atom in a structure
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resembling the transition state for a square-planar substitution reaction. The
structure of this transition state has been modeled in a molecular mechanics
calculation (Figure 9.27 See color plate section, page C_16.),147 and evidence
has been obtained that indicates selective binding of to the Etd N-8
amino position. 148
Since cisplatin is usually administered in combination chemotherapy with
other drugs, many of which contain intercalating functionalities, strong cova-
lent, DNA-promoted interactions between drug molecules at a target site must
be considered as possibly relevant to the molecular mechanism of action. In
such a situation, there must be a strong binding preference for both drug mole-
cules for the same target sequences, since on probability grounds alone it is
unlikely that both would migrate to the same site by random diffusion at the
low concentrations found in vivo.
d. Effects of DNA Function on Platinum Binding Although there is yet
little known about this topic for cisplatin, it is worth pointing out that other
DNA-targeted drugs, such as bifunctional alkylating agents, bind preferentially
to actively transcribed genes. It is therefore possible that platinum exhibits such
preferences, for example, to single-stranded DNA at or beyond the transcription
fork, compared to DNA in chromatin structures. Or, perhaps, it too
binds selectively to actively transcribed DNA. Investigation of these possibilities
seems worthwhile.
7. Speculations about the molecular mechanism
a. Is There a Single Mechanism? Most investigators now agree that DNA
is the cytotoxic target of cisplatin. We have seen that the drug inhibits DNA
replication by binding to the template and halting the processive action of DNA
polymerase. Less well-studied is the inhibition of transcription by pl::ltil1mnl-
DNA adducts, but recent evidence clearly indicates that can do so. Studies
of the effects of on cells growing in culture reveal that DNA replica-
tion and growth can continue without cell division in the presence of low
levels (l ,ug/mL) of cells are arrested at the G2 phase, the stage of
cell growth just preceding division. lOS G2 arrest was reversible, but at higher
cisplatin levels (8 ,ug/mL), cell death occurred. These observations led to the
speculation perhaps, post-replication DNA repair can handle the toxicity
associated a platinum-damaged template, at least for DNA synthesis, but
that there is no known by can circumvent Pt-DNA
lesions. Possibly, inhibition of transcription is a more lethal event
than inhibition of replication. This idea is inconsistent with the well-established
fact that incorporation into DNA is more affected by low levels of
cisplatin than is uridine incorporation into RNA. Might there be more than one
biochemical pathway by which cisplatin manifests its anticancer activity? Fur-
ther work is necessary to address this intriguing question.
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b. Is There a "Critical Lesion"? We now have an excellent understand-
ing of the major DNA adducts made by cis-DDP, their structures, and the cor-
responding DNA distortions. Information about adducts made by the inactive
trans isomer, not as complete, is also substantial. During the period
when this knowledge was being it was of interest to learn whether
a "critical lesion," a specific DNA with a unique molecular stnLlcture
might be responsible for the antitumor activity the drug. At present, it ap-
pears that bidentate adducts made by cis- and trans-DDP can repli-
cation, although they may not be equally efficient at doing SO.149 Even mono-
functional adducts of the kind formed by cis-[Pt(NH3M4-Br-py)CI] + can block
replication. 96 Thus, it be better to think about the concept of "critical
lesion" in a functional sense, where the rates of adduct formation, removal, and
enzyme inhibition together determine which of adducts will exhibit anti-
tumor activity and which will not. Here the biochemistry of the host cell will
also be an Clearly, more are required to delineate
these possibilities.
c. and in the Tumor Cell 150 If the anticancer activity
of cisplatin arises from damaged DNA then the drug could be selec-
tively toxic to cancer versus normal cells of the same tissue if of DNA
damage occurred more efficiently in latter. The best way to study this phe-
nomenon be to measure the platinum-DNA levels and list the sp(~ctrmn
of adducts formed in tumor versus normal biopsy tissue obtained from patients
undergoing cisplatin As described previously, methodologies are
now reaching the point where such experiments can be carried out in order to
test the key hypotheses the mechanism of action of cisplatin. In addition,
Dowe:rflll new methods have recently been to screen DNA bmdlnlg
proteins. If one could proteins that bind selectively to cis-DDP-platin-
ated DNA determine their insights into replication
and repair would be forthcoming. Such cellular factors that bind
selectively to DNA adducts have, in fact, recently been
discovered. 107 The experiments that led to this finding and their possible impli-
cations for the molecular mechanism of cisplatin are described in the next sec-
tion.
d. (or Damage) Recognition Proteins 150 If selective re-
of platinum-DNA adducts in cells of different origin is an integral part of
the mechanism of cis-DDP, then it is to identify the
lar factors associated this phenomenon. In bacteria, cis-DDP adducts on
DNA are removed by excision repair, a process in which the lesion is first
ide~ntified and then excised the uvrABC excinuclease system. 151 In this pro-
cess, the uvrA first binds to the adducted DNA. Subsequently, the uvrB
and C excise the damaged strand, additional cellular proteins
rebuild by copying the genetic from the remaining strand.
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The repair of cis-DDP intrastrand crosslinks in mammalian cells is much
less well understood. Under the assumption that an analogue of the uvrA protein
might exist in such cells, experiments were carried out to try to isolate and clone
the gene for such a protein. In the mobility of platinated DNA restric-
tion fragments of defined length was to be substantially retarded in elec-
trophoresis gels following incubation extracts from human HeLa cells. 107 This
gel-mobility shift was attributed to the binding of factors termed "damage rec-
ognition proteins" (or DRPs). Subsequent studies with site-specifically platin-
ated oligonucleotides (see V.D.8) revealed that the cisplatin DRP binds specifi-
cally to DNA containing the intrastrand cis-[Pt(NH3h{d(pGpG)}] or cis-
[Pt(NH3h{d(pApG)}] crosslink. In parallel work, the gene encoding for a DRP
was cloned 152 and used to demonstrate the occurrence of such a in nearly
all eukaryotic cells. Since binding of the DRP to platinated DNA is not specific
for the ammine ligands opposite the crosslinked nucleobases, the interaction is
thougllt to involve recognition of local changes in the twist and bending of the
double helix. Figure 9.28 depicts one possible structure for the complex formed
between cis-DDP platinated DNA and a DRP. More recently, cloned pro-
teins were found to contain a high mobility group (HMG) protein box, and even
HMG I itself binds to cisplatin-modified DNA. 152 The class of proteins was re-
named "structure-specific recognition proteins" (SSRPs).
The discovery of SSRPs that bind specifically to cisplatin-modified DNA
raises several questions that are the subjects of current study. The first is to
determine whether the proteins are an integral component in the mechanism of
action of the drug. Although it has not yet been possible to induce the proteins
by treating cells with cisplatin, nor have elevated or suppressed levels been
found in platinum-resistant cells, deletion of an SSRP gene in yeast has re(~enltlv
afforded a mutant strain less sensitive to cisplatin than cells. 153 This
result links a yeast SSRP with cellular sensitization to the drug. Such a protein
could contribute to the molecular mechanism in one of several ways (Figure
9.28). It might be the analogue of uvrA, which, as mentioned above, recognizes
damage and signals the cell to perform excision repair. If so, one would
• Damage recognition as the first step in
excision repair of the Pt/DNA lesion
• Titration of a tumor regulatory protein;
removal from its normal functional role
• Protection of the cisplatin/DNA lesion
from repair, thus assuring its ability to
block replication and cell division
Figure 9.28
Model depicting the binding of an SSRP to cisplatin-damaged DNA
and several hypotheses for its role in the molecular mechanism.
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like to depress the levels of the protein in cancer cells to make them more
sensitive to the drug. A second possibility is that the true role of the SSRP is to
serve as a tumor-cell activator, and that cisplatin lesions titrate it away from its
functionally active sites on the DNA. Alternatively, binding of the protein could
protect cisplatin adducts from repair, preserving their lethality at the time of cell
division and leading to the arrest of tumor growth. This last hypothesis would
require more of the SSRP in cells sensitive to the drug. Studies are currently in
progress to delineate these three and other hypotheses, and to learn whether the
discovery of the SSRPs has heralded the final chapter in the quest for the mo-
lecular mechanism of cisplatin or merely been an entertaining sidelight.
e. Drug Resistance: What Do We Know? 150 Perhaps the most serious
problem for successful chemotherapy of tumors is drug resistance. 102 In most
tumors there exists a subpopulation of cells that are naturally resistant to a given
drug; as the sensitive cells are these refractory clones take over. In ad-
dition, resistance can be acquired by tumor cells following repeated apl)lJ(~at]lon
of the drug. Attempts to identify mechanisms responsible for cisplatin resistance
have therefore been the subjects of considerable research activity. Other DNA-
damaging agents sometimes genes as a mechanism of drug resistance.
An example is the resistance phenomenon, in which a gene encoded
for a P-glycoprotein is amplified in cells resistant to agents such as daunomycin.
This protein is believed to increase efflux of the drug through the cell membrane
by an ATP-dependent, energy-driven pump. There is currently an intensive search
underway to see whether the cisplatin resistance phenomenon has a genetic ori-
gin. If a cisplatin resistance gene could be cloned and its phenotype identified,
a powerful new avenue would be opened to overcome drug resistance.
8. Site-specifically platinated 154
a. The Problem Much of the information obtained about the mechanism
of action of cisplatin has been derived from experiments where Pt-DNA binding
has occurred in vivo or in vitro, with the use of random-sequence DNA having
all available targets for the drug. In these studies, platination is controlled by
the inorganic chemistry of cis-DDP in the medium and the accessibility of target
sites on the DNA, as already discussed in considerable detail. As such, this
situation best represents drug action as it actually occurs in the tumor cell. On
the other the resultant spectrum of DNA adducts makes it if not
imlpm;sit)!e, to the structural and functional consequences of any spe-
cific adduct. In order to address this problem, a methodology has been devel-
oped in which a single adduct is built into a unique position in the
genome. This approach is powerful and has the potential to be extended to the
study of many other metal-based drugs. In this section, we discuss the strategy
used to construct such site-specifically platinated DNA molecules and the infor-
mation obtained far from their study. Some uses have already been dis-
cussed.
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Figure 9,29
Map of the genome crcated by insertion of cis-DDP platinated or unplatinated
d(TpCpTpApGpGpCpCpTpTpCpT)-d(ApGpApApGpGpCpCpTpApGpA) into
the Hinc II restriction site of bacteriophage M13mp18 DNA.
b. Synthesis and Characterization Figure 9.29 displays the map of a ge-
nome constructed by insertion of or dodecanucleotide du-
plexes d(pTpCpTpApGpGpCpCpTpTpCpT)'d(pApGpApApGpGpCpCpTpApGpA)
into DNA bacteriophage M13mp18. This genome was constructed in the
following manner. 154 Double-stranded DNA from M13mp18 was first digested
with Hinc a restriction enzyme recognizes a six-base-pair se-
quence in the DNA and cleaves the double helix there, leaving a blunt-ended
(no overhanging bases) cleavage site. The dodecamer was
next into the Hinc site, and the DNA in vivo. The dodeca-
mer can insert into the genome in two different orientations, the desired one of
termed M13-12A-Stu I, was identified by DNA sequencing. The pres-
ence of the insert in the new DNA was checked by its sensitivity to the restric-
tion enzyme Stu I, which cleaves at the d(AGGCCT) sequence situated
in the dodecamer insert, and the absence of cleavage by Hinc the site for
which was destroyed. Next, Hine II-linearized M13mpl8 replicative form
Hinc II
P---------
---------P
formamide t
denaturation,
renaturation
(.) [,AGMGGCCTAGA']
[GMGGCCTAG]
(+) M13 - 12A
gapped
heteroduplex
575
singly adducted
genome
1) T4 DNA ligase r3' - TCTTCCGGATCT - [32p] - 5'
2) drop dialysis v
3) sepharose 48
chromatography
AGAAGGCCTAGA
TCTTCC~GTACTJ
(+) (-) [32p]
M13 - 12A - Pt(-)
G N(l) N(l)G
'\. /
Pt
/ '\.
H3N NH3
Figure 9.30
Scheme for constructing site-specifically platinated genomes via gapped
heteroduplex synthesis (reproduced by permission from Reference 154).
DNA was allowed to form a heteroduplex with excess viral DNA has
only the + in the presence of the denaturant which was
dialyzed away during the experiment. The resulting circular DNA has a gap in
the minus strand into which the d(TCTAG*G*CCTTCT) was ligated
(Figure 9.30). The latter material was prepared by the methods described in
Section V.D.5.a and characterized by IH NMR spectroscopy. The resulting site-
specifically DNA contains a single cis-[Pt(NH3h{d(pGpG)}] intra-
strand crosslink built into a unique position. The methodology is general, and
has been used to create other known platinum-DNA adducts site-specifically in
M13mp18.
The chemical properties of the platinated DNA, termed M13-12A-Pt(-)-Stu
I, were investigated by enzymatic, digestion and gel electrophoresis experi-
ments. Platinum completely inhibits cleavage of the DNA by Stu I, as expected
from the earlier restriction enzyme mapping studies. In addition, the cis-
[Pt(NH3h{d(pGpG)}] and cis-[Pt(NH3h{d(pApG)}] intrastrand crosslinks were
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found to inhibit a variety of DNA polymerases, with only a small amount of
bypass of the platinum lesion. 149 These results indicate that the most abundant
adducts of cisplatin on DNA are able to block replication efficiently.
c. Biological Properties When M13-12A-Pt(-)-Stu I DNA was introduced
into E. coli cells by transformation, DNA synthesis was uninterrupted, because
the cell can both repair the damage and use the unmodified (+) strand for
synthesis. Consequently, a slightly different strategy was used to construct sin-
gle-stranded M13-12A-Pt( + )-Stu I DNA, the details of which are available
elsewhere. 154 This platinated template, in which the damage can neither be re-
paired nor bypassed by known mechanisms in vivo, was then transformed into
E. coli cells co-plated with GW5100 cells. Under these conditions, viral DNA
replication is detected by the expression of the f3-galactosidase gene, which, in
the presence of appropriate reagents in the medium, leads to formation of blue
plaques on a clear background. The results clearly indicate that many fewer
plaques appear when M13-12A-Pt( +) is introduced into the cells than when
M13-12A-u( +) was employed, where u stands for unmodified DNA. In three
repeats of this experiment, survival of DNA containing only a single cis-
[Pt(NH3h{d(pGpG)}] crosslink was only 11 ± 1 percent.
These data provide unambiguous proof that the most frequent DNA adduct
formed by cisplatin is toxic, capable of inhibiting replication when only a single
such lesion is present on a natural DNA template of 7,167 nucleotides. The fact
that as many as 10 percent of the transformed cells can bypass or repair the
lesion is also of interest, and parallels the results found in vitro. In related work,
it was found that the cis-[Pt(NH3Md(pGpG)}] intrastrand crosslink is not very
mutagenic, but that cis-[Pt(NH3h{d(pApG)}] intrastrand adducts are consider-
ably more so. This finding is important, since mutations could lead to long-term
secondary tumor production in patients treated with cisplatin. The methodology
affords a way to screen new compounds that one would like to be equally effec-
tive at inhibiting replication but less mutagenic. In addition, by using repair-
deficient mutant cell lines, as well as cisplatin resistant cells, one can study the
effects of varying the properties of the host cells. Incorporation of site-specifi-
cally platinated DNA sequences into appropriate shuttle vectors will also facili-
tate investigation of toxicity, repair, and resistance in mammalian cells.
d. Prospectus The foregoing discussion illustrates the power of site-spe-
cifically platinated DNAs as a probe of the molecular mechanism of the drug.
We recall similar strategies were employed to obtain uniquely modified
DNA in the bending 92•93 and unwinding 95 experiments discussed previously. In
principle, technique can be applied to examine other aspects of the molec-
ular mechanism of other metallochemotherapeutic agents. The requirements are
a synthetic route to the uniquely modified genome, for which both the inorganic
coordination chemistry and molecular biology must be amenable, an adduct stable
to the biological conditions for DNA synthesis, and a method (usually genetic)
for scoring the biological effects being investigated. Site-specifically platinated
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DNAs allow the bioinorganic chemist to have maximal control over the genetics
and should continue to provide valuable information about the molecular mech-
anism of action of cisplatin.
Design of New Inorganic Anticancer Drugs
1. Objectives
Although chemotherapy has made significant contributions to cancer treat-
ment, the effect of cisplatin on testicular cancer being a showcase example,
early detection and surgical removal of all neoplastic tissue still remain the pre-
ferred means of combating most forms of the disease. What steps need to be
taken to devise better chemotherapeutic agents? One answer is to understand the
biochemical mechanisms that underlie the transformation of normal into neo-
plastic cells and to attack the disease on the basis of that knowledge. The value
of this approach is indisputable, but it need not be the only one. We have seen
that cis-[Pt(NH3hClz], a simple third-row transition-metal complex containing
no carbon atoms, can contribute significantly to cancer chemotherapy. This ex-
ample alone should lead us to search for improved inorganic drugs based on the
evolving knowledge of the mechanism of action of cis-DDP. What then should
our objectives be? Three answers are immediately apparent. we need to
find compounds that are active against resistant cells. Such compounds are termed
"second-generation" platinum drugs, and are the focus of much activity in the
pharmaceutical industry. Their development will be facilitated by understanding
the fundamental biochemistry of cisplatin drug resistance, designing complexes
to circumvent the cellular resistance mechanisms. Second, there needs to be an
improved spectrum of activity, to be provided by the so-called "third-genera-
tion" compounds. The major cancers of the colon, breast, and lung are not
effectively diminished by cisplatin chemotherapy. Finally, cisplatin toxicity is
often dose-limiting, and there is a need for agents with a greater chemothera-
peutic index-to-toxicity ratio. Some of these objectives may ultimately be met
by modifying the mode of delivery of cisplatin, for example, by encapsulating
the drug in a tumor-seeking liposome or attaching it to a tissue-specific mono-
clonal antibody. A major step in alternative delivery has recently been taken
with the development of a class of oral platinum complexes that have just en-
tered clinical trials. 54 These complexes are platinum(IV) cycloalkylamine spe-
cies of the kind cis, trans, cis-[Pt(NH3)(C6H5NH2)(02CCH3hClz]. The pros-
pects are reasonably good that new platinum and other metal anticancer drugs
can be designed in a bioinorganic chemical approach to the problem.
2. Strategies for drug development
a. Can We Build on Our Knowledge About Cisplatin? If we consider what
is known about the molecular mechanism of cisplatin, what properties are desir-
able in the design of new metal complexes for testing? The molecules should
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be reasonably stable and soluble in biological cross the cell
membrane, bind covalently to DNA, and inhibit gene function. As described
previously in this section of the chapter, powerful methods are now available to
screen compounds for these properties in a relatively short time. But there are
additional factors required for metallodrug anticancer activity, above and be-
yond these criteria; trans-DDP, after all, has all five of the above properties and
is not active. Probably one should add to the list the requirement that the com-
plex have two substitutionally labile cis sites for intrastrand crosslinking of ad-
jacent DNA nucleotides; such a criterion would, of course, rule out molecules
like trans-DDP. Recall, however, that cis-[Pt(NH3h(4-X-py)CI] + complexes
(X = Br, Me) are active. These cations have the five properties listed above,
but, as far as is currently known, monofunctionally to DNA. The
pyridine ring moiety of a covalently attached atom could possibly in-
tercalate into a neighboring interbase pair site on the DNA, making a pseudo-
intrastrand crosslinked adduct structurally similar to the cis-DDP-d(pGpG) struc-
ture. Further information is required about these active, cations
before any firm conclusions can be drawn. Nevertheless, it is useful to remem-
ber if the requirement of two substitutionally labile cis ligands had been
rigorously followed, this new class of monofunctional complexes would
not have been discovered.
Another rationale for designing new or other metal antitumor drugs
could emerge with a better understanding of the SSRPs in the mechanism of
action of cisplatin. For example, if they serve to protect cisplatin lesions on
DNA from repair, one would want to design complexes that form adducts that
bind even more strongly to the protein. The strength of this binding
interaction, having been a serendipitous discovery, surely cannot have been
maximized. A tighter SSRP-platinated DNA complex would require the use of
less platinum, and thus afford lower toxicities.
b. Is Platinum Uniquely Suited? Given the above criteria, is the
only metal to be chosen for further drug development? The answer to this ques-
tion is "probably " but a few need to be kept in mind. Given the
assumption that the geometry of the cis-[Pt(NH3h{d(GpG)}] intrastrand cross-
link was important for the antitumor activity of cisplatin, computer graphics
methods were employed to probe the stereochemical consequences of modifying
structure. 155 Addition of axial chloride or water ligands in and
coordination positions to form pseudo-octahedral adducts, for intro-
duces several steric clashes with the guanosine 06 atoms. An octahedral com-
plex, for example cis,cis,cis-[Pt(NH3hCh(OHhL coordinated to
DNA either would not form an intrastrand d(GpG) crosslink or would form an
adduct different from that made by cis-DDP. This octahedral
complex, known as "tetraplatin" in the pharmaceutical industry, is active, but
is believed to be reduced in vivo to platinum(II) before coordinating to DNA. 156,157
These considerations might that the best strategy for inorganic drug de-
velopment would be to employ square-planar d 8 complexes. Clearly there are as
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yet no definitive answers. Nevertheless, the criteria derived from the mechanism
of action studies of an excellent starting for designing
new antitumor me~taJlo(lrulgs.
c. How Are Amine Ligands? Here again, the answer is not un-
equivocal, but amines (including NH3) are probably ideally suited ligands for
covalent DNA-binding metal complexes. Even completely inert complexes such
as [Co(NH3)6] 3+ show sequence and DNA binding preferences, 158
suggesting that the N-H bonds orient toward the phosphate and heterocyclic
nitrogen atoms groove, hydrogen-bonding interactions.
This chemistry is analogous to the binding and recognition of organic amines
and polyamines, such as spermine and spermidine, by nucleic acids. Apart from
amines, hydrophobic groove-binding and/or intercalating ligands as
O-I)he~nantl1follinle and its derivatives should be considered. Molecules such as
[Rh(DIPh]3+ , where DIP = 4,7-diphenyl-l, bind to DNA
and have proved to be useful structural probes (Chapter 8). Recent work has
shown that + binds preferentially to d(GpG) sequences, like cis-
anltitulm()r properties have not yet been investigated. 159
3. Second-
Imprc)vements over have been most notably the mOllecule
car'boplalm (Figure 9.4), which is less nephrotoxic and has been reported to be
effective in some patients where chemotherapy has failed. These prop-
erties come solely from the dicarboxylate leaving group, which is kinetically
more inert to Studies with antibodies have shown the
DNA adducts of to be identical with those formed cis-DDP. lI7
Other compounds that have undergone clinical trials are close ana-
logues of cis-[PtA2X 2L or tetraplatin, cis,cis,cis-[PtA2X 2Y 2L that obey
the classic relationships. The activity of cationic triamines, cis-
[Pt(NH3hLCI]CI, where L is pyridine, a substituted pyridine, or
IJU''''''~, against Sl80 ascites and L1210 tumors in mice opens a new vista of
possible structures to be tried. The intercalator-linked AO-Pt (Figure
9.26) has also been found to show activity in the S180 ascites system, suggest-
ing a further class of that could be studied. The oral compounds,
cis, trans, cis-[Pt(NH3)(C6H5NH2)(02CCH3hChJ, survive the digestive tract,
are taken across the gastrointestinal mucosa, and metabolize to cis-
"'UA,,, ''-'h'U~''un "'-"J , a analogue. 54 As such they are effective pro-
drugs that could become the agent in clinical use. Until these
recent advances, there was a general impression by chance, the best com-
discovered was the first one, cisplatin. There is now sufficient reason to
expect that innovative experimentation will to drugs, bearing in
mind the comment made earlier (Section IV.G.) that sustained individual effort
for up to a decade can be required to move a compound from the laboratory
bench into the clinic.
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4. metal complexes
a. Soft Metals As mentioned in Section IV.E., some compounds of Pd(II),
Au(I) , and or have been screened for antitumor activity, but
much more work needs to be done in this arena. The higher metal-ligand ex-
change rates of Pd(II), ~105 faster than those of Pt(Il), make these complexes
potentially more toxic, as some preliminary animal studies have shown. By use
of chelating or organometallic complexes, however, this problem might be
avoided. The properties of Ru, and to a lesser extent Au amine and poly-
pyridine complexes would seem to make them attractive candidates, and indeed
there appears to be renewed interest in these molecules. 160 Inorganic chemists
interested in pursuing drug development these metals need to forge alli-
ances with biological colleagues equipped to do the necessary animal screening
and to develop in-house expertise for cell culture and related biochemical work.
The techniques are not all that and it is actually fun to undertake stud-
ies of the biological consequences of metallodrug chemistry.
b. Metallocenes and Metallocene Dihalides.~6:37 Although complexes such
as [(CsHshTiChJ are superficially analogous to cis-DDP, in being potentially
bifunctional DNA crosslinking agents, their hydrolytic reactions are sufficiently
different to cast doubt on the value of this comparison. The fact that antitumor
activity has been found for this very different class of inorganic compound,
however, suggests that perhaps bioinorganic chemists have explored only a very
small sample of possible metallodrugs.
The topics discussed in this chapter are helping to expand bioinorganic chemis-
try from a subject that arose chiefly from spectroscopic analysis of metal centers
in proteins, because they were uniquely convenient functional groups, to a dis-
where knowledge about metal functions and application
of metals as diagnostic and chemotherapeutic agents are making important con-
tributions to medicine. As the case study of cisplatin is intended to demonstrate,
progress in understanding how metals function in chemotherapy can be made
only by the combined efforts of many disciplines, including synthetic and phys-
ical inorganic and organic chemistry, molecular and cell biology, immunology,
pharmacology, toxicology, and clinical medicine. Although we have not yet
reached the day where chemotherapeutic agents can be rationally designed from
knowledge of a molecular mechanism, such a concept does not seem that far-
fetched. If nothing else, knowledge of fundamental bioinorganic processes re-
lated to metal-macromolecule interactions will continue to grow enormously
through efforts to achieve this ultimate goal.
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,""'U"'0, 76-78
dependence, 50, 51
role of arginine, 57
structure, 49, 51, 75
structures of 62
substrate 75
substrate 75
zinc coordination, 49
Carb(mnl0[ioxyh(~ml)globJn structure, 233
Carbonmonoxymyoglobin structure, 235
Carboplatin, 519, 528, 579
structure, 518
O'-Carboxyglutamic acid Ill, 151
Carboxylic ester hydrolysis, 86
Carboxypeptidase, 39, 508
Carboxypeptidase 44, C-4
active site, 80-82, C-5
anion binding, 82
intermediates, 82
kinetics, 82
metal 81
proposed catalytic mechanism, 83, 84
structure, 80
Carcinogenic metals, 513
f3-Carotene, 263
Carotenoids, 328
Carp 111
Catalase, 191, 263, 295, 297
mec:hanism, 297
structure, 295
Catechol dioxygenases, 260, 276
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Catechol dioxygenases (continued)
active site, 277, 279
iron coordination, 280
mechanism, 280, 282, 283
spectroscopy, 277, 278, 280
structure, 279
substrate activation, 282
Cellular conditions, 253
Ceruloplasmin, 4, 263, 264, 509
Cervical cancer, 527
Charge separation, 329
Chelation therapy, 509, 5 513
Chiton, 30
Chlorocruorin, 169, 170, 184, 185
Chloroheme, 185
structure, 169
Chlorophyll a, 328
Chlorophyll b, 328
Chromate carcinogenicity, I I, 513
Chromatium 385, 386
Chromium, 10
biological significance,S
toxicity, 11
Chrysotherapy, 518
Chymotrypsin, Ill, 137, 152
Chymotrypsinogen, 111, 137, 152
Cisplatin (also see cis-DDP), 505, 519
administering with sulfur compounds,
528
clinical activity, 523
clinical picture, 527
discovery, 522
efficacy improvement, 577-579
mechanism of 526
pharmacology, 528
pre-clinical and clinical 524
target, 533
toxicology, 527
Citrate, 111, 393, 422
Clostridium pasteurianum hydrogenase I,
407
Clostridium pasteurianum hydrogenase
407
Co(DIPhH (shape-selective cleavage of
nucleic acids), 486
Co(phenhH , 468
Cobalamin (also see coenzyme B 98
Cobalamin reactivity, 100
Cobalt
biological significance, 4
chemistry, 205
oxyhemoglobin, 235
porphyrins, 198, 206, 224, 240
toxicity, 510
Cobalt(U)-rubredoxin, 377
Cobalt(H)-substituted carbonic anhydrase,
54,55,59,68
acid-base equilibria, 56, 57
inhibitors, 57, 58, 65-67
isozymes, 56
59,60
NMR, 62, 64, 65
NMRD, 63, 64
Cobalt(II)-substituted copper-zinc super-
oxide dismutase, 303
Cobalt(II)-substituted liver alcohol dehy-
drogenase, 93
Cobalt(Il)-substituted zinc proteins, 45
Cobalt-dioxygen model systems, 205
Cobalt-oxo 198
Cobalt-porphyrin hemoglobin and myo-
globin derivatives, 205
Cobalt-porphyrin oxo species, 205
Cobamides, 98
Coelenterazine, 113
Coenzyme B 12 , 100
biological reactivity and mechanism,
100
Co-C bond, 100
cyano complex (vitamin Bd, 98
enzymes dependent on, 98
physical properties, 98
UIH'UIH,,,, 100
radical formation, 101
spectroscopy, 99
structure, 98, 99
Coenzyme Q, 316
Collagenase, 39
Combination chemotherapy, 527
Complex I (NADH-Q reductase), 325
Complex II (succinate-Q reductase), 325
Complex III (ubiquinol-cytochrome c re-
ductase), 326
Complex IV (cytochrome c oxidase), 326
Cooperative ligand binding, 174-182
Copper
biological significance, 3
chemistry, 204
deficiency, 508
model complexes, 270
storage, 16
toxicity, 509
Copper(II) tet b, 300
Copper(II)-substituted carbonic anhy-
drase, 69
anion binding, 69
69
70,71
NMRD,71
Copper(II)-substituted liver alcohol dehy-
drogenase, 93
Copper(II)-substituted zinc proteins, 46
Copper-containing dioxygen carriers, 185
Copper-dioxygen model systems, 204
Copper-thiolate model complexes, 273
Copper-zinc superoxide dismutase, 298
active site, 301
active-site channel, 302, 304
activity, 299, 300
cobalt derivative, 303
308-310
mhllblt101n, 304
loss of bridging ligand, 304
mechanism, 303
metal-substituted derivatives, 305,
306, 308, 310
reaction with anions, 304
role of copper, 302
role of zinc, 48, 302
spectroscopy, 305, 306-310
structure, 300, 301-303
Core extrusion cluster 391
Correlation time, 63
Corrin, 98
Creatine kinase, 39
Cross electron-transfer reactions, 334,
337
Cruciform sites, 485-487
~U\Il'J'<OHJ2+, 471
Cu(phenh + DNA footprinting, 482
CUA,271
CUA ENDOR, 272
CUA 272
CUB, 271
Cyanobacterium (blue-green alga) Ana-
baena cylindrica, 413
Cyclic 132
INDEX 597
Cystine, 315
Cytochrome a, 271, 272, 326
Cytochrome a3, 271, 273, 326
Cytochrome arCus, 273
Cytochrome bs-cytochrome c, 349, C-12
Cytochrome bs62 , 326
Cytochrome bS66 , 326
Cytochrome bS68 , 326
Cytochrome c, 9, 322, 326, 352
alkaline transition, 352
electron transfer, 356, 357
interaction with redox 355
reduction potentials, 353, 354
structure, 322
structure of heme area, 353
zinc-substituted, 350
Cytochrome c oxidase, 260, 267, 326
carbonmonoxy derivative, 275
cyanide adduct, 272, 273
273
EXAFS,273
reduced, 275
mechanistic studies, 275
metal centers, 271
redox components, 267
spectroscopy, 271
Cytochrome c peroxidase, 295
Cytochrome c reductase, 326
Cytochrome c', 322
structure, 323
Cytochrome Cj, 326
Cytochrome C3, 322
structure, 323
'ytochn)me nOlll1en,2Iature, 321
Cytochrome PA50, 284, 285, 297,
332
active-site structure, 293
catalytic cycle, 285
dioxygen bond cleavage, 293
free radical intermediates, 292
metalloporphyrin model systems,
288
proposed mechanism, 286
specificity, 292, 294
structure, 292
Cytosine, 457
Cytosine N3, 459
Cytosol, 161
Cytosolic compartment, 123
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D
cis-DDP (also see cisplatin)
anticancer activity, 525
bifunctional adducts, 536, 538
bifunctional binding modes, 539
critical lesion, 571
crosslinks, 538
DNA adducts, 551-563
DNA antibodies, 553
DNA bending, 544, 545
DNA binding kinetics, 534
DNA binding sequence preference, 566
DNA-protein crosslinks mediated by,
539
drug resistance, 549
efficacy improvement, 577
ethidium bromide complexes, 569
Exom mapping, 568
hydrolysis, 532, 536
hydrolysis of chloride, 530
inhibition of replication, 546, 547
inhibition of transcription, 570
mediated structural changes in DNA,
540
model complexes with nucleobases,
563
molecular mechanism, 570
monofunctional adducts, 536, 538
mutagenesis and repair, 548
reaction with DMSO, 532
reaction with serum proteins, 532
reaction kinetics, 539
reactions in aqueous media, 530
regioselectivity, 55 J
site-specific DNA platination, 573
structure, 518
target, 533
trans-DDP
anticancer activity, 525
bifunctional adducts, 536, 538
DNA adducts, 551, 564
DNA binding kinetics, 534
hydrolysis, 536
monofunctional adducts, 536, 538
oligonucleotide structure, 565
reaction kinetics, 539
regioselectivity, 551
Dehydrogenation, 90
Deoxyhemoglobins and model complexes,
231
Deoxymyoglobin active-site structure,
231
Deoxyribonucleotides, 456
Desferrioxamine, 510
Desulforedoxin, 369
Desulfovibrio gigas 393, 394
Desulfovibrio gigas hydrogenase, 409
Detoxification enzymes, 263
Dewar-Chatt-Duncanson olefin binding,
438
Diacylglycerol, 149,518
cis-Diamminedichloroplatinum(II) (see
cisplatin, cis-DDP)
Diethylenetriaminepentaacetic acid
(DTPA),51O
Dihydride complexes, 411
Dihydrogen (see hydrogen)
Dinitrogen (see nitrogen)
Dioldehydrase, 98
Dioxygen
adducts, 234
carrying capacity of 179
chemistry, 183, 191,253-259
concentration in living systems, 178
coordination geometries, 195, 196,211
heterolytic bond cleavage, 293
kinetics, 256
orientation in hemoglobin, 232
radical pathways, 259
redox properties, 254, 255
sequestration and transport, 168
singlet state, 257
species (bond lengths), 194
storage proteins, 170
stretching frequencies, 195
thermodynamics, 254
toxicity, 260-267
triplet state, 256
use, biological, 253
Dioxygen binding
cooperative, 174-182
cooperativity models, 180
curves, 175
distal effects, 223, 228, 229, 235, 236
kinetics, 172, 182, 186, 187
models, 170, 229, 238, 240
non-cooperative, 174
proximal effects, 225, 228, 229
thermodynamics, 172, 173, 186, 187
to hemoglobin, 238
Dioxygen carriers, 167-246
biological, 167-170, 183- 215,
216
ligand affinity, 219-221
model systems, 170, 171,204,205,
217-219,222
properties, 171
thermodynamic and kinetic parameters,
186, 187
2,3-Dimercaptopropan-l-ol, 509
Dioxygenases, 276-283, 332
Dipeptidase, 39
2,3-Diphosphoglycerate (2,3-DPG), 179
Distal effects, 223, 228, 229, 235-237
Distal histidine, 216, 235
interaction with dioxygen, 236
Distamycin-Fe(Il)EDTA,489
1,2-Dithiolate ligands, 441
1,2-Dithiolenes, 441
DNA
A-DNA, 457, 566, 567, C-14
B-DNA, 457, 566, 567, C-14
bending, 543
bent, 484
conformational changes with Pt bind-
ing, 542
crosslinks with protein, 539
DDP interactions (see cis-DDP, trans-
DDP)
double 456
footprinting, 481
insertion into a plasmid, 574
interactions with protein, 550
metal stabilization of structure, 461
oxidative damage repair, 264
oxidative degradation, 262
repair, 549
shape-selective probes of, 485-487
strand scission, 476
structural changes upon platination,
565,566
unwinding, 475, 540, 544
Z-DNA, 458, 566, 567, C-J4
DNA polymerase, 39
INDEX 599
DNA topoisomerase, 500
DNAse 1,500
Dominant Hypothesis, 414, 416-419
Doming, 226
Dopamine-,B-hydroxyJase, 508
Drug design, 524, 577-580
Drug resistance, 528, 549, 573
Drugs, anticancer, 519-526
DTPA,510
E
EcoRI,500
EDTA, 111,509,510,513
EF-hand, 137, 141, 146, 147, 159, 160
EGTA, 111
Electrochemical mode of redox activa-
tion, 401
Electrogenic pump, 131, 161
Electron energy loss spectroscopy
(EELS), 118, 190
Electron paramagnetic resonance
193,374
of Fe2S2 ferredoxin, 380
of Fe3S4, 395
of FeMoco, 420, 421, 424
of Fe-S proteins, 374, 375
of hydrogenases, 405-410
of nitrogenase, 419-424
Electron probe x-ray microanalysis
(EPMA), 118, J19
Electron transfer
cross reactions, 334-336, 342, 343
distance dependence, 344
in biology, 315-333
in cytochrome c, 352-358
in photosynthetic reaction centers, 358,
359
in protein-protein complexes, 349-351
in ruthenium-modified proteins, 347,
348, 356-358
long-range reactions in proteins, 343-
349
pathways, 345, 348, 356-358
self-exchange reactions, 334-336
theory, 336-342
Electronic coupling, 338, 343, 356
Electronic relaxation time, 63
Electrophoresis, 543
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Endocytic vesicles, 123
Endocytosis, 161
Endodermis, 9
Endonexin, 135, 148
Endonucleases, 500, 501
Endoplasmic reticulum (ER), ll, 119,
124, 161
ENDOR spectroscopy, 374
of hydrogenase I, 408
of nitrogenase, 423, 425
Endosome, 18
Endothelial cell, 158
Energy release, 324
Energy storage, 324
Enterobactin, 20, 21, 23
Enzymes, detoxification, 263
Epidermis, 9
Epithelial cells, 122, 161
Epoxidation reactions, 256, 284
Erythrocruorins, 169, 170, 184
Erythrocytes, 124, 161
ESEEM spectroscopy, 374
of FeMoco, 424
of hydrogenase 1, 408
Essential metals, 506, 507
Ester hydrolysis, 79
ETH 1001, 113, 14
Ethanoldeaminase, 98
Ethidium bromide, 540, 568
complexes with cis-DDP, 569
Eubacterial methanotrophs, 413
Eukaryotic cells, 121, 161
Evolution, biological, 13
Exchange 63
Excision repair, 549
Exocytosis, 123, 148, 162
Exonucleases, 500
mapping, 551
Extended x-ray absorption fine structure
(EXAFS), 193, 372
of Fe3S4, 393-395
of FeMoco, 426
of ferredoxins, 388
of FeV protein, 434
of hydrogenases, 409, 410
of nitrogenase, 426
of rubredoxin, 372
of thiocubanes, 437
F
F430, 4
F center, 407, 408
5F-BAPTA, 117
NMR,117
Facultative aerobes, 413
FAD (see flavin adenine dinucleotide)
Fatty acid w-hydroxylation, 369
Fe(Bis-Poc)(l,2-Me2Im), 220-222
Fe(C2Cap)((l-Melm)(CO), 237, 240
Fe(C2Cap)(l-Melm), 220-222
Fe(C2Cap)(I,2-Me2Im), 220-222
Fe(C2COP)(l-MeIm)(CO), 234
Fe(PF)(l-MeIm), 220, 239
Fe(PF)(l-Melm)(02), 234, 238, 240
Fe(PF)(l,2-Me2Im), 220-222
Fe(PF)(2-MeIm), 231, 240
Fe(PF)(2-Melm)(02), 234
222
Fe(Poc)(l,2-MeIm)(CO), 234
Fe(Poc-PF)( -MeIm), 220-222
I ,2-Me2Im), 220-222
,2-Me2Im)(CO), 237, 238
Fe(TPP)(2-MeIm), 231, 240
Fe(TPP)(Py)(CO), 234
Fe2S2 centers, 366, 368, 379, 383, 386
EPR, 375, 380
in ferredoxins, 320, 370, 378-382
in Rieske proteins, 382
localized valence trapping, 381
mixed-valence, 384
models, 382-384
Mossbauer spectra, 376, 381
381
redox potential, 370, 400
resonance Raman spectra, 381
Fe3 model systems, 395
Fe3/Fe4 proteins, 395
Fe3S3 center, 392
Fe3S4 centers, 367, 368, 391-395
ENDOR,396
375, 392, 393, 395, 396
EXAFS, 393, 394
in proteins, 371, 391-395
Mossbauer spectra, 376, 395
396
redox potential, 371, 400
resonance Raman spectra, 395
Fe4S4 centers, 366-368, 388-390, 442
375,385,386
EXAES,388
in ferredoxins, 320, 384-388
~ 320, 384-388
MCD,387
models, 388-390
Mossbauer spectra, 376, 387
NMR,388
properties in proteins, 370, 371
redox potential, 370, 371, 400
resonance Raman spectra, 387
Fe6S63+/Z+ cores, 398
Fe6Sl- cores, 397, 398
Fe7S63+ cores, 398
FegS65 + cores, 398
FelgS3010- cores, 398, 399
FeFe protein, 435
FeFeco,435
FeMo cofactor (see FeMoco)
FeMo protein, 414, 416-420, 424, 425
424
EXAFS,424
Mossbauer spectrum, 425
structure, 443
FeMoco, 414, 418, 420-442
assembly reactions, 422
biosynthesis, 414
EPR,424
ESEEM,424
EXAFS,424
models, 428, 429, 436, 437
oxidation states, 421
structure, 443, 444
FeMoS clusters, 430, 436, 437
Fenton reaction, 463, 464, 482, 484
fepA protein receptor, 22
Ferredoxins, 320, 365-367, 370, 371
FezSz (see FezSz centers)
Fe4S4 (see Fe4S4 centers)
Ferrihydrite, 30, 31
Ferritin, ]2-16,31,263
core, ]5
formation, 15
models, 31,32
structure, 14
Ferryl complex, 289
FeV proteins, 433-435
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FeVco, 435
FeWS clusters. 430
Filamentous bacterial growth, 523
Flavin, 512
Flavin adenine dinucleotide (FAD), 326
Flavin mononucleotide (FMN), 317, 318
Flavodoxins, 317, 414
structure, 318
Flavohemoglobin, 349
Fluo-3, 11], 115
Fluorescent probes of Caz +, 115
FMN (see flavin mononucleotide)
2-Formylpyridine thiosemicarbazone, 521
Franck-Condon principle, 336
Free-radical autoxidation, 258
Fur protein, 494
Fura-2, 111, 115, 116, C-7
GAL4,493
Gallium anticancer activity, 520
Giant squid axon, 129
Gla-Gla dipeptide, III
Glucocorticoid receptor, 493
Gluconeogenesis, 107, 162
Glucose tolerance factor, 10
Glutamate mutase, 98
Glutathione, 262, 263
Glutathione peroxidase, 295
Gly-Gly dipeptide, III
Gly-Gly-His, 489, 490
Glyceroldehydrase, 98
Glycolysis, 107, 162
Glyoxalase, 44
Goethite, 31
Gold
anticancer activity, 520, 580
pharmaceuticals, 518
thioglucose (Solganol), 518
thiomalate, 518
Growth retardation, 505
Guanine, 457
Guanosine triphosphate(GTP)-binding
proteins, 518
Gypsum, 112, 156
H center, 407, 408
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Hz (see hydrogen)
Haber-Bosch process, 412
Haldane effect, 176
Head and neck cancers, 527
Heart disease, 505
Heavy-metal poison, 505
Heavy-metal staining of RNA, 461
Heme a, 271,321
Heme b, 169, 185,27.°,285,295,321
Heme c, 9, 321
Heme octapeptide, 353
Heme-containing dioxygen carriers, 184
Hemerythrin, 168, 170, 184, 187-190,
210-212, 216
active site, 190,210
dioxygen coordination, 211
dioxygen stretching frequencies, 195
Hill coefficients, 189
metal ligands, 211, 216
oligomerization, 189
spectral changes with oxygenation, 212
structure, 190
Hemochromatosis, 509
Hemocyanin, 168, 170, 184, 185, 187,
188,210-212,216
active site, 210
cooperativity, 188
dioxygen stretching frequencies, 195
metal ligands, 211, 216
spectral changes with oxygenation, 212
structure, 188, 189
Hemoglobin, 168-170, 180-186,229-
244
cooperativity, molecular mechanism
for, 238
dioxygen stretching frequencies, 195
distal histidine mutants, 236
electron transfer, 351
electronic structure, 213
hybrid, 350
hydrophobic pocket, 232
ligand affinities, 220, 221
metal ligands, 215
model systems, 217, 218, 229-234
mutants, 244
structures, 241-243, 351
tetramer, 185
Hemosiderin, 13
Heterothiocubane models, 437
Heterotropic allosteric effectors, 178
Heterotropic allosteric interaction, 176
High-mobility group (HMG) protein, 540,
572
High-potential iron-sulfur proteins
(HiPIPs), 320, 384-387
High-valent metal-oxo complex, 291,
295-298
Hill coefficient, 177
Hill equation, 177
Hill plot, 174, 175, 177
Hin recombinase, 489
Histones, 540
Homocitrate, 422
Homotropic allosteric interaction, 174
Horseradish peroxidase (also see peroxi-
dase), 295
Human carbonic anhydrase II, C-2, C-3
Human testes-determining factor, 491
Hybrid hemoglobins, 350
Hydrazine (NzH4), 415
Hydride transfer, 90
Hydrogen (Hz), 403
activation, 412, 441
bonding to metal sulfides, 412
bonding to metals, 411
energy-level diagram, 404
inhibition of nitrogen fixation, 433
modes of Hz/H bonding, 412
molecular orbital scheme, 404
redox properties, 404, 405
Hydrogen peroxide, 254, 255, 295
Hydrogenase, 401, 402, 405
H clusters, 409
hydrogenase I, 406
hydrogenase II, 406
Mossbauer spectra, 408
Hydrogenomonas, 403
Hydrolases, 38
Hydrolysis reactions, 37-39
Hydrolytic chemistry of nucleic acids,
465-467
Hydropathy, 162
Hydropathy plots, 125
Hydroperoxo coordination geometries,
196
Hydroxide coordination to metals, 42
Hydroxide transfer, 89
Hydroxyapatite, 112, 156
j3-Hydroxyaspartic acid (Hya), 154
Hydroxyl radical, 254, 266
reaction with nucleic acids, 463
Hydroxylation reactions, 255, 256, 284,
291
Hypochromism,473
I
I.L.S.,525
ICaBP, 122
ID90 , 526
Imaging reagents, Fe(III), Gd(III),
Mn(II), 517
Indices of antitumor activity and toxicity,
525
Infrared spectroscopy (IR), 193
Initiators, 259
Inner-sphere electron-transfer reactions,
335
Inner-sphere reorganization energy, 339,
340
Inorganic pyrophosphatase, 39
Inorganic sulfide, 379
Inositol, 517
Inositol phosphates, 517
inositol 1,4,5-triphosphate, 132,518
inositol phosphate mechanism of ac-
tion, 133
Intercalation of metal complexes in DNA
460, 462, 470
Intercalators, 541, 542
Intradiol catechol dioxygenase (also see
catechol dioxygenase), 276
Inverted free-energy region, 341
Iodosylbenzene, 287, 288, 291
Ion microscopy, 120
Ion-selective electrodes, 113
Iron (also see Fe)
biological significance, 2, 3
biomineralization, 30
deficiency, 506
distribution in humans, 7
EXAFS of FeMoco, 426
hydrogenases, 405
ligand field considerations, 6
nitrogenase, 435
oxo complexes, 198,274,287-291,
296,497
peroxo complexes, 291
INDEX 603
porphyrin, 198, 202
porphyrin, autooxidation, 199
porphyrin, biological oxidation and
spin states, 201, 203
porphyrin, dioxygen and carbon mon-
oxide affinities, 224
proteins, 7, 414, 418
redox potentials, 8
solubility, 6
storage and transport,S, 12, 17
superoxide dismutases, 298
terrestrial distribution, 6
toxicity, 509
uptake by siderophores, 22
Iron-sulfur proteins, 319, 370, 371
Mossbauer spectra, 376
NMR,377
resonance Raman spectra, 377
Iron-sulfur units, 367, 368
Iron-tyrosinate proteins, 277
Isocitrate, 393
Isocyanide binding to metals, 209
K
Kidney toxicity, 527
Kinases,97
Kruppel protein, 491
L
Laccases, 309
a-Lactalbumin, Ill, 152, 154
j3-Lactamase II, 39,44
Lactate, III
Lactoferrin, 18
Lactotransferrin structure, 19
Langmuir isotherm, 174, 177
LDso,526
Lead cleavage of RNA, 466
Lead toxicity, 512
Leghemoglobin, 184, 185, 243
Leguminous plants, 413
Lepidocrocite, 31
Leucine aminopeptidases, 39
Ligand affinities (hemoglobins and
models), 220
Lipid peroxidation, 262, 266
Lipocortin, 135, 148
Lithium and mental health, 517
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Liver alcohol dehydrogenase \,-,n.LJUI.
90, C-6
active site, 91
conformational change, 91
electronic spectra, 93
kinetics, 94
metal-substituted derivatives, 92, 93
NADH binding, 91
dependence of activity, 92, 95
proposed catalytic cycle, 95, 96
protonation scheme, 94
structure, 90
Longitudinal relaxation time, 63
Lumen, 123
Lyases, 39, 90
M
M center (also see FeMoco), 420
M-N binding, 439
M-S bonding to H2/H, 412
M-T4MPyP, 471
M13mp 18, 575
Macrobicyclic amino cryptate, Ill, 137
Magnesium ion (Mg2+) complex stability
constants, III
Magnetic circular dichroism (MCD) of
Fe2S2 clusters, 387
Magnetic resonance imaging (MRI), 517
Magnetic susceptibility, 193
Magnetite, 13, 30, 31
Magneto-bacteria, 30
Malonate, III
Manganese
biological significance, 4
peroxo complexes, 291
porphyrin, 199
porphyrins, DNA footprinting, 482
superoxide dismutase, 298
toxicity, 5 I0
Manganese(I1)-substituted zinc proteins,
47
Manic-depressive behavior, 517
Marcus cross relation, 342
Marcus theory, 339
Mastoparan, 138
MECAM, 20, 23, 24
Mellitin, 138
Membrane cytoskeleton, 148
mer operon, 5 II
MerA, mercuric reductase, 5ll, 512
MerB, organomercury lyase, 511, 512
Mercury resistance, 494, 5 II
Mercury toxicity, 510
Mercury-binding protein, 494
MerP, 511
MerR, 494, 495, 511
MerT, 51 I
Mesophilic bacteria, 413
Metal complexes
antitumor (nonplatinum), 580
binding to nucleic acids, 468-475
Metal ion storage, 16
Metal ion transport, 17,25,126
thermodynamics, 126
Metal phosphine anticancer activity, 520
Metal requirements, biological, 507
Metal storage, I
Metal substitution in zinc proteins, 44
Metal toxicity, 508
Metal transport, I
Metal-dioxygen species, 197
Metal-dioxygen structure and spectros-
copy, 192
Metal-ion mediated oxidation, 264
Metal-N2 complexes, 439
Metal-oxo orbital scheme, 199
Metal-peroxo intermediate, 299
Metal-substituted heme protein, 350
Metal-substituted zinc proteins, 44-48
Metallocene anticancer activity, 519, 580
Metallodrug design, 524, 577
Metalloenzyme-mediated dioxygen reac-
260
Metallofootprinting reagents, 48 I
Metallohydrolases, 38
Metallointercalation, 470, 471, 520, 542
Metallopeptidases, 38
Metalloporphyrin
binding of carbon monoxide, 208
binding of isocyanide, 209
binding of nitric oxide, 208
binding of nitroso species, 209
complex geometry, 226
d-orbital splitting diagram, 20 I
electronic structure, 213-215
ligand binding, 215
model systems, 288
Metalloregulatory proteins, 493, 5 I I
Metallothionein, 3, 16, 17, 264
Methane monooxygenase, 284
Methane synthetase, 98
Methanogens, archaebacterial, 413
Methemoglobin, 200
Methidium-propyl-FeEDTA,478
Methionine synthetase, 98
N-methyl-n-aspartate (NMDA), 132
Methyl transferase, 98
ll'-Methylene-glutarate mutase, 98
MethylmalonylCoA mutase, 98
Metmyoglobin active-site structure, 231
Michaelis-Menten scheme, 163
Mitochondria, II, 119, 162
inner membrane, 124
Mitochondrial electron-transfer chain, 324
Mitochondrial redox component (com-
plexes I-IV), 325
Mo K-edge EXAFS (Klebsiella pneumo-
niae MoFe protein), 427
Mo K-edge EXAFS of nitrogenase, 426
M03S44+ core, 395
MoFe protein, 416-418
crystals, 426
structure, 442-444
Molecular light switches, 480
Molecular mechanics, 561
Molybdenum (also see 12
biological significance, 5
Molybdenum nitrogenases (see nitrogen-
ases)
Molybdoferredoxin, 416
Monocapped prismatic structure, 399
Monoimidazole complexes of iron por-
phyrins, 268, 269
Monooxygenase enzymes, 284, 294, 332
Mossbauer spectroscopy, 193, 374
481,482
Mugeneic acid, 25
Mugeneic acid-Co(III) complex, 26
Multisite redox enzymes, 400
Mung bean nuclease, 500
MWC two-state model for cooperative li-
gand binding, 180, 181
Mycobactin, 21
Myeloperoxidase, 295
Myochrisin,518
Myoglobin, 184
active-site structure, 231
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cyanogen-bromide modified, 348, 349
distal ligand mutations, 235
electron transfer, 347-349
electron-tunneling pathway, 348
ligand-binding parameters, 239
oxy and carbonmonoxy derivatives,
203
structure, 169
thermodynamic parameters for electron
transfer, 348
Myosin, 141
Myosin light-chain kinase (MLCK), 138
N
N2 (see nitrogen)
N2H2 (diimine, diazene, diamide), 415
N2H4 (hydrazine), 415
Nested al!ostery, 188
Neutral protease, 39
Nickel, biological significance, 4
Nickel carcinogenicity, 513
Nickel, EPR signals in hydrogenases, 409
Nickel hydrogenases, 409, 410
activation/reactivity scheme for, 410
inactivation by dioxygen, 412
Nickel(H)-rubredoxin, 377
Nickel-iron hydrogenases, 405, 409, 411
Nicotinamide, 315
Nicotinamide adenine dinucleotide
(NAD),316
Nicotinamide adenine dinucleotide phos-
phate (NADP), 316
Nicotinic cholinergic agonist, 132
NitB-,421
nit D and nit K genes, 419
nit genes, 413, 414
Nit V mutants, 421
Nit V nitrogenase, 422
NiFe3S4 thiocubane structures, 395
Nitrate reductase, 12
Nitric oxide binding, 208, 209
Nitrilotriacetate, III
Nitrogen (N2), 415
binding modes, 438
complexes, 437
kinetic inertness, 415
reduction to NH3, 415, 416
Nitrogen fixation, 412-416
in Klebsiella pneumoniae, 414
606 INDEX
Nitrogen fixation (continued)
inhibition by Hz, 433
intermediates, 414
role of ATP, 432
Nitrogenases,412
all-iron, 435, 436
alternative, 433
crystal structure, 442
FeMo protein, 414
FeMoco structure, 444
homogeneous preparations, 419
inhibitors, 432
models, 436
molybdenum, properties of, 417
P-clusters, 422, 423
purity, 419
redox activation, 401
substrates, 431, 432
Nitroso species binding, 209
NMR (see nuclear magnetic resonance)
Non-cooperative dioxygen binding, 174
Non-heme iron dioxygen carriers, 188
Nonadiabatic electron transfer, 338,
339
Nonbiological Fe-S clusters, 398, 399
Nonsymbiotic nitrogen-fixing plants,
413
Normal free-energy region, 340
Nuclear magnetic relaxation dispersion
(NMRD), 63, 64
Nuclear magnetic resonance (NMR), 193
43Ca, 152
113Cd, 146
19F, I 7
of Fe-S proteins, 377
of metal complex/nucleic acid struc-
tures, 473-475
probes of Caz +, I 17
67Zn, 44
Nucleases, 500
Nucleic acid/metal complex interactions,
468, 479, 484, 485
chirality, 468, 480
H-bindimg, 462
luminescence, 480
Nucleic acids
hydrolytic chemistry, 465-467
metal coordination, 459, 460
reactions with metals, 462
redox chemistry with metal complexes,
463,489
structures, 456
Nucleophilic addition of hydride, 89
Nucleophilic ~ddition of hydroxide, 89
Nucleoside diphosphate kinase, 97
Nucleosome core particles, 540
o
Olefin binding, 438
Oligonucleotide cleavage by metal com-
plexes, 476-479
Orbitals, bonding u and antibonding u*,
403
Organelles, 162
Organomercury lyase, 511, 512
ortho hydrogen, 403
Osmate esters, 461
Osmium tetroxide, 461, 485
Osteoblast, 157, 158
Osteocalcin, 157
Osteoclast, 157, 158
Osteocyte, 158
Osteogenic cell, 158
Osteoid, 158
Osteonectin, 157
Osteoporosis, 157, 162
Outer-sphere electron-transfer reaction,
335, 336
Outer-sphere reorganization energy, 340
Ovarian carcinomas, 527
Oxidant scavengers, 262
Oxidation
of 284
of iron porphyrins (mechanism), 198
of nucleic acids by metal complexes,
462
Oxidative addition, 197
Oxidative damage repair, 264
Oxidative dealkylation, 284
Oxidative phosphorylation, 267
Oxygen rebound mechanism, 291
Oxygenases, 276
Oxyhemerythrin (also see hemerythrin),
196,210
Oxyhemocyanin (also see hemocyanin),
196, 204, 210
Oxyhemoglobin (also see hemoglobin),
196, 213, 233
Oxymyoglobin (also see myoglobin),
233, 235
OxyR,265
p
P-clusters, 418, 420, 422, 423, 442, 443
p36 (Ca2 + /phospholipid-binding protein),
135, 148
para hydrogen, 403
Parvalbumin, 135, 137, 144-147
Penicillamine, 513
Peptidases, 38, 39
Periodate, 287
Pernicious anemia, 4, 505
Peroxidase, 263, 295-298
Peroxide anion, 194
Peroxide shunt, 286, 291
Peroxide stretching frequencies, 195
Peroxisomes, 263
Peroxo complexes, 274
Peroxo coordination geometries, 196
Peroxo species, 210
Peroxo-bridged copper complexes, 274
Peroxy intermediate, 283
Peroxynitrite, 266
Phenolate-to-iron(lH) charge-transfer tran-
sitions, 277
Phorbol esters, 135, 162
Phosphatases, 39
,B-Phosphate, 112
Phosphate backbone, 456
reactions with metal complexes, 462
PhosphatidyIserine, 149
Phosphocitrate, 131
Phosphoglucomutase, 39
Phosphoinositol, 149
Phospholipase A2 , 39, Ill, 137, 152,
264
catalytic mechanism, 153
Phospholipase C, 39, 149
Phosphoproteins, 157
Photoactivated cleavage of DNA, 464,
476,483
Photosynthesis, 324, 327-330
Photosynthetic bacteria, 329, 358
Photosynthetic organisms, 413
Photosynthetic reaction center, 329, 330,
358, C-13
electron-transfer rates, 359
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Photosystem pigments, 327, 328
Phycocyanin, 328
Phycoerythrin, 328
Picket-fence porphyrin, 217
ligand-binding properties, 220-224,
228,239,243
structure, 218, 229, 230, 232
Plasma membrane, 124
Plastocyanin, 345
electron transfer, 345
reaction with inorganic reagents, 343
remote and surface binding sites, 346
structure, 346
Platination of DNA, 565
Platinol, 524
Platinum anticancer drugs, 519, 522
molecular mechanism, 529
Platinum-nucleobase model complexes,
563
Plutonium toxicity, 510
bis-strapped, 222
capped, 219, 220, 222, 228
cation radical, 289
chelated, 217
flat-open, 222
models for hemeproteins , 218
picket-fence (pocket), 217, 218,
222
strapped, 222
tail-under, 217
Prebiotic era, 12, 260
Primitive organisms, 12, 13
Prokaryotic cells, 159, 162
Proline trans/cis bond, 147
Propeller twisting, 458, 487
Protection of the metal-dioxygen moiety,
216
Protein binding to cis-DDP modified
DNA, 572
Protein kinase C (PKC), III, 133, 135,
149
activation, 149
structure, 150
Protein-based radical, 315
Protein-protein complexes, 349
Proteoglycans, 157
Prothrombin, 154
Prothrombinase complex, 155
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Protocatechuate 3,4-dioxygenase (PCD),
276
structure, 279
Protoheme, 185
Proton pumping, 276
Proton-induced x-ray emission (PIXEL
120
microprobe, C-8
Protoporphyrin IX dianion, 171
Protoporphyrin structure, 169
Proximal effects, 223, 225, 228, 229
Proximal histidine, 215
Proximal ligand, 232
Proximation, 400
Pseudobactin, 21
Pt(terpy)Cl + , 462
PtA2 {d(GMP)}, 2,531
PtA2{d(pApG)},531
PtA2{d(pGpG)}, 531
Purine heterocycles, 456
Purine N7, 459
Putidamonooxin, 379
Putidaredoxin, 332, 379
Pyochelin, 21
Pyridoxal-requiring monamine oxidase,
508
Pyrogallol, 28
Pyruvate carboxylase, 4, 44
Pyruvate kinase, 39
Pyruvate-flavoprotein oxidoreductase, 414
Quin-2, Ill, 115, 116
Quinone, 315, 316
R
Rabbit skeletal muscle, III
Radical autoxidation, 258
Radiodiagnostic agents, 514
Radionuclides in medicine, 514
Raman and resonance Raman spectros-
copy, 193
Reaction center cofactors, C-13
Recognition proteins, 571
Redox
activation, electrochemical mode of,
401
active disulfide, 512
behavior of Fe-S sites, 398, 400
chemistry of nucleic acids, 463, 465
enzymes, 400
properties of hydrogenases, 408
properties of nitrogenase, 419
properties of the nitrogenase iron pro-
tein, 417
states of Fe2S2 proteins, 380
states of Fe4S4 proteins, 386, 387
Reduced dinitrogen intermediates, 439
Reduced intermediates of N2, 415
Reduction of N2 to 2NH3, 415
Reduction potentials for dioxygen, 255
Relaxed state (R), 180
Reorganization energy, 339
Repair of oxidative damage, 264
Replication mapping, 552
Resonance Raman spectra
of Fe-S proteins, 377
of Fe2S2 sites, 381
of Fe3S4, 395
of ferredoxins, 387
of hydrogenase I, 408
Respiration, 253, 324
Respiratory electron-transport chain, 267,
325, 326
Restriction endonucleases, 465
Reticulocytes, 18
Reverse transcriptase, 524
Rh(DIPh3+ structure, 485
Rh(phenhphi3+ (shape-selective cleavage
of nucleic acids), 486, 487
Rh(phenhphi3+ structure, 485
Rh(phenh3+ , 468
Rh(phihbpy3+
DNA footprinting, 483
structure, 482
Rheumatoid arthritis, 518
Rhodium anticancer activity, 521, 580
Ribonucleotide reductase, 98, 331
Ribozymes, 459
Rieske centers, 382
RNA
A-form, 459
cleavage by lead, 466
hydrolytic cleavage, 466
shape-selective probes of, 487
5S,487
structure, 458, C-15
tRNAPhe , 458, 475, 487, 488, C-15
RNA polymerase, 44, 500
Root effect, 176
Root hair surface, 9
Rotational correlation 63
Ru(bpYhdppz2+, 480, 481
Ru(DlPh2+, 480, 481
+ (shape-selective cleavage of
nucleic acids), 486
Ru(phenhdppz2+, 480
Ru(phenhphi2+, 471
Ru(phenh2+, 468, 469
luminescence with 475
metal-to-ligand charge-transfer band,
472
shape-selective cleavage of nucleic
acids, 486
structure, 485
Ruberythrin, 369
Rubredoxin, 9, 319, 365-370
373
374
ligand field, 373
373
models, 377, 378
Mossbauer spectrum, 374
redox potential, 400
reductase, 369
S-7Fe charge-transfer transitions, 373
structure, 372, 373
Ruthenium anticancer activity, 521, 580
Ruthenium-modified cytochrome c, 356
Ruthenium-modified myoglobin, 347
S
S-100 135
SI endonuclease,
Sanocrysin, 518
Sarcoplasmic Ca2+-binding proteins, 148,
C-II
Sarcoplasmic 121, 125, 128,
132, 162
Sea 27, C-I
Self-exchange reactions, 334-337, 341
Serine proteases, 152
Serum proteins, 532
Shape selection, 485
Shape-selective recognition, 491
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Sickle cell anemia, 507
Siderophores, 20
Siderosis, 510
Silica, 30
Singlet dioxygen reactivity, 257
Singlet oxygen reaction with nucleic
acids, 464
Site-specifically platinated 573
Six-electron reduction of N2, 415
Skeletal muscle thin filament, 141
Sodium biological concentration, 130
Solubility products (calcium phosphates),
112
Spl transcription factor, 491
Spatial resolution of ion concentration,
I 8
Special 329
Spin-state changes with dioxygen bind-
ing, 238
Spin-coupling in Fe2S2 ferredoxins, 381
Spilugermaniurn, 521
structure, 518
Staphylococcal nuclease, 500
Stele, 9
Stellacyanin
cross electron-transfer reaction, 342
reaction with inorganic reagents, 343
self-exchange reaction, 335
Stinging nettle hair, C-8
Strapped 228, 243
Structure-specific recognition prc)teins,
571,572
Substrate activation, 282
Succinate dehydrogenase, 379
Sulfide oxidation, 284
Superacid, 40
Superhelical 475,477
Superoxide, 254, 255, 265
anion radical, 191, 194
disproportionation, 298
reaction with nucleic acids, 464
stretching frequencies, 195
toxicity, 265, 266
Superioxide dismutase (also see copper-
zinc superoxide dismutase), 191,
263, 266, 298
Superoxo coordination geometries, 196
Superoxo species, 197
SV40 540, 546, 548
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T
T antigen, 540
T4 DNA ligase, 575
Technetium radiopharmaceuticals, 514,
515
Tense state (T), 180
Testicular cancer, 527
Tet b, 300
Tetraplatin, 579
Tetrathiomolybdate (MOS42 -), 437
Therapeutic index (TI), 526
Thermolysin, 39, 44
active-site structure, 85
Thermophilic archaebacterial methanogen,
413
Thiocubanes, 367, 385, 386,429,437
Thioprismanes, 398, 399
Thioredoxin, 315
Three-iron centers, 391
Three-state model, 386, 387
Thrombin fragment, III
Thrombospondin, 154
Thymidine kinase, 508
Thymine, 457
Thymine N3, 459
Timescales, experimental, 335
Tin anticancer activity, 520
0'-Tocopherol, 262
Transcarboxylase, 44
Transcription factors, 491
Transferrin, 8, 12, 17, 18,263,264
structure, 19
Transverse relaxation time, 63
TRENCAM, 28, 29
TRENPAM, 28, 29
Triethylphosphinegold(I) tetra-O-acetyl-
thioglucose, 518
TRIMCAM,24
1,4,5-Triphosphoinositol (I,4,5-IP3), 131
Triple-helix formation, 489
Triplet dioxygen reactivity, 256
Trophoblasts, 124, 162
Tropomyosin, 141
Troponin C (TnC), 135, 140, 142
Ca2 + binding, 143
Ca2 + /Mg2 + sites, III
conformational change, 143, 144
Mg2 + binding, 143
regulatory sites, 143
structure, 142
Troponin I 140
Troponin T (TnT), 140
Trypsin, III, 137, 152
Trypsinogen, 111, 137, 152
Tryptic digest, 162
Tryptic fragments, 138
Tunicates, 5, 10,27, C-I
Tunichrome, 10, 28, 29
Tunneling pathways, 345
Two-iron ferredoxins, 367
Tyrosinase, 284, 508
Tyrosine ligation, 296
Tyrosine radical, 315
U
Ubiquinol, 316
Ubiquinone, 316
Uniporter, 131, 162
Uracil N3, 459
Uranyl acetate DNA footprinting, 483
UV-visible spectroscopy, 193
uvrABC excinuclease system, 571
UW-45,421
V
Valerite, 156
Vanadate, 27
Vanadium, 10
accumulation mechanism, 28
biological significance, 5
nitrogenase, 433, 434
transport, 27
Vesicular transport, 123
Vicinal 1,2 interchange, 97
Vinblastine, 527
Vinyl-disulfide-chelating ligand, 441
Vitamin (also see coenzyme Bd, 4,
98
structure, 99
Vitamin D, 122, 146
Vitamin E, 263
Vitamin K, 154
W
Water coordination, 41, 42
WeddelJite, 156
Whew(~lIite, 112, 156
Wilson's disease, 509
X
X-ray absorption near-edge structure
(XANES), 193, 372
X-ray absorption spectroscopy, 372,
426
X-ray photoelectron spectroscopy (XPS),
193
X-ray single-crystal diffraction,
193
Xanthine oxidase, 12,315,329,366,
367, 379
structure, 33
Xeroderma pigmentosum (XP) human fi-
broblast cells, 549
491
Xylem vessels, 9
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y
Yeast calmodulin, 159
Z
Z-form DNA, 458, 566
structure, 567
Zinc
biological significance, 3
coordination, 40, 43
deficiency, 507
enzymes, 39, 40, 43
fingers, 3,48,456,491,492, C-l
protein-mediated peptide hydrolysis, 79
reactivity in cavities, 43
regulatory role, 48
storage, 16
structural role in proteins, 48, 302,
492,493
thioneins, 48
toxicity, 510
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